{"BGC0001186.1|Misakinolide_1 # 312 # 479 # 1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.494": {"gnl|BL_ORD_ID|4831|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 312, "orf_end": 479, "orf_from": "BGC0001186.1|Misakinolide_1 ", "model_name": "AAC(6')-Iap", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "5817", "ARO_accession": "3007204", "ARO_name": "AAC(6')-Iap", "ARO_category": {"36484": {"category_aro_accession": "3000345", "category_aro_cvterm_id": "36484", "category_aro_name": "AAC(6')", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 6'-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 6-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35926": {"category_aro_accession": "0000007", "category_aro_cvterm_id": "35926", "category_aro_name": "dibekacin", "category_aro_description": "Dibekacin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Dibekacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35953": {"category_aro_accession": "0000035", "category_aro_cvterm_id": "35953", "category_aro_name": "sisomicin", "category_aro_description": "Sisomicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Sisomicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35956": {"category_aro_accession": "0000038", "category_aro_cvterm_id": "35956", "category_aro_name": "netilmicin", "category_aro_description": "Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "46128": {"category_aro_accession": "3007378", "category_aro_cvterm_id": "46128", "category_aro_name": "2'-N-ethylnetilmicin", "category_aro_description": "2'-N-ethylnetilmicin is an aminoglycoside antibiotic and a derivative of netilmicin.", "category_aro_class_name": "Antibiotic"}, "46129": {"category_aro_accession": "3007379", "category_aro_cvterm_id": "46129", "category_aro_name": "5-episisomicin", "category_aro_description": "5-episosomicin is a semisynthetic aminoglycoside antibiotic similar to sisomicin.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.72927, "max_identities": 10, "bit_score": 21.9422, "cvterm_id": "37076", "query": "VGWDNRSSSFWPRSSDHFDPFGKHQSGIYMPQGPEFIRC", "match": "  W       WP   D  DP  +    +  P+G  F+ C", "sequence_from_db": "AAWSQLRVGLWP---DADDPLEELAQSLADPEGAVFLAC", "sequence_from_broadstreet": "MSGCAATIRQATPADAAAWSQLRVGLWPDADDPLEELAQSLADPEGAVFLACAADGEAVGFAEVRLRHDYVNGTGSSPVGFLEGWYVTPQWQGRAVGRALLAEVQAWTRDAGCSELASDSRLEDLEAHAAHRACGFVETERVVYFRMPLDAVTRG", "dna_sequence_from_broadstreet": "GTGAGCGGCTGCGCTGCCACGATCCGCCAGGCCACACCGGCCGATGCCGCTGCATGGTCGCAGCTGCGCGTGGGCCTGTGGCCCGACGCCGATGATCCACTGGAGGAGCTGGCGCAGTCGCTGGCCGATCCGGAAGGTGCGGTGTTCCTGGCGTGCGCGGCTGATGGTGAGGCGGTCGGTTTCGCTGAGGTACGCCTGCGCCACGACTATGTGAACGGCACCGGTTCCTCGCCGGTCGGGTTCCTGGAAGGCTGGTATGTAACGCCGCAGTGGCAGGGCCGCGCTGTCGGCCGTGCCCTGCTGGCGGAAGTGCAGGCGTGGACGCGGGACGCGGGCTGCAGCGAGCTGGCCTCGGACAGCCGCCTGGAGGACTTAGAGGCGCACGCGGCACACCGCGCCTGTGGCTTTGTAGAGACCGAGCGGGTGGTCTATTTCCGCATGCCGCTGGACGCGGTCACGCGGGGGTAG", "partial": "0", "query_start": 315, "query_end": 431, "hit_start": 48, "hit_end": 156, "orf_dna_sequence": "GTGGTGGGCTGGGATAATCGCAGCTCCTCTTTCTGGCCTCGTTCGAGTGATCATTTTGATCCTTTTGGCAAACATCAGAGCGGGATTTATATGCCTCAGGGTCCTGAATTTATCCGTTGTGATTATCCCAACCCACTACCTGACCGCTTTATTGTCCCGTGGCCGTAA", "orf_prot_sequence": "MVGWDNRSSSFWPRSSDHFDPFGKHQSGIYMPQGPEFIRCDYPNPLPDRFIVPWP", "perc_identity": 25.64}, "gnl|BL_ORD_ID|4698|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 312, "orf_end": 479, "orf_from": "BGC0001186.1|Misakinolide_1 ", "model_name": "Staphylococcus aureus mupB conferring resistance to mupirocin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "2271", "ARO_accession": "3000510", "ARO_name": "Staphylococcus aureus mupB conferring resistance to mupirocin", "ARO_category": {"36585": {"category_aro_accession": "3000446", "category_aro_cvterm_id": "36585", "category_aro_name": "antibiotic-resistant isoleucyl-tRNA synthetase (ileS)", "category_aro_description": "Mupirocin inhibits protein synthesis by interfering with isoleucyl-tRNA synthetase (ileS).  Mutations in ileS can confer low-level mupirocin resistance.", "category_aro_class_name": "AMR Gene Family"}, "36693": {"category_aro_accession": "3000554", "category_aro_cvterm_id": "36693", "category_aro_name": "mupirocin", "category_aro_description": "Mupirocin, also known as pseudomonic acid, is a bacteriostatic polyketide antibiotic from Pseudomonas fluorescens used to treat S. aureus and MRSA. It inhibits Ile tRNA synthetase.", "category_aro_class_name": "Antibiotic"}, "45733": {"category_aro_accession": "3007151", "category_aro_cvterm_id": "45733", "category_aro_name": "mupirocin-like antibiotic", "category_aro_description": "A group of antibiotics including mupirocin and similar mixtures (such as those including pseudomonic acid A).", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.42565, "max_identities": 10, "bit_score": 21.1718, "cvterm_id": "35508", "query": "RSSDHFDPFGKHQSGIYMPQGPEFIRCDYPNPLPDR", "match": "+  D+ D   KH+       G EF+  +Y  P P++", "sequence_from_db": "KDEDNIDIVSKHK-------GKEFVGKEYLAPFPNK", "sequence_from_broadstreet": "MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN", "dna_sequence_from_broadstreet": "TTGGAAAACGAGAATATAATAGAAGAACAAAAAATCTTAAATTTTTGGAAAGAAGAAAACATTTTCAAAAAGAGTATTGATAATAGAAAAAATGATAATCCATTTGTTTTTTACGATGGTCCTCCAACTGCCAATGGCTTACCACATACAGGTCACGTGTTAGGAAGAGTAATAAAAGATTTATTTGCTCGATATAAGACAATGCAAGGATTTTATGTTGAAAGAAAAGCTGGGTGGGATACCCATGGACTACCTGTAGAACTTGGTGTTGAAAAAAAACTTGGAATTAAGGATAAAAATGAAATAGAAAAATATGGAATAGAAAAATTTATAAATGAATGTAAAAATAGTGTGTTTATGTATGAAAAACAGTGGAGAGAATTTAGTGAACTAATCGGATATTGGGTAGATATGGAAAAACCGTACAAAACAATGGATAATACGTATATAGAATCAATCTGGTATATATTGTCTGACTTTCATAAAAAAGGTCTTTTATACAAAGGGCATAAAGTTACCCCGTATTGTCCAAGCTGTGAAACTTCTTTAAGTTCTCATGAAGTAGCTCAGGGATATAAGGAAGTAAAAGATATCTCTGTAATCTTAAAATTTCCGATTTTAGACAGTGATGAGAATTTCTTAGTTTGGACGACAACTCCATGGAGCTTACCAGGTAATATAGCTTTAGCCATAAATGCTGAAGAAATATATGTTAAAGTTAATTATGATAATGAAATTTTTATTATCATGGAAAGTTTGTTGCAAAGTGTTTTTAAAGATGAAGACAATATAGATATAGTAAGTAAACATAAAGGAAAAGAATTTGTAGGAAAAGAATACCTCGCTCCTTTCCCTAACAAGTCTCTTATGAACAATGAAAACTCATATAAAGTTTTACCTGCTGATTTTGTTACAAATAAAGATGGTACGGGTATCGTCCATATTGCTCCGGCTTATGGGGAAGATGATTACAAATTAGTTCAAGAAAATAATATACCCTTTATTAATGTTATTGATTCTAGAGGAAAATATAATCAAGATTCTCCTATTTTTAAAGGAGAGCTAGCTAAAGAATCAGATATTAACATTATTAAAGAACTTACACATTTAAATCTACTTTTCAAAAAAGAAAAATATGAACATAGCTATCCTTTTTGTTGGAGATGTGATAATCCATTAATCTATTATGCAATGGAAGGTTGGTTTATAAAAACAACGGCTTATAAAAATGAAATAAAGGAAAACAATCAAAAAATAGAATGGTATCCAGACCATATTAAAAATGGAAGGTTTGGAAATTTCTTAGATAATATGATTGATTGGAATATTGGTAGAAAAAGATATTGGGGCACTCCACTAAATATATGGAAATGCTCCACGTGTTCCCATGAGTTTTCACCTAAAAGCATAAATGATCTAATACAACATTCCATTGAAGATATTCCTTCTGATATAGAATTACATCGACCTTATATAGATAATGTGAAATGTAAATGTCAAAATTGTGGTGGTGACATGTGTAGAGAAGAAGAAGTCATTGATGTATGGTTTGATAGTGGATCGATGCCTTTTGCACAAAATCACTATCCATTTAGTGGTCCCATTCAAAACTCATACCCAGCTGACTTTATAGCTGAAGGAGTTGATCAAACTAGAGGGTGGTTTTATAGCTTATTGGTGATTTCAACAATTTTCAAAGGGGAAGCACCTTATAAAAACGCATTGTCATTAGGACATATATTAGATTCCAATGGACAAAAAATGTCGAAAAGTAAAGGGAATGTTATAGATCCTATATCAATGATAAAAACTTATGGCGCTGATTCTTTAAGATGGACATTAGTTTCTGACAGCGTTCCTTGGACTAACAAAAGGTTTTCAGAAAATATGGTGGCACAATCAAAATCGAGAGTAATTGATACTTTAAAAAATATATTTAACTTCTATAATATGTATCAAAAAATTGATAATTATGACTATACTAGGGATACTCCTAAACAGCTGAATTTACTTGATAATTGGGCTATATCTCGAATGAATTCAGTTATAAAAGAGGTAGAGCTGCATTTAGAAAAATATAACCCTACAAATGCATCAAGAGCTATTGGGGAGTTTATCAATGAAATAAGTAATTGGTATATTAGAAGATCTAGAAGTCGATTTTGGAGTAGTGAAATGAATGAGGATAAAAAGAGTGCGTATTTTACTCTTAGACTTATTTTGATTAATACTTGTAAAATAATAGCTCCTTTCACCCCATTTACTAGCGAGGAAATACATCTAAATCTCACCAAAAAAAGTGTACACTTAGAAGATTTCCCTCAAGCCAAGGAAGAATATATAAATTTAAAACTAGAAGAAGATATGAATAAAGTTTTAGATATTGTCGAAAAATCTAGAAGCATAAGAAATAACATAAACATCAAAACAAAACAACCACTTTCAAACATGTATATATATGACAATAATAATCTTGATAATGAATTTCTAAGAAAATACAAAGACATCATTAAAGATGAAATAAATGTTAAAAAGATAAATATTGTTTCTGATTTAGACAATTTTTTAGAATATGATGTAAAACCGAACTTTTCAACTTTAGGCCCTAAATTAGGAAAAGATATGAAACAATTCCAAATTTTATTTAAAAATATTAAAAAAGAAGAAATGAATAAACTAATCAATGATTTCGATAAACTTCAAAAAGTTTTTGACTCTTTAGGTGTAACAATTGAGGAAAAGGATTTTATTATTAGTAAAATACCTAAAAAGGGATTCTCTCTTTCAAGCAATGACTCTGATCGTCTTATCATTTTAGACACTAATTTGACTCAAGAATTAATTCGCGAAGGGTTTGTCAGAGAATTAATTCGTGTTATTCAACAACTAAGAAAACAACAGAACTTTAATATTGAAGAACGTATAAATGTAGTAATAGACATAGATTCCGATGGTTTACTATCAATTAAAAATAATATCAATATATTGAAAGAAAATGTACTAATTAATAATCTAAAATTTGAGAAAAGAGAAACTATGAAATATTTTAAAATTAATCAGAAAGAAATTGGTATTCAGTTAATGTCTAGCTTTACAAATTAA", "partial": "0", "query_start": 351, "query_end": 458, "hit_start": 774, "hit_end": 861, "orf_dna_sequence": "GTGGTGGGCTGGGATAATCGCAGCTCCTCTTTCTGGCCTCGTTCGAGTGATCATTTTGATCCTTTTGGCAAACATCAGAGCGGGATTTATATGCCTCAGGGTCCTGAATTTATCCGTTGTGATTATCCCAACCCACTACCTGACCGCTTTATTGTCCCGTGGCCGTAA", "orf_prot_sequence": "MVGWDNRSSSFWPRSSDHFDPFGKHQSGIYMPQGPEFIRCDYPNPLPDRFIVPWP", "perc_identity": 27.78}}, "BGC0001186.1|Misakinolide_2 # 768 # 1025 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.481": {"gnl|BL_ORD_ID|2355|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 768, "orf_end": 1025, "orf_from": "BGC0001186.1|Misakinolide_2 ", "model_name": "OprM", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "850", "model_id": "1305", "ARO_accession": "3000379", "ARO_name": "OprM", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35933": {"category_aro_accession": "0000014", "category_aro_cvterm_id": "35933", "category_aro_name": "gentamicin C", "category_aro_description": "Gentamicin C is a mixture of gentamicin C1, gentamicin C1a, and gentamicin C2 (these differ in substituents at position C6'). Gentamicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35977": {"category_aro_accession": "0000060", "category_aro_cvterm_id": "35977", "category_aro_name": "ceftazidime", "category_aro_description": "Ceftazidime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa, however it has weaker activity against Gram-positive microorganisms and is not used for such infections.", "category_aro_class_name": "Antibiotic"}, "35979": {"category_aro_accession": "0000062", "category_aro_cvterm_id": "35979", "category_aro_name": "ceftriaxone", "category_aro_description": "Ceftriaxone is a third-generation cephalosporin antibiotic. The presence of an aminothiazolyl sidechain increases ceftriazone's resistance to beta-lactamases. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "35990": {"category_aro_accession": "0000073", "category_aro_cvterm_id": "35990", "category_aro_name": "meropenem", "category_aro_description": "Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem.", "category_aro_class_name": "Antibiotic"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36468": {"category_aro_accession": "3000329", "category_aro_cvterm_id": "36468", "category_aro_name": "sulfamethoxazole", "category_aro_description": "Sulfamethoxazole is a sulfonamide antibiotic usually taken with trimethoprim, a diaminopyrimidine antibiotic. Sulfamethoxazole inhibits dihydropteroate synthase, essential to tetrahydrofolic acid biosynthesis. This pathway generates compounds used in the synthesis of many amino acids and nucleotides.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36595": {"category_aro_accession": "3000456", "category_aro_cvterm_id": "36595", "category_aro_name": "thiamphenicol", "category_aro_description": "Derivative of Chloramphenicol. The nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3).", "category_aro_class_name": "Antibiotic"}, "36689": {"category_aro_accession": "3000550", "category_aro_cvterm_id": "36689", "category_aro_name": "aztreonam", "category_aro_description": "Aztreonam was the first monobactam discovered, and is greatly effective against Gram-negative bacteria while inactive against Gram-positive bacteria. Artreonam is a poor substrate for beta-lactamases, and may even act as an inhibitor. In Gram-negative bacteria, Aztreonam interferes with filamentation, inhibiting cell division and leading to cell death.", "category_aro_class_name": "Antibiotic"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37007": {"category_aro_accession": "3000663", "category_aro_cvterm_id": "37007", "category_aro_name": "ofloxacin", "category_aro_description": "Ofloxacin is a 6-fluoro, 7-piperazinyl quinolone with a methyl-substituted oxazine ring. It has a broad spectrum of activity including many enterobacteria and mycoplasma but most anaerobes are resistant.", "category_aro_class_name": "Antibiotic"}, "40362": {"category_aro_accession": "3003708", "category_aro_cvterm_id": "40362", "category_aro_name": "panipenem", "category_aro_description": "Panipenem is a carbapenem antibacterial agent with a broad spectrum of in vitro activity covering a wide range of Gram-negative and Gram-positive aerobic and anaerobic bacterial.  It is used in combination with betamipron to inhibit panipenem uptake into the renal tubule and prevent nephrotoxicity.", "category_aro_class_name": "Antibiotic"}, "40523": {"category_aro_accession": "3003832", "category_aro_cvterm_id": "40523", "category_aro_name": "ticarcillin", "category_aro_description": "Ticarcillin is a carboxypenicillin used for the treatment of Gram-negative bacteria, particularly P. aeruginosa. Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cell death.", "category_aro_class_name": "Antibiotic"}, "40957": {"category_aro_accession": "3004024", "category_aro_cvterm_id": "40957", "category_aro_name": "trimethoprim-sulfamethoxazole", "category_aro_description": "An antibiotic cocktail containing the diaminopyrimidine antibiotic Trimethoprim and the sulfonamide antibiotic sulfamethoxazole (1 TMP:5 SMX).", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36421": {"category_aro_accession": "3000282", "category_aro_cvterm_id": "36421", "category_aro_name": "sulfonamide antibiotic", "category_aro_description": "Sulfonamides are broad spectrum, synthetic antibiotics that contain the sulfonamide group. Sulfonamides inhibit dihydropteroate synthase, which catalyzes the conversion of p-aminobenzoic acid to dihydropteroic acid as part of the tetrahydrofolic acid biosynthetic pathway. Tetrahydrofolic acid is essential for folate synthesis, a precursor of many nucleotides and amino acids. Many sulfamides are taken with trimethoprim, an inhibitor of dihydrofolate reductase, also disturbing the trihydrofolic acid synthesis pathway.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.455085, "max_identities": 11, "bit_score": 25.7942, "cvterm_id": "36804", "query": "ARGYFVSTVGANEQVIRAYSENQEKADQRFQNLFD", "match": "ARG F   + A   +++A  E  + AD+R++   D", "sequence_from_db": "ARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVD", "sequence_from_broadstreet": "MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA", "dna_sequence_from_broadstreet": "ATGAAACGGTCCTTCCTTTCCCTGGCGGTAGCCGCTGTCGTTCTGTCCGGCTGCTCGCTGATCCCCGACTACCAGCGCCCCGAGGCGCCGGTAGCCGCGGCCTACCCGCAAGGGCAGGCCTACGGGCAGAACACCGGCGCGGCGGCCGTTCCGGCCGCCGACATCGGCTGGCGCGAGTTCTTCCGCGACCCGCAGTTGCAGCAACTGATCGGCGTGGCGCTGGAAAACAACCGCGACCTGCGGGTCGCCGCGCTGAACGTCGAGGCCTTCCGGGCGCAGTACCGCATCCAGCGGGCCGACCTGTTCCCGCGGATCGGCGTGGACGGTAGCGGCACCCGCCAGCGTTTGCCGGGCGACCTGTCGACCACCGGCAGTCCGGCGATTTCCAGCCAGTACGGGGTGACCCTGGGCACTACCGCCTGGGAACTCGATCTCTTCGGCCGCCTGCGCAGCCTGCGCGACCAGGCCCTGGAGCAGTACCTGGCGACCGAACAGGCGCAGCGCAGCGCGCAGACCACCCTGGTGGCCAGCGTGGCGACCGCCTACCTGACGCTGAAGGCCGACCAGGCGCAGTTGCAGCTGACCAAGGACACCCTGGGCACCTACCAGAAGAGTTTCGACCTGACCCAGCGCAGCTACGACGTCGGCGTCGCCTCCGCGCTCGACCTGCGCCAGGCGCAGACCGCCGTGGAAGGCGCCCGCGCGACCCTGGCGCAGTACACCCGCCTGGTAGCCCAGGACCAGAATGCGCTGGTCCTGCTGCTGGGCTCCGGGATCCCGGCGAACCTGCCGCAAGGCCTGGGCCTGGACCAGACCCTGCTGACCGAAGTGCCGGCGGGTCTGCCGTCGGACCTGCTGCAACGGCGCCCGGACATCCTCGAGGCCGAGCACCAGCTCATGGCTGCCAACGCCAGCATCGGCGCCGCGCGCGCGGCGTTCTTCCCGAGCATCAGCCTGACCGCCAACGCCGGCACCATGAGCCGCCAACTGTCCGGCCTGTTCGACGCCGGTTCGGGTTCCTGGTTGTTCCAGCCGTCGATCAACCTGCCGATCTTCACCGCCGGCAGCCTGCGTGCCAGCCTGGACTACGCGAAGATCCAGAAGGACATCAACGTCGCGCAGTACGAGAAGGCGATCCAGACGGCGTTCCAGGAAGTCGCCGACGGCCTGGCCGCGCGCGGTACCTTCACCGAGCAGTTGCAGGCGCAGCGCGATCTGGTCAAGGCCAGCGACGAGTACTACCAGCTCGCCGACAAGCGCTATCGCACGGGGGTGGACAACTACCTGACCCTGCTCGACGCGCAACGCTCGCTGTTCACCGCGCAGCAGCAACTGATCACCGACCGCCTCAATCAGCTGACCAGCGAGGTCAACCTGTACAAGGCCCTCGGCGGCGGCTGGAACCAGCAGACCGTGACCCAGCAGCAGACCGCGAAGAAGGAAGATCCCCAGGCTTGA", "partial": "0", "query_start": 915, "query_end": 1019, "hit_start": 1173, "hit_end": 1278, "orf_dna_sequence": "ATGCCGGATCATGTTCATATGCTGATTGCCATTCCCCCCAAACACAGTGTGGCGACGATCGTAGGTTTTCTCAAAGGCAAGAGTTCGATCTGGGTCGCTGAGAATGTGGACAACAAACAGCGAAACTTTGTTGGGCATAAGTTCTGGGCCAGAGGCTATTTTGTCTCCACGGTTGGGGCCAATGAGCAAGTTATCCGAGCGTATAGTGAGAATCAAGAGAAAGCGGATCAGCGTTTTCAAAACCTGTTTGACAGGTAG", "orf_prot_sequence": "MPDHVHMLIAIPPKHSVATIVGFLKGKSSIWVAENVDNKQRNFVGHKFWARGYFVSTVGANEQVIRAYSENQEKADQRFQNLFDR", "perc_identity": 31.43}, "gnl|BL_ORD_ID|2278|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 768, "orf_end": 1025, "orf_from": "BGC0001186.1|Misakinolide_2 ", "model_name": "OXA-444", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "3514", "ARO_accession": "3003600", "ARO_name": "OXA-444", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.61553, "max_identities": 16, "bit_score": 22.7126, "cvterm_id": "42837", "query": "MPDHVHMLIAIPPKHSVATIVGFLKGKSSIWVAENVDNKQRNFVGHKFWARG", "match": "+P+ +  L A+P    VA  VG  + ++ +  A +  N+Q   V  +FW RG", "sequence_from_db": "LPEAIR-LSAVPIYQEVARRVGLERMQAYV-DAFDYGNRQLGSVIDQFWLRG", "sequence_from_broadstreet": "MFSRWSKPLVLAATVCAMAMSAATAHAELIVRNDLKRVFDEAGVSGTFVLMDISADRTYVVDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVLPYGGKPQPYKQWEHDMALPEAIRLSAVPIYQEVARRVGLERMQAYVDAFDYGNRQLGSVIDQFWLRGPLEISALEEARFTSRMALKQLPVKPRTWDMVHRMLLIEQQGDAALYAKTGVATEYQPEIGWWVGWVERAGRVYAFALNIDMPREGDMAKRIPLGKQLMQALDVWPVL", "dna_sequence_from_broadstreet": "ATGTTCTCTCGTTGGTCGAAACCTCTCGTGCTTGCCGCCACGGTGTGCGCCATGGCGATGAGCGCCGCCACCGCCCACGCCGAACTCATCGTGCGCAACGATCTCAAGCGCGTGTTCGACGAGGCCGGCGTCTCCGGTACCTTCGTCCTGATGGATATCAGCGCCGACCGCACCTACGTCGTTGACCCGGCCCGCGCCGCGCGGCGCATTCATCCGGCCTCAACTTTCAAGATCCCGAACAGCCTCATCGCCTTCGACACGGGCGCGGTGCGTGACGATCATGAAGTGCTGCCATACGGCGGCAAGCCGCAGCCCTACAAGCAGTGGGAGCACGACATGGCGCTGCCCGAGGCGATCCGCCTGTCGGCCGTGCCGATCTACCAGGAAGTGGCGCGCCGCGTCGGCTTGGAGCGCATGCAGGCGTATGTCGATGCGTTCGACTATGGCAATCGCCAGCTTGGCAGCGTGATCGACCAGTTCTGGCTGCGCGGTCCGCTCGAAATCTCGGCGCTTGAAGAGGCGCGCTTCACCAGCCGCATGGCGCTCAAGCAGTTGCCGGTGAAGCCGCGCACGTGGGACATGGTTCACCGCATGCTGCTGATCGAGCAGCAAGGGGATGCCGCGCTGTACGCCAAGACCGGCGTCGCCACGGAATACCAGCCGGAGATCGGCTGGTGGGTCGGCTGGGTCGAGCGTGCCGGACGCGTCTATGCCTTTGCGCTGAACATCGACATGCCGCGCGAGGGCGACATGGCCAAGCGCATTCCGCTGGGCAAGCAGTTGATGCAGGCGCTGGACGTGTGGCCGGTACTCTGA", "partial": "0", "query_start": 768, "query_end": 923, "hit_start": 342, "hit_end": 492, "orf_dna_sequence": "ATGCCGGATCATGTTCATATGCTGATTGCCATTCCCCCCAAACACAGTGTGGCGACGATCGTAGGTTTTCTCAAAGGCAAGAGTTCGATCTGGGTCGCTGAGAATGTGGACAACAAACAGCGAAACTTTGTTGGGCATAAGTTCTGGGCCAGAGGCTATTTTGTCTCCACGGTTGGGGCCAATGAGCAAGTTATCCGAGCGTATAGTGAGAATCAAGAGAAAGCGGATCAGCGTTTTCAAAACCTGTTTGACAGGTAG", "orf_prot_sequence": "MPDHVHMLIAIPPKHSVATIVGFLKGKSSIWVAENVDNKQRNFVGHKFWARGYFVSTVGANEQVIRAYSENQEKADQRFQNLFDR", "perc_identity": 30.77}, "gnl|BL_ORD_ID|3031|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 768, "orf_end": 1025, "orf_from": "BGC0001186.1|Misakinolide_2 ", "model_name": "OXA-571", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "4058", "ARO_accession": "3005326", "ARO_name": "OXA-571", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.36525, "max_identities": 16, "bit_score": 22.3274, "cvterm_id": "42837", "query": "MPDHVHMLIAIPPKHSVATIVGFLKGKSSIWVAENVDNKQRNFVGHKFWARG", "match": "+P+ +  L A+P    VA  VG  + ++ +  A +  N+Q   V  +FW RG", "sequence_from_db": "LPEAIR-LSAVPIYQEVARRVGLERMQAYV-DAFDYGNRQLGSVIDQFWLRG", "sequence_from_broadstreet": "MFSRWSKPFVLAATVCAMAMSAATAHAELIVRNDLKRVFDEAGVSGTFVLMDISADRTYVVDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVLPYGGKPQPYKQWEHDMALPEAIRLSAVPIYQEVARRVGLERMQAYVDAFDYGNRQLGSVIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVHRMLLIEQQGDAALYAKTGVATEYQPEIGWWVGWVERAGRVYAFALNIDMPREGDMAKRIPLGKQLMQALEVWPAP", "dna_sequence_from_broadstreet": "ATGTTCTCTCGTTGGTCGAAACCTTTCGTGCTTGCCGCCACGGTGTGCGCCATGGCGATGAGCGCCGCCACTGCCCACGCCGAGCTCATCGTGCGCAACGATCTCAAGCGCGTGTTCGACGAGGCCGGCGTCTCCGGCACCTTCGTGCTGATGGATATCAGCGCCGACCGCACCTACGTCGTTGACCCGGCCCGCGCCGCGCGGCGTATCCATCCGGCCTCAACTTTCAAGATCCCGAACAGCCTCATCGCCTTCGACACGGGCGCAGTGCGTGACGATCATGAAGTGCTGCCATACGGCGGCAAGCCGCAGCCCTACAAGCAGTGGGAGCACGACATGGCGCTGCCCGAGGCGATCCGCCTGTCGGCCGTGCCGATCTACCAGGAAGTGGCGCGCCGCGTCGGCCTTGAGCGCATGCAGGCGTATGTCGATGCGTTCGACTATGGCAATCGCCAGCTTGGCAGCGTGATCGACCAGTTCTGGCTGCGCGGTCCGCTCGAAATCTCGGCGTTTGAAGAGGCGCGCTTCACCAGCCGCATGGCGCTCAAGCAGCTGCCGGTGAAGCCGCGCACGTGGGACATGGTCCATCGCATGCTGCTGATCGAGCAGCAAGGCGATGCCGCGCTGTACGCCAAGACCGGCGTCGCCACGGAATACCAGCCGGAGATCGGCTGGTGGGTCGGTTGGGTCGAGCGTGCCGGGCGCGTCTATGCCTTTGCGCTGAACATCGACATGCCGCGCGAGGGCGACATGGCCAAGCGCATTCCGCTGGGCAAGCAGTTGATGCAGGCGCTGGAGGTGTGGCCGGCACCCTGA", "partial": "0", "query_start": 768, "query_end": 923, "hit_start": 342, "hit_end": 492, "orf_dna_sequence": "ATGCCGGATCATGTTCATATGCTGATTGCCATTCCCCCCAAACACAGTGTGGCGACGATCGTAGGTTTTCTCAAAGGCAAGAGTTCGATCTGGGTCGCTGAGAATGTGGACAACAAACAGCGAAACTTTGTTGGGCATAAGTTCTGGGCCAGAGGCTATTTTGTCTCCACGGTTGGGGCCAATGAGCAAGTTATCCGAGCGTATAGTGAGAATCAAGAGAAAGCGGATCAGCGTTTTCAAAACCTGTTTGACAGGTAG", "orf_prot_sequence": "MPDHVHMLIAIPPKHSVATIVGFLKGKSSIWVAENVDNKQRNFVGHKFWARGYFVSTVGANEQVIRAYSENQEKADQRFQNLFDR", "perc_identity": 30.77}, "gnl|BL_ORD_ID|1791|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 768, "orf_end": 1025, "orf_from": "BGC0001186.1|Misakinolide_2 ", "model_name": "tet(38)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "850", "model_id": "1835", "ARO_accession": "3000565", "ARO_name": "tet(38)", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.24582, "max_identities": 12, "bit_score": 22.3274, "cvterm_id": "35508", "query": "PKHSVATIVGFLKGKSSIWVAENVDNKQ", "match": "P + VA IVG L GK    + E +++KQ", "sequence_from_db": "PGYIVAVIVGALSGK----IGEYLNSKQ", "sequence_from_broadstreet": "MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVILNRWTQSEK", "dna_sequence_from_broadstreet": "ATGAATGTTGAATATTCTAAAATAAAGAAAGCAGTACCTATTTTATTATTCTTATTTGTATTCAGTTTGGTTATAGACAACTCATTTAAATTGATTTCTGTAGCCATTGCTGATGACTTAAACATATCTGTAACGACAGTAAGTTGGCAAGCGACATTAGCCGGTTTAGTAATTGGTATTGGCGCTGTAGTATACGCTTCATTATCTGATGCCATTAGTATACGCACACTATTTATTTATGGCGTGATATTAATCATTATCGGATCAATTATTGGTTACATTTTCCAACATCAATTCCCATTACTTTTAGTTGGACGTATTATTCAAACTGCCGGTTTAGCTGCTGCAGAGACATTATATGTGATATATGTTGCAAAGTATCTTTCTAAAGAGGACCAGAAGACTTACCTTGGCTTAAGTACGAGCAGTTATTCCTTGTCATTAGTTATCGGTACATTATCAGGTGGATTTATTTCTACGTATTTACACTGGACAAATATGTTTTTAATTGCATTAATCGTAGTATTTACGTTGCCATTCCTATTTAAATTATTACCAAAAGAAAATAATACGAATAAAGCTCATTTAGATTTTGTTGGCTTAATTCTAGTGGCAACTATTGCTACAACAGTCATGCTGTTTATTACGAACTTTAATTGGTTATATATGATTGGTGCCTTAATTGCGATTATCGTTTTTGCGCTATATATTAAAAATGCGCAACGTCCATTAGTAAATAAATCATTTTTCCAAAATAAACGTTATGCTTCATTTTTATTTATAGTATTTGTAATGTATGCTATCCAATTGGGTTATATTTTTACGTTCCCATTCATAATGGAGCAAATTTATCATCTGCAACTAGACACAACATCACTGTTATTAGTACCGGGTTATATAGTAGCAGTCATTGTTGGTGCATTAAGTGGTAAAATCGGCGAATATCTGAATTCAAAACAAGCGATTATCACAGCAATTATTTTAATAGCACTGAGCTTGATTTTACCTGCATTTGCAGTAGGTAATCACATTTCAATCTTCGTCATTTCTATGATATTCTTTGCAGGTAGCTTTGCTTTAATGTATGCACCTTTACTTAACGAAGCCATTAAAACAATAGATCTTAATATGACAGGTGTGGCTATTGGTTTTTATAATTTAATTATTAATGTGGCGGTATCTGTAGGTATTGCGATTGCTGCGGCTCTAATCGATTTTAAAGCATTAAATTTCCCAGGCAATGATGCATTAAGTTCACATTTCGGTATTATTTTAATTATTTTAGGTTTAATGAGTATTGTCGGATTAGTTTTATTCGTCATCTTAAATCGTTGGACACAATCTGAAAAATAA", "partial": "0", "query_start": 804, "query_end": 887, "hit_start": 888, "hit_end": 960, "orf_dna_sequence": "ATGCCGGATCATGTTCATATGCTGATTGCCATTCCCCCCAAACACAGTGTGGCGACGATCGTAGGTTTTCTCAAAGGCAAGAGTTCGATCTGGGTCGCTGAGAATGTGGACAACAAACAGCGAAACTTTGTTGGGCATAAGTTCTGGGCCAGAGGCTATTTTGTCTCCACGGTTGGGGCCAATGAGCAAGTTATCCGAGCGTATAGTGAGAATCAAGAGAAAGCGGATCAGCGTTTTCAAAACCTGTTTGACAGGTAG", "orf_prot_sequence": "MPDHVHMLIAIPPKHSVATIVGFLKGKSSIWVAENVDNKQRNFVGHKFWARGYFVSTVGANEQVIRAYSENQEKADQRFQNLFDR", "perc_identity": 42.86}}, "BGC0001186.1|Misakinolide_3 # 1092 # 1274 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.525": {"gnl|BL_ORD_ID|2503|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 1092, "orf_end": 1274, "orf_from": "BGC0001186.1|Misakinolide_3 ", "model_name": "Enterococcus faecium chloramphenicol acetyltransferase", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "2895", "ARO_accession": "3004456", "ARO_name": "Enterococcus faecium chloramphenicol acetyltransferase", "ARO_category": {"36261": {"category_aro_accession": "3000122", "category_aro_cvterm_id": "36261", "category_aro_name": "chloramphenicol acetyltransferase (CAT)", "category_aro_description": "Inactivates chloramphenicol by addition of an acyl group. CAT is used to describe many variants of the chloramphenicol acetyltransferase gene in a range of organisms including Acinetobacter calcoaceticus, Agrobacterium tumefaciens, Alkalihalobacillus clausii, Bacillus subtilis, Campylobacter coli, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Listeria monocytogenes, Listonella anguillarum, Morganella morganii, Photobacterium damselae subsp. piscicida, Proteus mirabilis, Salmonella typhi, Serratia marcescens, Shigella flexneri, Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus intermedius, Streptococcus agalactiae, Streptococcus suis and Streptomyces acrimycini.", "category_aro_class_name": "AMR Gene Family"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0884279, "max_identities": 11, "bit_score": 26.9498, "cvterm_id": "36779", "query": "KDKGAQTFSVLCHIALNMLKREGQNKRGIKARRKRAGWDR", "match": "KDKG + +  L H  ++++ R    + GI +      WD+", "sequence_from_db": "KDKGYELYPALIHAIVSVINRNKVFRTGINSEGNLGYWDK", "sequence_from_broadstreet": "MTFNIINLETWDRKEYFNHYFNQQTTYSVTKELDITLLKSMIKDKGYELYPALIHAIVSVINRNKVFRTGINSEGNLGYWDKLEPLYTVFNKETEKFSNIWTESNASFNSFYNSYKNDLFKYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKDDKIYLPFSLQVHHAVCDGYHVSLFMNEFQNIIDNVNEWI", "dna_sequence_from_broadstreet": "ATGACTTTTAATATTATTAATTTAGAAACTTGGGATAGAAAAGAATATTTCAATCATTATTTTAATCAACAAACAACTTATAGTGTTACTAAAGAATTAGATATTACCTTGTTAAAAAGTATGATAAAAGATAAAGGATATGAACTGTATCCTGCTTTGATTCATGCAATTGTAAGTGTTATAAATCGAAATAAAGTATTTAGAACAGGGATTAATAGTGAGGGGAATTTGGGTTATTGGGATAAATTAGAACCTTTATATACAGTCTTTAATAAAGAAACTGAAAAATTTTCTAATATTTGGACAGAATCAAATGCTAGTTTTAACTCTTTTTATAATAGTTATAAGAATGATTTATTTAAATATAAAGATAAAAATGAAATGTTTCCTAAAAAGCCGATACCTGAAAACACAGTTCCTATCTCGATGATTCCTTGGATTGATTTTAGTTCATTTAATTTAAATATTGGTAATAATAGTAGATTTTTATTGCCAATTATTACAATAGGTAAATTTTATAGTAAGGATGATAAGATCTATTTACCATTTTCATTGCAAGTTCATCATGCAGTATGTGATGGTTACCATGTTTCATTATTTATGAATGAATTTCAAAATATAATTGATAATGTAAATGAATGGATTTAA", "partial": "0", "query_start": 1125, "query_end": 1244, "hit_start": 126, "hit_end": 246, "orf_dna_sequence": "GTGAGTTTTGATGAGGGTGCCTGTCGGATTCGCAAGGACAAGGGGGCACAGACTTTCAGTGTGCTGTGCCATATCGCGCTCAATATGCTCAAGCGGGAAGGCCAGAATAAACGCGGGATCAAAGCCAGACGCAAGCGAGCGGGATGGGATCGCAACTATCTACTACAAGTGTTGATGGCTTAA", "orf_prot_sequence": "MSFDEGACRIRKDKGAQTFSVLCHIALNMLKREGQNKRGIKARRKRAGWDRNYLLQVLMA", "perc_identity": 27.5}, "gnl|BL_ORD_ID|2199|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 1092, "orf_end": 1274, "orf_from": "BGC0001186.1|Misakinolide_3 ", "model_name": "catA8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3358", "ARO_accession": "3004658", "ARO_name": "catA8", "ARO_category": {"36261": {"category_aro_accession": "3000122", "category_aro_cvterm_id": "36261", "category_aro_name": "chloramphenicol acetyltransferase (CAT)", "category_aro_description": "Inactivates chloramphenicol by addition of an acyl group. CAT is used to describe many variants of the chloramphenicol acetyltransferase gene in a range of organisms including Acinetobacter calcoaceticus, Agrobacterium tumefaciens, Alkalihalobacillus clausii, Bacillus subtilis, Campylobacter coli, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Listeria monocytogenes, Listonella anguillarum, Morganella morganii, Photobacterium damselae subsp. piscicida, Proteus mirabilis, Salmonella typhi, Serratia marcescens, Shigella flexneri, Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus intermedius, Streptococcus agalactiae, Streptococcus suis and Streptomyces acrimycini.", "category_aro_class_name": "AMR Gene Family"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.24487, "max_identities": 8, "bit_score": 21.557, "cvterm_id": "36757", "query": "KDKGAQTFSVLCHIALNMLKREGQNKRGIKARRKRAGWDR", "match": "K+KG + +  L +  +N++ +    + GI +      W++", "sequence_from_db": "KNKGYELYPALIYTIVNIINQNKVFRTGINSEGNLGYWEK", "sequence_from_broadstreet": "MTFNIINLETWDRKEYFNHYFNQQTTYSVTKEFDITLLKSMIKNKGYELYPALIYTIVNIINQNKVFRTGINSEGNLGYWEKLNPLYTVFNKETEKFSNIWTESNVSFNSFYNSYKSDLLEYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKNNKIYLPVSLQVHHAVCDGYHVSLFMSEFQNIVDSVNEWI", "dna_sequence_from_broadstreet": "ATGACTTTTAATATTATTAATTTGGAAACTTGGGATAGAAAAGAATATTTTAATCATTATTTCAATCAACAAACAACTTACAGTGTTACTAAAGAATTTGATATCACTTTACTTAAAAGTATGATAAAAAATAAAGGATATGAACTGTATCCTGCTTTGATTTATACAATTGTAAATATTATAAATCAAAATAAAGTATTTAGAACAGGAATTAATAGTGAGGGAAATTTGGGTTATTGGGAAAAATTAAACCCTTTATATACAGTCTTTAATAAAGAAACTGAAAAATTTTCTAACATTTGGACAGAATCAAATGTTAGTTTTAATTCTTTTTATAATAGTTATAAGAGTGACTTACTTGAATATAAAGATAAAAATGAAATGTTTCCTAAAAAACCAATACCTGAAAACACAGTTCCTATTTCGATGATTCCTTGGATTGATTTTAGTTCATTTAATTTAAATATTGGTAATAATAGTAGATTCCTATTGCCAATTATTACAATAGGTAAATTTTATAGTAAGAATAATAAGATCTATTTACCAGTCTCATTGCAAGTTCATCATGCGGTATGTGATGGTTACCATGTTTCATTATTTATGAGTGAATTTCAAAATATAGTTGATAGTGTAAATGAATGGATTTAA", "partial": "0", "query_start": 1125, "query_end": 1244, "hit_start": 126, "hit_end": 246, "orf_dna_sequence": "GTGAGTTTTGATGAGGGTGCCTGTCGGATTCGCAAGGACAAGGGGGCACAGACTTTCAGTGTGCTGTGCCATATCGCGCTCAATATGCTCAAGCGGGAAGGCCAGAATAAACGCGGGATCAAAGCCAGACGCAAGCGAGCGGGATGGGATCGCAACTATCTACTACAAGTGTTGATGGCTTAA", "orf_prot_sequence": "MSFDEGACRIRKDKGAQTFSVLCHIALNMLKREGQNKRGIKARRKRAGWDRNYLLQVLMA", "perc_identity": 20.0}}, "BGC0001186.1|Misakinolide_4 # 1542 # 2219 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.541": {"gnl|BL_ORD_ID|2572|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 1542, "orf_end": 2219, "orf_from": "BGC0001186.1|Misakinolide_4 ", "model_name": "mphH", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3216", "ARO_accession": "3004539", "ARO_name": "mphH", "ARO_category": {"36472": {"category_aro_accession": "3000333", "category_aro_cvterm_id": "36472", "category_aro_name": "macrolide phosphotransferase (MPH)", "category_aro_description": "Macrolide phosphotransferases (MPH) are enzymes encoded by macrolide phosphotransferase genes (mph genes). These enzymes phosphorylate macrolides in GTP dependent manner at 2'-OH of desosamine sugar thereby inactivating them. Characterized MPH's are differentiated based on their substrate specificity.", "category_aro_class_name": "AMR Gene Family"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.52147, "max_identities": 13, "bit_score": 25.7942, "cvterm_id": "42602", "query": "LDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTL", "match": "LDL G T+  + +G    +A      G D+VL L +    L", "sequence_from_db": "LDLDGGTLRTEEIGLDFRVAFARAHDGGDWVLRLPRRPDVL", "sequence_from_broadstreet": "MPEDLDALLDLAARHGLDLDGGTLRTEEIGLDFRVAFARAHDGGDWVLRLPRRPDVLERAAVEGRLLAMLAPHLDVAVPDWRISTSELIAYPLLPGSPGLTVAADGEVSWHVDMASTVYARSLGSVVAQLHAVDAEAAAATGIEVRSPAQVRGAWRQDLARVGAEFEIAPALRERWEAWLADDGCWPGHSVLTHGELYPAHTLVEDERITAVLDWTTAAVGDPAKDLMFHQVSAPSAIFEVALQAYAEGGGRPWPGLARHCTEMFSAAPLGYGLYALATGEAAHREAAAAALNPPEER", "dna_sequence_from_broadstreet": "ATGCCCGAGGACCTGGACGCACTGCTGGACCTCGCCGCCCGTCACGGCCTCGACCTCGACGGCGGCACGCTGCGCACCGAGGAGATCGGGCTGGACTTCCGGGTCGCATTCGCCCGCGCGCACGACGGCGGCGACTGGGTGCTGCGCCTCCCCCGCCGGCCCGACGTGCTCGAGCGCGCCGCGGTCGAGGGCCGGCTGCTGGCGATGCTCGCCCCGCACCTCGATGTCGCGGTGCCGGACTGGCGCATCAGCACCTCCGAGCTGATCGCCTACCCGCTGCTGCCGGGCAGTCCGGGGCTCACCGTCGCTGCGGACGGCGAGGTCTCCTGGCACGTCGACATGGCCTCGACCGTCTACGCCCGCTCCCTCGGGAGCGTGGTCGCGCAGCTGCATGCCGTGGATGCCGAGGCGGCCGCCGCCACCGGCATCGAGGTGCGCTCCCCCGCACAGGTGCGCGGGGCGTGGCGGCAGGACCTCGCACGCGTGGGCGCGGAGTTCGAGATCGCCCCGGCGCTGCGGGAGCGCTGGGAGGCCTGGCTCGCGGACGACGGCTGCTGGCCCGGGCACAGCGTGCTCACCCATGGCGAGCTCTATCCGGCCCACACCCTCGTCGAGGACGAGCGGATCACGGCAGTGCTCGACTGGACCACCGCCGCGGTGGGCGATCCCGCCAAGGACCTCATGTTCCACCAGGTCAGCGCCCCGTCGGCGATCTTCGAGGTGGCGCTGCAGGCGTACGCCGAGGGCGGCGGCCGCCCCTGGCCGGGGCTGGCACGGCACTGCACCGAGATGTTCTCCGCCGCGCCGCTGGGCTACGGGCTGTACGCGCTGGCCACCGGGGAGGCCGCTCATCGGGAGGCCGCCGCCGCGGCGCTGAACCCGCCCGAGGAGCGCTGA", "partial": "0", "query_start": 2034, "query_end": 2156, "hit_start": 48, "hit_end": 171, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTCGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAGCGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTTAGCGCGTGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGSEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALSDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 31.71}, "gnl|BL_ORD_ID|2375|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 1542, "orf_end": 2219, "orf_from": "BGC0001186.1|Misakinolide_4 ", "model_name": "BRO-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "3565", "ARO_accession": "3004761", "ARO_name": "BRO-1", "ARO_category": {"42873": {"category_aro_accession": "3004760", "category_aro_cvterm_id": "42873", "category_aro_name": "BRO Beta-lactamase", "category_aro_description": "BRO is a class A beta-lactamase that is found in M.catarrhalis.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.43641, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "41250", "query": "DLSGATVTLDAMGCQKEIAQVITEQGADYVLA", "match": "D   A + LD +G      Q + E GAD VLA", "sequence_from_db": "DNGSANILLDKIGGLTAFNQFLKEIGADMVLA", "sequence_from_broadstreet": "MQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWENKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLDFKNQKDEIMAQIGKEIYPFL", "dna_sequence_from_broadstreet": "ATGCAACGCCGGCATTTTTTACAAAAAACCTTATTGGCACTACCTATTATTTTTTCTGGCAATTTATTAACTGGATGTAAAACGAATTTATCTGATGATTATTTGCCCGATGATAAGATAACAAACAATCCAAATTTATTACAAAATAAATTAAAAGAGATATTGCCAATTTGGGAAAATAAATTTAATGCCAAAATTGGTATGACGATTATTGCTGACAATGGTGAACTATCCAGTCATCGTGGTAATGAATATTTTCCTGTTAATAGTACCATTAAAGCCTTTATTGCAAGTCATATATTATTACTTGTAGATAAAGAAAAATTGGATTTAAACGAAAAAATCATCATTAAAGAAAGCGATTTGATAGAATATTCTCCTGTCTGTAAAAAATACTTTGATGAGAATAAACCAATTTCTATTAGTGAATTGTGCGAAGCTACCATAACACTGAGTGATAATGGTTCTGCTAATATCTTGTTGGATAAAATTGGGGGTTTGACTGCATTCAATCAATTTTTGAAAGAGATTGGGGCGGATATGGTGCTGGCAAATAATGAGCCTTTATTAAATCGCTCACATTATGGTGAAACCAGTGATACCGCAAAACCAATTCCTTACACAAAAAGCCTAAAAGCACTGATTGTAGGCAATATCCTATCCAATCAAAGCAAAGAACAGTTGATAACTTGGCTTATCAATGATAAAGTTGCTGATAATTTATTGAGAAAATATTTACCAAAAAATTGGCGAATTGGCGACAAAACAGGCACAGGTAGTGAATCAAAAAATATCATTGCTGTGATTTGGAATGAAAATAATAAACCTTATTTTATCAGCCTATTTATCACCCAGCCCCATGATGGTAAATCCCTTGATTTTAAAAATCAAAAAGATGAAATAATGGCACAAATTGGTAAAGAAATTTATCCATTTTTATAA", "partial": "0", "query_start": 2037, "query_end": 2132, "hit_start": 456, "hit_end": 552, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTCGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAGCGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTTAGCGCGTGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGSEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALSDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 40.62}, "gnl|BL_ORD_ID|2406|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 1542, "orf_end": 2219, "orf_from": "BGC0001186.1|Misakinolide_4 ", "model_name": "BRO-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "634", "model_id": "3566", "ARO_accession": "3004762", "ARO_name": "BRO-2", "ARO_category": {"42873": {"category_aro_accession": "3004760", "category_aro_cvterm_id": "42873", "category_aro_name": "BRO Beta-lactamase", "category_aro_description": "BRO is a class A beta-lactamase that is found in M.catarrhalis.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.44173, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "42876", "query": "DLSGATVTLDAMGCQKEIAQVITEQGADYVLA", "match": "D   A + LD +G      Q + E GAD VLA", "sequence_from_db": "DNGSANILLDKIGGLTAFNQFLKEIGADMVLA", "sequence_from_broadstreet": "MMQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWENKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLGFKNQKDEIMAQIGKEIYPFL", "dna_sequence_from_broadstreet": "ATGATGCAACGCCGTCATTTTTTACAAAAAACCTTATTGGCACTACCTATTATTTTTTCTGGCAATTTATTAACTGGATGTAAAACGAATTTGTCTGATGATTATTTGCCCGATGACAAGATAACAAACAATCCAAATTTATTACAAAATAAATTAAAAGAGATATTGCCAATTTGGGAAAATAAATTTAATGCCAAAATTGGTATGACGATTATTGCTGACAATGGTGAACTATCCAGTCATCGTGGTAATGAATATTTTCCTGTTAATAGTACCATTAAAGCCTTTATTGCAAGTCATATATTATTACTTGTAGATAAAGAAAAATTGGATTTAAACGAAAAAATCATCATTAAAGAAAGCGATTTGATAGAATATTCTCCTGTCTGTAAAAAATACTTTGATGAGAATAAACCAATTTCTATTAGTGAATTGTGCGAAGCTACCATAACACTGAGTGATAATGGTTCTGCTAATATCTTGTTGGATAAAATTGGGGGTTTGACTGCATTCAATCAATTTTTGAAAGAGATTGGGGCGGATATGGTGCTGGCAAATAATGAACCTTTATTAAATCGCTCACATTATGGTGAAACCAGTGATACCGCAAAACCAATTCCTTACACAAAAAGCCTAAAAGCACTGATTGTAGGCAATATCCTATCCAATCAAAGCAAAGAACAGTTGATAACTTGGCTTATCAACGATAAAGTTGCTGATAATTTATTGAGAAAATATTTACCAAAAAATTGGCGAATTGGCGACAAAACAGGCACAGGTAGTGAATCAAAAAATATCATTGCTGTGATTTGGAATGAAAATAATAAACCTTATTTTATCAGCCTATTTATCACCCAGCCCCATGATGGTAAATCCCTTGGTTTTAAAAATCAAAAAGATGAAATAATGGCACAAATTGGTAAAGAAATTTATCCATTTTTATAA", "partial": "0", "query_start": 2037, "query_end": 2132, "hit_start": 459, "hit_end": 555, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTCGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAGCGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTTAGCGCGTGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGSEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALSDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 40.62}, "gnl|BL_ORD_ID|2348|hsp_num:0": {"type_match": "Loose", "snp": {"original": "G", "change": "D", "position": 131}, "query_snp": {"original": "G", "change": "D", "position": 24}, "orf_strand": "-", "orf_start": 1542, "orf_end": 2219, "orf_from": "BGC0001186.1|Misakinolide_4 ", "model_name": "Escherichia coli nfsA mutations conferring resistance to nitrofurantoin", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 425, "model_id": "2267", "ARO_accession": "3003751", "ARO_name": "Escherichia coli nfsA mutations conferring resistance to nitrofurantoin", "ARO_category": {"40411": {"category_aro_accession": "3003754", "category_aro_cvterm_id": "40411", "category_aro_name": "antibiotic resistant nfsA", "category_aro_description": "The nfsA-encoded nitroreductase is the major oxygen-insensitive nitroreductase present in E. coli. NfsA uses only NADPH and has broad electron acceptor specificity. Mutations in nfsA cause resistance to nitrofurazone and furazolidone. Resistance to nitrofurantoin via mutation of nfsA reduces the fitness of clinical isolates of E. coli.", "category_aro_class_name": "AMR Gene Family"}, "35992": {"category_aro_accession": "0000075", "category_aro_cvterm_id": "35992", "category_aro_name": "nitrofurantoin", "category_aro_description": "Nitrofurantoin is an antibiotic used to treat urinary tract infections. It inhibits enzyme synthesis by inhibiting essential enzymes involved in the citric acid cycle, as well as those involved in DNA, RNA, and protein synthesis. It is marketed under the following brand names: Furadantin, Macrobid, Macrodantin, Nitro Macro and Urantoin.", "category_aro_class_name": "Antibiotic"}, "41240": {"category_aro_accession": "3004116", "category_aro_cvterm_id": "41240", "category_aro_name": "nitrofuran antibiotic", "category_aro_description": "Nitrofurans are chemotherapeutic agents with antibacterial and antiprotozoal activity.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.38905, "bit_score": 26.9498, "max_identities": 15, "cvterm_id": "36849", "query": "SAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKI", "match": "+A+   +A   A  LGLG V +    N I A+ KLLK+", "sequence_from_db": "TAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKL", "sequence_from_broadstreet": "MTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIRITDKALREELVTLTGGQKHVAQAAEFWVFCADFNRHLQICPDAQLGLAEQLLLGVVDTAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKLPQHVLPLFGLCLGWPADNPDLKPRLPASILVHENSYQPLDKGALAQYDEQLAEYYLTRGSNNRRDTWSDHIRRTIIKESRPFILDYLHKQGWATR", "dna_sequence_from_broadstreet": "ATGACGCCAACCATTGAACTTATTTGTGGCCATCGCTCCATTCGCCATTTCACTGATGAACCCATTTCCGAAGCGCAGCGTGAGGCGATTATTAACAGCGCCCGTGCGACGTCCAGTTCCAGTTTTTTGCAGTGCAGTAGCATTATTCGCATTACCGACAAAGCGTTACGTGAAGAACTGGTGACGCTGACCGGCGGGCAAAAACACGTAGCGCAAGCGGCGGAGTTCTGGGTGTTCTGTGCCGACTTTAACCGCCATTTACAGATCTGTCCGGATGCTCAGCTCGGCCTGGCGGAACAACTGTTGCTCGGTGTCGTTGATACGGCAATGATGGCGCAGAATGCATTAATCGCAGCGGAATCGCTGGGATTGGGCGGGGTATATATCGGCGGCCTGCGCAATAATATTGAAGCGGTGACGAAACTGCTTAAATTACCGCAGCATGTTCTGCCGCTGTTTGGGCTGTGCCTTGGCTGGCCTGCGGATAATCCGGATCTTAAGCCGCGTTTACCGGCCTCCATTTTGGTGCATGAAAACAGCTATCAACCGCTGGATAAAGGCGCACTGGCGCAGTATGACGAGCAACTGGCGGAATATTACCTCACCCGTGGCAGCAATAATCGCCGGGATACCTGGAGCGATCATATCCGCCGAACAATCATTAAAGAAAGCCGCCCATTTATTCTGGATTATTTGCACAAACAGGGTTGGGCGACGCGCTAA", "partial": "0", "query_start": 1920, "query_end": 2033, "hit_start": 321, "hit_end": 435, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTCGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAGCGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTTAGCGCGTGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGSEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALSDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 39.47}, "gnl|BL_ORD_ID|2348|hsp_num:1": {"type_match": "Loose", "snp": {"original": "R", "change": "S", "position": 133}, "query_snp": {"original": "R", "change": "S", "position": 26}, "orf_strand": "-", "orf_start": 1542, "orf_end": 2219, "orf_from": "BGC0001186.1|Misakinolide_4 ", "model_name": "Escherichia coli nfsA mutations conferring resistance to nitrofurantoin", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 425, "model_id": "2267", "ARO_accession": "3003751", "ARO_name": "Escherichia coli nfsA mutations conferring resistance to nitrofurantoin", "ARO_category": {"40411": {"category_aro_accession": "3003754", "category_aro_cvterm_id": "40411", "category_aro_name": "antibiotic resistant nfsA", "category_aro_description": "The nfsA-encoded nitroreductase is the major oxygen-insensitive nitroreductase present in E. coli. NfsA uses only NADPH and has broad electron acceptor specificity. Mutations in nfsA cause resistance to nitrofurazone and furazolidone. Resistance to nitrofurantoin via mutation of nfsA reduces the fitness of clinical isolates of E. coli.", "category_aro_class_name": "AMR Gene Family"}, "35992": {"category_aro_accession": "0000075", "category_aro_cvterm_id": "35992", "category_aro_name": "nitrofurantoin", "category_aro_description": "Nitrofurantoin is an antibiotic used to treat urinary tract infections. It inhibits enzyme synthesis by inhibiting essential enzymes involved in the citric acid cycle, as well as those involved in DNA, RNA, and protein synthesis. It is marketed under the following brand names: Furadantin, Macrobid, Macrodantin, Nitro Macro and Urantoin.", "category_aro_class_name": "Antibiotic"}, "41240": {"category_aro_accession": "3004116", "category_aro_cvterm_id": "41240", "category_aro_name": "nitrofuran antibiotic", "category_aro_description": "Nitrofurans are chemotherapeutic agents with antibacterial and antiprotozoal activity.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.38905, "bit_score": 26.9498, "max_identities": 15, "cvterm_id": "36849", "query": "SAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKI", "match": "+A+   +A   A  LGLG V +    N I A+ KLLK+", "sequence_from_db": "TAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKL", "sequence_from_broadstreet": "MTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIRITDKALREELVTLTGGQKHVAQAAEFWVFCADFNRHLQICPDAQLGLAEQLLLGVVDTAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKLPQHVLPLFGLCLGWPADNPDLKPRLPASILVHENSYQPLDKGALAQYDEQLAEYYLTRGSNNRRDTWSDHIRRTIIKESRPFILDYLHKQGWATR", "dna_sequence_from_broadstreet": "ATGACGCCAACCATTGAACTTATTTGTGGCCATCGCTCCATTCGCCATTTCACTGATGAACCCATTTCCGAAGCGCAGCGTGAGGCGATTATTAACAGCGCCCGTGCGACGTCCAGTTCCAGTTTTTTGCAGTGCAGTAGCATTATTCGCATTACCGACAAAGCGTTACGTGAAGAACTGGTGACGCTGACCGGCGGGCAAAAACACGTAGCGCAAGCGGCGGAGTTCTGGGTGTTCTGTGCCGACTTTAACCGCCATTTACAGATCTGTCCGGATGCTCAGCTCGGCCTGGCGGAACAACTGTTGCTCGGTGTCGTTGATACGGCAATGATGGCGCAGAATGCATTAATCGCAGCGGAATCGCTGGGATTGGGCGGGGTATATATCGGCGGCCTGCGCAATAATATTGAAGCGGTGACGAAACTGCTTAAATTACCGCAGCATGTTCTGCCGCTGTTTGGGCTGTGCCTTGGCTGGCCTGCGGATAATCCGGATCTTAAGCCGCGTTTACCGGCCTCCATTTTGGTGCATGAAAACAGCTATCAACCGCTGGATAAAGGCGCACTGGCGCAGTATGACGAGCAACTGGCGGAATATTACCTCACCCGTGGCAGCAATAATCGCCGGGATACCTGGAGCGATCATATCCGCCGAACAATCATTAAAGAAAGCCGCCCATTTATTCTGGATTATTTGCACAAACAGGGTTGGGCGACGCGCTAA", "partial": "0", "query_start": 1920, "query_end": 2033, "hit_start": 321, "hit_end": 435, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTCGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAGCGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTTAGCGCGTGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGSEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALSDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 39.47}}, "BGC0001186.1|Misakinolide_5 # 2658 # 3380 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGGGGG;rbs_spacer=10bp;gc_cont=0.505": {"gnl|BL_ORD_ID|2180|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3326", "ARO_accession": "3004627", "ARO_name": "QnrS15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00164005, "max_identities": 21, "bit_score": 35.8094, "cvterm_id": "35914", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "E+ D+EG R     L++A  Q   L  A+ S+     ++    +L+GAN S+  F+  V N +    A +   N  +  +", "sequence_from_db": "EQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANM", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCGCTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2685, "query_end": 2909, "hit_start": 147, "hit_end": 387, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 26.25}, "gnl|BL_ORD_ID|2180|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3326", "ARO_accession": "3004627", "ARO_name": "QnrS15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.198506, "max_identities": 20, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCGCTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|1239|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00608949, "max_identities": 21, "bit_score": 33.8834, "cvterm_id": "36789", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "DL  A  +  +L  +  +GA+     L D D     L+GAN S+V F   V N +    A +   N  +    Q  +++", "sequence_from_db": "DLRDASFKNCQLSMSHFKGANCFGIELRDCD-----LKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEK", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2930, "hit_start": 186, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 26.58}, "gnl|BL_ORD_ID|1449|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00998268, "max_identities": 21, "bit_score": 33.4982, "cvterm_id": "39615", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "DL  A  +  +L  +  +GA+     L D D     L+GAN S+V F   V N +    A +   N  +    Q  +++", "sequence_from_db": "DLRDASFKDCQLSMSHFKGANCFGIELRDCD-----LKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEK", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2930, "hit_start": 186, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 26.58}, "gnl|BL_ORD_ID|1470|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.010467, "max_identities": 23, "bit_score": 33.4982, "cvterm_id": "36771", "query": "AAHRGERLDLEGARLQRVRLQEARLQG----------------ADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "++H        G    RV L++A+  G                ADL+ A   +  LS AN QGAN   +      L      QA   N", "sequence_from_db": "SSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVN", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 2670, "query_end": 2885, "hit_start": 54, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 26.14}, "gnl|BL_ORD_ID|1470|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.73717, "max_identities": 20, "bit_score": 26.1794, "cvterm_id": "36771", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSD----------LDLSRANLQGANLSKVIFSGTVLNDVQVDQ", "match": "E+ DL   +     LQ A  + +DL R   SD           DL+ + L G    KV  +G  +   Q +Q", "sequence_from_db": "EKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQ", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 2685, "query_end": 2870, "hit_start": 402, "hit_end": 618, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.78}, "gnl|BL_ORD_ID|1663|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.012896, "max_identities": 20, "bit_score": 33.113, "cvterm_id": "36920", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "DL  A  +  +L  +  +GA+     L D D     L+GAN ++V F   V N +    A +   N  +    Q  +++", "sequence_from_db": "DLRDASFKNCQLSMSHFKGANCFGIELRDCD-----LKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEK", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2930, "hit_start": 186, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 25.32}, "gnl|BL_ORD_ID|436|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0196165, "max_identities": 15, "bit_score": 32.7278, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+ R +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.71}, "gnl|BL_ORD_ID|436|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.79007, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|436|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.67548, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|1714|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.020531, "max_identities": 15, "bit_score": 32.3426, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+ R +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.71}, "gnl|BL_ORD_ID|1714|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.79007, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1714|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.99322, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "35914", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|238|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.020719, "max_identities": 15, "bit_score": 32.3426, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+ R +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.71}, "gnl|BL_ORD_ID|238|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.76503, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|238|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.75385, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|1882|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0211, "max_identities": 15, "bit_score": 32.3426, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+ R +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.71}, "gnl|BL_ORD_ID|1882|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.60944, "max_identities": 16, "bit_score": 26.5646, "cvterm_id": "35915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++S    QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 19.51}, "gnl|BL_ORD_ID|1882|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.46377, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + +   R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|322|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0212096, "max_identities": 15, "bit_score": 32.3426, "cvterm_id": "36771", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+ R +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.71}, "gnl|BL_ORD_ID|322|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.81094, "max_identities": 16, "bit_score": 26.5646, "cvterm_id": "36771", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++S    QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 153, "hit_end": 399, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 19.51}, "gnl|BL_ORD_ID|322|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.835, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "36771", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + +   R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|734|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "mfpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "801", "ARO_accession": "3003035", "ARO_name": "mfpA", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0222112, "max_identities": 22, "bit_score": 32.3426, "cvterm_id": "39507", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATL", "match": "DL G  L   RL+E  L   DL++  L   DLS A   GA L      G  ++ V    A+L", "sequence_from_db": "DLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASL", "sequence_from_broadstreet": "MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG", "dna_sequence_from_broadstreet": "TTGCAGCAGTGGGTTGATTGCGAATTCACCGGTCGAGACTTCCGCGACGAGGACCTTAGCCGCCTGCACACCGAACGGGCGATGTTCAGCGAATGCGATTTCAGCGGCGTGAATCTGGCCGAGTCACAACACCGAGGGTCGGCGTTTCGTAATTGCACCTTCGAACGGACGACACTGTGGCACAGCACATTTGCCCAGTGCAGCATGTTGGGCTCGGTCTTCGTGGCTTGCCGGCTGCGGCCGCTGACGTTGGACGACGTGGATTTCACGCTCGCCGTGCTCGGCGGAAATGATCTGCGTGGTCTCAACTTGACCGGCTGCCGGTTGCGAGAGACCAGCCTGGTGGATACCGACTTGCGCAAGTGCGTGCTGCGCGGCGCCGACCTCAGTGGTGCCCGTACCACGGGCGCCCGGCTGGATGACGCCGACTTGCGGGGCGCGACCGTGGACCCGGTATTGTGGCGGACCGCGTCGTTGGTGGGTGCGCGTGTCGACGTCGACCAAGCCGTGGCCTTTGCGGCGGCGCACGGGCTGTGCTTGGCAGGGGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2879, "hit_start": 291, "hit_end": 477, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.48}, "gnl|BL_ORD_ID|734|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "mfpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "801", "ARO_accession": "3003035", "ARO_name": "mfpA", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0339799, "max_identities": 18, "bit_score": 31.5722, "cvterm_id": "39507", "query": "LQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLE", "match": "L+   L G  L+   L D DL +  L+GA+LS    +G  L+D  +  AT++", "sequence_from_db": "LRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVD", "sequence_from_broadstreet": "MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG", "dna_sequence_from_broadstreet": "TTGCAGCAGTGGGTTGATTGCGAATTCACCGGTCGAGACTTCCGCGACGAGGACCTTAGCCGCCTGCACACCGAACGGGCGATGTTCAGCGAATGCGATTTCAGCGGCGTGAATCTGGCCGAGTCACAACACCGAGGGTCGGCGTTTCGTAATTGCACCTTCGAACGGACGACACTGTGGCACAGCACATTTGCCCAGTGCAGCATGTTGGGCTCGGTCTTCGTGGCTTGCCGGCTGCGGCCGCTGACGTTGGACGACGTGGATTTCACGCTCGCCGTGCTCGGCGGAAATGATCTGCGTGGTCTCAACTTGACCGGCTGCCGGTTGCGAGAGACCAGCCTGGTGGATACCGACTTGCGCAAGTGCGTGCTGCGCGGCGCCGACCTCAGTGGTGCCCGTACCACGGGCGCCCGGCTGGATGACGCCGACTTGCGGGGCGCGACCGTGGACCCGGTATTGTGGCGGACCGCGTCGTTGGTGGGTGCGCGTGTCGACGTCGACCAAGCCGTGGCCTTTGCGGCGGCGCACGGGCTGTGCTTGGCAGGGGGCTAG", "partial": "0", "query_start": 2727, "query_end": 2882, "hit_start": 294, "hit_end": 450, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 34.62}, "gnl|BL_ORD_ID|734|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "mfpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "801", "ARO_accession": "3003035", "ARO_name": "mfpA", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.118004, "max_identities": 24, "bit_score": 30.0314, "cvterm_id": "39507", "query": "LDLEGARLQRVRL-----QEARLQGADLKRAHLSDLDLSRANLQGANLSKVIF--SGTVLNDVQVDQA", "match": "L+L G RL+   L     ++  L+GADL  A  +   L  A+L+GA +  V++  +  V   V VDQA", "sequence_from_db": "LNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQA", "sequence_from_broadstreet": "MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG", "dna_sequence_from_broadstreet": "TTGCAGCAGTGGGTTGATTGCGAATTCACCGGTCGAGACTTCCGCGACGAGGACCTTAGCCGCCTGCACACCGAACGGGCGATGTTCAGCGAATGCGATTTCAGCGGCGTGAATCTGGCCGAGTCACAACACCGAGGGTCGGCGTTTCGTAATTGCACCTTCGAACGGACGACACTGTGGCACAGCACATTTGCCCAGTGCAGCATGTTGGGCTCGGTCTTCGTGGCTTGCCGGCTGCGGCCGCTGACGTTGGACGACGTGGATTTCACGCTCGCCGTGCTCGGCGGAAATGATCTGCGTGGTCTCAACTTGACCGGCTGCCGGTTGCGAGAGACCAGCCTGGTGGATACCGACTTGCGCAAGTGCGTGCTGCGCGGCGCCGACCTCAGTGGTGCCCGTACCACGGGCGCCCGGCTGGATGACGCCGACTTGCGGGGCGCGACCGTGGACCCGGTATTGTGGCGGACCGCGTCGTTGGTGGGTGCGCGTGTCGACGTCGACCAAGCCGTGGCCTTTGCGGCGGCGCACGGGCTGTGCTTGGCAGGGGGCTAG", "partial": "0", "query_start": 2691, "query_end": 2873, "hit_start": 303, "hit_end": 507, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.29}, "gnl|BL_ORD_ID|571|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0222857, "max_identities": 15, "bit_score": 32.3426, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+ R +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.71}, "gnl|BL_ORD_ID|571|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.24719, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "35915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +A +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 19.51}, "gnl|BL_ORD_ID|571|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.69126, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1392|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0232398, "max_identities": 15, "bit_score": 32.3426, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+ R +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKL", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.71}, "gnl|BL_ORD_ID|1392|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.63268, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|4916|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0770954, "max_identities": 16, "bit_score": 30.8018, "cvterm_id": "46173", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSG", "match": "E+ DL   +     LQ A  +G+DL R   S+    +  +Q ANL      G", "sequence_from_db": "EKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDG", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 2685, "query_end": 2840, "hit_start": 402, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.77}, "gnl|BL_ORD_ID|162|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.085994, "max_identities": 16, "bit_score": 30.4166, "cvterm_id": "36891", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "DL      R   Q+  L+G DL  A L  LD  R NL+G  + ", "sequence_from_db": "DLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2694, "query_end": 2822, "hit_start": 471, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 37.21}, "gnl|BL_ORD_ID|162|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.681648, "max_identities": 20, "bit_score": 27.7202, "cvterm_id": "36891", "query": "RLDLEGARLQRVRLQEARLQGADLKRA----------------HLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "R DL  +R +R R  +       L+ A                H S  DL  A+ +   LS   FSG     ++  +  L+  N", "sequence_from_db": "RQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGAN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2688, "query_end": 2891, "hit_start": 42, "hit_end": 294, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 23.81}, "gnl|BL_ORD_ID|162|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.739543, "max_identities": 24, "bit_score": 27.7202, "cvterm_id": "36891", "query": "LDLEGARLQRVR--------------------LQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": " DL+GA   R R                    L  A L G  L++  L + + S ANL GA+L     S    +     Q  L   +  F +L", "sequence_from_db": "CDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 273, "hit_end": 552, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 25.81}, "gnl|BL_ORD_ID|162|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.95047, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36891", "query": "ADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "ADL+ A      LS AN  GAN   + F    L      +A   N", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2751, "query_end": 2885, "hit_start": 183, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1541|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.139267, "max_identities": 16, "bit_score": 30.0314, "cvterm_id": "36771", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "DL      R   Q+  L+G DL  A L  LD  R NL+G  + ", "sequence_from_db": "DLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2694, "query_end": 2822, "hit_start": 471, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 37.21}, "gnl|BL_ORD_ID|1541|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.605913, "max_identities": 20, "bit_score": 28.1054, "cvterm_id": "36771", "query": "RLDLEGARLQRVRLQEARLQGADLKRA----------------HLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "R DL  +R +R R  +       L+ A                H S  DL  A+ +   LS   FSG     ++  +  L+  N", "sequence_from_db": "RQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGAN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2688, "query_end": 2891, "hit_start": 42, "hit_end": 294, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 23.81}, "gnl|BL_ORD_ID|1541|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.84714, "max_identities": 27, "bit_score": 27.7202, "cvterm_id": "36771", "query": "LDLEGARLQRVR--------------------LQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFS-GTVLNDVQVDQATLENTNPLFPEL", "match": " DL+GA   R R                    L  A L G  L++  L + + S ANL GA+L     S GT   D    Q  L   +  F +L", "sequence_from_db": "CDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCW-QQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 273, "hit_end": 552, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.72}, "gnl|BL_ORD_ID|1541|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.95047, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36771", "query": "ADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "ADL+ A      LS AN  GAN   + F    L      +A   N", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2751, "query_end": 2885, "hit_start": 183, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|952|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.139267, "max_identities": 16, "bit_score": 30.0314, "cvterm_id": "36891", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "DL      R   Q+  L+G DL  A L  LD  R NL+G  + ", "sequence_from_db": "DLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2694, "query_end": 2822, "hit_start": 471, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 37.21}, "gnl|BL_ORD_ID|952|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.605913, "max_identities": 20, "bit_score": 28.1054, "cvterm_id": "36891", "query": "RLDLEGARLQRVRLQEARLQGADLKRA----------------HLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "R DL  +R +R R  +       L+ A                H S  DL  A+ +   LS   FSG     ++  +  L+  N", "sequence_from_db": "RQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGAN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2688, "query_end": 2891, "hit_start": 42, "hit_end": 294, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 23.81}, "gnl|BL_ORD_ID|952|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.839504, "max_identities": 27, "bit_score": 27.7202, "cvterm_id": "36891", "query": "LDLEGARLQRVR--------------------LQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFS-GTVLNDVQVDQATLENTNPLFPEL", "match": " DL+GA   R R                    L  A L G  L++  L + + S ANL GA+L     S GT   D    Q  L   +  F +L", "sequence_from_db": "CDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCW-QQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 273, "hit_end": 552, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.72}, "gnl|BL_ORD_ID|952|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.95047, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36891", "query": "ADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "ADL+ A      LS AN  GAN   + F    L      +A   N", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2751, "query_end": 2885, "hit_start": 183, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|4920|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.140141, "max_identities": 14, "bit_score": 30.0314, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|4920|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.56764, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1668|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.141115, "max_identities": 14, "bit_score": 30.0314, "cvterm_id": "35665", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1668|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.38944, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "35665", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 285, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1668|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.75385, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35665", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|787|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.142401, "max_identities": 14, "bit_score": 30.0314, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|787|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.50547, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 285, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|787|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.32257, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|1435|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.149009, "max_identities": 14, "bit_score": 30.0314, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1435|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.69126, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1435|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.36894, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|863|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.149359, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|863|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.27921, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "39584", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|244|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.150725, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|244|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.21384, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1153|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.152103, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1153|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.02125, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "39584", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1229|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.153493, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1229|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.50317, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +A +++", "sequence_from_db": "KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEK", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 153, "hit_end": 399, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 19.51}, "gnl|BL_ORD_ID|1229|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.82383, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|327|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.153493, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|327|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.27921, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|682|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.154896, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|682|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.16623, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "35914", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +A +++", "sequence_from_db": "KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEK", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 153, "hit_end": 399, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 19.51}, "gnl|BL_ORD_ID|682|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.54662, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35914", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|323|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.155924, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|323|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.30881, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "VDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2691, "query_end": 2864, "hit_start": 255, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 26.98}, "gnl|BL_ORD_ID|1549|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.157741, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1549|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.27921, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "39584", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|354|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.157741, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|354|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.08487, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "39584", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1886|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB72", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2049", "ARO_accession": "3002784", "ARO_name": "QnrB72", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.159182, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39586", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCATGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1853|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.159182, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1853|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.0738, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +A +++", "sequence_from_db": "KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEK", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 153, "hit_end": 399, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 19.51}, "gnl|BL_ORD_ID|1853|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.68397, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCEL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1163|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.159182, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1163|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.21384, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "39584", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|349|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.159182, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|349|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.34516, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "39584", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|717|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.160637, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|717|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.14907, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|85|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.160637, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|85|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.93823, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +A +++", "sequence_from_db": "KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEK", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 153, "hit_end": 399, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 19.51}, "gnl|BL_ORD_ID|85|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.54662, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCEL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|4917|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.162106, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39643", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|4917|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.48527, "max_identities": 16, "bit_score": 24.6386, "cvterm_id": "39643", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QG+D + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 25.81}, "gnl|BL_ORD_ID|529|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.162106, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|529|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.14907, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35914", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1009|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.164644, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1009|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.43717, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "VDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2691, "query_end": 2864, "hit_start": 255, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 26.98}, "gnl|BL_ORD_ID|316|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.164644, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|316|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.61945, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|316|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.07322, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|1453|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.165082, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1453|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.14907, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1255|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.165082, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|490|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.166144, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|490|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.51269, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 285, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1835|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.167032, "max_identities": 16, "bit_score": 29.6462, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "DL      R   Q+  L+G DL  A L  LD  R NL+G  + ", "sequence_from_db": "DLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2694, "query_end": 2822, "hit_start": 471, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 37.21}, "gnl|BL_ORD_ID|1835|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.902564, "max_identities": 20, "bit_score": 27.335, "cvterm_id": "35915", "query": "RLDLEGARLQRVRLQEARLQGADLKRA----------------HLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "R DL  +R +R R  +       L+ A                H S  DL  A+ +   LS   FSG     ++  +  L+  N", "sequence_from_db": "RQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGAN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2688, "query_end": 2891, "hit_start": 42, "hit_end": 294, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 23.81}, "gnl|BL_ORD_ID|1835|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.28767, "max_identities": 26, "bit_score": 25.7942, "cvterm_id": "35915", "query": "LDLEGARLQRVR--------------------LQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFS-GTVLNDVQVDQATLENTNPLFPEL", "match": " DL+GA   R R                    L    L G  L++  L + + S ANL GA+L     S GT   D    Q  L   +  F +L", "sequence_from_db": "CDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCW-QQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 273, "hit_end": 552, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.66}, "gnl|BL_ORD_ID|1835|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.75947, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "35915", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "E+ +L         L  A L G+DL R   S     + NL+G +L+", "sequence_from_db": "EKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2685, "query_end": 2822, "hit_start": 402, "hit_end": 540, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.43}, "gnl|BL_ORD_ID|1835|hsp_num:4": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.0134, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35915", "query": "ADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "ADL+ A      LS AN  GAN   + F    L      +A   N", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2751, "query_end": 2885, "hit_start": 183, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|356|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.170096, "max_identities": 21, "bit_score": 29.6462, "cvterm_id": "36957", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L+R  L E R  G  L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 35.59}, "gnl|BL_ORD_ID|1072|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB34", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1160", "ARO_accession": "3002749", "ARO_name": "QnrB34", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.170156, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39583", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGTACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGGTTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 465, "hit_end": 591, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|48|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.172765, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|48|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.27921, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|779|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.173852, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|779|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.19396, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|291|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.175937, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|291|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.20106, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1346|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.177034, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36943", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1346|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.31118, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36943", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|459|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.177034, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|459|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.80483, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 285, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|459|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.75123, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|1568|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.177544, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A +   DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1568|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.67786, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "35914", "query": "GERLD---LEGARLQRVRLQEARLQGADLKRAHLSDLDL-SRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "GE++D     G +++          GADL            R + +G N S+      +     +  A   N N L  E+", "sequence_from_db": "GEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2682, "query_end": 2909, "hit_start": 18, "hit_end": 258, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 21.25}, "gnl|BL_ORD_ID|821|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.177544, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A +   DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|688|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.178002, "max_identities": 16, "bit_score": 29.6462, "cvterm_id": "36891", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "DL      R   Q+  L+G DL  A L  LD  R NL+G  + ", "sequence_from_db": "DLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2694, "query_end": 2822, "hit_start": 471, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 37.21}, "gnl|BL_ORD_ID|688|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.732875, "max_identities": 20, "bit_score": 27.7202, "cvterm_id": "36891", "query": "RLDLEGARLQRVRLQEARLQGADLKRA----------------HLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "R DL  +R +R R  +       L+ A                H S  DL  A+ +   LS   FSG     ++  +  L+  N", "sequence_from_db": "RQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGAN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2688, "query_end": 2891, "hit_start": 42, "hit_end": 294, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 23.81}, "gnl|BL_ORD_ID|688|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.824438, "max_identities": 27, "bit_score": 27.7202, "cvterm_id": "36891", "query": "LDLEGARLQRVR--------------------LQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFS-GTVLNDVQVDQATLENTNPLFPEL", "match": " DL+GA   R R                    L  A L G  L++  L + + S ANL GA+L     S GT   D    Q  L   +  F +L", "sequence_from_db": "CDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCW-QQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 273, "hit_end": 552, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.72}, "gnl|BL_ORD_ID|688|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.16191, "max_identities": 14, "bit_score": 25.0238, "cvterm_id": "36891", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "E+ +L         L  A L G+DL R   S     + NL+G +L+", "sequence_from_db": "EKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2685, "query_end": 2822, "hit_start": 402, "hit_end": 540, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.43}, "gnl|BL_ORD_ID|688|hsp_num:4": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.76507, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36891", "query": "ADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "ADL+ A      LS AN  GAN   + F    L      +A   N", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2751, "query_end": 2885, "hit_start": 183, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|4925|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.178646, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "43754", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|4925|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.02584, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "43754", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|4925|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.57746, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "43754", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|1296|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.178646, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1296|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.612161, "max_identities": 17, "bit_score": 28.1054, "cvterm_id": "36915", "query": "GERLD---LEGARLQRVRLQEARLQGADLKRAHLSDLDL-SRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "GE++D     G +++          GADL            R + +G N S+ +    +     +  A   N N L  E+", "sequence_from_db": "GEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2682, "query_end": 2909, "hit_start": 54, "hit_end": 294, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 21.25}, "gnl|BL_ORD_ID|1296|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.64317, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1296|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.57746, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|499|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.178646, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|499|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.14757, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "35914", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G +  R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|499|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.6236, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35914", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 285, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|4919|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.179167, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|735|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.179627, "max_identities": 16, "bit_score": 29.6462, "cvterm_id": "36891", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "DL      R   Q+  L+G DL  A L  LD  R NL+G  + ", "sequence_from_db": "DLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2694, "query_end": 2822, "hit_start": 471, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 37.21}, "gnl|BL_ORD_ID|735|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.663372, "max_identities": 20, "bit_score": 27.7202, "cvterm_id": "36891", "query": "RLDLEGARLQRVRLQEARLQGADLKRA----------------HLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "R DL  +R +R R  +       L+ A                H S  DL  A+ +   LS   FSG     ++  +  L+  N", "sequence_from_db": "RQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGAN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2688, "query_end": 2891, "hit_start": 42, "hit_end": 294, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 23.81}, "gnl|BL_ORD_ID|735|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.854845, "max_identities": 27, "bit_score": 27.7202, "cvterm_id": "36891", "query": "LDLEGARLQRVR--------------------LQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFS-GTVLNDVQVDQATLENTNPLFPEL", "match": " DL+GA   R R                    L  A L G  L++  L + + S ANL GA+L     S GT   D    Q  L   +  F +L", "sequence_from_db": "CDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCW-QQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 273, "hit_end": 552, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.72}, "gnl|BL_ORD_ID|735|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.16191, "max_identities": 14, "bit_score": 25.0238, "cvterm_id": "36891", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "E+ +L         L  A L G+DL R   S     + NL+G +L+", "sequence_from_db": "EKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2685, "query_end": 2822, "hit_start": 402, "hit_end": 540, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.43}, "gnl|BL_ORD_ID|735|hsp_num:4": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.40893, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "36891", "query": "ADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "ADL+ A      LS AN  GAN   + F    L      +A   N", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 2751, "query_end": 2885, "hit_start": 183, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|120|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.180274, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|120|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.29401, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 285, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|32|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.180274, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|32|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.25204, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|542|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.18074, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|542|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.87198, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 2721, "query_end": 2864, "hit_start": 285, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|525|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.180804, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A +   DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|525|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.55285, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "36915", "query": "GERLD---LEGARLQRVRLQEARLQGADLKRAHLSDLDL-SRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "GE++D     G +++          GADL            R + +G N S+      +     +  A   N N L  E+", "sequence_from_db": "GEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2682, "query_end": 2909, "hit_start": 18, "hit_end": 258, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 21.25}, "gnl|BL_ORD_ID|525|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.96622, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSDLD-----LSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +++     +     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 153, "hit_end": 399, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|525|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.63967, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1627|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1775", "ARO_accession": "3002796", "ARO_name": "QnrS7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.181267, "max_identities": 20, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCATGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|1175|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.18134, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39583", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 465, "hit_end": 591, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1788|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.181916, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1788|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.1369, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|377|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.181916, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36950", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|377|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.1653, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36950", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1111|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.182456, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1111|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.53555, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1613|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.184123, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1613|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.55306, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +A +++", "sequence_from_db": "KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEK", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 153, "hit_end": 399, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 19.51}, "gnl|BL_ORD_ID|1613|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.03838, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCEL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|99|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.185245, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|99|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.40191, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|4921|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.185805, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|4921|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.53066, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLS-----DLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "+G    R  L++A  +  DL  A        D+++     QGA+     F   +        A + NTN  +   ", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANF", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2909, "hit_start": 153, "hit_end": 378, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 21.33}, "gnl|BL_ORD_ID|1389|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.186275, "max_identities": 16, "bit_score": 29.6462, "cvterm_id": "36891", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "DL      R   Q+  L+G DL  A L  LD  R NL+G  + ", "sequence_from_db": "DLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 2694, "query_end": 2822, "hit_start": 471, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 37.21}, "gnl|BL_ORD_ID|1389|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.663372, "max_identities": 20, "bit_score": 27.7202, "cvterm_id": "36891", "query": "RLDLEGARLQRVRLQEARLQGADLKRA----------------HLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "R DL  +R +R R  +       L+ A                H S  DL  A+ +   LS   FSG     ++  +  L+  N", "sequence_from_db": "RQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGAN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 2688, "query_end": 2891, "hit_start": 42, "hit_end": 294, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 23.81}, "gnl|BL_ORD_ID|1389|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.88637, "max_identities": 27, "bit_score": 27.335, "cvterm_id": "36891", "query": "LDLEGARLQRVR--------------------LQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFS-GTVLNDVQVDQATLENTNPLFPEL", "match": " DL+GA   R R                    L  A L G  L++  L + + S ANL GA+L     S GT   D    Q  L   +  F +L", "sequence_from_db": "CDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCW-QQVNLRGCDLTFADL", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 273, "hit_end": 552, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.72}, "gnl|BL_ORD_ID|1389|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.35151, "max_identities": 14, "bit_score": 25.0238, "cvterm_id": "36891", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "E+ +L         L  A L G+DL R   S     + NL+G +L+", "sequence_from_db": "EKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 2685, "query_end": 2822, "hit_start": 402, "hit_end": 540, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.43}, "gnl|BL_ORD_ID|1389|hsp_num:4": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.46696, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "36891", "query": "ADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "ADL+ A      LS AN  GAN   + F    L      +A   N", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 2751, "query_end": 2885, "hit_start": 183, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|2054|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "425", "model_id": "3320", "ARO_accession": "3004622", "ARO_name": "QnrS10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.187976, "max_identities": 20, "bit_score": 29.6462, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAATCTACAGTCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|371|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.188058, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 465, "hit_end": 591, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|901|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.190945, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|901|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.75359, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|503|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "552", "ARO_accession": "3002743", "ARO_name": "QnrB28", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.190945, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGAGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|2142|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "430", "model_id": "3325", "ARO_accession": "3004625", "ARO_name": "QnrS12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.191422, "max_identities": 20, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCGCCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCACAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|2107|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "455", "model_id": "3323", "ARO_accession": "3004624", "ARO_name": "QnrS11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.191422, "max_identities": 20, "bit_score": 29.6462, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGGTCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|348|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "381", "ARO_accession": "3002790", "ARO_name": "QnrS1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.191422, "max_identities": 20, "bit_score": 29.6462, "cvterm_id": "35711", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|1445|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.19445, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1445|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.69891, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|961|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1048", "ARO_accession": "3002748", "ARO_name": "QnrB33", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.19445, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCAGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|961|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1048", "ARO_accession": "3002748", "ARO_name": "QnrB33", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.82383, "max_identities": 16, "bit_score": 24.6386, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QG+D + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCAGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 25.81}, "gnl|BL_ORD_ID|61|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.19445, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|61|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.47886, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|973|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1063", "ARO_accession": "3002785", "ARO_name": "QnrB73", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.196226, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGAGTCTGGCACTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCTCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAATCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|764|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.196226, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39585", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A +   DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|764|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.94686, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "39585", "query": "GERLD---LEGARLQRVRLQEARLQGADLKRAHLSDLDL-SRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "GE++D     G +++          GADL         L  R + +G N S+      +     +  A   N N L  E+", "sequence_from_db": "GEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2682, "query_end": 2909, "hit_start": 18, "hit_end": 258, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 22.5}, "gnl|BL_ORD_ID|645|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "699", "ARO_accession": "3002798", "ARO_name": "QnrS9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.196711, "max_identities": 20, "bit_score": 29.6462, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTTCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|1455|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.198019, "max_identities": 14, "bit_score": 29.6462, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1455|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.25881, "max_identities": 16, "bit_score": 24.6386, "cvterm_id": "39584", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QG+D + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 25.81}, "gnl|BL_ORD_ID|212|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "234", "ARO_accession": "3002797", "ARO_name": "QnrS8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.198506, "max_identities": 20, "bit_score": 29.6462, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACACTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|50|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.198506, "max_identities": 26, "bit_score": 29.6462, "cvterm_id": "36810", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQA", "match": "++E   L++  L E R  G  L  A L + DLSR           +LQGANL      G  L+  +VD + ++  +    +LL+A", "sequence_from_db": "NMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG--LDPRKVDTSGIKIASWQQEQLLEA", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 2694, "query_end": 2918, "hit_start": 381, "hit_end": 630, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.59}, "gnl|BL_ORD_ID|661|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.199828, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|661|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.62385, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +  +NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|4918|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.201653, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|4918|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.18816, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "+G +  R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +   ", "sequence_from_db": "KGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANF", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2909, "hit_start": 153, "hit_end": 378, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 20.0}, "gnl|BL_ORD_ID|4918|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.18467, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|629|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "682", "ARO_accession": "3002793", "ARO_name": "QnrS4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.202145, "max_identities": 20, "bit_score": 29.261, "cvterm_id": "35767", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGCCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 2694, "query_end": 2840, "hit_start": 381, "hit_end": 558, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|1166|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1270", "ARO_accession": "3002792", "ARO_name": "QnrS3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.20527, "max_identities": 20, "bit_score": 29.261, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSG", "match": "++E   L++  L E R  G +L  A L + DLSR           +LQGANL      G", "sequence_from_db": "NMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG", "sequence_from_broadstreet": "ETYNHTYRHRNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "GAAACCTACAATCATACATATCGGCACCGCAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "1", "query_start": 2694, "query_end": 2840, "hit_start": 378, "hit_end": 555, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.9}, "gnl|BL_ORD_ID|703|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.216869, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "36884", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|703|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.41006, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36884", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1643|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.222865, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1643|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.63268, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1084|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.225554, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "39583", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A +   DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 465, "hit_end": 591, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1084|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.25696, "max_identities": 17, "bit_score": 25.0238, "cvterm_id": "39583", "query": "GERLD---LEGARLQRVRLQEARLQGADLKRAHLSDLDL-SRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "GE++D     G +++          GADL            R + +G N S+      +     +  A   N N L  E+", "sequence_from_db": "GEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEI", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 2682, "query_end": 2909, "hit_start": 21, "hit_end": 261, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 21.25}, "gnl|BL_ORD_ID|1868|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.257754, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1868|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.63268, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|2119|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.364026, "max_identities": 14, "bit_score": 28.4906, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKL", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|2119|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.456775, "max_identities": 20, "bit_score": 28.4906, "cvterm_id": "35914", "query": "VRLQEARLQGADLKRAHLSDLDLSR----------ANLQGANLSKVIFSGTVL-----NDVQVDQATLENTN", "match": "+ ++E R QGAD + A   ++  +R          +NL  AN SKV+     L     N  Q+  AT   ++", "sequence_from_db": "IEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSD", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 2721, "query_end": 2891, "hit_start": 249, "hit_end": 465, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.78}, "gnl|BL_ORD_ID|2119|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.567912, "max_identities": 18, "bit_score": 28.1054, "cvterm_id": "35914", "query": "LDLEGARLQRVRLQEARLQGADLKRAHLSDLDLS-----------RANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "L  EG ++ R R    +++ A  +    S  DL+           RA+ QG N ++      +     +  A   ++N L  E+", "sequence_from_db": "LIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEI", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 6, "hit_end": 258, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 21.43}, "gnl|BL_ORD_ID|2118|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.367346, "max_identities": 14, "bit_score": 28.4906, "cvterm_id": "35915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKL", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 33.33}, "gnl|BL_ORD_ID|2118|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.452648, "max_identities": 20, "bit_score": 28.4906, "cvterm_id": "35915", "query": "VRLQEARLQGADLKRAHLSDLDLSR----------ANLQGANLSKVIFSGTVL-----NDVQVDQATLENTN", "match": "+ ++E R QGAD + A   ++  +R          +NL  AN SKV+     L     N  Q+  AT   ++", "sequence_from_db": "IEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSD", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 2721, "query_end": 2891, "hit_start": 249, "hit_end": 465, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.78}, "gnl|BL_ORD_ID|2118|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.03212, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "35915", "query": "LDLEGARLQRVRLQEARLQGADLKRAHLSDLDLS-----------RANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPEL", "match": "L  EG ++ R R    +++ A  +    S  DL+           R + QG N ++      +     +  A   ++N L  E+", "sequence_from_db": "LIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEI", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 2691, "query_end": 2909, "hit_start": 6, "hit_end": 258, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 20.24}, "gnl|BL_ORD_ID|1159|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.382408, "max_identities": 13, "bit_score": 28.4906, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        +       DL  + L DLD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.95}, "gnl|BL_ORD_ID|1159|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.50547, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "36915", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 285, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1159|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.83292, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|1692|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.385081, "max_identities": 26, "bit_score": 28.4906, "cvterm_id": "35715", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRA----------NLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQA", "match": "++E   L++  L E R  G  L  A L + DLSR           +LQGANL      G  L+  +VD + ++  +    +LL+A", "sequence_from_db": "NMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDG--LDPRKVDTSGIKIASWQQEQLLEA", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 2694, "query_end": 2918, "hit_start": 381, "hit_end": 630, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.59}, "gnl|BL_ORD_ID|475|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.395024, "max_identities": 18, "bit_score": 28.4906, "cvterm_id": "35743", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "+R  LEG    R +L+ A  +  DL  ++  +     L++S    QGA+     F   +        A +  TN", "sequence_from_db": "DRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTN", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 2685, "query_end": 2891, "hit_start": 138, "hit_end": 360, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 24.32}, "gnl|BL_ORD_ID|475|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.486735, "max_identities": 17, "bit_score": 28.1054, "cvterm_id": "35743", "query": "AAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "A  RG   DL            A   G DL    L +LD  R NL G  L", "sequence_from_db": "AVFRGS--DLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKL", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 2670, "query_end": 2819, "hit_start": 444, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 34.0}, "gnl|BL_ORD_ID|758|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.456775, "max_identities": 18, "bit_score": 28.4906, "cvterm_id": "35711", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "+R  LEG    R +L+ A  +  DL  ++  +     L++S    QGA+     F   +        A +  TN", "sequence_from_db": "DRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTN", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 2685, "query_end": 2891, "hit_start": 138, "hit_end": 360, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 24.32}, "gnl|BL_ORD_ID|758|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.952171, "max_identities": 17, "bit_score": 27.335, "cvterm_id": "35711", "query": "AAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "A  RG   DL            A   G DL    L +LD  R NL G  L", "sequence_from_db": "AVFRGS--DLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKL", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 2670, "query_end": 2819, "hit_start": 444, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 34.0}, "gnl|BL_ORD_ID|1062|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.55342, "max_identities": 15, "bit_score": 28.1054, "cvterm_id": "39525", "query": "LQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "++R  L+      +DL+ A   +  LS +  +GAN   + F    L      QA+  N", "sequence_from_db": "IERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMN", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2712, "query_end": 2885, "hit_start": 144, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1062|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.65739, "max_identities": 16, "bit_score": 27.7202, "cvterm_id": "39525", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "E+ DL   R     L  A  + +DL R   S+   S+  LQG +LS", "sequence_from_db": "EKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLS", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2685, "query_end": 2822, "hit_start": 402, "hit_end": 540, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 34.78}, "gnl|BL_ORD_ID|1062|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.03112, "max_identities": 11, "bit_score": 25.7942, "cvterm_id": "39525", "query": "EARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "+ RLQG DL  + L  LD  + +L G  + ", "sequence_from_db": "QCRLQGCDLSHSELYGLDPRKVDLTGVKIC", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2733, "query_end": 2822, "hit_start": 510, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 36.67}, "gnl|BL_ORD_ID|408|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.65739, "max_identities": 16, "bit_score": 27.7202, "cvterm_id": "36936", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "E+ DL   R     L  A  + +DL R   S+   S+  LQG +LS", "sequence_from_db": "EKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLS", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2685, "query_end": 2822, "hit_start": 402, "hit_end": 540, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 34.78}, "gnl|BL_ORD_ID|408|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.97035, "max_identities": 15, "bit_score": 27.335, "cvterm_id": "36936", "query": "LQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "++R  L+      +DL+ A   +  LS +  +GAN   + F    L      QA+  N", "sequence_from_db": "IERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMN", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2712, "query_end": 2885, "hit_start": 144, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 25.86}, "gnl|BL_ORD_ID|408|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.00387, "max_identities": 11, "bit_score": 25.7942, "cvterm_id": "36936", "query": "EARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "+ RLQG DL  + L  LD  + +L G  + ", "sequence_from_db": "QCRLQGCDLSHSELYGLDPRKVDLTGVKIC", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2733, "query_end": 2822, "hit_start": 510, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 36.67}, "gnl|BL_ORD_ID|1506|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.746884, "max_identities": 13, "bit_score": 27.7202, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L +LD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 498, "hit_end": 624, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.95}, "gnl|BL_ORD_ID|1506|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.84083, "max_identities": 17, "bit_score": 25.7942, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 258, "hit_end": 444, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}, "gnl|BL_ORD_ID|1506|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.49173, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "36915", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDR", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   +        A + NTN  +    +  +++", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2700, "query_end": 2930, "hit_start": 189, "hit_end": 435, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 18.29}, "gnl|BL_ORD_ID|1839|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.918277, "max_identities": 13, "bit_score": 27.335, "cvterm_id": "35914", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "D  G        + A     DL  + L DLD+   +LQG  L", "sequence_from_db": "DFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.95}, "gnl|BL_ORD_ID|1839|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.87208, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "35914", "query": "VRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "+ ++  R QGAD + A   ++ ++R     A +   NLS   FS  VL   ++", "sequence_from_db": "IEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2721, "query_end": 2864, "hit_start": 249, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1839|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.73247, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "35914", "query": "EGARLQRVRLQEARLQGADLKRAHLSD-----LDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTN", "match": "+G    R  L++A  +  DL  A   +     +++     QGA+     F   ++       A + NTN", "sequence_from_db": "KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTN", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 2700, "query_end": 2891, "hit_start": 153, "hit_end": 360, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 21.74}, "gnl|BL_ORD_ID|1717|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.997059, "max_identities": 15, "bit_score": 27.335, "cvterm_id": "36789", "query": "LQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLEN", "match": "++R  L+      +DL+ A   +  LS +  +GAN   + F    L      QA+  N", "sequence_from_db": "IERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMN", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2712, "query_end": 2885, "hit_start": 144, "hit_end": 318, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1717|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.22968, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "36789", "query": "ERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "E+ DL   R     L     + +DL R   S+   S+  LQG +LS", "sequence_from_db": "EKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLS", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2685, "query_end": 2822, "hit_start": 402, "hit_end": 540, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 32.61}, "gnl|BL_ORD_ID|1717|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.87127, "max_identities": 11, "bit_score": 25.7942, "cvterm_id": "36789", "query": "EARLQGADLKRAHLSDLDLSRANLQGANLS", "match": "+ RLQG DL  + L  LD  + +L G  + ", "sequence_from_db": "QCRLQGCDLSHSELYGLDPRKVDLTGVKIC", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 2733, "query_end": 2822, "hit_start": 510, "hit_end": 600, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 36.67}, "gnl|BL_ORD_ID|869|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.65427, "max_identities": 13, "bit_score": 26.5646, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANL", "match": "DL G        + A     DL  + L  LD+   +LQG  L", "sequence_from_db": "DLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2819, "hit_start": 462, "hit_end": 588, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 30.95}, "gnl|BL_ORD_ID|869|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2658, "orf_end": 3380, "orf_from": "BGC0001186.1|Misakinolide_5 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.63268, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "36915", "query": "DLEGARLQRVRLQEARLQGADLKRAHLSDLDLSR-----ANLQGANLSKVIFSGTVLNDVQV", "match": "D   A    + ++  R QGAD + A   ++  +R     A +   NLS   FS  VL   ++", "sequence_from_db": "DFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 2694, "query_end": 2864, "hit_start": 222, "hit_end": 408, "orf_dna_sequence": "GTGGCGTGGCGTGCGGCGCATCGGGGAGAGCGGTTGGACCTCGAAGGGGCCAGACTCCAAAGGGTCAGACTCCAAGAGGCCAGACTCCAAGGGGCCGACCTCAAAAGGGCCCACCTGAGTGATTTGGATCTCAGTAGAGCAAATCTTCAAGGCGCGAACCTCAGCAAGGTCATTTTCAGTGGTACGGTCCTCAATGATGTACAGGTCGATCAGGCAACACTTGAAAATACGAACCCTTTATTCCCTGAGTTGTTGCAAGCGTTTGTCGATCGCTTTTCGCCTCCAGATGGTCTGTTTCGAATTATTCGCGAAATCGAATTTCCGCCCGAGTACCGGCAAGCAGGCATCGGTATACTTCACTATTTTAGCGAGATTCTGCGCCATGAATATCCTGACGTTATTGTTCCTGTTCGCATTGAGCAAGAAGTTCTTATTGTACGGATGATCATCGAGACGCCGGAGGGGCAGCAGGACACGATTGAGCGTACGCTTGCAGACTATGGCTTAGTGGTGACGGGTAAAATGCCACCGGAGCAATTCTTATCTGATCCCTATGCGGTGATAGCCGTGAAAAGTGAGCTGCGTGTCGCCCATGGGCGAATCGAGACTCAGAAAGAGCTTATCGAAACAGCTCAATACTATGCTATGGTCAACAACAGCAAGATCAGATCGCATTTCAACAAAATCGCATCACCTTCCTCGAATCCCAAGTCGGCAAATTAA", "orf_prot_sequence": "MAWRAAHRGERLDLEGARLQRVRLQEARLQGADLKRAHLSDLDLSRANLQGANLSKVIFSGTVLNDVQVDQATLENTNPLFPELLQAFVDRFSPPDGLFRIIREIEFPPEYRQAGIGILHYFSEILRHEYPDVIVPVRIEQEVLIVRMIIETPEGQQDTIERTLADYGLVVTGKMPPEQFLSDPYAVIAVKSELRVAHGRIETQKELIETAQYYAMVNNSKIRSHFNKIASPSSNPKSAN", "perc_identity": 27.42}}, "BGC0001186.1|Misakinolide_6 # 3429 # 3710 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.496": {"gnl|BL_ORD_ID|3516|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3429, "orf_end": 3710, "orf_from": "BGC0001186.1|Misakinolide_6 ", "model_name": "EAM-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "575", "model_id": "4585", "ARO_accession": "3006873", "ARO_name": "EAM-1", "ARO_category": {"43865": {"category_aro_accession": "3005405", "category_aro_cvterm_id": "43865", "category_aro_name": "EAM beta-lactamase", "category_aro_description": "EAM beta-lactamase are class B3 beta-lactamases found in Qipengyuania aquimaris.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.19061, "max_identities": 9, "bit_score": 24.2534, "cvterm_id": "35506", "query": "VGWDNRSSSFWPRSSDHFDHFGKHQS", "match": "+G+D +   +   S +HFDH G H +", "sequence_from_db": "LGFDAKDVRYLLMSHEHFDHVGAHAA", "sequence_from_broadstreet": "MSVKALFAALPLLIAACAAIPAPQVEDADAPPSPAPTETVVNAHEMQMAFLDACEPWDEWDKPAPPFQLMGNSWYVGTCGISAVLITGEDGHILIDSGVPEAAPLVLANIASLGFDAKDVRYLLMSHEHFDHVGAHAAIKEATGAQVLASVRAKPVLETGKVAADDPQAASGHPDMTPVKVDRVIGDGEILDLGNLRVTAHETPGHSPGALSWTWWSCSLPGEPPVCNRFAYVDSLSAVSADDYRFTDHPEMVRAFRTSIDKARMLQCEFLVTPHPSAGSMLDLMSGEHGLYLHKGCGFYAKRLSKRLDERLAKEAAE", "dna_sequence_from_broadstreet": "ATGTCCGTTAAAGCGCTGTTCGCGGCCCTGCCCTTGCTCATCGCTGCTTGCGCGGCAATTCCAGCACCGCAAGTTGAAGATGCGGACGCGCCGCCCTCGCCCGCGCCAACGGAAACGGTGGTGAACGCCCACGAGATGCAGATGGCGTTTCTCGATGCGTGCGAGCCGTGGGACGAGTGGGACAAGCCCGCTCCACCGTTCCAATTGATGGGCAACAGCTGGTATGTCGGCACCTGCGGTATCTCGGCAGTCCTGATTACCGGCGAAGACGGACACATCCTGATCGACAGCGGCGTCCCCGAGGCCGCCCCGCTGGTCCTCGCGAACATCGCCTCGCTCGGTTTCGATGCGAAGGATGTGCGCTATCTCCTGATGAGCCATGAGCATTTCGACCATGTCGGCGCGCATGCCGCAATCAAGGAAGCGACAGGTGCGCAAGTGTTGGCTTCGGTAAGAGCCAAGCCCGTGCTCGAAACGGGGAAAGTCGCCGCCGACGATCCGCAGGCCGCATCCGGCCATCCAGACATGACCCCGGTAAAGGTCGACCGCGTGATCGGCGATGGGGAAATACTCGATCTCGGCAACCTGCGCGTTACGGCTCATGAAACGCCCGGCCATTCGCCCGGGGCGCTCAGCTGGACATGGTGGTCGTGTTCGCTCCCTGGCGAGCCGCCCGTGTGCAACCGCTTCGCCTATGTCGACAGCCTGTCCGCGGTTTCCGCAGACGATTACCGCTTCACCGATCACCCGGAGATGGTTCGCGCATTCCGGACCAGCATCGACAAGGCACGCATGCTCCAGTGTGAGTTTCTGGTGACACCGCACCCCTCGGCCGGGTCCATGCTCGACCTGATGAGCGGAGAACACGGGCTCTACCTGCACAAGGGCTGCGGCTTCTATGCAAAGCGGCTTAGCAAACGCCTCGATGAGCGCTTGGCCAAGGAAGCTGCCGAGTGA", "partial": "0", "query_start": 3486, "query_end": 3563, "hit_start": 336, "hit_end": 414, "orf_dna_sequence": "ATGTGGTCATCCCGACAGTACCCGTTTGATCTCCCTGTGAGGCCACGGTTTGTGGTGGTGGGCTGGGATAATCGCAGCTCCTCTTTCTGGCCTCGTTCGAGTGATCATTTTGATCATTTTGGCAAACATCAGAGCGGGATTTATATGCCTCAGGGTCCTGAATTTATCCGTTGTGATTATCCCAACCCACCACCCGGTTTGTCATCCCTCAATCTGAACGCAACTCTCGATTCCCATGCGATTTATCCACCCGTTAAGTCACGAAACCCTGCAGTTGCTTAA", "orf_prot_sequence": "MWSSRQYPFDLPVRPRFVVVGWDNRSSSFWPRSSDHFDHFGKHQSGIYMPQGPEFIRCDYPNPPPGLSSLNLNATLDSHAIYPPVKSRNPAVA", "perc_identity": 34.62}}, "BGC0001186.1|Misakinolide_7 # 3664 # 4662 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.467": {"gnl|BL_ORD_ID|759|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3664, "orf_end": 4662, "orf_from": "BGC0001186.1|Misakinolide_7 ", "model_name": "vanD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "824", "ARO_accession": "3000005", "ARO_name": "vanD", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "39340": {"category_aro_accession": "3002906", "category_aro_cvterm_id": "39340", "category_aro_name": "Van ligase", "category_aro_description": "Van ligases synthesize alternative substrates for peptidoglycan synthesis that reduce vancomycin binding affinity.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "35948": {"category_aro_accession": "0000029", "category_aro_cvterm_id": "35948", "category_aro_name": "teicoplanin", "category_aro_description": "Teicoplanin is a glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria. Teicoplanin has a unique acyl-aliphatic chain, and binds to cell wall precursors to inhibit transglycosylation  and transpeptidation.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.21884, "max_identities": 18, "bit_score": 26.9498, "cvterm_id": "36779", "query": "QVDRITIYHWFNAWEHNGFPGLYSRKASGRLPLFTPDQ-KEQIRQWIKLFPRNLN", "match": "+VD+I + H F        P   S  A  R+P   PD+ +EQI++  K   R L ", "sequence_from_db": "EVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLG", "sequence_from_broadstreet": "MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWENYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYVGCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFGVNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGSIVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR", "dna_sequence_from_broadstreet": "ATGTATAAGCTTAAAATTGCAGTCCTGTTTGGAGGCTGCTCAGAGGAACATGATGTTTCAGTGAAATCTGCGATGGAGGTTGCAGCAAATATAAACAAGGAAAAATACCAGCCGTTTTATATTGGAATCACAAAATCCGGCGCATGGAAACTATGCGATAAGCCCTGCCGGGACTGGGAGAACTATGCGGGATACCCGGCTGTGATTTCTCCGGACAGAAGGATCCATGGCCTGCTGATACAAAAGGACGGCGGATATGAGAGCCAGCCTGTAGACGTGGTGCTTCCGATGATTCATGGAAAATTTGGCGAGGACGGAACCATACAGGGTCTGCTTGAGCTGTCCGGCATTCCTTATGTGGGATGCGACATTCAAAGTTCTGTAATCTGTATGGATAAGTCGCTCGCTTATATGGTTGTGAAAAATGCGGGAATTGAGGTACCTGGGTTTCGAGTTCTACAAAAGGGGGACAGCCTGGAAGCAGAGACGCTCTCGTATCCGGTCTTTGTAAAGCCTGCCCGTTCCGGCTCCTCTTTTGGCGTGAATAAGGTATGCCGGGCAGAGGAACTGCAGGCAGCGGTCACAGAGGCGGGTAAGTATGACAGCAAAATATTGGTTGAGGAGGCCGTTTCCGGGAGTGAGGTAGGATGTGCCATACTGGGAAACGGAAACGATCTCATCACCGGCGAGGTCGATCAGATTGAATTGAAACACGGGTTTTTTAAGATCCATCAGGAAGCACAGCCGGAAAAGGGGTCTGAAAATGCTGTGATTAGAGTTCCAGCCGCCCTGCCGGATGAAGTTAGGGAGCAGATTCAGGAAACGGCGAAGAAGATTTACCGGGTACTTGGCTGCAGAGGTCTGGCCCGCATTGATTTGTTTTTACGGGAGGATGGAAGCATTGTCCTGAATGAAGTGAACACCATGCCCGGATTTACTTCCTATAGCCGTTATCCACGCATGATGACAGCAGCAGGGTTTACGCTTTCTGAAATATTGGACCGCTTGATTGGACTTTCACTTAGGAGGTAA", "partial": "0", "query_start": 3814, "query_end": 3975, "hit_start": 687, "hit_end": 852, "orf_dna_sequence": "ATGCGATTTATCCACCCGTTAAGTCACGAAACCCTGCAGTTGCTTAACCGTGTTCACAAACAAAGCCGTCATCACCGCGTCCGCCAACGCGCTCATTGTATTGTGCTGAGTTCTCAAGGTTACACGACCACGCATCGTGCTGACATTTTTCAGGTAGATCGCATCACCATTTATCATTGGTTCAATGCCTGGGAGCACAATGGATTTCCAGGCTTATACTCCCGTAAAGCGTCAGGTCGCCTGCCTCTATTCACGCCGGATCAAAAAGAGCAGATTCGACAGTGGATCAAACTCTTTCCCAGGAATCTGAACAAGATTCGATCCCTCATCCACGATGAATTTGGTCTCAAGGTCAGCAAGCAAACCATTAAGCGGGTGTTGAAATCCTATCGCTTGATCTGGAAACGCATGCGTAAGCGCGTAAAGGGGCAACCGGCTCCTGAGCTGTACCAACAACGTAAAGCAGCTCTTGAGATACTCCAGACAGAAGATTGCGACGGGATTATTGACCTGCGATATTTTGATGAATCTGGATTTTGCTTAGTGCCTTACGTGCCTTATGCCTGGCAGCAAAGTGGTCACACGATTTCGCTTGAGAGTACCCAAAGTAAGCGTTTGAAAGTCTTGGGATTTATGAACAAGCGCAACGAGTTAGAAGCCTATACATTTGAAGGCACCGTAGATGGCGCCGTGGTCATTCGGTGTATAGACGAATTTTGTAAAACTCTCCAAGGTCCTACAATTGTGGTGATGGATAATGCCTCGCTTCCTACCAGGCCGACTTTCCAAGCACAGCTCCCGAGATGGGAACAGCAGGGCTTAGAGATTTTCTACCTTCCCGAGTATTCGCCGCACTTGCACCTCATTGAAATTTTATGGCGATTTATGAAGTACGAATGGATTGAATCATGGGCATACACGAGCTGGAGTCATCTGGTTCGCTATATCGACGAGGTCATTCAGAATGTTGGAGACAAATATAAAATTCATTTTGGATAG", "orf_prot_sequence": "MRFIHPLSHETLQLLNRVHKQSRHHRVRQRAHCIVLSSQGYTTTHRADIFQVDRITIYHWFNAWEHNGFPGLYSRKASGRLPLFTPDQKEQIRQWIKLFPRNLNKIRSLIHDEFGLKVSKQTIKRVLKSYRLIWKRMRKRVKGQPAPELYQQRKAALEILQTEDCDGIIDLRYFDESGFCLVPYVPYAWQQSGHTISLESTQSKRLKVLGFMNKRNELEAYTFEGTVDGAVVIRCIDEFCKTLQGPTIVVMDNASLPTRPTFQAQLPRWEQQGLEIFYLPEYSPHLHLIEILWRFMKYEWIESWAYTSWSHLVRYIDEVIQNVGDKYKIHFG", "perc_identity": 32.73}}, "BGC0001186.1|Misakinolide_8 # 4800 # 7088 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=11bp;gc_cont=0.559": {"gnl|BL_ORD_ID|4649|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 4800, "orf_end": 7088, "orf_from": "BGC0001186.1|Misakinolide_8 ", "model_name": "VIM-71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5720", "ARO_accession": "3005519", "ARO_name": "VIM-71", "ARO_category": {"36030": {"category_aro_accession": "3000021", "category_aro_cvterm_id": "36030", "category_aro_name": "VIM beta-lactamase", "category_aro_description": "The Verone integron-encoded metallo-beta-lactamase (VIM) family was reported from Italy in 1999. There are, to date, 23 reported variants.  VIM enzymes mostly occur in P. aeruginosa, also P. putida and, very rarely, Enterobacteriaceae. Integron-associated, sometimes within plasmids. Hydrolyses all beta-lactams except monobactams, and evades all beta-lactam inhibitors.  There is a strong incidence of these in East Asia.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.31651, "max_identities": 20, "bit_score": 26.1794, "cvterm_id": "43205", "query": "LLRRLESNLDVRIRLHGLTDQLDMGGGIIVANHFTRLETFVVPFVVHRATNIILRILASHVLFGN", "match": "L RRL       I  H L      G  +     F  +E F  P   H   NI++ + +S+VLFG ", "sequence_from_db": "LTRRLAEAEGNEIPTHSLEGLASSGDAV----RFGPVELFY-PGAAHSTDNIVVYVPSSNVLFGG", "sequence_from_broadstreet": "MSKVISRLLVYMTASVMAVASSLSHSGAPSGEYPTVNEIPVGEVRLFQIADSVWSHIATQSFNGTVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPITRAVSTHFHDDRVGGDDVLRAAGVATYASPLTRRLAEAEGNEIPTHSLEGLASSGDAVRFGPVELFYPGAAHSTDNIVVYVPSSNVLFGGCAVHELSRTSAGNVADADLAEWPTSLERIQERYPEAEVVIPGHGLPGTLDLLQHTANVVKAHKIRSVAE", "dna_sequence_from_broadstreet": "ATGTCAAAAGTTATTAGTAGATTATTGGTCTACATGACCGCGTCCGTCATGGCTGTGGCTAGTTCGTTAAGCCATTCCGGGGCGCCGAGTGGTGAGTATCCGACAGTCAACGAAATTCCGGTCGGAGAGGTCCGGCTTTTCCAGATTGCCGATAGTGTTTGGTCGCATATCGCAACGCAGTCGTTTAATGGCACGGTCTACCCGTCCAATGGACTCATTGTCCGTGATGGTGATGAGTTGCTATTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCCCTTCTCGCGGAGATTGAGAAGCAAATTGGCCTTCCCATAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGATGATGTGCTTCGGGCGGCTGGGGTGGCCACGTACGCATCACCGTTGACACGCCGGCTAGCCGAGGCAGAGGGGAACGAGATTCCCACGCACTCTCTAGAAGGACTCGCATCGAGTGGGGACGCAGTGCGCTTCGGCCCAGTAGAGCTCTTCTATCCTGGTGCTGCGCATTCGACCGACAATATCGTTGTATACGTCCCGTCATCGAACGTGCTATTCGGTGGTTGTGCCGTTCATGAGTTGTCACGCACGTCTGCGGGGAACGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCCTTGAGCGGATTCAAGAACGCTACCCGGAAGCAGAGGTCGTCATTCCCGGGCACGGTCTACCGGGCACTCTAGACTTACTCCAGCACACAGCGAACGTTGTCAAAGCACACAAAATTCGCTCAGTCGCCGAGTAG", "partial": "0", "query_start": 4863, "query_end": 5057, "hit_start": 411, "hit_end": 591, "orf_dna_sequence": "ATGCAACCGCCAGAGCTCGATCTACCGCCGATCAACACGCGGAATCACAATCTGACCCTATTTTTACTCAGGCGCCTGGAAAGCAATCTCGACGTCCGCATTCGGCTCCATGGTCTCACCGATCAACTCGACATGGGTGGTGGCATCATCGTGGCTAATCACTTCACCCGCCTTGAGACGTTTGTGGTGCCGTTTGTGGTGCATCGCGCGACCAATATTATCCTCCGGATTCTCGCCTCCCATGTCCTCTTTGGCAACAAAACCTTTGGTGATTATCTCATGAGTATTGGGGCCTTGCCCACCAATCACCCCAACAAATATGAGCTCATCGCCCGCGACATTCTCAACGGTGGCTGGTGGTTGATTTTTCCTGAAGGTGGCTTGATCAAAGACCGCCGAGTGATTGAAAAAGGCCGACTCAACGTCACGACCGATGCCGGTCAGGTGCGACGCCGGCCGCGCTCGGGCTCCGCCATCTTGGCGATGACCGTGCAACGCTATAAAGCGGCGTTGCGCCAAGCGCTAGAACACAACGGCGACATACAGAGCATCTGCGAATCGCTCGGACTAGACGATCGCCGCCCCTCGGAACTCAAGGCGCTCGCTTTTCGCCCAACTCCGATCATACCGCTCAACATCACGTATTATCCGCTCAATCCACAGGAAAACGCGTTCAAATCCTTGGCCACACACATTTTACCCAATTTGCCGCACTCCACCTTTGGACAAGAGTTATTGGAGGAGCTCACCGTCGAGGGCTCGATGCTTCTCAAAGGGGTGGAAATCGATATGCGCTTTGGCAACCCTCTACTGGTCGGTGACGACGACTTACAGTTCGTTGACGATTGGCGCATCGTGCCCTGGTCACCATCGCCCTGGCGGCGCTATCTCAATGCGCTACGCTCGTGGCGCCCCATGCGACCCTACACCCATTTGGTCGATCGCTGGGCGGTATCGAGCAGTTGGCGGCAGCGCCAACGGGCTTGGCAGATCACGCGCACCACCATGCAGGCATTGTATCGCTTGGCAAACATTCATATCGGTCACTTGATCTCAGCCATCGTGCTGCAGACGTTACGCACGACAAAACAACGTCGTTTTGAAGTGTTAGAGCTGCAAAAACGCCTTTATCTCGCGACTCGGCGTCTCCAGGAAGGCGGCAATTTGGCACTGCATCCCAATCTCACCGACCCGGATCTACAATATCTCTTGGCCACCGAGACCCCGCATCCGTTTCTCGAAGACTTTGCTCGGCGAGCCAGCGAGTTGGAGTTGCTCACCGTCAAGGATCAAATGTGGGAACCCAATACGGAAATCTTGCTCGAGCCCTGGTCATTTAGCAGCATACGGTTGAAAAACTTCATTCAGGTTTACTTCAATGAAATCGAACCCGTCACCGAGGTGATGCAAGCGGTGCGCTACGCCATGCGAGCGGAGCTGGGAGACTACCGCGAGCTCTTTAGCGATGCCATGCACAACTACGAAGATCAGCTCTACGAAGCGGACCACGCCGAATTCGTCACCCCGGCAACCGCCGCGAAACTCACCCCTCTGGTCCCAGAGCACGGTCGCCCGGCCCTGCTGCGTGGCCACGGGAGCAACCGTGCCATTGGCATCCTCCTCCTACATGGCTTTAGCGCCTCGCCGGGTGAGGTGATGCCCTTGGCTAAAACCCTGAATGGACGCGGCTACACCGTCTATGTCGTGCGGCTGCGTGGCCACGGCACCTCGCCCTACGATCTACAACAACGCTCCTGGCAGGATTGGTACGACTCCGTACAGCGCGGCTACGCCTATCTTCGCACCATTACAGATGTACAATTTGTCGGCGGCATGTCGACCGGCGGCGGGCTCGCCCTCTATTTGTCCGTGCACGAACCGACCGTGTGCGGGGTGTTTGCCGTCGCGGCCCCGATCAGACTAACCAACCGCGCCATTCACCTGGCCCCCATTGTCAAAACCGTACGGGGCTTTGTCAATTCAAACCCAGGCAATCCCCACACCAACTATTTGGCTTTTCCGGTGCAAGCCCTACAAGAATTGTTGCAATTTATCTCCGCTTACAGCAAGACACTCCAAGATGTCACGGTCCCCACTTTGCTTATCCAAGCGCAAGGCGATACCACCGTGCGGCCCGATAGTGCCCAATACATCTACGATGAACTCGGTACGGAGACCAAAGAACTCATTTGGAAAGATGCCAACCAACACGTCATCGTCAGCGACGCCTTTCCGGATGTACACGACGATGTGTTGACCTTCTTACAACAACACCAGCCATCATCGTAA", "orf_prot_sequence": "MQPPELDLPPINTRNHNLTLFLLRRLESNLDVRIRLHGLTDQLDMGGGIIVANHFTRLETFVVPFVVHRATNIILRILASHVLFGNKTFGDYLMSIGALPTNHPNKYELIARDILNGGWWLIFPEGGLIKDRRVIEKGRLNVTTDAGQVRRRPRSGSAILAMTVQRYKAALRQALEHNGDIQSICESLGLDDRRPSELKALAFRPTPIIPLNITYYPLNPQENAFKSLATHILPNLPHSTFGQELLEELTVEGSMLLKGVEIDMRFGNPLLVGDDDLQFVDDWRIVPWSPSPWRRYLNALRSWRPMRPYTHLVDRWAVSSSWRQRQRAWQITRTTMQALYRLANIHIGHLISAIVLQTLRTTKQRRFEVLELQKRLYLATRRLQEGGNLALHPNLTDPDLQYLLATETPHPFLEDFARRASELELLTVKDQMWEPNTEILLEPWSFSSIRLKNFIQVYFNEIEPVTEVMQAVRYAMRAELGDYRELFSDAMHNYEDQLYEADHAEFVTPATAAKLTPLVPEHGRPALLRGHGSNRAIGILLLHGFSASPGEVMPLAKTLNGRGYTVYVVRLRGHGTSPYDLQQRSWQDWYDSVQRGYAYLRTITDVQFVGGMSTGGGLALYLSVHEPTVCGVFAVAAPIRLTNRAIHLAPIVKTVRGFVNSNPGNPHTNYLAFPVQALQELLQFISAYSKTLQDVTVPTLLIQAQGDTTVRPDSAQYIYDELGTETKELIWKDANQHVIVSDAFPDVHDDVLTFLQQHQPSS", "perc_identity": 30.77}}, "BGC0001186.1|Misakinolide_9 # 7385 # 8065 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.593": {"gnl|BL_ORD_ID|3785|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7385, "orf_end": 8065, "orf_from": "BGC0001186.1|Misakinolide_9 ", "model_name": "OXA-520", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4855", "ARO_accession": "3005750", "ARO_name": "OXA-520", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.61193, "max_identities": 24, "bit_score": 26.1794, "cvterm_id": "36752", "query": "QGGLFISASPLLQALADALRAEDIATCMADINWSHIATARLNGF--KTHYGNALTENALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVPHLRGH", "match": "+G + +SA P+ Q +A                   +   R+  +  K  YGN      +D   L+G  R+ A+   ++   L +L+  +L    E   +V      E  P    H", "sequence_from_db": "RGAIQVSAVPVFQQIA-----------------REVGEVRMQKYLKKFSYGNQNISGGIDKFGLEGQLRISAV---NQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVH", "sequence_from_broadstreet": "MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFGLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG", "dna_sequence_from_broadstreet": "ATGAAAACATTTGCCGCATATGTAATTATCGCGTGTCTTTCGAGTACGGCATTAGCTGGTTCAATTACAGAAAATACGTCTTGGAACAAAGAGTTCTCTGCCGAAGCCGTCAATGGTGTCTTCGTGCTTTGTAAAAGTAGCAGTAAATCCTGCGCTACCAATGACTTAGCTCGTGCATCAAAGGAATATCTTCCAGCATCAACATTTAAGATCCCCAACGCAATTATCGGCCTAGAAACTGGTGTCATAAAGAATGAGCATCAGGTTTTCAAATGGGACGGAAAGCCAAGAGCCATGAAGCAATGGGAAAGAGACTTGACCTTAAGAGGGGCAATACAAGTTTCAGCTGTTCCCGTATTTCAACAAATCGCCAGAGAAGTTGGCGAAGTAAGAATGCAGAAATACCTTAAAAAATTTTCCTATGGCAACCAGAATATCAGTGGTGGCATTGACAAATTCGGGTTGGAAGGCCAGCTTAGAATTTCCGCAGTTAATCAAGTGGAGTTTCTAGAGTCTCTATATTTAAATAAATTGTCAGCATCTAAAGAAAACCAGCTAATAGTAAAAGAGGCTTTGGTAACGGAGGCGGCACCTGAATATCTAGTGCATTCAAAAACTGGTTTTTCTGGTGTGGGAACTGAGTCAAATCCTGGTGTCGCATGGTGGGTTGGGTGGGTTGAGAAGGAGACAGAGGTTTACTTTTTCGCCTTTAACATGGATATAGACAACGAAAGTAAGTTGCCGCTAAGAAAATCCATTCCCACCAAAATCATGGAAAGTGAGGGCATCATTGGTGGCTAA", "partial": "0", "query_start": 7607, "query_end": 7945, "hit_start": 324, "hit_end": 609, "orf_dna_sequence": "ATGCCGTGGCCAGAGCGCGCCTTTCTCGCCTGGGTAGCACCGCGCGGCATTGTGGCCGCGGCGATGGCCTCCATTTTTACCTTGCGCTTACAAGCCGAGGGCTATGCCCAAGCCGATCAACTCGTGCCGATTACTTTTTTGGTCATCATTGGTTGCGTCGCGGTTTACGGCCTCACCGCGACCCCCGTCGCCCGCTGGTTGGGGGTAGCTCAAGACAACCCACAAGGGGGCCTGTTCATCAGCGCCTCACCGCTGTTGCAAGCCCTGGCCGACGCCCTCCGAGCCGAAGACATCGCCACCTGTATGGCCGACATCAACTGGTCCCATATTGCCACTGCCCGCCTTAACGGCTTCAAAACCCACTATGGTAACGCCCTCACCGAAAACGCGCTCGACAATATGGATCTCGATGGTATTGGTCGCGTGCTCGCCCTCACCCCCAATGATGAAGCCAACGCACTGGCCGCACTTCACTTTGCCGAGCTGTTCGGCCACGCCGAAGCCTATAAGCTGGTGCCCAGCACCGCTAACCGCGAAACCGTGCCGCACCTACGCGGGCACTTTCTCTTTGATGAAAGCGCCAATTACAACGTCCTGAGCTTGCATCTGGCGTCCGGTGCGACCATCAAAACCACGGGTCTCAGCGAGCAGTTCGACTACGAGGCTTTTCAAGACTACTAA", "orf_prot_sequence": "MPWPERAFLAWVAPRGIVAAAMASIFTLRLQAEGYAQADQLVPITFLVIIGCVAVYGLTATPVARWLGVAQDNPQGGLFISASPLLQALADALRAEDIATCMADINWSHIATARLNGFKTHYGNALTENALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVPHLRGHFLFDESANYNVLSLHLASGATIKTTGLSEQFDYEAFQDY", "perc_identity": 20.87}, "gnl|BL_ORD_ID|325|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7385, "orf_end": 8065, "orf_from": "BGC0001186.1|Misakinolide_9 ", "model_name": "ErmU", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "356", "ARO_accession": "3001305", "ARO_name": "ErmU", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.7946, "max_identities": 18, "bit_score": 25.409, "cvterm_id": "36862", "query": "THYGNALTE-----NALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVP", "match": "T  G+ L E       + + DL    R   ++P      L A  +A L+G A   + VP T     +P", "sequence_from_db": "TGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLP", "sequence_from_broadstreet": "MPSRYGSRQDLGQNFLVDPDIIKLIRRAPNERKVPSLIWRRRGHVTLPLSRLGRPVTAVELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWVSAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERRPEPLVRERREYQAFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG", "dna_sequence_from_broadstreet": "GTGCCCAGCCGGTACGGCAGCCGGCAGGACCTCGGTCAGAACTTCCTCGTCGACCCCGACATCATCAAGCTGATCCGCCGAGCGCCGAACGAGCGGAAGGTCCCATCGTTGATCTGGCGCCGGAGAGGGCACGTGACGCTGCCCTTGAGTCGCTTGGGCCGCCCGGTCACCGCGGTTGAGCTCGACCCCCGCCGGGTCAAACGGCTCTCGGCGCGTGCCCCGGAAAACGTCAAGGTCGTCGGCGAGGACATCCTGCGCTTCCGGCTCCCGACCGTTCCGCACACCGTCGTGGGGAACATCCCCTTCCATGTCACGACGGCCACGATGCGCCGGATCCTCGTGGCTCCCGCATGGGTGTCGGCCGTCCTCGTGGTGCAGTGGGAAGTGGCGCGCCGCCGGGCCGGCATCGGCGGCTGCTCGCTGGTCACGGCGGAGTCCTGGCCGTGGTTCGACTTCTCGGTGCTCAAGCGGGTGCCGAGGTTCGCCTTCCGGCCCGCGCCCTCCGTGGACGGCGGGATCCTCGTCATCGAGCGGCGGCCCGAGCCACTGGTGCGGGAGCGCAGGGAGTACCAGGCATTCGTCAGACAGGTCTTCACCGGGCGCGGTCACGGGCTGCGGGAGATCCTCCAACGCATCGGGCGGGTCCAGGACAGCGACCTGTCCGCGTGGTTCAGGGCACATGGAGTCTCGCCGCAGGCGCTGCCGAAGGACCTCACCGCCGAGCAGTGGGCGTCGCTCTGGGGCATGGCGCGTGGCGGCCGGTCCGTGCCGCGGACGCGGCGACCCCGGGGCCTGCCGCCCCGCACGTCCCGCGGGCCGCGGCGCAACAGCGGCTGA", "partial": "0", "query_start": 7742, "query_end": 7930, "hit_start": 594, "hit_end": 798, "orf_dna_sequence": "ATGCCGTGGCCAGAGCGCGCCTTTCTCGCCTGGGTAGCACCGCGCGGCATTGTGGCCGCGGCGATGGCCTCCATTTTTACCTTGCGCTTACAAGCCGAGGGCTATGCCCAAGCCGATCAACTCGTGCCGATTACTTTTTTGGTCATCATTGGTTGCGTCGCGGTTTACGGCCTCACCGCGACCCCCGTCGCCCGCTGGTTGGGGGTAGCTCAAGACAACCCACAAGGGGGCCTGTTCATCAGCGCCTCACCGCTGTTGCAAGCCCTGGCCGACGCCCTCCGAGCCGAAGACATCGCCACCTGTATGGCCGACATCAACTGGTCCCATATTGCCACTGCCCGCCTTAACGGCTTCAAAACCCACTATGGTAACGCCCTCACCGAAAACGCGCTCGACAATATGGATCTCGATGGTATTGGTCGCGTGCTCGCCCTCACCCCCAATGATGAAGCCAACGCACTGGCCGCACTTCACTTTGCCGAGCTGTTCGGCCACGCCGAAGCCTATAAGCTGGTGCCCAGCACCGCTAACCGCGAAACCGTGCCGCACCTACGCGGGCACTTTCTCTTTGATGAAAGCGCCAATTACAACGTCCTGAGCTTGCATCTGGCGTCCGGTGCGACCATCAAAACCACGGGTCTCAGCGAGCAGTTCGACTACGAGGCTTTTCAAGACTACTAA", "orf_prot_sequence": "MPWPERAFLAWVAPRGIVAAAMASIFTLRLQAEGYAQADQLVPITFLVIIGCVAVYGLTATPVARWLGVAQDNPQGGLFISASPLLQALADALRAEDIATCMADINWSHIATARLNGFKTHYGNALTENALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVPHLRGHFLFDESANYNVLSLHLASGATIKTTGLSEQFDYEAFQDY", "perc_identity": 26.47}, "gnl|BL_ORD_ID|4649|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7385, "orf_end": 8065, "orf_from": "BGC0001186.1|Misakinolide_9 ", "model_name": "VIM-71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5720", "ARO_accession": "3005519", "ARO_name": "VIM-71", "ARO_category": {"36030": {"category_aro_accession": "3000021", "category_aro_cvterm_id": "36030", "category_aro_name": "VIM beta-lactamase", "category_aro_description": "The Verone integron-encoded metallo-beta-lactamase (VIM) family was reported from Italy in 1999. There are, to date, 23 reported variants.  VIM enzymes mostly occur in P. aeruginosa, also P. putida and, very rarely, Enterobacteriaceae. Integron-associated, sometimes within plasmids. Hydrolyses all beta-lactams except monobactams, and evades all beta-lactam inhibitors.  There is a strong incidence of these in East Asia.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.8819, "max_identities": 10, "bit_score": 24.6386, "cvterm_id": "43205", "query": "MADINWSHIATARLNG", "match": "+AD  WSHIAT   NG", "sequence_from_db": "IADSVWSHIATQSFNG", "sequence_from_broadstreet": "MSKVISRLLVYMTASVMAVASSLSHSGAPSGEYPTVNEIPVGEVRLFQIADSVWSHIATQSFNGTVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPITRAVSTHFHDDRVGGDDVLRAAGVATYASPLTRRLAEAEGNEIPTHSLEGLASSGDAVRFGPVELFYPGAAHSTDNIVVYVPSSNVLFGGCAVHELSRTSAGNVADADLAEWPTSLERIQERYPEAEVVIPGHGLPGTLDLLQHTANVVKAHKIRSVAE", "dna_sequence_from_broadstreet": "ATGTCAAAAGTTATTAGTAGATTATTGGTCTACATGACCGCGTCCGTCATGGCTGTGGCTAGTTCGTTAAGCCATTCCGGGGCGCCGAGTGGTGAGTATCCGACAGTCAACGAAATTCCGGTCGGAGAGGTCCGGCTTTTCCAGATTGCCGATAGTGTTTGGTCGCATATCGCAACGCAGTCGTTTAATGGCACGGTCTACCCGTCCAATGGACTCATTGTCCGTGATGGTGATGAGTTGCTATTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCCCTTCTCGCGGAGATTGAGAAGCAAATTGGCCTTCCCATAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGATGATGTGCTTCGGGCGGCTGGGGTGGCCACGTACGCATCACCGTTGACACGCCGGCTAGCCGAGGCAGAGGGGAACGAGATTCCCACGCACTCTCTAGAAGGACTCGCATCGAGTGGGGACGCAGTGCGCTTCGGCCCAGTAGAGCTCTTCTATCCTGGTGCTGCGCATTCGACCGACAATATCGTTGTATACGTCCCGTCATCGAACGTGCTATTCGGTGGTTGTGCCGTTCATGAGTTGTCACGCACGTCTGCGGGGAACGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCCTTGAGCGGATTCAAGAACGCTACCCGGAAGCAGAGGTCGTCATTCCCGGGCACGGTCTACCGGGCACTCTAGACTTACTCCAGCACACAGCGAACGTTGTCAAAGCACACAAAATTCGCTCAGTCGCCGAGTAG", "partial": "0", "query_start": 7688, "query_end": 7735, "hit_start": 144, "hit_end": 192, "orf_dna_sequence": "ATGCCGTGGCCAGAGCGCGCCTTTCTCGCCTGGGTAGCACCGCGCGGCATTGTGGCCGCGGCGATGGCCTCCATTTTTACCTTGCGCTTACAAGCCGAGGGCTATGCCCAAGCCGATCAACTCGTGCCGATTACTTTTTTGGTCATCATTGGTTGCGTCGCGGTTTACGGCCTCACCGCGACCCCCGTCGCCCGCTGGTTGGGGGTAGCTCAAGACAACCCACAAGGGGGCCTGTTCATCAGCGCCTCACCGCTGTTGCAAGCCCTGGCCGACGCCCTCCGAGCCGAAGACATCGCCACCTGTATGGCCGACATCAACTGGTCCCATATTGCCACTGCCCGCCTTAACGGCTTCAAAACCCACTATGGTAACGCCCTCACCGAAAACGCGCTCGACAATATGGATCTCGATGGTATTGGTCGCGTGCTCGCCCTCACCCCCAATGATGAAGCCAACGCACTGGCCGCACTTCACTTTGCCGAGCTGTTCGGCCACGCCGAAGCCTATAAGCTGGTGCCCAGCACCGCTAACCGCGAAACCGTGCCGCACCTACGCGGGCACTTTCTCTTTGATGAAAGCGCCAATTACAACGTCCTGAGCTTGCATCTGGCGTCCGGTGCGACCATCAAAACCACGGGTCTCAGCGAGCAGTTCGACTACGAGGCTTTTCAAGACTACTAA", "orf_prot_sequence": "MPWPERAFLAWVAPRGIVAAAMASIFTLRLQAEGYAQADQLVPITFLVIIGCVAVYGLTATPVARWLGVAQDNPQGGLFISASPLLQALADALRAEDIATCMADINWSHIATARLNGFKTHYGNALTENALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVPHLRGHFLFDESANYNVLSLHLASGATIKTTGLSEQFDYEAFQDY", "perc_identity": 62.5}, "gnl|BL_ORD_ID|666|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7385, "orf_end": 8065, "orf_from": "BGC0001186.1|Misakinolide_9 ", "model_name": "OXA-28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "721", "ARO_accession": "3001423", "ARO_name": "OXA-28", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.15917, "max_identities": 24, "bit_score": 24.6386, "cvterm_id": "36752", "query": "QGGLFISASPLLQALADALRAEDIATCMADINWSHIATARLNGF--KTHYGNALTENALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVPHLRGH", "match": "+G + +SA P+ Q +A                   +   R+  +  K  YGN      +D   L+G  R+ A+   ++   L +L   +L    E   +V      E  P    H", "sequence_from_db": "RGAIQVSAVPVFQQIA-----------------REVGEVRMQKYLKKFSYGNQNISGGIDKFGLEGQLRISAV---NQVEFLESLFLNKLSASKENQLIVKEALVTEAAPEYLVH", "sequence_from_broadstreet": "MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFGLEGQLRISAVNQVEFLESLFLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMDIDNENKLPLRKSIPTKIMASEGIIGG", "dna_sequence_from_broadstreet": "ATGAAAACATTTGCCGCATATGTAATTACTGCGTGTCTTTCAAGTACGGCATTAGCTAGTTCAATTACAGAAAATACGTCTTGGAACAAAGAGTTCTCTGCCGAAGCCGTCAATGGTGTTTTCGTGCTTTGTAAAAGTAGCAGTAAATCCTGCGCTACCAATAACTTAGCTCGTGCATCAAAGGAATATCTTCCAGCATCAACATTTAAGATCCCCAACGCAATTATCGGCCTAGAAACTGGTGTCATAAAGAATGAGCATCAGGTTTTCAAATGGGACGGAAAGCCAAGAGCCATGAAACAATGGGAAAGAGACTTGAGCTTAAGAGGGGCAATACAAGTTTCAGCGGTTCCCGTATTTCAACAAATCGCCAGAGAAGTTGGCGAAGTAAGAATGCAGAAATACCTTAAAAAATTTTCATATGGCAACCAGAATATCAGTGGTGGCATTGACAAATTCGGGTTGGAGGGTCAGCTAAGAATTTCCGCAGTTAATCAAGTGGAGTTTCTAGAGTCTCTATTTTTAAATAAATTGTCAGCATCAAAAGAAAATCAGCTAATAGTAAAAGAGGCTTTGGTAACGGAGGCTGCGCCTGAATATCTTGTGCATTCAAAAACTGGTTTTTCTGGTGTGGGAACTGAGTCAAATCCTGGTGTCGCATGGTGGGTTGGTTGGGTTGAGAAGGGAACAGAGGTTTACTTTTTCGCCTTTAACATGGATATAGACAACGAAAATAAGTTGCCGCTAAGAAAATCCATTCCCACCAAAATCATGGCAAGTGAGGGCATCATTGGTGGCTAA", "partial": "0", "query_start": 7607, "query_end": 7945, "hit_start": 324, "hit_end": 609, "orf_dna_sequence": "ATGCCGTGGCCAGAGCGCGCCTTTCTCGCCTGGGTAGCACCGCGCGGCATTGTGGCCGCGGCGATGGCCTCCATTTTTACCTTGCGCTTACAAGCCGAGGGCTATGCCCAAGCCGATCAACTCGTGCCGATTACTTTTTTGGTCATCATTGGTTGCGTCGCGGTTTACGGCCTCACCGCGACCCCCGTCGCCCGCTGGTTGGGGGTAGCTCAAGACAACCCACAAGGGGGCCTGTTCATCAGCGCCTCACCGCTGTTGCAAGCCCTGGCCGACGCCCTCCGAGCCGAAGACATCGCCACCTGTATGGCCGACATCAACTGGTCCCATATTGCCACTGCCCGCCTTAACGGCTTCAAAACCCACTATGGTAACGCCCTCACCGAAAACGCGCTCGACAATATGGATCTCGATGGTATTGGTCGCGTGCTCGCCCTCACCCCCAATGATGAAGCCAACGCACTGGCCGCACTTCACTTTGCCGAGCTGTTCGGCCACGCCGAAGCCTATAAGCTGGTGCCCAGCACCGCTAACCGCGAAACCGTGCCGCACCTACGCGGGCACTTTCTCTTTGATGAAAGCGCCAATTACAACGTCCTGAGCTTGCATCTGGCGTCCGGTGCGACCATCAAAACCACGGGTCTCAGCGAGCAGTTCGACTACGAGGCTTTTCAAGACTACTAA", "orf_prot_sequence": "MPWPERAFLAWVAPRGIVAAAMASIFTLRLQAEGYAQADQLVPITFLVIIGCVAVYGLTATPVARWLGVAQDNPQGGLFISASPLLQALADALRAEDIATCMADINWSHIATARLNGFKTHYGNALTENALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVPHLRGHFLFDESANYNVLSLHLASGATIKTTGLSEQFDYEAFQDY", "perc_identity": 20.87}, "gnl|BL_ORD_ID|4128|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7385, "orf_end": 8065, "orf_from": "BGC0001186.1|Misakinolide_9 ", "model_name": "OXA-905", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5198", "ARO_accession": "3006093", "ARO_name": "OXA-905", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.45696, "max_identities": 16, "bit_score": 24.2534, "cvterm_id": "37066", "query": "ALADALRAEDIATCMADINWSHIATARLNGFKTHYGNALTENALDNMDLDGIGRVLAL", "match": "+L DA++A ++           +   R N  +  YGNA    A+DN  L G  ++ A+", "sequence_from_db": "SLRDAIKASNVPVYQELARRIGLERMRANVSRLGYGNAEIGQAVDNFWLVGPLKISAM", "sequence_from_broadstreet": "MRPLLFSALLLLSGHAQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAETRFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQELARRIGLERMRANVSRLGYGNAEIGQAVDNFWLVGPLKISAMEQTRFLLRLAQGELPFPAPVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGGEADIGKRVELGKASLKALGILP", "dna_sequence_from_broadstreet": "ATGCGCCCTCTCCTCTTCAGCGCCCTTCTCCTGCTCTCCGGGCATGCCCAGGCCAGCGAATGGAACGACAGCCAGGCCGTGGACAAGCTATTCGGAGCGGCCGGTGTGAAAGGCACCTTCGTCCTCTACGATGTGCAGCGGCAGCGCTATGTCGGCCATGACCGGGAGCGCGCGGAAACCCGCTTCGTTCCCGCTTCCACCTACAAGGTGGCGAACAGCCTGATCGGCTTATCCACAGGGGCGGTTAGATCCGCCGACGAGGTTCTTCCCTATGGCGGCAAACCCCAGCGCTTCAAGGCCTGGGAGCACGACATGAGCCTGCGCGACGCGATCAAGGCATCGAACGTACCGGTCTACCAGGAACTGGCGCGGCGCATCGGCCTGGAGCGGATGCGCGCCAATGTCTCGCGCCTGGGTTACGGCAACGCGGAAATCGGCCAGGCTGTGGATAACTTCTGGTTGGTGGGACCGCTGAAGATCAGCGCGATGGAACAGACCCGCTTTCTGCTCCGACTGGCGCAGGGAGAATTGCCATTCCCCGCCCCGGTGCAGTCCACCGTGCGCGCCATGACCCTGCTGGAAAGCGGCCCGGGCTGGGAGCTGCACGGCAAGACCGGCTGGTGCTTCGACTGCACGCCGGAACTCGGCTGGTGGGTGGGCTGGGTGAAGCGCAACGAGCGGCTCTACGGCTTCGCCCTGAACATCGACATGCCCGGCGGCGAGGCCGACATCGGCAAGCGCGTCGAACTGGGCAAGGCCAGTCTCAAGGCTCTCGGGATACTGCCCTGA", "partial": "0", "query_start": 7646, "query_end": 7819, "hit_start": 315, "hit_end": 489, "orf_dna_sequence": "ATGCCGTGGCCAGAGCGCGCCTTTCTCGCCTGGGTAGCACCGCGCGGCATTGTGGCCGCGGCGATGGCCTCCATTTTTACCTTGCGCTTACAAGCCGAGGGCTATGCCCAAGCCGATCAACTCGTGCCGATTACTTTTTTGGTCATCATTGGTTGCGTCGCGGTTTACGGCCTCACCGCGACCCCCGTCGCCCGCTGGTTGGGGGTAGCTCAAGACAACCCACAAGGGGGCCTGTTCATCAGCGCCTCACCGCTGTTGCAAGCCCTGGCCGACGCCCTCCGAGCCGAAGACATCGCCACCTGTATGGCCGACATCAACTGGTCCCATATTGCCACTGCCCGCCTTAACGGCTTCAAAACCCACTATGGTAACGCCCTCACCGAAAACGCGCTCGACAATATGGATCTCGATGGTATTGGTCGCGTGCTCGCCCTCACCCCCAATGATGAAGCCAACGCACTGGCCGCACTTCACTTTGCCGAGCTGTTCGGCCACGCCGAAGCCTATAAGCTGGTGCCCAGCACCGCTAACCGCGAAACCGTGCCGCACCTACGCGGGCACTTTCTCTTTGATGAAAGCGCCAATTACAACGTCCTGAGCTTGCATCTGGCGTCCGGTGCGACCATCAAAACCACGGGTCTCAGCGAGCAGTTCGACTACGAGGCTTTTCAAGACTACTAA", "orf_prot_sequence": "MPWPERAFLAWVAPRGIVAAAMASIFTLRLQAEGYAQADQLVPITFLVIIGCVAVYGLTATPVARWLGVAQDNPQGGLFISASPLLQALADALRAEDIATCMADINWSHIATARLNGFKTHYGNALTENALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVPHLRGHFLFDESANYNVLSLHLASGATIKTTGLSEQFDYEAFQDY", "perc_identity": 27.59}}, "BGC0001186.1|Misakinolide_10 # 8259 # 8936 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.540": {"gnl|BL_ORD_ID|2572|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8259, "orf_end": 8936, "orf_from": "BGC0001186.1|Misakinolide_10 ", "model_name": "mphH", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3216", "ARO_accession": "3004539", "ARO_name": "mphH", "ARO_category": {"36472": {"category_aro_accession": "3000333", "category_aro_cvterm_id": "36472", "category_aro_name": "macrolide phosphotransferase (MPH)", "category_aro_description": "Macrolide phosphotransferases (MPH) are enzymes encoded by macrolide phosphotransferase genes (mph genes). These enzymes phosphorylate macrolides in GTP dependent manner at 2'-OH of desosamine sugar thereby inactivating them. Characterized MPH's are differentiated based on their substrate specificity.", "category_aro_class_name": "AMR Gene Family"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.85091, "max_identities": 13, "bit_score": 25.409, "cvterm_id": "42602", "query": "LDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTL", "match": "LDL G T+  + +G    +A      G D+VL L +    L", "sequence_from_db": "LDLDGGTLRTEEIGLDFRVAFARAHDGGDWVLRLPRRPDVL", "sequence_from_broadstreet": "MPEDLDALLDLAARHGLDLDGGTLRTEEIGLDFRVAFARAHDGGDWVLRLPRRPDVLERAAVEGRLLAMLAPHLDVAVPDWRISTSELIAYPLLPGSPGLTVAADGEVSWHVDMASTVYARSLGSVVAQLHAVDAEAAAATGIEVRSPAQVRGAWRQDLARVGAEFEIAPALRERWEAWLADDGCWPGHSVLTHGELYPAHTLVEDERITAVLDWTTAAVGDPAKDLMFHQVSAPSAIFEVALQAYAEGGGRPWPGLARHCTEMFSAAPLGYGLYALATGEAAHREAAAAALNPPEER", "dna_sequence_from_broadstreet": "ATGCCCGAGGACCTGGACGCACTGCTGGACCTCGCCGCCCGTCACGGCCTCGACCTCGACGGCGGCACGCTGCGCACCGAGGAGATCGGGCTGGACTTCCGGGTCGCATTCGCCCGCGCGCACGACGGCGGCGACTGGGTGCTGCGCCTCCCCCGCCGGCCCGACGTGCTCGAGCGCGCCGCGGTCGAGGGCCGGCTGCTGGCGATGCTCGCCCCGCACCTCGATGTCGCGGTGCCGGACTGGCGCATCAGCACCTCCGAGCTGATCGCCTACCCGCTGCTGCCGGGCAGTCCGGGGCTCACCGTCGCTGCGGACGGCGAGGTCTCCTGGCACGTCGACATGGCCTCGACCGTCTACGCCCGCTCCCTCGGGAGCGTGGTCGCGCAGCTGCATGCCGTGGATGCCGAGGCGGCCGCCGCCACCGGCATCGAGGTGCGCTCCCCCGCACAGGTGCGCGGGGCGTGGCGGCAGGACCTCGCACGCGTGGGCGCGGAGTTCGAGATCGCCCCGGCGCTGCGGGAGCGCTGGGAGGCCTGGCTCGCGGACGACGGCTGCTGGCCCGGGCACAGCGTGCTCACCCATGGCGAGCTCTATCCGGCCCACACCCTCGTCGAGGACGAGCGGATCACGGCAGTGCTCGACTGGACCACCGCCGCGGTGGGCGATCCCGCCAAGGACCTCATGTTCCACCAGGTCAGCGCCCCGTCGGCGATCTTCGAGGTGGCGCTGCAGGCGTACGCCGAGGGCGGCGGCCGCCCCTGGCCGGGGCTGGCACGGCACTGCACCGAGATGTTCTCCGCCGCGCCGCTGGGCTACGGGCTGTACGCGCTGGCCACCGGGGAGGCCGCTCATCGGGAGGCCGCCGCCGCGGCGCTGAACCCGCCCGAGGAGCGCTGA", "partial": "0", "query_start": 8751, "query_end": 8873, "hit_start": 48, "hit_end": 171, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTGGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAACGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTCAGCGCATGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGWEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALNDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 31.71}, "gnl|BL_ORD_ID|2375|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8259, "orf_end": 8936, "orf_from": "BGC0001186.1|Misakinolide_10 ", "model_name": "BRO-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "3565", "ARO_accession": "3004761", "ARO_name": "BRO-1", "ARO_category": {"42873": {"category_aro_accession": "3004760", "category_aro_cvterm_id": "42873", "category_aro_name": "BRO Beta-lactamase", "category_aro_description": "BRO is a class A beta-lactamase that is found in M.catarrhalis.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.37925, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "41250", "query": "DLSGATVTLDAMGCQKEIAQVITEQGADYVLA", "match": "D   A + LD +G      Q + E GAD VLA", "sequence_from_db": "DNGSANILLDKIGGLTAFNQFLKEIGADMVLA", "sequence_from_broadstreet": "MQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWENKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLDFKNQKDEIMAQIGKEIYPFL", "dna_sequence_from_broadstreet": "ATGCAACGCCGGCATTTTTTACAAAAAACCTTATTGGCACTACCTATTATTTTTTCTGGCAATTTATTAACTGGATGTAAAACGAATTTATCTGATGATTATTTGCCCGATGATAAGATAACAAACAATCCAAATTTATTACAAAATAAATTAAAAGAGATATTGCCAATTTGGGAAAATAAATTTAATGCCAAAATTGGTATGACGATTATTGCTGACAATGGTGAACTATCCAGTCATCGTGGTAATGAATATTTTCCTGTTAATAGTACCATTAAAGCCTTTATTGCAAGTCATATATTATTACTTGTAGATAAAGAAAAATTGGATTTAAACGAAAAAATCATCATTAAAGAAAGCGATTTGATAGAATATTCTCCTGTCTGTAAAAAATACTTTGATGAGAATAAACCAATTTCTATTAGTGAATTGTGCGAAGCTACCATAACACTGAGTGATAATGGTTCTGCTAATATCTTGTTGGATAAAATTGGGGGTTTGACTGCATTCAATCAATTTTTGAAAGAGATTGGGGCGGATATGGTGCTGGCAAATAATGAGCCTTTATTAAATCGCTCACATTATGGTGAAACCAGTGATACCGCAAAACCAATTCCTTACACAAAAAGCCTAAAAGCACTGATTGTAGGCAATATCCTATCCAATCAAAGCAAAGAACAGTTGATAACTTGGCTTATCAATGATAAAGTTGCTGATAATTTATTGAGAAAATATTTACCAAAAAATTGGCGAATTGGCGACAAAACAGGCACAGGTAGTGAATCAAAAAATATCATTGCTGTGATTTGGAATGAAAATAATAAACCTTATTTTATCAGCCTATTTATCACCCAGCCCCATGATGGTAAATCCCTTGATTTTAAAAATCAAAAAGATGAAATAATGGCACAAATTGGTAAAGAAATTTATCCATTTTTATAA", "partial": "0", "query_start": 8754, "query_end": 8849, "hit_start": 456, "hit_end": 552, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTGGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAACGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTCAGCGCATGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGWEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALNDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 40.62}, "gnl|BL_ORD_ID|2406|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8259, "orf_end": 8936, "orf_from": "BGC0001186.1|Misakinolide_10 ", "model_name": "BRO-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "634", "model_id": "3566", "ARO_accession": "3004762", "ARO_name": "BRO-2", "ARO_category": {"42873": {"category_aro_accession": "3004760", "category_aro_cvterm_id": "42873", "category_aro_name": "BRO Beta-lactamase", "category_aro_description": "BRO is a class A beta-lactamase that is found in M.catarrhalis.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.44173, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "42876", "query": "DLSGATVTLDAMGCQKEIAQVITEQGADYVLA", "match": "D   A + LD +G      Q + E GAD VLA", "sequence_from_db": "DNGSANILLDKIGGLTAFNQFLKEIGADMVLA", "sequence_from_broadstreet": "MMQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWENKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLGFKNQKDEIMAQIGKEIYPFL", "dna_sequence_from_broadstreet": "ATGATGCAACGCCGTCATTTTTTACAAAAAACCTTATTGGCACTACCTATTATTTTTTCTGGCAATTTATTAACTGGATGTAAAACGAATTTGTCTGATGATTATTTGCCCGATGACAAGATAACAAACAATCCAAATTTATTACAAAATAAATTAAAAGAGATATTGCCAATTTGGGAAAATAAATTTAATGCCAAAATTGGTATGACGATTATTGCTGACAATGGTGAACTATCCAGTCATCGTGGTAATGAATATTTTCCTGTTAATAGTACCATTAAAGCCTTTATTGCAAGTCATATATTATTACTTGTAGATAAAGAAAAATTGGATTTAAACGAAAAAATCATCATTAAAGAAAGCGATTTGATAGAATATTCTCCTGTCTGTAAAAAATACTTTGATGAGAATAAACCAATTTCTATTAGTGAATTGTGCGAAGCTACCATAACACTGAGTGATAATGGTTCTGCTAATATCTTGTTGGATAAAATTGGGGGTTTGACTGCATTCAATCAATTTTTGAAAGAGATTGGGGCGGATATGGTGCTGGCAAATAATGAACCTTTATTAAATCGCTCACATTATGGTGAAACCAGTGATACCGCAAAACCAATTCCTTACACAAAAAGCCTAAAAGCACTGATTGTAGGCAATATCCTATCCAATCAAAGCAAAGAACAGTTGATAACTTGGCTTATCAACGATAAAGTTGCTGATAATTTATTGAGAAAATATTTACCAAAAAATTGGCGAATTGGCGACAAAACAGGCACAGGTAGTGAATCAAAAAATATCATTGCTGTGATTTGGAATGAAAATAATAAACCTTATTTTATCAGCCTATTTATCACCCAGCCCCATGATGGTAAATCCCTTGGTTTTAAAAATCAAAAAGATGAAATAATGGCACAAATTGGTAAAGAAATTTATCCATTTTTATAA", "partial": "0", "query_start": 8754, "query_end": 8849, "hit_start": 459, "hit_end": 555, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTGGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAACGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTCAGCGCATGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGWEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALNDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 40.62}, "gnl|BL_ORD_ID|2348|hsp_num:0": {"type_match": "Loose", "snp": {"original": "G", "change": "D", "position": 131}, "query_snp": {"original": "G", "change": "D", "position": 24}, "orf_strand": "+", "orf_start": 8259, "orf_end": 8936, "orf_from": "BGC0001186.1|Misakinolide_10 ", "model_name": "Escherichia coli nfsA mutations conferring resistance to nitrofurantoin", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 425, "model_id": "2267", "ARO_accession": "3003751", "ARO_name": "Escherichia coli nfsA mutations conferring resistance to nitrofurantoin", "ARO_category": {"40411": {"category_aro_accession": "3003754", "category_aro_cvterm_id": "40411", "category_aro_name": "antibiotic resistant nfsA", "category_aro_description": "The nfsA-encoded nitroreductase is the major oxygen-insensitive nitroreductase present in E. coli. NfsA uses only NADPH and has broad electron acceptor specificity. Mutations in nfsA cause resistance to nitrofurazone and furazolidone. Resistance to nitrofurantoin via mutation of nfsA reduces the fitness of clinical isolates of E. coli.", "category_aro_class_name": "AMR Gene Family"}, "35992": {"category_aro_accession": "0000075", "category_aro_cvterm_id": "35992", "category_aro_name": "nitrofurantoin", "category_aro_description": "Nitrofurantoin is an antibiotic used to treat urinary tract infections. It inhibits enzyme synthesis by inhibiting essential enzymes involved in the citric acid cycle, as well as those involved in DNA, RNA, and protein synthesis. It is marketed under the following brand names: Furadantin, Macrobid, Macrodantin, Nitro Macro and Urantoin.", "category_aro_class_name": "Antibiotic"}, "41240": {"category_aro_accession": "3004116", "category_aro_cvterm_id": "41240", "category_aro_name": "nitrofuran antibiotic", "category_aro_description": "Nitrofurans are chemotherapeutic agents with antibacterial and antiprotozoal activity.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.31581, "bit_score": 26.9498, "max_identities": 15, "cvterm_id": "36849", "query": "SAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKI", "match": "+A+   +A   A  LGLG V +    N I A+ KLLK+", "sequence_from_db": "TAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKL", "sequence_from_broadstreet": "MTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIRITDKALREELVTLTGGQKHVAQAAEFWVFCADFNRHLQICPDAQLGLAEQLLLGVVDTAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKLPQHVLPLFGLCLGWPADNPDLKPRLPASILVHENSYQPLDKGALAQYDEQLAEYYLTRGSNNRRDTWSDHIRRTIIKESRPFILDYLHKQGWATR", "dna_sequence_from_broadstreet": "ATGACGCCAACCATTGAACTTATTTGTGGCCATCGCTCCATTCGCCATTTCACTGATGAACCCATTTCCGAAGCGCAGCGTGAGGCGATTATTAACAGCGCCCGTGCGACGTCCAGTTCCAGTTTTTTGCAGTGCAGTAGCATTATTCGCATTACCGACAAAGCGTTACGTGAAGAACTGGTGACGCTGACCGGCGGGCAAAAACACGTAGCGCAAGCGGCGGAGTTCTGGGTGTTCTGTGCCGACTTTAACCGCCATTTACAGATCTGTCCGGATGCTCAGCTCGGCCTGGCGGAACAACTGTTGCTCGGTGTCGTTGATACGGCAATGATGGCGCAGAATGCATTAATCGCAGCGGAATCGCTGGGATTGGGCGGGGTATATATCGGCGGCCTGCGCAATAATATTGAAGCGGTGACGAAACTGCTTAAATTACCGCAGCATGTTCTGCCGCTGTTTGGGCTGTGCCTTGGCTGGCCTGCGGATAATCCGGATCTTAAGCCGCGTTTACCGGCCTCCATTTTGGTGCATGAAAACAGCTATCAACCGCTGGATAAAGGCGCACTGGCGCAGTATGACGAGCAACTGGCGGAATATTACCTCACCCGTGGCAGCAATAATCGCCGGGATACCTGGAGCGATCATATCCGCCGAACAATCATTAAAGAAAGCCGCCCATTTATTCTGGATTATTTGCACAAACAGGGTTGGGCGACGCGCTAA", "partial": "0", "query_start": 8637, "query_end": 8750, "hit_start": 321, "hit_end": 435, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTGGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAACGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTCAGCGCATGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGWEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALNDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 39.47}, "gnl|BL_ORD_ID|2348|hsp_num:1": {"type_match": "Loose", "snp": {"original": "R", "change": "S", "position": 133}, "query_snp": {"original": "R", "change": "S", "position": 26}, "orf_strand": "+", "orf_start": 8259, "orf_end": 8936, "orf_from": "BGC0001186.1|Misakinolide_10 ", "model_name": "Escherichia coli nfsA mutations conferring resistance to nitrofurantoin", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 425, "model_id": "2267", "ARO_accession": "3003751", "ARO_name": "Escherichia coli nfsA mutations conferring resistance to nitrofurantoin", "ARO_category": {"40411": {"category_aro_accession": "3003754", "category_aro_cvterm_id": "40411", "category_aro_name": "antibiotic resistant nfsA", "category_aro_description": "The nfsA-encoded nitroreductase is the major oxygen-insensitive nitroreductase present in E. coli. NfsA uses only NADPH and has broad electron acceptor specificity. Mutations in nfsA cause resistance to nitrofurazone and furazolidone. Resistance to nitrofurantoin via mutation of nfsA reduces the fitness of clinical isolates of E. coli.", "category_aro_class_name": "AMR Gene Family"}, "35992": {"category_aro_accession": "0000075", "category_aro_cvterm_id": "35992", "category_aro_name": "nitrofurantoin", "category_aro_description": "Nitrofurantoin is an antibiotic used to treat urinary tract infections. It inhibits enzyme synthesis by inhibiting essential enzymes involved in the citric acid cycle, as well as those involved in DNA, RNA, and protein synthesis. It is marketed under the following brand names: Furadantin, Macrobid, Macrodantin, Nitro Macro and Urantoin.", "category_aro_class_name": "Antibiotic"}, "41240": {"category_aro_accession": "3004116", "category_aro_cvterm_id": "41240", "category_aro_name": "nitrofuran antibiotic", "category_aro_description": "Nitrofurans are chemotherapeutic agents with antibacterial and antiprotozoal activity.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.31581, "bit_score": 26.9498, "max_identities": 15, "cvterm_id": "36849", "query": "SAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKI", "match": "+A+   +A   A  LGLG V +    N I A+ KLLK+", "sequence_from_db": "TAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKL", "sequence_from_broadstreet": "MTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIRITDKALREELVTLTGGQKHVAQAAEFWVFCADFNRHLQICPDAQLGLAEQLLLGVVDTAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKLPQHVLPLFGLCLGWPADNPDLKPRLPASILVHENSYQPLDKGALAQYDEQLAEYYLTRGSNNRRDTWSDHIRRTIIKESRPFILDYLHKQGWATR", "dna_sequence_from_broadstreet": "ATGACGCCAACCATTGAACTTATTTGTGGCCATCGCTCCATTCGCCATTTCACTGATGAACCCATTTCCGAAGCGCAGCGTGAGGCGATTATTAACAGCGCCCGTGCGACGTCCAGTTCCAGTTTTTTGCAGTGCAGTAGCATTATTCGCATTACCGACAAAGCGTTACGTGAAGAACTGGTGACGCTGACCGGCGGGCAAAAACACGTAGCGCAAGCGGCGGAGTTCTGGGTGTTCTGTGCCGACTTTAACCGCCATTTACAGATCTGTCCGGATGCTCAGCTCGGCCTGGCGGAACAACTGTTGCTCGGTGTCGTTGATACGGCAATGATGGCGCAGAATGCATTAATCGCAGCGGAATCGCTGGGATTGGGCGGGGTATATATCGGCGGCCTGCGCAATAATATTGAAGCGGTGACGAAACTGCTTAAATTACCGCAGCATGTTCTGCCGCTGTTTGGGCTGTGCCTTGGCTGGCCTGCGGATAATCCGGATCTTAAGCCGCGTTTACCGGCCTCCATTTTGGTGCATGAAAACAGCTATCAACCGCTGGATAAAGGCGCACTGGCGCAGTATGACGAGCAACTGGCGGAATATTACCTCACCCGTGGCAGCAATAATCGCCGGGATACCTGGAGCGATCATATCCGCCGAACAATCATTAAAGAAAGCCGCCCATTTATTCTGGATTATTTGCACAAACAGGGTTGGGCGACGCGCTAA", "partial": "0", "query_start": 8637, "query_end": 8750, "hit_start": 321, "hit_end": 435, "orf_dna_sequence": "ATGCGTGTGCCCTCATCGTTTCAGGACCATTTTGCCTCGTTGAGCGATCCACGTTCTTTTCGCACACCCAATTTGCGCCATGACTTGATCGATATTCTGGTCATGGCCGTCTGTGCCGTCATTTGGGGGGCTGAGGGCTGGGAAGACCTTGAGGACTATGGCTATGCCCAAGCCGCGTGGTTCTCTGACGTCCTCGATTTACCCCATGGCCTCCCCTCTCACGATACCTTCAGGCGGGTCTTATCCCAATTGGACCCTGATGAATTGACCAAGTGTTTTGTGTCTTGGACCACGGCACTCAACGATCTTGCTGGGGGCGATATTGTCGCGATTGACGGGAAAACCCTCCGTCAGTCCTTTGATCGAGCGACCTCGCAATCGGCGATCCCCATGGTCAGCGCATGGGCTACTGCCAATCGTCTGGGGCTCGGGCAGGTGAAAGTCGATGACAAATCCAATGAGATCACTGCGATTCCCAAGTTACTCAAGATCTTAGACTTGAGTGGCGCCACGGTGACCCTTGACGCAATGGGGTGTCAGAAAGAGATTGCCCAGGTCATCACCGAGCAAGGCGCCGATTATGTCTTGGCTCTGAAGAAAAATCACAGCACCCTCTATGGCGATGTGAAGCTCTTTCTTGACGATGCTCAGGCCAGTGGCTTTGCTGACCTTGACTAG", "orf_prot_sequence": "MRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGWEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVSWTTALNDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGADYVLALKKNHSTLYGDVKLFLDDAQASGFADLD", "perc_identity": 39.47}}, "BGC0001186.1|Misakinolide_11 # 9204 # 9386 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.525": {"gnl|BL_ORD_ID|2503|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9204, "orf_end": 9386, "orf_from": "BGC0001186.1|Misakinolide_11 ", "model_name": "Enterococcus faecium chloramphenicol acetyltransferase", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "2895", "ARO_accession": "3004456", "ARO_name": "Enterococcus faecium chloramphenicol acetyltransferase", "ARO_category": {"36261": {"category_aro_accession": "3000122", "category_aro_cvterm_id": "36261", "category_aro_name": "chloramphenicol acetyltransferase (CAT)", "category_aro_description": "Inactivates chloramphenicol by addition of an acyl group. CAT is used to describe many variants of the chloramphenicol acetyltransferase gene in a range of organisms including Acinetobacter calcoaceticus, Agrobacterium tumefaciens, Alkalihalobacillus clausii, Bacillus subtilis, Campylobacter coli, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Listeria monocytogenes, Listonella anguillarum, Morganella morganii, Photobacterium damselae subsp. piscicida, Proteus mirabilis, Salmonella typhi, Serratia marcescens, Shigella flexneri, Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus intermedius, Streptococcus agalactiae, Streptococcus suis and Streptomyces acrimycini.", "category_aro_class_name": "AMR Gene Family"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0884279, "max_identities": 11, "bit_score": 26.9498, "cvterm_id": "36779", "query": "KDKGAQTFSVLCHIALNMLKREGQNKRGIKARRKRAGWDR", "match": "KDKG + +  L H  ++++ R    + GI +      WD+", "sequence_from_db": "KDKGYELYPALIHAIVSVINRNKVFRTGINSEGNLGYWDK", "sequence_from_broadstreet": "MTFNIINLETWDRKEYFNHYFNQQTTYSVTKELDITLLKSMIKDKGYELYPALIHAIVSVINRNKVFRTGINSEGNLGYWDKLEPLYTVFNKETEKFSNIWTESNASFNSFYNSYKNDLFKYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKDDKIYLPFSLQVHHAVCDGYHVSLFMNEFQNIIDNVNEWI", "dna_sequence_from_broadstreet": "ATGACTTTTAATATTATTAATTTAGAAACTTGGGATAGAAAAGAATATTTCAATCATTATTTTAATCAACAAACAACTTATAGTGTTACTAAAGAATTAGATATTACCTTGTTAAAAAGTATGATAAAAGATAAAGGATATGAACTGTATCCTGCTTTGATTCATGCAATTGTAAGTGTTATAAATCGAAATAAAGTATTTAGAACAGGGATTAATAGTGAGGGGAATTTGGGTTATTGGGATAAATTAGAACCTTTATATACAGTCTTTAATAAAGAAACTGAAAAATTTTCTAATATTTGGACAGAATCAAATGCTAGTTTTAACTCTTTTTATAATAGTTATAAGAATGATTTATTTAAATATAAAGATAAAAATGAAATGTTTCCTAAAAAGCCGATACCTGAAAACACAGTTCCTATCTCGATGATTCCTTGGATTGATTTTAGTTCATTTAATTTAAATATTGGTAATAATAGTAGATTTTTATTGCCAATTATTACAATAGGTAAATTTTATAGTAAGGATGATAAGATCTATTTACCATTTTCATTGCAAGTTCATCATGCAGTATGTGATGGTTACCATGTTTCATTATTTATGAATGAATTTCAAAATATAATTGATAATGTAAATGAATGGATTTAA", "partial": "0", "query_start": 9237, "query_end": 9356, "hit_start": 126, "hit_end": 246, "orf_dna_sequence": "GTGAGTTTTGATGAGGGTGCCTGTCGGATTCGCAAGGACAAGGGGGCACAGACTTTCAGTGTGCTGTGCCATATCGCGCTCAATATGCTCAAGCGGGAAGGCCAGAATAAACGCGGGATCAAAGCCAGACGCAAGCGAGCGGGATGGGATCGCAACTATCTACTACAAGTGTTGATGGCTTAA", "orf_prot_sequence": "MSFDEGACRIRKDKGAQTFSVLCHIALNMLKREGQNKRGIKARRKRAGWDRNYLLQVLMA", "perc_identity": 27.5}, "gnl|BL_ORD_ID|2199|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9204, "orf_end": 9386, "orf_from": "BGC0001186.1|Misakinolide_11 ", "model_name": "catA8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3358", "ARO_accession": "3004658", "ARO_name": "catA8", "ARO_category": {"36261": {"category_aro_accession": "3000122", "category_aro_cvterm_id": "36261", "category_aro_name": "chloramphenicol acetyltransferase (CAT)", "category_aro_description": "Inactivates chloramphenicol by addition of an acyl group. CAT is used to describe many variants of the chloramphenicol acetyltransferase gene in a range of organisms including Acinetobacter calcoaceticus, Agrobacterium tumefaciens, Alkalihalobacillus clausii, Bacillus subtilis, Campylobacter coli, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Listeria monocytogenes, Listonella anguillarum, Morganella morganii, Photobacterium damselae subsp. piscicida, Proteus mirabilis, Salmonella typhi, Serratia marcescens, Shigella flexneri, Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus intermedius, Streptococcus agalactiae, Streptococcus suis and Streptomyces acrimycini.", "category_aro_class_name": "AMR Gene Family"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.24487, "max_identities": 8, "bit_score": 21.557, "cvterm_id": "36757", "query": "KDKGAQTFSVLCHIALNMLKREGQNKRGIKARRKRAGWDR", "match": "K+KG + +  L +  +N++ +    + GI +      W++", "sequence_from_db": "KNKGYELYPALIYTIVNIINQNKVFRTGINSEGNLGYWEK", "sequence_from_broadstreet": "MTFNIINLETWDRKEYFNHYFNQQTTYSVTKEFDITLLKSMIKNKGYELYPALIYTIVNIINQNKVFRTGINSEGNLGYWEKLNPLYTVFNKETEKFSNIWTESNVSFNSFYNSYKSDLLEYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKNNKIYLPVSLQVHHAVCDGYHVSLFMSEFQNIVDSVNEWI", "dna_sequence_from_broadstreet": "ATGACTTTTAATATTATTAATTTGGAAACTTGGGATAGAAAAGAATATTTTAATCATTATTTCAATCAACAAACAACTTACAGTGTTACTAAAGAATTTGATATCACTTTACTTAAAAGTATGATAAAAAATAAAGGATATGAACTGTATCCTGCTTTGATTTATACAATTGTAAATATTATAAATCAAAATAAAGTATTTAGAACAGGAATTAATAGTGAGGGAAATTTGGGTTATTGGGAAAAATTAAACCCTTTATATACAGTCTTTAATAAAGAAACTGAAAAATTTTCTAACATTTGGACAGAATCAAATGTTAGTTTTAATTCTTTTTATAATAGTTATAAGAGTGACTTACTTGAATATAAAGATAAAAATGAAATGTTTCCTAAAAAACCAATACCTGAAAACACAGTTCCTATTTCGATGATTCCTTGGATTGATTTTAGTTCATTTAATTTAAATATTGGTAATAATAGTAGATTCCTATTGCCAATTATTACAATAGGTAAATTTTATAGTAAGAATAATAAGATCTATTTACCAGTCTCATTGCAAGTTCATCATGCGGTATGTGATGGTTACCATGTTTCATTATTTATGAGTGAATTTCAAAATATAGTTGATAGTGTAAATGAATGGATTTAA", "partial": "0", "query_start": 9237, "query_end": 9356, "hit_start": 126, "hit_end": 246, "orf_dna_sequence": "GTGAGTTTTGATGAGGGTGCCTGTCGGATTCGCAAGGACAAGGGGGCACAGACTTTCAGTGTGCTGTGCCATATCGCGCTCAATATGCTCAAGCGGGAAGGCCAGAATAAACGCGGGATCAAAGCCAGACGCAAGCGAGCGGGATGGGATCGCAACTATCTACTACAAGTGTTGATGGCTTAA", "orf_prot_sequence": "MSFDEGACRIRKDKGAQTFSVLCHIALNMLKREGQNKRGIKARRKRAGWDRNYLLQVLMA", "perc_identity": 20.0}}, "BGC0001186.1|Misakinolide_12 # 9397 # 10263 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=12bp;gc_cont=0.576": {"gnl|BL_ORD_ID|2427|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 9397, "orf_end": 10263, "orf_from": "BGC0001186.1|Misakinolide_12 ", "model_name": "NPS-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "2840", "ARO_accession": "3004239", "ARO_name": "NPS-1", "ARO_category": {"41404": {"category_aro_accession": "3004240", "category_aro_cvterm_id": "41404", "category_aro_name": "NPS beta-lactamase", "category_aro_description": "NPS beta-lactamases are class D beta-lactamases that have partial hydrolyzing abilities against penicillins and cephalosporin.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.65001, "max_identities": 14, "bit_score": 25.0238, "cvterm_id": "36752", "query": "TVLLISGLFILLSARLNVNDLAQLGQ", "match": "+ LL  GLFI LSAR     +AQL Q", "sequence_from_db": "STLLAFGLFIALSARAENQAIAQLFQ", "sequence_from_broadstreet": "MLKSTLLAFGLFIALSARAENQAIAQLFQRAGVDGTIVIESLTTRQRLVHNDPRAQQRYPAASTFKVLNTLIALEEGAISGENQIFHWNGTQYSIANWNQDQTLDSAFKVSCVWCYQQIALRVGALKYPAYIQQTNYGHLLEPFNGTEFWLDGSLTISAEEQVAFLRRVVERKLPFKASSYDSLKKVMFADENAQYRLYAKTGWATRITPSVGWYVGYVEAQDDVWLFALNLATRDANDLPLRTQIAKDALKAIGAFHAK", "dna_sequence_from_broadstreet": "ATGCTGAAGAGCACCCTTCTGGCCTTTGGTCTCTTTATCGCACTCTCAGCGCGTGCAGAGAACCAGGCAATCGCCCAGCTTTTCCAGAGGGCAGGAGTCGATGGGACCATCGTCATCGAGTCTCTAACCACCAGACAGCGCTTGGTTCACAACGATCCTCGTGCGCAACAACGATACCCGGCAGCTTCCACGTTCAAGGTACTCAATACCTTGATTGCTCTCGAAGAGGGCGCCATTTCAGGTGAGAACCAGATCTTTCACTGGAACGGTACCCAGTATTCGATTGCGAATTGGAACCAGGACCAGACTCTAGACAGTGCGTTTAAAGTGAGTTGTGTCTGGTGCTACCAGCAGATTGCCCTTCGAGTGGGGGCACTCAAGTACCCAGCCTATATTCAACAGACAAACTATGGTCATTTACTGGAACCCTTCAATGGAACGGAGTTTTGGCTGGATGGCTCTTTGACGATCAGCGCGGAAGAACAGGTTGCCTTTCTCCGACGGGTTGTTGAGCGAAAACTACCGTTCAAAGCGAGCAGCTATGATTCCCTGAAGAAAGTCATGTTCGCCGATGAGAATGCCCAGTATCGCCTTTATGCAAAAACGGGTTGGGCGACCCGCATCACTCCCTCGGTGGGTTGGTATGTTGGCTATGTTGAAGCACAGGACGATGTTTGGCTGTTTGCCCTGAATCTTGCTACCCGCGACGCAAATGACCTGCCCCTACGAACGCAGATAGCCAAAGACGCGCTGAAGGCGATAGGTGCGTTTCATGCGAAGTAA", "partial": "0", "query_start": 10180, "query_end": 10257, "hit_start": 9, "hit_end": 87, "orf_dna_sequence": "GTGGCCCTAGGCATTGCAGCCCAGTGGCTGGCCTGGTGTATCCGCATTCCCTCAATTTTTCTCTTGCTGCTGCTGGGTCTCGTGGCAGGGCCTTTTACCGGGTGGTTACAACCGCAGCACCTCTTTGGCGAGTTATTGTTTCCGGCCGTGTCACTCTCAGTGGCTGTTATTTTATTTGAGGGCGGTCTCAGCCTGCGCACCGTGGTGCTGCGAGACATTGGCCGCGTGCTGCGCGATCTCGTCACCCTCGGCGTGCTGGTCACATGGCTCATCACGTCAGCCGCCGCCTATGTCTTTTTGGGGCTCGATGGCTCGATGGCCATACTCATCGGCGCCATGCTCGTGGTCTCCGGTCCAACTGTGGTCGGTCCGCTGTTGCGGCATGTGCGCCCGGTCGAGCGCTTGCGATCGACCCTGCAATGGGAGGGCATTCTCATCGACCCCATCGGGGTGCTCCTCGCCGTGCTCGTCTTTGAAGTGATTCTCGTCGGCGAACTCCAGGCAGCGACGACCTTGGTCATCACCGGCATGCTCAAAATGGTCGTGCTCGGCAGTGCCCTTGGCTGGGTGAGTGCCAAAACCGTCGTGTGGCTCATCCAGCGCGGTTTCATACCGGATTATCTCCACAATGCGGTCACGCTGATGATCGTGGTGGTCTCCTTTACCTTCGCCAATGTGTTGCACCATGAAGCCGGCCTGTTTACCGTCACGGTGATGGGTATTGTCATGGCCAACCAAAAAGATATTCTTGTACGGCACATTATCGAGTTCAAAGAAACGCTGACCGTACTTCTCATCTCCGGGCTGTTCATTCTATTATCCGCCCGCCTCAACGTCAACGATCTCGCCCAGTTAGGTCAGGGCTAG", "orf_prot_sequence": "MALGIAAQWLAWCIRIPSIFLLLLLGLVAGPFTGWLQPQHLFGELLFPAVSLSVAVILFEGGLSLRTVVLRDIGRVLRDLVTLGVLVTWLITSAAAYVFLGLDGSMAILIGAMLVVSGPTVVGPLLRHVRPVERLRSTLQWEGILIDPIGVLLAVLVFEVILVGELQAATTLVITGMLKMVVLGSALGWVSAKTVVWLIQRGFIPDYLHNAVTLMIVVVSFTFANVLHHEAGLFTVTVMGIVMANQKDILVRHIIEFKETLTVLLISGLFILLSARLNVNDLAQLGQG", "perc_identity": 53.85}}, "BGC0001186.1|Misakinolide_13 # 10763 # 13333 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.556": {"gnl|BL_ORD_ID|2235|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10763, "orf_end": 13333, "orf_from": "BGC0001186.1|Misakinolide_13 ", "model_name": "rphB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1500", "model_id": "2528", "ARO_accession": "3003992", "ARO_name": "rphB", "ARO_category": {"41087": {"category_aro_accession": "3004040", "category_aro_cvterm_id": "41087", "category_aro_name": "rifampin phosphotransferase", "category_aro_description": "Enzymes, protein or other gene products that inactivate rifampin (rifamycin) antibiotics through phosphorylation of the antibiotic at the 21-OH position.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.42941e-92, "max_identities": 266, "bit_score": 307.375, "cvterm_id": "40862", "query": "QGFQVPPGIVLTTAFFQPWFEQ---IQRTACWAKLLAAEP-DEWSSLCRELKALSAGLTFGEAQQQALEGLREDLHALGDAR-FAVRSSSLEEDLPQASFAGGYETCLGVRSEDLEIA-VRRCFASTLDERVLMYKRERGFDIRSPRLAVVVQQQIHSEVAGVGFSLNPLNNDYDEAVINANWGLGESVVAGRVSPDHFVLDKVGRQVVERKQGAKQLSIWVSEAGGTTEKQGYRSQEFS--LNDAQLSELIDAICEIETFYQRPIDIEWSYANDQLYLLQARPITTYIPLAPRMMTQPGERRCLYADMALSSGLTINAHISPLGLDWMREGLVLLADMTFGKLDFDLRFEEAFCFCAGGRMYQNVSNVLWLTTPEQLAKMSAASDVLMAETQAYIDADRYRSQVKPPWAKVAMLKYLPRVMWRGRYFVGTLLWAILAPEHAWRSYQVKADGYKTELTGDLDYSLSLDAFRRQYTS---------TDNARLMLTFTM----------------SVVWASVGAIAMVDVLVGKSAEGKALGDKLKRGFTGNIVVEMGITLFRLAKMLPP--SDFDDL-----DQLVERINTRQMPAQFCHAWDAFMAKFGCRGPLEMDLASPRYADDPVLALKQMSLMPL---DDERFDPELTHQRQVEEREQAFAA---LMAR-----SGWLRRRLLRRVYHVIDLFAGIRDHPKYYMLLFYQGLRKRALSEGERLTREGRLDASEDIFDLTFDDIDSAVRDPALDL--RAIRQQ-RTAFNQILSNQVHTF--------PAVIDSRGRILRPP-ARESKPGE-YRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVSAAAIVIEVGGALQHGAVVAREYGKPCVVGIDQLISQFEDGQQVEVDGTAGMVRLL", "match": "+G +VP G  +TT  +Q   EQ    Q       +L+AE  D+   + R+++     +   E     +  +   L   G+ + +AVRSS+  EDLP ASFAG  +T L +   D  +  + +C+AS   +R ++Y+ + GFD R   L+VVVQ+ +  E +G+ F+ +P+ ++     I+A +GLGE++V+G VS D + + +   +++E++  AK L+I+  + GGT  KQ    Q+ S  L D Q+ +L     +IE  + +P DIEW  A D  Y++Q+RPITT  P+ P    Q      +Y  +     +T    + PLGL                   F L    A    AGGR        L++ T   LA   +  +VL    Q+             P  K A++     ++ RG  F+ +L   I   E       + + GY+T +  D D ++  D   R  +S         T +   +  F +                +V+ A++ A   ++  + +    K   D L +   GN+  EMG+ L  +A ++ P     D L     D  ++++ T     Q   A   F+ K+G R   E+DL   R+++ P+      +L+PL   + + F+P  +H++  + R++A      L+ R      G  + +  +R+  +I  F G R++PKY M+  Y   ++  L E ERL + G +   EDI+ LTF+++D  VR   LD     + QQ + A  Q++S +   +        P VI S G I+     RE+ P E   G+ VS+G  +G  +V+    +  +++GDILV   TDP WTPLFVS   +V EVGG + HGAV+AREYG P VVG++    + +DGQ++ V G+ G + +L", "sequence_from_db": "EGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEV---EIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVRE--GEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPI-PEANDQENH---VYVSVGHQQMMT--DPMKPLGLS------------------FFLLTTPAPMRTAGGR--------LFVDTTAMLASPVSRENVLNTLGQS------------DPLIKDALMT----ILERGD-FIKSL--PIAENEQTPGKNNISSAGYQTPI--DHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPI------ALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEIL", "sequence_from_broadstreet": "MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS", "dna_sequence_from_broadstreet": "ATGCGTTCGTTGGTTCTCGATTTTCAGGAAATGGACAAAAAGCAGCTTGGGCTCGTTGGTGGAAAAGGGCTCCATTTAGGGGAATTATCAAAAATTGAGGGAATACGAGTTCCCGAAGGATTTTGCGTGACAACCATAGGATATCAAAGAGCCATCGAACAAAACGAAACGTATCAAGCTATGCTCAATCGACTAACCATGCTATCAGCAGAGGATCGAGATCAAATGGTTGAAATCAGCAGGAAGATCAGACAAACCATTATGGAGGTAGAAATTCCATCCGATGTAGTGACAGCAGTAACTCGCTATCTCTCCCGGTTTGGCGAGGAACAGGCTTATGCCGTACGATCCAGTGCAACTGCTGAAGATTTACCGCATGCCTCTTTTGCGGGTCAACAAGACACCTATCTAAACATCATCGGCGTCGATGCCATCTTGCAGCATATCAGCAAATGCTGGGCTTCCTTGTTTACAGATCGCGCGGTGATCTATCGCATGCAAAATGGATTTGACCATCGTCAAGTTTATTTATCCGTAGTCGTTCAAAGGATGGTTTTCCCCGAGGCTTCAGGGATATTATTCACCGCTGATCCGATGACTTCTAATCGAAAGCTGCTATCCATCGATGCCGGTTTCGGACTTGGAGAAGCACTGGTCTCTGGCTTGGTATCTGCCGATGGTTACAAAGTACGGGAAGGAGAAATCATCGAGAAGCGGATAGCAGCCAAAACATTGGCGATCTACGGACGAAAAGAAGGCGGAACAGAAACAAAGCAAATCGATCCCGATCAGCAAAAGTCACAAACACTTACGGATGAGCAAATTTTACAACTGGCACGCATCGGGAGACAGATTGAGGCTCATTTTGGCCAACCCCAAGATATCGAGTGGTGTTTGGCCCAGGATACCTTTTATATTGTCCAGAGTCGGCCAATCACGACGCTATACCCGATACCTGAAGCGAATGATCAAGAAAATCACGTATACGTATCTGTCGGTCATCAACAAATGATGACGGATCCCATGAAACCGCTGGGATTGTCTTTTTTCCTGCTAACGACTCCTGCACCCATGCGTACAGCTGGCGGAAGGTTGTTTGTTGATACTACGGCTATGCTGGCTTCACCGGTTAGCAGAGAAAATGTATTAAATACCCTGGGACAATCCGATCCACTCATCAAAGACGCTCTTATGACCATCTTAGAGCGAGGAGATTTTATAAAATCGCTACCCATCGCTGAAAATGAACAGACTCCCGGAAAAAACAATATATCGTCTGCGGGTTATCAAACGCCAATCGACCACGATCCGACAATCGTTTCTGATTTAATGGAACGTACTCAATCATCGATCGAAGTGTTGAAACAAAACATCCAAACGAAATCCGGATCCGATTTATTTGATTTTATATTGGAAGATATCCAGGAACTGAAGAAGAATTTATTTGACCCACAAAGCTCGGCTGTCATCATGGCTGCAATGAATGCTTCAACCTGGATCAACGAAAAAATGAATGAATGGTTAGGCGAAAAAAACGCAGCCGACACGCTTTCTCAATCCGTACCGGGCAATGTTACTTCGGAAATGGGTCTGGCGCTGCTGGATGTTGCAGACGTCATTCGTCCTTATCCGGAAATCATTGATTATTTGGAGCAAGCAAAAGATGATCACTTTTTGGATAAGCTGCTTACATTTGATGGCGGGCAGCAAGCTCAAGACGCGATCCTAGATTTTCTTGACAAATATGGCATGCGATGTGCTGGAGAAATCGATTTAACAAGAACTCGTTGGAGTGAAAAACCAATTGCGCTTGTTCCGTTGATTCTGGGTAACATCAAAAACTTCGAGCCTAATGCCAGCCATCGGAAATTCGAGCAAGGGCGGCAGGAAGCTTTGAAAAAAGAACAAGAGCTATTAGATCGATTGAAACAATTGCCGGACGGTGAAGGAAAAGCCCAAGAAACCAAACGAATGATTGACCTCATTCGGAATTTCATGGGTTATCGGGAATACCCGAAATACGGTATGGTGAATCGTTACTTTATTTATAAGCAGGCTTTACTGAAAGAGGCTGAACGACTCGTACAAGCGGGCGTTATTCATCATAAGGAAGATATATATTATCTCACTTTTGAAGAGCTTGACGAGGTCGTACGCACAAATAAACTGGATAACCCGGGTTCCATGGTCGAGCAGCAAGCAAAGCTTGCGATCAGACAGATGATCAGCAAACGAAAAGAGGAGTACAACGTATTTGAAAAACTAACTCCTCCGCGCGTGATCACGTCGGATGGTGAAATCATCGCAGGGGAGTACAAACGAGAAAATATCCCAGCCGAAGCTATTGTCGGCCTGCCTGTTTCTTCCGGAACGGTCGAAGGACGAGCGCGTGTCATCTTAAACATGAAAGACGCCGATCTCGAGGAAGGAGATATATTAGTCACCGCTTTTACCGACCCTAGCTGGACGCCTCTGTTTGTATCCATTAAGGGCTTGGTCACCGAAGTGGGCGGACTGATGACCCATGGAGCCGTTATCGCGCGTGAATATGGCTTACCGGCCGTTGTCGGCGTTGAGAATGCTACCAAACGGATAAAGGACGGGCAGCGCATTCGCGTACATGGGTCCGAAGGCTATATTGAAATATTGTCATAG", "partial": "0", "query_start": 10778, "query_end": 13330, "hit_start": 96, "hit_end": 2649, "orf_dna_sequence": "ATGTTGCTGGCGCAGCAAGGTTTTCAGGTTCCTCCCGGAATCGTGCTCACCACTGCGTTTTTCCAACCTTGGTTTGAACAGATTCAGCGCACGGCTTGCTGGGCAAAGCTCCTCGCTGCCGAGCCCGATGAGTGGTCAAGCCTGTGTCGTGAACTCAAGGCCTTGAGCGCTGGTCTGACGTTCGGAGAGGCGCAGCAGCAAGCCCTGGAGGGTTTGCGAGAAGACTTGCATGCTCTAGGTGATGCGCGGTTTGCAGTGCGCTCTTCTTCTCTTGAAGAAGACCTGCCCCAGGCTTCCTTCGCTGGCGGGTATGAGACGTGTCTGGGCGTGCGGTCGGAAGATCTTGAAATCGCGGTGCGGCGATGCTTTGCCTCTACGCTGGATGAGCGGGTTTTGATGTACAAACGGGAACGCGGTTTTGATATTCGCTCGCCGCGACTTGCTGTGGTTGTACAGCAGCAAATTCATAGCGAGGTGGCTGGAGTTGGTTTCTCACTCAACCCGCTTAACAATGATTATGACGAGGCCGTCATCAACGCCAACTGGGGACTGGGGGAATCGGTGGTGGCCGGGCGCGTCTCACCCGATCACTTTGTTCTTGACAAGGTCGGGCGTCAGGTTGTCGAAAGAAAACAGGGTGCAAAACAGCTTTCGATTTGGGTGTCTGAAGCGGGTGGCACGACCGAGAAGCAGGGCTATCGCTCGCAAGAGTTCTCGCTGAATGACGCGCAGCTAAGCGAGCTGATCGATGCGATATGTGAGATTGAAACGTTTTACCAGAGACCGATAGACATTGAATGGTCATATGCGAACGACCAGCTTTATCTCCTGCAAGCTCGCCCTATCACGACCTACATTCCACTCGCTCCGCGGATGATGACGCAGCCTGGTGAACGTCGGTGCCTGTACGCCGATATGGCACTATCGAGCGGGCTGACGATCAACGCGCACATCTCACCCTTGGGGCTTGATTGGATGAGAGAGGGGTTGGTATTACTTGCCGACATGACGTTTGGCAAACTCGATTTCGACCTTCGTTTTGAAGAGGCATTCTGCTTTTGTGCAGGCGGCCGAATGTATCAGAACGTCTCCAATGTATTGTGGCTGACAACGCCCGAGCAGTTGGCGAAGATGAGTGCCGCAAGCGATGTGCTGATGGCCGAGACGCAAGCCTATATTGATGCTGATCGCTACCGTTCGCAAGTCAAGCCCCCTTGGGCGAAGGTCGCCATGTTGAAGTACCTACCCCGGGTCATGTGGCGAGGACGTTATTTTGTTGGCACGCTGTTGTGGGCGATTCTCGCCCCCGAGCACGCATGGCGAAGCTACCAAGTCAAGGCCGATGGCTACAAGACGGAGCTCACGGGCGACCTAGACTACAGTTTGTCTCTCGATGCATTCCGGCGCCAGTACACCTCGACTGACAATGCCCGTCTTATGCTTACCTTCACCATGTCGGTGGTTTGGGCGTCGGTTGGGGCAATCGCCATGGTTGACGTTCTGGTTGGAAAATCCGCCGAAGGCAAAGCCCTTGGCGACAAACTCAAGCGGGGTTTTACGGGCAATATTGTGGTTGAAATGGGCATCACCTTGTTCCGCCTGGCGAAGATGCTTCCGCCATCTGATTTCGATGATCTGGATCAGTTGGTCGAGCGGATCAACACGCGACAGATGCCGGCCCAATTCTGCCACGCTTGGGATGCGTTTATGGCCAAATTTGGCTGTCGCGGTCCGCTAGAGATGGATTTAGCAAGTCCACGCTACGCGGATGACCCTGTGCTTGCCCTCAAGCAGATGTCGCTGATGCCCCTCGATGACGAGCGGTTTGATCCCGAGTTGACTCACCAACGTCAGGTCGAAGAGCGCGAGCAAGCGTTTGCGGCATTGATGGCGCGTTCAGGATGGCTGCGCCGACGCTTGTTACGGCGCGTCTATCACGTGATTGACTTGTTCGCGGGCATCCGTGATCATCCCAAATACTACATGCTGTTATTTTATCAGGGGCTGCGCAAACGTGCTCTGAGCGAAGGTGAACGCCTGACGCGTGAAGGGCGTCTCGATGCGTCTGAAGATATCTTCGATTTAACTTTTGATGATATCGACTCGGCGGTGAGAGATCCGGCTTTGGATTTAAGGGCGATTCGTCAGCAGCGTACCGCCTTCAATCAAATCCTCAGCAACCAGGTCCACACCTTTCCGGCGGTCATCGACTCTCGGGGCCGCATCCTGCGTCCGCCAGCGCGCGAATCCAAGCCCGGTGAATATCGTGGCATGGCGGTGTCAGCGGGCCTCGCCAAGGGGCCGGTGAAGGTGTTGCAACGTCCGGACGAGAAGCCCGTTGACAAGGGAGACATCTTGGTTGTATACACCACAGATCCTGGCTGGACCCCGCTATTTGTGAGCGCCGCTGCGATTGTGATCGAAGTCGGTGGCGCTTTACAGCATGGGGCCGTGGTGGCACGTGAGTATGGCAAGCCTTGTGTTGTAGGTATTGATCAACTGATCAGTCAATTTGAGGACGGGCAGCAGGTTGAAGTTGATGGAACGGCTGGGATGGTCAGGCTTTTATAA", "orf_prot_sequence": "MLLAQQGFQVPPGIVLTTAFFQPWFEQIQRTACWAKLLAAEPDEWSSLCRELKALSAGLTFGEAQQQALEGLREDLHALGDARFAVRSSSLEEDLPQASFAGGYETCLGVRSEDLEIAVRRCFASTLDERVLMYKRERGFDIRSPRLAVVVQQQIHSEVAGVGFSLNPLNNDYDEAVINANWGLGESVVAGRVSPDHFVLDKVGRQVVERKQGAKQLSIWVSEAGGTTEKQGYRSQEFSLNDAQLSELIDAICEIETFYQRPIDIEWSYANDQLYLLQARPITTYIPLAPRMMTQPGERRCLYADMALSSGLTINAHISPLGLDWMREGLVLLADMTFGKLDFDLRFEEAFCFCAGGRMYQNVSNVLWLTTPEQLAKMSAASDVLMAETQAYIDADRYRSQVKPPWAKVAMLKYLPRVMWRGRYFVGTLLWAILAPEHAWRSYQVKADGYKTELTGDLDYSLSLDAFRRQYTSTDNARLMLTFTMSVVWASVGAIAMVDVLVGKSAEGKALGDKLKRGFTGNIVVEMGITLFRLAKMLPPSDFDDLDQLVERINTRQMPAQFCHAWDAFMAKFGCRGPLEMDLASPRYADDPVLALKQMSLMPLDDERFDPELTHQRQVEEREQAFAALMARSGWLRRRLLRRVYHVIDLFAGIRDHPKYYMLLFYQGLRKRALSEGERLTREGRLDASEDIFDLTFDDIDSAVRDPALDLRAIRQQRTAFNQILSNQVHTFPAVIDSRGRILRPPARESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVSAAAIVIEVGGALQHGAVVAREYGKPCVVGIDQLISQFEDGQQVEVDGTAGMVRLL", "perc_identity": 29.07}, "gnl|BL_ORD_ID|890|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10763, "orf_end": 13333, "orf_from": "BGC0001186.1|Misakinolide_13 ", "model_name": "rphA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1500", "model_id": "910", "ARO_accession": "3000444", "ARO_name": "rphA", "ARO_category": {"41087": {"category_aro_accession": "3004040", "category_aro_cvterm_id": "41087", "category_aro_name": "rifampin phosphotransferase", "category_aro_description": "Enzymes, protein or other gene products that inactivate rifampin (rifamycin) antibiotics through phosphorylation of the antibiotic at the 21-OH position.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.41395e-40, "max_identities": 124, "bit_score": 155.992, "cvterm_id": "39689", "query": "KALGDKLKRGFTGNIVVEMGITLFRLAKML--PPSDFDDLDQLVERINTRQMP-----AQFCHAWDAFMAKFGCRGPLEMDLASPRYADDPVLALKQMSLMP--LDDER-FDPELTHQRQVEEREQAFAA---LMAR-----SGWLRRRLLRRVYHVIDLFAGIRDHPKYYMLLFYQGLRKRALSEGERLTREGRLDASEDIFDLTFDDIDSAVRDPALDLRAIRQQRTAFNQILSNQVHTFPAVIDSRGRILRPPAR--ESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVSAAAIVIEVGGALQHGAVVAREYGKPCVVGIDQLISQFEDGQQVEVDGTAGMVRLL", "match": "K   D L      N+  EMG+ L  +A ++   P     L+ + +     ++P     A+   A++A++ ++G R   E+D+  P   + P       +L+P  LD  R F P    +R  + R +A A    ++ R      G  R    RR+   +  FAG R++PKY ++      R+  L E + L R G L   ED+  LTFD+ + AVR   +D R +R+++ AF    S Q  T P V+ S G  L    R  +   G   G+AVSAG  +G  +V+    E  ++ GDILV   TDP W+PLFV  A +V EVGG + HGAV+AREYG   VVG+++      DGQ++ V GT G + LL", "sequence_from_db": "KNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERP------SALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFR---SYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELL", "sequence_from_broadstreet": "MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS", "dna_sequence_from_broadstreet": "ATGAGCGGGCGTCTGGTCGTGGATCTTCAGGACGTCGACGCGGCGGGGCTCGCCGAGGTCGGCGGCAAGGGCGCCCACCTGGGCGAGCTGTCCCGGATCGACGGGGTCCGGGTGCCGTCCGGGTTCTGTGTGACGACGCACGCCTTCCGGCGGATCATGGCGGAGGCACCCGAGAGCGGGGAACTCCTCGACCGGCTGTCCCGCGTGGACGAGGGCGACCAGGAGGCGGTCCGATCCCTCGCCGCCCGTCTACGGCAGGTCGTCGGGGCGACGCCCCTCCCGGACGAGGTGGCGGCGGCCGTCACCGGGGCGCTCGCCCGGCACGGTGAGCGGTCCGCGTACGCCGTACGGTCCAGCGCGACGGCCGAGGACCTGCCGACCGCGTCGTTCGCCGGCCAGCAGGACACGTACCTGAACGTCGTCGGCACCGAGGAGATCCTCCGGCACGTCAGCCGGTGCTGGGCCTCCCTGTTCACCGAGCGGGCGGTGACCTACCGCGGGCGTCAGGGCGTCGACCACCGTACGGTCCACATGGGCGTGGTCGTGCAGCGGATGGTCGTGCCGCGGGCGTCCGGCATCCTGTTCACCGCCGACCCGGTGACGGGAGACCGCCGCACGGCGACCGTGGACGCCGGTTTCGGTCTCGGCGAGGCCCTGGTGTCGGGGCTGGTCGACCCGGACGTCCTCACGGTGCGGCACGGCGAGGTCGTCGCGCGGACGATCGCCGCGAAGCGGCGCGCCCTGCACGCCGTGCAGGGCGGTGGGACGCGCGAGACCCCGATCGAGGAACGGCGGCAGCGCGAACCGGTACTGACGGACGATCAGGCCGTGGAGCTGGTCGCGCTCGGGCGGCGGATCGAGGCGCACTTCGGCAGCCCGCAGGACATCGAGTGGTGCCTGGACGACGACGGCTTCCACATCGTGCAGAGCCGGCCGATCACCACGCTGTTCCCCGTGCCCGAGCGGGACGACGACGTCTTCCGCGTCTATCTCTCGGTCGGCCACCAGCAGATGATGACCGACGCCATGAAGCCCCTGGGCCTCTCGATGTGGCGGCTGACGGCCCTGGCACCGATGTACGAGGCCGGCGGGCGGCTGTTCGTCGACGCCACCGCCCGGCTGGCGGTGCCCGGGAGCCGTGCCACTCTCCTGGACGTCGTCGGCCGTGGCGACCCGCTGACCCGGGACGCGCTCGAAACGGTCCTGGAGAACGGCGAGTTCGAGCCGACGCCGGCGGAGACGGACGGAGGCGCGCCGCCCGCCGGTGACGGGGCCGAACCGGACGAGGCCGATCCTTCCATCGTCACCGAGCTGATCGAGCGCAGCCGGCGCTCCCTCGCCGAGCTGGAGCGGGAGATCGGCACGAAGAGCGGTCCCGCCCTGTTCGCGTTCCTGCGGGAGGCGTTCGAGGAGCACAAGCGGGTGGTCGGCGATCCGCTGAACATCCGCGCGATCATGGCGGGCATGGAGGCCACCTGGTGGCTGAACGACCGGCTGGAGGAGTGGCTCGGCGAGAAGAACGCCGCCGACACGCTCACGCTGTCCGCCCCCGACAACGTGACCTCGGAGATGGGGCTGGAGCTGCTCGACGTCGCCGACGTGGTCCGCACGCACCCGGAGGTGGTGGCCTTCCTGGAGGGCGTCGAGGACGACGGCTTCCTGGACGAGCTGCCCAAGGTCCCCGGTGGCGCCGAGGCCCGGGACGCCTTCGAGGCATACCTGGACCGGTACGGCATGCGCTGCGTCGGCGAGATCGACATCACGNGGCCCCCGGTGCGGGAACGGCCCAGCGCGCTCGTGCCGGTCGTCCTCGACCACGTGCGCGCCTTCGGGCCCGGCGCCGCCGCGCGCCGCTTCGAGGACGGCCGGCGCAGGGCGCTCGCGAAGGAGCGTGAGGTGCTGGAGCGGCTGCGGGACCTGCCGGACGGGGAGCGCAGGGCCGACGCGGCGCGCCGGATGATCCGGCAGGTCCGCGCGTTCGCCGGCTACCGGGAGTACCCGAAGTACGCGATCGTCAGCCGCTCCTTCGTCTACCGTCAGGCCCTGCTGCGGGAGGCCGACGAGCTGGTGCGGGCCGGCGTCCTCGCCGACCGGGAGGACGTCCACTACCTGACGTTCGACGAGTTCGAGGAGGCCGTCCGCGTGCGCCGGGTGGACGAGCGGCTGGTGCGGCGCCGCAAGGACGCCTTCCGTTCGTACCAGGCGCTGACCCCGCCCCGCGTCCTCACCTCGGAGGGTGTGGCCCTCTCCGGGGCGTACCGGCGCGACGACGTGCCGGAAGGGGCGCTGGCGGGTCTCGCGGTGTCCGCGGGGACCGTGGAGGGCCGGGCCCGGGTGGTCCTCGACATGGCGGAGGCCGATCTGGAGGCGGGCGACATCCTGGTCACGCGGTTCACGGACCCCAGCTGGTCACCGCTGTTCGTCGGGATCGCGGGCCTGGTGACGGAGGTGGGCGGTCTGATGACCCATGGCGCGGTGATCGCCCGCGAGTACGGTCTGGCGGCCGTGGTCGGGGTGGAGCGGGCCACCCGGCTGATCCGGGACGGGCAGCGCATCCGGGTGCACGGGACGGAGGGCTATATCGAGCTTCTGTCCTGA", "partial": "0", "query_start": 12287, "query_end": 13330, "hit_start": 1515, "hit_end": 2592, "orf_dna_sequence": "ATGTTGCTGGCGCAGCAAGGTTTTCAGGTTCCTCCCGGAATCGTGCTCACCACTGCGTTTTTCCAACCTTGGTTTGAACAGATTCAGCGCACGGCTTGCTGGGCAAAGCTCCTCGCTGCCGAGCCCGATGAGTGGTCAAGCCTGTGTCGTGAACTCAAGGCCTTGAGCGCTGGTCTGACGTTCGGAGAGGCGCAGCAGCAAGCCCTGGAGGGTTTGCGAGAAGACTTGCATGCTCTAGGTGATGCGCGGTTTGCAGTGCGCTCTTCTTCTCTTGAAGAAGACCTGCCCCAGGCTTCCTTCGCTGGCGGGTATGAGACGTGTCTGGGCGTGCGGTCGGAAGATCTTGAAATCGCGGTGCGGCGATGCTTTGCCTCTACGCTGGATGAGCGGGTTTTGATGTACAAACGGGAACGCGGTTTTGATATTCGCTCGCCGCGACTTGCTGTGGTTGTACAGCAGCAAATTCATAGCGAGGTGGCTGGAGTTGGTTTCTCACTCAACCCGCTTAACAATGATTATGACGAGGCCGTCATCAACGCCAACTGGGGACTGGGGGAATCGGTGGTGGCCGGGCGCGTCTCACCCGATCACTTTGTTCTTGACAAGGTCGGGCGTCAGGTTGTCGAAAGAAAACAGGGTGCAAAACAGCTTTCGATTTGGGTGTCTGAAGCGGGTGGCACGACCGAGAAGCAGGGCTATCGCTCGCAAGAGTTCTCGCTGAATGACGCGCAGCTAAGCGAGCTGATCGATGCGATATGTGAGATTGAAACGTTTTACCAGAGACCGATAGACATTGAATGGTCATATGCGAACGACCAGCTTTATCTCCTGCAAGCTCGCCCTATCACGACCTACATTCCACTCGCTCCGCGGATGATGACGCAGCCTGGTGAACGTCGGTGCCTGTACGCCGATATGGCACTATCGAGCGGGCTGACGATCAACGCGCACATCTCACCCTTGGGGCTTGATTGGATGAGAGAGGGGTTGGTATTACTTGCCGACATGACGTTTGGCAAACTCGATTTCGACCTTCGTTTTGAAGAGGCATTCTGCTTTTGTGCAGGCGGCCGAATGTATCAGAACGTCTCCAATGTATTGTGGCTGACAACGCCCGAGCAGTTGGCGAAGATGAGTGCCGCAAGCGATGTGCTGATGGCCGAGACGCAAGCCTATATTGATGCTGATCGCTACCGTTCGCAAGTCAAGCCCCCTTGGGCGAAGGTCGCCATGTTGAAGTACCTACCCCGGGTCATGTGGCGAGGACGTTATTTTGTTGGCACGCTGTTGTGGGCGATTCTCGCCCCCGAGCACGCATGGCGAAGCTACCAAGTCAAGGCCGATGGCTACAAGACGGAGCTCACGGGCGACCTAGACTACAGTTTGTCTCTCGATGCATTCCGGCGCCAGTACACCTCGACTGACAATGCCCGTCTTATGCTTACCTTCACCATGTCGGTGGTTTGGGCGTCGGTTGGGGCAATCGCCATGGTTGACGTTCTGGTTGGAAAATCCGCCGAAGGCAAAGCCCTTGGCGACAAACTCAAGCGGGGTTTTACGGGCAATATTGTGGTTGAAATGGGCATCACCTTGTTCCGCCTGGCGAAGATGCTTCCGCCATCTGATTTCGATGATCTGGATCAGTTGGTCGAGCGGATCAACACGCGACAGATGCCGGCCCAATTCTGCCACGCTTGGGATGCGTTTATGGCCAAATTTGGCTGTCGCGGTCCGCTAGAGATGGATTTAGCAAGTCCACGCTACGCGGATGACCCTGTGCTTGCCCTCAAGCAGATGTCGCTGATGCCCCTCGATGACGAGCGGTTTGATCCCGAGTTGACTCACCAACGTCAGGTCGAAGAGCGCGAGCAAGCGTTTGCGGCATTGATGGCGCGTTCAGGATGGCTGCGCCGACGCTTGTTACGGCGCGTCTATCACGTGATTGACTTGTTCGCGGGCATCCGTGATCATCCCAAATACTACATGCTGTTATTTTATCAGGGGCTGCGCAAACGTGCTCTGAGCGAAGGTGAACGCCTGACGCGTGAAGGGCGTCTCGATGCGTCTGAAGATATCTTCGATTTAACTTTTGATGATATCGACTCGGCGGTGAGAGATCCGGCTTTGGATTTAAGGGCGATTCGTCAGCAGCGTACCGCCTTCAATCAAATCCTCAGCAACCAGGTCCACACCTTTCCGGCGGTCATCGACTCTCGGGGCCGCATCCTGCGTCCGCCAGCGCGCGAATCCAAGCCCGGTGAATATCGTGGCATGGCGGTGTCAGCGGGCCTCGCCAAGGGGCCGGTGAAGGTGTTGCAACGTCCGGACGAGAAGCCCGTTGACAAGGGAGACATCTTGGTTGTATACACCACAGATCCTGGCTGGACCCCGCTATTTGTGAGCGCCGCTGCGATTGTGATCGAAGTCGGTGGCGCTTTACAGCATGGGGCCGTGGTGGCACGTGAGTATGGCAAGCCTTGTGTTGTAGGTATTGATCAACTGATCAGTCAATTTGAGGACGGGCAGCAGGTTGAAGTTGATGGAACGGCTGGGATGGTCAGGCTTTTATAA", "orf_prot_sequence": "MLLAQQGFQVPPGIVLTTAFFQPWFEQIQRTACWAKLLAAEPDEWSSLCRELKALSAGLTFGEAQQQALEGLREDLHALGDARFAVRSSSLEEDLPQASFAGGYETCLGVRSEDLEIAVRRCFASTLDERVLMYKRERGFDIRSPRLAVVVQQQIHSEVAGVGFSLNPLNNDYDEAVINANWGLGESVVAGRVSPDHFVLDKVGRQVVERKQGAKQLSIWVSEAGGTTEKQGYRSQEFSLNDAQLSELIDAICEIETFYQRPIDIEWSYANDQLYLLQARPITTYIPLAPRMMTQPGERRCLYADMALSSGLTINAHISPLGLDWMREGLVLLADMTFGKLDFDLRFEEAFCFCAGGRMYQNVSNVLWLTTPEQLAKMSAASDVLMAETQAYIDADRYRSQVKPPWAKVAMLKYLPRVMWRGRYFVGTLLWAILAPEHAWRSYQVKADGYKTELTGDLDYSLSLDAFRRQYTSTDNARLMLTFTMSVVWASVGAIAMVDVLVGKSAEGKALGDKLKRGFTGNIVVEMGITLFRLAKMLPPSDFDDLDQLVERINTRQMPAQFCHAWDAFMAKFGCRGPLEMDLASPRYADDPVLALKQMSLMPLDDERFDPELTHQRQVEEREQAFAALMARSGWLRRRLLRRVYHVIDLFAGIRDHPKYYMLLFYQGLRKRALSEGERLTREGRLDASEDIFDLTFDDIDSAVRDPALDLRAIRQQRTAFNQILSNQVHTFPAVIDSRGRILRPPARESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVSAAAIVIEVGGALQHGAVVAREYGKPCVVGIDQLISQFEDGQQVEVDGTAGMVRLL", "perc_identity": 33.7}, "gnl|BL_ORD_ID|890|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10763, "orf_end": 13333, "orf_from": "BGC0001186.1|Misakinolide_13 ", "model_name": "rphA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1500", "model_id": "910", "ARO_accession": "3000444", "ARO_name": "rphA", "ARO_category": {"41087": {"category_aro_accession": "3004040", "category_aro_cvterm_id": "41087", "category_aro_name": "rifampin phosphotransferase", "category_aro_description": "Enzymes, protein or other gene products that inactivate rifampin (rifamycin) antibiotics through phosphorylation of the antibiotic at the 21-OH position.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.06211e-34, "max_identities": 97, "bit_score": 138.658, "cvterm_id": "39689", "query": "GFQVPPGIVLTTAFFQPWFEQIQRTACWAKLLA----AEPDEWSSLCRELKALSAGLTFGEAQQQALEGLREDLHALGD-ARFAVRSSSLEEDLPQASFAGGYETCLGV-RSEDLEIAVRRCFASTLDERVLMYKRERGFDIRSPRLAVVVQQQIHSEVAGVGFSLNPLNNDYDEAVINANWGLGESVVAGRVSPDHFVLDKVGRQVVERKQGAKQLSIWVSEAGGTTEK--QGYRSQEFSLNDAQLSELIDAICEIETFYQRPIDIEWSYANDQLYLLQARPITTYIPLAPR", "match": "G +VP G  +TT  F+    +   +      L+     + +   SL   L+ +       +    A+ G    L   G+ + +AVRSS+  EDLP ASFAG  +T L V  +E++   V RC+AS   ER + Y+  +G D R+  + VVVQ+ +    +G+ F+ +P+  D   A ++A +GLGE++V+G V PD  VL     +VV R   AK+ ++   + GGT E   +  R +E  L D Q  EL+     IE  +  P DIEW   +D  +++Q+RPITT  P+  R", "sequence_from_db": "GVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGA---LARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPD--VLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPER", "sequence_from_broadstreet": "MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS", "dna_sequence_from_broadstreet": "ATGAGCGGGCGTCTGGTCGTGGATCTTCAGGACGTCGACGCGGCGGGGCTCGCCGAGGTCGGCGGCAAGGGCGCCCACCTGGGCGAGCTGTCCCGGATCGACGGGGTCCGGGTGCCGTCCGGGTTCTGTGTGACGACGCACGCCTTCCGGCGGATCATGGCGGAGGCACCCGAGAGCGGGGAACTCCTCGACCGGCTGTCCCGCGTGGACGAGGGCGACCAGGAGGCGGTCCGATCCCTCGCCGCCCGTCTACGGCAGGTCGTCGGGGCGACGCCCCTCCCGGACGAGGTGGCGGCGGCCGTCACCGGGGCGCTCGCCCGGCACGGTGAGCGGTCCGCGTACGCCGTACGGTCCAGCGCGACGGCCGAGGACCTGCCGACCGCGTCGTTCGCCGGCCAGCAGGACACGTACCTGAACGTCGTCGGCACCGAGGAGATCCTCCGGCACGTCAGCCGGTGCTGGGCCTCCCTGTTCACCGAGCGGGCGGTGACCTACCGCGGGCGTCAGGGCGTCGACCACCGTACGGTCCACATGGGCGTGGTCGTGCAGCGGATGGTCGTGCCGCGGGCGTCCGGCATCCTGTTCACCGCCGACCCGGTGACGGGAGACCGCCGCACGGCGACCGTGGACGCCGGTTTCGGTCTCGGCGAGGCCCTGGTGTCGGGGCTGGTCGACCCGGACGTCCTCACGGTGCGGCACGGCGAGGTCGTCGCGCGGACGATCGCCGCGAAGCGGCGCGCCCTGCACGCCGTGCAGGGCGGTGGGACGCGCGAGACCCCGATCGAGGAACGGCGGCAGCGCGAACCGGTACTGACGGACGATCAGGCCGTGGAGCTGGTCGCGCTCGGGCGGCGGATCGAGGCGCACTTCGGCAGCCCGCAGGACATCGAGTGGTGCCTGGACGACGACGGCTTCCACATCGTGCAGAGCCGGCCGATCACCACGCTGTTCCCCGTGCCCGAGCGGGACGACGACGTCTTCCGCGTCTATCTCTCGGTCGGCCACCAGCAGATGATGACCGACGCCATGAAGCCCCTGGGCCTCTCGATGTGGCGGCTGACGGCCCTGGCACCGATGTACGAGGCCGGCGGGCGGCTGTTCGTCGACGCCACCGCCCGGCTGGCGGTGCCCGGGAGCCGTGCCACTCTCCTGGACGTCGTCGGCCGTGGCGACCCGCTGACCCGGGACGCGCTCGAAACGGTCCTGGAGAACGGCGAGTTCGAGCCGACGCCGGCGGAGACGGACGGAGGCGCGCCGCCCGCCGGTGACGGGGCCGAACCGGACGAGGCCGATCCTTCCATCGTCACCGAGCTGATCGAGCGCAGCCGGCGCTCCCTCGCCGAGCTGGAGCGGGAGATCGGCACGAAGAGCGGTCCCGCCCTGTTCGCGTTCCTGCGGGAGGCGTTCGAGGAGCACAAGCGGGTGGTCGGCGATCCGCTGAACATCCGCGCGATCATGGCGGGCATGGAGGCCACCTGGTGGCTGAACGACCGGCTGGAGGAGTGGCTCGGCGAGAAGAACGCCGCCGACACGCTCACGCTGTCCGCCCCCGACAACGTGACCTCGGAGATGGGGCTGGAGCTGCTCGACGTCGCCGACGTGGTCCGCACGCACCCGGAGGTGGTGGCCTTCCTGGAGGGCGTCGAGGACGACGGCTTCCTGGACGAGCTGCCCAAGGTCCCCGGTGGCGCCGAGGCCCGGGACGCCTTCGAGGCATACCTGGACCGGTACGGCATGCGCTGCGTCGGCGAGATCGACATCACGNGGCCCCCGGTGCGGGAACGGCCCAGCGCGCTCGTGCCGGTCGTCCTCGACCACGTGCGCGCCTTCGGGCCCGGCGCCGCCGCGCGCCGCTTCGAGGACGGCCGGCGCAGGGCGCTCGCGAAGGAGCGTGAGGTGCTGGAGCGGCTGCGGGACCTGCCGGACGGGGAGCGCAGGGCCGACGCGGCGCGCCGGATGATCCGGCAGGTCCGCGCGTTCGCCGGCTACCGGGAGTACCCGAAGTACGCGATCGTCAGCCGCTCCTTCGTCTACCGTCAGGCCCTGCTGCGGGAGGCCGACGAGCTGGTGCGGGCCGGCGTCCTCGCCGACCGGGAGGACGTCCACTACCTGACGTTCGACGAGTTCGAGGAGGCCGTCCGCGTGCGCCGGGTGGACGAGCGGCTGGTGCGGCGCCGCAAGGACGCCTTCCGTTCGTACCAGGCGCTGACCCCGCCCCGCGTCCTCACCTCGGAGGGTGTGGCCCTCTCCGGGGCGTACCGGCGCGACGACGTGCCGGAAGGGGCGCTGGCGGGTCTCGCGGTGTCCGCGGGGACCGTGGAGGGCCGGGCCCGGGTGGTCCTCGACATGGCGGAGGCCGATCTGGAGGCGGGCGACATCCTGGTCACGCGGTTCACGGACCCCAGCTGGTCACCGCTGTTCGTCGGGATCGCGGGCCTGGTGACGGAGGTGGGCGGTCTGATGACCCATGGCGCGGTGATCGCCCGCGAGTACGGTCTGGCGGCCGTGGTCGGGGTGGAGCGGGCCACCCGGCTGATCCGGGACGGGCAGCGCATCCGGGTGCACGGGACGGAGGGCTATATCGAGCTTCTGTCCTGA", "partial": "0", "query_start": 10781, "query_end": 11635, "hit_start": 102, "hit_end": 966, "orf_dna_sequence": "ATGTTGCTGGCGCAGCAAGGTTTTCAGGTTCCTCCCGGAATCGTGCTCACCACTGCGTTTTTCCAACCTTGGTTTGAACAGATTCAGCGCACGGCTTGCTGGGCAAAGCTCCTCGCTGCCGAGCCCGATGAGTGGTCAAGCCTGTGTCGTGAACTCAAGGCCTTGAGCGCTGGTCTGACGTTCGGAGAGGCGCAGCAGCAAGCCCTGGAGGGTTTGCGAGAAGACTTGCATGCTCTAGGTGATGCGCGGTTTGCAGTGCGCTCTTCTTCTCTTGAAGAAGACCTGCCCCAGGCTTCCTTCGCTGGCGGGTATGAGACGTGTCTGGGCGTGCGGTCGGAAGATCTTGAAATCGCGGTGCGGCGATGCTTTGCCTCTACGCTGGATGAGCGGGTTTTGATGTACAAACGGGAACGCGGTTTTGATATTCGCTCGCCGCGACTTGCTGTGGTTGTACAGCAGCAAATTCATAGCGAGGTGGCTGGAGTTGGTTTCTCACTCAACCCGCTTAACAATGATTATGACGAGGCCGTCATCAACGCCAACTGGGGACTGGGGGAATCGGTGGTGGCCGGGCGCGTCTCACCCGATCACTTTGTTCTTGACAAGGTCGGGCGTCAGGTTGTCGAAAGAAAACAGGGTGCAAAACAGCTTTCGATTTGGGTGTCTGAAGCGGGTGGCACGACCGAGAAGCAGGGCTATCGCTCGCAAGAGTTCTCGCTGAATGACGCGCAGCTAAGCGAGCTGATCGATGCGATATGTGAGATTGAAACGTTTTACCAGAGACCGATAGACATTGAATGGTCATATGCGAACGACCAGCTTTATCTCCTGCAAGCTCGCCCTATCACGACCTACATTCCACTCGCTCCGCGGATGATGACGCAGCCTGGTGAACGTCGGTGCCTGTACGCCGATATGGCACTATCGAGCGGGCTGACGATCAACGCGCACATCTCACCCTTGGGGCTTGATTGGATGAGAGAGGGGTTGGTATTACTTGCCGACATGACGTTTGGCAAACTCGATTTCGACCTTCGTTTTGAAGAGGCATTCTGCTTTTGTGCAGGCGGCCGAATGTATCAGAACGTCTCCAATGTATTGTGGCTGACAACGCCCGAGCAGTTGGCGAAGATGAGTGCCGCAAGCGATGTGCTGATGGCCGAGACGCAAGCCTATATTGATGCTGATCGCTACCGTTCGCAAGTCAAGCCCCCTTGGGCGAAGGTCGCCATGTTGAAGTACCTACCCCGGGTCATGTGGCGAGGACGTTATTTTGTTGGCACGCTGTTGTGGGCGATTCTCGCCCCCGAGCACGCATGGCGAAGCTACCAAGTCAAGGCCGATGGCTACAAGACGGAGCTCACGGGCGACCTAGACTACAGTTTGTCTCTCGATGCATTCCGGCGCCAGTACACCTCGACTGACAATGCCCGTCTTATGCTTACCTTCACCATGTCGGTGGTTTGGGCGTCGGTTGGGGCAATCGCCATGGTTGACGTTCTGGTTGGAAAATCCGCCGAAGGCAAAGCCCTTGGCGACAAACTCAAGCGGGGTTTTACGGGCAATATTGTGGTTGAAATGGGCATCACCTTGTTCCGCCTGGCGAAGATGCTTCCGCCATCTGATTTCGATGATCTGGATCAGTTGGTCGAGCGGATCAACACGCGACAGATGCCGGCCCAATTCTGCCACGCTTGGGATGCGTTTATGGCCAAATTTGGCTGTCGCGGTCCGCTAGAGATGGATTTAGCAAGTCCACGCTACGCGGATGACCCTGTGCTTGCCCTCAAGCAGATGTCGCTGATGCCCCTCGATGACGAGCGGTTTGATCCCGAGTTGACTCACCAACGTCAGGTCGAAGAGCGCGAGCAAGCGTTTGCGGCATTGATGGCGCGTTCAGGATGGCTGCGCCGACGCTTGTTACGGCGCGTCTATCACGTGATTGACTTGTTCGCGGGCATCCGTGATCATCCCAAATACTACATGCTGTTATTTTATCAGGGGCTGCGCAAACGTGCTCTGAGCGAAGGTGAACGCCTGACGCGTGAAGGGCGTCTCGATGCGTCTGAAGATATCTTCGATTTAACTTTTGATGATATCGACTCGGCGGTGAGAGATCCGGCTTTGGATTTAAGGGCGATTCGTCAGCAGCGTACCGCCTTCAATCAAATCCTCAGCAACCAGGTCCACACCTTTCCGGCGGTCATCGACTCTCGGGGCCGCATCCTGCGTCCGCCAGCGCGCGAATCCAAGCCCGGTGAATATCGTGGCATGGCGGTGTCAGCGGGCCTCGCCAAGGGGCCGGTGAAGGTGTTGCAACGTCCGGACGAGAAGCCCGTTGACAAGGGAGACATCTTGGTTGTATACACCACAGATCCTGGCTGGACCCCGCTATTTGTGAGCGCCGCTGCGATTGTGATCGAAGTCGGTGGCGCTTTACAGCATGGGGCCGTGGTGGCACGTGAGTATGGCAAGCCTTGTGTTGTAGGTATTGATCAACTGATCAGTCAATTTGAGGACGGGCAGCAGGTTGAAGTTGATGGAACGGCTGGGATGGTCAGGCTTTTATAA", "orf_prot_sequence": "MLLAQQGFQVPPGIVLTTAFFQPWFEQIQRTACWAKLLAAEPDEWSSLCRELKALSAGLTFGEAQQQALEGLREDLHALGDARFAVRSSSLEEDLPQASFAGGYETCLGVRSEDLEIAVRRCFASTLDERVLMYKRERGFDIRSPRLAVVVQQQIHSEVAGVGFSLNPLNNDYDEAVINANWGLGESVVAGRVSPDHFVLDKVGRQVVERKQGAKQLSIWVSEAGGTTEKQGYRSQEFSLNDAQLSELIDAICEIETFYQRPIDIEWSYANDQLYLLQARPITTYIPLAPRMMTQPGERRCLYADMALSSGLTINAHISPLGLDWMREGLVLLADMTFGKLDFDLRFEEAFCFCAGGRMYQNVSNVLWLTTPEQLAKMSAASDVLMAETQAYIDADRYRSQVKPPWAKVAMLKYLPRVMWRGRYFVGTLLWAILAPEHAWRSYQVKADGYKTELTGDLDYSLSLDAFRRQYTSTDNARLMLTFTMSVVWASVGAIAMVDVLVGKSAEGKALGDKLKRGFTGNIVVEMGITLFRLAKMLPPSDFDDLDQLVERINTRQMPAQFCHAWDAFMAKFGCRGPLEMDLASPRYADDPVLALKQMSLMPLDDERFDPELTHQRQVEEREQAFAALMARSGWLRRRLLRRVYHVIDLFAGIRDHPKYYMLLFYQGLRKRALSEGERLTREGRLDASEDIFDLTFDDIDSAVRDPALDLRAIRQQRTAFNQILSNQVHTFPAVIDSRGRILRPPARESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVSAAAIVIEVGGALQHGAVVAREYGKPCVVGIDQLISQFEDGQQVEVDGTAGMVRLL", "perc_identity": 33.11}, "gnl|BL_ORD_ID|2429|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10763, "orf_end": 13333, "orf_from": "BGC0001186.1|Misakinolide_13 ", "model_name": "LAP-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "585", "model_id": "3621", "ARO_accession": "3004826", "ARO_name": "LAP-2", "ARO_category": {"42954": {"category_aro_accession": "3004824", "category_aro_cvterm_id": "42954", "category_aro_name": "LAP beta-lactamase", "category_aro_description": "LAP is a Ambler Class A beta-lactamase gene family that confers resistance to beta-lactams.", "category_aro_class_name": "AMR Gene Family"}, "35976": {"category_aro_accession": "0000059", "category_aro_cvterm_id": "35976", "category_aro_name": "cefepime", "category_aro_description": "Cefepime (INN) is a fourth-generation cephalosporin antibiotic developed in 1994. It contains an aminothiazolyl group that decreases its affinity with beta-lactamases. Cefepime shows high binding affinity with penicillin-binding proteins and has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents.", "category_aro_class_name": "Antibiotic"}, "35980": {"category_aro_accession": "0000063", "category_aro_cvterm_id": "35980", "category_aro_name": "cefuroxime", "category_aro_description": "Cefuroxime is a second-generation cephalosporin antibiotic with increased stability with beta-lactamases than first-generation cephalosporins. Cefuroxime is active against Gram-positive organisms but less active against methicillin-resistant strains.", "category_aro_class_name": "Antibiotic"}, "35981": {"category_aro_accession": "0000064", "category_aro_cvterm_id": "35981", "category_aro_name": "amoxicillin", "category_aro_description": "Amoxicillin is a moderate-spectrum, bacteriolytic, beta-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. A derivative of penicillin, it has a wider range of treatment but remains relatively ineffective against Gram-negative bacteria. It is commonly taken with clavulanic acid, a beta-lactamase inhibitor. Like other beta-lactams, amoxicillin interferes with the synthesis of peptidoglycan.", "category_aro_class_name": "Antibiotic"}, "35995": {"category_aro_accession": "0000078", "category_aro_cvterm_id": "35995", "category_aro_name": "piperacillin", "category_aro_description": "Piperacillin is an acetylureidopenicillin and has an extended spectrum of targets relative to other beta-lactam antibiotics. It inhibits cell wall synthesis in bacteria, and is usually taken with the beta-lactamase inhibitor tazobactam to overcome penicillin-resistant bacteria.", "category_aro_class_name": "Antibiotic"}, "36976": {"category_aro_accession": "3000632", "category_aro_cvterm_id": "36976", "category_aro_name": "benzylpenicillin", "category_aro_description": "Benzylpenicillin, commonly referred to as penicillin G, is effective against both Gram-positive and Gram-negative bacteria. It is unstable in acid.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "40523": {"category_aro_accession": "3003832", "category_aro_cvterm_id": "40523", "category_aro_name": "ticarcillin", "category_aro_description": "Ticarcillin is a carboxypenicillin used for the treatment of Gram-negative bacteria, particularly P. aeruginosa. Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cell death.", "category_aro_class_name": "Antibiotic"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.46817, "max_identities": 30, "bit_score": 29.261, "cvterm_id": "36884", "query": "TAFNQILSN------QVHTFPAVIDSRGRILR--PPARESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVS---AAAIVIEVGGALQHGA", "match": "TA N +LS         H   +  DS  R+ R  P   E+KPG+ R     A +A+   K+L         +  ++     D    PLF S   A  ++ +  GA  HG+", "sequence_from_db": "TAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTPAAMAQTLQKLLNESVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGS", "sequence_from_broadstreet": "MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRREERFPMMSTFKVLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELCNAAITTSDNTAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTPAAMAQTLQKLLNESVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGSRGIVALLGPGGKPSRIVVLYITNTHSSMNELNEHIAGIGDSVIKNW", "dna_sequence_from_broadstreet": "ATGAAAAAGATCCGCCTTATTATAATCTCTTTACTGGCTGGAATGTGTACTCCAGCATTATCTACACCAGTCAATGTTACTGATACAATACAAAGCACAGAAGACCATATCAAAGGTCGGGTTGGTTTTACTGAAATAGACTTTTTATCCGGGAAGGTTCTGAGTAGTCATCGCCGTGAAGAACGTTTTCCTATGATGAGCACATTCAAAGTTTTGTTATGTGGAGCAATATTAGTACGTGTTGATAAAGGGCTTGAACAACTTGAACGCCGAATTACCTATAATAAGCATGACCTGGACGACTATTCTCCACTAACCAGTCAGCACATTGCAGATGGAATGACGGTTTCTGAGTTATGCAATGCTGCCATTACCACCAGTGATAACACTGCTGCAAATTTATTGCTATCAACTATTGGCGGGCCGGAGGGATTAACTCATTTTCTGCGTAGCACTGGTGATAGTTATACAAGGCTTGATCGACACGAACCCAGCCTTAATGAGGCGAAGCCTGGCGATGAGCGTGATACCACCACTCCGGCAGCGATGGCTCAAACGCTACAAAAATTGTTAAACGAAAGTGTACTTACAGAAAAATCTCGAAAAAAATTAATAAGCTGGATGCAGGAAGATAAAGTCGGCGGGCCTCTGTTCCGCTCTGTACTGCCAGCTGGCTGGATGATAGCGGATAAAACAGGAGCAGGTGATCACGGATCTCGGGGCATCGTTGCACTGTTGGGCCCCGGAGGCAAGCCATCTCGTATAGTAGTCCTGTATATTACAAATACTCATTCATCTATGAATGAACTCAACGAGCATATTGCAGGGATCGGAGATTCAGTAATTAAGAACTGGTAA", "partial": "0", "query_start": 12917, "query_end": 13213, "hit_start": 387, "hit_end": 717, "orf_dna_sequence": "ATGTTGCTGGCGCAGCAAGGTTTTCAGGTTCCTCCCGGAATCGTGCTCACCACTGCGTTTTTCCAACCTTGGTTTGAACAGATTCAGCGCACGGCTTGCTGGGCAAAGCTCCTCGCTGCCGAGCCCGATGAGTGGTCAAGCCTGTGTCGTGAACTCAAGGCCTTGAGCGCTGGTCTGACGTTCGGAGAGGCGCAGCAGCAAGCCCTGGAGGGTTTGCGAGAAGACTTGCATGCTCTAGGTGATGCGCGGTTTGCAGTGCGCTCTTCTTCTCTTGAAGAAGACCTGCCCCAGGCTTCCTTCGCTGGCGGGTATGAGACGTGTCTGGGCGTGCGGTCGGAAGATCTTGAAATCGCGGTGCGGCGATGCTTTGCCTCTACGCTGGATGAGCGGGTTTTGATGTACAAACGGGAACGCGGTTTTGATATTCGCTCGCCGCGACTTGCTGTGGTTGTACAGCAGCAAATTCATAGCGAGGTGGCTGGAGTTGGTTTCTCACTCAACCCGCTTAACAATGATTATGACGAGGCCGTCATCAACGCCAACTGGGGACTGGGGGAATCGGTGGTGGCCGGGCGCGTCTCACCCGATCACTTTGTTCTTGACAAGGTCGGGCGTCAGGTTGTCGAAAGAAAACAGGGTGCAAAACAGCTTTCGATTTGGGTGTCTGAAGCGGGTGGCACGACCGAGAAGCAGGGCTATCGCTCGCAAGAGTTCTCGCTGAATGACGCGCAGCTAAGCGAGCTGATCGATGCGATATGTGAGATTGAAACGTTTTACCAGAGACCGATAGACATTGAATGGTCATATGCGAACGACCAGCTTTATCTCCTGCAAGCTCGCCCTATCACGACCTACATTCCACTCGCTCCGCGGATGATGACGCAGCCTGGTGAACGTCGGTGCCTGTACGCCGATATGGCACTATCGAGCGGGCTGACGATCAACGCGCACATCTCACCCTTGGGGCTTGATTGGATGAGAGAGGGGTTGGTATTACTTGCCGACATGACGTTTGGCAAACTCGATTTCGACCTTCGTTTTGAAGAGGCATTCTGCTTTTGTGCAGGCGGCCGAATGTATCAGAACGTCTCCAATGTATTGTGGCTGACAACGCCCGAGCAGTTGGCGAAGATGAGTGCCGCAAGCGATGTGCTGATGGCCGAGACGCAAGCCTATATTGATGCTGATCGCTACCGTTCGCAAGTCAAGCCCCCTTGGGCGAAGGTCGCCATGTTGAAGTACCTACCCCGGGTCATGTGGCGAGGACGTTATTTTGTTGGCACGCTGTTGTGGGCGATTCTCGCCCCCGAGCACGCATGGCGAAGCTACCAAGTCAAGGCCGATGGCTACAAGACGGAGCTCACGGGCGACCTAGACTACAGTTTGTCTCTCGATGCATTCCGGCGCCAGTACACCTCGACTGACAATGCCCGTCTTATGCTTACCTTCACCATGTCGGTGGTTTGGGCGTCGGTTGGGGCAATCGCCATGGTTGACGTTCTGGTTGGAAAATCCGCCGAAGGCAAAGCCCTTGGCGACAAACTCAAGCGGGGTTTTACGGGCAATATTGTGGTTGAAATGGGCATCACCTTGTTCCGCCTGGCGAAGATGCTTCCGCCATCTGATTTCGATGATCTGGATCAGTTGGTCGAGCGGATCAACACGCGACAGATGCCGGCCCAATTCTGCCACGCTTGGGATGCGTTTATGGCCAAATTTGGCTGTCGCGGTCCGCTAGAGATGGATTTAGCAAGTCCACGCTACGCGGATGACCCTGTGCTTGCCCTCAAGCAGATGTCGCTGATGCCCCTCGATGACGAGCGGTTTGATCCCGAGTTGACTCACCAACGTCAGGTCGAAGAGCGCGAGCAAGCGTTTGCGGCATTGATGGCGCGTTCAGGATGGCTGCGCCGACGCTTGTTACGGCGCGTCTATCACGTGATTGACTTGTTCGCGGGCATCCGTGATCATCCCAAATACTACATGCTGTTATTTTATCAGGGGCTGCGCAAACGTGCTCTGAGCGAAGGTGAACGCCTGACGCGTGAAGGGCGTCTCGATGCGTCTGAAGATATCTTCGATTTAACTTTTGATGATATCGACTCGGCGGTGAGAGATCCGGCTTTGGATTTAAGGGCGATTCGTCAGCAGCGTACCGCCTTCAATCAAATCCTCAGCAACCAGGTCCACACCTTTCCGGCGGTCATCGACTCTCGGGGCCGCATCCTGCGTCCGCCAGCGCGCGAATCCAAGCCCGGTGAATATCGTGGCATGGCGGTGTCAGCGGGCCTCGCCAAGGGGCCGGTGAAGGTGTTGCAACGTCCGGACGAGAAGCCCGTTGACAAGGGAGACATCTTGGTTGTATACACCACAGATCCTGGCTGGACCCCGCTATTTGTGAGCGCCGCTGCGATTGTGATCGAAGTCGGTGGCGCTTTACAGCATGGGGCCGTGGTGGCACGTGAGTATGGCAAGCCTTGTGTTGTAGGTATTGATCAACTGATCAGTCAATTTGAGGACGGGCAGCAGGTTGAAGTTGATGGAACGGCTGGGATGGTCAGGCTTTTATAA", "orf_prot_sequence": "MLLAQQGFQVPPGIVLTTAFFQPWFEQIQRTACWAKLLAAEPDEWSSLCRELKALSAGLTFGEAQQQALEGLREDLHALGDARFAVRSSSLEEDLPQASFAGGYETCLGVRSEDLEIAVRRCFASTLDERVLMYKRERGFDIRSPRLAVVVQQQIHSEVAGVGFSLNPLNNDYDEAVINANWGLGESVVAGRVSPDHFVLDKVGRQVVERKQGAKQLSIWVSEAGGTTEKQGYRSQEFSLNDAQLSELIDAICEIETFYQRPIDIEWSYANDQLYLLQARPITTYIPLAPRMMTQPGERRCLYADMALSSGLTINAHISPLGLDWMREGLVLLADMTFGKLDFDLRFEEAFCFCAGGRMYQNVSNVLWLTTPEQLAKMSAASDVLMAETQAYIDADRYRSQVKPPWAKVAMLKYLPRVMWRGRYFVGTLLWAILAPEHAWRSYQVKADGYKTELTGDLDYSLSLDAFRRQYTSTDNARLMLTFTMSVVWASVGAIAMVDVLVGKSAEGKALGDKLKRGFTGNIVVEMGITLFRLAKMLPPSDFDDLDQLVERINTRQMPAQFCHAWDAFMAKFGCRGPLEMDLASPRYADDPVLALKQMSLMPLDDERFDPELTHQRQVEEREQAFAALMARSGWLRRRLLRRVYHVIDLFAGIRDHPKYYMLLFYQGLRKRALSEGERLTREGRLDASEDIFDLTFDDIDSAVRDPALDLRAIRQQRTAFNQILSNQVHTFPAVIDSRGRILRPPARESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVSAAAIVIEVGGALQHGAVVAREYGKPCVVGIDQLISQFEDGQQVEVDGTAGMVRLL", "perc_identity": 27.27}, "gnl|BL_ORD_ID|2541|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10763, "orf_end": 13333, "orf_from": "BGC0001186.1|Misakinolide_13 ", "model_name": "LAP-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "585", "model_id": "3620", "ARO_accession": "3004825", "ARO_name": "LAP-1", "ARO_category": {"42954": {"category_aro_accession": "3004824", "category_aro_cvterm_id": "42954", "category_aro_name": "LAP beta-lactamase", "category_aro_description": "LAP is a Ambler Class A beta-lactamase gene family that confers resistance to beta-lactams.", "category_aro_class_name": "AMR Gene Family"}, "35976": {"category_aro_accession": "0000059", "category_aro_cvterm_id": "35976", "category_aro_name": "cefepime", "category_aro_description": "Cefepime (INN) is a fourth-generation cephalosporin antibiotic developed in 1994. It contains an aminothiazolyl group that decreases its affinity with beta-lactamases. Cefepime shows high binding affinity with penicillin-binding proteins and has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents.", "category_aro_class_name": "Antibiotic"}, "35980": {"category_aro_accession": "0000063", "category_aro_cvterm_id": "35980", "category_aro_name": "cefuroxime", "category_aro_description": "Cefuroxime is a second-generation cephalosporin antibiotic with increased stability with beta-lactamases than first-generation cephalosporins. Cefuroxime is active against Gram-positive organisms but less active against methicillin-resistant strains.", "category_aro_class_name": "Antibiotic"}, "35981": {"category_aro_accession": "0000064", "category_aro_cvterm_id": "35981", "category_aro_name": "amoxicillin", "category_aro_description": "Amoxicillin is a moderate-spectrum, bacteriolytic, beta-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. A derivative of penicillin, it has a wider range of treatment but remains relatively ineffective against Gram-negative bacteria. It is commonly taken with clavulanic acid, a beta-lactamase inhibitor. Like other beta-lactams, amoxicillin interferes with the synthesis of peptidoglycan.", "category_aro_class_name": "Antibiotic"}, "35995": {"category_aro_accession": "0000078", "category_aro_cvterm_id": "35995", "category_aro_name": "piperacillin", "category_aro_description": "Piperacillin is an acetylureidopenicillin and has an extended spectrum of targets relative to other beta-lactam antibiotics. It inhibits cell wall synthesis in bacteria, and is usually taken with the beta-lactamase inhibitor tazobactam to overcome penicillin-resistant bacteria.", "category_aro_class_name": "Antibiotic"}, "36976": {"category_aro_accession": "3000632", "category_aro_cvterm_id": "36976", "category_aro_name": "benzylpenicillin", "category_aro_description": "Benzylpenicillin, commonly referred to as penicillin G, is effective against both Gram-positive and Gram-negative bacteria. It is unstable in acid.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "40523": {"category_aro_accession": "3003832", "category_aro_cvterm_id": "40523", "category_aro_name": "ticarcillin", "category_aro_description": "Ticarcillin is a carboxypenicillin used for the treatment of Gram-negative bacteria, particularly P. aeruginosa. Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cell death.", "category_aro_class_name": "Antibiotic"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.63257, "max_identities": 30, "bit_score": 28.4906, "cvterm_id": "36884", "query": "TAFNQILSN------QVHTFPAVIDSRGRILR--PPARESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVS---AAAIVIEVGGALQHGA", "match": "TA N +LS         H   +  DS  R+ R  P   E+KPG+ R     A +A+   K+L         +  ++     D    PLF S   A  ++ +  GA  HG+", "sequence_from_db": "TAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTPAAMAQTLQKLLNGSVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGS", "sequence_from_broadstreet": "MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRREERFPMMSTFKVLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELCNAAITTSDNTAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTPAAMAQTLQKLLNGSVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGSRGIVALLGPGGKPSRIVVLYITNTHSSMNELNEHIAGIGDSVIKNW", "dna_sequence_from_broadstreet": "ATGAAAAAGATCCGCCTTATTATAATCTCTTTACTGGCTGGAATGTGTACTCCAGCATTATCTACACCAGTCAATGTTACTGATACAATACAAAGCACAGAAGACCATATCAAAGGTCGGGTTGGTTTTACTGAAATAGACTTTTTATCCGGGAAGGTTCTGAGTAGTCATCGCCGTGAAGAACGTTTTCCTATGATGAGCACATTCAAAGTTTTGTTATGTGGAGCAATATTAGTACGTGTTGATAAAGGGCTTGAACAACTTGAACGCCGAATTACCTATAATAAGCATGACCTGGACGACTATTCTCCACTAACCAGTCAGCACATTGCAGATGGAATGACGGTTTCTGAGTTATGCAATGCTGCCATTACCACCAGTGATAACACTGCTGCAAATTTATTGCTATCAACTATTGGCGGGCCGGAGGGATTAACTCATTTTCTGCGTAGCACTGGTGATAGTTATACAAGGCTTGATCGACACGAACCCAGCCTTAATGAGGCGAAGCCTGGCGATGAGCGTGATACCACCACTCCGGCAGCGATGGCTCAAACGCTACAAAAATTGTTAAACGGAAGTGTACTTACAGAAAAATCTCGAAAAAAATTAATAAGCTGGATGCAGGAAGATAAAGTCGGCGGGCCTCTGTTCCGCTCTGTACTGCCAGCTGGCTGGATGATAGCGGATAAAACAGGAGCAGGTGATCACGGATCTCGGGGCATCGTTGCACTGTTGGGCCCCGGAGGCAAGCCATCTCGTATAGTAGTCCTGTATATTACAAATACTCATTCATCTATGAATGAACTCAACGAGCATATTGCAGGGATCGGAGATTCAGTAATTAAGAACTGGTAA", "partial": "0", "query_start": 12917, "query_end": 13213, "hit_start": 387, "hit_end": 717, "orf_dna_sequence": "ATGTTGCTGGCGCAGCAAGGTTTTCAGGTTCCTCCCGGAATCGTGCTCACCACTGCGTTTTTCCAACCTTGGTTTGAACAGATTCAGCGCACGGCTTGCTGGGCAAAGCTCCTCGCTGCCGAGCCCGATGAGTGGTCAAGCCTGTGTCGTGAACTCAAGGCCTTGAGCGCTGGTCTGACGTTCGGAGAGGCGCAGCAGCAAGCCCTGGAGGGTTTGCGAGAAGACTTGCATGCTCTAGGTGATGCGCGGTTTGCAGTGCGCTCTTCTTCTCTTGAAGAAGACCTGCCCCAGGCTTCCTTCGCTGGCGGGTATGAGACGTGTCTGGGCGTGCGGTCGGAAGATCTTGAAATCGCGGTGCGGCGATGCTTTGCCTCTACGCTGGATGAGCGGGTTTTGATGTACAAACGGGAACGCGGTTTTGATATTCGCTCGCCGCGACTTGCTGTGGTTGTACAGCAGCAAATTCATAGCGAGGTGGCTGGAGTTGGTTTCTCACTCAACCCGCTTAACAATGATTATGACGAGGCCGTCATCAACGCCAACTGGGGACTGGGGGAATCGGTGGTGGCCGGGCGCGTCTCACCCGATCACTTTGTTCTTGACAAGGTCGGGCGTCAGGTTGTCGAAAGAAAACAGGGTGCAAAACAGCTTTCGATTTGGGTGTCTGAAGCGGGTGGCACGACCGAGAAGCAGGGCTATCGCTCGCAAGAGTTCTCGCTGAATGACGCGCAGCTAAGCGAGCTGATCGATGCGATATGTGAGATTGAAACGTTTTACCAGAGACCGATAGACATTGAATGGTCATATGCGAACGACCAGCTTTATCTCCTGCAAGCTCGCCCTATCACGACCTACATTCCACTCGCTCCGCGGATGATGACGCAGCCTGGTGAACGTCGGTGCCTGTACGCCGATATGGCACTATCGAGCGGGCTGACGATCAACGCGCACATCTCACCCTTGGGGCTTGATTGGATGAGAGAGGGGTTGGTATTACTTGCCGACATGACGTTTGGCAAACTCGATTTCGACCTTCGTTTTGAAGAGGCATTCTGCTTTTGTGCAGGCGGCCGAATGTATCAGAACGTCTCCAATGTATTGTGGCTGACAACGCCCGAGCAGTTGGCGAAGATGAGTGCCGCAAGCGATGTGCTGATGGCCGAGACGCAAGCCTATATTGATGCTGATCGCTACCGTTCGCAAGTCAAGCCCCCTTGGGCGAAGGTCGCCATGTTGAAGTACCTACCCCGGGTCATGTGGCGAGGACGTTATTTTGTTGGCACGCTGTTGTGGGCGATTCTCGCCCCCGAGCACGCATGGCGAAGCTACCAAGTCAAGGCCGATGGCTACAAGACGGAGCTCACGGGCGACCTAGACTACAGTTTGTCTCTCGATGCATTCCGGCGCCAGTACACCTCGACTGACAATGCCCGTCTTATGCTTACCTTCACCATGTCGGTGGTTTGGGCGTCGGTTGGGGCAATCGCCATGGTTGACGTTCTGGTTGGAAAATCCGCCGAAGGCAAAGCCCTTGGCGACAAACTCAAGCGGGGTTTTACGGGCAATATTGTGGTTGAAATGGGCATCACCTTGTTCCGCCTGGCGAAGATGCTTCCGCCATCTGATTTCGATGATCTGGATCAGTTGGTCGAGCGGATCAACACGCGACAGATGCCGGCCCAATTCTGCCACGCTTGGGATGCGTTTATGGCCAAATTTGGCTGTCGCGGTCCGCTAGAGATGGATTTAGCAAGTCCACGCTACGCGGATGACCCTGTGCTTGCCCTCAAGCAGATGTCGCTGATGCCCCTCGATGACGAGCGGTTTGATCCCGAGTTGACTCACCAACGTCAGGTCGAAGAGCGCGAGCAAGCGTTTGCGGCATTGATGGCGCGTTCAGGATGGCTGCGCCGACGCTTGTTACGGCGCGTCTATCACGTGATTGACTTGTTCGCGGGCATCCGTGATCATCCCAAATACTACATGCTGTTATTTTATCAGGGGCTGCGCAAACGTGCTCTGAGCGAAGGTGAACGCCTGACGCGTGAAGGGCGTCTCGATGCGTCTGAAGATATCTTCGATTTAACTTTTGATGATATCGACTCGGCGGTGAGAGATCCGGCTTTGGATTTAAGGGCGATTCGTCAGCAGCGTACCGCCTTCAATCAAATCCTCAGCAACCAGGTCCACACCTTTCCGGCGGTCATCGACTCTCGGGGCCGCATCCTGCGTCCGCCAGCGCGCGAATCCAAGCCCGGTGAATATCGTGGCATGGCGGTGTCAGCGGGCCTCGCCAAGGGGCCGGTGAAGGTGTTGCAACGTCCGGACGAGAAGCCCGTTGACAAGGGAGACATCTTGGTTGTATACACCACAGATCCTGGCTGGACCCCGCTATTTGTGAGCGCCGCTGCGATTGTGATCGAAGTCGGTGGCGCTTTACAGCATGGGGCCGTGGTGGCACGTGAGTATGGCAAGCCTTGTGTTGTAGGTATTGATCAACTGATCAGTCAATTTGAGGACGGGCAGCAGGTTGAAGTTGATGGAACGGCTGGGATGGTCAGGCTTTTATAA", "orf_prot_sequence": "MLLAQQGFQVPPGIVLTTAFFQPWFEQIQRTACWAKLLAAEPDEWSSLCRELKALSAGLTFGEAQQQALEGLREDLHALGDARFAVRSSSLEEDLPQASFAGGYETCLGVRSEDLEIAVRRCFASTLDERVLMYKRERGFDIRSPRLAVVVQQQIHSEVAGVGFSLNPLNNDYDEAVINANWGLGESVVAGRVSPDHFVLDKVGRQVVERKQGAKQLSIWVSEAGGTTEKQGYRSQEFSLNDAQLSELIDAICEIETFYQRPIDIEWSYANDQLYLLQARPITTYIPLAPRMMTQPGERRCLYADMALSSGLTINAHISPLGLDWMREGLVLLADMTFGKLDFDLRFEEAFCFCAGGRMYQNVSNVLWLTTPEQLAKMSAASDVLMAETQAYIDADRYRSQVKPPWAKVAMLKYLPRVMWRGRYFVGTLLWAILAPEHAWRSYQVKADGYKTELTGDLDYSLSLDAFRRQYTSTDNARLMLTFTMSVVWASVGAIAMVDVLVGKSAEGKALGDKLKRGFTGNIVVEMGITLFRLAKMLPPSDFDDLDQLVERINTRQMPAQFCHAWDAFMAKFGCRGPLEMDLASPRYADDPVLALKQMSLMPLDDERFDPELTHQRQVEEREQAFAALMARSGWLRRRLLRRVYHVIDLFAGIRDHPKYYMLLFYQGLRKRALSEGERLTREGRLDASEDIFDLTFDDIDSAVRDPALDLRAIRQQRTAFNQILSNQVHTFPAVIDSRGRILRPPARESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVSAAAIVIEVGGALQHGAVVAREYGKPCVVGIDQLISQFEDGQQVEVDGTAGMVRLL", "perc_identity": 27.27}}, "BGC0001186.1|Misakinolide_14 # 13519 # 14196 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.491": {"gnl|BL_ORD_ID|4545|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5615", "ARO_accession": "3006133", "ARO_name": "PER-12", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.40347, "max_identities": 22, "bit_score": 28.4906, "cvterm_id": "36944", "query": "SISHTDKYACAIAFPLI-HPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "S+SH+D  AC + F L+  P ALD   I  + VK  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "SVSHSDNVACDLLFELVGGPAALDA-YIRSIGVK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWSPMMEEHPGDEFTVAVQQLLQYSVSHSDNVACDLLFELVGGPAALDAYIRSIGVKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCTGCACAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGTCGCCCATGATGGAAGAGCATCCGGGCGATGAATTTACTGTTGCTGTGCAGCAGTTGTTGCAATATTCGGTGTCGCATAGTGACAACGTGGCTTGTGATTTGTTATTCGAACTGGTTGGAGGGCCTGCAGCCTTAGATGCCTACATCCGTTCTATAGGAGTGAAAGAGACGGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAGGGGGCCGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCAGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTGTCAGAGCCGGGAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGGCTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13765, "query_end": 13983, "hit_start": 390, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 29.73}, "gnl|BL_ORD_ID|72|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "82", "ARO_accession": "3002366", "ARO_name": "PER-4", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.598736, "max_identities": 21, "bit_score": 28.1054, "cvterm_id": "36943", "query": "PSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "P  + L  S+SHTD  AC + F L+   A   + I  + +K  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "PVQQLLQYSVSHTDNVACDLLFELVGGPAALHDYIQSMGIK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHTDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGGCTCCGATAATGAAAGCGTATCAGGGAGACGAGTTTAGTGTTCCAGTGCAGCAACTGCTGCAATACTCGGTCTCGCACACCGATAACGTGGCCTGTGATTTGTTATTTGAACTGGTTGGTGGACCAGCTGCTTTGCATGACTATATCCAGTCTATGGGTATAAAGGAGACCGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAAGGTGCTGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTATCAAAGCCGGAAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGACTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13741, "query_end": 13983, "hit_start": 366, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 25.93}, "gnl|BL_ORD_ID|4549|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5619", "ARO_accession": "3006137", "ARO_name": "PER-16", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.856947, "max_identities": 18, "bit_score": 27.7202, "cvterm_id": "36771", "query": "SISHTDKYACAIAFPLI-HPLALDVERIDRVSVKAMKSQILPHELQTEA", "match": "S+SH+D  AC + F L+  P ALD   I  + VK  ++ ++ +E Q  A", "sequence_from_db": "SVSHSDNVACDLLFELVGGPAALDA-YIRSIGVK--ETAVVANEAQMHA", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWSPMMEEHPGDEFTVAVQQLLQYSVSHSDNVACDLLFELVGGPAALDAYIRSIGVKETAVVANEAQMHADDQVQYQNWTSMKGAAEILRKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGTCGCCCATGATGGAAGAGCATCCGGGCGATGAATTTACTGTTGCTGTGCAGCAGTTGTTGCAATATTCGGTGTCGCATAGTGACAACGTGGCTTGTGATTTGTTATTCGAACTGGTTGGAGGGCCTGCAGCCTTAGATGCCTACATCCGTTCTATAGGAGTGAAAGAGACGGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAAGGTGCTGCAGAGATCCTGAGAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTGTCAGAGCCGGGAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACTAATGAAGCTATCATTGCGCAGGTTGCTCAGGCTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13765, "query_end": 13908, "hit_start": 390, "hit_end": 528, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 36.73}, "gnl|BL_ORD_ID|4547|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5617", "ARO_accession": "3006135", "ARO_name": "PER-14", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.17251, "max_identities": 24, "bit_score": 27.335, "cvterm_id": "35506", "query": "LGVSISHTDKYACAIAFPLI-HPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "L  S+SHTD  AC + F L+  P AL    I  + VK  ++ ++ +E Q  A  ++         WT+ +A ++VL+", "sequence_from_db": "LQYSVSHTDNVACDLLFELVGGPQALHA-YIQSLGVK--EAAVVANEAQMHADDQVQYQN-----WTSMKAAAQVLQ", "sequence_from_broadstreet": "MNVITKCVFTASALLMLGLSSFVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLLLNPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQSVTVNRAAVLQNTWSPMMKDHQGDEFTVAVQQLLQYSVSHTDNVACDLLFELVGGPQALHAYIQSLGVKEAAVVANEAQMHADDQVQYQNWTSMKAAAQVLQKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTIVAHKTGTSGVRAGKTAATNDAGVIMLPDGRPLLVAVFVKDSAESERTNEAIIAQVAQAAYQFELKKLSAVSPD", "dna_sequence_from_broadstreet": "ATGAATGTCATCACAAAATGTGTTTTCACCGCTTCTGCTCTGCTGATGCTTGGCTTAAGTTCATTTGTAGTATCAGCCCAATCCCCTTTGTTAAAAGAGCAGATTGAAACCATAGTGACGGGTAAAAAGGCCACTGTAGGTGTAGCAGTGTGGGGGCCTGACGATCTGGAACCTTTGTTGCTGAATCCATTTGAAAAGTTTCCGATGCAAAGTGTGTTTAAACTGCATTTAGCTATGTTAGTTCTGCATCAGGTCGATCAGGGGAAACTGGATTTAAATCAGTCTGTTACTGTTAATCGTGCTGCAGTATTACAAAATACCTGGTCGCCAATGATGAAAGATCATCAGGGCGATGAATTTACTGTTGCAGTACAGCAGTTACTGCAGTATTCGGTGTCACACACCGACAATGTGGCCTGCGATTTGTTATTTGAACTGGTGGGCGGGCCGCAAGCTTTGCATGCTTATATCCAGTCTTTAGGCGTTAAAGAAGCTGCCGTGGTAGCAAATGAAGCGCAAATGCATGCGGATGATCAGGTGCAATATCAAAACTGGACGTCGATGAAAGCCGCAGCACAAGTTCTGCAAAAGTTTGAACAGAAAAAGCAGTTGTCTGAAACCTCTCAGGCCTTGTTATGGAAATGGATGGTTGAAACCACCACAGGACCACAGCGGTTAAAAGGCTTGTTACCTGCTGGTACTATAGTGGCGCATAAAACCGGTACTTCGGGCGTCAGAGCAGGAAAAACTGCGGCGACTAATGATGCGGGCGTCATTATGTTGCCTGATGGACGGCCTTTATTGGTGGCGGTATTTGTCAAGGATTCGGCTGAATCAGAACGAACCAATGAAGCTATTATTGCGCAGGTTGCGCAAGCGGCTTATCAGTTTGAGCTGAAAAAACTCTCTGCAGTGAGTCCGGATTGA", "partial": "0", "query_start": 13756, "query_end": 13983, "hit_start": 381, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 31.17}, "gnl|BL_ORD_ID|797|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "863", "ARO_accession": "3002369", "ARO_name": "PER-7", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.47982, "max_identities": 21, "bit_score": 26.9498, "cvterm_id": "35507", "query": "FQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "+Q      P  + L  S+SH+D  AC + F L+   A   + I  + +K  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "YQGDQFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGGCTCCGATAATGAAAGCGTATCAGGGAGACCAGTTTAGTGTTCCAGTGCAGCAACTGCTGCAATACTCGGTCTCGCACAGCGATAACGTGGCCTGTGATTTGTTATTTGAACTGGTTGGTGGACCAGCTGCTTTGCATGACTATATCCAGTCTATGGGTATAAAGGAGACCGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAGGGGGCCGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTGTCAGAGCCGGGAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGGCTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13717, "query_end": 13983, "hit_start": 342, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 23.6}, "gnl|BL_ORD_ID|4550|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5620", "ARO_accession": "3003184", "ARO_name": "PER-8", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.53376, "max_identities": 20, "bit_score": 26.9498, "cvterm_id": "35507", "query": "PSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "P  + L  S+SH+D  AC + F L+   A   + I  + +K  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "PVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIEKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGAAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGGCTCCGATAATGAAAGCGTATCAGGGAGACCAGTTTAGTGTTCCAGTGCAGCAACTGCTGCAATACTCGGTCTCGCACAGCGATAACGTGGCCTGTGATTTGTTATTTGAACTGGTTGGTGGACCAGCTGCTTTGCATGACTATATCCAGTCTATGGGTATAAAGGAGACCGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAGGGGGCCGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTGTCAGAGCCGGGAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGGCTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13741, "query_end": 13983, "hit_start": 366, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 24.69}, "gnl|BL_ORD_ID|4548|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5618", "ARO_accession": "3006136", "ARO_name": "PER-15", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.58966, "max_identities": 20, "bit_score": 26.9498, "cvterm_id": "36752", "query": "PSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "P  + L  S+SH+D  AC + F L+   A   + I  + +K  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "PVQQLLQYSVSHSDNVACDLLFELVGAPAALHDYIQSMGIK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDNVACDLLFELVGAPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGGCTCCGATAATGAAAGCGTATCAGGGAGACGAGTTTAGTGTTCCAGTGCAGCAACTGCTGCAATACTCGGTCTCGCACAGCGATAACGTGGCCTGTGATTTGTTATTTGAACTGGTTGGTGCACCAGCTGCTTTGCATGACTATATCCAGTCTATGGGTATAAAGGAGACCGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAAGGTGCTGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTATCAAAGCCGGAAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGACTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13741, "query_end": 13983, "hit_start": 366, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 24.69}, "gnl|BL_ORD_ID|4546|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5616", "ARO_accession": "3006134", "ARO_name": "PER-13", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.63291, "max_identities": 20, "bit_score": 26.5646, "cvterm_id": "35507", "query": "PSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "P  + L  S+SH+D  AC + F L+   A   + I  + +K  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "PVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTSGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGGCTCCGATAATGAAAGCGTATCAGGGAGACGAGTTTAGTGTTCCAGTGCAGCAACTGCTGCAATACTCGGTCTCGCACAGCGATAACGTGGCCTGTGATTTGTTATTTGAACTGGTTGGTGGACCAGCTGCTTTGCATGACTATATCCAGTCTATGGGTATAAAGGAGACCGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAAGGTGCTGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCTCAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTATCAAAGCCGGAAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGACTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13741, "query_end": 13983, "hit_start": 366, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 24.69}, "gnl|BL_ORD_ID|1411|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1534", "ARO_accession": "3002367", "ARO_name": "PER-5", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.6624, "max_identities": 20, "bit_score": 26.5646, "cvterm_id": "36944", "query": "PSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "P  + L  S+SH+D  AC + F L+   A   + I  + +K  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "PVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKGQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGGGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGGCTCCGATAATGAAAGCGTATCAGGGAGACGAGTTTAGTGTTCCAGTGCAGCAACTGCTGCAATACTCGGTCTCGCACAGCGATAACGTGGCCTGTGATTTGTTATTTGAACTGGTTGGTGGACCAGCTGCTTTGCATGACTATATCCAGTCTATGGGTATAAAGGAGACCGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAAGGTGCTGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTATCAAAGCCGGAAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGACTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13741, "query_end": 13983, "hit_start": 366, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 24.69}, "gnl|BL_ORD_ID|846|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "919", "ARO_accession": "3002363", "ARO_name": "PER-1", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.70764, "max_identities": 20, "bit_score": 26.5646, "cvterm_id": "36752", "query": "PSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "P  + L  S+SH+D  AC + F L+   A   + I  + +K  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "PVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGGCTCCGATAATGAAAGCGTATCAGGGAGACGAGTTTAGTGTTCCAGTGCAGCAACTGCTGCAATACTCGGTCTCGCACAGCGATAACGTGGCCTGTGATTTGTTATTTGAACTGGTTGGTGGACCAGCTGCTTTGCATGACTATATCCAGTCTATGGGTATAAAGGAGACCGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAAGGTGCTGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTATCAAAGCCGGAAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGACTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13741, "query_end": 13983, "hit_start": 366, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 24.69}, "gnl|BL_ORD_ID|4551|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5621", "ARO_accession": "3006138", "ARO_name": "PER-9", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.19346, "max_identities": 20, "bit_score": 25.7942, "cvterm_id": "35507", "query": "PSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "P  + L  S+SH+D  AC + F L+   A   + I  + +K  ++ ++ +E Q  A  ++         WT+ +  +++LK", "sequence_from_db": "PVQQLLLYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIK--ETAVVANEAQMHADDQVQYQN-----WTSMKGAAEILK", "sequence_from_broadstreet": "MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLLYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN", "dna_sequence_from_broadstreet": "ATGAATGTCATTATAAAAGCTGTAGTTACTGCCTCGACGCTACTGATGGTATCTTTTAGTTCATTCGAAACCTCAGCGCAATCCCCACTGTTAAAAGAGCAAATTGAATCCATAGTCATTGGAAAAAAAGCCACTGTAGGCGTTGCAGTGTGGGGGCCTGACGATCTGGAACCTTTACTGATTAATCCTTTTGAAAAATTCCCAATGCAAAGTGTATTTAAATTGCATTTAGCTATGTTGGTACTGCATCAGGTTGATCAGGGAAAGTTGGATTTAAATCAGACCGTTATCGTAAACAGGGCTAAGGTTTTACAGAATACCTGGGCTCCGATAATGAAAGCGTATCAGGGAGACGAGTTTAGTGTTCCAGTGCAGCAACTGCTGCTATACTCGGTCTCGCACAGCGATAACGTGGCCTGTGATTTGTTATTTGAACTGGTTGGTGGACCAGCTGCTTTGCATGACTATATCCAGTCTATGGGTATAAAGGAGACCGCTGTGGTCGCAAATGAAGCGCAGATGCACGCCGATGATCAGGTGCAGTATCAAAACTGGACCTCGATGAAAGGTGCTGCAGAGATCCTGAAAAAGTTTGAGCAAAAAACACAGCTGTCTGAAACCTCGCAGGCTTTGTTATGGAAGTGGATGGTCGAAACCACCACAGGACCAGAGCGGTTAAAAGGTTTGTTACCAGCTGGTACTGTGGTCGCACATAAAACTGGTACTTCGGGTATCAAAGCCGGAAAAACTGCGGCCACTAATGATTTAGGTATCATTCTGTTGCCTGATGGACGGCCCTTGCTGGTTGCTGTTTTTGTGAAAGACTCAGCCGAGTCAAGCCGAACCAATGAAGCTATCATTGCGCAGGTTGCTCAGACTGCGTATCAATTTGAATTGAAAAAGCTTTCTGCCCTAAGCCCAAATTAA", "partial": "0", "query_start": 13741, "query_end": 13983, "hit_start": 366, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 24.69}, "gnl|BL_ORD_ID|451|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "491", "ARO_accession": "3002364", "ARO_name": "PER-2", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.39962, "max_identities": 23, "bit_score": 25.7942, "cvterm_id": "35732", "query": "LGVSISHTDKYACAIAFPLI-HPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "L  S+SH+D  AC + F L+  P AL    I  + VK  ++ ++ +E Q  A  ++         WT+ +A ++VL+", "sequence_from_db": "LQYSVSHSDNVACDLLFELVGGPQALHA-YIQSLGVK--EAAVVANEAQMHADDQVQYQN-----WTSMKAAAQVLQ", "sequence_from_broadstreet": "MNVITKCVFTASALLMLGLSSFVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLLLNPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQSVTVNRAAVLQNTWSPMMKDHQGDEFTVAVQQLLQYSVSHSDNVACDLLFELVGGPQALHAYIQSLGVKEAAVVANEAQMHADDQVQYQNWTSMKAAAQVLQKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTIVAHKTGTSGVRAGKTAATNDAGVIMLPDGRPLLVAVFVKDSAESERTNEAIIAQVAQAAYQFELKKLSAVSPD", "dna_sequence_from_broadstreet": "ATGAATGTCATCACAAAATGTGTTTTCACCGCTTCTGCTCTGCTGATGCTTGGCTTAAGTTCATTTGTAGTATCAGCCCAATCCCCTTTGTTAAAAGAGCAGATTGAAACCATAGTGACGGGTAAAAAGGCCACTGTAGGTGTAGCAGTGTGGGGGCCTGACGATCTGGAACCTTTGTTGCTGAATCCATTTGAAAAGTTTCCGATGCAAAGTGTGTTTAAACTGCATTTAGCTATGTTAGTTCTGCATCAGGTCGATCAGGGGAAACTGGATTTAAATCAGTCTGTTACTGTTAATCGTGCTGCAGTATTACAAAATACCTGGTCGCCAATGATGAAAGATCATCAGGGCGATGAATTTACTGTTGCAGTACAGCAGTTACTGCAGTATTCGGTGTCACACAGCGACAATGTGGCCTGCGATTTGTTATTTGAACTGGTGGGCGGGCCGCAAGCTTTGCATGCTTATATCCAGTCTTTAGGCGTTAAAGAAGCTGCCGTGGTAGCAAATGAAGCGCAAATGCATGCGGATGATCAGGTGCAATATCAAAACTGGACGTCGATGAAAGCCGCAGCACAAGTTCTGCAAAAGTTTGAACAGAAAAAGCAGTTGTCTGAAACCTCTCAGGCCTTGTTATGGAAATGGATGGTTGAAACCACCACAGGACCACAGCGGTTAAAAGGCTTGTTACCTGCTGGTACTATAGTGGCGCATAAAACCGGTACTTCGGGCGTCAGAGCAGGAAAAACTGCGGCGACTAATGATGCGGGCGTCATTATGTTGCCTGATGGACGGCCTTTATTGGTGGCGGTATTTGTCAAGGATTCGGCTGAATCAGAACGAACCAATGAAGCTATTATTGCGCAGGTTGCGCAAGCGGCTTATCAGTTTGAGCTGAAAAAACTCTCTGCAGTGAGTCCGGATTGA", "partial": "0", "query_start": 13756, "query_end": 13983, "hit_start": 381, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 29.87}, "gnl|BL_ORD_ID|1353|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "AcrF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1900", "model_id": "1437", "ARO_accession": "3000502", "ARO_name": "AcrF", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.56926, "max_identities": 10, "bit_score": 25.7942, "cvterm_id": "36849", "query": "ASGIFQQPIVKYPSPEPLGVSIS", "match": "A  I Q P+ +YP+  P  VS+S", "sequence_from_db": "ALAILQLPVAQYPTIAPPAVSVS", "sequence_from_broadstreet": "MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG", "dna_sequence_from_broadstreet": "ATGGCAAACTTTTTTATTCGACGACCGATATTTGCATGGGTGCTGGCCATTATTCTGATGATGGCGGGCGCACTGGCGATCCTACAATTGCCCGTCGCTCAGTATCCAACAATTGCACCGCCTGCGGTTTCTGTTTCAGCAAACTATCCGGGCGCTGATGCGCAGACCGTGCAGGATACGGTGACGCAGGTTATCGAACAGAATATGAACGGTATCGATAACCTGATGTATATGTCCTCCACCAGCGATTCCGCCGGTAGCGTGACAATTACCCTTACCTTCCAGTCCGGGACCGATCCTGATATCGCGCAAGTGCAGGTGCAGAACAAACTCCAGCTCGCCACGCCGTTGCTGCCGCAGGAGGTTCAGCAGCAGGGGATCAGTGTTGAAAAGTCCAGTAGCAGCTATTTGATGGTGGCGGGCTTTGTCTCTGATAACCCAGGCACCACACAGGACGATATCTCGGACTATGTGGCCTCTAACGTTAAAGATACGCTTAGCCGTCTGAATGGCGTCGGTGACGTACAGCTTTTCGGCGCACAGTATGCGATGCGTATCTGGCTGGATGCCGATCTGCTAAACAAATATAAACTGACACCGGTTGATGTGATTAACCAGTTGAAGGTACAGAACGATCAGATCGCTGCCGGACAGTTGGGCGGAACGCCAGCGTTACCAGGGCAACAATTGAACGCCTCGATTATTGCTCAGACGCGGTTTAAAAATCCGGAAGAATTCGGCAAAGTGACCCTGCGCGTAAACAGTGACGGCTCGGTGGTACGCCTGAAAGATGTCGCACGGGTTGAACTTGGCGGTGAAAACTATAACGTTATCGCTCGTATCAACGGAAAACCGGCGGCGGGCCTGGGGATTAAGCTGGCAACCGGCGCGAATGCTCTCGATACCGCGAAAGCCATTAAGGCAAAACTGGCGGAATTACAGCCATTCTTCCCGCAGGGAATGAAGGTTCTCTACCCTTATGACACCACGCCATTCGTCCAGCTTTCTATTCACGAAGTGGTAAAAACGCTGTTCGAAGCCATTATGCTGGTGTTCCTGGTGATGTATCTGTTCTTGCAGAATATGCGAGCAACGCTGATCCCCACCATTGCGGTACCCGTGGTGTTGTTAGGGACGTTTGCCATCCTCGCCGCTTTTGGTTACTCCATCAACACACTAACGATGTTCGGGATGGTGCTTGCCATCGGGCTGCTCGTCGATGATGCGATAGTGGTGGTGGAGAACGTCGAGCGCGTGATGATGGAGGATAAGCTCCCGCCAAAAGAAGCGACGGAAAAATCGATGTCGCAAATTCAGGGCGCACTGGTGGGTATCGCGATGGTGCTGTCAGCGGTATTTATTCCGATGGCATTCTTCGGCGGTTCTACTGGGGCAATTTATCGCCAGTTCTCTATCACCATCGTTTCGGCAATGGCGCTTTCTGTTCTGGTGGCATTGATTCTTACCCCTGCGTTATGTGCAACGCTGCTTAAACCCGTCTCTGCTGAGCATCACGAAAATAAGGGCGGTTTCTTCGGTTGGTTTAATACCACCTTCGATCATAGCGTTAACCACTACACCAACAGCGTCGGCAAAATCCTCGGATCCACAGGACGATATTTACTGATCTATGCGCTGATTGTTGCAGGAATGGTGGTGTTGTTTTTACGTCTTCCGTCTTCCTTCTTACCTGAAGAGGATCAGGGTGTCTTTCTGACCATGATTCAGTTACCCGCTGGCGCGACGCAAGAGCGGACGCAAAAAGTGTTGGATCAAGTTACGGATTACTATCTGAAGAACGAGAAAGCGAACGTTGAAAGTGTCTTTACGGTTAACGGCTTTAGCTTCAGCGGCCAGGCACAAAACGCCGGTATGGCCTTCGTCAGTCTGAAACCGTGGGAAGAGCGTAATGGTGACGAAAACAGTGCGGAAGCGGTAATCCATCGTGCCAAAATGGAATTGGGCAAGATCCGCGACGGTTTTGTCATTCCATTCAATATGCCAGCCATTGTTGAACTGGGCACGGCAACGGGTTTCGACTTTGAGTTAATTGATCAGGCTGGGCTGGGTCACGATGCCCTAACCCAGGCCCGTAACCAGTTGCTTGGTATGGCGGCGCAACATCCTGCCAGCTTAGTCAGCGTGCGCCCTAATGGCCTGGAAGACACCGCGCAGTTTAAACTGGAAGTTGACCAGGAAAAGGCGCAGGCATTAGGTGTTTCACTTTCTGACATCAATCAGACCATTTCAACGGCGCTGGGTGGGACTTACGTTAACGACTTCATCGACCGTGGCCGCGTGAAAAAGTTGTATGTTCAGGCGGATGCCAAATTCCGTATGCTGCCAGAAGATGTCGATAAACTTTATGTCCGCAGCGCCAACGGCGAAATGGTGCCATTCTCGGCCTTTACCACTTCACATTGGGTGTATGGCTCTCCGCGACTGGAACGCTACAACGGTCTGCCGTCAATGGAGATTCAGGGGGAAGCCGCGCCAGGAACCAGTTCCGGCGATGCCATGGCGTTGATGGAAAACCTTGCGTCAAAATTACCTGCGGGCATTGGTTATGACTGGACGGGTATGTCGTATCAGGAACGCTTATCGGGAAACCAGGCTCCCGCTCTGGTAGCAATTTCCTTTGTGGTTGTTTTCCTGTGCCTTGCTGCACTCTATGAAAGCTGGTCAATTCCTGTCTCGGTTATGTTGGTAGTGCCGTTAGGGATTGTCGGCGTGCTGCTGGCGGCGACACTCTTTAATCAAAAAAATGACGTCTACTTTATGGTGGGCTTGCTAACGACAATTGGCTTGTCGGCCAAAAACGCTATTTTGATCGTTGAGTTCGCTAAAGATCTCATGGAGAAAGAGGGTAAAGGTGTTGTTGAAGCGACACTGATGGCAGTACGTATGCGTCTGCGTCCTATCCTGATGACCTCTCTCGCCTTTATTCTCGGCGTATTACCGCTAGCTATCAGTAACGGTGCCGGCAGTGGCGCGCAGAACGCTGTGGGTATCGGGGTAATGGGAGGAATGGTCTCTGCAACGTTGCTGGCAATCTTCTTCGTACCGGTGTTCTTTGTGGTGATCCGCCGTTGCTTTAAAGGATAA", "partial": "0", "query_start": 13705, "query_end": 13773, "hit_start": 69, "hit_end": 138, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 43.48}, "gnl|BL_ORD_ID|1375|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "PER-6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1493", "ARO_accession": "3002368", "ARO_name": "PER-6", "ARO_category": {"36195": {"category_aro_accession": "3000056", "category_aro_cvterm_id": "36195", "category_aro_name": "PER beta-lactamase", "category_aro_description": "PER beta-lactamases are plasmid-mediated extended spectrum beta-lactamases found in the Enterobacteriaceae family.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.68431, "max_identities": 20, "bit_score": 25.7942, "cvterm_id": "36947", "query": "SISHTDKYACAIAFPLI-HPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLK", "match": "S+SH+D  AC + F L+  P AL    I  + +K  +++++ +E Q  A  ++         WT+ +A +++L+", "sequence_from_db": "SVSHSDNVACDLLFELVGGPAALHA-YIQSLGIK--ETEVVANEAQMHADDQVQYKN-----WTSMKAAAQLLR", "sequence_from_broadstreet": "MNVIAKGVFTTTALLMLSLSSWVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLLVNPFEKFPMQSVFKMHLAMLVLHQVDQGKLDLNKTVAVNRAAVLQNTWSPMMKDHQGDEFTVTVQQLLQYSVSHSDNVACDLLFELVGGPAALHAYIQSLGIKETEVVANEAQMHADDQVQYKNWTSMKAAAQLLRKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTVVAHKTGTSGVRAGKTAATNDIGVIMLPDGRPLLVAVFVKDSAESARTNEAIIAQVAQAAYQFELKKLSAVSPD", "dna_sequence_from_broadstreet": "ATGAATGTCATCGCAAAAGGTGTTTTTACTACTACAGCTCTGCTGATGTTGAGTTTAAGTTCATGGGTCGTCTCTGCCCAATCCCCGCTGTTAAAAGAGCAAATTGAGACCATAGTGACAGGTAAAAAAGCCACTGTAGGTGTTGCCGTATGGGGCCCTGATGATCTGGAGCCTTTGCTGGTTAATCCTTTTGAGAAATTCCCGATGCAAAGCGTATTTAAGATGCATTTAGCCATGCTGGTTCTGCATCAGGTGGATCAGGGCAAACTGGATTTAAATAAAACTGTTGCTGTTAATCGTGCTGCAGTATTACAAAATACCTGGTCGCCTATGATGAAAGATCATCAAGGCGATGAATTTACCGTTACTGTGCAGCAGTTGCTGCAGTATTCGGTGTCGCACAGTGATAACGTGGCCTGTGATTTATTGTTCGAACTGGTTGGAGGGCCTGCAGCTCTGCATGCTTACATTCAGTCTTTAGGTATTAAAGAAACTGAAGTGGTAGCAAATGAAGCACAAATGCATGCTGATGATCAGGTGCAATATAAAAACTGGACCTCGATGAAAGCAGCAGCGCAACTTTTGCGAAAGTTTGAACAAAAAAAGCAGTTGTCTGAAACCTCTCAGGCTTTATTGTGGAAGTGGATGGTGGAAACCACCACAGGACCACAGCGGTTAAAAGGCCTGTTACCTGCCGGAACTGTAGTAGCGCATAAAACCGGTACGTCCGGTGTCAGAGCAGGAAAAACGGCGGCGACCAATGATATAGGCGTCATTATGTTGCCTGATGGGCGGCCTTTATTGGTGGCGGTATTTGTCAAAGATTCCGCCGAATCAGCAAGAACCAATGAAGCCATTATCGCGCAGGTGGCTCAAGCTGCTTATCAGTTTGAGCTGAAAAAACTCTCCGCAGTAAGTCCGGATTAA", "partial": "0", "query_start": 13765, "query_end": 13983, "hit_start": 390, "hit_end": 588, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 27.03}, "gnl|BL_ORD_ID|1828|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "FosA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "1979", "ARO_accession": "3003210", "ARO_name": "FosA4", "ARO_category": {"36272": {"category_aro_accession": "3000133", "category_aro_cvterm_id": "36272", "category_aro_name": "fosfomycin thiol transferase", "category_aro_description": "Catalyzes the addition of a thiol group from a nucleophilic molecule to fosfomycin.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.13622, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "35914", "query": "VNELAYYQRVPAIRRKTSFLIGRYAAKQAL-----------SSLVHESDYT", "match": " + LA+YQR+P +R    +  G Y +  AL            +   ESDYT", "sequence_from_db": "ASSLAFYQRLPGMRLHARWDSGAYLSCGALWLCLSLDAQRRKTPAQESDYT", "sequence_from_broadstreet": "MLQGLNHLTLAVSDLASSLAFYQRLPGMRLHARWDSGAYLSCGALWLCLSLDAQRRKTPAQESDYTHYAFSVAEEHFAEVVAQLAHAGAEVWKDNRSEGASYYFLDPDGHKLELHVGHLAQRLAACRERPYKGMVFFD", "dna_sequence_from_broadstreet": "ATGCTGCAGGGATTGAATCATCTGACGCTGGCGGTCAGCGATCTGGCGTCAAGCCTGGCGTTTTATCAGCGGTTACCTGGAATGCGTCTGCACGCCCGTTGGGATAGCGGAGCATATCTTTCCTGCGGGGCGTTGTGGCTATGCTTGTCGCTGGATGCGCAGCGGCGTAAAACGCCCGCTCAGGAAAGCGACTATACCCATTATGCTTTCAGCGTGGCGGAAGAGCACTTTGCCGAGGTGGTCGCCCAGCTGGCGCACGCGGGGGCCGAAGTATGGAAAGACAACCGCAGCGAAGGGGCGTCGTACTATTTTCTCGACCCTGACGGCCATAAGCTGGAACTGCATGTGGGTCATTTGGCACAGCGGCTGGCCGCCTGTCGGGAACGCCCGTACAAGGGGATGGTCTTTTTTGACTGA", "partial": "0", "query_start": 13573, "query_end": 13692, "hit_start": 45, "hit_end": 198, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 31.37}, "gnl|BL_ORD_ID|2152|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "oqxB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "2400", "ARO_accession": "3003923", "ARO_name": "oqxB", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35992": {"category_aro_accession": "0000075", "category_aro_cvterm_id": "35992", "category_aro_name": "nitrofurantoin", "category_aro_description": "Nitrofurantoin is an antibiotic used to treat urinary tract infections. It inhibits enzyme synthesis by inhibiting essential enzymes involved in the citric acid cycle, as well as those involved in DNA, RNA, and protein synthesis. It is marketed under the following brand names: Furadantin, Macrobid, Macrodantin, Nitro Macro and Urantoin.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "41240": {"category_aro_accession": "3004116", "category_aro_cvterm_id": "41240", "category_aro_name": "nitrofuran antibiotic", "category_aro_description": "Nitrofurans are chemotherapeutic agents with antibacterial and antiprotozoal activity.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.30674, "max_identities": 23, "bit_score": 25.409, "cvterm_id": "35914", "query": "KSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETM------------DLSQEPDWIVGHFKNF--GQYKFHAWVLDDHVVS", "match": "++Q+       +A ARLPE  R   I T K++ +  L   + SP   ++++            +L++ P   VG  + F  G+Y    W+  + V +", "sequence_from_db": "QAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPG--VGQIQIFGSGEYAMRVWLDPNKVAA", "sequence_from_broadstreet": "MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA", "dna_sequence_from_broadstreet": "ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCACTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTCTCCCCCGGCGGGAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCTGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGATGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGTTGATCGCTGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCTATCGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGCTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTTTCCATCCTGCCGCCGCCGATTTTAGGTCTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAGACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGATCTGTTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCTGACGGACCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTACCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCGCAGGCGATGACGCATCTGGAAGAGCTGTCGAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCATTCCTCGTACTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTACCGATGACGATGCTCTCCGCGCTGTTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGTCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGCTGGAGATCCAGGGGAAAGGCATCATGGAAGCGGCGCTGGAGGCATGCCGCCTGCGTCTGCGCCCGATCGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCGGGGGCGGAAGTCCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTACGGAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG", "partial": "0", "query_start": 13870, "query_end": 14118, "hit_start": 309, "hit_end": 594, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 23.71}, "gnl|BL_ORD_ID|771|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "FosA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "834", "ARO_accession": "3002872", "ARO_name": "FosA3", "ARO_category": {"36272": {"category_aro_accession": "3000133", "category_aro_cvterm_id": "36272", "category_aro_name": "fosfomycin thiol transferase", "category_aro_description": "Catalyzes the addition of a thiol group from a nucleophilic molecule to fosfomycin.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.5781, "max_identities": 11, "bit_score": 24.6386, "cvterm_id": "35914", "query": "VNELAYYQRVPAIRRKTSFLIGRYAAKQAL", "match": " + LA+YQ++P +R   S+  G Y +  AL", "sequence_from_db": "ASSLAFYQQLPGMRLHASWDSGAYLSCGAL", "sequence_from_broadstreet": "MLQGLNHLTLAVSDLASSLAFYQQLPGMRLHASWDSGAYLSCGALWLCLSLDEQRRKTPPQESDYTHYAFSVAEEEFAGVVALLAQAGAEVWKDNRSEGASYYFLDPDGHKLELHVGNLAQRLAACRERPYKGMVFFD", "dna_sequence_from_broadstreet": "ATGCTGCAGGGATTGAATCATCTGACGCTGGCGGTCAGCGATCTGGCGTCAAGCCTGGCATTTTATCAGCAGTTACCTGGAATGCGCCTGCACGCCAGCTGGGATAGCGGAGCCTATCTCTCCTGTGGGGCGCTGTGGCTGTGCTTGTCGCTGGATGAGCAGCGGCGTAAAACGCCCCCTCAGGAAAGCGACTATACCCACTACGCCTTCAGCGTGGCGGAAGAAGAGTTTGCCGGGGTGGTGGCTCTGCTGGCGCAGGCGGGGGCTGAGGTATGGAAAGATAACCGCAGTGAAGGGGCGTCTTACTATTTTCTCGACCCTGACGGCCATAAGCTGGAGCTGCATGTGGGGAATCTGGCGCAGCGGCTGGCCGCCTGTCGCGAACGCCCCTACAAGGGGATGGTCTTTTTTGATTGA", "partial": "0", "query_start": 13573, "query_end": 13662, "hit_start": 45, "hit_end": 135, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 36.67}, "gnl|BL_ORD_ID|1218|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "LRA-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "1324", "ARO_accession": "3002485", "ARO_name": "LRA-2", "ARO_category": {"41390": {"category_aro_accession": "3004226", "category_aro_cvterm_id": "41390", "category_aro_name": "subclass B3 LRA beta-lactamase", "category_aro_description": "Beta-lactamases that are part of the LRA gene family and are classified as B3 (metallo-) beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.88324, "max_identities": 27, "bit_score": 25.0238, "cvterm_id": "39080", "query": "AADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQ-PIVKYPSPEPLGVSISHTDKYACAIAFPLIHP", "match": "AA   A    C +    N+    QR P      ++ +G       LSS++  SDY  + I  G+ Q  P++K  + E LG  ++       AI    +HP", "sequence_from_db": "AAGGEAAFKDCPQCAQWNQ----QRKPFRIYGNTYFVG----TAGLSSILVTSDYGHVLIDGGLAQSAPLIK-ANIEALGFKLTDVK----AILVSHVHP", "sequence_from_broadstreet": "MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG", "dna_sequence_from_broadstreet": "ATGATGGATGGAATAAAGAAGAAGACGGCGGCCGGCGCTGCAGCAGGTTCACTGCTGATGATGCTGGGTGTTTTTGCCACGCCCGCCGCGGGCGGTGAAGCGGCATTCAAGGATTGCCCGCAGTGCGCCCAGTGGAATCAGCAGCGCAAGCCGTTTCGCATCTACGGTAATACCTATTTCGTCGGCACCGCCGGTCTCAGCTCGATTCTCGTCACCTCCGACTACGGCCATGTGCTGATCGACGGCGGGCTCGCGCAATCCGCGCCGCTCATCAAGGCAAACATCGAAGCACTGGGCTTCAAGCTCACCGATGTAAAGGCCATCCTGGTCTCGCATGTGCATCCAGACCATGCGGGTGGCGTCGCCGAGCTGCAGCGGCAGAGCGGTGCGCAGGTCTATGCATTGCGAACCGCAGAAGCCGTGCTGCGAACGGGCAGGCTCACGCAGGACGATCCCCAATCCGCCAGCAAGACGGCAACCATCACACCGGTGCCGCAGGTCTGGGTGGTGCAGGATGACCAGCTGCTCGGCGTCGGCGCGCTGCGGATGCGGGCCATCGCGACCCCCGGTCACACGCCTGGCGGTACCAGCTGGACCTGGGACGCCTGCGAAGACGGCAACTGCCTGAAGATGATCTATGCAGACAGCCTGTCCGCCGTAGCTGCCGGCAAGTATCGCTTCAAGGATCACCCCGAAGTGCTGCAGGCCTTTGCCAGCAGCTTCTCCCGGGCGGAGTCCGCACCCTGCGATGTACTGCTCACGCCGCATCCGGATGCTTCGCAGTTGTTCCAGCGGCTGGATCCGGAGGGCGGCACCCGGGCAGCCAGCATCAAGGACGACACGGCATGCCGGCGATACGTGCAGGCAGCGCGGGACACGCTTGCCCGGAAACTCGCCAGCGAGGGCTGA", "partial": "0", "query_start": 13525, "query_end": 13821, "hit_start": 84, "hit_end": 345, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 27.0}, "gnl|BL_ORD_ID|4575|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "SGM-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5645", "ARO_accession": "3006988", "ARO_name": "SGM-2", "ARO_category": {"43905": {"category_aro_accession": "3005445", "category_aro_cvterm_id": "43905", "category_aro_name": "SGM beta-lactamase", "category_aro_description": "SGM beta-lactamases are class A beta-lactamases found in members of the Sphingobium genus.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.73688, "max_identities": 12, "bit_score": 24.6386, "cvterm_id": "35506", "query": "VSVKAMKSQILPHELQTEALARL", "match": "VS  AMKS   P E++TE+  RL", "sequence_from_db": "VSESAMKSVRNPKEIETESGGRL", "sequence_from_broadstreet": "MPRRLIFAALLLAAPAAAQQEAPRQSLLPPPPRYMVSESAMKSVRNPKEIETESGGRLGVALVDGKGALILGFNRDERFAMCSTFKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDYAPVVRKNVKRGRMSMEELAAAAVEVSDNSAANLLLPMVGGPEGLTRFIRAHGDMVTRLDRNEPSLNENAEGDERDTTSPAAMAGLMGRLIFRDLAPESAGKLRGWLNASTTGANRIKAGLPKGWISGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVDKAQKTGLE", "dna_sequence_from_broadstreet": "TTGCCCAGGCGCCTGATATTCGCGGCCCTGCTGCTCGCCGCCCCGGCGGCCGCGCAGCAGGAAGCGCCGCGCCAGTCGCTGCTCCCGCCGCCGCCCCGCTATATGGTGAGCGAATCCGCCATGAAGTCGGTCCGCAATCCCAAGGAGATAGAGACGGAAAGCGGCGGCCGGCTGGGCGTGGCGCTGGTCGACGGCAAGGGCGCGCTGATCCTTGGTTTCAACCGGGACGAGCGTTTCGCCATGTGCTCGACCTTCAAGGCGCCGCTCGCCGCCGCCGTGCTGGCGGGCGCGGAAGGCGGCAAGTTCGGGCTGGAGGGGCAGATCAGCTTCGCCAAGGCCGATCTGCTGGACTATGCCCCGGTCGTCAGGAAGAATGTGAAGCGCGGCCGCATGTCGATGGAGGAACTCGCCGCCGCCGCCGTGGAGGTCAGCGACAACAGCGCGGCCAACCTGCTGCTGCCGATGGTCGGCGGGCCGGAGGGCCTGACCCGCTTCATCCGCGCCCATGGCGACATGGTGACGCGGCTCGACCGCAATGAGCCGTCTCTCAACGAGAATGCGGAGGGCGACGAGCGCGACACCACCAGCCCCGCCGCCATGGCCGGCCTGATGGGCCGCCTGATCTTCCGCGACCTCGCTCCGGAAAGCGCCGGAAAGCTGCGCGGCTGGCTCAATGCCAGCACCACCGGCGCCAACCGGATCAAGGCGGGCCTGCCCAAGGGCTGGATCTCCGGCAGCAAGACGGGAAGCTGCGGCACCGCCTATAATGACGTGGCGCTGGTGAAGGCCCCGTCGGGCGAGGAATATATCCTGGCCATCTATCTCGACCGCCCGACGGTCGACGCCAAGGCCGCCGAAGCCGCCATAGCCGAAACCGCCCGCGCCGCGCTGGATTTCGTGGATAAGGCGCAGAAGACCGGGCTGGAATAG", "partial": "0", "query_start": 13852, "query_end": 13920, "hit_start": 105, "hit_end": 174, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 52.17}, "gnl|BL_ORD_ID|4808|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "Streptomyces lividans otr(A)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "5797", "ARO_accession": "3007127", "ARO_name": "Streptomyces lividans otr(A)", "ARO_category": {"35921": {"category_aro_accession": "0000002", "category_aro_cvterm_id": "35921", "category_aro_name": "tetracycline-resistant ribosomal protection protein", "category_aro_description": "A family of proteins known to bind to the 30S ribosomal subunit. This interaction prevents tetracycline and tetracycline derivatives from inhibiting ribosomal function. Thus, these proteins confer elevated resistance to tetracycline derivatives as a ribosomal protection protein.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.81979, "max_identities": 13, "bit_score": 24.6386, "cvterm_id": "39551", "query": "LPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSP", "match": "LP     EA  RLP  T    +W+++    + LK G   P", "sequence_from_db": "LPARRVREAELRLPGLTHGEAVWSSRPCEDRPLKAGNSGP", "sequence_from_broadstreet": "MRTLNIGILAHVDAGKTSLTERLLFDHGAVDRLGSVDAGDTRTVDGGIERRRGITIRSAVAAFTVGDTRVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRALRRLRLPTIVFVNKIDRAGARTDGLLGDVRRLLTPHVAPLTEVADAGTPRARVTRRPPDGRTAEALAEVDTEVLAALVDGPEPTGEDVARALAARTADGSFHPLYHGSALGGQGVAELVEGLLGLIPAATPGTSGGTSGGTEPRGTVFAVRPGPAGERTAYLRLYGGEVHPRRRLTFLRRESDGRTTEVSGRVTRLDVVGGDATLTAGNIAALTVPGGLRVGDRLGGPTDRAPQFAPPTLQTLVRARHPEQAAPLRSALLALADQDPLLHARPAASGATALLLYGEVQMEVLAATLAEDFGIEAEFTPGRVRFLERPAGTDEAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGYETELGALPRAFHQAVEETVHDTLRTGLTGAAVTDYRVTLIRSGFSSPLSTAADFRGLTPLVLRRALARAGTVLHEPYQAFEAEVPADTLAAVTALLASLGADFTGTTGGDPAWIVTGELPARRVREAELRLPGLTHGEAVWSSRPCEDRPLKAGNSGPGTGVGGHSGE", "dna_sequence_from_broadstreet": "ATGCGCACCCTGAACATCGGCATTCTGGCCCACGTCGACGCGGGTAAGACCAGCCTGACCGAACGGCTCCTGTTCGACCACGGCGCCGTCGACCGGCTCGGCAGCGTCGACGCCGGCGACACCCGTACGGTCGACGGCGGTATCGAGCGCCGCCGCGGCATCACCATCCGCTCCGCCGTCGCCGCCTTCACCGTCGGCGACACGCGCGTCAACCTGATCGACACCCCGGGACACTCCGACTTCGTCGCGGAGGTCGAGCGGGCCCTGGAAGTGCTCGACGGGGCGGTGCTGCTGCTGTCCGCCGTCGAGGGCGTCCAGGCGCGGACCCGCGTCCTGATGCGCGCGCTGCGGCGGCTGCGGCTGCCCACGATCGTGTTCGTCAACAAGATCGACCGGGCCGGCGCGCGCACCGACGGCCTCCTCGGTGACGTCCGGCGCCTGCTGACGCCGCACGTCGCGCCGCTGACCGAGGTGGCGGACGCCGGTACCCCGCGCGCCCGGGTCACCCGCCGCCCGCCGGACGGGCGGACCGCGGAGGCCCTCGCCGAGGTCGACACGGAGGTCCTGGCCGCGCTGGTCGACGGCCCCGAGCCGACCGGGGAGGACGTGGCCCGCGCCCTCGCCGCCCGTACCGCCGACGGCTCGTTCCACCCGCTGTACCACGGCTCCGCGCTCGGCGGACAGGGCGTCGCGGAGCTGGTCGAGGGCCTGCTCGGCCTGATCCCGGCCGCCACGCCGGGCACGTCCGGCGGCACGTCCGGCGGCACGGAACCGCGCGGCACGGTCTTCGCCGTGCGCCCCGGACCCGCCGGCGAGCGCACCGCGTACCTCAGGCTGTACGGCGGCGAGGTGCACCCGCGCCGGCGGCTCACCTTCCTGCGGCGCGAGTCCGACGGGCGGACCACCGAGGTCTCCGGCCGGGTGACCCGCCTCGACGTCGTCGGCGGCGACGCCACGCTCACCGCCGGGAACATCGCCGCGCTCACCGTTCCCGGGGGCCTGCGCGTCGGCGACCGGCTCGGCGGACCGACCGACCGTGCACCGCAGTTCGCGCCACCGACCCTGCAGACGCTGGTCCGGGCCCGGCACCCGGAGCAGGCGGCGCCGCTGCGCTCCGCCCTGCTGGCGCTGGCCGACCAGGACCCGCTGCTGCACGCCCGACCGGCGGCGTCCGGCGCCACCGCCCTGCTCCTGTACGGCGAGGTCCAGATGGAGGTGCTCGCGGCGACACTGGCCGAGGACTTCGGGATCGAGGCGGAGTTCACGCCGGGCCGCGTCCGGTTCCTGGAGCGTCCGGCGGGCACCGACGAGGCCGCGGAGGAGATGCCGTGGCTCGACCGCACCCGGTACTTCGCGACGATCGGGCTGCGCGTCGAACCGGGTCCGCGCGGCTCCGGCGGGGCCTTCGGGTACGAGACGGAGCTCGGCGCGCTCCCCCGGGCCTTCCACCAGGCCGTCGAGGAGACCGTCCACGACACGCTGCGGACCGGGCTCACCGGTGCGGCGGTCACCGACTACCGGGTCACGCTGATCCGCTCCGGCTTCAGCTCGCCGCTCAGCACGGCCGCCGACTTCCGCGGGCTGACACCGCTCGTGCTGCGCCGTGCCCTCGCCCGCGCGGGGACCGTGCTCCACGAGCCGTACCAGGCCTTCGAGGCGGAGGTCCCGGCGGACACGCTGGCCGCCGTGACGGCCCTGCTGGCCTCGCTGGGCGCGGACTTCACCGGAACGACGGGGGGCGACCCGGCCTGGATCGTCACCGGCGAGCTGCCGGCCCGGCGGGTGCGGGAGGCCGAGCTGCGGCTGCCGGGGCTGACGCACGGGGAGGCGGTCTGGTCCTCCCGCCCTTGCGAGGACCGACCGCTGAAGGCCGGAAACTCTGGGCCTGGCACGGGAGTTGGCGGGCATTCGGGTGAGTAG", "partial": "0", "query_start": 13882, "query_end": 14001, "hit_start": 1767, "hit_end": 1887, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 32.5}, "gnl|BL_ORD_ID|2010|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 13519, "orf_end": 14196, "orf_from": "BGC0001186.1|Misakinolide_14 ", "model_name": "mexQ", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1900", "model_id": "2212", "ARO_accession": "3003699", "ARO_name": "mexQ", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36309": {"category_aro_accession": "3000170", "category_aro_cvterm_id": "36309", "category_aro_name": "imipenem", "category_aro_description": "Imipenem is a broad-spectrum antibiotic and is usually taken with cilastatin, which prevents hydrolysis of imipenem by renal dehydropeptidase-I. It is resistant to hydrolysis by most other beta-lactamases. Notable exceptions are the KPC beta-lactamases and Ambler Class B enzymes.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36595": {"category_aro_accession": "3000456", "category_aro_cvterm_id": "36595", "category_aro_name": "thiamphenicol", "category_aro_description": "Derivative of Chloramphenicol. The nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3).", "category_aro_class_name": "Antibiotic"}, "37626": {"category_aro_accession": "3001227", "category_aro_cvterm_id": "37626", "category_aro_name": "kitasamycin", "category_aro_description": "Kitasamycin is a macrolide antibiotic and is produced by Streptoverticillium kitasatoense. The drug has antimicrobial activity against a wide spectrum of pathogens.", "category_aro_class_name": "Antibiotic"}, "40353": {"category_aro_accession": "3003701", "category_aro_cvterm_id": "40353", "category_aro_name": "rokitamycin", "category_aro_description": "Rokitamycin is a macrolide antibiotic. Synthesized from strains of Streptomyces kitasatoensis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.30684, "max_identities": 22, "bit_score": 24.6386, "cvterm_id": "36752", "query": "DVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNF", "match": "D  R  R + K       PH +Q EA+ RL    R A               G M P   F T+  S  PD ++ H+  +", "sequence_from_db": "DFNRFGR-TYKVTAQADAPHRMQAEAIGRL--QVRNA--------------AGAMLPLSSFVTVTPSSGPDRVI-HYNGY", "sequence_from_broadstreet": "MTFPRFFIDRPIFAIVLSVLMMIGGIVSFFQLPLSEYPAVTPPTVQVTTAYPGANPDVIAQTVATPLEQAITGVEGMLYMSSQSATDGRMILTITFDQHIDPDMAQIQVQNRVSRVLSRLPDEVQRQGVVTQKTSPDILMVVHLLSPEQRYDPLYISNYAYLQVRDELLRLPGISDVVVWGAGEYSMRLWLDPDLIAARGLTAGEVIAAVREQNVQVAAGAVGQAPDSTAAFQVTVNTLGRLSDEEQFGDIIVRTGADGQVTRLRDVARIEMGGDAYALRSLLDGEPAVALQIIQSPGANALDTAEAVRATVARLEGNFPAGLSARIAYDPTVFVRASLQTVATTLLEAILLVVVVVVLFLRSWRASLIPLMAVPVSLVGTFAVMHLMGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHIENGEPPLQAARRAMDEVTGPIMAITSVLAAVFIPTAFLSGLQGEFYRQFALTIAISTILSALNSLTLSPALAGLLLRPRPAGGAVAGRFQRLLQVLGRPLRNAPEAYGNAVRKVVRVSGLALVVYGGLLGLTWVGFQAVPPGFVPMQDKYYLIGIAQLPNGASLERTDAVVRQMSRIGLDEPGVESVVAFPGLSVNGFVNVPNAAVMFFMLDPFESRTSADLGALAIAGRLQARFASIPDGFLGVFPPPPVPGLGTIGGFKMQVEDRGGAGLEALARQTQVLMMKATESGQLGGLMTSFDINAPQLEVVVDRTKVKSQGVRLADVFEALQVYLGSLYINDFNRFGRTYKVTAQADAPHRMQAEAIGRLQVRNAAGAMLPLSSFVTVTPSSGPDRVIHYNGYPSADISGGALPGVSSGQAVALMERLAGEVLPEGMTFEWTDLTYQQKLAGNSALFIFPLCVLLAYLILAAQYNSWLLPLAVLLIVPMCLLSAIAGVWLVGGDNNVFVQIGLVVLVGLAAKNAILIVEFARTLEAEGARALEAVVEACRLRLRPILMTSLAFIAGVVPLVMASGAGAEMRQAMGVAVFAGMLGVTLFGLFLTPVFYVLVRALAARLERRAGGSLAHLEGGRP", "dna_sequence_from_broadstreet": "ATGACATTCCCACGCTTCTTCATCGATAGGCCGATCTTCGCCATCGTTCTTTCGGTGCTGATGATGATCGGAGGCATCGTTTCGTTCTTCCAGTTGCCGCTGAGCGAATACCCGGCGGTGACGCCGCCGACCGTGCAGGTGACTACCGCCTATCCCGGCGCCAACCCCGACGTGATCGCGCAGACGGTGGCGACACCGCTGGAGCAGGCGATCACCGGGGTCGAGGGGATGCTGTACATGTCCTCGCAGTCGGCCACCGACGGGCGAATGATCCTGACCATCACCTTCGACCAGCACATCGATCCCGACATGGCCCAGATCCAGGTGCAGAACCGGGTCTCGCGGGTGCTCTCGCGCCTGCCCGACGAGGTGCAGCGGCAGGGCGTGGTCACCCAGAAGACCTCGCCGGACATCCTCATGGTGGTGCACCTGCTGTCGCCGGAGCAACGCTACGACCCGCTGTACATCTCGAACTACGCCTACCTCCAGGTGCGCGACGAACTGCTGCGCCTGCCGGGGATCAGCGATGTGGTGGTGTGGGGCGCCGGCGAGTACAGCATGCGCCTGTGGCTCGACCCCGACCTGATCGCCGCGCGCGGGCTGACGGCGGGCGAAGTGATCGCCGCGGTACGCGAACAGAACGTCCAGGTGGCGGCCGGCGCCGTCGGCCAGGCGCCGGACTCCACCGCGGCCTTCCAGGTCACGGTGAATACCCTCGGGCGGCTGAGCGACGAAGAGCAGTTCGGCGACATCATCGTCCGCACCGGCGCCGACGGCCAGGTGACGCGCCTGCGCGACGTCGCGCGGATCGAGATGGGCGGCGATGCCTATGCGCTGCGCAGCCTGCTGGACGGCGAGCCGGCGGTGGCCTTGCAGATCATCCAGAGCCCCGGAGCCAACGCGCTGGATACCGCCGAAGCGGTGCGTGCCACCGTGGCGAGGCTCGAAGGCAACTTCCCGGCCGGCCTGAGCGCGCGCATCGCCTACGACCCGACGGTGTTCGTCCGCGCTTCGTTGCAGACCGTGGCCACCACCCTGCTGGAGGCGATCCTGCTGGTCGTGGTGGTGGTGGTGCTGTTCCTGCGTAGCTGGCGTGCTTCGCTGATTCCGCTGATGGCCGTGCCGGTCTCGCTGGTCGGCACCTTCGCCGTCATGCACCTGATGGGTTTCTCGCTGAATACCCTGTCGTTGTTCGGCCTGGTGTTGTCGATCGGCATCGTCGTCGATGACGCCATCGTGGTGGTGGAAAACGTCGAGCGCCACATCGAGAACGGCGAGCCGCCGCTCCAGGCCGCGCGGCGTGCGATGGACGAGGTCACCGGGCCGATCATGGCGATCACCTCGGTGCTGGCGGCGGTGTTCATCCCCACGGCCTTTCTCAGTGGCCTGCAGGGCGAGTTCTATCGTCAGTTCGCCCTGACCATCGCCATCTCCACCATCCTGTCGGCGCTCAACTCGCTGACCCTCAGCCCGGCCCTGGCGGGCCTGCTGTTGCGTCCGCGGCCGGCCGGAGGTGCGGTGGCGGGGCGCTTCCAGCGACTGCTCCAGGTCCTCGGCCGACCGTTGCGAAATGCCCCCGAGGCCTACGGCAACGCGGTGCGCAAGGTGGTGCGGGTGAGCGGCCTGGCCCTGGTGGTGTATGGGGGCCTGCTTGGCCTGACCTGGGTCGGTTTCCAGGCGGTGCCGCCGGGCTTCGTGCCGATGCAGGACAAGTACTATCTGATCGGCATCGCCCAGTTGCCGAACGGAGCGTCGCTGGAGCGTACCGATGCGGTGGTCAGGCAGATGTCCCGGATCGGCCTCGACGAGCCGGGGGTGGAGAGCGTCGTGGCCTTCCCGGGCCTGTCGGTGAACGGTTTCGTCAACGTGCCGAACGCCGCGGTCATGTTCTTCATGCTCGATCCGTTCGAATCGCGCACCTCCGCCGATCTCGGCGCGCTGGCCATCGCCGGGCGCCTGCAAGCCAGGTTCGCCAGCATTCCCGACGGCTTCCTCGGGGTCTTCCCGCCGCCGCCGGTACCGGGGCTGGGAACCATCGGCGGCTTCAAGATGCAGGTCGAGGATCGCGGCGGCGCCGGGCTGGAAGCCCTGGCCAGGCAGACCCAGGTGCTGATGATGAAGGCCACTGAGTCCGGCCAGCTCGGGGGCTTGATGACCAGCTTCGATATCAATGCCCCGCAGCTCGAGGTGGTGGTCGACCGCACCAAGGTGAAGAGCCAGGGCGTTCGCCTGGCCGATGTGTTCGAGGCATTGCAGGTCTACCTCGGCTCGCTGTACATCAACGACTTCAACCGCTTCGGTCGCACCTACAAGGTCACTGCCCAGGCCGATGCGCCGCACCGCATGCAGGCCGAAGCCATCGGGCGCCTGCAGGTACGCAATGCCGCCGGGGCGATGTTGCCGCTGTCCTCGTTCGTCACCGTGACGCCCAGCTCCGGTCCCGACCGGGTGATCCACTACAACGGCTATCCGTCGGCGGATATCAGCGGCGGCGCGCTTCCCGGCGTCAGTTCGGGACAGGCGGTGGCGTTGATGGAGCGCCTGGCCGGCGAAGTGCTGCCCGAGGGCATGACCTTCGAATGGACCGACCTGACCTACCAGCAGAAGCTGGCCGGCAACAGCGCGCTGTTCATCTTCCCGCTGTGCGTGCTGCTGGCCTACCTGATCCTCGCCGCGCAGTACAACAGCTGGCTGTTGCCGCTGGCGGTCCTGCTGATCGTGCCGATGTGCCTGCTCAGCGCGATCGCCGGGGTGTGGCTGGTGGGCGGCGACAACAACGTGTTCGTCCAGATCGGGCTGGTGGTGCTGGTAGGCCTGGCGGCGAAGAACGCGATCCTGATCGTCGAGTTCGCCCGCACGCTGGAGGCCGAGGGCGCCCGTGCGCTGGAGGCGGTGGTCGAGGCTTGCCGCCTGCGCCTGCGGCCGATCCTGATGACCTCGCTGGCGTTCATCGCCGGCGTGGTGCCGTTGGTCATGGCCAGCGGCGCCGGAGCGGAAATGCGCCAGGCGATGGGCGTCGCGGTATTCGCCGGGATGCTCGGGGTGACGCTGTTCGGCCTGTTCCTCACGCCGGTGTTCTACGTACTGGTACGGGCACTGGCGGCGCGCCTGGAGCGACGCGCCGGCGGCAGCCTGGCGCATCTGGAGGGAGGCCGTCCATGA", "partial": "0", "query_start": 13831, "query_end": 14070, "hit_start": 2283, "hit_end": 2469, "orf_dna_sequence": "GTGCATGCCGCCGACTACCCGGCGCTGCACGACACATGCTCGCGGGTGCTCCACGTCAATGAGCTTGCTTATTATCAAAGGGTGCCGGCGATCCGACGGAAAACCAGCTTTCTGATAGGGCGATATGCCGCGAAGCAAGCGCTTTCAAGCCTGGTACATGAGTCGGACTATACTAGAATTGAAATTGCATCTGGCATTTTTCAACAACCGATTGTCAAATATCCATCGCCGGAGCCGCTTGGTGTGAGTATTAGCCACACAGATAAATATGCCTGTGCCATCGCATTTCCGCTTATCCATCCGCTTGCCCTTGACGTGGAACGTATCGACCGCGTCAGCGTTAAGGCCATGAAAAGCCAGATATTGCCGCATGAGTTGCAAACCGAGGCTCTCGCTCGATTGCCTGAACCCACGAGATGCGCCATTATTTGGACTGCCAAGGAAGCGTTATCCAAAGTCTTGAAATGTGGAATGATGAGCCCGTTTTGTATTTTTGAAACCATGGATTTAAGTCAAGAGCCGGATTGGATTGTAGGACACTTCAAAAATTTTGGGCAATACAAATTTCATGCCTGGGTATTAGACGATCATGTCGTTTCTATGGCGGTGCCCAAACGAACCGATATCGATGTCGATCTCTCAACGCTCCTGCATGATTTGCTACCGATAGGGGACTAA", "orf_prot_sequence": "MHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIVKYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMDLSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD", "perc_identity": 27.5}}, "BGC0001186.1|Misakinolide_15 # 15190 # 33063 # 1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=GGGGG;rbs_spacer=8bp;gc_cont=0.515": {"gnl|BL_ORD_ID|745|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15190, "orf_end": 33063, "orf_from": "BGC0001186.1|Misakinolide_15 ", "model_name": "OprJ", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "850", "model_id": "704", "ARO_accession": "3000802", "ARO_name": "OprJ", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35933": {"category_aro_accession": "0000014", "category_aro_cvterm_id": "35933", "category_aro_name": "gentamicin C", "category_aro_description": "Gentamicin C is a mixture of gentamicin C1, gentamicin C1a, and gentamicin C2 (these differ in substituents at position C6'). Gentamicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "37007": {"category_aro_accession": "3000663", "category_aro_cvterm_id": "37007", "category_aro_name": "ofloxacin", "category_aro_description": "Ofloxacin is a 6-fluoro, 7-piperazinyl quinolone with a methyl-substituted oxazine ring. It has a broad spectrum of activity including many enterobacteria and mycoplasma but most anaerobes are resistant.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.33997, "max_identities": 15, "bit_score": 30.4166, "cvterm_id": "36752", "query": "DASSDPFLNE--FLDLIGDDVLTFKDVVTLIGNGWDTGKEDLFH", "match": "DA    FLNE  F+D      +   D+   +G GWD G+  + H", "sequence_from_db": "DAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVH", "sequence_from_broadstreet": "MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVDAELRRLVDMALDNIRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAGNRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYLSYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQKQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRARNADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSCSFLPTLTLPIFDGGRNRANLSLAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYESGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS", "dna_sequence_from_broadstreet": "ATGCGCAAACCTGCTTTCGGCGTATCGGCGCTGCTGATCGCCCTGACCCTCGGCGCCTGCTCCATGGCGCCGACCTACGAACGTCCCGCCGCGCCGGTGGCCGACAGCTGGAGCGGCGCCGCCGCCCAGCGCCAGGGCGCGGCGATCGACACGCTGGATTGGAAGAGTTTCATCGTCGATGCCGAACTACGCCGCCTGGTGGACATGGCCCTGGATAACATCCGCTCGCTGCGCCAGACCCTCCTGGATATCGAGGCGGCCCGCGCGCAGTACCGAATCCAGCGCGCCGACCGGGTTCCGGGCCTGAATGCCGCTGCCACCGGCAACCGCCAGCGGCAGCCGGCCGACCTGTCCGCCGGCAATCGCTCGGAAGTGGCCAGCAGCTACCAGGTCGGGCTGGCCCTGCCGGAGTACGAACTGGACCTCTTCGGTCGGGTCAAGAGCCTGACCGACGCAGCCCTGCAACAGTACCTGGCCAGCGAGGAGGCAGCGCGCGCGGCACGGATCGCCCTGGTCGCCGAGGTCAGCCAGGCCTACCTGAGCTACGACGGCGCCCTGCGGCGCCTGGCGCTGACCCGTCAGACCCTGGTCAGCCGCGAGTATTCCTTCGCCCTGATCGACCAGCGCCGCGCGGCCGGCGCCGCCACCGCGCTGGACTACCAGGAAGCCCTTGGCCTGGTGGAGCAGGCGCGCGCCGAGCAGGAGCGCAACCTGCGGCAGAAACAGCAGGCATTCAACGCGCTGGTGTTGCTGCTGGGTAGCGACGATGCCGCGCAGGCGATTCCGCGGAGTCCGGGGCAGCGGCCGAAGCTGCTGCAGGACATCGCTCCCGGCACGCCGTCCGAGCTGATCGAGCGACGTCCGGACATCCTTGCCGCCGAACATCGTTTGCGGGCGCGCAACGCGGATATCGGCGCGGCGCGCGCGGCGTTCTTCCCGCGCATCAGCCTGACCGGCAGCTTCGGCACCTCCAGCGCGGAAATGTCCGGCCTGTTCGATGGCGGCTCGCGCTCCTGTAGCTTCCTGCCGACGTTGACGCTGCCGATCTTCGATGGCGGGCGCAACCGTGCCAACCTGAGCCTGGCCGAGGCGCGCAAGGATTCGGCGGTGGCCGCCTACGAGGGGACCATCCAGACCGCTTTCCGCGAGGTCGCCGACGCCCTGGCGGCCAGCGATACCCTGCGTCGCGAAGAGAAGGCCCTGCGCGCCCTGGCGAACAGCAGCAACGAAGCCCTGAAGCTGGCCAAGGCACGCTACGAGAGTGGCGTCGACAACCACCTGCGCTACCTCGATGCGCAGCGCAGCAGCTTCCTCAACGAGATCGCCTTCATCGACGGCAGCACCCAGCGGCAGATCGCCCTGGTCGACCTGTTCCGCGCGCTCGGCGGAGGCTGGGACGAGGGACGGAGCCTGGTGGTACATCGAGGCGGCAGGAGTTGA", "partial": "0", "query_start": 17521, "query_end": 17646, "hit_start": 1290, "hit_end": 1422, "orf_dna_sequence": "TTGGAGGCCAAGGACATTGCTGTCATTGGAGTGGGGGTTCTATTTCCTGGTGCCAGTCATCATGACCTGTTTTGGGAAAATTTAATTGCTGGTATTGATAGTATTCAGGAGATACCTGTATCTCGCTGGGACATAGACGCCTATTATTCACCTGATTTTAATGAACCGGGAAAAAGTATTAGTAAATGGGGCGGACTGATTCAGGGGATTGATCAATTTGATCACCAGTTTTTTAATATTTCCCCGCGTGAAGCGCGGAATATGGACCCGCAACAACGTTTATTATTACAGGAAGCCTGGCACTGCGTCGAAGACTCCGGTATTGCCCTCAAAACCCTTCAGGAAAAAGTCACTTCCGTATTTGTTGGGGTCATGGCGATTGACTACCATCAGCATATGGCACAGAGCCGTCAGCCTGTGGATAGCTACGCCTGCCTTGGGAATTACGGCTCTATATTAGCGAACCGTCTATCGTTTTGCCTCGGGTTGAGCGGGGAGAGTAAAGCCATTGATGCTGCTTGTGCCTCATCATTGGTGGCAGTCCATGATGCGAGACGGAGTTTACAGGCAGGAGAATGTGACTATGCGATTGCCGCCGGCGTGAGTGTGATCTGTCATCCCTGGAAGTATATTTCCTTCTCGAAATCTCGCATGTTGAGTCCCTCCGGGAGATGCAAAACCTTTGATAAGAGTGCTGATGGGTATGTACCCGGCGAAGGGGTGGGCGTTCTTCTCATGCAATCGCTGGAAAGAGCGCAGGAGCAGAAATGCCACATTTATGGTGTTTTAAAAGGCTCGGCGCTCAACAACAATGGTCTTCATGGACAAAGACACGCTGACGACCGGGGCAGAAAAAAGGCGTCCATCACTGCCCCCAGCATAGACGCCCAGCGCCGGGTCATTACCGACGCGTTGCGTAGTGCGGATATTGACCCGGCGAGTGTGAGCTACGTGGAAGCCCACGGCACGGGGACATCCCTGGGAGATCCCATTGAAATTGAAGCCTTAAAACAGGTATTCGCTGTCCCTGGTCGGACAACACCGTCTTGTGCTATCGGCTCGGTAAAAACCAATATTGGTCACTTGGAAGCCGCTGCTGGAGTCGCGGGCGTGATCAAGGTGCTCTTGATGATGAAGCACAAAATGATTCCCCAAGTGCTTCATCTCAATACCGTGAATCCGATGATTGATTTGACAGATACGTCTCTTTATCTAAGCGATCAGCTACACTCTTGGGAGTCTAAAGAGGGCATTCAACGCAGAGCGGGGGTGAGTTCCTTTGGTTTTGGTGGAAGCAATGCCCATGCCATTTTCGAGGAGTATGTCGATACGCGACATACTCCTCAAGGTACACTTCAGCGCACGAGTGGCGAGCACCTGTTTGTCTTATCTGCAAAATCCCACTCAAGTCTAGATGGCCTGTTAAACGATTGGGTCGCGTTCCTTAACCACCCCCAGCGCTCTGCGATATCGCTTGAGGATATGTGCGCAACGCTCATGACGGGACGGGAATCGTTTCCGTTCCGCTTTGCGCTGTCCGTGACAGATAAAAAGGCGTTGCGCTCAGCCCTCATCTCACCACCGGAGAGCGCTTTCGGCCATGCAGAGATGCCGTCCGTACTGTTGCGTATTGGCTCTGTCAATGCCGAGCAAGCCGCGGTGATTGCCTCCTGGTATCGCAAGCATCCAGGATTTCGCGAGCCTTTTGATGCTTGTCGTCGCTTGGCTAAAATGCTTTGCAGTGAGGAGGCCGTTCGCGACTGGACGGCCCAATTTCCCAAGGTGTTGGCCGAGCATGAAGCTCTGTATGGTTTTGCCGCTGCCTATGCGACTGCGCGTTTACTGTTAGATTCGGGGGTGCAGCCACGCTTAATCTGTGGCGAGGGGATTGGCCATGGTGTTGCTTTATGTCTTAGTGGGCTGTGGACGCTCTCCCAAGGGCTAAGGCATGCGATGAGGTTGATCGATCAGCTCGATCTAAGCCCACAGCGCTTAGATTACCCCATTTATGACCAGATTCAAGGCACAACTTTGTCGCCTTATCAGCCTAGCAGAGGTTATTTGCAGGCCTTGTTGAAGAATATTCAGGTAAGAGATGACCTCTTCATCAGAGACTTGCAAAAAGCCCTTTTATTGCATGAGCATCAGTATACGTTTAAAAATTATCTCGAATCGTGGAATTCTGCACTAAAGGAGATTGGTCTCGAAATTTATCAGCTGATAGGTCTTCACGCGGAGCTACAGGAAGATATCTCTAAAAAATTTCTTGTCTATATTATAGTTGCCTATAGTCTAAAACAGCTCTATGAAAAATGGGATTTAGTTGAGTATGATGCCTCATCAGATCCTTTTTTAAATGAGTTTTTGGACCTGATCGGCGATGATGTTTTGACATTTAAAGACGTTGTTACGTTGATTGGTAACGGATGGGATACCGGCAAAGAGGACTTATTTCATGGTATAACAGCGCGAGTGATTCCTGTTTCCAGCGTTAAACCATATGAATATCTGCAGCAATATCAATTTGAGCGATTTGATCATATCCGCTCATGGCTGGAGAAGATTGGCGATGTTCCTTTAGAGACGCCGATCCATGAGGATGACCTACTGTTGACGGTCGGTGACGAAGGCGATGTATCCCGCTTGAAGATCGTGAGCAACTCAGGCCATAGTCTGAGTTTTCTGACCCGTGGCCAAAAGGCTAGCCATTTGACCGAGGATGTGAGACAGCTCTGGTTACATGGCCTGAATATCGACTGGCAGAGCTTCGTTGATGCCGGCTCGTTTACCAAGGCTTCTCTTCCTGGCTATTCCTTTGATGGCTCGCCGTTTTGGATCGAAAACAGTAGATCAGATTCACCATTCATACAAGGCGAAGGTATTAAGGCTGAGCCTGTTCAAAATTCTTACTACCATTTTGTATGGCAAGCGAGTAAGCACCCTACCGTTCTTGACCGCAAGCCTGATGTCAAGAATAATGAGGCAATTTTGCTGTTTGATAGTGATGCATCACTCGCTCAATTGTTGCGTGAACAGTGGCATGCAGAAATTATACTTATTCGGCCTGCAAGAGCATTTGATTGGAAAAGTTGGCACGATGTTGAGATCGATCCAGATAACGAAAATCATTATAAATTGGTATGTACAGCTCTTCAGCAAAAAAATCTGAGGCCTGTATGTGCGATTTTTACCTGGACGCTACAGGAGTCTACCAGTACAGGTGAAAGTTTACTGTCTCACCCCGAACCGTGGTTATCCAAGGGGATATACGCCGTTTATCACCTTCTAAAAAGTCTCTCGCAAAGCGCCCATCCACCTTTATCTCAGCTTTTATTTTTTTTTCATGGCAACGAAGGACAGGGCAATCCATTGATGGAAGCGGTCGCGGGTTACGGGCGCTCACTAAAGCTCACCTACCCGCAGATGCGTTTCCGCTCCATTCAATTTGAAACCGGTTCGCCGGATACAATCGAGGTCGTGACCGCCGTTATCAGGGAATTTTCCCTCCTAAAAGGTGAAGAACGACAAGAGGTGGACACAGAGGTCTTATATCGTCATGGGCAGCGGCTGATCAAAACCCCTGTCCGTTTACACTTGGACGCTGTGGCGCAGGCGCCTTGGAAGCAGAGTGGCGTGTATTTGATTACCGGTGGTATGGGCGCCTTAGGGTCGATTTGGGCGCGCTATCTGGCAGAGCGTTATCAAGCGCGTTTAATCCTCACCGGCCGCTCCGTCTGCCAGGGAGACATCGGGAAATCCATTCGTGTGTTCATCAAACAGCTCCAGCAATTGGGCGGTGACGCGGTTTACCTTCAGGCTGATATCACAGAGCCGCATGCTGTGCGCCAGCTTATAGAACAGGCTTATCAGGCTTTCGGCCCCGTACGAGGTTTAATTCATGCTGCCGGCCAGATGAGTGCGGTATCGTTTGCAGAAAAGTCACTGGCGGATTTTCAACAGACCTTAAGTGCAAAGATTCAAGGAACCCTGGTGTTGGACCGGGTCTTACATGAATCAATAGAAAAGCAAGCCCTGGACATCGTCATTTATTTTTCTTCCGCTGCTTCTACTTTAGGGGATTTTGGGCAATGCGATTACGCTATTGGCAACCGATTTTTGGATGGCTATGGCCGTTTCCGAGAGGGGTTGCGCACACAGGGGCAGCGCCAGGGCCGCACGGTCGTCGTCAACTGGCCCTTGTGGCGAGAAGGTGGCATGCACCTCGACTCTGAGGCTGAAGCGCTGTATCTGTCTGCTTCGGGGCTGGACTATTTAGAGGCGGAGCAGGGGTTGGACGCGCTAGATCGAATTCTCGTCAGCCCCCATACGCAGGTGATGGTCTTCGCGGGAGACCCGGCGAACATCGACCGCAATCTGGGCGTCAATAAGGTTGTCGATATGCAAGTTGATGAAACGTTTGTCGCGAGCCGCATTGAAGCAGATCTGCAACACCTGGCAGCCGTGCTGCTACAAATGCAGGCGGATGAGATCGCGCTTGATGACAACCTCAGCGCCTATGGGTTTGACTCCATTGCCATCAAAGAATTTGCCGATCAACTGAGCCAGTATTATCAACTTGAAATCTCACCTATCGTATTCTTCGCCCACGCCAGCCTTCGAAGTCTTGGCGCCTACTTTTGGGAGCATTTTGCGGCGGACATGAAAGCGTTTTATGCCGCCGAACCGTCGAACCAGATGCCCGAAGCGAGGCATGCCGAAGCACCTGCACGCCAGGTGTCACAACCCGCTCGCGCCGAAGCTGACCAGGATATCGCCATTATCGGTATGAGCGGCGTGTTCCCCGGTTCACCCGATCTCGCAACCTTCTGGAAACACCTGAGTCGTGGGCGCGATCTGGTCGGAGAAGTGCCTGCCGGGCGCTGGGATTGGCGCGTATACGATGGCGACTTGATGCGTGAGCATGAGGCGAAGAAAACCGCTATCAAATGGGGTGGTTTTATCGAGAATGTCGATCGCTTTGACGCTGATTTCTTTTCTATCTCCCGGCGCGAAGCGGAATTCATGGATCCGCAGCACCGCTTATTTTTGCAATGTGTGTGGGCGACGATCGAAGATGCCGGATACGCCACCGCCGCGTTATCGGGAGAAAACATCGGCGTCTTTGTGGGGGTCCAGTTTAGCGATTATCAACAGCTCTTGAAGCAGGCGGGAGAGCGTGGCGCACAAATTCTCACTGGCAATGCGCATTCGGTGTTAGCCAATCGAATTTCGTATCTGCTGGATGTGCGGGGGCCAAGCCTGGCCATTGATACCGCTTGCGCTAGCAGTTTGGTGGCGGTGCATCAGGGCGTCCAGGCGATACGCAATGGCGATTGTACGGCGGCCATCGTTGGCGGCGTTAGTTTGATGTTGTCGCCAGATACCTTTTTGGATATCAACCACTTGGGTGTGTTGTCCCCGGATGGGCGGTGCAAGACGTTTGATCGTAACGCCAATGGTTATGTGCGGGGCGAAGGGGTTGGCAGCTTTTTATTGAAGCCGTTGTCCCGCGCTTTGCAGGACCGCGATCCGATTCATGGCATTATTCGCGGCAGTGCGGTGCAGCATGGCGGCAAGGCGAATTCCTTAACCGCGCCGAACTCTGAAATGCAGGCGGCGTTGTTGTTAAAAGCCTATGAGGATGCTGGGATTGGCCTCGACACCGTCAGTTATATCGAAACCCACGGTACGGCGACAGAGCTAGGCGATCCCGTCGAAATTGAAGGGTTGAAACAGGCATATCGGACTTATAGACAACAGACCGGCGCGGCAGCAAGTCGGACCGGCGCCTGTGGGTTGGGGTCGGTGAAAACCAACATCGGTCATTTAGAGCCTGCGGCAGGCATTGCCGGATTGGCCAAGGTGCTATTGGCCATGCGCCATCAAATCTTGCCCGCGACATTGCACTTTGATTCGTTAAACCCCTATATCGATTTGAGCGAGAGCCCCTTTTATATCGTTGACGAAAAGACGCCGTGGCAGCGTCGGCTCGATGAGCAGGGCGAGGAGATACCGCGCCGCGCCGGCGTCAGTTCGTTCGGTTTTGGTGGTGCCATTGCGCATCTTGTGCTGGAAGAATATCGAGTGCCGCAAGACACGCTCGAAAACGGTGACGATGATACGTCGCCCTACTTGATTGTCCTGTCCGCGAAGAACGAAGCGCGGCTCAAAGAGGTGGCGACAAATTTGTATGGCCATCTCATTGAAACGGCATCAGTGGCCCCGATCAAGTTGCGCGATCTCGCCTATACCCTGCAAGTCGGGCGCGACGCCTTGCCGCAAAGACTCGCTCTGGTCGTGGACGAAACAGCGCACTTGCTTGATGGGCTGGCGGCTTATGTGCAAGGCGAACCTGATCGAGGCCGATGGTTTGCAGGTACTGCCAGGCGTGACCGCTGCCCGCTCACGTCGCTTGTCGAAGCGGGCGAGGCGATGATCGCCATGCGAATTGAAAAGGAAGCGCTGCGCGAGTTCGCGCAATCTTGGGTGCAAGGTGCGTCGATCAATTGGCAACAGATGTATCCGGTGAACAAGCCCAGGCGTCAATCTTTACCGACATATCCTTTTGCCCAACAAAGATATTGGTTTGATACATCAGCCAATACAAAGCCACAAGAACGTCATGCTGCCGTCGCACCTATTGACAATAAGTCTAACATCGAACGCATCTATTATCGTCGTGAATGGGCTCAGACGGCGTTGCTCTCCCCAGTTTCGATTGAGACGGGTGACCAAGCGCAGTTTGTCCTTCTATTTGAAACGAATCCACAAATAGGCGAGGTCTGGCAGACACAGCTAGAGCAACATGGACTGCGATGTATCAGAGTGTGTATTGGAGAGCGTTTTCGTCTACTGGAGCCACACTATTACCAACTCAACCCACGTCAATATGACGATTACGCCAGCCTGGCTCAGGCGCTTCGACAGAATGCGTCGTGGCCACGTCGCGTGGTTCACCTTTGGCAGTCAAACGAACCGGACGTCAACCATGACCAGCACCTGAGTTTGCAGTTAGAGCGGGGGTTTTATTCGCTTTGTCATTTCACTCGGGCACTCATGCAACACACGTTTGGCGATGCCTGCGACATTCTCTATAGTTATCGCGCTGAAGCCTGGCAGCCCGAGCCCGCTTGTGCAGCCGTGAGCGGTTTTGCCCACACGCTGGCCTTAGAGCATCCGGGATTTTCCTGTAAAACGATTGAGATACCCGCGTTCTTGTCTTATCGCGATGCCCGCACCATCGATCTTTTGCTGTCGGAATTGCAGGGACATGCTTTATCCGACACGACCGTTCGCTATCAGGAGCAAGGCACGTTACAGCGTTGGGTGCAGCACTTTTGTGAATGGCAAGCATCTCCAATCGAGGTTGTATCAAAATACCCGCGTCCCCACGGCGTGTATCTCATCACCGGCGCCAGCGGTAGCTTGGGGGCACAATTCGCCCGCCATATAGCGGCTCAGGTCAAAGCGACCTTTGTTCTGTGCGCCCGCTCTGAGCGAACACCCGCGTGTGAACAACTGATCAACACGCTGCGCACGATGGGTTCCGAGGCCGTCTATATTCGCTCGGATCTCTCCCAACGTGATCACGTCTTCAAACTGATTGAAGAAATTCAAGCGCGTTTTAAGGCTCTGCACGGCATTGTCCATAGTGCAGGGGTCATTAGCGACGCGCTGGTATTTAATAAAACCCATCACCAGATCGCTCAAGTCTTAGCGCCTAAGGTCTATGGTACGGTTTATCTGGATGAGGCCACTAAAGATATTCCACTCGATTTTTGGGTGTTGTTCTCTTCAACCACTGCGGTAACCGGCAATGTCGGGCAAAGTGACTATGCTTGTGCCAATCGTTTTATGGATGAGTTTGCGGTGTGGCGAGAACAATTACGCGGCATGAAACAGCGATCCGGAAAAACCCTTGCCATCAACTGGCCATACTGGCGCGACGGCGGCATGTCGATGTCCGAGCCGGGTTACCAGGGGTGGATGGAACGAACTGGGCTTCAGGCGCTGCCTACCAGCGAGGGGGTCGCGGCTTGGGATGATTTGTTGAACGCACCAAGTGGGCACGCCTATGTCGTCGCTTACGGCTTTAGGGAGTTGCTCAGTCGCATGTTTGCAAGGCCGCAGAGTGCTGCGGCGCAGCCGAGCGCTGATGAACGGGCTACATCGAGCGAGACGCTTTATGAAGACACGATGAGCTGGTTGCAACATGAAATTGCCTCGGTGGTCAAAGCATCGCCGCAAGATATTGACGTAGATACCGCCTTTCATCAATTCGGCTTGGATTCGGTCGTGATGCGTCAGACCAATGTTGTGTTGGAGAAAAAACTCGGTGCATTGCCAAAAACACTATTATTGGAATATACAACCATTCGTGACTTAACCGACCATTTATCTACACAGTATATTCGTGAACTCAATGGTGTTTTAGGAAGTGCGTTTTTAGAACAGAGCCCAAATGGTGAAAGACAAGTCCGCAAGAGAGTTGGGTCGGAAAATTCAATGCGTAACGGTATCTTTAGTGCCGAACCTATTGACAGTCAAGCACTCGAGCAGGAACAGACCAATAACTTAGAAGAGATTGCGATCGTCGGTCTGAGCGGGCGTTACCCTCAAGCAGAGGACCTGGATGAGTTTTGGGAGAACCTCAAAGCTGGAAAAAGCGCTATCGCCGACATCCCGGACAGCCGCTGGGATTACAGAGCCTATTACGATGCCGACCCTGACCAGGCGAGTAGGGGCAAGATGTATTGTTCTCAGGGTGGGTTTTTAAACGATATTGATCAATTTGATCCTCTGTTTTTTAATATCACGCCGCTGGAAGCGAAAAGCATGCCTCCCGAAGAGCGACTGATGTTGGAAACGGTGTGGTCGACATTGGAAGATGCAGGTTATGCCGGCGAACACATGCGTAGCCAGAAGGTGGGTGTTTTTGTTGGTGTGACCTCGAACACATATCCACTAGAATGCGATCATAGCGATGGTGTGCGTTATCAGTCGCCGATTGATACTTCCTATTTTAATATACCCAACCGGATTTCTTACTTTTTTAACTTTACGGGTCCCAGCATTGCCATAGATACAGCATGCTCTTCCTCATTGGTCGCCATTCACATGGCATGTGAAAGTCTGCGTCACGGCGAATGTGAGATGGCCATTGCCGGAGGTGTTAATCTTTATCTGCACCCTTCGAAATATATCTTAATGTGTCAGAAGAGACTATTATCCACCAAAATATCTACCGGTATGTTTGAAGAGGGTGGTGACGGATTTATACCTGGGGAGGGCGTGGGCGCTGTTGTACTCAAGCCGCTTACACAGGCGGTGCGCGACCGTGACAATATTTATGGTGTGATCAAAGCTTCCTCTGTTTTTCATAAAGGACGCAGTAATGGCTATTTACTACCGTCTCCTGAAAGTCAGACTGAACTCTTGCGACAGACTTTGCAACAAGCCAAGGTAGCACCGGAGACGATCAACTACATCGAGGTTCAGGCTTTAGGCTCGGAGATGGTTGATCAAGTGGAATGGCGCAGCTTGATCCAGGCTTACGGGGCTAAAGGCAAAAGTGATGAATACAAACCGTACTGTGGTTTAGGTTCATTGAAACCCAATATTGGCCATTTGGAAGCTGCTTCGGGCATTGCTCAGCTGAGCAAAGTCCTGCTGCAAATGAAATACTGCCAGTTTCTCCCCAGCAACGTCTCAGATCGCAGAGACCCGATTTTAGACGCGAGTATCAACCATCCCGATTCGCCTTTTTATTTTCAAGGTGAATGGAGGGTTTGGGAACGGGTTTCACGACAACGTGACGACACGGTTGGCCTGACAGTGCAGCCAAGGCGAGCGGGCATCAATTCTTTTGGCGCTGGGGGGGTGAACGCGCATGTGATCGTCGAAGAATATATCTCGCCAGTAGAATCCAGTCATGCGCCCCGGTTGGAGGAAGAGTCCGCCGCGCTGATTGTGGTGTCGTCAAAAACTCAACAGCAGTTGCGTCAAGCACTGGTCCGATTGAGAGCATACCTACTACGCGAGGCGAATCGTGCGGATGGGCCGTCCGATCGGGTTTCCCTTGCTGACATCGCGTTCACGCTTCAACAGGGGCGCGAAGCCTTCGCCGAGCGCTGGGCGATGGTGGCTAAAAGCAAGGCACAATTGCTAGAGTCACTCACTCGCTTTCTAGATGATAAGACCGTACATGCACCTCTTTTTGTTGGCCGTGTGCCTTCAACGAATCATGAAAATCATGTGTTCATGACTCATGATCGTATCGAAGCATTATGGCATAGTCATCAACTAGAGAAGCTTGCGCAATTGTGGAGACAAGGCCAGAATATCTCCTGGGAGCATCTCTCTTATCGCTATTCTCCGCGCCGTGTGTCACTACCAACTTACCCCTTTGAAAAACGCCACTGCTGGTGGGGAACATCGGACGATAAAGATCCTGTCGAAGTCACTGCTCAAAGTATGCCTGATCTCATTTCCCAAAAAACACATGAAACCCGAGTTAATATGTCAGATATAGGTCAAGTTGTTGCCGATTACTATGACCAAGTTACTGAATCTCTGAAACAAAAAATAGGCTCTCAAGAGGTCTATCTGCTCTTTGCCCCCTTTCAAGAGCGTGTTGAAGGCTTTTCCTGGTTGAAGATGTTTTTTGAACCTGAAAAACATCGCGAGCATTTTGAGCTGACCTTGCAAAAACAACATGAGCTCAAATCCATGCTTTACCGCCTGGTAGAGTTTGCGAACGTACATCGCATTTTTGATATTGGCTGCGGCTATGCTACCGATTTAATCCAACTCGCAAAGCGCCATCCGCAGGTGAGGGGCTGGGGTTTTAGCATCTCGCTCAATCAAGTTGAATTCGGTCAGCAGCGTATTCAAGACGAAGGTCTTGGTGAACGTGTGCAGCTCTCTTGCAACGATAGCACCAAAGACCCATTGCCAGGTCTGTTTGATTTGATTATTGGCTTCGAGGTCGTCGTACATATTGCTGATAAACAAGGCGTATTTGGCAATATGGCGCGACATCTCAGCAATAATGGTACCATTGTCCTGGCTGATTGTGTGGCCAATACTGTAACTTCCATTAACACCTCTTATATAGGGCAATATACAAGCACTGCCGAAGAGTATAGTGATATCCTAGCTCAGAATGGTTTGGCCATTGTCGACTGTGTAGATGTTGGACCTGAGATAAGTAATTTTTTATACGACCCTAATTATTTAGAGAATGCTGCTTATTTAAGTTCGATTTATCCAGAGATGGTAAATATTGAAAAAGAACATCAAGGCTGGAGTAACTTCGGAAAGGCTTTGGAGGTAAACCTGGTCCGTTATGTGCTACTTACTATTCGAAAAGCTACTGCCTCTCAAACTTATGATCATCTATTACAGATTAACCTGGAGCGCTTAGGCTCTGGAGCTCTGTCGTATGCTGAGGCGCTTCAAGCCTACCCCCATATAGAGCAAATCGTCATAGAGCAAATCGCCGAAACGAAAAGCCCTGATTCGAATGCAACTACCACATCCGTGGCAGATATCGAACAGACCATTGTGGAGCTGGCCGCTCAGGTGCTTGAAATGATGCCTGACGAAGTGAATACGCAAGCGCGCTTCATTGATTTTGGGGTAGATTCGTTGCGCGGTTTGATTTTGTTGGACGCGGTCAATCGGCGCTTAGGGCTGACTTTACAGATTCCAGTGTTGTTTGATCATTCCAGTATTCATGAATTGAGTATATATATTGCCTCCCAGCTTCCGTCTTCACCCCAAGCTGTTGTGTCCGCTCCTGCCGCCTCTGTACCCGTTGTCTCACCCGCCGTCGCGGTCAGCTCTGTGCGCTCTGTCGCTTCTAGTCATACCGCGCATTCCGATATCGCCGTGATCGGTATGTCCGGACGTTTTCCGGGGGCGCCTGATCTGCATACTTTTTGGCAAAACTTAGAGCAGGGTATCGACAGTATATCTGAAGTGCCTCCCACGCGTTGGGAGCTTACGCAGTACTATGACGCCGATCGCCGCCTACCCAACCACAGCTATAGTAAATGGGGTGGCTTCCTGGATGATGTGGATCAATTCGATCCCAAGTTTTTTAATATTTCTCCAGCCGAGGCAGAGTTGATGGATCCGCAGCAGCGGCTGTTTCTGCAAACCAGCTGGAACGCGCTGGAGGATACCGGATATGCGGGTCAAACCCTGGATGGCATGAAGTGTGGCGTCTATGTGGGGGTGTTGAATCACGCATACGATATCCTGATCGATCGCGCTAACATTTCCCAGCATCGTGCGTATGCTTTGCTGGGCAATAGTTCGTCAATTTTGGCGGCGCGCATTGCCTATCTGCTCAACCTTAAAGGCCCTGCCGTCACCCTAGACACCGCCTGTTCCTCTTCGTTGGTCGCGCTGCACTGGGCTTGTAAAAGCCTCCGGGACGACGAAGTAGATATGATGTTAGCCGGTGGGGTGACTCTTTATCTGGGGGAAAGAGAGTATATTGAGGCGAGCCAGGCGGGGATGCTCTCCCCCACGGGCAAATGCCGAGCTTTTTCTCAGGAGGCCGACGGGATCACTTTGGCAGAAGGGGTGGGTGTTGTCGTGTTGAAACGTTTAGATAAAGCTCTGCAGGATCGCGATGCGATCTACGGTGTGATCAAAGGTACCGGGATCAACCAGGATGGCAAAACGAACGGCATTACCGCGCCTAGCGCCAAATCGCAGTATGAACTGCAAACTGAGGTCTATACGCGATACGGCATTCGTCCCGAGCGCATTAGCTACGTAGAAGCGCATGGTACGGGAACAAAGTTAGGCGATCCCATTGAAGTGGAAGCATTGACGCAAAGTTTTAGGCAGTATACCCAGAAACAAAATTATTGTGCCATTGGCTCCGTCAAAAGTAATATTGGTCATACTTCTGCCGCCGCGGGCATCGCAGGCTTGATTAAAATTTTACTGAGTTTGCAGCATCATTCTATACCTCCCACACTGCATGTAGAGCATAAAAATGAACACATTAACTTTAGGGACAGTCCGTTTTACGTCAATACCCAGCTTCGTCCCTGGACCCATGAAGATGATTTGCCAAGACAGGCCGCTGTAAGCTCCTTTGGTTTTAGCGGTACAAACTGCCATGTGGTTGTGGAAGAGCCGCCCGCTCGCATTGTTCATCAACATATCGCATCAACATTAGACGCTCCCGTATTGATGGTACTTTCAGCTGCAAATCAAGATCGGCTGCGGGGCTATGTGGCGTTGATGATTCGCTATCTCGAAGCAAGAAAGACGCGTCAACATACCCGCAAGGCATGGCCATCTGACAGCCTGACTGATATCGCGTATACCCTGCAAACCGGGCGAACGCCACTAGAGCAACGTCTCGCTATGGTCGTTGCCAGTGAAGACGAATGGCTCGACAAGCTACGACGCTATGAGCGTGGCGAAAACGTGATTGATGCCTGTTACGAGGGCCAGGCAAATGCCGAGCCCGCCAAACTGGATTTGCTCATCGAGGGAGAGGAAGGTCGAGCGTTTATCGAATCTATCGTGCGCCGAAAAAACCTGTCTAAACTCGCCCAGTTATGGGTTGGCGGAACCGATATTGACTGGACCTTACTCTATCATCGCCCTTCGTCAGATGCTGCCGTGTTGCCCCAGCGAATTTCGCTGCCAGGTTACCCGTTCGCGCGAGAATCGTATTGGCTTGCCGCGCCAACGCTAGCCGCTTCTTCGTTGGTGGTCGAGCGGTTGCCCCATCAAGATGACATCTGTTTTAAAACCGTGTTGAGTGGCGATGCCTTTTTTCTGCGCGATCATTGTATCGACAGGCAAAAAGTCTTACCCGGTGTCGTTTATTTGGAAATGGCCAGGAAAGCAGCTACCAGCTTTCGTCCTGATGCCCCGCAGCCCGTACTCAAAAATGTGATTTGGCTTCGTCCACTCATGGTCAATGCGACAGATGTCGTGGCCTACACACGTCTGAAGCAACAGGCGCAGCGGATTGATTTTGAAATTTCAACCTTGGATGAGCAGAACAACCGGGTGCTACATGCTCAGGGACAATTGCACGATCCGGAGCCGGTTACGCCACAGCATCCGGATTGGCCCTCATTTGATCTTCGGCTTATTCAAGAGCGTTGCCCACGTACGCTAGAAGGCGAAGCGTTTTTCCAGGCCATACAGGCGCAGGGCTTTCGTACCGGGCCGAGTTTTCAGGTGGTCCGGAAAGCCTGGTATAACCAAACCGAAGCTCTGTGTGAGTTGGGCCTGCCGGCGTTGCGCGAAGCTGATTTTCAAGACTACCTACTGCATCCTTCACTCGTCAATGCCGCACTGGAGTCGGTGATTCTATTGATCGCGAAGGACCCCTCGGCATCTGACGCTCCTCATCTTCCCTACACGTTGGGCACATGGGCATATGACGACACGGTTTGGCCGACATCGCTATATGCGTATGCGCGACTGACCGCACCTCAGCCGGAGACAGAGGCTTTGACTGCCGCTACCACGGTTCAACGGTATGAGATCAATCTGTTGGATCGCAGCGGCAGACTGATCGCACGCGGCAAAGATTTTTGTGTTCGTGCGTTGCGCTCAAGTGGCGAGACACGGCCTGCCAGCTCCGCGGCCCAGTATCCGGTCAAGTATTATTATCCGCGGTGGGAGGCATGTGAAAACGAACGTGTCGCGGCCAATATTGTAGTTGAGCGCAGTTGGCTGGTGTTTGAAACCGAGAATTCGCTCTGGCATGCGCTGGATGAAAAACTGCGTGCGTTGGGTGTCACATGCATTCAGGTTAGACCCGGTTACCGGTTTCAGGTCTTGGAAAAAAGGCGCTACGAAATTCACCCCGAGCGGGCTGGTGACTACCAAAAACTGGTCGCTGAACTCAAACGCAACCACGCAATCCCCGAGCGTATTATTCACGCGTGGTCGGAAGAGCAATGGTGTGACAACGCCGAGCTCGATCCACGATCACTGGCGTGGGGTTTCTATTCCGTGTTTTATCTGAGTCAGGCCTTGATCTCCTGTTGGCAAGATACGCCGCTTCACTTGCTGTATCTCTATCGTCAAGATCAGGACTCACCACAGGCCCACTACGCGGCGGTTCGTGGCTTTGCTCAGTCCCTCACGCATGAACGATTGGATTGGCATTGGAAAACCCTGGCTTTGCCCACCACCCTGCCGCAAGCCCAAGTCGCTAACATGTTATGGGATGAGCTACGGTATGCAAATCAACTGGAGCGCGAAATTCGCTATGACGCAAATCGGCAACGTTGGGTGAGGCGTTGGCATGCAGGTGAAGGGACACCTGGTCAAGGGCCAGCCGCACCCGACACGAGTTTGCTGCGCCAACAAGGCGTATACCTGATTACTGGTGGGGGTGGCGGCCTTAGCCTGCTACTGGGGGAATATCTGGCGCGCGAGTATCAGGCCAAAGTCATTCTCGTAGGCAGAGCCGAGGGGACTGAAGCGCAACAAGCGAAGATAGACAGTTGGAAACGATGGGGGGGAGAAGCGCTCTATTTACAAGGGGATATCTCCCGGCGAGAGGATGTGGATCATGTCATGGCACAGTTGCGCTCTCGCTTTCCTGTCTTGCACGGTGTTTTTCATGCGGCGGGACTCACGCGTGATGCTTCTCTTGTCAACAAAACCGTCCGTGACATCGACGAGGTGCTGGCAGCTAAGGTTTACGGAACCATTTACCTGGATCAAGCTACCCGTAGTGAAGAATTGGACTTTTTTGTCTTATTTTCGTCTCTATCCGGAGTCGTTGGTAATATAGGGCAATCTGACTATGCTTATGCCAATAGCTTTTTGGATCATTTTGCCGAGCGTCGCGAAGCACAACGGAGTATGCAAAAGCGTTTTGGTTTAACGGTTGCAATTGATTGGCCACTGTGGCGTCATGGCACGATGCAGGTAGATGCTACGACCGAGAAATTTCTGGCGCGCTCGATCGGTATGCAGGCGCTAGAGACCGATGACGGTTGGATGGCCCTACAACATGCCTTGGCGGGTTCGAAGAGCCAACTCCTGGTGCTGTGTGGCGATCAGGGGCGATTTAGCCAGGCCTTGGGCGTACAGCAACATCATACAGTTGCCGAGCGGGCTGAGAGCCCGAGTGAAAACCTAAGTGAGACCTCGAGCTTCGATTTACTAACGCATTTGCAGATTGACCTCAGGTCCATCATGGCTGCCGTACTCAAGCTGAGCCCTCAGGAGATCGAGTGGGAGCGTGAGATGAGCAGCTTTGGCTTTGATTCCATTTCGTTTGTCGCTTTGGCTAACGAGTTGAATGATACTTTCGAGTTGGATCTTTTGCCTGCCGTGTTTTTTGAGTGTTTGAACGCTGGTGATTTGCTCAAACACTTGCACCACCACCACTGTGACGCCTTATTTGCGTATTACCGTAGACGTGTGCCTGAACCTGCGGCGCAAGAAGTGTTAGGTACGCCGGGACAAGCCAACGTTGAGGGGCCGGTTCATGTACGTCAATTGGAAAAACCGAGCGGCCTTAATCACCATGCCGGCACAGAGCCGATAGCCATTGTTGGCATGAGTGCTGTGATGCCGCAGTCCCCCGACCTGGAGACGTTTTGGCAGCACCTGGCGGCGGGGCAGGATTTGATCACAGAGATCCCCAAAGACCGATGGGACTGGCAAAACGCAGGAGGTGATACGACGATTCGCTGGGGCGGTTTTATGCCGGATATCGATCAATTCGACGCGCTGTTTTTTGGTATTTCGCCTCGTGAAGCCGACCTGATGGACCCGCAGCAACGCCTGTTGCTTCAGACCGTGTGGAAAACCATCGAGCACGCGGGTTACAAAGCCTCGGATTTATCCGGGAGCGATACCGGCGTTTTTGTCGGAGTTGCCAATTCCGATTATCGCGAGCTGATCCATGCGGCAGGGCCTGGGATCGATGCGCAAAGCTCTACCGGAACGTTTTCCTCGATCTTAGCCAATCGGGTGTCGTACATTTTCAATTTTACCGGCCCAAGCGAGCCCATTGACACGGCTTGCTCCAGCTCTTTGGTGGCGCTCCACCACGCGTTGAATGCGTTATCCCGTGGCGAATGCTCCAGCGCCATCGTTGGTGGCGTGAATGCGTTGTTAACCCCAACCCTCCATATTACCAGCAACAAGACCGGCATGTTGAGCCACGATGGGCGCTGCAAAACCTTTGATCAAGCGGCGAATGGCTATGTGCGGGGAGAGGGGGTTGCCGCGCTCTTGTTAAAACCGCTCAGCCTGGCTAAAGCGCAGGGGGACGAAATTTATGCGCTGATTCAAGGTAGCAATGTAAACCATGGTGGACACGCCACCTCCCTCACTGCGCCCAACCCCCGGGCACAGGCTGAATTGCTGATCCACGCCTATGAAGATGCAGGTATCGACCCCACAACCGTCACCTATATTGAAACCCATGGCACCGGAACAAGCCTGGGGGATCCGATTGAAATCAGTGGTTTAAAGCAGGCTTTTGCCACTTTGTATGAGCGTTTTGGTCACGTGGCCGATGTTTCCGCTTACCATCGGTGTGGTCTTGGCTCTGTTAAAACCAATGTCGGTCACCTGGAAGCAGCAGCAGGCATGGCTGGACTGCTCAAAGTGGTTTTAGCCATGCATCACAAAACCTTACCTGCACATCTTCATTTTCATAACCTCAACCCGTATATCGATTTGAGCGGCAGTCCTTTCTATATTACCCGGCAAACTTGTTCCTGGGACGCTTTACAAGATGCTGCCGGTAAGGCGCTTCCCCGGCGTGCCGGTGTCAGCTCGTTTGGTTTTGGTGGCGTCAATGCACATGTCATTGTTGAGGAATATGTTGAGGACCGGCATGAAGACAGATAG", "orf_prot_sequence": "MEAKDIAVIGVGVLFPGASHHDLFWENLIAGIDSIQEIPVSRWDIDAYYSPDFNEPGKSISKWGGLIQGIDQFDHQFFNISPREARNMDPQQRLLLQEAWHCVEDSGIALKTLQEKVTSVFVGVMAIDYHQHMAQSRQPVDSYACLGNYGSILANRLSFCLGLSGESKAIDAACASSLVAVHDARRSLQAGECDYAIAAGVSVICHPWKYISFSKSRMLSPSGRCKTFDKSADGYVPGEGVGVLLMQSLERAQEQKCHIYGVLKGSALNNNGLHGQRHADDRGRKKASITAPSIDAQRRVITDALRSADIDPASVSYVEAHGTGTSLGDPIEIEALKQVFAVPGRTTPSCAIGSVKTNIGHLEAAAGVAGVIKVLLMMKHKMIPQVLHLNTVNPMIDLTDTSLYLSDQLHSWESKEGIQRRAGVSSFGFGGSNAHAIFEEYVDTRHTPQGTLQRTSGEHLFVLSAKSHSSLDGLLNDWVAFLNHPQRSAISLEDMCATLMTGRESFPFRFALSVTDKKALRSALISPPESAFGHAEMPSVLLRIGSVNAEQAAVIASWYRKHPGFREPFDACRRLAKMLCSEEAVRDWTAQFPKVLAEHEALYGFAAAYATARLLLDSGVQPRLICGEGIGHGVALCLSGLWTLSQGLRHAMRLIDQLDLSPQRLDYPIYDQIQGTTLSPYQPSRGYLQALLKNIQVRDDLFIRDLQKALLLHEHQYTFKNYLESWNSALKEIGLEIYQLIGLHAELQEDISKKFLVYIIVAYSLKQLYEKWDLVEYDASSDPFLNEFLDLIGDDVLTFKDVVTLIGNGWDTGKEDLFHGITARVIPVSSVKPYEYLQQYQFERFDHIRSWLEKIGDVPLETPIHEDDLLLTVGDEGDVSRLKIVSNSGHSLSFLTRGQKASHLTEDVRQLWLHGLNIDWQSFVDAGSFTKASLPGYSFDGSPFWIENSRSDSPFIQGEGIKAEPVQNSYYHFVWQASKHPTVLDRKPDVKNNEAILLFDSDASLAQLLREQWHAEIILIRPARAFDWKSWHDVEIDPDNENHYKLVCTALQQKNLRPVCAIFTWTLQESTSTGESLLSHPEPWLSKGIYAVYHLLKSLSQSAHPPLSQLLFFFHGNEGQGNPLMEAVAGYGRSLKLTYPQMRFRSIQFETGSPDTIEVVTAVIREFSLLKGEERQEVDTEVLYRHGQRLIKTPVRLHLDAVAQAPWKQSGVYLITGGMGALGSIWARYLAERYQARLILTGRSVCQGDIGKSIRVFIKQLQQLGGDAVYLQADITEPHAVRQLIEQAYQAFGPVRGLIHAAGQMSAVSFAEKSLADFQQTLSAKIQGTLVLDRVLHESIEKQALDIVIYFSSAASTLGDFGQCDYAIGNRFLDGYGRFREGLRTQGQRQGRTVVVNWPLWREGGMHLDSEAEALYLSASGLDYLEAEQGLDALDRILVSPHTQVMVFAGDPANIDRNLGVNKVVDMQVDETFVASRIEADLQHLAAVLLQMQADEIALDDNLSAYGFDSIAIKEFADQLSQYYQLEISPIVFFAHASLRSLGAYFWEHFAADMKAFYAAEPSNQMPEARHAEAPARQVSQPARAEADQDIAIIGMSGVFPGSPDLATFWKHLSRGRDLVGEVPAGRWDWRVYDGDLMREHEAKKTAIKWGGFIENVDRFDADFFSISRREAEFMDPQHRLFLQCVWATIEDAGYATAALSGENIGVFVGVQFSDYQQLLKQAGERGAQILTGNAHSVLANRISYLLDVRGPSLAIDTACASSLVAVHQGVQAIRNGDCTAAIVGGVSLMLSPDTFLDINHLGVLSPDGRCKTFDRNANGYVRGEGVGSFLLKPLSRALQDRDPIHGIIRGSAVQHGGKANSLTAPNSEMQAALLLKAYEDAGIGLDTVSYIETHGTATELGDPVEIEGLKQAYRTYRQQTGAAASRTGACGLGSVKTNIGHLEPAAGIAGLAKVLLAMRHQILPATLHFDSLNPYIDLSESPFYIVDEKTPWQRRLDEQGEEIPRRAGVSSFGFGGAIAHLVLEEYRVPQDTLENGDDDTSPYLIVLSAKNEARLKEVATNLYGHLIETASVAPIKLRDLAYTLQVGRDALPQRLALVVDETAHLLDGLAAYVQGEPDRGRWFAGTARRDRCPLTSLVEAGEAMIAMRIEKEALREFAQSWVQGASINWQQMYPVNKPRRQSLPTYPFAQQRYWFDTSANTKPQERHAAVAPIDNKSNIERIYYRREWAQTALLSPVSIETGDQAQFVLLFETNPQIGEVWQTQLEQHGLRCIRVCIGERFRLLEPHYYQLNPRQYDDYASLAQALRQNASWPRRVVHLWQSNEPDVNHDQHLSLQLERGFYSLCHFTRALMQHTFGDACDILYSYRAEAWQPEPACAAVSGFAHTLALEHPGFSCKTIEIPAFLSYRDARTIDLLLSELQGHALSDTTVRYQEQGTLQRWVQHFCEWQASPIEVVSKYPRPHGVYLITGASGSLGAQFARHIAAQVKATFVLCARSERTPACEQLINTLRTMGSEAVYIRSDLSQRDHVFKLIEEIQARFKALHGIVHSAGVISDALVFNKTHHQIAQVLAPKVYGTVYLDEATKDIPLDFWVLFSSTTAVTGNVGQSDYACANRFMDEFAVWREQLRGMKQRSGKTLAINWPYWRDGGMSMSEPGYQGWMERTGLQALPTSEGVAAWDDLLNAPSGHAYVVAYGFRELLSRMFARPQSAAAQPSADERATSSETLYEDTMSWLQHEIASVVKASPQDIDVDTAFHQFGLDSVVMRQTNVVLEKKLGALPKTLLLEYTTIRDLTDHLSTQYIRELNGVLGSAFLEQSPNGERQVRKRVGSENSMRNGIFSAEPIDSQALEQEQTNNLEEIAIVGLSGRYPQAEDLDEFWENLKAGKSAIADIPDSRWDYRAYYDADPDQASRGKMYCSQGGFLNDIDQFDPLFFNITPLEAKSMPPEERLMLETVWSTLEDAGYAGEHMRSQKVGVFVGVTSNTYPLECDHSDGVRYQSPIDTSYFNIPNRISYFFNFTGPSIAIDTACSSSLVAIHMACESLRHGECEMAIAGGVNLYLHPSKYILMCQKRLLSTKISTGMFEEGGDGFIPGEGVGAVVLKPLTQAVRDRDNIYGVIKASSVFHKGRSNGYLLPSPESQTELLRQTLQQAKVAPETINYIEVQALGSEMVDQVEWRSLIQAYGAKGKSDEYKPYCGLGSLKPNIGHLEAASGIAQLSKVLLQMKYCQFLPSNVSDRRDPILDASINHPDSPFYFQGEWRVWERVSRQRDDTVGLTVQPRRAGINSFGAGGVNAHVIVEEYISPVESSHAPRLEEESAALIVVSSKTQQQLRQALVRLRAYLLREANRADGPSDRVSLADIAFTLQQGREAFAERWAMVAKSKAQLLESLTRFLDDKTVHAPLFVGRVPSTNHENHVFMTHDRIEALWHSHQLEKLAQLWRQGQNISWEHLSYRYSPRRVSLPTYPFEKRHCWWGTSDDKDPVEVTAQSMPDLISQKTHETRVNMSDIGQVVADYYDQVTESLKQKIGSQEVYLLFAPFQERVEGFSWLKMFFEPEKHREHFELTLQKQHELKSMLYRLVEFANVHRIFDIGCGYATDLIQLAKRHPQVRGWGFSISLNQVEFGQQRIQDEGLGERVQLSCNDSTKDPLPGLFDLIIGFEVVVHIADKQGVFGNMARHLSNNGTIVLADCVANTVTSINTSYIGQYTSTAEEYSDILAQNGLAIVDCVDVGPEISNFLYDPNYLENAAYLSSIYPEMVNIEKEHQGWSNFGKALEVNLVRYVLLTIRKATASQTYDHLLQINLERLGSGALSYAEALQAYPHIEQIVIEQIAETKSPDSNATTTSVADIEQTIVELAAQVLEMMPDEVNTQARFIDFGVDSLRGLILLDAVNRRLGLTLQIPVLFDHSSIHELSIYIASQLPSSPQAVVSAPAASVPVVSPAVAVSSVRSVASSHTAHSDIAVIGMSGRFPGAPDLHTFWQNLEQGIDSISEVPPTRWELTQYYDADRRLPNHSYSKWGGFLDDVDQFDPKFFNISPAEAELMDPQQRLFLQTSWNALEDTGYAGQTLDGMKCGVYVGVLNHAYDILIDRANISQHRAYALLGNSSSILAARIAYLLNLKGPAVTLDTACSSSLVALHWACKSLRDDEVDMMLAGGVTLYLGEREYIEASQAGMLSPTGKCRAFSQEADGITLAEGVGVVVLKRLDKALQDRDAIYGVIKGTGINQDGKTNGITAPSAKSQYELQTEVYTRYGIRPERISYVEAHGTGTKLGDPIEVEALTQSFRQYTQKQNYCAIGSVKSNIGHTSAAAGIAGLIKILLSLQHHSIPPTLHVEHKNEHINFRDSPFYVNTQLRPWTHEDDLPRQAAVSSFGFSGTNCHVVVEEPPARIVHQHIASTLDAPVLMVLSAANQDRLRGYVALMIRYLEARKTRQHTRKAWPSDSLTDIAYTLQTGRTPLEQRLAMVVASEDEWLDKLRRYERGENVIDACYEGQANAEPAKLDLLIEGEEGRAFIESIVRRKNLSKLAQLWVGGTDIDWTLLYHRPSSDAAVLPQRISLPGYPFARESYWLAAPTLAASSLVVERLPHQDDICFKTVLSGDAFFLRDHCIDRQKVLPGVVYLEMARKAATSFRPDAPQPVLKNVIWLRPLMVNATDVVAYTRLKQQAQRIDFEISTLDEQNNRVLHAQGQLHDPEPVTPQHPDWPSFDLRLIQERCPRTLEGEAFFQAIQAQGFRTGPSFQVVRKAWYNQTEALCELGLPALREADFQDYLLHPSLVNAALESVILLIAKDPSASDAPHLPYTLGTWAYDDTVWPTSLYAYARLTAPQPETEALTAATTVQRYEINLLDRSGRLIARGKDFCVRALRSSGETRPASSAAQYPVKYYYPRWEACENERVAANIVVERSWLVFETENSLWHALDEKLRALGVTCIQVRPGYRFQVLEKRRYEIHPERAGDYQKLVAELKRNHAIPERIIHAWSEEQWCDNAELDPRSLAWGFYSVFYLSQALISCWQDTPLHLLYLYRQDQDSPQAHYAAVRGFAQSLTHERLDWHWKTLALPTTLPQAQVANMLWDELRYANQLEREIRYDANRQRWVRRWHAGEGTPGQGPAAPDTSLLRQQGVYLITGGGGGLSLLLGEYLAREYQAKVILVGRAEGTEAQQAKIDSWKRWGGEALYLQGDISRREDVDHVMAQLRSRFPVLHGVFHAAGLTRDASLVNKTVRDIDEVLAAKVYGTIYLDQATRSEELDFFVLFSSLSGVVGNIGQSDYAYANSFLDHFAERREAQRSMQKRFGLTVAIDWPLWRHGTMQVDATTEKFLARSIGMQALETDDGWMALQHALAGSKSQLLVLCGDQGRFSQALGVQQHHTVAERAESPSENLSETSSFDLLTHLQIDLRSIMAAVLKLSPQEIEWEREMSSFGFDSISFVALANELNDTFELDLLPAVFFECLNAGDLLKHLHHHHCDALFAYYRRRVPEPAAQEVLGTPGQANVEGPVHVRQLEKPSGLNHHAGTEPIAIVGMSAVMPQSPDLETFWQHLAAGQDLITEIPKDRWDWQNAGGDTTIRWGGFMPDIDQFDALFFGISPREADLMDPQQRLLLQTVWKTIEHAGYKASDLSGSDTGVFVGVANSDYRELIHAAGPGIDAQSSTGTFSSILANRVSYIFNFTGPSEPIDTACSSSLVALHHALNALSRGECSSAIVGGVNALLTPTLHITSNKTGMLSHDGRCKTFDQAANGYVRGEGVAALLLKPLSLAKAQGDEIYALIQGSNVNHGGHATSLTAPNPRAQAELLIHAYEDAGIDPTTVTYIETHGTGTSLGDPIEISGLKQAFATLYERFGHVADVSAYHRCGLGSVKTNVGHLEAAAGMAGLLKVVLAMHHKTLPAHLHFHNLNPYIDLSGSPFYITRQTCSWDALQDAAGKALPRRAGVSSFGFGGVNAHVIVEEYVEDRHEDR", "perc_identity": 34.09}, "gnl|BL_ORD_ID|4683|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15190, "orf_end": 33063, "orf_from": "BGC0001186.1|Misakinolide_15 ", "model_name": "MexI", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1900", "model_id": "1647", "ARO_accession": "3000808", "ARO_name": "MexI", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.28584, "max_identities": 15, "bit_score": 29.6462, "cvterm_id": "36804", "query": "HTLALEHPGFSCKTIEIPAFLSYRDARTIDLLLSELQGHA", "match": " T A+ + GFS KT+ IPA   Y  +R ++ + S + G A", "sequence_from_db": "ETTAVAYVGFSSKTLPIPALTDYL-SRVVEPMFSSIDGVA", "sequence_from_broadstreet": "MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA", "dna_sequence_from_broadstreet": "ATGACCTTTACCGACCTGTTCGTCCGCCGGCCGGTGCTGGCGCTGGTGGTCAGCACGCTGATCCTGCTGCTCGGCCTGTTCTCCCTGGGCAAGCTGCCGATCCGCCAGTACCCGCTGCTGGAAAGCTCGACCATCACCGTCACCACCGAGTACCCCGGCGCCTCCGCCGATCTCATGCAAGGCTTCGTCACCCAGCCGATCGCCCAGGCGGTGTCGTCGGTGGAGGGCATCGACTACCTTTCCTCGACCTCGGTGCAGGGGCGTAGCGTGGTGACCATCCGCATGCTGCTCAACCGCGATTCGACCCAGGCGATGACCGAGACCATGGCCAAGGTCAACTCGGTGCGCTACAAGCTGCCCGAGCGTGCCTACGACTCGGTGATCGAACGCTCTTCCGGCGAGACCACCGCGGTAGCCTACGTCGGCTTTTCCAGCAAGACCCTGCCGATCCCGGCGTTGACCGACTACCTGTCGCGGGTGGTCGAGCCGATGTTCTCTTCCATCGACGGCGTGGCCAAGGTCCAGACCTTTGGCGGCCAGCGCCTGGCCATGCGCCTCTGGCTCGACGCCGACCGCCTCGCCGGGCGCGGCCTGACCGCCTCCGACGTGGCCGAGGCGATCCGCCGCAACAACTACCAGGCGGCGCCGGGGATGGTGAAGGGGCAGTACGTGCTGTCCAACGTGCGGGTCAACACCGACCTGACCAACGTCGACGACTTCCGCGAGATGGTCATCCGCAACGATGGCAACGGCCTGGTGCGCCTGCGCGACGTCGGTACCGTCGAACTGGGCGCCGCGGCCACCGAGACCAGCGCACTGATGGACGGCGACCCGGCGGTGCACCTGGGGTTGTTCCCGACGCCCACCGGCAACCCGCTGGTGATCGTCGACGGCATCCGCAAGCTGCTGCCGGAGATCCAGAAGACCCTGCCGCCGGATGTCCGCGTCGACCTCGCCTACGAGACTTCGCGCTTCATCCAGGCCTCCATCGACGAGGTGGTGCGGACCCTGGTGGAAGCGCTGCTGATCGTGGTGCTGGTGATCTACCTCTGCCTCGGCTCGCTGCGCAGCGTGCTGATCCCGGTGGCGACCATTCCCCTGTCGATGCTCGGCGCCGCCGCGCTGATGCTGGCCTTCGGCTTCAGCGTCAACCTGCTGACCCTGCTGGCGATGGTGCTGGCCATCGGGCTGGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCCACCGCCACATCGAGGAAGGCAAGTCGCCGGTGGCGGCGGCGCTGATCGGCGCCCGCGAAGTGGCCGGCCCGGTGATCGCCATGACCATCACCCTGGCCGCCGTGTACACCCCCATCGGCCTGATGGGCGGCCTCACCGGCGCGCTGTTCCGCGAGTTCGCCCTGACCCTGGCGGGCGCGGTGATCGTGTCCGGGGTGGTGGCGCTGACCCTGTCGCCGGTGATGAGTTCGCTGCTGCTCCAGGCGCACCAGAACGAGGGGCGCATGGGCCGCGCCGCCGAGTGGTTCTTCGGCGGCCTGACGCGGCGCTACGGGCAGGTCCTGGAGTTCTCCCTGGGCCACCGCTGGCTGACCGGCGGCCTGGCATTGCTGGTGTGCATCAGCCTGCCGCTGCTGTATTCGATGCCCAAGCGCGAACTGGCGCCGACCGAGGACCAGGCCGCGGTGCTCACCGCGATCAAGGCGCCGCAGCACGCCAACCTCGACTATGTCGAACTGTTCGCGCGCAAGCTCGACCAGGTCTACACCAGCATCCCGGAAACCGTGAGCACCTGGATCATCAACGGCACCGACGGACCGGCGGCGAGCTTCGGCGGGATCAACCTGGCGGCCTGGGAAAAACGCGAGCGCGACGCCTCGGCGATCCAGTCCGAGCTGCAAGGCAAGGTCGGCGATGTCGAGGGCAGCAGCATCTTCGCCTTCCAGTTGGCCGCCCTGCCCGGCTCCACCGGCGGCCTGCCGGTGCAGATGGTGCTGCGCAGCCCGCAGGACTATCCAGTGCTCTACCGGACCATGGAAGAGATCAAGCAGAAGGCCCGACAGAGCGGGCTGTTCGTGGTGGTCGACAGCGACCTCGACTACAACAACCCGGTGGTCCAGGTCCGCATCGACCGCGCCAAGGCCAACAGCCTGGGCATCCGCATGCAGGACATCGGCGAGTCGCTGGCGGTGCTGGTGGGCGAGAACTACGTCAACCGCTTCGGCATGGAGGGCCGCTCCTACGACGTGATCCCACAGAGCCTGCGCGACCAGCGTTTCACTCCGCAAGCGCTGGCACGACAGTTCGTGCGCACCCAGGACGGCAACCTGGTGCCGCTGTCGACGGTGGTCCGGGTGGCGCTTCAGGTCGAACCGAACAAGCTGATCCAGTTCGACCAGCAGAACGCCGCGACCCTCCAGGCGATCCCCGCGCCCGGCGTCTCCATGGGCCAGGCGGTGGCCTTCCTCGACGACGTGGCGCGCGGCCTGCCGGCCGGCTTCAGCCACGACTGGCAATCCGACTCGCGGCAATACACCCAGGAAGGCAACACCCTGGTGTTCGCCTTCCTCGCCGCCCTGGTGGTGATCTACCTGGTGCTCGCCGCGCAGTACGAGAGCCTGGCCGACCCGCTGATCATCCTGATCACCGTGCCGCTGTCGATCTGCGGCGCGCTGCTGCCGCTGGCGCTGGGCTACGCGACGATGAACATCTATACGCAGATCGGCCTGGTCACCCTGATCGGCCTGATCAGCAAGCACGGCATCCTCATGGTCGAGTTCGCCAACGAACTGCAACTCCACGAGCGCCTCGACCGCCGCGCGGCGATCCTGCGCGCCGCGCAGATCCGCCTGCGGCCGGTGCTGATGACCACCGCGGCAATGGTCTTCGGCCTGGTGCCGCTGCTCTTCGCCAGCGGCGCCGGCGCCGCCAGCCGCTTCGGCCTGGGCGTGGTGATCGTCTCCGGGATGCTGGTCGGCACCCTCTTCACCCTGTTCGTGCTGCCCACCGTCTATACCCTGCTGGCGCGCAACCACGCGGAAGTCGACAAGAGCCCGCGCAGCCGGCAACTGGCCGAGGCCGATCTGCTGGTGAACAAGGCATGA", "partial": "0", "query_start": 22345, "query_end": 22464, "hit_start": 399, "hit_end": 516, "orf_dna_sequence": "TTGGAGGCCAAGGACATTGCTGTCATTGGAGTGGGGGTTCTATTTCCTGGTGCCAGTCATCATGACCTGTTTTGGGAAAATTTAATTGCTGGTATTGATAGTATTCAGGAGATACCTGTATCTCGCTGGGACATAGACGCCTATTATTCACCTGATTTTAATGAACCGGGAAAAAGTATTAGTAAATGGGGCGGACTGATTCAGGGGATTGATCAATTTGATCACCAGTTTTTTAATATTTCCCCGCGTGAAGCGCGGAATATGGACCCGCAACAACGTTTATTATTACAGGAAGCCTGGCACTGCGTCGAAGACTCCGGTATTGCCCTCAAAACCCTTCAGGAAAAAGTCACTTCCGTATTTGTTGGGGTCATGGCGATTGACTACCATCAGCATATGGCACAGAGCCGTCAGCCTGTGGATAGCTACGCCTGCCTTGGGAATTACGGCTCTATATTAGCGAACCGTCTATCGTTTTGCCTCGGGTTGAGCGGGGAGAGTAAAGCCATTGATGCTGCTTGTGCCTCATCATTGGTGGCAGTCCATGATGCGAGACGGAGTTTACAGGCAGGAGAATGTGACTATGCGATTGCCGCCGGCGTGAGTGTGATCTGTCATCCCTGGAAGTATATTTCCTTCTCGAAATCTCGCATGTTGAGTCCCTCCGGGAGATGCAAAACCTTTGATAAGAGTGCTGATGGGTATGTACCCGGCGAAGGGGTGGGCGTTCTTCTCATGCAATCGCTGGAAAGAGCGCAGGAGCAGAAATGCCACATTTATGGTGTTTTAAAAGGCTCGGCGCTCAACAACAATGGTCTTCATGGACAAAGACACGCTGACGACCGGGGCAGAAAAAAGGCGTCCATCACTGCCCCCAGCATAGACGCCCAGCGCCGGGTCATTACCGACGCGTTGCGTAGTGCGGATATTGACCCGGCGAGTGTGAGCTACGTGGAAGCCCACGGCACGGGGACATCCCTGGGAGATCCCATTGAAATTGAAGCCTTAAAACAGGTATTCGCTGTCCCTGGTCGGACAACACCGTCTTGTGCTATCGGCTCGGTAAAAACCAATATTGGTCACTTGGAAGCCGCTGCTGGAGTCGCGGGCGTGATCAAGGTGCTCTTGATGATGAAGCACAAAATGATTCCCCAAGTGCTTCATCTCAATACCGTGAATCCGATGATTGATTTGACAGATACGTCTCTTTATCTAAGCGATCAGCTACACTCTTGGGAGTCTAAAGAGGGCATTCAACGCAGAGCGGGGGTGAGTTCCTTTGGTTTTGGTGGAAGCAATGCCCATGCCATTTTCGAGGAGTATGTCGATACGCGACATACTCCTCAAGGTACACTTCAGCGCACGAGTGGCGAGCACCTGTTTGTCTTATCTGCAAAATCCCACTCAAGTCTAGATGGCCTGTTAAACGATTGGGTCGCGTTCCTTAACCACCCCCAGCGCTCTGCGATATCGCTTGAGGATATGTGCGCAACGCTCATGACGGGACGGGAATCGTTTCCGTTCCGCTTTGCGCTGTCCGTGACAGATAAAAAGGCGTTGCGCTCAGCCCTCATCTCACCACCGGAGAGCGCTTTCGGCCATGCAGAGATGCCGTCCGTACTGTTGCGTATTGGCTCTGTCAATGCCGAGCAAGCCGCGGTGATTGCCTCCTGGTATCGCAAGCATCCAGGATTTCGCGAGCCTTTTGATGCTTGTCGTCGCTTGGCTAAAATGCTTTGCAGTGAGGAGGCCGTTCGCGACTGGACGGCCCAATTTCCCAAGGTGTTGGCCGAGCATGAAGCTCTGTATGGTTTTGCCGCTGCCTATGCGACTGCGCGTTTACTGTTAGATTCGGGGGTGCAGCCACGCTTAATCTGTGGCGAGGGGATTGGCCATGGTGTTGCTTTATGTCTTAGTGGGCTGTGGACGCTCTCCCAAGGGCTAAGGCATGCGATGAGGTTGATCGATCAGCTCGATCTAAGCCCACAGCGCTTAGATTACCCCATTTATGACCAGATTCAAGGCACAACTTTGTCGCCTTATCAGCCTAGCAGAGGTTATTTGCAGGCCTTGTTGAAGAATATTCAGGTAAGAGATGACCTCTTCATCAGAGACTTGCAAAAAGCCCTTTTATTGCATGAGCATCAGTATACGTTTAAAAATTATCTCGAATCGTGGAATTCTGCACTAAAGGAGATTGGTCTCGAAATTTATCAGCTGATAGGTCTTCACGCGGAGCTACAGGAAGATATCTCTAAAAAATTTCTTGTCTATATTATAGTTGCCTATAGTCTAAAACAGCTCTATGAAAAATGGGATTTAGTTGAGTATGATGCCTCATCAGATCCTTTTTTAAATGAGTTTTTGGACCTGATCGGCGATGATGTTTTGACATTTAAAGACGTTGTTACGTTGATTGGTAACGGATGGGATACCGGCAAAGAGGACTTATTTCATGGTATAACAGCGCGAGTGATTCCTGTTTCCAGCGTTAAACCATATGAATATCTGCAGCAATATCAATTTGAGCGATTTGATCATATCCGCTCATGGCTGGAGAAGATTGGCGATGTTCCTTTAGAGACGCCGATCCATGAGGATGACCTACTGTTGACGGTCGGTGACGAAGGCGATGTATCCCGCTTGAAGATCGTGAGCAACTCAGGCCATAGTCTGAGTTTTCTGACCCGTGGCCAAAAGGCTAGCCATTTGACCGAGGATGTGAGACAGCTCTGGTTACATGGCCTGAATATCGACTGGCAGAGCTTCGTTGATGCCGGCTCGTTTACCAAGGCTTCTCTTCCTGGCTATTCCTTTGATGGCTCGCCGTTTTGGATCGAAAACAGTAGATCAGATTCACCATTCATACAAGGCGAAGGTATTAAGGCTGAGCCTGTTCAAAATTCTTACTACCATTTTGTATGGCAAGCGAGTAAGCACCCTACCGTTCTTGACCGCAAGCCTGATGTCAAGAATAATGAGGCAATTTTGCTGTTTGATAGTGATGCATCACTCGCTCAATTGTTGCGTGAACAGTGGCATGCAGAAATTATACTTATTCGGCCTGCAAGAGCATTTGATTGGAAAAGTTGGCACGATGTTGAGATCGATCCAGATAACGAAAATCATTATAAATTGGTATGTACAGCTCTTCAGCAAAAAAATCTGAGGCCTGTATGTGCGATTTTTACCTGGACGCTACAGGAGTCTACCAGTACAGGTGAAAGTTTACTGTCTCACCCCGAACCGTGGTTATCCAAGGGGATATACGCCGTTTATCACCTTCTAAAAAGTCTCTCGCAAAGCGCCCATCCACCTTTATCTCAGCTTTTATTTTTTTTTCATGGCAACGAAGGACAGGGCAATCCATTGATGGAAGCGGTCGCGGGTTACGGGCGCTCACTAAAGCTCACCTACCCGCAGATGCGTTTCCGCTCCATTCAATTTGAAACCGGTTCGCCGGATACAATCGAGGTCGTGACCGCCGTTATCAGGGAATTTTCCCTCCTAAAAGGTGAAGAACGACAAGAGGTGGACACAGAGGTCTTATATCGTCATGGGCAGCGGCTGATCAAAACCCCTGTCCGTTTACACTTGGACGCTGTGGCGCAGGCGCCTTGGAAGCAGAGTGGCGTGTATTTGATTACCGGTGGTATGGGCGCCTTAGGGTCGATTTGGGCGCGCTATCTGGCAGAGCGTTATCAAGCGCGTTTAATCCTCACCGGCCGCTCCGTCTGCCAGGGAGACATCGGGAAATCCATTCGTGTGTTCATCAAACAGCTCCAGCAATTGGGCGGTGACGCGGTTTACCTTCAGGCTGATATCACAGAGCCGCATGCTGTGCGCCAGCTTATAGAACAGGCTTATCAGGCTTTCGGCCCCGTACGAGGTTTAATTCATGCTGCCGGCCAGATGAGTGCGGTATCGTTTGCAGAAAAGTCACTGGCGGATTTTCAACAGACCTTAAGTGCAAAGATTCAAGGAACCCTGGTGTTGGACCGGGTCTTACATGAATCAATAGAAAAGCAAGCCCTGGACATCGTCATTTATTTTTCTTCCGCTGCTTCTACTTTAGGGGATTTTGGGCAATGCGATTACGCTATTGGCAACCGATTTTTGGATGGCTATGGCCGTTTCCGAGAGGGGTTGCGCACACAGGGGCAGCGCCAGGGCCGCACGGTCGTCGTCAACTGGCCCTTGTGGCGAGAAGGTGGCATGCACCTCGACTCTGAGGCTGAAGCGCTGTATCTGTCTGCTTCGGGGCTGGACTATTTAGAGGCGGAGCAGGGGTTGGACGCGCTAGATCGAATTCTCGTCAGCCCCCATACGCAGGTGATGGTCTTCGCGGGAGACCCGGCGAACATCGACCGCAATCTGGGCGTCAATAAGGTTGTCGATATGCAAGTTGATGAAACGTTTGTCGCGAGCCGCATTGAAGCAGATCTGCAACACCTGGCAGCCGTGCTGCTACAAATGCAGGCGGATGAGATCGCGCTTGATGACAACCTCAGCGCCTATGGGTTTGACTCCATTGCCATCAAAGAATTTGCCGATCAACTGAGCCAGTATTATCAACTTGAAATCTCACCTATCGTATTCTTCGCCCACGCCAGCCTTCGAAGTCTTGGCGCCTACTTTTGGGAGCATTTTGCGGCGGACATGAAAGCGTTTTATGCCGCCGAACCGTCGAACCAGATGCCCGAAGCGAGGCATGCCGAAGCACCTGCACGCCAGGTGTCACAACCCGCTCGCGCCGAAGCTGACCAGGATATCGCCATTATCGGTATGAGCGGCGTGTTCCCCGGTTCACCCGATCTCGCAACCTTCTGGAAACACCTGAGTCGTGGGCGCGATCTGGTCGGAGAAGTGCCTGCCGGGCGCTGGGATTGGCGCGTATACGATGGCGACTTGATGCGTGAGCATGAGGCGAAGAAAACCGCTATCAAATGGGGTGGTTTTATCGAGAATGTCGATCGCTTTGACGCTGATTTCTTTTCTATCTCCCGGCGCGAAGCGGAATTCATGGATCCGCAGCACCGCTTATTTTTGCAATGTGTGTGGGCGACGATCGAAGATGCCGGATACGCCACCGCCGCGTTATCGGGAGAAAACATCGGCGTCTTTGTGGGGGTCCAGTTTAGCGATTATCAACAGCTCTTGAAGCAGGCGGGAGAGCGTGGCGCACAAATTCTCACTGGCAATGCGCATTCGGTGTTAGCCAATCGAATTTCGTATCTGCTGGATGTGCGGGGGCCAAGCCTGGCCATTGATACCGCTTGCGCTAGCAGTTTGGTGGCGGTGCATCAGGGCGTCCAGGCGATACGCAATGGCGATTGTACGGCGGCCATCGTTGGCGGCGTTAGTTTGATGTTGTCGCCAGATACCTTTTTGGATATCAACCACTTGGGTGTGTTGTCCCCGGATGGGCGGTGCAAGACGTTTGATCGTAACGCCAATGGTTATGTGCGGGGCGAAGGGGTTGGCAGCTTTTTATTGAAGCCGTTGTCCCGCGCTTTGCAGGACCGCGATCCGATTCATGGCATTATTCGCGGCAGTGCGGTGCAGCATGGCGGCAAGGCGAATTCCTTAACCGCGCCGAACTCTGAAATGCAGGCGGCGTTGTTGTTAAAAGCCTATGAGGATGCTGGGATTGGCCTCGACACCGTCAGTTATATCGAAACCCACGGTACGGCGACAGAGCTAGGCGATCCCGTCGAAATTGAAGGGTTGAAACAGGCATATCGGACTTATAGACAACAGACCGGCGCGGCAGCAAGTCGGACCGGCGCCTGTGGGTTGGGGTCGGTGAAAACCAACATCGGTCATTTAGAGCCTGCGGCAGGCATTGCCGGATTGGCCAAGGTGCTATTGGCCATGCGCCATCAAATCTTGCCCGCGACATTGCACTTTGATTCGTTAAACCCCTATATCGATTTGAGCGAGAGCCCCTTTTATATCGTTGACGAAAAGACGCCGTGGCAGCGTCGGCTCGATGAGCAGGGCGAGGAGATACCGCGCCGCGCCGGCGTCAGTTCGTTCGGTTTTGGTGGTGCCATTGCGCATCTTGTGCTGGAAGAATATCGAGTGCCGCAAGACACGCTCGAAAACGGTGACGATGATACGTCGCCCTACTTGATTGTCCTGTCCGCGAAGAACGAAGCGCGGCTCAAAGAGGTGGCGACAAATTTGTATGGCCATCTCATTGAAACGGCATCAGTGGCCCCGATCAAGTTGCGCGATCTCGCCTATACCCTGCAAGTCGGGCGCGACGCCTTGCCGCAAAGACTCGCTCTGGTCGTGGACGAAACAGCGCACTTGCTTGATGGGCTGGCGGCTTATGTGCAAGGCGAACCTGATCGAGGCCGATGGTTTGCAGGTACTGCCAGGCGTGACCGCTGCCCGCTCACGTCGCTTGTCGAAGCGGGCGAGGCGATGATCGCCATGCGAATTGAAAAGGAAGCGCTGCGCGAGTTCGCGCAATCTTGGGTGCAAGGTGCGTCGATCAATTGGCAACAGATGTATCCGGTGAACAAGCCCAGGCGTCAATCTTTACCGACATATCCTTTTGCCCAACAAAGATATTGGTTTGATACATCAGCCAATACAAAGCCACAAGAACGTCATGCTGCCGTCGCACCTATTGACAATAAGTCTAACATCGAACGCATCTATTATCGTCGTGAATGGGCTCAGACGGCGTTGCTCTCCCCAGTTTCGATTGAGACGGGTGACCAAGCGCAGTTTGTCCTTCTATTTGAAACGAATCCACAAATAGGCGAGGTCTGGCAGACACAGCTAGAGCAACATGGACTGCGATGTATCAGAGTGTGTATTGGAGAGCGTTTTCGTCTACTGGAGCCACACTATTACCAACTCAACCCACGTCAATATGACGATTACGCCAGCCTGGCTCAGGCGCTTCGACAGAATGCGTCGTGGCCACGTCGCGTGGTTCACCTTTGGCAGTCAAACGAACCGGACGTCAACCATGACCAGCACCTGAGTTTGCAGTTAGAGCGGGGGTTTTATTCGCTTTGTCATTTCACTCGGGCACTCATGCAACACACGTTTGGCGATGCCTGCGACATTCTCTATAGTTATCGCGCTGAAGCCTGGCAGCCCGAGCCCGCTTGTGCAGCCGTGAGCGGTTTTGCCCACACGCTGGCCTTAGAGCATCCGGGATTTTCCTGTAAAACGATTGAGATACCCGCGTTCTTGTCTTATCGCGATGCCCGCACCATCGATCTTTTGCTGTCGGAATTGCAGGGACATGCTTTATCCGACACGACCGTTCGCTATCAGGAGCAAGGCACGTTACAGCGTTGGGTGCAGCACTTTTGTGAATGGCAAGCATCTCCAATCGAGGTTGTATCAAAATACCCGCGTCCCCACGGCGTGTATCTCATCACCGGCGCCAGCGGTAGCTTGGGGGCACAATTCGCCCGCCATATAGCGGCTCAGGTCAAAGCGACCTTTGTTCTGTGCGCCCGCTCTGAGCGAACACCCGCGTGTGAACAACTGATCAACACGCTGCGCACGATGGGTTCCGAGGCCGTCTATATTCGCTCGGATCTCTCCCAACGTGATCACGTCTTCAAACTGATTGAAGAAATTCAAGCGCGTTTTAAGGCTCTGCACGGCATTGTCCATAGTGCAGGGGTCATTAGCGACGCGCTGGTATTTAATAAAACCCATCACCAGATCGCTCAAGTCTTAGCGCCTAAGGTCTATGGTACGGTTTATCTGGATGAGGCCACTAAAGATATTCCACTCGATTTTTGGGTGTTGTTCTCTTCAACCACTGCGGTAACCGGCAATGTCGGGCAAAGTGACTATGCTTGTGCCAATCGTTTTATGGATGAGTTTGCGGTGTGGCGAGAACAATTACGCGGCATGAAACAGCGATCCGGAAAAACCCTTGCCATCAACTGGCCATACTGGCGCGACGGCGGCATGTCGATGTCCGAGCCGGGTTACCAGGGGTGGATGGAACGAACTGGGCTTCAGGCGCTGCCTACCAGCGAGGGGGTCGCGGCTTGGGATGATTTGTTGAACGCACCAAGTGGGCACGCCTATGTCGTCGCTTACGGCTTTAGGGAGTTGCTCAGTCGCATGTTTGCAAGGCCGCAGAGTGCTGCGGCGCAGCCGAGCGCTGATGAACGGGCTACATCGAGCGAGACGCTTTATGAAGACACGATGAGCTGGTTGCAACATGAAATTGCCTCGGTGGTCAAAGCATCGCCGCAAGATATTGACGTAGATACCGCCTTTCATCAATTCGGCTTGGATTCGGTCGTGATGCGTCAGACCAATGTTGTGTTGGAGAAAAAACTCGGTGCATTGCCAAAAACACTATTATTGGAATATACAACCATTCGTGACTTAACCGACCATTTATCTACACAGTATATTCGTGAACTCAATGGTGTTTTAGGAAGTGCGTTTTTAGAACAGAGCCCAAATGGTGAAAGACAAGTCCGCAAGAGAGTTGGGTCGGAAAATTCAATGCGTAACGGTATCTTTAGTGCCGAACCTATTGACAGTCAAGCACTCGAGCAGGAACAGACCAATAACTTAGAAGAGATTGCGATCGTCGGTCTGAGCGGGCGTTACCCTCAAGCAGAGGACCTGGATGAGTTTTGGGAGAACCTCAAAGCTGGAAAAAGCGCTATCGCCGACATCCCGGACAGCCGCTGGGATTACAGAGCCTATTACGATGCCGACCCTGACCAGGCGAGTAGGGGCAAGATGTATTGTTCTCAGGGTGGGTTTTTAAACGATATTGATCAATTTGATCCTCTGTTTTTTAATATCACGCCGCTGGAAGCGAAAAGCATGCCTCCCGAAGAGCGACTGATGTTGGAAACGGTGTGGTCGACATTGGAAGATGCAGGTTATGCCGGCGAACACATGCGTAGCCAGAAGGTGGGTGTTTTTGTTGGTGTGACCTCGAACACATATCCACTAGAATGCGATCATAGCGATGGTGTGCGTTATCAGTCGCCGATTGATACTTCCTATTTTAATATACCCAACCGGATTTCTTACTTTTTTAACTTTACGGGTCCCAGCATTGCCATAGATACAGCATGCTCTTCCTCATTGGTCGCCATTCACATGGCATGTGAAAGTCTGCGTCACGGCGAATGTGAGATGGCCATTGCCGGAGGTGTTAATCTTTATCTGCACCCTTCGAAATATATCTTAATGTGTCAGAAGAGACTATTATCCACCAAAATATCTACCGGTATGTTTGAAGAGGGTGGTGACGGATTTATACCTGGGGAGGGCGTGGGCGCTGTTGTACTCAAGCCGCTTACACAGGCGGTGCGCGACCGTGACAATATTTATGGTGTGATCAAAGCTTCCTCTGTTTTTCATAAAGGACGCAGTAATGGCTATTTACTACCGTCTCCTGAAAGTCAGACTGAACTCTTGCGACAGACTTTGCAACAAGCCAAGGTAGCACCGGAGACGATCAACTACATCGAGGTTCAGGCTTTAGGCTCGGAGATGGTTGATCAAGTGGAATGGCGCAGCTTGATCCAGGCTTACGGGGCTAAAGGCAAAAGTGATGAATACAAACCGTACTGTGGTTTAGGTTCATTGAAACCCAATATTGGCCATTTGGAAGCTGCTTCGGGCATTGCTCAGCTGAGCAAAGTCCTGCTGCAAATGAAATACTGCCAGTTTCTCCCCAGCAACGTCTCAGATCGCAGAGACCCGATTTTAGACGCGAGTATCAACCATCCCGATTCGCCTTTTTATTTTCAAGGTGAATGGAGGGTTTGGGAACGGGTTTCACGACAACGTGACGACACGGTTGGCCTGACAGTGCAGCCAAGGCGAGCGGGCATCAATTCTTTTGGCGCTGGGGGGGTGAACGCGCATGTGATCGTCGAAGAATATATCTCGCCAGTAGAATCCAGTCATGCGCCCCGGTTGGAGGAAGAGTCCGCCGCGCTGATTGTGGTGTCGTCAAAAACTCAACAGCAGTTGCGTCAAGCACTGGTCCGATTGAGAGCATACCTACTACGCGAGGCGAATCGTGCGGATGGGCCGTCCGATCGGGTTTCCCTTGCTGACATCGCGTTCACGCTTCAACAGGGGCGCGAAGCCTTCGCCGAGCGCTGGGCGATGGTGGCTAAAAGCAAGGCACAATTGCTAGAGTCACTCACTCGCTTTCTAGATGATAAGACCGTACATGCACCTCTTTTTGTTGGCCGTGTGCCTTCAACGAATCATGAAAATCATGTGTTCATGACTCATGATCGTATCGAAGCATTATGGCATAGTCATCAACTAGAGAAGCTTGCGCAATTGTGGAGACAAGGCCAGAATATCTCCTGGGAGCATCTCTCTTATCGCTATTCTCCGCGCCGTGTGTCACTACCAACTTACCCCTTTGAAAAACGCCACTGCTGGTGGGGAACATCGGACGATAAAGATCCTGTCGAAGTCACTGCTCAAAGTATGCCTGATCTCATTTCCCAAAAAACACATGAAACCCGAGTTAATATGTCAGATATAGGTCAAGTTGTTGCCGATTACTATGACCAAGTTACTGAATCTCTGAAACAAAAAATAGGCTCTCAAGAGGTCTATCTGCTCTTTGCCCCCTTTCAAGAGCGTGTTGAAGGCTTTTCCTGGTTGAAGATGTTTTTTGAACCTGAAAAACATCGCGAGCATTTTGAGCTGACCTTGCAAAAACAACATGAGCTCAAATCCATGCTTTACCGCCTGGTAGAGTTTGCGAACGTACATCGCATTTTTGATATTGGCTGCGGCTATGCTACCGATTTAATCCAACTCGCAAAGCGCCATCCGCAGGTGAGGGGCTGGGGTTTTAGCATCTCGCTCAATCAAGTTGAATTCGGTCAGCAGCGTATTCAAGACGAAGGTCTTGGTGAACGTGTGCAGCTCTCTTGCAACGATAGCACCAAAGACCCATTGCCAGGTCTGTTTGATTTGATTATTGGCTTCGAGGTCGTCGTACATATTGCTGATAAACAAGGCGTATTTGGCAATATGGCGCGACATCTCAGCAATAATGGTACCATTGTCCTGGCTGATTGTGTGGCCAATACTGTAACTTCCATTAACACCTCTTATATAGGGCAATATACAAGCACTGCCGAAGAGTATAGTGATATCCTAGCTCAGAATGGTTTGGCCATTGTCGACTGTGTAGATGTTGGACCTGAGATAAGTAATTTTTTATACGACCCTAATTATTTAGAGAATGCTGCTTATTTAAGTTCGATTTATCCAGAGATGGTAAATATTGAAAAAGAACATCAAGGCTGGAGTAACTTCGGAAAGGCTTTGGAGGTAAACCTGGTCCGTTATGTGCTACTTACTATTCGAAAAGCTACTGCCTCTCAAACTTATGATCATCTATTACAGATTAACCTGGAGCGCTTAGGCTCTGGAGCTCTGTCGTATGCTGAGGCGCTTCAAGCCTACCCCCATATAGAGCAAATCGTCATAGAGCAAATCGCCGAAACGAAAAGCCCTGATTCGAATGCAACTACCACATCCGTGGCAGATATCGAACAGACCATTGTGGAGCTGGCCGCTCAGGTGCTTGAAATGATGCCTGACGAAGTGAATACGCAAGCGCGCTTCATTGATTTTGGGGTAGATTCGTTGCGCGGTTTGATTTTGTTGGACGCGGTCAATCGGCGCTTAGGGCTGACTTTACAGATTCCAGTGTTGTTTGATCATTCCAGTATTCATGAATTGAGTATATATATTGCCTCCCAGCTTCCGTCTTCACCCCAAGCTGTTGTGTCCGCTCCTGCCGCCTCTGTACCCGTTGTCTCACCCGCCGTCGCGGTCAGCTCTGTGCGCTCTGTCGCTTCTAGTCATACCGCGCATTCCGATATCGCCGTGATCGGTATGTCCGGACGTTTTCCGGGGGCGCCTGATCTGCATACTTTTTGGCAAAACTTAGAGCAGGGTATCGACAGTATATCTGAAGTGCCTCCCACGCGTTGGGAGCTTACGCAGTACTATGACGCCGATCGCCGCCTACCCAACCACAGCTATAGTAAATGGGGTGGCTTCCTGGATGATGTGGATCAATTCGATCCCAAGTTTTTTAATATTTCTCCAGCCGAGGCAGAGTTGATGGATCCGCAGCAGCGGCTGTTTCTGCAAACCAGCTGGAACGCGCTGGAGGATACCGGATATGCGGGTCAAACCCTGGATGGCATGAAGTGTGGCGTCTATGTGGGGGTGTTGAATCACGCATACGATATCCTGATCGATCGCGCTAACATTTCCCAGCATCGTGCGTATGCTTTGCTGGGCAATAGTTCGTCAATTTTGGCGGCGCGCATTGCCTATCTGCTCAACCTTAAAGGCCCTGCCGTCACCCTAGACACCGCCTGTTCCTCTTCGTTGGTCGCGCTGCACTGGGCTTGTAAAAGCCTCCGGGACGACGAAGTAGATATGATGTTAGCCGGTGGGGTGACTCTTTATCTGGGGGAAAGAGAGTATATTGAGGCGAGCCAGGCGGGGATGCTCTCCCCCACGGGCAAATGCCGAGCTTTTTCTCAGGAGGCCGACGGGATCACTTTGGCAGAAGGGGTGGGTGTTGTCGTGTTGAAACGTTTAGATAAAGCTCTGCAGGATCGCGATGCGATCTACGGTGTGATCAAAGGTACCGGGATCAACCAGGATGGCAAAACGAACGGCATTACCGCGCCTAGCGCCAAATCGCAGTATGAACTGCAAACTGAGGTCTATACGCGATACGGCATTCGTCCCGAGCGCATTAGCTACGTAGAAGCGCATGGTACGGGAACAAAGTTAGGCGATCCCATTGAAGTGGAAGCATTGACGCAAAGTTTTAGGCAGTATACCCAGAAACAAAATTATTGTGCCATTGGCTCCGTCAAAAGTAATATTGGTCATACTTCTGCCGCCGCGGGCATCGCAGGCTTGATTAAAATTTTACTGAGTTTGCAGCATCATTCTATACCTCCCACACTGCATGTAGAGCATAAAAATGAACACATTAACTTTAGGGACAGTCCGTTTTACGTCAATACCCAGCTTCGTCCCTGGACCCATGAAGATGATTTGCCAAGACAGGCCGCTGTAAGCTCCTTTGGTTTTAGCGGTACAAACTGCCATGTGGTTGTGGAAGAGCCGCCCGCTCGCATTGTTCATCAACATATCGCATCAACATTAGACGCTCCCGTATTGATGGTACTTTCAGCTGCAAATCAAGATCGGCTGCGGGGCTATGTGGCGTTGATGATTCGCTATCTCGAAGCAAGAAAGACGCGTCAACATACCCGCAAGGCATGGCCATCTGACAGCCTGACTGATATCGCGTATACCCTGCAAACCGGGCGAACGCCACTAGAGCAACGTCTCGCTATGGTCGTTGCCAGTGAAGACGAATGGCTCGACAAGCTACGACGCTATGAGCGTGGCGAAAACGTGATTGATGCCTGTTACGAGGGCCAGGCAAATGCCGAGCCCGCCAAACTGGATTTGCTCATCGAGGGAGAGGAAGGTCGAGCGTTTATCGAATCTATCGTGCGCCGAAAAAACCTGTCTAAACTCGCCCAGTTATGGGTTGGCGGAACCGATATTGACTGGACCTTACTCTATCATCGCCCTTCGTCAGATGCTGCCGTGTTGCCCCAGCGAATTTCGCTGCCAGGTTACCCGTTCGCGCGAGAATCGTATTGGCTTGCCGCGCCAACGCTAGCCGCTTCTTCGTTGGTGGTCGAGCGGTTGCCCCATCAAGATGACATCTGTTTTAAAACCGTGTTGAGTGGCGATGCCTTTTTTCTGCGCGATCATTGTATCGACAGGCAAAAAGTCTTACCCGGTGTCGTTTATTTGGAAATGGCCAGGAAAGCAGCTACCAGCTTTCGTCCTGATGCCCCGCAGCCCGTACTCAAAAATGTGATTTGGCTTCGTCCACTCATGGTCAATGCGACAGATGTCGTGGCCTACACACGTCTGAAGCAACAGGCGCAGCGGATTGATTTTGAAATTTCAACCTTGGATGAGCAGAACAACCGGGTGCTACATGCTCAGGGACAATTGCACGATCCGGAGCCGGTTACGCCACAGCATCCGGATTGGCCCTCATTTGATCTTCGGCTTATTCAAGAGCGTTGCCCACGTACGCTAGAAGGCGAAGCGTTTTTCCAGGCCATACAGGCGCAGGGCTTTCGTACCGGGCCGAGTTTTCAGGTGGTCCGGAAAGCCTGGTATAACCAAACCGAAGCTCTGTGTGAGTTGGGCCTGCCGGCGTTGCGCGAAGCTGATTTTCAAGACTACCTACTGCATCCTTCACTCGTCAATGCCGCACTGGAGTCGGTGATTCTATTGATCGCGAAGGACCCCTCGGCATCTGACGCTCCTCATCTTCCCTACACGTTGGGCACATGGGCATATGACGACACGGTTTGGCCGACATCGCTATATGCGTATGCGCGACTGACCGCACCTCAGCCGGAGACAGAGGCTTTGACTGCCGCTACCACGGTTCAACGGTATGAGATCAATCTGTTGGATCGCAGCGGCAGACTGATCGCACGCGGCAAAGATTTTTGTGTTCGTGCGTTGCGCTCAAGTGGCGAGACACGGCCTGCCAGCTCCGCGGCCCAGTATCCGGTCAAGTATTATTATCCGCGGTGGGAGGCATGTGAAAACGAACGTGTCGCGGCCAATATTGTAGTTGAGCGCAGTTGGCTGGTGTTTGAAACCGAGAATTCGCTCTGGCATGCGCTGGATGAAAAACTGCGTGCGTTGGGTGTCACATGCATTCAGGTTAGACCCGGTTACCGGTTTCAGGTCTTGGAAAAAAGGCGCTACGAAATTCACCCCGAGCGGGCTGGTGACTACCAAAAACTGGTCGCTGAACTCAAACGCAACCACGCAATCCCCGAGCGTATTATTCACGCGTGGTCGGAAGAGCAATGGTGTGACAACGCCGAGCTCGATCCACGATCACTGGCGTGGGGTTTCTATTCCGTGTTTTATCTGAGTCAGGCCTTGATCTCCTGTTGGCAAGATACGCCGCTTCACTTGCTGTATCTCTATCGTCAAGATCAGGACTCACCACAGGCCCACTACGCGGCGGTTCGTGGCTTTGCTCAGTCCCTCACGCATGAACGATTGGATTGGCATTGGAAAACCCTGGCTTTGCCCACCACCCTGCCGCAAGCCCAAGTCGCTAACATGTTATGGGATGAGCTACGGTATGCAAATCAACTGGAGCGCGAAATTCGCTATGACGCAAATCGGCAACGTTGGGTGAGGCGTTGGCATGCAGGTGAAGGGACACCTGGTCAAGGGCCAGCCGCACCCGACACGAGTTTGCTGCGCCAACAAGGCGTATACCTGATTACTGGTGGGGGTGGCGGCCTTAGCCTGCTACTGGGGGAATATCTGGCGCGCGAGTATCAGGCCAAAGTCATTCTCGTAGGCAGAGCCGAGGGGACTGAAGCGCAACAAGCGAAGATAGACAGTTGGAAACGATGGGGGGGAGAAGCGCTCTATTTACAAGGGGATATCTCCCGGCGAGAGGATGTGGATCATGTCATGGCACAGTTGCGCTCTCGCTTTCCTGTCTTGCACGGTGTTTTTCATGCGGCGGGACTCACGCGTGATGCTTCTCTTGTCAACAAAACCGTCCGTGACATCGACGAGGTGCTGGCAGCTAAGGTTTACGGAACCATTTACCTGGATCAAGCTACCCGTAGTGAAGAATTGGACTTTTTTGTCTTATTTTCGTCTCTATCCGGAGTCGTTGGTAATATAGGGCAATCTGACTATGCTTATGCCAATAGCTTTTTGGATCATTTTGCCGAGCGTCGCGAAGCACAACGGAGTATGCAAAAGCGTTTTGGTTTAACGGTTGCAATTGATTGGCCACTGTGGCGTCATGGCACGATGCAGGTAGATGCTACGACCGAGAAATTTCTGGCGCGCTCGATCGGTATGCAGGCGCTAGAGACCGATGACGGTTGGATGGCCCTACAACATGCCTTGGCGGGTTCGAAGAGCCAACTCCTGGTGCTGTGTGGCGATCAGGGGCGATTTAGCCAGGCCTTGGGCGTACAGCAACATCATACAGTTGCCGAGCGGGCTGAGAGCCCGAGTGAAAACCTAAGTGAGACCTCGAGCTTCGATTTACTAACGCATTTGCAGATTGACCTCAGGTCCATCATGGCTGCCGTACTCAAGCTGAGCCCTCAGGAGATCGAGTGGGAGCGTGAGATGAGCAGCTTTGGCTTTGATTCCATTTCGTTTGTCGCTTTGGCTAACGAGTTGAATGATACTTTCGAGTTGGATCTTTTGCCTGCCGTGTTTTTTGAGTGTTTGAACGCTGGTGATTTGCTCAAACACTTGCACCACCACCACTGTGACGCCTTATTTGCGTATTACCGTAGACGTGTGCCTGAACCTGCGGCGCAAGAAGTGTTAGGTACGCCGGGACAAGCCAACGTTGAGGGGCCGGTTCATGTACGTCAATTGGAAAAACCGAGCGGCCTTAATCACCATGCCGGCACAGAGCCGATAGCCATTGTTGGCATGAGTGCTGTGATGCCGCAGTCCCCCGACCTGGAGACGTTTTGGCAGCACCTGGCGGCGGGGCAGGATTTGATCACAGAGATCCCCAAAGACCGATGGGACTGGCAAAACGCAGGAGGTGATACGACGATTCGCTGGGGCGGTTTTATGCCGGATATCGATCAATTCGACGCGCTGTTTTTTGGTATTTCGCCTCGTGAAGCCGACCTGATGGACCCGCAGCAACGCCTGTTGCTTCAGACCGTGTGGAAAACCATCGAGCACGCGGGTTACAAAGCCTCGGATTTATCCGGGAGCGATACCGGCGTTTTTGTCGGAGTTGCCAATTCCGATTATCGCGAGCTGATCCATGCGGCAGGGCCTGGGATCGATGCGCAAAGCTCTACCGGAACGTTTTCCTCGATCTTAGCCAATCGGGTGTCGTACATTTTCAATTTTACCGGCCCAAGCGAGCCCATTGACACGGCTTGCTCCAGCTCTTTGGTGGCGCTCCACCACGCGTTGAATGCGTTATCCCGTGGCGAATGCTCCAGCGCCATCGTTGGTGGCGTGAATGCGTTGTTAACCCCAACCCTCCATATTACCAGCAACAAGACCGGCATGTTGAGCCACGATGGGCGCTGCAAAACCTTTGATCAAGCGGCGAATGGCTATGTGCGGGGAGAGGGGGTTGCCGCGCTCTTGTTAAAACCGCTCAGCCTGGCTAAAGCGCAGGGGGACGAAATTTATGCGCTGATTCAAGGTAGCAATGTAAACCATGGTGGACACGCCACCTCCCTCACTGCGCCCAACCCCCGGGCACAGGCTGAATTGCTGATCCACGCCTATGAAGATGCAGGTATCGACCCCACAACCGTCACCTATATTGAAACCCATGGCACCGGAACAAGCCTGGGGGATCCGATTGAAATCAGTGGTTTAAAGCAGGCTTTTGCCACTTTGTATGAGCGTTTTGGTCACGTGGCCGATGTTTCCGCTTACCATCGGTGTGGTCTTGGCTCTGTTAAAACCAATGTCGGTCACCTGGAAGCAGCAGCAGGCATGGCTGGACTGCTCAAAGTGGTTTTAGCCATGCATCACAAAACCTTACCTGCACATCTTCATTTTCATAACCTCAACCCGTATATCGATTTGAGCGGCAGTCCTTTCTATATTACCCGGCAAACTTGTTCCTGGGACGCTTTACAAGATGCTGCCGGTAAGGCGCTTCCCCGGCGTGCCGGTGTCAGCTCGTTTGGTTTTGGTGGCGTCAATGCACATGTCATTGTTGAGGAATATGTTGAGGACCGGCATGAAGACAGATAG", "orf_prot_sequence": "MEAKDIAVIGVGVLFPGASHHDLFWENLIAGIDSIQEIPVSRWDIDAYYSPDFNEPGKSISKWGGLIQGIDQFDHQFFNISPREARNMDPQQRLLLQEAWHCVEDSGIALKTLQEKVTSVFVGVMAIDYHQHMAQSRQPVDSYACLGNYGSILANRLSFCLGLSGESKAIDAACASSLVAVHDARRSLQAGECDYAIAAGVSVICHPWKYISFSKSRMLSPSGRCKTFDKSADGYVPGEGVGVLLMQSLERAQEQKCHIYGVLKGSALNNNGLHGQRHADDRGRKKASITAPSIDAQRRVITDALRSADIDPASVSYVEAHGTGTSLGDPIEIEALKQVFAVPGRTTPSCAIGSVKTNIGHLEAAAGVAGVIKVLLMMKHKMIPQVLHLNTVNPMIDLTDTSLYLSDQLHSWESKEGIQRRAGVSSFGFGGSNAHAIFEEYVDTRHTPQGTLQRTSGEHLFVLSAKSHSSLDGLLNDWVAFLNHPQRSAISLEDMCATLMTGRESFPFRFALSVTDKKALRSALISPPESAFGHAEMPSVLLRIGSVNAEQAAVIASWYRKHPGFREPFDACRRLAKMLCSEEAVRDWTAQFPKVLAEHEALYGFAAAYATARLLLDSGVQPRLICGEGIGHGVALCLSGLWTLSQGLRHAMRLIDQLDLSPQRLDYPIYDQIQGTTLSPYQPSRGYLQALLKNIQVRDDLFIRDLQKALLLHEHQYTFKNYLESWNSALKEIGLEIYQLIGLHAELQEDISKKFLVYIIVAYSLKQLYEKWDLVEYDASSDPFLNEFLDLIGDDVLTFKDVVTLIGNGWDTGKEDLFHGITARVIPVSSVKPYEYLQQYQFERFDHIRSWLEKIGDVPLETPIHEDDLLLTVGDEGDVSRLKIVSNSGHSLSFLTRGQKASHLTEDVRQLWLHGLNIDWQSFVDAGSFTKASLPGYSFDGSPFWIENSRSDSPFIQGEGIKAEPVQNSYYHFVWQASKHPTVLDRKPDVKNNEAILLFDSDASLAQLLREQWHAEIILIRPARAFDWKSWHDVEIDPDNENHYKLVCTALQQKNLRPVCAIFTWTLQESTSTGESLLSHPEPWLSKGIYAVYHLLKSLSQSAHPPLSQLLFFFHGNEGQGNPLMEAVAGYGRSLKLTYPQMRFRSIQFETGSPDTIEVVTAVIREFSLLKGEERQEVDTEVLYRHGQRLIKTPVRLHLDAVAQAPWKQSGVYLITGGMGALGSIWARYLAERYQARLILTGRSVCQGDIGKSIRVFIKQLQQLGGDAVYLQADITEPHAVRQLIEQAYQAFGPVRGLIHAAGQMSAVSFAEKSLADFQQTLSAKIQGTLVLDRVLHESIEKQALDIVIYFSSAASTLGDFGQCDYAIGNRFLDGYGRFREGLRTQGQRQGRTVVVNWPLWREGGMHLDSEAEALYLSASGLDYLEAEQGLDALDRILVSPHTQVMVFAGDPANIDRNLGVNKVVDMQVDETFVASRIEADLQHLAAVLLQMQADEIALDDNLSAYGFDSIAIKEFADQLSQYYQLEISPIVFFAHASLRSLGAYFWEHFAADMKAFYAAEPSNQMPEARHAEAPARQVSQPARAEADQDIAIIGMSGVFPGSPDLATFWKHLSRGRDLVGEVPAGRWDWRVYDGDLMREHEAKKTAIKWGGFIENVDRFDADFFSISRREAEFMDPQHRLFLQCVWATIEDAGYATAALSGENIGVFVGVQFSDYQQLLKQAGERGAQILTGNAHSVLANRISYLLDVRGPSLAIDTACASSLVAVHQGVQAIRNGDCTAAIVGGVSLMLSPDTFLDINHLGVLSPDGRCKTFDRNANGYVRGEGVGSFLLKPLSRALQDRDPIHGIIRGSAVQHGGKANSLTAPNSEMQAALLLKAYEDAGIGLDTVSYIETHGTATELGDPVEIEGLKQAYRTYRQQTGAAASRTGACGLGSVKTNIGHLEPAAGIAGLAKVLLAMRHQILPATLHFDSLNPYIDLSESPFYIVDEKTPWQRRLDEQGEEIPRRAGVSSFGFGGAIAHLVLEEYRVPQDTLENGDDDTSPYLIVLSAKNEARLKEVATNLYGHLIETASVAPIKLRDLAYTLQVGRDALPQRLALVVDETAHLLDGLAAYVQGEPDRGRWFAGTARRDRCPLTSLVEAGEAMIAMRIEKEALREFAQSWVQGASINWQQMYPVNKPRRQSLPTYPFAQQRYWFDTSANTKPQERHAAVAPIDNKSNIERIYYRREWAQTALLSPVSIETGDQAQFVLLFETNPQIGEVWQTQLEQHGLRCIRVCIGERFRLLEPHYYQLNPRQYDDYASLAQALRQNASWPRRVVHLWQSNEPDVNHDQHLSLQLERGFYSLCHFTRALMQHTFGDACDILYSYRAEAWQPEPACAAVSGFAHTLALEHPGFSCKTIEIPAFLSYRDARTIDLLLSELQGHALSDTTVRYQEQGTLQRWVQHFCEWQASPIEVVSKYPRPHGVYLITGASGSLGAQFARHIAAQVKATFVLCARSERTPACEQLINTLRTMGSEAVYIRSDLSQRDHVFKLIEEIQARFKALHGIVHSAGVISDALVFNKTHHQIAQVLAPKVYGTVYLDEATKDIPLDFWVLFSSTTAVTGNVGQSDYACANRFMDEFAVWREQLRGMKQRSGKTLAINWPYWRDGGMSMSEPGYQGWMERTGLQALPTSEGVAAWDDLLNAPSGHAYVVAYGFRELLSRMFARPQSAAAQPSADERATSSETLYEDTMSWLQHEIASVVKASPQDIDVDTAFHQFGLDSVVMRQTNVVLEKKLGALPKTLLLEYTTIRDLTDHLSTQYIRELNGVLGSAFLEQSPNGERQVRKRVGSENSMRNGIFSAEPIDSQALEQEQTNNLEEIAIVGLSGRYPQAEDLDEFWENLKAGKSAIADIPDSRWDYRAYYDADPDQASRGKMYCSQGGFLNDIDQFDPLFFNITPLEAKSMPPEERLMLETVWSTLEDAGYAGEHMRSQKVGVFVGVTSNTYPLECDHSDGVRYQSPIDTSYFNIPNRISYFFNFTGPSIAIDTACSSSLVAIHMACESLRHGECEMAIAGGVNLYLHPSKYILMCQKRLLSTKISTGMFEEGGDGFIPGEGVGAVVLKPLTQAVRDRDNIYGVIKASSVFHKGRSNGYLLPSPESQTELLRQTLQQAKVAPETINYIEVQALGSEMVDQVEWRSLIQAYGAKGKSDEYKPYCGLGSLKPNIGHLEAASGIAQLSKVLLQMKYCQFLPSNVSDRRDPILDASINHPDSPFYFQGEWRVWERVSRQRDDTVGLTVQPRRAGINSFGAGGVNAHVIVEEYISPVESSHAPRLEEESAALIVVSSKTQQQLRQALVRLRAYLLREANRADGPSDRVSLADIAFTLQQGREAFAERWAMVAKSKAQLLESLTRFLDDKTVHAPLFVGRVPSTNHENHVFMTHDRIEALWHSHQLEKLAQLWRQGQNISWEHLSYRYSPRRVSLPTYPFEKRHCWWGTSDDKDPVEVTAQSMPDLISQKTHETRVNMSDIGQVVADYYDQVTESLKQKIGSQEVYLLFAPFQERVEGFSWLKMFFEPEKHREHFELTLQKQHELKSMLYRLVEFANVHRIFDIGCGYATDLIQLAKRHPQVRGWGFSISLNQVEFGQQRIQDEGLGERVQLSCNDSTKDPLPGLFDLIIGFEVVVHIADKQGVFGNMARHLSNNGTIVLADCVANTVTSINTSYIGQYTSTAEEYSDILAQNGLAIVDCVDVGPEISNFLYDPNYLENAAYLSSIYPEMVNIEKEHQGWSNFGKALEVNLVRYVLLTIRKATASQTYDHLLQINLERLGSGALSYAEALQAYPHIEQIVIEQIAETKSPDSNATTTSVADIEQTIVELAAQVLEMMPDEVNTQARFIDFGVDSLRGLILLDAVNRRLGLTLQIPVLFDHSSIHELSIYIASQLPSSPQAVVSAPAASVPVVSPAVAVSSVRSVASSHTAHSDIAVIGMSGRFPGAPDLHTFWQNLEQGIDSISEVPPTRWELTQYYDADRRLPNHSYSKWGGFLDDVDQFDPKFFNISPAEAELMDPQQRLFLQTSWNALEDTGYAGQTLDGMKCGVYVGVLNHAYDILIDRANISQHRAYALLGNSSSILAARIAYLLNLKGPAVTLDTACSSSLVALHWACKSLRDDEVDMMLAGGVTLYLGEREYIEASQAGMLSPTGKCRAFSQEADGITLAEGVGVVVLKRLDKALQDRDAIYGVIKGTGINQDGKTNGITAPSAKSQYELQTEVYTRYGIRPERISYVEAHGTGTKLGDPIEVEALTQSFRQYTQKQNYCAIGSVKSNIGHTSAAAGIAGLIKILLSLQHHSIPPTLHVEHKNEHINFRDSPFYVNTQLRPWTHEDDLPRQAAVSSFGFSGTNCHVVVEEPPARIVHQHIASTLDAPVLMVLSAANQDRLRGYVALMIRYLEARKTRQHTRKAWPSDSLTDIAYTLQTGRTPLEQRLAMVVASEDEWLDKLRRYERGENVIDACYEGQANAEPAKLDLLIEGEEGRAFIESIVRRKNLSKLAQLWVGGTDIDWTLLYHRPSSDAAVLPQRISLPGYPFARESYWLAAPTLAASSLVVERLPHQDDICFKTVLSGDAFFLRDHCIDRQKVLPGVVYLEMARKAATSFRPDAPQPVLKNVIWLRPLMVNATDVVAYTRLKQQAQRIDFEISTLDEQNNRVLHAQGQLHDPEPVTPQHPDWPSFDLRLIQERCPRTLEGEAFFQAIQAQGFRTGPSFQVVRKAWYNQTEALCELGLPALREADFQDYLLHPSLVNAALESVILLIAKDPSASDAPHLPYTLGTWAYDDTVWPTSLYAYARLTAPQPETEALTAATTVQRYEINLLDRSGRLIARGKDFCVRALRSSGETRPASSAAQYPVKYYYPRWEACENERVAANIVVERSWLVFETENSLWHALDEKLRALGVTCIQVRPGYRFQVLEKRRYEIHPERAGDYQKLVAELKRNHAIPERIIHAWSEEQWCDNAELDPRSLAWGFYSVFYLSQALISCWQDTPLHLLYLYRQDQDSPQAHYAAVRGFAQSLTHERLDWHWKTLALPTTLPQAQVANMLWDELRYANQLEREIRYDANRQRWVRRWHAGEGTPGQGPAAPDTSLLRQQGVYLITGGGGGLSLLLGEYLAREYQAKVILVGRAEGTEAQQAKIDSWKRWGGEALYLQGDISRREDVDHVMAQLRSRFPVLHGVFHAAGLTRDASLVNKTVRDIDEVLAAKVYGTIYLDQATRSEELDFFVLFSSLSGVVGNIGQSDYAYANSFLDHFAERREAQRSMQKRFGLTVAIDWPLWRHGTMQVDATTEKFLARSIGMQALETDDGWMALQHALAGSKSQLLVLCGDQGRFSQALGVQQHHTVAERAESPSENLSETSSFDLLTHLQIDLRSIMAAVLKLSPQEIEWEREMSSFGFDSISFVALANELNDTFELDLLPAVFFECLNAGDLLKHLHHHHCDALFAYYRRRVPEPAAQEVLGTPGQANVEGPVHVRQLEKPSGLNHHAGTEPIAIVGMSAVMPQSPDLETFWQHLAAGQDLITEIPKDRWDWQNAGGDTTIRWGGFMPDIDQFDALFFGISPREADLMDPQQRLLLQTVWKTIEHAGYKASDLSGSDTGVFVGVANSDYRELIHAAGPGIDAQSSTGTFSSILANRVSYIFNFTGPSEPIDTACSSSLVALHHALNALSRGECSSAIVGGVNALLTPTLHITSNKTGMLSHDGRCKTFDQAANGYVRGEGVAALLLKPLSLAKAQGDEIYALIQGSNVNHGGHATSLTAPNPRAQAELLIHAYEDAGIDPTTVTYIETHGTGTSLGDPIEISGLKQAFATLYERFGHVADVSAYHRCGLGSVKTNVGHLEAAAGMAGLLKVVLAMHHKTLPAHLHFHNLNPYIDLSGSPFYITRQTCSWDALQDAAGKALPRRAGVSSFGFGGVNAHVIVEEYVEDRHEDR", "perc_identity": 37.5}, "gnl|BL_ORD_ID|1968|hsp_num:0": {"type_match": "Loose", "snp": {"original": "F", "change": "L", "position": 413}, "query_snp": {"original": "F", "change": "L", "position": 352}, "orf_strand": "+", "orf_start": 15190, "orf_end": 33063, "orf_from": "BGC0001186.1|Misakinolide_15 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.55205e-11, "bit_score": 65.4698, "max_identities": 104, "cvterm_id": "39507", "query": "SPDLATFWKHLSRGRDLVGEVP---AGRWDWRVYDGDLMREHEAKKTAIKWGGFIENVDRFDADFFSISRREAEFMDPQHRLFLQCVWATIEDAGYATAALSGENIGVFVGVQFSDYQQ------LLKQAGER-----GAQILTGNAHSVLANRISYLLDVRGPSLAIDTACASSLVAVHQGVQAIRNGDCTAAIVGGVSLMLSPDTFLDINHLGVLS-----PDGRCKTFDRNANGYVRGEGVGSFLL------------KPLSRALQDRDPIHGIIRGSAVQHGGKANSLTAPNSEMQAA--LLLKAYEDAGIGLDTVSYIETHGTATELGDPVEIEGLKQAYRTYRQQTGAAASRTGACGLGSV---KTNIGHLEPAAGIAGLAKVLLAMRHQILPATLHFDSLNPYIDLSESPFYIVDEKTPWQRRLDEQGEEIPRRAGVSSFGFGGAIAHLVLEEY", "match": "SPD+ + WK L  G   +  +      +WD                 A+K GG ++  D  D+    +  R   ++    +L    +W   E AG  +  +  +   V VG      ++      L+   G R       Q++  N  + +   I   L  R   +   +AC+S   A+    + I  GD   A+ GGV   +        + +  +S     P+   + FD++ +G+V GE  G+ +L            KPL+R L           G+ +     A  + AP ++   A   + ++ E AG+    + ++  HGTAT +GD  E                A A R   C   +V   K+ +GH   A G       +L +R  ++P TL++++ +P IDL         +    + R  +      R A  +SFGFGG    L    Y", "sequence_from_db": "SPDIESTWKGLLAGESGIHALEDEFVTKWDL----------------AVKIGGHLK--DPVDSHMGRLDMRRMSYVQRMGKLLGGQLW---ESAG--SPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAV---IGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGE-AGALMLIETEEHAKARGAKPLARLL-----------GAGITS--DAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAE----------------ANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDL---------DVVAGEPRYGDY-----RYAVNNSFGFGGHNVALAFGRY", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 19996, "query_end": 21270, "hit_start": 75, "hit_end": 1248, "orf_dna_sequence": "TTGGAGGCCAAGGACATTGCTGTCATTGGAGTGGGGGTTCTATTTCCTGGTGCCAGTCATCATGACCTGTTTTGGGAAAATTTAATTGCTGGTATTGATAGTATTCAGGAGATACCTGTATCTCGCTGGGACATAGACGCCTATTATTCACCTGATTTTAATGAACCGGGAAAAAGTATTAGTAAATGGGGCGGACTGATTCAGGGGATTGATCAATTTGATCACCAGTTTTTTAATATTTCCCCGCGTGAAGCGCGGAATATGGACCCGCAACAACGTTTATTATTACAGGAAGCCTGGCACTGCGTCGAAGACTCCGGTATTGCCCTCAAAACCCTTCAGGAAAAAGTCACTTCCGTATTTGTTGGGGTCATGGCGATTGACTACCATCAGCATATGGCACAGAGCCGTCAGCCTGTGGATAGCTACGCCTGCCTTGGGAATTACGGCTCTATATTAGCGAACCGTCTATCGTTTTGCCTCGGGTTGAGCGGGGAGAGTAAAGCCATTGATGCTGCTTGTGCCTCATCATTGGTGGCAGTCCATGATGCGAGACGGAGTTTACAGGCAGGAGAATGTGACTATGCGATTGCCGCCGGCGTGAGTGTGATCTGTCATCCCTGGAAGTATATTTCCTTCTCGAAATCTCGCATGTTGAGTCCCTCCGGGAGATGCAAAACCTTTGATAAGAGTGCTGATGGGTATGTACCCGGCGAAGGGGTGGGCGTTCTTCTCATGCAATCGCTGGAAAGAGCGCAGGAGCAGAAATGCCACATTTATGGTGTTTTAAAAGGCTCGGCGCTCAACAACAATGGTCTTCATGGACAAAGACACGCTGACGACCGGGGCAGAAAAAAGGCGTCCATCACTGCCCCCAGCATAGACGCCCAGCGCCGGGTCATTACCGACGCGTTGCGTAGTGCGGATATTGACCCGGCGAGTGTGAGCTACGTGGAAGCCCACGGCACGGGGACATCCCTGGGAGATCCCATTGAAATTGAAGCCTTAAAACAGGTATTCGCTGTCCCTGGTCGGACAACACCGTCTTGTGCTATCGGCTCGGTAAAAACCAATATTGGTCACTTGGAAGCCGCTGCTGGAGTCGCGGGCGTGATCAAGGTGCTCTTGATGATGAAGCACAAAATGATTCCCCAAGTGCTTCATCTCAATACCGTGAATCCGATGATTGATTTGACAGATACGTCTCTTTATCTAAGCGATCAGCTACACTCTTGGGAGTCTAAAGAGGGCATTCAACGCAGAGCGGGGGTGAGTTCCTTTGGTTTTGGTGGAAGCAATGCCCATGCCATTTTCGAGGAGTATGTCGATACGCGACATACTCCTCAAGGTACACTTCAGCGCACGAGTGGCGAGCACCTGTTTGTCTTATCTGCAAAATCCCACTCAAGTCTAGATGGCCTGTTAAACGATTGGGTCGCGTTCCTTAACCACCCCCAGCGCTCTGCGATATCGCTTGAGGATATGTGCGCAACGCTCATGACGGGACGGGAATCGTTTCCGTTCCGCTTTGCGCTGTCCGTGACAGATAAAAAGGCGTTGCGCTCAGCCCTCATCTCACCACCGGAGAGCGCTTTCGGCCATGCAGAGATGCCGTCCGTACTGTTGCGTATTGGCTCTGTCAATGCCGAGCAAGCCGCGGTGATTGCCTCCTGGTATCGCAAGCATCCAGGATTTCGCGAGCCTTTTGATGCTTGTCGTCGCTTGGCTAAAATGCTTTGCAGTGAGGAGGCCGTTCGCGACTGGACGGCCCAATTTCCCAAGGTGTTGGCCGAGCATGAAGCTCTGTATGGTTTTGCCGCTGCCTATGCGACTGCGCGTTTACTGTTAGATTCGGGGGTGCAGCCACGCTTAATCTGTGGCGAGGGGATTGGCCATGGTGTTGCTTTATGTCTTAGTGGGCTGTGGACGCTCTCCCAAGGGCTAAGGCATGCGATGAGGTTGATCGATCAGCTCGATCTAAGCCCACAGCGCTTAGATTACCCCATTTATGACCAGATTCAAGGCACAACTTTGTCGCCTTATCAGCCTAGCAGAGGTTATTTGCAGGCCTTGTTGAAGAATATTCAGGTAAGAGATGACCTCTTCATCAGAGACTTGCAAAAAGCCCTTTTATTGCATGAGCATCAGTATACGTTTAAAAATTATCTCGAATCGTGGAATTCTGCACTAAAGGAGATTGGTCTCGAAATTTATCAGCTGATAGGTCTTCACGCGGAGCTACAGGAAGATATCTCTAAAAAATTTCTTGTCTATATTATAGTTGCCTATAGTCTAAAACAGCTCTATGAAAAATGGGATTTAGTTGAGTATGATGCCTCATCAGATCCTTTTTTAAATGAGTTTTTGGACCTGATCGGCGATGATGTTTTGACATTTAAAGACGTTGTTACGTTGATTGGTAACGGATGGGATACCGGCAAAGAGGACTTATTTCATGGTATAACAGCGCGAGTGATTCCTGTTTCCAGCGTTAAACCATATGAATATCTGCAGCAATATCAATTTGAGCGATTTGATCATATCCGCTCATGGCTGGAGAAGATTGGCGATGTTCCTTTAGAGACGCCGATCCATGAGGATGACCTACTGTTGACGGTCGGTGACGAAGGCGATGTATCCCGCTTGAAGATCGTGAGCAACTCAGGCCATAGTCTGAGTTTTCTGACCCGTGGCCAAAAGGCTAGCCATTTGACCGAGGATGTGAGACAGCTCTGGTTACATGGCCTGAATATCGACTGGCAGAGCTTCGTTGATGCCGGCTCGTTTACCAAGGCTTCTCTTCCTGGCTATTCCTTTGATGGCTCGCCGTTTTGGATCGAAAACAGTAGATCAGATTCACCATTCATACAAGGCGAAGGTATTAAGGCTGAGCCTGTTCAAAATTCTTACTACCATTTTGTATGGCAAGCGAGTAAGCACCCTACCGTTCTTGACCGCAAGCCTGATGTCAAGAATAATGAGGCAATTTTGCTGTTTGATAGTGATGCATCACTCGCTCAATTGTTGCGTGAACAGTGGCATGCAGAAATTATACTTATTCGGCCTGCAAGAGCATTTGATTGGAAAAGTTGGCACGATGTTGAGATCGATCCAGATAACGAAAATCATTATAAATTGGTATGTACAGCTCTTCAGCAAAAAAATCTGAGGCCTGTATGTGCGATTTTTACCTGGACGCTACAGGAGTCTACCAGTACAGGTGAAAGTTTACTGTCTCACCCCGAACCGTGGTTATCCAAGGGGATATACGCCGTTTATCACCTTCTAAAAAGTCTCTCGCAAAGCGCCCATCCACCTTTATCTCAGCTTTTATTTTTTTTTCATGGCAACGAAGGACAGGGCAATCCATTGATGGAAGCGGTCGCGGGTTACGGGCGCTCACTAAAGCTCACCTACCCGCAGATGCGTTTCCGCTCCATTCAATTTGAAACCGGTTCGCCGGATACAATCGAGGTCGTGACCGCCGTTATCAGGGAATTTTCCCTCCTAAAAGGTGAAGAACGACAAGAGGTGGACACAGAGGTCTTATATCGTCATGGGCAGCGGCTGATCAAAACCCCTGTCCGTTTACACTTGGACGCTGTGGCGCAGGCGCCTTGGAAGCAGAGTGGCGTGTATTTGATTACCGGTGGTATGGGCGCCTTAGGGTCGATTTGGGCGCGCTATCTGGCAGAGCGTTATCAAGCGCGTTTAATCCTCACCGGCCGCTCCGTCTGCCAGGGAGACATCGGGAAATCCATTCGTGTGTTCATCAAACAGCTCCAGCAATTGGGCGGTGACGCGGTTTACCTTCAGGCTGATATCACAGAGCCGCATGCTGTGCGCCAGCTTATAGAACAGGCTTATCAGGCTTTCGGCCCCGTACGAGGTTTAATTCATGCTGCCGGCCAGATGAGTGCGGTATCGTTTGCAGAAAAGTCACTGGCGGATTTTCAACAGACCTTAAGTGCAAAGATTCAAGGAACCCTGGTGTTGGACCGGGTCTTACATGAATCAATAGAAAAGCAAGCCCTGGACATCGTCATTTATTTTTCTTCCGCTGCTTCTACTTTAGGGGATTTTGGGCAATGCGATTACGCTATTGGCAACCGATTTTTGGATGGCTATGGCCGTTTCCGAGAGGGGTTGCGCACACAGGGGCAGCGCCAGGGCCGCACGGTCGTCGTCAACTGGCCCTTGTGGCGAGAAGGTGGCATGCACCTCGACTCTGAGGCTGAAGCGCTGTATCTGTCTGCTTCGGGGCTGGACTATTTAGAGGCGGAGCAGGGGTTGGACGCGCTAGATCGAATTCTCGTCAGCCCCCATACGCAGGTGATGGTCTTCGCGGGAGACCCGGCGAACATCGACCGCAATCTGGGCGTCAATAAGGTTGTCGATATGCAAGTTGATGAAACGTTTGTCGCGAGCCGCATTGAAGCAGATCTGCAACACCTGGCAGCCGTGCTGCTACAAATGCAGGCGGATGAGATCGCGCTTGATGACAACCTCAGCGCCTATGGGTTTGACTCCATTGCCATCAAAGAATTTGCCGATCAACTGAGCCAGTATTATCAACTTGAAATCTCACCTATCGTATTCTTCGCCCACGCCAGCCTTCGAAGTCTTGGCGCCTACTTTTGGGAGCATTTTGCGGCGGACATGAAAGCGTTTTATGCCGCCGAACCGTCGAACCAGATGCCCGAAGCGAGGCATGCCGAAGCACCTGCACGCCAGGTGTCACAACCCGCTCGCGCCGAAGCTGACCAGGATATCGCCATTATCGGTATGAGCGGCGTGTTCCCCGGTTCACCCGATCTCGCAACCTTCTGGAAACACCTGAGTCGTGGGCGCGATCTGGTCGGAGAAGTGCCTGCCGGGCGCTGGGATTGGCGCGTATACGATGGCGACTTGATGCGTGAGCATGAGGCGAAGAAAACCGCTATCAAATGGGGTGGTTTTATCGAGAATGTCGATCGCTTTGACGCTGATTTCTTTTCTATCTCCCGGCGCGAAGCGGAATTCATGGATCCGCAGCACCGCTTATTTTTGCAATGTGTGTGGGCGACGATCGAAGATGCCGGATACGCCACCGCCGCGTTATCGGGAGAAAACATCGGCGTCTTTGTGGGGGTCCAGTTTAGCGATTATCAACAGCTCTTGAAGCAGGCGGGAGAGCGTGGCGCACAAATTCTCACTGGCAATGCGCATTCGGTGTTAGCCAATCGAATTTCGTATCTGCTGGATGTGCGGGGGCCAAGCCTGGCCATTGATACCGCTTGCGCTAGCAGTTTGGTGGCGGTGCATCAGGGCGTCCAGGCGATACGCAATGGCGATTGTACGGCGGCCATCGTTGGCGGCGTTAGTTTGATGTTGTCGCCAGATACCTTTTTGGATATCAACCACTTGGGTGTGTTGTCCCCGGATGGGCGGTGCAAGACGTTTGATCGTAACGCCAATGGTTATGTGCGGGGCGAAGGGGTTGGCAGCTTTTTATTGAAGCCGTTGTCCCGCGCTTTGCAGGACCGCGATCCGATTCATGGCATTATTCGCGGCAGTGCGGTGCAGCATGGCGGCAAGGCGAATTCCTTAACCGCGCCGAACTCTGAAATGCAGGCGGCGTTGTTGTTAAAAGCCTATGAGGATGCTGGGATTGGCCTCGACACCGTCAGTTATATCGAAACCCACGGTACGGCGACAGAGCTAGGCGATCCCGTCGAAATTGAAGGGTTGAAACAGGCATATCGGACTTATAGACAACAGACCGGCGCGGCAGCAAGTCGGACCGGCGCCTGTGGGTTGGGGTCGGTGAAAACCAACATCGGTCATTTAGAGCCTGCGGCAGGCATTGCCGGATTGGCCAAGGTGCTATTGGCCATGCGCCATCAAATCTTGCCCGCGACATTGCACTTTGATTCGTTAAACCCCTATATCGATTTGAGCGAGAGCCCCTTTTATATCGTTGACGAAAAGACGCCGTGGCAGCGTCGGCTCGATGAGCAGGGCGAGGAGATACCGCGCCGCGCCGGCGTCAGTTCGTTCGGTTTTGGTGGTGCCATTGCGCATCTTGTGCTGGAAGAATATCGAGTGCCGCAAGACACGCTCGAAAACGGTGACGATGATACGTCGCCCTACTTGATTGTCCTGTCCGCGAAGAACGAAGCGCGGCTCAAAGAGGTGGCGACAAATTTGTATGGCCATCTCATTGAAACGGCATCAGTGGCCCCGATCAAGTTGCGCGATCTCGCCTATACCCTGCAAGTCGGGCGCGACGCCTTGCCGCAAAGACTCGCTCTGGTCGTGGACGAAACAGCGCACTTGCTTGATGGGCTGGCGGCTTATGTGCAAGGCGAACCTGATCGAGGCCGATGGTTTGCAGGTACTGCCAGGCGTGACCGCTGCCCGCTCACGTCGCTTGTCGAAGCGGGCGAGGCGATGATCGCCATGCGAATTGAAAAGGAAGCGCTGCGCGAGTTCGCGCAATCTTGGGTGCAAGGTGCGTCGATCAATTGGCAACAGATGTATCCGGTGAACAAGCCCAGGCGTCAATCTTTACCGACATATCCTTTTGCCCAACAAAGATATTGGTTTGATACATCAGCCAATACAAAGCCACAAGAACGTCATGCTGCCGTCGCACCTATTGACAATAAGTCTAACATCGAACGCATCTATTATCGTCGTGAATGGGCTCAGACGGCGTTGCTCTCCCCAGTTTCGATTGAGACGGGTGACCAAGCGCAGTTTGTCCTTCTATTTGAAACGAATCCACAAATAGGCGAGGTCTGGCAGACACAGCTAGAGCAACATGGACTGCGATGTATCAGAGTGTGTATTGGAGAGCGTTTTCGTCTACTGGAGCCACACTATTACCAACTCAACCCACGTCAATATGACGATTACGCCAGCCTGGCTCAGGCGCTTCGACAGAATGCGTCGTGGCCACGTCGCGTGGTTCACCTTTGGCAGTCAAACGAACCGGACGTCAACCATGACCAGCACCTGAGTTTGCAGTTAGAGCGGGGGTTTTATTCGCTTTGTCATTTCACTCGGGCACTCATGCAACACACGTTTGGCGATGCCTGCGACATTCTCTATAGTTATCGCGCTGAAGCCTGGCAGCCCGAGCCCGCTTGTGCAGCCGTGAGCGGTTTTGCCCACACGCTGGCCTTAGAGCATCCGGGATTTTCCTGTAAAACGATTGAGATACCCGCGTTCTTGTCTTATCGCGATGCCCGCACCATCGATCTTTTGCTGTCGGAATTGCAGGGACATGCTTTATCCGACACGACCGTTCGCTATCAGGAGCAAGGCACGTTACAGCGTTGGGTGCAGCACTTTTGTGAATGGCAAGCATCTCCAATCGAGGTTGTATCAAAATACCCGCGTCCCCACGGCGTGTATCTCATCACCGGCGCCAGCGGTAGCTTGGGGGCACAATTCGCCCGCCATATAGCGGCTCAGGTCAAAGCGACCTTTGTTCTGTGCGCCCGCTCTGAGCGAACACCCGCGTGTGAACAACTGATCAACACGCTGCGCACGATGGGTTCCGAGGCCGTCTATATTCGCTCGGATCTCTCCCAACGTGATCACGTCTTCAAACTGATTGAAGAAATTCAAGCGCGTTTTAAGGCTCTGCACGGCATTGTCCATAGTGCAGGGGTCATTAGCGACGCGCTGGTATTTAATAAAACCCATCACCAGATCGCTCAAGTCTTAGCGCCTAAGGTCTATGGTACGGTTTATCTGGATGAGGCCACTAAAGATATTCCACTCGATTTTTGGGTGTTGTTCTCTTCAACCACTGCGGTAACCGGCAATGTCGGGCAAAGTGACTATGCTTGTGCCAATCGTTTTATGGATGAGTTTGCGGTGTGGCGAGAACAATTACGCGGCATGAAACAGCGATCCGGAAAAACCCTTGCCATCAACTGGCCATACTGGCGCGACGGCGGCATGTCGATGTCCGAGCCGGGTTACCAGGGGTGGATGGAACGAACTGGGCTTCAGGCGCTGCCTACCAGCGAGGGGGTCGCGGCTTGGGATGATTTGTTGAACGCACCAAGTGGGCACGCCTATGTCGTCGCTTACGGCTTTAGGGAGTTGCTCAGTCGCATGTTTGCAAGGCCGCAGAGTGCTGCGGCGCAGCCGAGCGCTGATGAACGGGCTACATCGAGCGAGACGCTTTATGAAGACACGATGAGCTGGTTGCAACATGAAATTGCCTCGGTGGTCAAAGCATCGCCGCAAGATATTGACGTAGATACCGCCTTTCATCAATTCGGCTTGGATTCGGTCGTGATGCGTCAGACCAATGTTGTGTTGGAGAAAAAACTCGGTGCATTGCCAAAAACACTATTATTGGAATATACAACCATTCGTGACTTAACCGACCATTTATCTACACAGTATATTCGTGAACTCAATGGTGTTTTAGGAAGTGCGTTTTTAGAACAGAGCCCAAATGGTGAAAGACAAGTCCGCAAGAGAGTTGGGTCGGAAAATTCAATGCGTAACGGTATCTTTAGTGCCGAACCTATTGACAGTCAAGCACTCGAGCAGGAACAGACCAATAACTTAGAAGAGATTGCGATCGTCGGTCTGAGCGGGCGTTACCCTCAAGCAGAGGACCTGGATGAGTTTTGGGAGAACCTCAAAGCTGGAAAAAGCGCTATCGCCGACATCCCGGACAGCCGCTGGGATTACAGAGCCTATTACGATGCCGACCCTGACCAGGCGAGTAGGGGCAAGATGTATTGTTCTCAGGGTGGGTTTTTAAACGATATTGATCAATTTGATCCTCTGTTTTTTAATATCACGCCGCTGGAAGCGAAAAGCATGCCTCCCGAAGAGCGACTGATGTTGGAAACGGTGTGGTCGACATTGGAAGATGCAGGTTATGCCGGCGAACACATGCGTAGCCAGAAGGTGGGTGTTTTTGTTGGTGTGACCTCGAACACATATCCACTAGAATGCGATCATAGCGATGGTGTGCGTTATCAGTCGCCGATTGATACTTCCTATTTTAATATACCCAACCGGATTTCTTACTTTTTTAACTTTACGGGTCCCAGCATTGCCATAGATACAGCATGCTCTTCCTCATTGGTCGCCATTCACATGGCATGTGAAAGTCTGCGTCACGGCGAATGTGAGATGGCCATTGCCGGAGGTGTTAATCTTTATCTGCACCCTTCGAAATATATCTTAATGTGTCAGAAGAGACTATTATCCACCAAAATATCTACCGGTATGTTTGAAGAGGGTGGTGACGGATTTATACCTGGGGAGGGCGTGGGCGCTGTTGTACTCAAGCCGCTTACACAGGCGGTGCGCGACCGTGACAATATTTATGGTGTGATCAAAGCTTCCTCTGTTTTTCATAAAGGACGCAGTAATGGCTATTTACTACCGTCTCCTGAAAGTCAGACTGAACTCTTGCGACAGACTTTGCAACAAGCCAAGGTAGCACCGGAGACGATCAACTACATCGAGGTTCAGGCTTTAGGCTCGGAGATGGTTGATCAAGTGGAATGGCGCAGCTTGATCCAGGCTTACGGGGCTAAAGGCAAAAGTGATGAATACAAACCGTACTGTGGTTTAGGTTCATTGAAACCCAATATTGGCCATTTGGAAGCTGCTTCGGGCATTGCTCAGCTGAGCAAAGTCCTGCTGCAAATGAAATACTGCCAGTTTCTCCCCAGCAACGTCTCAGATCGCAGAGACCCGATTTTAGACGCGAGTATCAACCATCCCGATTCGCCTTTTTATTTTCAAGGTGAATGGAGGGTTTGGGAACGGGTTTCACGACAACGTGACGACACGGTTGGCCTGACAGTGCAGCCAAGGCGAGCGGGCATCAATTCTTTTGGCGCTGGGGGGGTGAACGCGCATGTGATCGTCGAAGAATATATCTCGCCAGTAGAATCCAGTCATGCGCCCCGGTTGGAGGAAGAGTCCGCCGCGCTGATTGTGGTGTCGTCAAAAACTCAACAGCAGTTGCGTCAAGCACTGGTCCGATTGAGAGCATACCTACTACGCGAGGCGAATCGTGCGGATGGGCCGTCCGATCGGGTTTCCCTTGCTGACATCGCGTTCACGCTTCAACAGGGGCGCGAAGCCTTCGCCGAGCGCTGGGCGATGGTGGCTAAAAGCAAGGCACAATTGCTAGAGTCACTCACTCGCTTTCTAGATGATAAGACCGTACATGCACCTCTTTTTGTTGGCCGTGTGCCTTCAACGAATCATGAAAATCATGTGTTCATGACTCATGATCGTATCGAAGCATTATGGCATAGTCATCAACTAGAGAAGCTTGCGCAATTGTGGAGACAAGGCCAGAATATCTCCTGGGAGCATCTCTCTTATCGCTATTCTCCGCGCCGTGTGTCACTACCAACTTACCCCTTTGAAAAACGCCACTGCTGGTGGGGAACATCGGACGATAAAGATCCTGTCGAAGTCACTGCTCAAAGTATGCCTGATCTCATTTCCCAAAAAACACATGAAACCCGAGTTAATATGTCAGATATAGGTCAAGTTGTTGCCGATTACTATGACCAAGTTACTGAATCTCTGAAACAAAAAATAGGCTCTCAAGAGGTCTATCTGCTCTTTGCCCCCTTTCAAGAGCGTGTTGAAGGCTTTTCCTGGTTGAAGATGTTTTTTGAACCTGAAAAACATCGCGAGCATTTTGAGCTGACCTTGCAAAAACAACATGAGCTCAAATCCATGCTTTACCGCCTGGTAGAGTTTGCGAACGTACATCGCATTTTTGATATTGGCTGCGGCTATGCTACCGATTTAATCCAACTCGCAAAGCGCCATCCGCAGGTGAGGGGCTGGGGTTTTAGCATCTCGCTCAATCAAGTTGAATTCGGTCAGCAGCGTATTCAAGACGAAGGTCTTGGTGAACGTGTGCAGCTCTCTTGCAACGATAGCACCAAAGACCCATTGCCAGGTCTGTTTGATTTGATTATTGGCTTCGAGGTCGTCGTACATATTGCTGATAAACAAGGCGTATTTGGCAATATGGCGCGACATCTCAGCAATAATGGTACCATTGTCCTGGCTGATTGTGTGGCCAATACTGTAACTTCCATTAACACCTCTTATATAGGGCAATATACAAGCACTGCCGAAGAGTATAGTGATATCCTAGCTCAGAATGGTTTGGCCATTGTCGACTGTGTAGATGTTGGACCTGAGATAAGTAATTTTTTATACGACCCTAATTATTTAGAGAATGCTGCTTATTTAAGTTCGATTTATCCAGAGATGGTAAATATTGAAAAAGAACATCAAGGCTGGAGTAACTTCGGAAAGGCTTTGGAGGTAAACCTGGTCCGTTATGTGCTACTTACTATTCGAAAAGCTACTGCCTCTCAAACTTATGATCATCTATTACAGATTAACCTGGAGCGCTTAGGCTCTGGAGCTCTGTCGTATGCTGAGGCGCTTCAAGCCTACCCCCATATAGAGCAAATCGTCATAGAGCAAATCGCCGAAACGAAAAGCCCTGATTCGAATGCAACTACCACATCCGTGGCAGATATCGAACAGACCATTGTGGAGCTGGCCGCTCAGGTGCTTGAAATGATGCCTGACGAAGTGAATACGCAAGCGCGCTTCATTGATTTTGGGGTAGATTCGTTGCGCGGTTTGATTTTGTTGGACGCGGTCAATCGGCGCTTAGGGCTGACTTTACAGATTCCAGTGTTGTTTGATCATTCCAGTATTCATGAATTGAGTATATATATTGCCTCCCAGCTTCCGTCTTCACCCCAAGCTGTTGTGTCCGCTCCTGCCGCCTCTGTACCCGTTGTCTCACCCGCCGTCGCGGTCAGCTCTGTGCGCTCTGTCGCTTCTAGTCATACCGCGCATTCCGATATCGCCGTGATCGGTATGTCCGGACGTTTTCCGGGGGCGCCTGATCTGCATACTTTTTGGCAAAACTTAGAGCAGGGTATCGACAGTATATCTGAAGTGCCTCCCACGCGTTGGGAGCTTACGCAGTACTATGACGCCGATCGCCGCCTACCCAACCACAGCTATAGTAAATGGGGTGGCTTCCTGGATGATGTGGATCAATTCGATCCCAAGTTTTTTAATATTTCTCCAGCCGAGGCAGAGTTGATGGATCCGCAGCAGCGGCTGTTTCTGCAAACCAGCTGGAACGCGCTGGAGGATACCGGATATGCGGGTCAAACCCTGGATGGCATGAAGTGTGGCGTCTATGTGGGGGTGTTGAATCACGCATACGATATCCTGATCGATCGCGCTAACATTTCCCAGCATCGTGCGTATGCTTTGCTGGGCAATAGTTCGTCAATTTTGGCGGCGCGCATTGCCTATCTGCTCAACCTTAAAGGCCCTGCCGTCACCCTAGACACCGCCTGTTCCTCTTCGTTGGTCGCGCTGCACTGGGCTTGTAAAAGCCTCCGGGACGACGAAGTAGATATGATGTTAGCCGGTGGGGTGACTCTTTATCTGGGGGAAAGAGAGTATATTGAGGCGAGCCAGGCGGGGATGCTCTCCCCCACGGGCAAATGCCGAGCTTTTTCTCAGGAGGCCGACGGGATCACTTTGGCAGAAGGGGTGGGTGTTGTCGTGTTGAAACGTTTAGATAAAGCTCTGCAGGATCGCGATGCGATCTACGGTGTGATCAAAGGTACCGGGATCAACCAGGATGGCAAAACGAACGGCATTACCGCGCCTAGCGCCAAATCGCAGTATGAACTGCAAACTGAGGTCTATACGCGATACGGCATTCGTCCCGAGCGCATTAGCTACGTAGAAGCGCATGGTACGGGAACAAAGTTAGGCGATCCCATTGAAGTGGAAGCATTGACGCAAAGTTTTAGGCAGTATACCCAGAAACAAAATTATTGTGCCATTGGCTCCGTCAAAAGTAATATTGGTCATACTTCTGCCGCCGCGGGCATCGCAGGCTTGATTAAAATTTTACTGAGTTTGCAGCATCATTCTATACCTCCCACACTGCATGTAGAGCATAAAAATGAACACATTAACTTTAGGGACAGTCCGTTTTACGTCAATACCCAGCTTCGTCCCTGGACCCATGAAGATGATTTGCCAAGACAGGCCGCTGTAAGCTCCTTTGGTTTTAGCGGTACAAACTGCCATGTGGTTGTGGAAGAGCCGCCCGCTCGCATTGTTCATCAACATATCGCATCAACATTAGACGCTCCCGTATTGATGGTACTTTCAGCTGCAAATCAAGATCGGCTGCGGGGCTATGTGGCGTTGATGATTCGCTATCTCGAAGCAAGAAAGACGCGTCAACATACCCGCAAGGCATGGCCATCTGACAGCCTGACTGATATCGCGTATACCCTGCAAACCGGGCGAACGCCACTAGAGCAACGTCTCGCTATGGTCGTTGCCAGTGAAGACGAATGGCTCGACAAGCTACGACGCTATGAGCGTGGCGAAAACGTGATTGATGCCTGTTACGAGGGCCAGGCAAATGCCGAGCCCGCCAAACTGGATTTGCTCATCGAGGGAGAGGAAGGTCGAGCGTTTATCGAATCTATCGTGCGCCGAAAAAACCTGTCTAAACTCGCCCAGTTATGGGTTGGCGGAACCGATATTGACTGGACCTTACTCTATCATCGCCCTTCGTCAGATGCTGCCGTGTTGCCCCAGCGAATTTCGCTGCCAGGTTACCCGTTCGCGCGAGAATCGTATTGGCTTGCCGCGCCAACGCTAGCCGCTTCTTCGTTGGTGGTCGAGCGGTTGCCCCATCAAGATGACATCTGTTTTAAAACCGTGTTGAGTGGCGATGCCTTTTTTCTGCGCGATCATTGTATCGACAGGCAAAAAGTCTTACCCGGTGTCGTTTATTTGGAAATGGCCAGGAAAGCAGCTACCAGCTTTCGTCCTGATGCCCCGCAGCCCGTACTCAAAAATGTGATTTGGCTTCGTCCACTCATGGTCAATGCGACAGATGTCGTGGCCTACACACGTCTGAAGCAACAGGCGCAGCGGATTGATTTTGAAATTTCAACCTTGGATGAGCAGAACAACCGGGTGCTACATGCTCAGGGACAATTGCACGATCCGGAGCCGGTTACGCCACAGCATCCGGATTGGCCCTCATTTGATCTTCGGCTTATTCAAGAGCGTTGCCCACGTACGCTAGAAGGCGAAGCGTTTTTCCAGGCCATACAGGCGCAGGGCTTTCGTACCGGGCCGAGTTTTCAGGTGGTCCGGAAAGCCTGGTATAACCAAACCGAAGCTCTGTGTGAGTTGGGCCTGCCGGCGTTGCGCGAAGCTGATTTTCAAGACTACCTACTGCATCCTTCACTCGTCAATGCCGCACTGGAGTCGGTGATTCTATTGATCGCGAAGGACCCCTCGGCATCTGACGCTCCTCATCTTCCCTACACGTTGGGCACATGGGCATATGACGACACGGTTTGGCCGACATCGCTATATGCGTATGCGCGACTGACCGCACCTCAGCCGGAGACAGAGGCTTTGACTGCCGCTACCACGGTTCAACGGTATGAGATCAATCTGTTGGATCGCAGCGGCAGACTGATCGCACGCGGCAAAGATTTTTGTGTTCGTGCGTTGCGCTCAAGTGGCGAGACACGGCCTGCCAGCTCCGCGGCCCAGTATCCGGTCAAGTATTATTATCCGCGGTGGGAGGCATGTGAAAACGAACGTGTCGCGGCCAATATTGTAGTTGAGCGCAGTTGGCTGGTGTTTGAAACCGAGAATTCGCTCTGGCATGCGCTGGATGAAAAACTGCGTGCGTTGGGTGTCACATGCATTCAGGTTAGACCCGGTTACCGGTTTCAGGTCTTGGAAAAAAGGCGCTACGAAATTCACCCCGAGCGGGCTGGTGACTACCAAAAACTGGTCGCTGAACTCAAACGCAACCACGCAATCCCCGAGCGTATTATTCACGCGTGGTCGGAAGAGCAATGGTGTGACAACGCCGAGCTCGATCCACGATCACTGGCGTGGGGTTTCTATTCCGTGTTTTATCTGAGTCAGGCCTTGATCTCCTGTTGGCAAGATACGCCGCTTCACTTGCTGTATCTCTATCGTCAAGATCAGGACTCACCACAGGCCCACTACGCGGCGGTTCGTGGCTTTGCTCAGTCCCTCACGCATGAACGATTGGATTGGCATTGGAAAACCCTGGCTTTGCCCACCACCCTGCCGCAAGCCCAAGTCGCTAACATGTTATGGGATGAGCTACGGTATGCAAATCAACTGGAGCGCGAAATTCGCTATGACGCAAATCGGCAACGTTGGGTGAGGCGTTGGCATGCAGGTGAAGGGACACCTGGTCAAGGGCCAGCCGCACCCGACACGAGTTTGCTGCGCCAACAAGGCGTATACCTGATTACTGGTGGGGGTGGCGGCCTTAGCCTGCTACTGGGGGAATATCTGGCGCGCGAGTATCAGGCCAAAGTCATTCTCGTAGGCAGAGCCGAGGGGACTGAAGCGCAACAAGCGAAGATAGACAGTTGGAAACGATGGGGGGGAGAAGCGCTCTATTTACAAGGGGATATCTCCCGGCGAGAGGATGTGGATCATGTCATGGCACAGTTGCGCTCTCGCTTTCCTGTCTTGCACGGTGTTTTTCATGCGGCGGGACTCACGCGTGATGCTTCTCTTGTCAACAAAACCGTCCGTGACATCGACGAGGTGCTGGCAGCTAAGGTTTACGGAACCATTTACCTGGATCAAGCTACCCGTAGTGAAGAATTGGACTTTTTTGTCTTATTTTCGTCTCTATCCGGAGTCGTTGGTAATATAGGGCAATCTGACTATGCTTATGCCAATAGCTTTTTGGATCATTTTGCCGAGCGTCGCGAAGCACAACGGAGTATGCAAAAGCGTTTTGGTTTAACGGTTGCAATTGATTGGCCACTGTGGCGTCATGGCACGATGCAGGTAGATGCTACGACCGAGAAATTTCTGGCGCGCTCGATCGGTATGCAGGCGCTAGAGACCGATGACGGTTGGATGGCCCTACAACATGCCTTGGCGGGTTCGAAGAGCCAACTCCTGGTGCTGTGTGGCGATCAGGGGCGATTTAGCCAGGCCTTGGGCGTACAGCAACATCATACAGTTGCCGAGCGGGCTGAGAGCCCGAGTGAAAACCTAAGTGAGACCTCGAGCTTCGATTTACTAACGCATTTGCAGATTGACCTCAGGTCCATCATGGCTGCCGTACTCAAGCTGAGCCCTCAGGAGATCGAGTGGGAGCGTGAGATGAGCAGCTTTGGCTTTGATTCCATTTCGTTTGTCGCTTTGGCTAACGAGTTGAATGATACTTTCGAGTTGGATCTTTTGCCTGCCGTGTTTTTTGAGTGTTTGAACGCTGGTGATTTGCTCAAACACTTGCACCACCACCACTGTGACGCCTTATTTGCGTATTACCGTAGACGTGTGCCTGAACCTGCGGCGCAAGAAGTGTTAGGTACGCCGGGACAAGCCAACGTTGAGGGGCCGGTTCATGTACGTCAATTGGAAAAACCGAGCGGCCTTAATCACCATGCCGGCACAGAGCCGATAGCCATTGTTGGCATGAGTGCTGTGATGCCGCAGTCCCCCGACCTGGAGACGTTTTGGCAGCACCTGGCGGCGGGGCAGGATTTGATCACAGAGATCCCCAAAGACCGATGGGACTGGCAAAACGCAGGAGGTGATACGACGATTCGCTGGGGCGGTTTTATGCCGGATATCGATCAATTCGACGCGCTGTTTTTTGGTATTTCGCCTCGTGAAGCCGACCTGATGGACCCGCAGCAACGCCTGTTGCTTCAGACCGTGTGGAAAACCATCGAGCACGCGGGTTACAAAGCCTCGGATTTATCCGGGAGCGATACCGGCGTTTTTGTCGGAGTTGCCAATTCCGATTATCGCGAGCTGATCCATGCGGCAGGGCCTGGGATCGATGCGCAAAGCTCTACCGGAACGTTTTCCTCGATCTTAGCCAATCGGGTGTCGTACATTTTCAATTTTACCGGCCCAAGCGAGCCCATTGACACGGCTTGCTCCAGCTCTTTGGTGGCGCTCCACCACGCGTTGAATGCGTTATCCCGTGGCGAATGCTCCAGCGCCATCGTTGGTGGCGTGAATGCGTTGTTAACCCCAACCCTCCATATTACCAGCAACAAGACCGGCATGTTGAGCCACGATGGGCGCTGCAAAACCTTTGATCAAGCGGCGAATGGCTATGTGCGGGGAGAGGGGGTTGCCGCGCTCTTGTTAAAACCGCTCAGCCTGGCTAAAGCGCAGGGGGACGAAATTTATGCGCTGATTCAAGGTAGCAATGTAAACCATGGTGGACACGCCACCTCCCTCACTGCGCCCAACCCCCGGGCACAGGCTGAATTGCTGATCCACGCCTATGAAGATGCAGGTATCGACCCCACAACCGTCACCTATATTGAAACCCATGGCACCGGAACAAGCCTGGGGGATCCGATTGAAATCAGTGGTTTAAAGCAGGCTTTTGCCACTTTGTATGAGCGTTTTGGTCACGTGGCCGATGTTTCCGCTTACCATCGGTGTGGTCTTGGCTCTGTTAAAACCAATGTCGGTCACCTGGAAGCAGCAGCAGGCATGGCTGGACTGCTCAAAGTGGTTTTAGCCATGCATCACAAAACCTTACCTGCACATCTTCATTTTCATAACCTCAACCCGTATATCGATTTGAGCGGCAGTCCTTTCTATATTACCCGGCAAACTTGTTCCTGGGACGCTTTACAAGATGCTGCCGGTAAGGCGCTTCCCCGGCGTGCCGGTGTCAGCTCGTTTGGTTTTGGTGGCGTCAATGCACATGTCATTGTTGAGGAATATGTTGAGGACCGGCATGAAGACAGATAG", "orf_prot_sequence": "MEAKDIAVIGVGVLFPGASHHDLFWENLIAGIDSIQEIPVSRWDIDAYYSPDFNEPGKSISKWGGLIQGIDQFDHQFFNISPREARNMDPQQRLLLQEAWHCVEDSGIALKTLQEKVTSVFVGVMAIDYHQHMAQSRQPVDSYACLGNYGSILANRLSFCLGLSGESKAIDAACASSLVAVHDARRSLQAGECDYAIAAGVSVICHPWKYISFSKSRMLSPSGRCKTFDKSADGYVPGEGVGVLLMQSLERAQEQKCHIYGVLKGSALNNNGLHGQRHADDRGRKKASITAPSIDAQRRVITDALRSADIDPASVSYVEAHGTGTSLGDPIEIEALKQVFAVPGRTTPSCAIGSVKTNIGHLEAAAGVAGVIKVLLMMKHKMIPQVLHLNTVNPMIDLTDTSLYLSDQLHSWESKEGIQRRAGVSSFGFGGSNAHAIFEEYVDTRHTPQGTLQRTSGEHLFVLSAKSHSSLDGLLNDWVAFLNHPQRSAISLEDMCATLMTGRESFPFRFALSVTDKKALRSALISPPESAFGHAEMPSVLLRIGSVNAEQAAVIASWYRKHPGFREPFDACRRLAKMLCSEEAVRDWTAQFPKVLAEHEALYGFAAAYATARLLLDSGVQPRLICGEGIGHGVALCLSGLWTLSQGLRHAMRLIDQLDLSPQRLDYPIYDQIQGTTLSPYQPSRGYLQALLKNIQVRDDLFIRDLQKALLLHEHQYTFKNYLESWNSALKEIGLEIYQLIGLHAELQEDISKKFLVYIIVAYSLKQLYEKWDLVEYDASSDPFLNEFLDLIGDDVLTFKDVVTLIGNGWDTGKEDLFHGITARVIPVSSVKPYEYLQQYQFERFDHIRSWLEKIGDVPLETPIHEDDLLLTVGDEGDVSRLKIVSNSGHSLSFLTRGQKASHLTEDVRQLWLHGLNIDWQSFVDAGSFTKASLPGYSFDGSPFWIENSRSDSPFIQGEGIKAEPVQNSYYHFVWQASKHPTVLDRKPDVKNNEAILLFDSDASLAQLLREQWHAEIILIRPARAFDWKSWHDVEIDPDNENHYKLVCTALQQKNLRPVCAIFTWTLQESTSTGESLLSHPEPWLSKGIYAVYHLLKSLSQSAHPPLSQLLFFFHGNEGQGNPLMEAVAGYGRSLKLTYPQMRFRSIQFETGSPDTIEVVTAVIREFSLLKGEERQEVDTEVLYRHGQRLIKTPVRLHLDAVAQAPWKQSGVYLITGGMGALGSIWARYLAERYQARLILTGRSVCQGDIGKSIRVFIKQLQQLGGDAVYLQADITEPHAVRQLIEQAYQAFGPVRGLIHAAGQMSAVSFAEKSLADFQQTLSAKIQGTLVLDRVLHESIEKQALDIVIYFSSAASTLGDFGQCDYAIGNRFLDGYGRFREGLRTQGQRQGRTVVVNWPLWREGGMHLDSEAEALYLSASGLDYLEAEQGLDALDRILVSPHTQVMVFAGDPANIDRNLGVNKVVDMQVDETFVASRIEADLQHLAAVLLQMQADEIALDDNLSAYGFDSIAIKEFADQLSQYYQLEISPIVFFAHASLRSLGAYFWEHFAADMKAFYAAEPSNQMPEARHAEAPARQVSQPARAEADQDIAIIGMSGVFPGSPDLATFWKHLSRGRDLVGEVPAGRWDWRVYDGDLMREHEAKKTAIKWGGFIENVDRFDADFFSISRREAEFMDPQHRLFLQCVWATIEDAGYATAALSGENIGVFVGVQFSDYQQLLKQAGERGAQILTGNAHSVLANRISYLLDVRGPSLAIDTACASSLVAVHQGVQAIRNGDCTAAIVGGVSLMLSPDTFLDINHLGVLSPDGRCKTFDRNANGYVRGEGVGSFLLKPLSRALQDRDPIHGIIRGSAVQHGGKANSLTAPNSEMQAALLLKAYEDAGIGLDTVSYIETHGTATELGDPVEIEGLKQAYRTYRQQTGAAASRTGACGLGSVKTNIGHLEPAAGIAGLAKVLLAMRHQILPATLHFDSLNPYIDLSESPFYIVDEKTPWQRRLDEQGEEIPRRAGVSSFGFGGAIAHLVLEEYRVPQDTLENGDDDTSPYLIVLSAKNEARLKEVATNLYGHLIETASVAPIKLRDLAYTLQVGRDALPQRLALVVDETAHLLDGLAAYVQGEPDRGRWFAGTARRDRCPLTSLVEAGEAMIAMRIEKEALREFAQSWVQGASINWQQMYPVNKPRRQSLPTYPFAQQRYWFDTSANTKPQERHAAVAPIDNKSNIERIYYRREWAQTALLSPVSIETGDQAQFVLLFETNPQIGEVWQTQLEQHGLRCIRVCIGERFRLLEPHYYQLNPRQYDDYASLAQALRQNASWPRRVVHLWQSNEPDVNHDQHLSLQLERGFYSLCHFTRALMQHTFGDACDILYSYRAEAWQPEPACAAVSGFAHTLALEHPGFSCKTIEIPAFLSYRDARTIDLLLSELQGHALSDTTVRYQEQGTLQRWVQHFCEWQASPIEVVSKYPRPHGVYLITGASGSLGAQFARHIAAQVKATFVLCARSERTPACEQLINTLRTMGSEAVYIRSDLSQRDHVFKLIEEIQARFKALHGIVHSAGVISDALVFNKTHHQIAQVLAPKVYGTVYLDEATKDIPLDFWVLFSSTTAVTGNVGQSDYACANRFMDEFAVWREQLRGMKQRSGKTLAINWPYWRDGGMSMSEPGYQGWMERTGLQALPTSEGVAAWDDLLNAPSGHAYVVAYGFRELLSRMFARPQSAAAQPSADERATSSETLYEDTMSWLQHEIASVVKASPQDIDVDTAFHQFGLDSVVMRQTNVVLEKKLGALPKTLLLEYTTIRDLTDHLSTQYIRELNGVLGSAFLEQSPNGERQVRKRVGSENSMRNGIFSAEPIDSQALEQEQTNNLEEIAIVGLSGRYPQAEDLDEFWENLKAGKSAIADIPDSRWDYRAYYDADPDQASRGKMYCSQGGFLNDIDQFDPLFFNITPLEAKSMPPEERLMLETVWSTLEDAGYAGEHMRSQKVGVFVGVTSNTYPLECDHSDGVRYQSPIDTSYFNIPNRISYFFNFTGPSIAIDTACSSSLVAIHMACESLRHGECEMAIAGGVNLYLHPSKYILMCQKRLLSTKISTGMFEEGGDGFIPGEGVGAVVLKPLTQAVRDRDNIYGVIKASSVFHKGRSNGYLLPSPESQTELLRQTLQQAKVAPETINYIEVQALGSEMVDQVEWRSLIQAYGAKGKSDEYKPYCGLGSLKPNIGHLEAASGIAQLSKVLLQMKYCQFLPSNVSDRRDPILDASINHPDSPFYFQGEWRVWERVSRQRDDTVGLTVQPRRAGINSFGAGGVNAHVIVEEYISPVESSHAPRLEEESAALIVVSSKTQQQLRQALVRLRAYLLREANRADGPSDRVSLADIAFTLQQGREAFAERWAMVAKSKAQLLESLTRFLDDKTVHAPLFVGRVPSTNHENHVFMTHDRIEALWHSHQLEKLAQLWRQGQNISWEHLSYRYSPRRVSLPTYPFEKRHCWWGTSDDKDPVEVTAQSMPDLISQKTHETRVNMSDIGQVVADYYDQVTESLKQKIGSQEVYLLFAPFQERVEGFSWLKMFFEPEKHREHFELTLQKQHELKSMLYRLVEFANVHRIFDIGCGYATDLIQLAKRHPQVRGWGFSISLNQVEFGQQRIQDEGLGERVQLSCNDSTKDPLPGLFDLIIGFEVVVHIADKQGVFGNMARHLSNNGTIVLADCVANTVTSINTSYIGQYTSTAEEYSDILAQNGLAIVDCVDVGPEISNFLYDPNYLENAAYLSSIYPEMVNIEKEHQGWSNFGKALEVNLVRYVLLTIRKATASQTYDHLLQINLERLGSGALSYAEALQAYPHIEQIVIEQIAETKSPDSNATTTSVADIEQTIVELAAQVLEMMPDEVNTQARFIDFGVDSLRGLILLDAVNRRLGLTLQIPVLFDHSSIHELSIYIASQLPSSPQAVVSAPAASVPVVSPAVAVSSVRSVASSHTAHSDIAVIGMSGRFPGAPDLHTFWQNLEQGIDSISEVPPTRWELTQYYDADRRLPNHSYSKWGGFLDDVDQFDPKFFNISPAEAELMDPQQRLFLQTSWNALEDTGYAGQTLDGMKCGVYVGVLNHAYDILIDRANISQHRAYALLGNSSSILAARIAYLLNLKGPAVTLDTACSSSLVALHWACKSLRDDEVDMMLAGGVTLYLGEREYIEASQAGMLSPTGKCRAFSQEADGITLAEGVGVVVLKRLDKALQDRDAIYGVIKGTGINQDGKTNGITAPSAKSQYELQTEVYTRYGIRPERISYVEAHGTGTKLGDPIEVEALTQSFRQYTQKQNYCAIGSVKSNIGHTSAAAGIAGLIKILLSLQHHSIPPTLHVEHKNEHINFRDSPFYVNTQLRPWTHEDDLPRQAAVSSFGFSGTNCHVVVEEPPARIVHQHIASTLDAPVLMVLSAANQDRLRGYVALMIRYLEARKTRQHTRKAWPSDSLTDIAYTLQTGRTPLEQRLAMVVASEDEWLDKLRRYERGENVIDACYEGQANAEPAKLDLLIEGEEGRAFIESIVRRKNLSKLAQLWVGGTDIDWTLLYHRPSSDAAVLPQRISLPGYPFARESYWLAAPTLAASSLVVERLPHQDDICFKTVLSGDAFFLRDHCIDRQKVLPGVVYLEMARKAATSFRPDAPQPVLKNVIWLRPLMVNATDVVAYTRLKQQAQRIDFEISTLDEQNNRVLHAQGQLHDPEPVTPQHPDWPSFDLRLIQERCPRTLEGEAFFQAIQAQGFRTGPSFQVVRKAWYNQTEALCELGLPALREADFQDYLLHPSLVNAALESVILLIAKDPSASDAPHLPYTLGTWAYDDTVWPTSLYAYARLTAPQPETEALTAATTVQRYEINLLDRSGRLIARGKDFCVRALRSSGETRPASSAAQYPVKYYYPRWEACENERVAANIVVERSWLVFETENSLWHALDEKLRALGVTCIQVRPGYRFQVLEKRRYEIHPERAGDYQKLVAELKRNHAIPERIIHAWSEEQWCDNAELDPRSLAWGFYSVFYLSQALISCWQDTPLHLLYLYRQDQDSPQAHYAAVRGFAQSLTHERLDWHWKTLALPTTLPQAQVANMLWDELRYANQLEREIRYDANRQRWVRRWHAGEGTPGQGPAAPDTSLLRQQGVYLITGGGGGLSLLLGEYLAREYQAKVILVGRAEGTEAQQAKIDSWKRWGGEALYLQGDISRREDVDHVMAQLRSRFPVLHGVFHAAGLTRDASLVNKTVRDIDEVLAAKVYGTIYLDQATRSEELDFFVLFSSLSGVVGNIGQSDYAYANSFLDHFAERREAQRSMQKRFGLTVAIDWPLWRHGTMQVDATTEKFLARSIGMQALETDDGWMALQHALAGSKSQLLVLCGDQGRFSQALGVQQHHTVAERAESPSENLSETSSFDLLTHLQIDLRSIMAAVLKLSPQEIEWEREMSSFGFDSISFVALANELNDTFELDLLPAVFFECLNAGDLLKHLHHHHCDALFAYYRRRVPEPAAQEVLGTPGQANVEGPVHVRQLEKPSGLNHHAGTEPIAIVGMSAVMPQSPDLETFWQHLAAGQDLITEIPKDRWDWQNAGGDTTIRWGGFMPDIDQFDALFFGISPREADLMDPQQRLLLQTVWKTIEHAGYKASDLSGSDTGVFVGVANSDYRELIHAAGPGIDAQSSTGTFSSILANRVSYIFNFTGPSEPIDTACSSSLVALHHALNALSRGECSSAIVGGVNALLTPTLHITSNKTGMLSHDGRCKTFDQAANGYVRGEGVAALLLKPLSLAKAQGDEIYALIQGSNVNHGGHATSLTAPNPRAQAELLIHAYEDAGIDPTTVTYIETHGTGTSLGDPIEISGLKQAFATLYERFGHVADVSAYHRCGLGSVKTNVGHLEAAAGMAGLLKVVLAMHHKTLPAHLHFHNLNPYIDLSGSPFYITRQTCSWDALQDAAGKALPRRAGVSSFGFGGVNAHVIVEEYVEDRHEDR", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1968|hsp_num:1": {"type_match": "Loose", "snp": {"original": "D", "change": "N", "position": 66}, "query_snp": {"original": "D", "change": "N", "position": 38}, "orf_strand": "+", "orf_start": 15190, "orf_end": 33063, "orf_from": "BGC0001186.1|Misakinolide_15 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.55205e-11, "bit_score": 65.4698, "max_identities": 104, "cvterm_id": "39507", "query": "SPDLATFWKHLSRGRDLVGEVP---AGRWDWRVYDGDLMREHEAKKTAIKWGGFIENVDRFDADFFSISRREAEFMDPQHRLFLQCVWATIEDAGYATAALSGENIGVFVGVQFSDYQQ------LLKQAGER-----GAQILTGNAHSVLANRISYLLDVRGPSLAIDTACASSLVAVHQGVQAIRNGDCTAAIVGGVSLMLSPDTFLDINHLGVLS-----PDGRCKTFDRNANGYVRGEGVGSFLL------------KPLSRALQDRDPIHGIIRGSAVQHGGKANSLTAPNSEMQAA--LLLKAYEDAGIGLDTVSYIETHGTATELGDPVEIEGLKQAYRTYRQQTGAAASRTGACGLGSV---KTNIGHLEPAAGIAGLAKVLLAMRHQILPATLHFDSLNPYIDLSESPFYIVDEKTPWQRRLDEQGEEIPRRAGVSSFGFGGAIAHLVLEEY", "match": "SPD+ + WK L  G   +  +      +WD                 A+K GG ++  D  D+    +  R   ++    +L    +W   E AG  +  +  +   V VG      ++      L+   G R       Q++  N  + +   I   L  R   +   +AC+S   A+    + I  GD   A+ GGV   +        + +  +S     P+   + FD++ +G+V GE  G+ +L            KPL+R L           G+ +     A  + AP ++   A   + ++ E AG+    + ++  HGTAT +GD  E                A A R   C   +V   K+ +GH   A G       +L +R  ++P TL++++ +P IDL         +    + R  +      R A  +SFGFGG    L    Y", "sequence_from_db": "SPDIESTWKGLLAGESGIHALEDEFVTKWDL----------------AVKIGGHLK--DPVDSHMGRLDMRRMSYVQRMGKLLGGQLW---ESAG--SPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAV---IGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGE-AGALMLIETEEHAKARGAKPLARLL-----------GAGITS--DAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAE----------------ANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDL---------DVVAGEPRYGDY-----RYAVNNSFGFGGHNVALAFGRY", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 19996, "query_end": 21270, "hit_start": 75, "hit_end": 1248, "orf_dna_sequence": "TTGGAGGCCAAGGACATTGCTGTCATTGGAGTGGGGGTTCTATTTCCTGGTGCCAGTCATCATGACCTGTTTTGGGAAAATTTAATTGCTGGTATTGATAGTATTCAGGAGATACCTGTATCTCGCTGGGACATAGACGCCTATTATTCACCTGATTTTAATGAACCGGGAAAAAGTATTAGTAAATGGGGCGGACTGATTCAGGGGATTGATCAATTTGATCACCAGTTTTTTAATATTTCCCCGCGTGAAGCGCGGAATATGGACCCGCAACAACGTTTATTATTACAGGAAGCCTGGCACTGCGTCGAAGACTCCGGTATTGCCCTCAAAACCCTTCAGGAAAAAGTCACTTCCGTATTTGTTGGGGTCATGGCGATTGACTACCATCAGCATATGGCACAGAGCCGTCAGCCTGTGGATAGCTACGCCTGCCTTGGGAATTACGGCTCTATATTAGCGAACCGTCTATCGTTTTGCCTCGGGTTGAGCGGGGAGAGTAAAGCCATTGATGCTGCTTGTGCCTCATCATTGGTGGCAGTCCATGATGCGAGACGGAGTTTACAGGCAGGAGAATGTGACTATGCGATTGCCGCCGGCGTGAGTGTGATCTGTCATCCCTGGAAGTATATTTCCTTCTCGAAATCTCGCATGTTGAGTCCCTCCGGGAGATGCAAAACCTTTGATAAGAGTGCTGATGGGTATGTACCCGGCGAAGGGGTGGGCGTTCTTCTCATGCAATCGCTGGAAAGAGCGCAGGAGCAGAAATGCCACATTTATGGTGTTTTAAAAGGCTCGGCGCTCAACAACAATGGTCTTCATGGACAAAGACACGCTGACGACCGGGGCAGAAAAAAGGCGTCCATCACTGCCCCCAGCATAGACGCCCAGCGCCGGGTCATTACCGACGCGTTGCGTAGTGCGGATATTGACCCGGCGAGTGTGAGCTACGTGGAAGCCCACGGCACGGGGACATCCCTGGGAGATCCCATTGAAATTGAAGCCTTAAAACAGGTATTCGCTGTCCCTGGTCGGACAACACCGTCTTGTGCTATCGGCTCGGTAAAAACCAATATTGGTCACTTGGAAGCCGCTGCTGGAGTCGCGGGCGTGATCAAGGTGCTCTTGATGATGAAGCACAAAATGATTCCCCAAGTGCTTCATCTCAATACCGTGAATCCGATGATTGATTTGACAGATACGTCTCTTTATCTAAGCGATCAGCTACACTCTTGGGAGTCTAAAGAGGGCATTCAACGCAGAGCGGGGGTGAGTTCCTTTGGTTTTGGTGGAAGCAATGCCCATGCCATTTTCGAGGAGTATGTCGATACGCGACATACTCCTCAAGGTACACTTCAGCGCACGAGTGGCGAGCACCTGTTTGTCTTATCTGCAAAATCCCACTCAAGTCTAGATGGCCTGTTAAACGATTGGGTCGCGTTCCTTAACCACCCCCAGCGCTCTGCGATATCGCTTGAGGATATGTGCGCAACGCTCATGACGGGACGGGAATCGTTTCCGTTCCGCTTTGCGCTGTCCGTGACAGATAAAAAGGCGTTGCGCTCAGCCCTCATCTCACCACCGGAGAGCGCTTTCGGCCATGCAGAGATGCCGTCCGTACTGTTGCGTATTGGCTCTGTCAATGCCGAGCAAGCCGCGGTGATTGCCTCCTGGTATCGCAAGCATCCAGGATTTCGCGAGCCTTTTGATGCTTGTCGTCGCTTGGCTAAAATGCTTTGCAGTGAGGAGGCCGTTCGCGACTGGACGGCCCAATTTCCCAAGGTGTTGGCCGAGCATGAAGCTCTGTATGGTTTTGCCGCTGCCTATGCGACTGCGCGTTTACTGTTAGATTCGGGGGTGCAGCCACGCTTAATCTGTGGCGAGGGGATTGGCCATGGTGTTGCTTTATGTCTTAGTGGGCTGTGGACGCTCTCCCAAGGGCTAAGGCATGCGATGAGGTTGATCGATCAGCTCGATCTAAGCCCACAGCGCTTAGATTACCCCATTTATGACCAGATTCAAGGCACAACTTTGTCGCCTTATCAGCCTAGCAGAGGTTATTTGCAGGCCTTGTTGAAGAATATTCAGGTAAGAGATGACCTCTTCATCAGAGACTTGCAAAAAGCCCTTTTATTGCATGAGCATCAGTATACGTTTAAAAATTATCTCGAATCGTGGAATTCTGCACTAAAGGAGATTGGTCTCGAAATTTATCAGCTGATAGGTCTTCACGCGGAGCTACAGGAAGATATCTCTAAAAAATTTCTTGTCTATATTATAGTTGCCTATAGTCTAAAACAGCTCTATGAAAAATGGGATTTAGTTGAGTATGATGCCTCATCAGATCCTTTTTTAAATGAGTTTTTGGACCTGATCGGCGATGATGTTTTGACATTTAAAGACGTTGTTACGTTGATTGGTAACGGATGGGATACCGGCAAAGAGGACTTATTTCATGGTATAACAGCGCGAGTGATTCCTGTTTCCAGCGTTAAACCATATGAATATCTGCAGCAATATCAATTTGAGCGATTTGATCATATCCGCTCATGGCTGGAGAAGATTGGCGATGTTCCTTTAGAGACGCCGATCCATGAGGATGACCTACTGTTGACGGTCGGTGACGAAGGCGATGTATCCCGCTTGAAGATCGTGAGCAACTCAGGCCATAGTCTGAGTTTTCTGACCCGTGGCCAAAAGGCTAGCCATTTGACCGAGGATGTGAGACAGCTCTGGTTACATGGCCTGAATATCGACTGGCAGAGCTTCGTTGATGCCGGCTCGTTTACCAAGGCTTCTCTTCCTGGCTATTCCTTTGATGGCTCGCCGTTTTGGATCGAAAACAGTAGATCAGATTCACCATTCATACAAGGCGAAGGTATTAAGGCTGAGCCTGTTCAAAATTCTTACTACCATTTTGTATGGCAAGCGAGTAAGCACCCTACCGTTCTTGACCGCAAGCCTGATGTCAAGAATAATGAGGCAATTTTGCTGTTTGATAGTGATGCATCACTCGCTCAATTGTTGCGTGAACAGTGGCATGCAGAAATTATACTTATTCGGCCTGCAAGAGCATTTGATTGGAAAAGTTGGCACGATGTTGAGATCGATCCAGATAACGAAAATCATTATAAATTGGTATGTACAGCTCTTCAGCAAAAAAATCTGAGGCCTGTATGTGCGATTTTTACCTGGACGCTACAGGAGTCTACCAGTACAGGTGAAAGTTTACTGTCTCACCCCGAACCGTGGTTATCCAAGGGGATATACGCCGTTTATCACCTTCTAAAAAGTCTCTCGCAAAGCGCCCATCCACCTTTATCTCAGCTTTTATTTTTTTTTCATGGCAACGAAGGACAGGGCAATCCATTGATGGAAGCGGTCGCGGGTTACGGGCGCTCACTAAAGCTCACCTACCCGCAGATGCGTTTCCGCTCCATTCAATTTGAAACCGGTTCGCCGGATACAATCGAGGTCGTGACCGCCGTTATCAGGGAATTTTCCCTCCTAAAAGGTGAAGAACGACAAGAGGTGGACACAGAGGTCTTATATCGTCATGGGCAGCGGCTGATCAAAACCCCTGTCCGTTTACACTTGGACGCTGTGGCGCAGGCGCCTTGGAAGCAGAGTGGCGTGTATTTGATTACCGGTGGTATGGGCGCCTTAGGGTCGATTTGGGCGCGCTATCTGGCAGAGCGTTATCAAGCGCGTTTAATCCTCACCGGCCGCTCCGTCTGCCAGGGAGACATCGGGAAATCCATTCGTGTGTTCATCAAACAGCTCCAGCAATTGGGCGGTGACGCGGTTTACCTTCAGGCTGATATCACAGAGCCGCATGCTGTGCGCCAGCTTATAGAACAGGCTTATCAGGCTTTCGGCCCCGTACGAGGTTTAATTCATGCTGCCGGCCAGATGAGTGCGGTATCGTTTGCAGAAAAGTCACTGGCGGATTTTCAACAGACCTTAAGTGCAAAGATTCAAGGAACCCTGGTGTTGGACCGGGTCTTACATGAATCAATAGAAAAGCAAGCCCTGGACATCGTCATTTATTTTTCTTCCGCTGCTTCTACTTTAGGGGATTTTGGGCAATGCGATTACGCTATTGGCAACCGATTTTTGGATGGCTATGGCCGTTTCCGAGAGGGGTTGCGCACACAGGGGCAGCGCCAGGGCCGCACGGTCGTCGTCAACTGGCCCTTGTGGCGAGAAGGTGGCATGCACCTCGACTCTGAGGCTGAAGCGCTGTATCTGTCTGCTTCGGGGCTGGACTATTTAGAGGCGGAGCAGGGGTTGGACGCGCTAGATCGAATTCTCGTCAGCCCCCATACGCAGGTGATGGTCTTCGCGGGAGACCCGGCGAACATCGACCGCAATCTGGGCGTCAATAAGGTTGTCGATATGCAAGTTGATGAAACGTTTGTCGCGAGCCGCATTGAAGCAGATCTGCAACACCTGGCAGCCGTGCTGCTACAAATGCAGGCGGATGAGATCGCGCTTGATGACAACCTCAGCGCCTATGGGTTTGACTCCATTGCCATCAAAGAATTTGCCGATCAACTGAGCCAGTATTATCAACTTGAAATCTCACCTATCGTATTCTTCGCCCACGCCAGCCTTCGAAGTCTTGGCGCCTACTTTTGGGAGCATTTTGCGGCGGACATGAAAGCGTTTTATGCCGCCGAACCGTCGAACCAGATGCCCGAAGCGAGGCATGCCGAAGCACCTGCACGCCAGGTGTCACAACCCGCTCGCGCCGAAGCTGACCAGGATATCGCCATTATCGGTATGAGCGGCGTGTTCCCCGGTTCACCCGATCTCGCAACCTTCTGGAAACACCTGAGTCGTGGGCGCGATCTGGTCGGAGAAGTGCCTGCCGGGCGCTGGGATTGGCGCGTATACGATGGCGACTTGATGCGTGAGCATGAGGCGAAGAAAACCGCTATCAAATGGGGTGGTTTTATCGAGAATGTCGATCGCTTTGACGCTGATTTCTTTTCTATCTCCCGGCGCGAAGCGGAATTCATGGATCCGCAGCACCGCTTATTTTTGCAATGTGTGTGGGCGACGATCGAAGATGCCGGATACGCCACCGCCGCGTTATCGGGAGAAAACATCGGCGTCTTTGTGGGGGTCCAGTTTAGCGATTATCAACAGCTCTTGAAGCAGGCGGGAGAGCGTGGCGCACAAATTCTCACTGGCAATGCGCATTCGGTGTTAGCCAATCGAATTTCGTATCTGCTGGATGTGCGGGGGCCAAGCCTGGCCATTGATACCGCTTGCGCTAGCAGTTTGGTGGCGGTGCATCAGGGCGTCCAGGCGATACGCAATGGCGATTGTACGGCGGCCATCGTTGGCGGCGTTAGTTTGATGTTGTCGCCAGATACCTTTTTGGATATCAACCACTTGGGTGTGTTGTCCCCGGATGGGCGGTGCAAGACGTTTGATCGTAACGCCAATGGTTATGTGCGGGGCGAAGGGGTTGGCAGCTTTTTATTGAAGCCGTTGTCCCGCGCTTTGCAGGACCGCGATCCGATTCATGGCATTATTCGCGGCAGTGCGGTGCAGCATGGCGGCAAGGCGAATTCCTTAACCGCGCCGAACTCTGAAATGCAGGCGGCGTTGTTGTTAAAAGCCTATGAGGATGCTGGGATTGGCCTCGACACCGTCAGTTATATCGAAACCCACGGTACGGCGACAGAGCTAGGCGATCCCGTCGAAATTGAAGGGTTGAAACAGGCATATCGGACTTATAGACAACAGACCGGCGCGGCAGCAAGTCGGACCGGCGCCTGTGGGTTGGGGTCGGTGAAAACCAACATCGGTCATTTAGAGCCTGCGGCAGGCATTGCCGGATTGGCCAAGGTGCTATTGGCCATGCGCCATCAAATCTTGCCCGCGACATTGCACTTTGATTCGTTAAACCCCTATATCGATTTGAGCGAGAGCCCCTTTTATATCGTTGACGAAAAGACGCCGTGGCAGCGTCGGCTCGATGAGCAGGGCGAGGAGATACCGCGCCGCGCCGGCGTCAGTTCGTTCGGTTTTGGTGGTGCCATTGCGCATCTTGTGCTGGAAGAATATCGAGTGCCGCAAGACACGCTCGAAAACGGTGACGATGATACGTCGCCCTACTTGATTGTCCTGTCCGCGAAGAACGAAGCGCGGCTCAAAGAGGTGGCGACAAATTTGTATGGCCATCTCATTGAAACGGCATCAGTGGCCCCGATCAAGTTGCGCGATCTCGCCTATACCCTGCAAGTCGGGCGCGACGCCTTGCCGCAAAGACTCGCTCTGGTCGTGGACGAAACAGCGCACTTGCTTGATGGGCTGGCGGCTTATGTGCAAGGCGAACCTGATCGAGGCCGATGGTTTGCAGGTACTGCCAGGCGTGACCGCTGCCCGCTCACGTCGCTTGTCGAAGCGGGCGAGGCGATGATCGCCATGCGAATTGAAAAGGAAGCGCTGCGCGAGTTCGCGCAATCTTGGGTGCAAGGTGCGTCGATCAATTGGCAACAGATGTATCCGGTGAACAAGCCCAGGCGTCAATCTTTACCGACATATCCTTTTGCCCAACAAAGATATTGGTTTGATACATCAGCCAATACAAAGCCACAAGAACGTCATGCTGCCGTCGCACCTATTGACAATAAGTCTAACATCGAACGCATCTATTATCGTCGTGAATGGGCTCAGACGGCGTTGCTCTCCCCAGTTTCGATTGAGACGGGTGACCAAGCGCAGTTTGTCCTTCTATTTGAAACGAATCCACAAATAGGCGAGGTCTGGCAGACACAGCTAGAGCAACATGGACTGCGATGTATCAGAGTGTGTATTGGAGAGCGTTTTCGTCTACTGGAGCCACACTATTACCAACTCAACCCACGTCAATATGACGATTACGCCAGCCTGGCTCAGGCGCTTCGACAGAATGCGTCGTGGCCACGTCGCGTGGTTCACCTTTGGCAGTCAAACGAACCGGACGTCAACCATGACCAGCACCTGAGTTTGCAGTTAGAGCGGGGGTTTTATTCGCTTTGTCATTTCACTCGGGCACTCATGCAACACACGTTTGGCGATGCCTGCGACATTCTCTATAGTTATCGCGCTGAAGCCTGGCAGCCCGAGCCCGCTTGTGCAGCCGTGAGCGGTTTTGCCCACACGCTGGCCTTAGAGCATCCGGGATTTTCCTGTAAAACGATTGAGATACCCGCGTTCTTGTCTTATCGCGATGCCCGCACCATCGATCTTTTGCTGTCGGAATTGCAGGGACATGCTTTATCCGACACGACCGTTCGCTATCAGGAGCAAGGCACGTTACAGCGTTGGGTGCAGCACTTTTGTGAATGGCAAGCATCTCCAATCGAGGTTGTATCAAAATACCCGCGTCCCCACGGCGTGTATCTCATCACCGGCGCCAGCGGTAGCTTGGGGGCACAATTCGCCCGCCATATAGCGGCTCAGGTCAAAGCGACCTTTGTTCTGTGCGCCCGCTCTGAGCGAACACCCGCGTGTGAACAACTGATCAACACGCTGCGCACGATGGGTTCCGAGGCCGTCTATATTCGCTCGGATCTCTCCCAACGTGATCACGTCTTCAAACTGATTGAAGAAATTCAAGCGCGTTTTAAGGCTCTGCACGGCATTGTCCATAGTGCAGGGGTCATTAGCGACGCGCTGGTATTTAATAAAACCCATCACCAGATCGCTCAAGTCTTAGCGCCTAAGGTCTATGGTACGGTTTATCTGGATGAGGCCACTAAAGATATTCCACTCGATTTTTGGGTGTTGTTCTCTTCAACCACTGCGGTAACCGGCAATGTCGGGCAAAGTGACTATGCTTGTGCCAATCGTTTTATGGATGAGTTTGCGGTGTGGCGAGAACAATTACGCGGCATGAAACAGCGATCCGGAAAAACCCTTGCCATCAACTGGCCATACTGGCGCGACGGCGGCATGTCGATGTCCGAGCCGGGTTACCAGGGGTGGATGGAACGAACTGGGCTTCAGGCGCTGCCTACCAGCGAGGGGGTCGCGGCTTGGGATGATTTGTTGAACGCACCAAGTGGGCACGCCTATGTCGTCGCTTACGGCTTTAGGGAGTTGCTCAGTCGCATGTTTGCAAGGCCGCAGAGTGCTGCGGCGCAGCCGAGCGCTGATGAACGGGCTACATCGAGCGAGACGCTTTATGAAGACACGATGAGCTGGTTGCAACATGAAATTGCCTCGGTGGTCAAAGCATCGCCGCAAGATATTGACGTAGATACCGCCTTTCATCAATTCGGCTTGGATTCGGTCGTGATGCGTCAGACCAATGTTGTGTTGGAGAAAAAACTCGGTGCATTGCCAAAAACACTATTATTGGAATATACAACCATTCGTGACTTAACCGACCATTTATCTACACAGTATATTCGTGAACTCAATGGTGTTTTAGGAAGTGCGTTTTTAGAACAGAGCCCAAATGGTGAAAGACAAGTCCGCAAGAGAGTTGGGTCGGAAAATTCAATGCGTAACGGTATCTTTAGTGCCGAACCTATTGACAGTCAAGCACTCGAGCAGGAACAGACCAATAACTTAGAAGAGATTGCGATCGTCGGTCTGAGCGGGCGTTACCCTCAAGCAGAGGACCTGGATGAGTTTTGGGAGAACCTCAAAGCTGGAAAAAGCGCTATCGCCGACATCCCGGACAGCCGCTGGGATTACAGAGCCTATTACGATGCCGACCCTGACCAGGCGAGTAGGGGCAAGATGTATTGTTCTCAGGGTGGGTTTTTAAACGATATTGATCAATTTGATCCTCTGTTTTTTAATATCACGCCGCTGGAAGCGAAAAGCATGCCTCCCGAAGAGCGACTGATGTTGGAAACGGTGTGGTCGACATTGGAAGATGCAGGTTATGCCGGCGAACACATGCGTAGCCAGAAGGTGGGTGTTTTTGTTGGTGTGACCTCGAACACATATCCACTAGAATGCGATCATAGCGATGGTGTGCGTTATCAGTCGCCGATTGATACTTCCTATTTTAATATACCCAACCGGATTTCTTACTTTTTTAACTTTACGGGTCCCAGCATTGCCATAGATACAGCATGCTCTTCCTCATTGGTCGCCATTCACATGGCATGTGAAAGTCTGCGTCACGGCGAATGTGAGATGGCCATTGCCGGAGGTGTTAATCTTTATCTGCACCCTTCGAAATATATCTTAATGTGTCAGAAGAGACTATTATCCACCAAAATATCTACCGGTATGTTTGAAGAGGGTGGTGACGGATTTATACCTGGGGAGGGCGTGGGCGCTGTTGTACTCAAGCCGCTTACACAGGCGGTGCGCGACCGTGACAATATTTATGGTGTGATCAAAGCTTCCTCTGTTTTTCATAAAGGACGCAGTAATGGCTATTTACTACCGTCTCCTGAAAGTCAGACTGAACTCTTGCGACAGACTTTGCAACAAGCCAAGGTAGCACCGGAGACGATCAACTACATCGAGGTTCAGGCTTTAGGCTCGGAGATGGTTGATCAAGTGGAATGGCGCAGCTTGATCCAGGCTTACGGGGCTAAAGGCAAAAGTGATGAATACAAACCGTACTGTGGTTTAGGTTCATTGAAACCCAATATTGGCCATTTGGAAGCTGCTTCGGGCATTGCTCAGCTGAGCAAAGTCCTGCTGCAAATGAAATACTGCCAGTTTCTCCCCAGCAACGTCTCAGATCGCAGAGACCCGATTTTAGACGCGAGTATCAACCATCCCGATTCGCCTTTTTATTTTCAAGGTGAATGGAGGGTTTGGGAACGGGTTTCACGACAACGTGACGACACGGTTGGCCTGACAGTGCAGCCAAGGCGAGCGGGCATCAATTCTTTTGGCGCTGGGGGGGTGAACGCGCATGTGATCGTCGAAGAATATATCTCGCCAGTAGAATCCAGTCATGCGCCCCGGTTGGAGGAAGAGTCCGCCGCGCTGATTGTGGTGTCGTCAAAAACTCAACAGCAGTTGCGTCAAGCACTGGTCCGATTGAGAGCATACCTACTACGCGAGGCGAATCGTGCGGATGGGCCGTCCGATCGGGTTTCCCTTGCTGACATCGCGTTCACGCTTCAACAGGGGCGCGAAGCCTTCGCCGAGCGCTGGGCGATGGTGGCTAAAAGCAAGGCACAATTGCTAGAGTCACTCACTCGCTTTCTAGATGATAAGACCGTACATGCACCTCTTTTTGTTGGCCGTGTGCCTTCAACGAATCATGAAAATCATGTGTTCATGACTCATGATCGTATCGAAGCATTATGGCATAGTCATCAACTAGAGAAGCTTGCGCAATTGTGGAGACAAGGCCAGAATATCTCCTGGGAGCATCTCTCTTATCGCTATTCTCCGCGCCGTGTGTCACTACCAACTTACCCCTTTGAAAAACGCCACTGCTGGTGGGGAACATCGGACGATAAAGATCCTGTCGAAGTCACTGCTCAAAGTATGCCTGATCTCATTTCCCAAAAAACACATGAAACCCGAGTTAATATGTCAGATATAGGTCAAGTTGTTGCCGATTACTATGACCAAGTTACTGAATCTCTGAAACAAAAAATAGGCTCTCAAGAGGTCTATCTGCTCTTTGCCCCCTTTCAAGAGCGTGTTGAAGGCTTTTCCTGGTTGAAGATGTTTTTTGAACCTGAAAAACATCGCGAGCATTTTGAGCTGACCTTGCAAAAACAACATGAGCTCAAATCCATGCTTTACCGCCTGGTAGAGTTTGCGAACGTACATCGCATTTTTGATATTGGCTGCGGCTATGCTACCGATTTAATCCAACTCGCAAAGCGCCATCCGCAGGTGAGGGGCTGGGGTTTTAGCATCTCGCTCAATCAAGTTGAATTCGGTCAGCAGCGTATTCAAGACGAAGGTCTTGGTGAACGTGTGCAGCTCTCTTGCAACGATAGCACCAAAGACCCATTGCCAGGTCTGTTTGATTTGATTATTGGCTTCGAGGTCGTCGTACATATTGCTGATAAACAAGGCGTATTTGGCAATATGGCGCGACATCTCAGCAATAATGGTACCATTGTCCTGGCTGATTGTGTGGCCAATACTGTAACTTCCATTAACACCTCTTATATAGGGCAATATACAAGCACTGCCGAAGAGTATAGTGATATCCTAGCTCAGAATGGTTTGGCCATTGTCGACTGTGTAGATGTTGGACCTGAGATAAGTAATTTTTTATACGACCCTAATTATTTAGAGAATGCTGCTTATTTAAGTTCGATTTATCCAGAGATGGTAAATATTGAAAAAGAACATCAAGGCTGGAGTAACTTCGGAAAGGCTTTGGAGGTAAACCTGGTCCGTTATGTGCTACTTACTATTCGAAAAGCTACTGCCTCTCAAACTTATGATCATCTATTACAGATTAACCTGGAGCGCTTAGGCTCTGGAGCTCTGTCGTATGCTGAGGCGCTTCAAGCCTACCCCCATATAGAGCAAATCGTCATAGAGCAAATCGCCGAAACGAAAAGCCCTGATTCGAATGCAACTACCACATCCGTGGCAGATATCGAACAGACCATTGTGGAGCTGGCCGCTCAGGTGCTTGAAATGATGCCTGACGAAGTGAATACGCAAGCGCGCTTCATTGATTTTGGGGTAGATTCGTTGCGCGGTTTGATTTTGTTGGACGCGGTCAATCGGCGCTTAGGGCTGACTTTACAGATTCCAGTGTTGTTTGATCATTCCAGTATTCATGAATTGAGTATATATATTGCCTCCCAGCTTCCGTCTTCACCCCAAGCTGTTGTGTCCGCTCCTGCCGCCTCTGTACCCGTTGTCTCACCCGCCGTCGCGGTCAGCTCTGTGCGCTCTGTCGCTTCTAGTCATACCGCGCATTCCGATATCGCCGTGATCGGTATGTCCGGACGTTTTCCGGGGGCGCCTGATCTGCATACTTTTTGGCAAAACTTAGAGCAGGGTATCGACAGTATATCTGAAGTGCCTCCCACGCGTTGGGAGCTTACGCAGTACTATGACGCCGATCGCCGCCTACCCAACCACAGCTATAGTAAATGGGGTGGCTTCCTGGATGATGTGGATCAATTCGATCCCAAGTTTTTTAATATTTCTCCAGCCGAGGCAGAGTTGATGGATCCGCAGCAGCGGCTGTTTCTGCAAACCAGCTGGAACGCGCTGGAGGATACCGGATATGCGGGTCAAACCCTGGATGGCATGAAGTGTGGCGTCTATGTGGGGGTGTTGAATCACGCATACGATATCCTGATCGATCGCGCTAACATTTCCCAGCATCGTGCGTATGCTTTGCTGGGCAATAGTTCGTCAATTTTGGCGGCGCGCATTGCCTATCTGCTCAACCTTAAAGGCCCTGCCGTCACCCTAGACACCGCCTGTTCCTCTTCGTTGGTCGCGCTGCACTGGGCTTGTAAAAGCCTCCGGGACGACGAAGTAGATATGATGTTAGCCGGTGGGGTGACTCTTTATCTGGGGGAAAGAGAGTATATTGAGGCGAGCCAGGCGGGGATGCTCTCCCCCACGGGCAAATGCCGAGCTTTTTCTCAGGAGGCCGACGGGATCACTTTGGCAGAAGGGGTGGGTGTTGTCGTGTTGAAACGTTTAGATAAAGCTCTGCAGGATCGCGATGCGATCTACGGTGTGATCAAAGGTACCGGGATCAACCAGGATGGCAAAACGAACGGCATTACCGCGCCTAGCGCCAAATCGCAGTATGAACTGCAAACTGAGGTCTATACGCGATACGGCATTCGTCCCGAGCGCATTAGCTACGTAGAAGCGCATGGTACGGGAACAAAGTTAGGCGATCCCATTGAAGTGGAAGCATTGACGCAAAGTTTTAGGCAGTATACCCAGAAACAAAATTATTGTGCCATTGGCTCCGTCAAAAGTAATATTGGTCATACTTCTGCCGCCGCGGGCATCGCAGGCTTGATTAAAATTTTACTGAGTTTGCAGCATCATTCTATACCTCCCACACTGCATGTAGAGCATAAAAATGAACACATTAACTTTAGGGACAGTCCGTTTTACGTCAATACCCAGCTTCGTCCCTGGACCCATGAAGATGATTTGCCAAGACAGGCCGCTGTAAGCTCCTTTGGTTTTAGCGGTACAAACTGCCATGTGGTTGTGGAAGAGCCGCCCGCTCGCATTGTTCATCAACATATCGCATCAACATTAGACGCTCCCGTATTGATGGTACTTTCAGCTGCAAATCAAGATCGGCTGCGGGGCTATGTGGCGTTGATGATTCGCTATCTCGAAGCAAGAAAGACGCGTCAACATACCCGCAAGGCATGGCCATCTGACAGCCTGACTGATATCGCGTATACCCTGCAAACCGGGCGAACGCCACTAGAGCAACGTCTCGCTATGGTCGTTGCCAGTGAAGACGAATGGCTCGACAAGCTACGACGCTATGAGCGTGGCGAAAACGTGATTGATGCCTGTTACGAGGGCCAGGCAAATGCCGAGCCCGCCAAACTGGATTTGCTCATCGAGGGAGAGGAAGGTCGAGCGTTTATCGAATCTATCGTGCGCCGAAAAAACCTGTCTAAACTCGCCCAGTTATGGGTTGGCGGAACCGATATTGACTGGACCTTACTCTATCATCGCCCTTCGTCAGATGCTGCCGTGTTGCCCCAGCGAATTTCGCTGCCAGGTTACCCGTTCGCGCGAGAATCGTATTGGCTTGCCGCGCCAACGCTAGCCGCTTCTTCGTTGGTGGTCGAGCGGTTGCCCCATCAAGATGACATCTGTTTTAAAACCGTGTTGAGTGGCGATGCCTTTTTTCTGCGCGATCATTGTATCGACAGGCAAAAAGTCTTACCCGGTGTCGTTTATTTGGAAATGGCCAGGAAAGCAGCTACCAGCTTTCGTCCTGATGCCCCGCAGCCCGTACTCAAAAATGTGATTTGGCTTCGTCCACTCATGGTCAATGCGACAGATGTCGTGGCCTACACACGTCTGAAGCAACAGGCGCAGCGGATTGATTTTGAAATTTCAACCTTGGATGAGCAGAACAACCGGGTGCTACATGCTCAGGGACAATTGCACGATCCGGAGCCGGTTACGCCACAGCATCCGGATTGGCCCTCATTTGATCTTCGGCTTATTCAAGAGCGTTGCCCACGTACGCTAGAAGGCGAAGCGTTTTTCCAGGCCATACAGGCGCAGGGCTTTCGTACCGGGCCGAGTTTTCAGGTGGTCCGGAAAGCCTGGTATAACCAAACCGAAGCTCTGTGTGAGTTGGGCCTGCCGGCGTTGCGCGAAGCTGATTTTCAAGACTACCTACTGCATCCTTCACTCGTCAATGCCGCACTGGAGTCGGTGATTCTATTGATCGCGAAGGACCCCTCGGCATCTGACGCTCCTCATCTTCCCTACACGTTGGGCACATGGGCATATGACGACACGGTTTGGCCGACATCGCTATATGCGTATGCGCGACTGACCGCACCTCAGCCGGAGACAGAGGCTTTGACTGCCGCTACCACGGTTCAACGGTATGAGATCAATCTGTTGGATCGCAGCGGCAGACTGATCGCACGCGGCAAAGATTTTTGTGTTCGTGCGTTGCGCTCAAGTGGCGAGACACGGCCTGCCAGCTCCGCGGCCCAGTATCCGGTCAAGTATTATTATCCGCGGTGGGAGGCATGTGAAAACGAACGTGTCGCGGCCAATATTGTAGTTGAGCGCAGTTGGCTGGTGTTTGAAACCGAGAATTCGCTCTGGCATGCGCTGGATGAAAAACTGCGTGCGTTGGGTGTCACATGCATTCAGGTTAGACCCGGTTACCGGTTTCAGGTCTTGGAAAAAAGGCGCTACGAAATTCACCCCGAGCGGGCTGGTGACTACCAAAAACTGGTCGCTGAACTCAAACGCAACCACGCAATCCCCGAGCGTATTATTCACGCGTGGTCGGAAGAGCAATGGTGTGACAACGCCGAGCTCGATCCACGATCACTGGCGTGGGGTTTCTATTCCGTGTTTTATCTGAGTCAGGCCTTGATCTCCTGTTGGCAAGATACGCCGCTTCACTTGCTGTATCTCTATCGTCAAGATCAGGACTCACCACAGGCCCACTACGCGGCGGTTCGTGGCTTTGCTCAGTCCCTCACGCATGAACGATTGGATTGGCATTGGAAAACCCTGGCTTTGCCCACCACCCTGCCGCAAGCCCAAGTCGCTAACATGTTATGGGATGAGCTACGGTATGCAAATCAACTGGAGCGCGAAATTCGCTATGACGCAAATCGGCAACGTTGGGTGAGGCGTTGGCATGCAGGTGAAGGGACACCTGGTCAAGGGCCAGCCGCACCCGACACGAGTTTGCTGCGCCAACAAGGCGTATACCTGATTACTGGTGGGGGTGGCGGCCTTAGCCTGCTACTGGGGGAATATCTGGCGCGCGAGTATCAGGCCAAAGTCATTCTCGTAGGCAGAGCCGAGGGGACTGAAGCGCAACAAGCGAAGATAGACAGTTGGAAACGATGGGGGGGAGAAGCGCTCTATTTACAAGGGGATATCTCCCGGCGAGAGGATGTGGATCATGTCATGGCACAGTTGCGCTCTCGCTTTCCTGTCTTGCACGGTGTTTTTCATGCGGCGGGACTCACGCGTGATGCTTCTCTTGTCAACAAAACCGTCCGTGACATCGACGAGGTGCTGGCAGCTAAGGTTTACGGAACCATTTACCTGGATCAAGCTACCCGTAGTGAAGAATTGGACTTTTTTGTCTTATTTTCGTCTCTATCCGGAGTCGTTGGTAATATAGGGCAATCTGACTATGCTTATGCCAATAGCTTTTTGGATCATTTTGCCGAGCGTCGCGAAGCACAACGGAGTATGCAAAAGCGTTTTGGTTTAACGGTTGCAATTGATTGGCCACTGTGGCGTCATGGCACGATGCAGGTAGATGCTACGACCGAGAAATTTCTGGCGCGCTCGATCGGTATGCAGGCGCTAGAGACCGATGACGGTTGGATGGCCCTACAACATGCCTTGGCGGGTTCGAAGAGCCAACTCCTGGTGCTGTGTGGCGATCAGGGGCGATTTAGCCAGGCCTTGGGCGTACAGCAACATCATACAGTTGCCGAGCGGGCTGAGAGCCCGAGTGAAAACCTAAGTGAGACCTCGAGCTTCGATTTACTAACGCATTTGCAGATTGACCTCAGGTCCATCATGGCTGCCGTACTCAAGCTGAGCCCTCAGGAGATCGAGTGGGAGCGTGAGATGAGCAGCTTTGGCTTTGATTCCATTTCGTTTGTCGCTTTGGCTAACGAGTTGAATGATACTTTCGAGTTGGATCTTTTGCCTGCCGTGTTTTTTGAGTGTTTGAACGCTGGTGATTTGCTCAAACACTTGCACCACCACCACTGTGACGCCTTATTTGCGTATTACCGTAGACGTGTGCCTGAACCTGCGGCGCAAGAAGTGTTAGGTACGCCGGGACAAGCCAACGTTGAGGGGCCGGTTCATGTACGTCAATTGGAAAAACCGAGCGGCCTTAATCACCATGCCGGCACAGAGCCGATAGCCATTGTTGGCATGAGTGCTGTGATGCCGCAGTCCCCCGACCTGGAGACGTTTTGGCAGCACCTGGCGGCGGGGCAGGATTTGATCACAGAGATCCCCAAAGACCGATGGGACTGGCAAAACGCAGGAGGTGATACGACGATTCGCTGGGGCGGTTTTATGCCGGATATCGATCAATTCGACGCGCTGTTTTTTGGTATTTCGCCTCGTGAAGCCGACCTGATGGACCCGCAGCAACGCCTGTTGCTTCAGACCGTGTGGAAAACCATCGAGCACGCGGGTTACAAAGCCTCGGATTTATCCGGGAGCGATACCGGCGTTTTTGTCGGAGTTGCCAATTCCGATTATCGCGAGCTGATCCATGCGGCAGGGCCTGGGATCGATGCGCAAAGCTCTACCGGAACGTTTTCCTCGATCTTAGCCAATCGGGTGTCGTACATTTTCAATTTTACCGGCCCAAGCGAGCCCATTGACACGGCTTGCTCCAGCTCTTTGGTGGCGCTCCACCACGCGTTGAATGCGTTATCCCGTGGCGAATGCTCCAGCGCCATCGTTGGTGGCGTGAATGCGTTGTTAACCCCAACCCTCCATATTACCAGCAACAAGACCGGCATGTTGAGCCACGATGGGCGCTGCAAAACCTTTGATCAAGCGGCGAATGGCTATGTGCGGGGAGAGGGGGTTGCCGCGCTCTTGTTAAAACCGCTCAGCCTGGCTAAAGCGCAGGGGGACGAAATTTATGCGCTGATTCAAGGTAGCAATGTAAACCATGGTGGACACGCCACCTCCCTCACTGCGCCCAACCCCCGGGCACAGGCTGAATTGCTGATCCACGCCTATGAAGATGCAGGTATCGACCCCACAACCGTCACCTATATTGAAACCCATGGCACCGGAACAAGCCTGGGGGATCCGATTGAAATCAGTGGTTTAAAGCAGGCTTTTGCCACTTTGTATGAGCGTTTTGGTCACGTGGCCGATGTTTCCGCTTACCATCGGTGTGGTCTTGGCTCTGTTAAAACCAATGTCGGTCACCTGGAAGCAGCAGCAGGCATGGCTGGACTGCTCAAAGTGGTTTTAGCCATGCATCACAAAACCTTACCTGCACATCTTCATTTTCATAACCTCAACCCGTATATCGATTTGAGCGGCAGTCCTTTCTATATTACCCGGCAAACTTGTTCCTGGGACGCTTTACAAGATGCTGCCGGTAAGGCGCTTCCCCGGCGTGCCGGTGTCAGCTCGTTTGGTTTTGGTGGCGTCAATGCACATGTCATTGTTGAGGAATATGTTGAGGACCGGCATGAAGACAGATAG", "orf_prot_sequence": "MEAKDIAVIGVGVLFPGASHHDLFWENLIAGIDSIQEIPVSRWDIDAYYSPDFNEPGKSISKWGGLIQGIDQFDHQFFNISPREARNMDPQQRLLLQEAWHCVEDSGIALKTLQEKVTSVFVGVMAIDYHQHMAQSRQPVDSYACLGNYGSILANRLSFCLGLSGESKAIDAACASSLVAVHDARRSLQAGECDYAIAAGVSVICHPWKYISFSKSRMLSPSGRCKTFDKSADGYVPGEGVGVLLMQSLERAQEQKCHIYGVLKGSALNNNGLHGQRHADDRGRKKASITAPSIDAQRRVITDALRSADIDPASVSYVEAHGTGTSLGDPIEIEALKQVFAVPGRTTPSCAIGSVKTNIGHLEAAAGVAGVIKVLLMMKHKMIPQVLHLNTVNPMIDLTDTSLYLSDQLHSWESKEGIQRRAGVSSFGFGGSNAHAIFEEYVDTRHTPQGTLQRTSGEHLFVLSAKSHSSLDGLLNDWVAFLNHPQRSAISLEDMCATLMTGRESFPFRFALSVTDKKALRSALISPPESAFGHAEMPSVLLRIGSVNAEQAAVIASWYRKHPGFREPFDACRRLAKMLCSEEAVRDWTAQFPKVLAEHEALYGFAAAYATARLLLDSGVQPRLICGEGIGHGVALCLSGLWTLSQGLRHAMRLIDQLDLSPQRLDYPIYDQIQGTTLSPYQPSRGYLQALLKNIQVRDDLFIRDLQKALLLHEHQYTFKNYLESWNSALKEIGLEIYQLIGLHAELQEDISKKFLVYIIVAYSLKQLYEKWDLVEYDASSDPFLNEFLDLIGDDVLTFKDVVTLIGNGWDTGKEDLFHGITARVIPVSSVKPYEYLQQYQFERFDHIRSWLEKIGDVPLETPIHEDDLLLTVGDEGDVSRLKIVSNSGHSLSFLTRGQKASHLTEDVRQLWLHGLNIDWQSFVDAGSFTKASLPGYSFDGSPFWIENSRSDSPFIQGEGIKAEPVQNSYYHFVWQASKHPTVLDRKPDVKNNEAILLFDSDASLAQLLREQWHAEIILIRPARAFDWKSWHDVEIDPDNENHYKLVCTALQQKNLRPVCAIFTWTLQESTSTGESLLSHPEPWLSKGIYAVYHLLKSLSQSAHPPLSQLLFFFHGNEGQGNPLMEAVAGYGRSLKLTYPQMRFRSIQFETGSPDTIEVVTAVIREFSLLKGEERQEVDTEVLYRHGQRLIKTPVRLHLDAVAQAPWKQSGVYLITGGMGALGSIWARYLAERYQARLILTGRSVCQGDIGKSIRVFIKQLQQLGGDAVYLQADITEPHAVRQLIEQAYQAFGPVRGLIHAAGQMSAVSFAEKSLADFQQTLSAKIQGTLVLDRVLHESIEKQALDIVIYFSSAASTLGDFGQCDYAIGNRFLDGYGRFREGLRTQGQRQGRTVVVNWPLWREGGMHLDSEAEALYLSASGLDYLEAEQGLDALDRILVSPHTQVMVFAGDPANIDRNLGVNKVVDMQVDETFVASRIEADLQHLAAVLLQMQADEIALDDNLSAYGFDSIAIKEFADQLSQYYQLEISPIVFFAHASLRSLGAYFWEHFAADMKAFYAAEPSNQMPEARHAEAPARQVSQPARAEADQDIAIIGMSGVFPGSPDLATFWKHLSRGRDLVGEVPAGRWDWRVYDGDLMREHEAKKTAIKWGGFIENVDRFDADFFSISRREAEFMDPQHRLFLQCVWATIEDAGYATAALSGENIGVFVGVQFSDYQQLLKQAGERGAQILTGNAHSVLANRISYLLDVRGPSLAIDTACASSLVAVHQGVQAIRNGDCTAAIVGGVSLMLSPDTFLDINHLGVLSPDGRCKTFDRNANGYVRGEGVGSFLLKPLSRALQDRDPIHGIIRGSAVQHGGKANSLTAPNSEMQAALLLKAYEDAGIGLDTVSYIETHGTATELGDPVEIEGLKQAYRTYRQQTGAAASRTGACGLGSVKTNIGHLEPAAGIAGLAKVLLAMRHQILPATLHFDSLNPYIDLSESPFYIVDEKTPWQRRLDEQGEEIPRRAGVSSFGFGGAIAHLVLEEYRVPQDTLENGDDDTSPYLIVLSAKNEARLKEVATNLYGHLIETASVAPIKLRDLAYTLQVGRDALPQRLALVVDETAHLLDGLAAYVQGEPDRGRWFAGTARRDRCPLTSLVEAGEAMIAMRIEKEALREFAQSWVQGASINWQQMYPVNKPRRQSLPTYPFAQQRYWFDTSANTKPQERHAAVAPIDNKSNIERIYYRREWAQTALLSPVSIETGDQAQFVLLFETNPQIGEVWQTQLEQHGLRCIRVCIGERFRLLEPHYYQLNPRQYDDYASLAQALRQNASWPRRVVHLWQSNEPDVNHDQHLSLQLERGFYSLCHFTRALMQHTFGDACDILYSYRAEAWQPEPACAAVSGFAHTLALEHPGFSCKTIEIPAFLSYRDARTIDLLLSELQGHALSDTTVRYQEQGTLQRWVQHFCEWQASPIEVVSKYPRPHGVYLITGASGSLGAQFARHIAAQVKATFVLCARSERTPACEQLINTLRTMGSEAVYIRSDLSQRDHVFKLIEEIQARFKALHGIVHSAGVISDALVFNKTHHQIAQVLAPKVYGTVYLDEATKDIPLDFWVLFSSTTAVTGNVGQSDYACANRFMDEFAVWREQLRGMKQRSGKTLAINWPYWRDGGMSMSEPGYQGWMERTGLQALPTSEGVAAWDDLLNAPSGHAYVVAYGFRELLSRMFARPQSAAAQPSADERATSSETLYEDTMSWLQHEIASVVKASPQDIDVDTAFHQFGLDSVVMRQTNVVLEKKLGALPKTLLLEYTTIRDLTDHLSTQYIRELNGVLGSAFLEQSPNGERQVRKRVGSENSMRNGIFSAEPIDSQALEQEQTNNLEEIAIVGLSGRYPQAEDLDEFWENLKAGKSAIADIPDSRWDYRAYYDADPDQASRGKMYCSQGGFLNDIDQFDPLFFNITPLEAKSMPPEERLMLETVWSTLEDAGYAGEHMRSQKVGVFVGVTSNTYPLECDHSDGVRYQSPIDTSYFNIPNRISYFFNFTGPSIAIDTACSSSLVAIHMACESLRHGECEMAIAGGVNLYLHPSKYILMCQKRLLSTKISTGMFEEGGDGFIPGEGVGAVVLKPLTQAVRDRDNIYGVIKASSVFHKGRSNGYLLPSPESQTELLRQTLQQAKVAPETINYIEVQALGSEMVDQVEWRSLIQAYGAKGKSDEYKPYCGLGSLKPNIGHLEAASGIAQLSKVLLQMKYCQFLPSNVSDRRDPILDASINHPDSPFYFQGEWRVWERVSRQRDDTVGLTVQPRRAGINSFGAGGVNAHVIVEEYISPVESSHAPRLEEESAALIVVSSKTQQQLRQALVRLRAYLLREANRADGPSDRVSLADIAFTLQQGREAFAERWAMVAKSKAQLLESLTRFLDDKTVHAPLFVGRVPSTNHENHVFMTHDRIEALWHSHQLEKLAQLWRQGQNISWEHLSYRYSPRRVSLPTYPFEKRHCWWGTSDDKDPVEVTAQSMPDLISQKTHETRVNMSDIGQVVADYYDQVTESLKQKIGSQEVYLLFAPFQERVEGFSWLKMFFEPEKHREHFELTLQKQHELKSMLYRLVEFANVHRIFDIGCGYATDLIQLAKRHPQVRGWGFSISLNQVEFGQQRIQDEGLGERVQLSCNDSTKDPLPGLFDLIIGFEVVVHIADKQGVFGNMARHLSNNGTIVLADCVANTVTSINTSYIGQYTSTAEEYSDILAQNGLAIVDCVDVGPEISNFLYDPNYLENAAYLSSIYPEMVNIEKEHQGWSNFGKALEVNLVRYVLLTIRKATASQTYDHLLQINLERLGSGALSYAEALQAYPHIEQIVIEQIAETKSPDSNATTTSVADIEQTIVELAAQVLEMMPDEVNTQARFIDFGVDSLRGLILLDAVNRRLGLTLQIPVLFDHSSIHELSIYIASQLPSSPQAVVSAPAASVPVVSPAVAVSSVRSVASSHTAHSDIAVIGMSGRFPGAPDLHTFWQNLEQGIDSISEVPPTRWELTQYYDADRRLPNHSYSKWGGFLDDVDQFDPKFFNISPAEAELMDPQQRLFLQTSWNALEDTGYAGQTLDGMKCGVYVGVLNHAYDILIDRANISQHRAYALLGNSSSILAARIAYLLNLKGPAVTLDTACSSSLVALHWACKSLRDDEVDMMLAGGVTLYLGEREYIEASQAGMLSPTGKCRAFSQEADGITLAEGVGVVVLKRLDKALQDRDAIYGVIKGTGINQDGKTNGITAPSAKSQYELQTEVYTRYGIRPERISYVEAHGTGTKLGDPIEVEALTQSFRQYTQKQNYCAIGSVKSNIGHTSAAAGIAGLIKILLSLQHHSIPPTLHVEHKNEHINFRDSPFYVNTQLRPWTHEDDLPRQAAVSSFGFSGTNCHVVVEEPPARIVHQHIASTLDAPVLMVLSAANQDRLRGYVALMIRYLEARKTRQHTRKAWPSDSLTDIAYTLQTGRTPLEQRLAMVVASEDEWLDKLRRYERGENVIDACYEGQANAEPAKLDLLIEGEEGRAFIESIVRRKNLSKLAQLWVGGTDIDWTLLYHRPSSDAAVLPQRISLPGYPFARESYWLAAPTLAASSLVVERLPHQDDICFKTVLSGDAFFLRDHCIDRQKVLPGVVYLEMARKAATSFRPDAPQPVLKNVIWLRPLMVNATDVVAYTRLKQQAQRIDFEISTLDEQNNRVLHAQGQLHDPEPVTPQHPDWPSFDLRLIQERCPRTLEGEAFFQAIQAQGFRTGPSFQVVRKAWYNQTEALCELGLPALREADFQDYLLHPSLVNAALESVILLIAKDPSASDAPHLPYTLGTWAYDDTVWPTSLYAYARLTAPQPETEALTAATTVQRYEINLLDRSGRLIARGKDFCVRALRSSGETRPASSAAQYPVKYYYPRWEACENERVAANIVVERSWLVFETENSLWHALDEKLRALGVTCIQVRPGYRFQVLEKRRYEIHPERAGDYQKLVAELKRNHAIPERIIHAWSEEQWCDNAELDPRSLAWGFYSVFYLSQALISCWQDTPLHLLYLYRQDQDSPQAHYAAVRGFAQSLTHERLDWHWKTLALPTTLPQAQVANMLWDELRYANQLEREIRYDANRQRWVRRWHAGEGTPGQGPAAPDTSLLRQQGVYLITGGGGGLSLLLGEYLAREYQAKVILVGRAEGTEAQQAKIDSWKRWGGEALYLQGDISRREDVDHVMAQLRSRFPVLHGVFHAAGLTRDASLVNKTVRDIDEVLAAKVYGTIYLDQATRSEELDFFVLFSSLSGVVGNIGQSDYAYANSFLDHFAERREAQRSMQKRFGLTVAIDWPLWRHGTMQVDATTEKFLARSIGMQALETDDGWMALQHALAGSKSQLLVLCGDQGRFSQALGVQQHHTVAERAESPSENLSETSSFDLLTHLQIDLRSIMAAVLKLSPQEIEWEREMSSFGFDSISFVALANELNDTFELDLLPAVFFECLNAGDLLKHLHHHHCDALFAYYRRRVPEPAAQEVLGTPGQANVEGPVHVRQLEKPSGLNHHAGTEPIAIVGMSAVMPQSPDLETFWQHLAAGQDLITEIPKDRWDWQNAGGDTTIRWGGFMPDIDQFDALFFGISPREADLMDPQQRLLLQTVWKTIEHAGYKASDLSGSDTGVFVGVANSDYRELIHAAGPGIDAQSSTGTFSSILANRVSYIFNFTGPSEPIDTACSSSLVALHHALNALSRGECSSAIVGGVNALLTPTLHITSNKTGMLSHDGRCKTFDQAANGYVRGEGVAALLLKPLSLAKAQGDEIYALIQGSNVNHGGHATSLTAPNPRAQAELLIHAYEDAGIDPTTVTYIETHGTGTSLGDPIEISGLKQAFATLYERFGHVADVSAYHRCGLGSVKTNVGHLEAAAGMAGLLKVVLAMHHKTLPAHLHFHNLNPYIDLSGSPFYITRQTCSWDALQDAAGKALPRRAGVSSFGFGGVNAHVIVEEYVEDRHEDR", "perc_identity": 22.56}}, "BGC0001186.1|Misakinolide_16 # 33035 # 60031 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.507": {"gnl|BL_ORD_ID|2332|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 33035, "orf_end": 60031, "orf_from": "BGC0001186.1|Misakinolide_16 ", "model_name": "bcr-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "2303", "ARO_accession": "3003801", "ARO_name": "bcr-1", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35972": {"category_aro_accession": "0000055", "category_aro_cvterm_id": "35972", "category_aro_name": "bicyclomycin", "category_aro_description": "Bicyclomycin represents a unique class of antibiotics, discovered in 1972. It is obtained by the fermentation of Streptomyces sapporonensis. In the crystalline form bicyclomycin is observed to be rhombic or monoclinic, depending on the solvent used. This antibiotic kills bacteria by inhibiting the Rho transcription terminator factor, halting ribonucleic acid (RNA) synthesis.", "category_aro_class_name": "Antibiotic"}, "45732": {"category_aro_accession": "3007150", "category_aro_cvterm_id": "45732", "category_aro_name": "bicyclomycin-like antibiotic", "category_aro_description": "A group of antibiotics including bicyclomycin and its analogues.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.37877, "max_identities": 23, "bit_score": 31.187, "cvterm_id": "36752", "query": "HSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGVNLMLTPYGYISMGRAGML", "match": "H G+ A R  +F  L    + + T CS+ LV  H     LR G    A  +G+ L+    GY ++G  G L", "sequence_from_db": "HFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSL-LACVSGLFLL----GYAALGERGGL", "sequence_from_broadstreet": "MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR", "dna_sequence_from_broadstreet": "GTGCCTGCGAGTGCATCGAGGATTCAGGTCGGAAGCGGCGAACGACGCCTGTTGCTGCTGTTGTCGGCGCTGGTGGCGTTCGGCCCGCTGTCGATCGACATGTACCTGCCGAGCCTGCCGGCGATCGCCGCCGATCTCGGCGCCAGCGATGCCCAGGTGCAGCGGAGCATCAGCGGCTTCCTGGTCGGCTTCTGCGTCGGCATGCTGTTCTACGGCCCCTTGTCCGACCGTTTCGGCCGGCGCCCGGTGCTGCTGGCCGGTATCGCCTTGTACCTGTTCAGCAGCCTGGCCTGCGCGCTGGCCGACAGCGCGGGGCAACTGGTCCTGCTGAGGGTGCTCCAGGCCCTCGGCGGCGGCGCCGCGTCGGTGCTGGCGCGGGCCATGGTGCGCGACCTCTATCCGTTGGGCGAGGCCGCCCGGATGCTGGCATTGATGCACATGGTGACCATGCTGGCACCGCTGGCCGCGCCGCTGCTCGGCGGCTACCTGATGCTCTGGGCCGGCTGGCGCGCGTTGTTCGTGGTCCTGGCGCTGTTCGCCGGGCTCTGCCTGCTGGCGGTCTGGCGGGTCGCCGAAAGCCACCCGCCGGAGCGCCGCGGCGGCAGCCTGGCCCAGGCCTTTCTCGCCTATGGGCGGCTGCTCGGCGACCGTCGCGCGCTGGGCTACGTGCTGTGCATGGGGCTGGCGTTCGCCGGGATGTTCGCCTACATCAGCGCCGCGCCCTTCGTGTTCATCGAGCATTTCGGCGTGCGCGCGGAGCGCTTCGGCTGGTTCTTCGGCCTGAACATCCTCGGCGTGATGCTCGCCACCTGGTGCAGCGCGCGCCTGGTGCGCCGCCACGGTCCGCGGCCGCTGCTGCGGGCCGGCAGCCTGCTGGCCTGCGTGTCCGGGCTGTTCCTCCTCGGCTATGCGGCGCTCGGCGAGCGGGGCGGGTTGTGGGCGCTGGTGCCCGGCCTGCTGTGCTTCGTCAGCGTCACCGGCCTGCTCGGCGCCAACTGCATCGCCAGCCTGCTGGCGTTGTATCCCGGACAGGCCGGGGCGGCTTCGGCGGTGGCGGTGTCCGGGCAGTTCGGCCTCGGCTGCCTGGCCAGCCTGGCGGTCGGCTGGCTGGCGCTGCCCGGCGTGCTGCCGATGGCGCTGGTGATGGCCGTCTGCGGCGTCGGCAGCCTGCTCGCGCTGGGCTTGGCCCTGCACGGCGGAAACCGTTGA", "partial": "0", "query_start": 53552, "query_end": 53764, "hit_start": 738, "hit_end": 936, "orf_dna_sequence": "ATGTTGAGGACCGGCATGAAGACAGATAGCCCGAATCATCCAGAAAACCAAGCGATCAATGTCAATCACTATTTAATGGTTTTGTCGGCCAAAACGAAAGAGCGCCTGCAAACGGTGGTTGAAAATCTACTTGACTACGCCAAAGCCAATCGTCGTCTCATCGAGTCCCGCCTTGCGGATGTCGCCTTTACCTTGCAAACGGGCCGCGAGGAGATGGAAGCGCGTTTGGCCTTCGTGGTATCGGATTATCATGATCTGATGGGTCAGTTAAGCGGTTATCTGGAGGATGCGCCCAACGCGAACACGATTTTCCGCGGACAGGTGGATCTGTTTGACCAATCTGCGCCGGTTCGTCAACATCGCGCGGCACAAGAGCGCGACTGCGAACGCATGATACGGACCCACGACCTGCCGGGCTTGGCCGAACTTTTTGTTCAGGGCGTGCCGATTGACTGGCGCCGTTTATATGTGCAGGGTCGCCCCAGGCGCATCGCGCTGCCCAGCTACCCCTTTGCCCCAGAGCGTCACTGGGTGGCGCGCCGGGAGCCTGACCATCTGGCTGCCGATATGCCCGCCGTTCGGCAGCCACACTCGCTGCTTGATGGACGTGATGATCGAATGAGTCTTGAGTCCGGCGTCGTGTTTCGAAAGCTGTTGCGCATTAACGATGGTGTCCTTCAGGATCATCAAGTCAATGAAACACCCGTATTCCCAGGCGTGGCCTATATAGAGATGGCCTGCGAAGCTTTGGCGCAGTTGTCGTTTTCTGATCCGGAGGTGTTGCGGAAGACCGTATTGAACCAAATGGTTTGGCTACAAGCCCTCGCCGTGACAGAGGCCGAGCATGAAATTTTGCTATGCTTGGAAAAAGATACACATGGTCTAGCATTTGAAGTCAAAGATCATCAAACGCTTTATGCCAAGGGCCGTTTCGATCAGTCGGATGACTTGAGTCAAGGCCATCAATACCTGGAACTGGAAACTATAAAAGGTGATTGTCCGCACGAAAAGCATCGCTCGGTCATTTACCATGACTTCCGCCTCTTAGGGCTAAATTATGGACCTTGGTTCCAGGGCTTAGAGCATACTTGGTTCAGTATAGATAGTGCTGAAGGGGAGGGTGAAGCGCTCGGCTATTTTAACATGCCGTTGATTTGCGAGTCGGAATTCTCCGCTTATACCTTTCATCCTGGCCTGTTGGATGCGGCATTGCAAGTCGTTGCCAGCGTGCCCGGATACGCTGACTCTGGCTTATTACTTCCCTATGCGGTAGAAAAGCTGGAGTGGTTCCACCCGTTTCCTGCTTGCGGATATTCCCATGTTCGCAAGCTGGCGAAGCATCGCTACGATGTCACCATCTGCGATGAACAAGGCAAGGTCTGCGCTAAATTTTCTGATCTTAGTGTTAGGCCCAGCCGAGTCGCAGGCTCAGAGCCCAGCCTGAATCAGCTGACCTACCGGGCGCGCTGGTCGCACCAAGAACTTGGGGAAAGACGATCGCCAGCAGGCCGTCCCGAAGAAACCGGAGTCGTGTTCATCATTCACACTCCGGAACAGCAGGCATTGGTACAAGAGCTAAGCAGCGTTTTAGCAGACATGCATGGCGATCATCGAGTACGACGGATGTGCCTAAATGCAAACGACTGGGATTTTAAATCGTTAGGGAATTGGAATCACCGTATTCGCGCCGTTCAGGACTTGCGCGATATCTATTTTCTTGCTGCTATGGAGCATACCGTTTCGAGCGGACAGGCCCATGTGGATCCTCTCTCTTTTACCAACCGACAGGAGCATGGGCTGCTCTCTTTATTCCGCTTGCTCAAAGCGCTGGATCAGAACCAGTTACTACTGCAACCGCTGTCGTTAAAAGTCCTAACGACAGGAAATTATCGCGTTTTGCCAAGCGATACGATTTGCCCTTTGAGTGCCGGTTTACCAGGTTTTTGCCGCTCCATTGCTCAGGAATACCCCTTGCTCGCTCTCAGTTGTATCGATCTCGGATGCCCGGATGGCGACGCCATGCAGCCATCCTCGCTTAAAAAACTGGCGCAGTTCATCGTTGCTGAGCCCGCGCATCAGCCTCATGAAACCGTCGGCATACGTGAACTCCGGCGCTATACTCGCAAGCTTGTTCCCGTTCGTTTTCCCGAACCCGGAGGGCAAAGAGCTTTTAAATCCCGAGGCGTCTACATGATCGTTGGCGGAGCTGGGGGCATTGGGATGGTGCTGGCCCAGTACCTGGCCGAGCGTGTTCAGGCGCGTCTGGTCTTGGTGGGCAGAAGTGCTTTGGATGAGGAGAAAAAGCAAAACCTTTCGACGCTCACTGCCGCCGGTGGAGAAGCCCTATATATCCAGGCAGATATCAGTCGTCTGTACAGCATGAAAGATGCCGTCGCCCAAGCCCGTCAGCGTTTTGGCAACATCAACGGTGTGGTGCATTCCGCCATGGTTTTAAATGACCAAAGCTTGGCCCGTATGAGTGAAGAGGGGTTGCGGGCCAGCCTGGCGCCAAAAGTCGAAGGCTGTATCGTGTTGCAGCAGGCGATGGCCGGTGAGCCACTGGATTTTATGTTGTTCTTTTCTTCGGCAATCTCCTTTAGCGGCAACGCCGGACAAAGTAACTATGCAGCAGCTAGTACATTTAAGGATGCCTTTGCCCATTATCTGACGCAAGTGGAAGCTTATCCCGTATTTAACATCAACTGGGGATATTGGGGGTGTGTTGGTGTGGTTGCGAATGCAGCTTACCGTGAACGTTGGGCAGCTCGAGGAGTCCATTCTATTGACCCAGAACAGGGTCTGCAAGTCATTGAATCGATCCTGACTAACCATATTGATCAAGTCGCTGCGGTGAATGTCGAGCCGTCTTTTCTAGAGCGCCTGGGCGTAGAACTGTCTCAAACACAAACTGTACTCCCACCACGTCGCTCGTCGCTGATTGCAAAACTTAATGCGTTGCCACTGCCGGAAACCGGGGGTTTTCAAGATAATGTTAATCGCCTAGAGATCGTGAGTGCATTCCGCTGGGCTGAAGTGTTTAAGCATATGCTTGATATGTCTAGCACTCAGGGAATGTATGCTCGCTCTGATCTTAAACGACAATTACAGATTAGCTCTGAACACGATCAGTTGTTTGATGTTCTCATTTCTATGCTCATTCAAGAGGGCTATCTCCATCAGCAGGGCAAAAATCTGACGCCTACACCTTACTTGAATGGCGAGTTTTTCCAGCAGCAGAGAGAACAAGTCGCATTGCTGGAAAGTGAGCTGTCGCAAACGGATAATGCCTATTTAAACTTGTTATCTCGCTGTCTGGATCACTATCCCGCTATGTTGCGCGGTGAAGTGGCGGCAACTGATGTGATATTCCCACAGGGCTCGATGGAATGGGTGGAAGGTATCTACCGCAGCCATGCTTCAGCCGACTATTTTAATCAGCAATTGGCCCAACGCCTCGTTGCCTATGTTGAGGCCCGCTTGCCTTCCCTGGGTGCGAATGAATCGATTCATATCCTAGAAATTGGCGCCGGCACCGGCGGCACCAGCGCCATTGTATTACAGGCGCTCCAGCCTTATGCAGCTCGCCTGCGTTATACCTACTCCGATATCTCGCCTGGTTTCCTCAATTACGGGCGCAAAACCTTTGGCGACGCGTATCCGTTTGTCGAATTCAGACACTTAAATATTGAACACAATGGCGAAGCTCAGGGCTATCAAGCAGGCGAGTACGATTTGGTCCTGGCGGCCAATGTGTTGCACGCTACCCGTCACATTGGCAACACCTTGGCCCGGGTTAAGTTTTTCATGAAACGCCATGGCTGGCTGTTATTGAATGAAGCCACCCAAGTGCGCCATTTTGGGACGTTGACCTTTGGTTTGCTAAAAGGTTGGTGGTTGTTTCAAGACGCTGAAAACCGGCTTGACGGATCGCCTTTGCTGTCAACCACTGCCTGGCAGCGGTTACTGTCGGAAGAGGGGTTCAAGCACACGCTTAGTTTGTGCGACGCGGTTGAAGAAGAGTCAATTTTTCAGGATGTCATTGTTGCTGAAAGTGATGGTGTCATTCAAATGAATCAGTCGGATTCACCTGTGCAGCCGCGTGAGCCTGTGGATGTGTCTGTGGATGTCCATCATGTCGATGACATGATGGAGCCTGGGCAAGTGGCGGATGTGGTTGAGTCACGACATGATTTTATCGTCAATAGCGTCAGCCAATGTATGGCTCAGTCTTTAGGTGTGGCGTTTACCGACATTCACATCAATCGTCCATTTAGCCTTTATGGTGTGGATTCGATCACGGGAGTTGATTTTATTCATCAGATCAATTCCCGTTTAGGGATCGTTTTGCGAACGACGGCCTTATTTGATCACGCGACGATTTTTGATTTATCCCGTTTTATCGACGAGAGCCACGGCGCGGCGATTGACGAGCAGCGTCAGCGCTTGAGGTCAACACCGTTGACCTCAAGCGATACGAAGCCAGCGGAGCGTGTCGCCCCGCCGGATGAAGCGCTTCCCCATATCGAAAGGGGCTGTCACCAGGCGGTCGTACTGGAAAAACCCAGCCAGATCGAGCACCTTCGCTTCCATCCCGTGAAAACCCGGGAACCTGCGGCGCATGAGGTGCAAATTGCAGTTCGCGCTTTTTCGCTCAACTTCGGGGATTTGCTATGCGTGACCGGGCTCTATCCCACCATGCCGGCGTATCCATTTACACCGGGCTTTGAAGTGTCCGGGCACGTCGCCAACGTGGGAGCGGCGGTCAGCCACGTTGCGGTGGGCGACGAGGTCATTGCCCTAGCGGGCCAGCAGTTGGGCGGCCACAGTACGCTGTTGACCACTGCAGGACACTTGGTGGTTCACAAACCGCGTCAGGTCAGCCACGAGGAAGCTTGCGCGTTTCCCGGCGTTTTTCTGACCGTCTACCATGCGTTTCAAAGCGCCAATATTCAAGCTGGGGAAAAAGTTTTGATTCAAGGCGCGGCCGGGGGAACGGGCTTAATTGCTGTACAAATGGCCCAGGCGGTGGGAGCGGAAATTTATGCCACAGCCGGTTCGCCCCAAAAACTGGATTATCTGCGTGAACGAGGCGTGCCGCATCTGATCAATTACCAGACGGACGATTTCGCCGAGGTCATTTTAGCAGATACAAACGGTTATGGCGTGGACGTGATCTTCAATACAGCAGCCGGGGACGCCATGCAAAAAGGGCTGGACATTCTGGCTCCCAATGGACGCTATTTGGAAATTGCGATGGTCGCCCTGAAGCGTTCGCGGTCGGTTGATTTATCTCATTTGGTTGATAATCAGGTGTTTTATAGCATCGATATGAGAAAGCTGATCGCTGGAAACCCACAGCTGATCAGCCGCTATCTGAATCGCATGGTGGAGCATCTGGCAGAAGGGCACGTGCAGCCGACGATAGGCGCAAGATTTGCGCTTGATGATATTCAAAGCGCCTACCGGCTGCTACACGACCGGCAAAATATTGGCAAAGTTGTTGTCAGTATCCCCGATGGGATGATGGACAATCAGGTCGGCCAAAGGATGGTGCCGGAATCCTCAACGGTTGAGGACTATCGCGTTGGAAACGCCACGGTTGAACAGGTTGCGGTAAAACAACCGGCGGACATGGATGAGCCGATTGCCGTTGTCGGTATGTCCGGCCGTTTTCCCGGGGCAAACAACTTGGAGCAGTTCTGGTTGAATCTTATAGGTGGCAACAACGCGATCACCGAAGTTCCCGCTGACCGCTGGGATGTCCATCAGTGGTATGACCCCGACCCGGCAGTCCTTGATAAGACCCATTGCAGATGGGGCGGTTTTCTGCGAGATATTGACAAATTTGATGCGCTGTTTTTTAAACTCTCAGGCCGGGAAGCCGAGTTGACTGACCCGCAACAGCGTTTATTTCTGGAGGTCGCTTGGGCCGCACTTGAAGATGCGGGGCATGCGAACCGCGCGATTTCCAATGCCCGCTGCGGGGTTTTTGTCGGAGCCGGTCCGAGCGATTACGTCACGTTAATGCGTGAACGGAGCGTGCCCGGCGAGCCCCAGTCATTCTGGGGCAATTCCAGCTCGCTAATCGCGTCGCGCATTGCCTATTTTTTAAACCTGAAAGGGCCGAGTATCACCATTGATACGGCCTGTTCCTCATCTCTGGTCGCCTTGCATTTAGGCTGCGAAAGTATTCGGCGTGGCGAATGCGACATGGTCATTGCCGGTGGCGTGTATATTGGGGTCACACCACACTTACATGTTATTGCTAGCAACGCCGGCATGCTCTCACCCGATGGCCAGTGTAAAGCCTTTGATCAAGGTGCAGATGGCTTTGTCCCGGGTGAAGGCGTTGGCGCGGTGGTCTTAAAACCACTGTCAGTGGCACGTCAAGCCGGTAATTTTATTTATGGGATTATTCGTGGCTCAGGTTCAAATCAAGATGGGCGAACTTATGGTATTACCGCGCCCAGCGCTGCTTCTCAAACAGAGCTAGAGCAAAGTGTCTACCGACAGGCCGAACTCGACCCGGCAAGCATTGGCTATGTTGAAGCTCACGGTACAGGTACCAAACTTGGTGATCCCATTGAGATTGATGCGCTGAATCGTGCCTTCCAAAGTGACGCGAAAAAGCAGCACTCTTGTGCCATTGGATCGGTTAAAACAAATATTGGACACGCTGGTGCGGCTGCCGGTATTGCTGGATTCATTAAGGTCTTATTGTGCCTGCAACATCAACAATTGGTGCCTTCGTTAAATTATCACACGTGTAATGAACATATCGATTTGGACAATAGCCCGTTCTATGTGAATACAGAATCAAAGGATTGGTTCGTCGCTCAGGGTGAGCCGAGACGGGCTGCGGTCAGCAGCTTTGGCTTTAGTGGTACTAATGCGCATATTTTGTTAGAAGAATACCAACACCATGAGGACGAGGCCCAGGCACTTGGAGATGACAAGGATGTGTTGATCGTCCTTTCAGCCAAGAATCAAGAACGTCTCAAAAAAGCGGCTGAAAATCTTCACCATTTTTTAGAAAGCAGAGTCTCCTATAAATTGTCCGACATTGCCTATACGTTGCAGGTTGGCCGTGAGGCGATGGAGGCGCGAGTTGCTTTTATGGTGGTCTCAGTCCTTGACTTACAACAAAAGCTTGTGTCATTGCTTCATGACCCAACAGACGAACAAGACATGTATTGGGGGGAGGTGCGCGATGGCGAGGGGCCTGCTGGAGTGGCTGCTTTTGAAGACGTCGCACTTGCCTTGGCTAACAAGCAGTTGGATCAGCTTGCCCAGTGGTGGGTGTCTGGGGTTGAAATAGACTGGACCCAGCTTGCACGCGTGGTGAAAGTCCGTCTCGTTCCTCTGCCTACGTATCCGTTTTCGCCTGATCGTTACTGGTTTGATTCGGTAGGTCCGGCGACGGTTGTACATGCCGAGCATTCAGCCTCTGCTCTGTATCCCCTATTGAATCGTATCGCTCCGCAGGCGAGCACTCAAATCGCGAACGGCTGCGTGTTTGAGACGTGCTTGAAATCCAGTGACCCTCTGTTGGCGCAACATCTCATTGACGGCCAGGCGGTGTTTCCGGCAGTGGGATTTCTGGAGATGGTCATAGCTGGCCTGCGCGAAATCCAGCCAGATAAAGCAGCGCGGTTGGAGAATGTGTTTTGGCTCCGGCCTCTTGATGTCATGGATGAACAACGCGTTCATCTGGTGTTTGAGGTGAAACAGGATCGTTTTCAATATCGAATTGTACCCGCAGAGTCTCACGGGGACGGGGCCTATTTTCGTGGCCAAGGCTACTGGTCAAACGATATGAATCCTGCGATTCCGATGGATATTGATCGCCTGAAAAGCCGTATGCGCCAACAGCCCTTGCTCAACGAATCCAGCCCCCGAGTCCGCCTGGGCCGCTTGTATCAAGGCGCGACTGAGGGGTGGACGGATGGTGAGCAAGCACTGATCGCCTTTGAGTTGCCAACGGCGCAACCGTATCGAGACGGGTCCCCCGATCAAAAATCATACCCATTTCACCCTGCAGCTTTTGTCGCGGCTTTGCAAGCCTATCACTGGATTCATGAGGCGCCTAAGCGTCTGGGGATGCCTTTTGCCGTGCAAAAAGTGGAGCTGTGGCGCCATCGTGATCAACCCGCTTATGCTTACGTTGCACTAGATGAGCATGGCAACGCGGACGTGCACATCCTGGATGCAGGCGGTCAGGTATGCGTCTGTTATCGTGGCATGGCCCTGCAGACCTTGAACAATGCGCACCACGATGGGAGACAAGAAAGCACTCAAAAAGATGAGCTTGGAAAATTGCTTTTTGTCCCTGTCTGGAAGCGTCTTGATACGAAACATGGGCGTGCACATGGCATGCATGCGCTTGCTCGCGGAACGGGCGTCTTACTGGTGTACACACACGAAAATGGGGTAGAGGCCGAGCAGCTCATGCAGCGTTATCGCGAAGAGCAATGTGAGTTACTCTCGGTTTGCTTATCTGCGGCGGATAGAGCACTGGACACCCTGGCGGCGCGTCTAAAGCATCTGCAGTCGCCACTGCGCCATGTCTGTTTTCTTGATCGTCATCAGGCCGCGCTTGATCCGGCTGACAAGCAGATTGACGAGCGATTGCGTGAACCCCAGACCCTCACAGGCTTTTTGGCATTAGTGAGAACCCTGAGCGAGCTTGGCTATGATGAACAGCCCCTACAATGGCTTGTGCTTACCTCTAGCGCATGTGCCGTCAATCAAGCAGACCCCATTAACCCGTATGCCGCTGCGATTGTCGGACTTGCCTCTTGTCTGGCGCAAGAGCATAGGTATTGGCAGGTGAGTGTCTGTGATCGGGGCAAAGGCACATCTTTCACAACGATTGCGAATCACGGGGAAACCTTGCGCGTTATTGCTGAGCGCAGTGGATACAGTTATGTGAGGCACATCAAAGAATTAGAGCTGCCCCCTCCCCGGCAGAGCCGTTTGCGTCACAAGGGCGTATATGTCTTGGTTGGCGGTGCCGGTTACGTGGGGACCTTGCTTAGCCGCTATCTGGTTCAGACCTATCAGGCAAAGGTGATATGGCTAGGTAGACGTGAGCAAGATGAGCAGATAGAGCAAAACATAGCCCTGATCGCTACCTTGGGATCGCGTCCGCAGTATCTGAGCCTGAAAACCGGATCAGACGACGAGCTACACCGTGCATTTGCGCAGATTAAGGCAGAAAACGGTTTGATCCACGGTGTGTTTAACCTGGTGATGGTCGCGCAGAGTACCCCGATGCGCAGCCTGAGCGAAGCACAATTTCGAGCTGGCTCCTTTAATTCCAAAGTGAACTCCGCGCAAGCCTTATACCGTATTCTGAAAAAGGAAGCTCTAGACTTTATGGTGTTCTTCTCTTCGATGCAAAGCTTTGCGCAGCAGCTCAATTTTATGTCAGCGAATATGAGTAGTTATGTTGCAGGTTGCATGTTTCAAGATGCTTTTGTGCATCAGATCAATTGCGAGTTATCTTATCCTGTAAAAACTATTAACTGGGGTTATTGGTCACAAGAGAGTTCAGAGAGCGAAAAGGCGAAGTGGTACGAGACTTATATCGCGGATAAAGGTATTTACAGTCTCAATGTTGGGGAGGCGATGCAAGCGTTGGAGTATATTTTGGCTCACGAACCAGAACAAGTGATCGTGACCAAAGTATCACATCGGGTTCTCAGCGACATGGGCTTTGTGCAAGATGACTCAGAGAACGTCGACCTACAGCCTGTTATTGACTCGAACGATGACAATACCCAGCTTGAGGACTTGATCGTTAATGGTATTCTCAAAACCTTTGAAACGCTCGATGTATTGCAGGTATTTGATAGCGCCTGTAATCTCGATGTTTCGAGATTACAGGCGCATGTGCCCGATAAATATCGCCGCCTGTGGCGTGAACTGCTTCTGATTTTGGTTCAGGCTGGAAAGATGGCACCACAGGGTGCTGGGTTTGCTCTACGAGAAAGCTATACCAGTTTGGCGAGCCAGCTTCGCTTAATGGATCTCGATCGGGAGGCTGGGCTATTGCGCGAGCGCCATCCCACCTTAGCCTCGAAACTTGCCTTGCTCGTACCCTGTCTGAAGGATATGGCCGAGGTGTTAACGGCTCGCAAACCAGCAACAGAAGTGTTGTTCGAACACGCTTCGCTGTCACGGGTTGAAGGGATTTATAGAGGAAATCCCACCACAGACTACTTTAACCAGCGTGTCGCTGACATTGTGAAGGCCGCAGTACAGCAGGCACTGCCCAGCCTGAGTGTAGGGAAAAAAGTACGCATTTTGGAAATCGGCGCGGGCACCGGTGGTACCAGTGCCTACTTGTTTCAAGCACTTAATACATATGCAGATCAGTTGCACTACATCTATACGGATATCTCTAAACGATTCTTAATTCATGCAGATGAAACTTTCTGTGAGCAGTATTCCTTTATAGAGACAAAATTGTTGAATATCGAACAAGATGTGGCAGGCCAGGGGTTCGATCCTGCTAGTATTGATATCGTGGTGGCAGCCAATGTTTTGCACGCCACACGCAACATTAGTAAAACTTTGCAACATGTTAAAGACTTACTCAAGAACGATGGGCTTCTGGTGTTAAATGAATTAGCGGACGTTTCGCCTTTCCTCACCGTGACCTTTGGTCTGTTAGATGGATGGTGGTTGTATGATGATGAAGCCATTCGCCAACCAGGCTCACCTGGCCTATCAGCAAAAAATTGGCAGCTTGTGTTGAAAAATCAGCGTTTTCACAATATTAGTCTCAACGATGAAAAAGCTCTGACGTCAGAGCAGCAAATTATTATCGCGCAAAACGAGAGTAAAGAGAGTGTGCCGGTCTCATCCACAGTATTATTAGGAACAGAACTTATCGCCTCAGTCGAAGCCAGTCTGATCGCACAATTGAGTCAGTGCATAAAAATCGAGCAAAACCGTCTCAATACCTATACCACGTTTTCAGATTATGGTGTGGATTCAATTTTGATGCTCGCCTATGTTGATCAAATTAATGGTGATCTTGGAATTGACCTCAATCCTTCAGAACTATTTAATTATACCACTGTTGAGCGTCTTACTAAGTTTATCGTTGATTATCATGGGAAAGAGATCATTTCAGCAAAAGAAAGCGTTGAGAGATCATTACTTCAGAATCAAGAAAGCAAATTTGACCTCAATGACATAGATGTCATCACAAAGGCAGGGAACGAAGCTCCGGAGATGGCGCGCAGCCTTCTCTTTGATAACGTTTTGCAAGTGCCGTCCGGTAACGTGCATCATCACCAGAGCGATAAGGCGCGACCTGATATTGCGGTTATTGGCATGTCGGGGCAATTCCCAGGTGCGACGAATGTTCAGCAGTTTTGGCAAAATCTGAGCGCCGGCGTCGATAGTGTGAGCGAGCTGCCTGAAAGCCGCCTGGATCGTCAGCTGTACAGTCCGCAGCCAGAGGCGGGAAAATGTTATTGCCAATGGGGCGGTATCTTAGAGGAACAGGCCTCTTTTGATCCACTGTTTTTTGAAATCTCTCCCAAAGAAGCCGCCGAGATGAATCCTTCTCAGCGGGTGTTTATGCAGGAGGCTTATCGAGCCCTGGAAGATGCGGGGCTGGTCAACGCAGGTCTCTCGCAACTGCATTGTGGCATTTATGTCGGTTGTGAGCCAAACGGCTATACCAAACAAGGTTTCACCGGCGCCTCCGAAGCCATTGTCGCTTCCAGAATCTCCTATTTTCTCAATTTGCAGGGACCGGCTCTGGTGATTAATTCCGGCTGCTCCTCTTCCTTGGTCGCCATTCATCTGGCTTGTGAAAGCCTTCGCCATGGCGAAAACGATATTGCCCTCGCCGGAGGCGTTTTTACGAATCTGAATAACGAGTTGCTCGTCTGTCTGTCGTCCATTGAGATGTTGTCATTCTCCGGTAAATGTCACGCCTTTGACGAAGCCGCCAATGGCACGGTGCTGTGTGAAGGTGTCAGCGTGCTGGTGTTGAAACGATTACAGGACGCGCTAGATGATGGCGATGTCATTTATGGCGTGATCAAAGGCAGTGGCATGAATCAGGACGGAAGAAGTAATGGCATCACTGCACCCAACGGACTTGCACAAGAAAATTTGATCAAGCGCATTTATCAGGATTACAACATTGATGCCAGCAAAATCAGCTACATAGAAGCCCATGGTACTGGAACGAAATTGGGTGACCCCGTTGAGGCGAATGCGNTGAAGAACGTATTTTCTTCAAGAAACACGGGTTTGGACTTTCGTTGCGGAATCGGTTCAGTTAAATCGAATATAGGACATGCGGCTGCAGCTGCGGGTGTGATCGGTCTGGTCAAGGTCTTATTATGCATGCAACACCGTCAGTTACCAGGGCTGGTGCATTTTAACAAACTCAACCCTCTAATCGATTTTAACGACACAGGTTTGTACATCGTTGAGCAATTGCAAAACTGGGAGCCAGCGTCTGGTGAGCCGTTGATGGCAGGCATCAACTCGTTCGGCCATAGCGGCACCAATGCCCATCTCGTGATTCAGGAACCCCCTGTGCGACCTGTCCGCGACAGCGAGAACCCATTCCATTTAATCTGTCTATCTGCCAAAACAGAGGAAGCGCTTAAACAAAAAATTAGCGATTTGAGTGCATATCTAAGGCGCAAAGAAGAGCCGCCAACTCTAGGAGCCATCAGTTATACCTTGAATACCGGCCGTGCTCACTTTAGAAAACGCTGCGCTTTCGTCGTGGATTCGCTGGAGGCTTTGCAAAATGCTCTCATGGGAGCTTTAGATGGTCTTGTTGGCAATGCAGAAAGGTTAAGTCCACAAGAACAGGCATTTTGTAAAAAAGCATTTGATTTGATTATCAAGGATTTACACGATGTAGAGAATCTTGAAAGTAGGGCTGATCAAACAATCTATAAAGATAACCTACTGGCTCTGACCGGACTTTATCTAAAAGGTTTTGACCTAGACTGGCAACGGGTGTACAAAGGTCAGAGCTATCACCGGGTATCCCTGCCGACATATCCTTTTTCCAGAGATACATACTGGATTGACGAGCCAAAACAAATTAGCTTCACCGAGCCTGGTACCGACAAGCCTGGAAACACCAGCAGGAATCATCAGCAGGATCAAAAAGATGAGGATGTGTTGGGTGGACAGTTTTATATACCGCAGTGGAAACGGCTTGATCAAACACAATCCTATGCCAGTTTAAGCGATCATGGGAAGTTGACCATCGCATCTGACCCTGTTGTCATTTTTTATCCGCCGACCATGACAAGTTTAAAAGATGATATTCAAACATGCTATGAGCAATTACCGGCAAGCCAAGTCGCTAGCTTCGAGCTTGGCTGCACACCTTCGTCTGAGGTCGATGTTCGCGATCCCCGTGCCTTTGAACGCATCTTTGTATCCCCTAGGCAGGCATTGGAAGAGCTGCTTGAGCAAGGTCGAACGTTAACGATCTACTTTATCCTGCCTGAACCGGATCAAAACCCGGACTCAGGGTGCAACCTCGAATGCCTTGAGGAATCCCTGTCACTCGGGCTGATCTCGTTGTTCCGTTTGATACAAGCGCTGTTGGCCCATCACGGCTATGCCAGCGAGCTGACCCTCAAAATCGTGACCCAGCAAACCCAGGTCTGTAAAGCTTCTGAGCGCATTGTGCCCTATGGCGCAGATGTGGTGGGTTTTGTGCAGTCGTTAGCGAAGGAATACGAGCTCTGGCAAATCAGTTGCGTGGATATTAATCGGCAGACATGGTGGACGCCCGCGCAAAGCAAAAACTTTGCCGAGGCGCTGATTGCCCTGAAGCCACCGGCGGACGGGCGCGCTCTATGTTGGCGGGACGGGTATGTTTATCACCGTGTTTTAACCCCGGCTAATCTCGTTGGCGTTCAGGGAAGTGCATTCAAGACGCGCGGTGTCTACCTAATTATTGGTGGCGCTGGAGGGTTGGGATTGGTGCTCAGCCAGTATCTGCTTGAACACGTGCAAGCGAAACTGGTATGGGTGGGGCGGCGCAGCCTCGAGGCGTTGGCGCCGGATGCGTTGCGGTTATTCAACACTCCGGGCGCCCACGTGCTATACGAGCAAGCGGATCTGTGTGATCCGGAAGCGCTGCAGCGCGCGCTGCAGCAAGCCAAAGGACGTTTTGGATACATTGATGGTGTCATCCATTCGGCTTTGATTCTAGAGGACCGAGCGATCGCCGACATGGATGAGAAAACGCTACGCAAAGTTCTCGCGCCCAAAGTACAGGGCAACGTGGTACTCCAGCAAGTGCTGGCCGATGAGCCTTTAGATTTTCTGTTGTATTTCTCCGCCGGACAGTCTTTTATGAGTCATGCTGGGCAGAGCAATTACGCCGCTGCCTGTACCTTTGAAGATGCCTGGGCGCTGTGCCAGGACCAGCGGCAAAACTATCCGATCAAAATTATCAACTGGGGCTATTGGGGCGAGGTGGGCATTGTCGCCACGGCTGACTACCGTAAACAAATGGCCAGGCAAGGCGTGCTATCGATTCATCCGCAAGAGGGCATGGAAGCGGTAGAGCGTTGTCTGGCGTCGTGCGCCACCCAGGCCGCTTATTTTAAAGTGGAACCCCGCGCCTTGAGCCGATTGGGCTTGGACGGCACTGGAATCTTGCATGCGAGCCGGAACCGTGTTCCACCTCAATTGATTCATGTCGTGATTGATGCCACCCAGGCGTGGTCAATCTCGATGCCGTACGCACAGCGCTATCAACAATCCCTTAAAAAGTTGGATCGGCTTGGTTGCTATCTCCTTCTGCGTGTATTCCAGGCTATGGGAGTGTTTAGTCAGCCTCATGAACACTATGAAAAACAGGAATTGGCCAGTAGATTAGCCATTTCAAAAGGCTATCATCACCTCTATCAAGAATGCTTGAACTTGCTAGATACGTCCGGTTTTATTGCAATCAATGGTTCGCACATTGAAGTCCAAGACGTGCTACCGGAAGAACATGACGAACACCACAGCTGGTTACAACCCTATCCCGAATTGGCCGCGCATGAAAAATTGTTGCGCATCTGCCTACAAGCTTTTCCGGATATCATCCGGGGATCGGTTGCCGCGACGGATATCATATTTCCGGATGCGTCTGTGGAATTGGTAGAAGGTATTTATCAGGGCAATCCCGCCACCGATGCGCTGAATACCAAAGCGAAAGATGCTGTGGTTGCCTACGTCAAAGCCCGCCTGGCAGACTGTCAGGAACAAATCATCTTTTTAGAAGTCGGAGCGGGAACCGGCGGCATGAGTCATGAGGTGTTGAAGGGGCTGGCCCCCTATGGGCAGTATATCGAGTATTATTACACCGATGTCTCCGAGCATTTTATCCAGTACGCTCGCCGCCGTTATGGTCAGGATTACCCCTTTGTCCGGTTTCAACGTTTAGACATTGAACAGGAGCATAGCGCGCTAAGTGAGGGGCTGCTCAGTGCCTGCGATGTCGTATTAGCCGCGAATGTTCTGCACGCCACCCAAAGCGTTCGCAATACCATCCAGCATGTCAAAGCCCTGCTAAAACGGCACGGCTTGTTAATCTTAAACGAAGCTACGACTTTGGAAAGCTTTGCCACATTGACATTCGGATTGTTAGAGGGCTGGTGGCGCTACCAGGATGCCGGAGACCGCCTACCTGGCGGGCCTTTGTTAAGCGCGTCCATGTGGCATCGCTTGCTCGAAGAAGAAGGTTTTGACCAGGTGGTGTCCCTGGGTGAGCCAGGCGAAGGCGACATGTTGGGACAGCATCTCATTGTCGGTCGAAGTGATGGCTGGAGCTTGCATCAATCTGCGAGGGACGATGAAACCCGTTCGGCCCCTGTTAGCCCTGTGGCGGCGAGCGACGTTATCCAAGGCAATCGAAATGACAAGCCCGCAGAGCTTATCAAACACGTTGAAGCGCAGATTGTGCAAACCCTTTCAGCCGCACTGGATATTGCTGCGGCTCGAGTGGAACGCGATGTGTCGTTTTCCGAGTATGGGGTGGATTCGATTCTGTCCGTTGCGATTATTAACCAATTAAACCAGCGCCTAGGGATTCGTCTGAAACGTCCGGATTTGTTTAATTACACCACCACAGAAAGCATGGCGGCGCATATTGTCGCAACCTTTGCTGACCACTTGACGGCGGCCTTAGTCGAAGAAGCTGAACCACCAACGCCAGTAACCGTAGCAAGTCCTCAACCGATAAAAGCGGCGGGGCAGCAGGATGTTCTTCAGCAAAACTTGCAAACCCAGCCTCAAGTCTCGCAAGGCGTTTGGCAAACCAAGCCGGAACCCATTGCTGTCATCGGCATGTCTGCCTGCGTGCCAGGGGCGGATCATGTGGGTGCGTTTTGGGACAACTTGGTTGCCGGCACAGATTCCGTCACCCGGATTCCCCATGAGCGTTGGCAGCGGGAGGCCGTCAATGAGCTGCCCGGCGGGCCGGATACCTCCCAGCGCAAAGCCGGATTTATGGACAATATTGCCGAATTTGACCCGCTTTTTTTTGCCATCTCTCCGCAAGAGGCGCAGTGGATGGACCCGACGCAGCGGCTGTTCTTACAGCAGGCTTGGGCCGCGTTGGAAGATGCCGGATACAATCCGCGAGCCTTAGCCGGCGCTTCATGTGCGGTGATGGTTGGCTGTGCGGCGACTGGCTATGGTGTGAAAGAGGGCGAGCGCACGGGGTATGTGTCCTATGCTATGACCAATAGCGAGGCCATCTTACCCGCGAGAATCTCCTATTTTCTCGACTTAAAAGGCCCGAGTATTCCCATTAACACCGCCTGCTCTTCGTCTTTAGTGGCGATTCATCTGGCCTGCGAACAACTTCGCTCCGGGCAAAGCGACATGGCGTTGGCTGGCGGTGCTTCCGCACTGATTGGTTCCGCGTTGCACATCGGACTCAATGGCGTTGGGATGCTATCTCCCGAGGGCGCATGCAAAGCATTTGATAAGGAGGCCAATGGCTTTGTGCTTGGCGAAGCGGTTGGCGTTGTCGTTCTCAAACCGTTGTCCAAGGCCGTGGCTGATGGCGATTCGATACATGGTTTAATTATTGGCTCGGCGATTAACCAGGACGGCAAAACCAATGGTATCATGGCGCCGAACGGTCCGTCTCAGACGGCATTAATTGAATCGGTGTACCGGAAATTCGAGATCGATCCTAAAACGATTAGCTATATCGAAACCCATGGCACCGGCACCCAACTCGGCGACCCAATAGAAGTCAACGCCTTGGCTGCTGCCTATGAAAATTTCACCACCTCGCAAACTCAGTACTGCGCCATCGGATCGGTAAAAACCAATATTGGTCACACCACCACTGCTGCCGGTGTCTGTGGATTGATTAAGACTTTATTATGTCTCAAACACCAAAAACTTGTCCCATCCCTGCACTATAAGGAGCCCAACGAAAATATTGAGTTTGAAAAGACGCCGTTTTACGTCAATACCCAGGTCAAAGATTGGCCGGGTCATCAAAACGGTGTCCGGCGTGCGGCGGTGAGTTCCTTTGGCTACAGTGGCACCAATGCGTATATGGTGGTGGAAGCGTTCGTGGAGACGAGCCCGCGCGCGGTCGGGCAGCAGGGACCTGCATTAATTGTCTTGTCGGCTAGGCATGAGGTGCGACTCAAAGAGCTGGCCAGCAATCTCATGGCCTATTTGAAGCGGTATGGCTTGAATCCGGATCGCCCGATTCAGCTCGAAGATATGGCGTATACGCTTCAGGTTGGCAGACAGGCCATGTCAGAGCGTCTGGCGTTTGTGGCGGACAGCGTGGCGGATGTCGTCAAACATTTAGCCACATTTGTTGACGGCGAGGCCAATGCCCAGGAACTTTACCGGGGGCAAGTTAAACCGTTCGGCGATAAGAGCGATTTGCTTTTGGAGGGCGAGGCGGGTCAGGCTTTTCTCAACACGATTTTAAGACAGCAGGATTACCGCAAATTAGCCGCCCTGTGGGTGGCGGGTACAGACTTGGACTGGAATTTACTCTACGACGGTGAAAACCGTGCCCGTCGCATTTCGCTACCGACCTATCCTTTTGCTAGGGAAACGTATTGGTTGGATGAGGGGATAGGGAGCAATGAAAAAGAGCTTCTAAGAGATCAGACTCAAAAAGAGTTACGTGATCGTGATCGTGAGCAAACTACGGAACTCATGACATTTGAAGAGATATGGCAGGAGGCGTCCTTAAACAATCATTCGGATTCCATCAAGTATAAAAGCATCGTTTGTTTTCTTTCCGGATCAGAACATCAGCAAGAAATGCGAACTGCCATGCAGGCGATTGATCCGGCTATCCATCTTACGATGATTGCTCAAGGCCATGGTTACACAAAGCACTCATCTGATCGTTACACAGTAGACCCCGCCGATATACAGAGCTTTCGTGAAGCTTTCCTCGATATCAGCCAGACTCATGGCGAGGTCGACGCGCTGCTTTATCTATGGCCAACCGAGGATTGGCGTCTCTTGTATGATCCATCCGCCGTCGTTTATATGTTGCAGGCTCTGGTCAAGAGTGAGCTAAAACCTTCCCGCTGCTTGCTGGTTGCTGCTTTTTCCACTGCTTTGGAGCGTTGTTACCTGGAATCCTGGATTGGCTTCGAGCGCTCGTTAAAGCTCATCATGCCTGGTTTCCAGGTCGCGGGACTGTTTCAGGAACATGCGGGGCCGGACCAGACGATTTCAATGACACATTGGAGTCAACACATTGTCTCTGAACTCAAAGCGCCTAAAGCACAGACGGTGCTGATACAAAATCACCGGCGCTACGTCAATCAGATTCAAAAAACCGAACTGGCCGCGCAAGGCGCTTCGGTTGCATCGGCCGTCAAACAGGGCGGTACTTACCTGATTACCGGTGGCTGTGGGGGATTAGGTTTTTTGGTCGCCCAGCACCTGGCAGAACACCTTGGGCAACCGGCAGCCTCAGCCTCGGGAAAAACGGTGCATTTAATTCTGACGGGTCGATCATCTCCCGATGACGCGATACAAAGCAAAATCACGCAACTGGAAGCATTAGGGGCAAAGGTTGGTTACGTTCAAGCGGATGTTGCCGATGCAGTCGCCATGAGACGTGGCCTTGCCCAGATGAAAAATCGCTTTGGCGACATACACGGTATTTTTCATATCGCTGGGATCGCCCCCAGCGAGAGTCTCCTCAATAAAGATATCGACGCCTTTCAAAACGTACTGGGGCCTAAAATTGCGGGCACGTTGATGCTTGACGATCTCTGTCGTGATGAACCGCTTGATGTTATCTGTTATTTTTCCTCCTCTGCCGCGATTTTAGGGGATTTTGGCGCCTGTGACTACGCGATTGGCAATCGTTTTCAGATGGCTTATGCCGCTTATCGCAACCATCTGCTGCAGCAGGGGATGCGACAGGGTAAGGCGTTGGTGATTAATTGGCCGCTTTGGCAAGAAGGCGGCATGGGGTTTCATCAAGACGAAAATACCAAGATGTACTTGAGCTCCAGCGGGCAGCGGGTTCTGGAAACTCAGGAAGCCTTGACGGTATTGGATCACGTCCTTAACCAGGACAAAACACAGCATTTGGTCCTGGTGGGGCAGCCAGGTCGGGTGTATGGCTTTTTAGGGTTGACTGAGGCGCCTATGACTCAGATGCCAGTGACTGAAGCGCCAGTGACGCAGACATCCACACGGCCAGAGTTGAGAGGCTTGAGTACGGAGCAGTCGGTATTATGGGATTTAAGAAATCTCATCGTCCAGCAACTCAAAGTGCCCTGGGAGCAGCTTGGGCGAGATCACAATCTCGCTGATTTCGGTTTTGATTCAATAAGCTTGTTGAGTTTTGCCAATCGTCTCAGCGAGCATTATCAACTTGACATTACACCTGCCTTGTTTTTTGGGTATTCGACTCTAGAGCAACTCACGCAGTACTTTTTAAGCGAGCATTGCGATTTTATCAACGCCTTTTATAAGGAACCCGAAAAATCGGAAATCCCTGTAAAAAAGGAAGCCGTTGAAGAGCGTGCTCCTATCCGGATTGTTTCTGAAGAAACCCGCCCAGAAAAAATAGATAATGCAAAAGATGAGCCCATTGCCATTATTGGCATGAGTGGCAGATTTCCCAAAGCTTACGATGTTGAACAAATGTGGCAGCTCTTGGCATCGGGTGAATGTGCGGTAGAAGAAATTTCACCACATTACTTTGATTGGCGCAGATACTTTGGAGAGCCGAGCCAGGAGGCTAACAAAACCAATGGAAAATGGTGTGCTAATATTCCTGGCGTTGCCGAATTCGACCCCCTGTTTTTCCAAATTTCCCCGAGAGAAGCGCCAAACATTGATCCTCGTCAACGGCACTTATTGCAAGAGTCTTGGAATGCTTTAGAACATGCCGGATACGGGCCGCATCAACTGAATAGCCAGAAGATCGGCACCTTTGTCGGGGCTGAAGAAGGGGATTATTATCAACGTGTCAAAGAGGGCAACATCACCTCCAATCACTCGGGCATTCTCGCCGCTCGTCTGGCCTATTTCTTAAACTTAAAAGGCCCGACCATGGCGATTAATACCGCGTGTTCCTCCTCACTGGTCGCGGCTCATCAGGCTTGTCTGAGTTTACGGCAGGGGGAATGTGATACGGCCATCGCGGCAGGGGTCAATCTAATGCTCACCCCTTACGGATATATCAGTATGGGCCGAGCAGGTATGCTCTCTGAGGATGGCCACTGTTATGCCTTTGATGAACGCGCCAATGGCTTAGTACCAGGTGAAGCCGTGGTCGTCGTGGTATTAAAGCGCCTTAGCCGAGCGCTTGCTGACGGTGATCCTATTCACGCGTTGATCTTGGCTAGCGGTGTTAACTATGATGGCAAAACCAATGGTATCACTGCACCAAATGGTGTTTCGCAGGCCGAGTTGGTGAGGGAGGTTCACCAACGAGCCGGGGTTCATCCGCAGGATATTGATTATATTGTGACACACGGTACGGGTACCCGGCTAGGTGACCCCGTGGAGGTCAACGCCCTTAACGAAGTCTTTAGGGACAGCCAACACCTTTGTGCGATTACATCCAGTAAAACCAATTTTGGCCATACGTTTTCCGCTTCGGGGCTGCTCAGTCTTGTCAATCTGGTACAGGCGCTTCGTCATGAGACCATTCCGAAAAGCCTGCATTTTGCTCAGCCAAACAAATTTATGACATGGGATCAAGGCCCTCTCTATGTCAATACGGCCAATAAGCCCTGGCTCGAAAAGCCGGGCGAAAAACGCATTGGCGGGGTGAGTGCGTTTGGAATGAGTGGCACCAATGCCCATATGCTGATTCAAGACTACCAGCTTCACAGAAAAGAACCACGTGCGGTCCCGCCTTATGCGCTGCTTGTGTTGTCTGCAAAAACGGCAGAGGCACTGCATCTCAAGGTCAAAGCCATGGTCGCGTTTTTGCAAGAAGGGCTTGCAGACACTGCCACCCTAGCGGATATCAGTTATACATTGTTTGAAGGCCGACACCACCTTCAATACCGTTTGGCTATTGTGGTGCAGGATATGACTGAGGCCATGTGTTGTTGGACACAAGCCGGGCAGCCAGATAAGAAACCCAATATTTTTCAGGGAAAAGTGCCTACCGAATTTAGTGGTCAAAAGGTCACACAGAATTATATTAACCAATTAGTAGAACAGCTTGATCGCTCTACCGGCGATGATGACGTATACCGAGAACGTCTCTTGGGTTTAGCTGATTTTTATTGTCAGGGGTATGATGTCCCTTGGTCTAGGCTATACGGTGATACACGGCCACGCCGTATAAGTCTGCCTGGGTATCCGTTTGCTAAACAACAATTTTGGCTGGATTTCTCTCCGAAGGATCATGGCGAACAAGAAAATGTCGAACTTCCTATTGGCAAGATGCAGAGACAAGTTCTAAATGAAAAAAACACGCTTGAAACATTAAGCTACATTCACAAATGGGAACAGCAGGATAAAGCTGAAGTCAAGATAGAAATCAGCCAGGTTTGCTTACTAGTTTACTTTGAATCTGCATCGCAATTTGAAAAAACGCTGGCAAGCTTCTTCTTGCAGCAGGGTGCATCTCAGGTGATCGAGATTCAATTGGGACTCGAAACCAAACCGGTGTCCGAACATAAATGGCGCTGCAATGTCAATGACGTCGACGCTTTTCAGCGTTGCCTTCAAGCCTATGCACAGACAATCAATAGCGTTTACTTTCTCTGTGTCGATACCCTCCAGCAGGGCATGGAAGAAAGCGAAATGCAGTTGCTACGGCTGGTCAAAGCCTTAAAATCACGTATGCAGAGCCATGCCTTTATCGATTTCACCCTTCTGACTCTGGATAATCACCGCGTCGATAACAGCGCGACAAGTCCCAACCACGGGGGGCTTAGCGGTCTTGGGTACTCGGTGGCGCAGAGCGATCACCGCTTCCGGGTTCGAAATATCGATTTGTCGCGGGAAGATCTGGTGAGCGCCGAACAACAATGCACCCTGCCAGGCATGATCGTCAGCGAAGCCCCGTCGGACCGAGGCGAGGTGGTCAAGTTGCAGGCAGGTTTGCGCTACAAGCAGCGCTTTTTCAAGCTCGACTGGCAGACGCTGCAAGCGGCACAGCCAGAGGCGGCGGGTTTGAAAACCGGTGGGGTCTATGTGTTGTTGGGTGGCGCGGGAACCGTTGGTGCGATTATAACCCGCTATCTCATCCAAAAATATCAGGCCAATGTGGTTTGGCTGGGGCGTCGTGCGCTGACATCGCCTGCCGTGCAGGAACAACTACACGCGTTCCGGAGCGTGGACGAAGGGTGTGTGCCACTCTATATTCAGGCCGATGTGACGGATCAGGCTTCCATGACTCAAGCGGTCAAAGAGATCAAGCAACATCACCCTTGCATCCATGGCGCGATTTTCTCCGCACTGGTCTTTAAGTTGGATAACTCAATTGCTAAGACTAGCGAGGAAGACTTTAATGAGGTTTTGGATACCAAGAAAAAGGGTGCGCAGTATTTTTATCATGCATTCAAAGATGAAAACTTAGATTTTATGTGTTATTTCTCGTCGGTCCAATCTTTTTTCTTTATCTCCTCTCGAGAGAGTGCAGGGTATGCAACCGGTATTACCAGCGCTGACACCTTTGTACATGCCATCGATCACGATAGCACCTTTCCTGTCGGTATCATCAATTGGGGTTACTGGGAGGCCTCTCTGGCGGGAACCGAAGCCGAGAAGCGTTTGCCCGGTCATTATGACTTAATCTCTGATCATGATGGATGTCAGTTTTTTGACGGATTTGTACCTATGCTTAGATCAGGCCTTATCAAACAGGCCGTTTGTTTAGGTGTGTCAAAAGCGATAGAGGATTTCATGGGCTGTGACGCCACGCAGATGATCACGGTGAACAAGCTTGAGGCTGATTCTTTGATTTTTAGCCTTTTTAATGAAAATGAGTGCGGCCAAGCTACGTGTGAGGAAACTGAAATCGAGCGCCTTTTGGATAAAGATTTCAACAATGAACTTAAGCAATGGTTGCCGCGGCTGCTATTTTCACAGCTGCAACAACTGGGGATCTTTTTAAATCGTGGTGAGCAGAGAGATTGTACGACGTGGCAACAACAAGCTGGTGTGATCAAAAAATATGAACGCTGGTGGCGAGAGTGTTGCTTAGGGCTGCTGGAGACCTCCGGCTACGTACAATGTGAAGGTGAGAGGGTTGAGGTCACTCACCATAGTCCGGCAGACGAGGCGGATCAACTCTGGCAAGGCTGGGAGAGCTTCCAAAATTTATTCCTCGACAAGCCGGAAAGAAAACCTGTGCTCGACTTATTGGAGAGCTGTCTGAGAAGCCTGACGCAAATCCTGTGCGGTGACATCCTGGCCACCGATATTCTTTTTCCAAAATCGTCAATGGAAAAAGTAGAAAATATATACCAGCGGAATGCCCTATCCGACTATTGTAATACCTTTGTCGCGAAAGGTATCGAAGCTTACATTCATCAGCGGATTCAGGCAGAGCCTCAGGCAAGGATCCGGATATTGGAAGTCGGTGCAGGTACTGGAGGTACCACCGCATTGGTCCTGCCACAACTGCGTCAGGTGCAGCATGCGATAGACGAGTATTGTTATACAGACATTTCCAAAGCCTTCTTGATACATGCAGAAAAGACTTATGGGCCGGATTATAACTATCTAGATTATAAGCTACTCAATCTCGAACAACCGTTAGCGCCACAAGGAATAGAGCCTGGCTCCTATGATATGGTAATCGCTACCAACGTGTTGCACGCTACAGAGAATATCAGACAAACCCTTCGCCATACTAAAACTGCTCTAAAACGTCATGGATTATTAGTGATCAATGAAGTGGTTGAGAAATCTATTGTCGGTATCTTAACCTTCGGGTTGTTAGACGGCTGGTGGCTCTACCAAGACGAATCATTACGCATCCCAGGCTCTCCGCTGATCACGCTGGATACCTGGCGTAAAATTTTAAAAGAAGAGGGCTTTGCCAGGGTCTTGTTGCCAATGCGAGCCGCATCTAAGTTGGGTCAGCAAGTGATGGTGGCGGAAAGTGACGGTCTGGTTAGACGGGAGAGAGAAGACTTGCCGGACGAGGACGAATCGGCTGTGACTGATAAAACGTCCGTGGTACAGGGCATGACTTTGACTCCGGAACAGCGAATTGCGCAAACACCGTCTGTACGGGAGCTGTCGTCCGAAACACTACGAGAACAGGTTGCCGAGCTTATTTTGACAGGATTGGCCGAAACATTAGGCATGGCGCAAGAAAATATTGACCCACTAGTTTCATTTTCTGACTATGGTATTGATTCTATTCTTGGTGTCGGTTTTATTGGTCAGCTTACTAAATCCTTCGGCATCACCATCAATACCGCTATATTGTATGATTATACCAATGTAGTGCGTCTTAGTGATTATCTGGTAGAAATCTATGCAGAGGACATACAAAACAAAATTCAAAACAACCGCATGTCTCCAGTTGAGAAAGATGCTGTTCTATATACAGAGACACAACTAGAAACAACAGTCGATCGTAATCCGGAAAAAAGTCAGCTTGAAAACTCAGTTCCTAATATGACCTCTGGCGAGAATAAGTCCGCCAAATGCCAGGAGATCGCTGTTATTGGTATGTCAGGGCAGTTCCCTAGAGCAAAAGACCTTGACGCCTTCTGGCAAAATCTGATTCAGGGACGGGATGGTGTTGTAGAGCTACCCGCGAATTATCTCAATCCGGCTTTGTTTAGCCCGCACAAACAAGCGGGAACAACCGATTGTAAATGGGGTGGCATTTTAGAGCAGCGTGATTGTTTTGACCCACTTTTTTTCAACCTTACGCCCAGGGAAGCGGAGTCGATGAACCCGCATCAGCGTCTCATTCTGAGTGAGAGCTGGAAAGCGCTGGAAGATGCCGGCTACAATCCCAAAGAGCTGGATAATACTCGCGTTAGCGTGTTTATTGGCGCGGAACCTACCGACTATTACCATGAAACCTTTACCGGCTCTTCTGATGCTATTGTTGCCTCCCGCTTATCCTACTACCTCAACCTCAAGGGACCGGCTTTGGTGGTCAATACGGGTTGTTCGTCTTCTGCTTTGGCGATTCACTTGGCCTGCGAAAGTTTACGCCGTGGCGAGTCTTCAATGGCCCTGACAGGTGGCATTTTTGCTGCAATGCATGAAGAAGCACTGGTTAAACTAGCCCAGATTGATATGCTTAGTGCCACCGGTCGCTGCCGTACATTTGATCAATTCTGCGATGGTACCGTATTGTCTGAAGGTGTTGGGGTGGTTGTGTTAAAACGGCTTGACGATGCCGTCAGGGACAACGACCCCATCTATGGCGTGATTCAAGCCTCTGGGGCAAATCAGGACGGTGCCAGCAATGGGATAACTGCGCCTAGTGGTTTGTCGCAGGAAGAACTCCTGACGTCTGTCTACCGGCAATATGACATCAATCCGGAAACGATCACGTATATTGAAGCTCATGGAACTGGTACCTCACTTGGAGATACCGTTGAGGCTAATGCGTTAAAGCGGGCCTTTAAACAGTTTACGGATAAAAAACAATTCTGTGCACTTGGCAGCGCAAAATCTCATATCGGCCATACAGGAGCTGCTGCTGGCGTTATTGGTTTAATCAAAGTTTTGTTGTCGATGCGCTATCATCAGCTGCCTAAACTGTTGCACTTCGAAGAACTCAATCCATCAATCGAATTGGAAGATTCTGCATTTTATATCAATCAACAGCAAATGGAATGGACGGGGCAGGGCGTGCCATTAACCGCAGGGCTGAATTCTTTTGGCCACAGTGGTACGAACGTTCACCTCGTGGTTCGGGAATACCTGCCGTTATCTGAGACGAAAGCCGAAATGGAGGCTGTACTGATTCCATTGTCTGCCAAAACCCTCGAATCCCTTAGAACCTATGCTGAAAGTTTATCGACGTTTCTGGAAAATGGGCATTCTGGTCATGGTGTTAGCCTCACCGATTTAGCCTTTACCCTCCAGCTTGGACGCGAAGCGATGCGGGAGCGCTGTATTTTCTTGGCTGGAAATGTCCCGGATTTGGTAGCCCAATTAAAGGCTTTTGCGAATGACAAGACGCTCAACAATGTGGGTTGGTACGGCCGGGTTGGACGCAGCAAGAACAGCCATTCCTTCAATGATCATGAGTCTCGGCAAATGATCACTCAATGGTTGCAACAAGGAAAATTGGATAAAATTGCCGCCGCTTGGGTACAGGGCCTGAGCATTGACTGGGCAGCCCTTTATCGCGAGCTCACAGCTCGTAAAATCCATGCGCCAACCTATCCTTTTGCCCAGGAACATTATTGGAAACCCGAACAGCAGAGTATGGTTCAGAAGCCCGTTGCGCCGGAAACACAGCCTGAGACCTTCGGAACACTGATGTTGCAGCCCTGTTGGATAGATCAACCCCTTGAACATTCATAA", "orf_prot_sequence": "MLRTGMKTDSPNHPENQAINVNHYLMVLSAKTKERLQTVVENLLDYAKANRRLIESRLADVAFTLQTGREEMEARLAFVVSDYHDLMGQLSGYLEDAPNANTIFRGQVDLFDQSAPVRQHRAAQERDCERMIRTHDLPGLAELFVQGVPIDWRRLYVQGRPRRIALPSYPFAPERHWVARREPDHLAADMPAVRQPHSLLDGRDDRMSLESGVVFRKLLRINDGVLQDHQVNETPVFPGVAYIEMACEALAQLSFSDPEVLRKTVLNQMVWLQALAVTEAEHEILLCLEKDTHGLAFEVKDHQTLYAKGRFDQSDDLSQGHQYLELETIKGDCPHEKHRSVIYHDFRLLGLNYGPWFQGLEHTWFSIDSAEGEGEALGYFNMPLICESEFSAYTFHPGLLDAALQVVASVPGYADSGLLLPYAVEKLEWFHPFPACGYSHVRKLAKHRYDVTICDEQGKVCAKFSDLSVRPSRVAGSEPSLNQLTYRARWSHQELGERRSPAGRPEETGVVFIIHTPEQQALVQELSSVLADMHGDHRVRRMCLNANDWDFKSLGNWNHRIRAVQDLRDIYFLAAMEHTVSSGQAHVDPLSFTNRQEHGLLSLFRLLKALDQNQLLLQPLSLKVLTTGNYRVLPSDTICPLSAGLPGFCRSIAQEYPLLALSCIDLGCPDGDAMQPSSLKKLAQFIVAEPAHQPHETVGIRELRRYTRKLVPVRFPEPGGQRAFKSRGVYMIVGGAGGIGMVLAQYLAERVQARLVLVGRSALDEEKKQNLSTLTAAGGEALYIQADISRLYSMKDAVAQARQRFGNINGVVHSAMVLNDQSLARMSEEGLRASLAPKVEGCIVLQQAMAGEPLDFMLFFSSAISFSGNAGQSNYAAASTFKDAFAHYLTQVEAYPVFNINWGYWGCVGVVANAAYRERWAARGVHSIDPEQGLQVIESILTNHIDQVAAVNVEPSFLERLGVELSQTQTVLPPRRSSLIAKLNALPLPETGGFQDNVNRLEIVSAFRWAEVFKHMLDMSSTQGMYARSDLKRQLQISSEHDQLFDVLISMLIQEGYLHQQGKNLTPTPYLNGEFFQQQREQVALLESELSQTDNAYLNLLSRCLDHYPAMLRGEVAATDVIFPQGSMEWVEGIYRSHASADYFNQQLAQRLVAYVEARLPSLGANESIHILEIGAGTGGTSAIVLQALQPYAARLRYTYSDISPGFLNYGRKTFGDAYPFVEFRHLNIEHNGEAQGYQAGEYDLVLAANVLHATRHIGNTLARVKFFMKRHGWLLLNEATQVRHFGTLTFGLLKGWWLFQDAENRLDGSPLLSTTAWQRLLSEEGFKHTLSLCDAVEEESIFQDVIVAESDGVIQMNQSDSPVQPREPVDVSVDVHHVDDMMEPGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVDSITGVDFIHQINSRLGIVLRTTALFDHATIFDLSRFIDESHGAAIDEQRQRLRSTPLTSSDTKPAERVAPPDEALPHIERGCHQAVVLEKPSQIEHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLLCVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGHSTLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGEKVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIAMVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQLISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPDGMMDNQVGQRMVPESSTVEDYRVGNATVEQVAVKQPADMDEPIAVVGMSGRFPGANNLEQFWLNLIGGNNAITEVPADRWDVHQWYDPDPAVLDKTHCRWGGFLRDIDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSVPGEPQSFWGNSSSLIASRIAYFLNLKGPSITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGIIRGSGSNQDGRTYGITAPSAASQTELEQSVYRQAELDPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFIKVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPRRAAVSSFGFSGTNAHILLEEYQHHEDEAQALGDDKDVLIVLSAKNQERLKKAAENLHHFLESRVSYKLSDIAYTLQVGREAMEARVAFMVVSVLDLQQKLVSLLHDPTDEQDMYWGEVRDGEGPAGVAAFEDVALALANKQLDQLAQWWVSGVEIDWTQLARVVKVRLVPLPTYPFSPDRYWFDSVGPATVVHAEHSASALYPLLNRIAPQASTQIANGCVFETCLKSSDPLLAQHLIDGQAVFPAVGFLEMVIAGLREIQPDKAARLENVFWLRPLDVMDEQRVHLVFEVKQDRFQYRIVPAESHGDGAYFRGQGYWSNDMNPAIPMDIDRLKSRMRQQPLLNESSPRVRLGRLYQGATEGWTDGEQALIAFELPTAQPYRDGSPDQKSYPFHPAAFVAALQAYHWIHEAPKRLGMPFAVQKVELWRHRDQPAYAYVALDEHGNADVHILDAGGQVCVCYRGMALQTLNNAHHDGRQESTQKDELGKLLFVPVWKRLDTKHGRAHGMHALARGTGVLLVYTHENGVEAEQLMQRYREEQCELLSVCLSAADRALDTLAARLKHLQSPLRHVCFLDRHQAALDPADKQIDERLREPQTLTGFLALVRTLSELGYDEQPLQWLVLTSSACAVNQADPINPYAAAIVGLASCLAQEHRYWQVSVCDRGKGTSFTTIANHGETLRVIAERSGYSYVRHIKELELPPPRQSRLRHKGVYVLVGGAGYVGTLLSRYLVQTYQAKVIWLGRREQDEQIEQNIALIATLGSRPQYLSLKTGSDDELHRAFAQIKAENGLIHGVFNLVMVAQSTPMRSLSEAQFRAGSFNSKVNSAQALYRILKKEALDFMVFFSSMQSFAQQLNFMSANMSSYVAGCMFQDAFVHQINCELSYPVKTINWGYWSQESSESEKAKWYETYIADKGIYSLNVGEAMQALEYILAHEPEQVIVTKVSHRVLSDMGFVQDDSENVDLQPVIDSNDDNTQLEDLIVNGILKTFETLDVLQVFDSACNLDVSRLQAHVPDKYRRLWRELLLILVQAGKMAPQGAGFALRESYTSLASQLRLMDLDREAGLLRERHPTLASKLALLVPCLKDMAEVLTARKPATEVLFEHASLSRVEGIYRGNPTTDYFNQRVADIVKAAVQQALPSLSVGKKVRILEIGAGTGGTSAYLFQALNTYADQLHYIYTDISKRFLIHADETFCEQYSFIETKLLNIEQDVAGQGFDPASIDIVVAANVLHATRNISKTLQHVKDLLKNDGLLVLNELADVSPFLTVTFGLLDGWWLYDDEAIRQPGSPGLSAKNWQLVLKNQRFHNISLNDEKALTSEQQIIIAQNESKESVPVSSTVLLGTELIASVEASLIAQLSQCIKIEQNRLNTYTTFSDYGVDSILMLAYVDQINGDLGIDLNPSELFNYTTVERLTKFIVDYHGKEIISAKESVERSLLQNQESKFDLNDIDVITKAGNEAPEMARSLLFDNVLQVPSGNVHHHQSDKARPDIAVIGMSGQFPGATNVQQFWQNLSAGVDSVSELPESRLDRQLYSPQPEAGKCYCQWGGILEEQASFDPLFFEISPKEAAEMNPSQRVFMQEAYRALEDAGLVNAGLSQLHCGIYVGCEPNGYTKQGFTGASEAIVASRISYFLNLQGPALVINSGCSSSLVAIHLACESLRHGENDIALAGGVFTNLNNELLVCLSSIEMLSFSGKCHAFDEAANGTVLCEGVSVLVLKRLQDALDDGDVIYGVIKGSGMNQDGRSNGITAPNGLAQENLIKRIYQDYNIDASKISYIEAHGTGTKLGDPVEANAXKNVFSSRNTGLDFRCGIGSVKSNIGHAAAAAGVIGLVKVLLCMQHRQLPGLVHFNKLNPLIDFNDTGLYIVEQLQNWEPASGEPLMAGINSFGHSGTNAHLVIQEPPVRPVRDSENPFHLICLSAKTEEALKQKISDLSAYLRRKEEPPTLGAISYTLNTGRAHFRKRCAFVVDSLEALQNALMGALDGLVGNAERLSPQEQAFCKKAFDLIIKDLHDVENLESRADQTIYKDNLLALTGLYLKGFDLDWQRVYKGQSYHRVSLPTYPFSRDTYWIDEPKQISFTEPGTDKPGNTSRNHQQDQKDEDVLGGQFYIPQWKRLDQTQSYASLSDHGKLTIASDPVVIFYPPTMTSLKDDIQTCYEQLPASQVASFELGCTPSSEVDVRDPRAFERIFVSPRQALEELLEQGRTLTIYFILPEPDQNPDSGCNLECLEESLSLGLISLFRLIQALLAHHGYASELTLKIVTQQTQVCKASERIVPYGADVVGFVQSLAKEYELWQISCVDINRQTWWTPAQSKNFAEALIALKPPADGRALCWRDGYVYHRVLTPANLVGVQGSAFKTRGVYLIIGGAGGLGLVLSQYLLEHVQAKLVWVGRRSLEALAPDALRLFNTPGAHVLYEQADLCDPEALQRALQQAKGRFGYIDGVIHSALILEDRAIADMDEKTLRKVLAPKVQGNVVLQQVLADEPLDFLLYFSAGQSFMSHAGQSNYAAACTFEDAWALCQDQRQNYPIKIINWGYWGEVGIVATADYRKQMARQGVLSIHPQEGMEAVERCLASCATQAAYFKVEPRALSRLGLDGTGILHASRNRVPPQLIHVVIDATQAWSISMPYAQRYQQSLKKLDRLGCYLLLRVFQAMGVFSQPHEHYEKQELASRLAISKGYHHLYQECLNLLDTSGFIAINGSHIEVQDVLPEEHDEHHSWLQPYPELAAHEKLLRICLQAFPDIIRGSVAATDIIFPDASVELVEGIYQGNPATDALNTKAKDAVVAYVKARLADCQEQIIFLEVGAGTGGMSHEVLKGLAPYGQYIEYYYTDVSEHFIQYARRRYGQDYPFVRFQRLDIEQEHSALSEGLLSACDVVLAANVLHATQSVRNTIQHVKALLKRHGLLILNEATTLESFATLTFGLLEGWWRYQDAGDRLPGGPLLSASMWHRLLEEEGFDQVVSLGEPGEGDMLGQHLIVGRSDGWSLHQSARDDETRSAPVSPVAASDVIQGNRNDKPAELIKHVEAQIVQTLSAALDIAAARVERDVSFSEYGVDSILSVAIINQLNQRLGIRLKRPDLFNYTTTESMAAHIVATFADHLTAALVEEAEPPTPVTVASPQPIKAAGQQDVLQQNLQTQPQVSQGVWQTKPEPIAVIGMSACVPGADHVGAFWDNLVAGTDSVTRIPHERWQREAVNELPGGPDTSQRKAGFMDNIAEFDPLFFAISPQEAQWMDPTQRLFLQQAWAALEDAGYNPRALAGASCAVMVGCAATGYGVKEGERTGYVSYAMTNSEAILPARISYFLDLKGPSIPINTACSSSLVAIHLACEQLRSGQSDMALAGGASALIGSALHIGLNGVGMLSPEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKTPFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTNAYMVVEAFVETSPRAVGQQGPALIVLSARHEVRLKELASNLMAYLKRYGLNPDRPIQLEDMAYTLQVGRQAMSERLAFVADSVADVVKHLATFVDGEANAQELYRGQVKPFGDKSDLLLEGEAGQAFLNTILRQQDYRKLAALWVAGTDLDWNLLYDGENRARRISLPTYPFARETYWLDEGIGSNEKELLRDQTQKELRDRDREQTTELMTFEEIWQEASLNNHSDSIKYKSIVCFLSGSEHQQEMRTAMQAIDPAIHLTMIAQGHGYTKHSSDRYTVDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVAAFSTALERCYLESWIGFERSLKLIMPGFQVAGLFQEHAGPDQTISMTHWSQHIVSELKAPKAQTVLIQNHRRYVNQIQKTELAAQGASVASAVKQGGTYLITGGCGGLGFLVAQHLAEHLGQPAASASGKTVHLILTGRSSPDDAIQSKITQLEALGAKVGYVQADVADAVAMRRGLAQMKNRFGDIHGIFHIAGIAPSESLLNKDIDAFQNVLGPKIAGTLMLDDLCRDEPLDVICYFSSSAAILGDFGACDYAIGNRFQMAYAAYRNHLLQQGMRQGKALVINWPLWQEGGMGFHQDENTKMYLSSSGQRVLETQEALTVLDHVLNQDKTQHLVLVGQPGRVYGFLGLTEAPMTQMPVTEAPVTQTSTRPELRGLSTEQSVLWDLRNLIVQQLKVPWEQLGRDHNLADFGFDSISLLSFANRLSEHYQLDITPALFFGYSTLEQLTQYFLSEHCDFINAFYKEPEKSEIPVKKEAVEERAPIRIVSEETRPEKIDNAKDEPIAIIGMSGRFPKAYDVEQMWQLLASGECAVEEISPHYFDWRRYFGEPSQEANKTNGKWCANIPGVAEFDPLFFQISPREAPNIDPRQRHLLQESWNALEHAGYGPHQLNSQKIGTFVGAEEGDYYQRVKEGNITSNHSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGVNLMLTPYGYISMGRAGMLSEDGHCYAFDERANGLVPGEAVVVVVLKRLSRALADGDPIHALILASGVNYDGKTNGITAPNGVSQAELVREVHQRAGVHPQDIDYIVTHGTGTRLGDPVEVNALNEVFRDSQHLCAITSSKTNFGHTFSASGLLSLVNLVQALRHETIPKSLHFAQPNKFMTWDQGPLYVNTANKPWLEKPGEKRIGGVSAFGMSGTNAHMLIQDYQLHRKEPRAVPPYALLVLSAKTAEALHLKVKAMVAFLQEGLADTATLADISYTLFEGRHHLQYRLAIVVQDMTEAMCCWTQAGQPDKKPNIFQGKVPTEFSGQKVTQNYINQLVEQLDRSTGDDDVYRERLLGLADFYCQGYDVPWSRLYGDTRPRRISLPGYPFAKQQFWLDFSPKDHGEQENVELPIGKMQRQVLNEKNTLETLSYIHKWEQQDKAEVKIEISQVCLLVYFESASQFEKTLASFFLQQGASQVIEIQLGLETKPVSEHKWRCNVNDVDAFQRCLQAYAQTINSVYFLCVDTLQQGMEESEMQLLRLVKALKSRMQSHAFIDFTLLTLDNHRVDNSATSPNHGGLSGLGYSVAQSDHRFRVRNIDLSREDLVSAEQQCTLPGMIVSEAPSDRGEVVKLQAGLRYKQRFFKLDWQTLQAAQPEAAGLKTGGVYVLLGGAGTVGAIITRYLIQKYQANVVWLGRRALTSPAVQEQLHAFRSVDEGCVPLYIQADVTDQASMTQAVKEIKQHHPCIHGAIFSALVFKLDNSIAKTSEEDFNEVLDTKKKGAQYFYHAFKDENLDFMCYFSSVQSFFFISSRESAGYATGITSADTFVHAIDHDSTFPVGIINWGYWEASLAGTEAEKRLPGHYDLISDHDGCQFFDGFVPMLRSGLIKQAVCLGVSKAIEDFMGCDATQMITVNKLEADSLIFSLFNENECGQATCEETEIERLLDKDFNNELKQWLPRLLFSQLQQLGIFLNRGEQRDCTTWQQQAGVIKKYERWWRECCLGLLETSGYVQCEGERVEVTHHSPADEADQLWQGWESFQNLFLDKPERKPVLDLLESCLRSLTQILCGDILATDILFPKSSMEKVENIYQRNALSDYCNTFVAKGIEAYIHQRIQAEPQARIRILEVGAGTGGTTALVLPQLRQVQHAIDEYCYTDISKAFLIHAEKTYGPDYNYLDYKLLNLEQPLAPQGIEPGSYDMVIATNVLHATENIRQTLRHTKTALKRHGLLVINEVVEKSIVGILTFGLLDGWWLYQDESLRIPGSPLITLDTWRKILKEEGFARVLLPMRAASKLGQQVMVAESDGLVRREREDLPDEDESAVTDKTSVVQGMTLTPEQRIAQTPSVRELSSETLREQVAELILTGLAETLGMAQENIDPLVSFSDYGIDSILGVGFIGQLTKSFGITINTAILYDYTNVVRLSDYLVEIYAEDIQNKIQNNRMSPVEKDAVLYTETQLETTVDRNPEKSQLENSVPNMTSGENKSAKCQEIAVIGMSGQFPRAKDLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGGILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIGAEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVNTGCSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATGRCRTFDQFCDGTVLSEGVGVVVLKRLDDAVRDNDPIYGVIQASGANQDGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMRYHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREYLPLSETKAEMEAVLIPLSAKTLESLRTYAESLSTFLENGHSGHGVSLTDLAFTLQLGREAMRERCIFLAGNVPDLVAQLKAFANDKTLNNVGWYGRVGRSKNSHSFNDHESRQMITQWLQQGKLDKIAAAWVQGLSIDWAALYRELTARKIHAPTYPFAQEHYWKPEQQSMVQKPVAPETQPETFGTLMLQPCWIDQPLEHS", "perc_identity": 32.39}, "gnl|BL_ORD_ID|1764|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 33035, "orf_end": 60031, "orf_from": "BGC0001186.1|Misakinolide_16 ", "model_name": "LRA-13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1200", "model_id": "1912", "ARO_accession": "3002484", "ARO_name": "LRA-13", "ARO_category": {"41395": {"category_aro_accession": "3004231", "category_aro_cvterm_id": "41395", "category_aro_name": "class C LRA beta-lactamase", "category_aro_description": "Beta-lactamases that are part of the LRA gene family and are classified as Class C beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "41405": {"category_aro_accession": "3004241", "category_aro_cvterm_id": "41405", "category_aro_name": "class D LRA beta-lactamase", "category_aro_description": "Beta-lactamases that are part of the LRA gene family and are classified as Class D beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.73718, "max_identities": 34, "bit_score": 31.187, "cvterm_id": "39085", "query": "PVDVSVDVHHVDDMME------PGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVD----SITGVDF------IHQINSRLGI---VLRTTALFDHATIFDLSRFIDESHG-AAIDEQRQR", "match": "P+ V   +   + +ME      PG  A    +  +  V  +    AQS+G+ F +   NR F   G+     ++   +        +Q N+ + I   VL T A        DL RF+D + G   +DE+ QR", "sequence_from_db": "PMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQR", "sequence_from_broadstreet": "MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR", "dna_sequence_from_broadstreet": "ATGAATTTTCGCCACATAGTCATGGCGGCGCTGTGCGGTCTCGCCTGGACGCCAGCCATCCACGCCACCGAAGTGTGTATCGCCATCGCCGAGGCCGGCACCGGCGCTGTGCTGGTCCAGCGCGGCGATTGCCAGCGCCAGGTGACGCCGGCGTCGACCTTCAAGATCGCCATCAGCCTGATGGGCTACGACTCGGGTTTTCTGAAGGACGCGCACGCGCCGAAACTGCCGTTCCGTCCAGGCTATGTCGATTGGCGGCCCAGCTGGCGCGAACCGACGGATCCGGCCAAGTGGATGAGCGATTCGGTCGTATGGTATTCGCAGCAGGTGACAAAATCCCTGGGCATGCAGCGTTTCGCCGACTACACGCGGAACTTCAAGTATGGCAATGCCGACGTTTCGGGGGACGCGGAAAATGACGGCCTGAGCATGTCGTGGATAAGTTCCTCGCTGCGGATCTCGCCGCTGGAACAACTCGCGTTCCTGGACAAGATCGTCAACCGTCGGCTGGGCGTGAGCGCCCATGCCTACGACATGACCGCGCAATTGACGAAATTCGATCAGCCTCCGGCGGGATGGCGCATCAACGGCAAGACCGGCGCCGCCTCCGGTTATGGCTGGTACGTGGGATGGGCGTCGAAAGGTTCGCGAACCTTCGTCTTTGCGCACCTGATGCAGAGGGACGCGACGCAGCCGCAAGACGTGTCGGCGGGCGTGCTGGCGCGTGACGAATTCCTCAAGGAACTCCCCGGCTTGATGATCAAGGATATGGTGGACCGCGCCGTCCAGCCGTTGATGAAGAAATACGATATCCCGGGGATGGCGGTGGCCGTCACCGACAACGGCAAGAACTACTTCTTCAACTACGGGCTGGCGTCGAGGGAAACCGGGCAAGCCGTTACCAGCCACACCCTGTTCGAGATCGGTTCGCTGAGCAAGACCATGGCGGCAACGCTGACTTCCTACGCGCAGGTCAACGGCCAGCTTGCGTTGACCGACACGGTCAGCCGGCATATGCCCAAGCTGCGCGGCGGCGGCTTCGACAAGATCAGCCTGCTCAATCTGGGCACCCACACGGCCGGCGATTTTCCGATGCAGGTTCCCGACCATATCGAGACCTACGAGCAGCTGATGGAGTACTACAAAAACTGGAAGCCCGGGGTTGCTGCGGGCGGCGCCAGGACCTACTCCAACCTGACCGTCGGCCTGCTGGGCATCATCACGGCGCAAAGCATGGGCATGCCGTTTGCGGAGGCGATGGAAAACAGGTTGTTCCCCCAGCTTGGCATGCATCACAGCTATATCAATGTGCCGGCGGCGGAGATGAAGAACTACGCGCAAGGCTACAACCAGGCCAACGCACCGGTCAGGATCAATCCGGCGGTGCTGGCAACCGAGGCATACGGGGTAAAGACCGATGCCGCCGACTTGATCCGGTTTGTCGACGCCAACATGGGGTTGGTCAAGCTGGACGAAAAACTGCAGCGCGCGGTCACCGGCACGCACACCGCCTACTTCAAGACGGGTGAGCTGACGCAGGATCTGATCTGGGAACAATATCCCGCCGCATCGAAACTCGATCGCATGCTGGCGGGCGTTTCCGAAAAAATGGTCTTTGAAAGCAATCCCGCGACCAGGCTGGCGCCGCCGATGCCGCCGCAAGCGGATGTGCTGATCAACAAGACCGGATCAACCGGCGGCTTTGGCGCCTATGCGCTGTTCAACCCGGGCAAGAAGACCGGCATCGTGATGCTGGCGAACAAGAGCTATCCTGGCGCAGAAAGGGTGACGGCGGCCTGGCACATACTGGATCAACTGGACCAGCGTTAG", "partial": "0", "query_start": 37139, "query_end": 37477, "hit_start": 1089, "hit_end": 1488, "orf_dna_sequence": "ATGTTGAGGACCGGCATGAAGACAGATAGCCCGAATCATCCAGAAAACCAAGCGATCAATGTCAATCACTATTTAATGGTTTTGTCGGCCAAAACGAAAGAGCGCCTGCAAACGGTGGTTGAAAATCTACTTGACTACGCCAAAGCCAATCGTCGTCTCATCGAGTCCCGCCTTGCGGATGTCGCCTTTACCTTGCAAACGGGCCGCGAGGAGATGGAAGCGCGTTTGGCCTTCGTGGTATCGGATTATCATGATCTGATGGGTCAGTTAAGCGGTTATCTGGAGGATGCGCCCAACGCGAACACGATTTTCCGCGGACAGGTGGATCTGTTTGACCAATCTGCGCCGGTTCGTCAACATCGCGCGGCACAAGAGCGCGACTGCGAACGCATGATACGGACCCACGACCTGCCGGGCTTGGCCGAACTTTTTGTTCAGGGCGTGCCGATTGACTGGCGCCGTTTATATGTGCAGGGTCGCCCCAGGCGCATCGCGCTGCCCAGCTACCCCTTTGCCCCAGAGCGTCACTGGGTGGCGCGCCGGGAGCCTGACCATCTGGCTGCCGATATGCCCGCCGTTCGGCAGCCACACTCGCTGCTTGATGGACGTGATGATCGAATGAGTCTTGAGTCCGGCGTCGTGTTTCGAAAGCTGTTGCGCATTAACGATGGTGTCCTTCAGGATCATCAAGTCAATGAAACACCCGTATTCCCAGGCGTGGCCTATATAGAGATGGCCTGCGAAGCTTTGGCGCAGTTGTCGTTTTCTGATCCGGAGGTGTTGCGGAAGACCGTATTGAACCAAATGGTTTGGCTACAAGCCCTCGCCGTGACAGAGGCCGAGCATGAAATTTTGCTATGCTTGGAAAAAGATACACATGGTCTAGCATTTGAAGTCAAAGATCATCAAACGCTTTATGCCAAGGGCCGTTTCGATCAGTCGGATGACTTGAGTCAAGGCCATCAATACCTGGAACTGGAAACTATAAAAGGTGATTGTCCGCACGAAAAGCATCGCTCGGTCATTTACCATGACTTCCGCCTCTTAGGGCTAAATTATGGACCTTGGTTCCAGGGCTTAGAGCATACTTGGTTCAGTATAGATAGTGCTGAAGGGGAGGGTGAAGCGCTCGGCTATTTTAACATGCCGTTGATTTGCGAGTCGGAATTCTCCGCTTATACCTTTCATCCTGGCCTGTTGGATGCGGCATTGCAAGTCGTTGCCAGCGTGCCCGGATACGCTGACTCTGGCTTATTACTTCCCTATGCGGTAGAAAAGCTGGAGTGGTTCCACCCGTTTCCTGCTTGCGGATATTCCCATGTTCGCAAGCTGGCGAAGCATCGCTACGATGTCACCATCTGCGATGAACAAGGCAAGGTCTGCGCTAAATTTTCTGATCTTAGTGTTAGGCCCAGCCGAGTCGCAGGCTCAGAGCCCAGCCTGAATCAGCTGACCTACCGGGCGCGCTGGTCGCACCAAGAACTTGGGGAAAGACGATCGCCAGCAGGCCGTCCCGAAGAAACCGGAGTCGTGTTCATCATTCACACTCCGGAACAGCAGGCATTGGTACAAGAGCTAAGCAGCGTTTTAGCAGACATGCATGGCGATCATCGAGTACGACGGATGTGCCTAAATGCAAACGACTGGGATTTTAAATCGTTAGGGAATTGGAATCACCGTATTCGCGCCGTTCAGGACTTGCGCGATATCTATTTTCTTGCTGCTATGGAGCATACCGTTTCGAGCGGACAGGCCCATGTGGATCCTCTCTCTTTTACCAACCGACAGGAGCATGGGCTGCTCTCTTTATTCCGCTTGCTCAAAGCGCTGGATCAGAACCAGTTACTACTGCAACCGCTGTCGTTAAAAGTCCTAACGACAGGAAATTATCGCGTTTTGCCAAGCGATACGATTTGCCCTTTGAGTGCCGGTTTACCAGGTTTTTGCCGCTCCATTGCTCAGGAATACCCCTTGCTCGCTCTCAGTTGTATCGATCTCGGATGCCCGGATGGCGACGCCATGCAGCCATCCTCGCTTAAAAAACTGGCGCAGTTCATCGTTGCTGAGCCCGCGCATCAGCCTCATGAAACCGTCGGCATACGTGAACTCCGGCGCTATACTCGCAAGCTTGTTCCCGTTCGTTTTCCCGAACCCGGAGGGCAAAGAGCTTTTAAATCCCGAGGCGTCTACATGATCGTTGGCGGAGCTGGGGGCATTGGGATGGTGCTGGCCCAGTACCTGGCCGAGCGTGTTCAGGCGCGTCTGGTCTTGGTGGGCAGAAGTGCTTTGGATGAGGAGAAAAAGCAAAACCTTTCGACGCTCACTGCCGCCGGTGGAGAAGCCCTATATATCCAGGCAGATATCAGTCGTCTGTACAGCATGAAAGATGCCGTCGCCCAAGCCCGTCAGCGTTTTGGCAACATCAACGGTGTGGTGCATTCCGCCATGGTTTTAAATGACCAAAGCTTGGCCCGTATGAGTGAAGAGGGGTTGCGGGCCAGCCTGGCGCCAAAAGTCGAAGGCTGTATCGTGTTGCAGCAGGCGATGGCCGGTGAGCCACTGGATTTTATGTTGTTCTTTTCTTCGGCAATCTCCTTTAGCGGCAACGCCGGACAAAGTAACTATGCAGCAGCTAGTACATTTAAGGATGCCTTTGCCCATTATCTGACGCAAGTGGAAGCTTATCCCGTATTTAACATCAACTGGGGATATTGGGGGTGTGTTGGTGTGGTTGCGAATGCAGCTTACCGTGAACGTTGGGCAGCTCGAGGAGTCCATTCTATTGACCCAGAACAGGGTCTGCAAGTCATTGAATCGATCCTGACTAACCATATTGATCAAGTCGCTGCGGTGAATGTCGAGCCGTCTTTTCTAGAGCGCCTGGGCGTAGAACTGTCTCAAACACAAACTGTACTCCCACCACGTCGCTCGTCGCTGATTGCAAAACTTAATGCGTTGCCACTGCCGGAAACCGGGGGTTTTCAAGATAATGTTAATCGCCTAGAGATCGTGAGTGCATTCCGCTGGGCTGAAGTGTTTAAGCATATGCTTGATATGTCTAGCACTCAGGGAATGTATGCTCGCTCTGATCTTAAACGACAATTACAGATTAGCTCTGAACACGATCAGTTGTTTGATGTTCTCATTTCTATGCTCATTCAAGAGGGCTATCTCCATCAGCAGGGCAAAAATCTGACGCCTACACCTTACTTGAATGGCGAGTTTTTCCAGCAGCAGAGAGAACAAGTCGCATTGCTGGAAAGTGAGCTGTCGCAAACGGATAATGCCTATTTAAACTTGTTATCTCGCTGTCTGGATCACTATCCCGCTATGTTGCGCGGTGAAGTGGCGGCAACTGATGTGATATTCCCACAGGGCTCGATGGAATGGGTGGAAGGTATCTACCGCAGCCATGCTTCAGCCGACTATTTTAATCAGCAATTGGCCCAACGCCTCGTTGCCTATGTTGAGGCCCGCTTGCCTTCCCTGGGTGCGAATGAATCGATTCATATCCTAGAAATTGGCGCCGGCACCGGCGGCACCAGCGCCATTGTATTACAGGCGCTCCAGCCTTATGCAGCTCGCCTGCGTTATACCTACTCCGATATCTCGCCTGGTTTCCTCAATTACGGGCGCAAAACCTTTGGCGACGCGTATCCGTTTGTCGAATTCAGACACTTAAATATTGAACACAATGGCGAAGCTCAGGGCTATCAAGCAGGCGAGTACGATTTGGTCCTGGCGGCCAATGTGTTGCACGCTACCCGTCACATTGGCAACACCTTGGCCCGGGTTAAGTTTTTCATGAAACGCCATGGCTGGCTGTTATTGAATGAAGCCACCCAAGTGCGCCATTTTGGGACGTTGACCTTTGGTTTGCTAAAAGGTTGGTGGTTGTTTCAAGACGCTGAAAACCGGCTTGACGGATCGCCTTTGCTGTCAACCACTGCCTGGCAGCGGTTACTGTCGGAAGAGGGGTTCAAGCACACGCTTAGTTTGTGCGACGCGGTTGAAGAAGAGTCAATTTTTCAGGATGTCATTGTTGCTGAAAGTGATGGTGTCATTCAAATGAATCAGTCGGATTCACCTGTGCAGCCGCGTGAGCCTGTGGATGTGTCTGTGGATGTCCATCATGTCGATGACATGATGGAGCCTGGGCAAGTGGCGGATGTGGTTGAGTCACGACATGATTTTATCGTCAATAGCGTCAGCCAATGTATGGCTCAGTCTTTAGGTGTGGCGTTTACCGACATTCACATCAATCGTCCATTTAGCCTTTATGGTGTGGATTCGATCACGGGAGTTGATTTTATTCATCAGATCAATTCCCGTTTAGGGATCGTTTTGCGAACGACGGCCTTATTTGATCACGCGACGATTTTTGATTTATCCCGTTTTATCGACGAGAGCCACGGCGCGGCGATTGACGAGCAGCGTCAGCGCTTGAGGTCAACACCGTTGACCTCAAGCGATACGAAGCCAGCGGAGCGTGTCGCCCCGCCGGATGAAGCGCTTCCCCATATCGAAAGGGGCTGTCACCAGGCGGTCGTACTGGAAAAACCCAGCCAGATCGAGCACCTTCGCTTCCATCCCGTGAAAACCCGGGAACCTGCGGCGCATGAGGTGCAAATTGCAGTTCGCGCTTTTTCGCTCAACTTCGGGGATTTGCTATGCGTGACCGGGCTCTATCCCACCATGCCGGCGTATCCATTTACACCGGGCTTTGAAGTGTCCGGGCACGTCGCCAACGTGGGAGCGGCGGTCAGCCACGTTGCGGTGGGCGACGAGGTCATTGCCCTAGCGGGCCAGCAGTTGGGCGGCCACAGTACGCTGTTGACCACTGCAGGACACTTGGTGGTTCACAAACCGCGTCAGGTCAGCCACGAGGAAGCTTGCGCGTTTCCCGGCGTTTTTCTGACCGTCTACCATGCGTTTCAAAGCGCCAATATTCAAGCTGGGGAAAAAGTTTTGATTCAAGGCGCGGCCGGGGGAACGGGCTTAATTGCTGTACAAATGGCCCAGGCGGTGGGAGCGGAAATTTATGCCACAGCCGGTTCGCCCCAAAAACTGGATTATCTGCGTGAACGAGGCGTGCCGCATCTGATCAATTACCAGACGGACGATTTCGCCGAGGTCATTTTAGCAGATACAAACGGTTATGGCGTGGACGTGATCTTCAATACAGCAGCCGGGGACGCCATGCAAAAAGGGCTGGACATTCTGGCTCCCAATGGACGCTATTTGGAAATTGCGATGGTCGCCCTGAAGCGTTCGCGGTCGGTTGATTTATCTCATTTGGTTGATAATCAGGTGTTTTATAGCATCGATATGAGAAAGCTGATCGCTGGAAACCCACAGCTGATCAGCCGCTATCTGAATCGCATGGTGGAGCATCTGGCAGAAGGGCACGTGCAGCCGACGATAGGCGCAAGATTTGCGCTTGATGATATTCAAAGCGCCTACCGGCTGCTACACGACCGGCAAAATATTGGCAAAGTTGTTGTCAGTATCCCCGATGGGATGATGGACAATCAGGTCGGCCAAAGGATGGTGCCGGAATCCTCAACGGTTGAGGACTATCGCGTTGGAAACGCCACGGTTGAACAGGTTGCGGTAAAACAACCGGCGGACATGGATGAGCCGATTGCCGTTGTCGGTATGTCCGGCCGTTTTCCCGGGGCAAACAACTTGGAGCAGTTCTGGTTGAATCTTATAGGTGGCAACAACGCGATCACCGAAGTTCCCGCTGACCGCTGGGATGTCCATCAGTGGTATGACCCCGACCCGGCAGTCCTTGATAAGACCCATTGCAGATGGGGCGGTTTTCTGCGAGATATTGACAAATTTGATGCGCTGTTTTTTAAACTCTCAGGCCGGGAAGCCGAGTTGACTGACCCGCAACAGCGTTTATTTCTGGAGGTCGCTTGGGCCGCACTTGAAGATGCGGGGCATGCGAACCGCGCGATTTCCAATGCCCGCTGCGGGGTTTTTGTCGGAGCCGGTCCGAGCGATTACGTCACGTTAATGCGTGAACGGAGCGTGCCCGGCGAGCCCCAGTCATTCTGGGGCAATTCCAGCTCGCTAATCGCGTCGCGCATTGCCTATTTTTTAAACCTGAAAGGGCCGAGTATCACCATTGATACGGCCTGTTCCTCATCTCTGGTCGCCTTGCATTTAGGCTGCGAAAGTATTCGGCGTGGCGAATGCGACATGGTCATTGCCGGTGGCGTGTATATTGGGGTCACACCACACTTACATGTTATTGCTAGCAACGCCGGCATGCTCTCACCCGATGGCCAGTGTAAAGCCTTTGATCAAGGTGCAGATGGCTTTGTCCCGGGTGAAGGCGTTGGCGCGGTGGTCTTAAAACCACTGTCAGTGGCACGTCAAGCCGGTAATTTTATTTATGGGATTATTCGTGGCTCAGGTTCAAATCAAGATGGGCGAACTTATGGTATTACCGCGCCCAGCGCTGCTTCTCAAACAGAGCTAGAGCAAAGTGTCTACCGACAGGCCGAACTCGACCCGGCAAGCATTGGCTATGTTGAAGCTCACGGTACAGGTACCAAACTTGGTGATCCCATTGAGATTGATGCGCTGAATCGTGCCTTCCAAAGTGACGCGAAAAAGCAGCACTCTTGTGCCATTGGATCGGTTAAAACAAATATTGGACACGCTGGTGCGGCTGCCGGTATTGCTGGATTCATTAAGGTCTTATTGTGCCTGCAACATCAACAATTGGTGCCTTCGTTAAATTATCACACGTGTAATGAACATATCGATTTGGACAATAGCCCGTTCTATGTGAATACAGAATCAAAGGATTGGTTCGTCGCTCAGGGTGAGCCGAGACGGGCTGCGGTCAGCAGCTTTGGCTTTAGTGGTACTAATGCGCATATTTTGTTAGAAGAATACCAACACCATGAGGACGAGGCCCAGGCACTTGGAGATGACAAGGATGTGTTGATCGTCCTTTCAGCCAAGAATCAAGAACGTCTCAAAAAAGCGGCTGAAAATCTTCACCATTTTTTAGAAAGCAGAGTCTCCTATAAATTGTCCGACATTGCCTATACGTTGCAGGTTGGCCGTGAGGCGATGGAGGCGCGAGTTGCTTTTATGGTGGTCTCAGTCCTTGACTTACAACAAAAGCTTGTGTCATTGCTTCATGACCCAACAGACGAACAAGACATGTATTGGGGGGAGGTGCGCGATGGCGAGGGGCCTGCTGGAGTGGCTGCTTTTGAAGACGTCGCACTTGCCTTGGCTAACAAGCAGTTGGATCAGCTTGCCCAGTGGTGGGTGTCTGGGGTTGAAATAGACTGGACCCAGCTTGCACGCGTGGTGAAAGTCCGTCTCGTTCCTCTGCCTACGTATCCGTTTTCGCCTGATCGTTACTGGTTTGATTCGGTAGGTCCGGCGACGGTTGTACATGCCGAGCATTCAGCCTCTGCTCTGTATCCCCTATTGAATCGTATCGCTCCGCAGGCGAGCACTCAAATCGCGAACGGCTGCGTGTTTGAGACGTGCTTGAAATCCAGTGACCCTCTGTTGGCGCAACATCTCATTGACGGCCAGGCGGTGTTTCCGGCAGTGGGATTTCTGGAGATGGTCATAGCTGGCCTGCGCGAAATCCAGCCAGATAAAGCAGCGCGGTTGGAGAATGTGTTTTGGCTCCGGCCTCTTGATGTCATGGATGAACAACGCGTTCATCTGGTGTTTGAGGTGAAACAGGATCGTTTTCAATATCGAATTGTACCCGCAGAGTCTCACGGGGACGGGGCCTATTTTCGTGGCCAAGGCTACTGGTCAAACGATATGAATCCTGCGATTCCGATGGATATTGATCGCCTGAAAAGCCGTATGCGCCAACAGCCCTTGCTCAACGAATCCAGCCCCCGAGTCCGCCTGGGCCGCTTGTATCAAGGCGCGACTGAGGGGTGGACGGATGGTGAGCAAGCACTGATCGCCTTTGAGTTGCCAACGGCGCAACCGTATCGAGACGGGTCCCCCGATCAAAAATCATACCCATTTCACCCTGCAGCTTTTGTCGCGGCTTTGCAAGCCTATCACTGGATTCATGAGGCGCCTAAGCGTCTGGGGATGCCTTTTGCCGTGCAAAAAGTGGAGCTGTGGCGCCATCGTGATCAACCCGCTTATGCTTACGTTGCACTAGATGAGCATGGCAACGCGGACGTGCACATCCTGGATGCAGGCGGTCAGGTATGCGTCTGTTATCGTGGCATGGCCCTGCAGACCTTGAACAATGCGCACCACGATGGGAGACAAGAAAGCACTCAAAAAGATGAGCTTGGAAAATTGCTTTTTGTCCCTGTCTGGAAGCGTCTTGATACGAAACATGGGCGTGCACATGGCATGCATGCGCTTGCTCGCGGAACGGGCGTCTTACTGGTGTACACACACGAAAATGGGGTAGAGGCCGAGCAGCTCATGCAGCGTTATCGCGAAGAGCAATGTGAGTTACTCTCGGTTTGCTTATCTGCGGCGGATAGAGCACTGGACACCCTGGCGGCGCGTCTAAAGCATCTGCAGTCGCCACTGCGCCATGTCTGTTTTCTTGATCGTCATCAGGCCGCGCTTGATCCGGCTGACAAGCAGATTGACGAGCGATTGCGTGAACCCCAGACCCTCACAGGCTTTTTGGCATTAGTGAGAACCCTGAGCGAGCTTGGCTATGATGAACAGCCCCTACAATGGCTTGTGCTTACCTCTAGCGCATGTGCCGTCAATCAAGCAGACCCCATTAACCCGTATGCCGCTGCGATTGTCGGACTTGCCTCTTGTCTGGCGCAAGAGCATAGGTATTGGCAGGTGAGTGTCTGTGATCGGGGCAAAGGCACATCTTTCACAACGATTGCGAATCACGGGGAAACCTTGCGCGTTATTGCTGAGCGCAGTGGATACAGTTATGTGAGGCACATCAAAGAATTAGAGCTGCCCCCTCCCCGGCAGAGCCGTTTGCGTCACAAGGGCGTATATGTCTTGGTTGGCGGTGCCGGTTACGTGGGGACCTTGCTTAGCCGCTATCTGGTTCAGACCTATCAGGCAAAGGTGATATGGCTAGGTAGACGTGAGCAAGATGAGCAGATAGAGCAAAACATAGCCCTGATCGCTACCTTGGGATCGCGTCCGCAGTATCTGAGCCTGAAAACCGGATCAGACGACGAGCTACACCGTGCATTTGCGCAGATTAAGGCAGAAAACGGTTTGATCCACGGTGTGTTTAACCTGGTGATGGTCGCGCAGAGTACCCCGATGCGCAGCCTGAGCGAAGCACAATTTCGAGCTGGCTCCTTTAATTCCAAAGTGAACTCCGCGCAAGCCTTATACCGTATTCTGAAAAAGGAAGCTCTAGACTTTATGGTGTTCTTCTCTTCGATGCAAAGCTTTGCGCAGCAGCTCAATTTTATGTCAGCGAATATGAGTAGTTATGTTGCAGGTTGCATGTTTCAAGATGCTTTTGTGCATCAGATCAATTGCGAGTTATCTTATCCTGTAAAAACTATTAACTGGGGTTATTGGTCACAAGAGAGTTCAGAGAGCGAAAAGGCGAAGTGGTACGAGACTTATATCGCGGATAAAGGTATTTACAGTCTCAATGTTGGGGAGGCGATGCAAGCGTTGGAGTATATTTTGGCTCACGAACCAGAACAAGTGATCGTGACCAAAGTATCACATCGGGTTCTCAGCGACATGGGCTTTGTGCAAGATGACTCAGAGAACGTCGACCTACAGCCTGTTATTGACTCGAACGATGACAATACCCAGCTTGAGGACTTGATCGTTAATGGTATTCTCAAAACCTTTGAAACGCTCGATGTATTGCAGGTATTTGATAGCGCCTGTAATCTCGATGTTTCGAGATTACAGGCGCATGTGCCCGATAAATATCGCCGCCTGTGGCGTGAACTGCTTCTGATTTTGGTTCAGGCTGGAAAGATGGCACCACAGGGTGCTGGGTTTGCTCTACGAGAAAGCTATACCAGTTTGGCGAGCCAGCTTCGCTTAATGGATCTCGATCGGGAGGCTGGGCTATTGCGCGAGCGCCATCCCACCTTAGCCTCGAAACTTGCCTTGCTCGTACCCTGTCTGAAGGATATGGCCGAGGTGTTAACGGCTCGCAAACCAGCAACAGAAGTGTTGTTCGAACACGCTTCGCTGTCACGGGTTGAAGGGATTTATAGAGGAAATCCCACCACAGACTACTTTAACCAGCGTGTCGCTGACATTGTGAAGGCCGCAGTACAGCAGGCACTGCCCAGCCTGAGTGTAGGGAAAAAAGTACGCATTTTGGAAATCGGCGCGGGCACCGGTGGTACCAGTGCCTACTTGTTTCAAGCACTTAATACATATGCAGATCAGTTGCACTACATCTATACGGATATCTCTAAACGATTCTTAATTCATGCAGATGAAACTTTCTGTGAGCAGTATTCCTTTATAGAGACAAAATTGTTGAATATCGAACAAGATGTGGCAGGCCAGGGGTTCGATCCTGCTAGTATTGATATCGTGGTGGCAGCCAATGTTTTGCACGCCACACGCAACATTAGTAAAACTTTGCAACATGTTAAAGACTTACTCAAGAACGATGGGCTTCTGGTGTTAAATGAATTAGCGGACGTTTCGCCTTTCCTCACCGTGACCTTTGGTCTGTTAGATGGATGGTGGTTGTATGATGATGAAGCCATTCGCCAACCAGGCTCACCTGGCCTATCAGCAAAAAATTGGCAGCTTGTGTTGAAAAATCAGCGTTTTCACAATATTAGTCTCAACGATGAAAAAGCTCTGACGTCAGAGCAGCAAATTATTATCGCGCAAAACGAGAGTAAAGAGAGTGTGCCGGTCTCATCCACAGTATTATTAGGAACAGAACTTATCGCCTCAGTCGAAGCCAGTCTGATCGCACAATTGAGTCAGTGCATAAAAATCGAGCAAAACCGTCTCAATACCTATACCACGTTTTCAGATTATGGTGTGGATTCAATTTTGATGCTCGCCTATGTTGATCAAATTAATGGTGATCTTGGAATTGACCTCAATCCTTCAGAACTATTTAATTATACCACTGTTGAGCGTCTTACTAAGTTTATCGTTGATTATCATGGGAAAGAGATCATTTCAGCAAAAGAAAGCGTTGAGAGATCATTACTTCAGAATCAAGAAAGCAAATTTGACCTCAATGACATAGATGTCATCACAAAGGCAGGGAACGAAGCTCCGGAGATGGCGCGCAGCCTTCTCTTTGATAACGTTTTGCAAGTGCCGTCCGGTAACGTGCATCATCACCAGAGCGATAAGGCGCGACCTGATATTGCGGTTATTGGCATGTCGGGGCAATTCCCAGGTGCGACGAATGTTCAGCAGTTTTGGCAAAATCTGAGCGCCGGCGTCGATAGTGTGAGCGAGCTGCCTGAAAGCCGCCTGGATCGTCAGCTGTACAGTCCGCAGCCAGAGGCGGGAAAATGTTATTGCCAATGGGGCGGTATCTTAGAGGAACAGGCCTCTTTTGATCCACTGTTTTTTGAAATCTCTCCCAAAGAAGCCGCCGAGATGAATCCTTCTCAGCGGGTGTTTATGCAGGAGGCTTATCGAGCCCTGGAAGATGCGGGGCTGGTCAACGCAGGTCTCTCGCAACTGCATTGTGGCATTTATGTCGGTTGTGAGCCAAACGGCTATACCAAACAAGGTTTCACCGGCGCCTCCGAAGCCATTGTCGCTTCCAGAATCTCCTATTTTCTCAATTTGCAGGGACCGGCTCTGGTGATTAATTCCGGCTGCTCCTCTTCCTTGGTCGCCATTCATCTGGCTTGTGAAAGCCTTCGCCATGGCGAAAACGATATTGCCCTCGCCGGAGGCGTTTTTACGAATCTGAATAACGAGTTGCTCGTCTGTCTGTCGTCCATTGAGATGTTGTCATTCTCCGGTAAATGTCACGCCTTTGACGAAGCCGCCAATGGCACGGTGCTGTGTGAAGGTGTCAGCGTGCTGGTGTTGAAACGATTACAGGACGCGCTAGATGATGGCGATGTCATTTATGGCGTGATCAAAGGCAGTGGCATGAATCAGGACGGAAGAAGTAATGGCATCACTGCACCCAACGGACTTGCACAAGAAAATTTGATCAAGCGCATTTATCAGGATTACAACATTGATGCCAGCAAAATCAGCTACATAGAAGCCCATGGTACTGGAACGAAATTGGGTGACCCCGTTGAGGCGAATGCGNTGAAGAACGTATTTTCTTCAAGAAACACGGGTTTGGACTTTCGTTGCGGAATCGGTTCAGTTAAATCGAATATAGGACATGCGGCTGCAGCTGCGGGTGTGATCGGTCTGGTCAAGGTCTTATTATGCATGCAACACCGTCAGTTACCAGGGCTGGTGCATTTTAACAAACTCAACCCTCTAATCGATTTTAACGACACAGGTTTGTACATCGTTGAGCAATTGCAAAACTGGGAGCCAGCGTCTGGTGAGCCGTTGATGGCAGGCATCAACTCGTTCGGCCATAGCGGCACCAATGCCCATCTCGTGATTCAGGAACCCCCTGTGCGACCTGTCCGCGACAGCGAGAACCCATTCCATTTAATCTGTCTATCTGCCAAAACAGAGGAAGCGCTTAAACAAAAAATTAGCGATTTGAGTGCATATCTAAGGCGCAAAGAAGAGCCGCCAACTCTAGGAGCCATCAGTTATACCTTGAATACCGGCCGTGCTCACTTTAGAAAACGCTGCGCTTTCGTCGTGGATTCGCTGGAGGCTTTGCAAAATGCTCTCATGGGAGCTTTAGATGGTCTTGTTGGCAATGCAGAAAGGTTAAGTCCACAAGAACAGGCATTTTGTAAAAAAGCATTTGATTTGATTATCAAGGATTTACACGATGTAGAGAATCTTGAAAGTAGGGCTGATCAAACAATCTATAAAGATAACCTACTGGCTCTGACCGGACTTTATCTAAAAGGTTTTGACCTAGACTGGCAACGGGTGTACAAAGGTCAGAGCTATCACCGGGTATCCCTGCCGACATATCCTTTTTCCAGAGATACATACTGGATTGACGAGCCAAAACAAATTAGCTTCACCGAGCCTGGTACCGACAAGCCTGGAAACACCAGCAGGAATCATCAGCAGGATCAAAAAGATGAGGATGTGTTGGGTGGACAGTTTTATATACCGCAGTGGAAACGGCTTGATCAAACACAATCCTATGCCAGTTTAAGCGATCATGGGAAGTTGACCATCGCATCTGACCCTGTTGTCATTTTTTATCCGCCGACCATGACAAGTTTAAAAGATGATATTCAAACATGCTATGAGCAATTACCGGCAAGCCAAGTCGCTAGCTTCGAGCTTGGCTGCACACCTTCGTCTGAGGTCGATGTTCGCGATCCCCGTGCCTTTGAACGCATCTTTGTATCCCCTAGGCAGGCATTGGAAGAGCTGCTTGAGCAAGGTCGAACGTTAACGATCTACTTTATCCTGCCTGAACCGGATCAAAACCCGGACTCAGGGTGCAACCTCGAATGCCTTGAGGAATCCCTGTCACTCGGGCTGATCTCGTTGTTCCGTTTGATACAAGCGCTGTTGGCCCATCACGGCTATGCCAGCGAGCTGACCCTCAAAATCGTGACCCAGCAAACCCAGGTCTGTAAAGCTTCTGAGCGCATTGTGCCCTATGGCGCAGATGTGGTGGGTTTTGTGCAGTCGTTAGCGAAGGAATACGAGCTCTGGCAAATCAGTTGCGTGGATATTAATCGGCAGACATGGTGGACGCCCGCGCAAAGCAAAAACTTTGCCGAGGCGCTGATTGCCCTGAAGCCACCGGCGGACGGGCGCGCTCTATGTTGGCGGGACGGGTATGTTTATCACCGTGTTTTAACCCCGGCTAATCTCGTTGGCGTTCAGGGAAGTGCATTCAAGACGCGCGGTGTCTACCTAATTATTGGTGGCGCTGGAGGGTTGGGATTGGTGCTCAGCCAGTATCTGCTTGAACACGTGCAAGCGAAACTGGTATGGGTGGGGCGGCGCAGCCTCGAGGCGTTGGCGCCGGATGCGTTGCGGTTATTCAACACTCCGGGCGCCCACGTGCTATACGAGCAAGCGGATCTGTGTGATCCGGAAGCGCTGCAGCGCGCGCTGCAGCAAGCCAAAGGACGTTTTGGATACATTGATGGTGTCATCCATTCGGCTTTGATTCTAGAGGACCGAGCGATCGCCGACATGGATGAGAAAACGCTACGCAAAGTTCTCGCGCCCAAAGTACAGGGCAACGTGGTACTCCAGCAAGTGCTGGCCGATGAGCCTTTAGATTTTCTGTTGTATTTCTCCGCCGGACAGTCTTTTATGAGTCATGCTGGGCAGAGCAATTACGCCGCTGCCTGTACCTTTGAAGATGCCTGGGCGCTGTGCCAGGACCAGCGGCAAAACTATCCGATCAAAATTATCAACTGGGGCTATTGGGGCGAGGTGGGCATTGTCGCCACGGCTGACTACCGTAAACAAATGGCCAGGCAAGGCGTGCTATCGATTCATCCGCAAGAGGGCATGGAAGCGGTAGAGCGTTGTCTGGCGTCGTGCGCCACCCAGGCCGCTTATTTTAAAGTGGAACCCCGCGCCTTGAGCCGATTGGGCTTGGACGGCACTGGAATCTTGCATGCGAGCCGGAACCGTGTTCCACCTCAATTGATTCATGTCGTGATTGATGCCACCCAGGCGTGGTCAATCTCGATGCCGTACGCACAGCGCTATCAACAATCCCTTAAAAAGTTGGATCGGCTTGGTTGCTATCTCCTTCTGCGTGTATTCCAGGCTATGGGAGTGTTTAGTCAGCCTCATGAACACTATGAAAAACAGGAATTGGCCAGTAGATTAGCCATTTCAAAAGGCTATCATCACCTCTATCAAGAATGCTTGAACTTGCTAGATACGTCCGGTTTTATTGCAATCAATGGTTCGCACATTGAAGTCCAAGACGTGCTACCGGAAGAACATGACGAACACCACAGCTGGTTACAACCCTATCCCGAATTGGCCGCGCATGAAAAATTGTTGCGCATCTGCCTACAAGCTTTTCCGGATATCATCCGGGGATCGGTTGCCGCGACGGATATCATATTTCCGGATGCGTCTGTGGAATTGGTAGAAGGTATTTATCAGGGCAATCCCGCCACCGATGCGCTGAATACCAAAGCGAAAGATGCTGTGGTTGCCTACGTCAAAGCCCGCCTGGCAGACTGTCAGGAACAAATCATCTTTTTAGAAGTCGGAGCGGGAACCGGCGGCATGAGTCATGAGGTGTTGAAGGGGCTGGCCCCCTATGGGCAGTATATCGAGTATTATTACACCGATGTCTCCGAGCATTTTATCCAGTACGCTCGCCGCCGTTATGGTCAGGATTACCCCTTTGTCCGGTTTCAACGTTTAGACATTGAACAGGAGCATAGCGCGCTAAGTGAGGGGCTGCTCAGTGCCTGCGATGTCGTATTAGCCGCGAATGTTCTGCACGCCACCCAAAGCGTTCGCAATACCATCCAGCATGTCAAAGCCCTGCTAAAACGGCACGGCTTGTTAATCTTAAACGAAGCTACGACTTTGGAAAGCTTTGCCACATTGACATTCGGATTGTTAGAGGGCTGGTGGCGCTACCAGGATGCCGGAGACCGCCTACCTGGCGGGCCTTTGTTAAGCGCGTCCATGTGGCATCGCTTGCTCGAAGAAGAAGGTTTTGACCAGGTGGTGTCCCTGGGTGAGCCAGGCGAAGGCGACATGTTGGGACAGCATCTCATTGTCGGTCGAAGTGATGGCTGGAGCTTGCATCAATCTGCGAGGGACGATGAAACCCGTTCGGCCCCTGTTAGCCCTGTGGCGGCGAGCGACGTTATCCAAGGCAATCGAAATGACAAGCCCGCAGAGCTTATCAAACACGTTGAAGCGCAGATTGTGCAAACCCTTTCAGCCGCACTGGATATTGCTGCGGCTCGAGTGGAACGCGATGTGTCGTTTTCCGAGTATGGGGTGGATTCGATTCTGTCCGTTGCGATTATTAACCAATTAAACCAGCGCCTAGGGATTCGTCTGAAACGTCCGGATTTGTTTAATTACACCACCACAGAAAGCATGGCGGCGCATATTGTCGCAACCTTTGCTGACCACTTGACGGCGGCCTTAGTCGAAGAAGCTGAACCACCAACGCCAGTAACCGTAGCAAGTCCTCAACCGATAAAAGCGGCGGGGCAGCAGGATGTTCTTCAGCAAAACTTGCAAACCCAGCCTCAAGTCTCGCAAGGCGTTTGGCAAACCAAGCCGGAACCCATTGCTGTCATCGGCATGTCTGCCTGCGTGCCAGGGGCGGATCATGTGGGTGCGTTTTGGGACAACTTGGTTGCCGGCACAGATTCCGTCACCCGGATTCCCCATGAGCGTTGGCAGCGGGAGGCCGTCAATGAGCTGCCCGGCGGGCCGGATACCTCCCAGCGCAAAGCCGGATTTATGGACAATATTGCCGAATTTGACCCGCTTTTTTTTGCCATCTCTCCGCAAGAGGCGCAGTGGATGGACCCGACGCAGCGGCTGTTCTTACAGCAGGCTTGGGCCGCGTTGGAAGATGCCGGATACAATCCGCGAGCCTTAGCCGGCGCTTCATGTGCGGTGATGGTTGGCTGTGCGGCGACTGGCTATGGTGTGAAAGAGGGCGAGCGCACGGGGTATGTGTCCTATGCTATGACCAATAGCGAGGCCATCTTACCCGCGAGAATCTCCTATTTTCTCGACTTAAAAGGCCCGAGTATTCCCATTAACACCGCCTGCTCTTCGTCTTTAGTGGCGATTCATCTGGCCTGCGAACAACTTCGCTCCGGGCAAAGCGACATGGCGTTGGCTGGCGGTGCTTCCGCACTGATTGGTTCCGCGTTGCACATCGGACTCAATGGCGTTGGGATGCTATCTCCCGAGGGCGCATGCAAAGCATTTGATAAGGAGGCCAATGGCTTTGTGCTTGGCGAAGCGGTTGGCGTTGTCGTTCTCAAACCGTTGTCCAAGGCCGTGGCTGATGGCGATTCGATACATGGTTTAATTATTGGCTCGGCGATTAACCAGGACGGCAAAACCAATGGTATCATGGCGCCGAACGGTCCGTCTCAGACGGCATTAATTGAATCGGTGTACCGGAAATTCGAGATCGATCCTAAAACGATTAGCTATATCGAAACCCATGGCACCGGCACCCAACTCGGCGACCCAATAGAAGTCAACGCCTTGGCTGCTGCCTATGAAAATTTCACCACCTCGCAAACTCAGTACTGCGCCATCGGATCGGTAAAAACCAATATTGGTCACACCACCACTGCTGCCGGTGTCTGTGGATTGATTAAGACTTTATTATGTCTCAAACACCAAAAACTTGTCCCATCCCTGCACTATAAGGAGCCCAACGAAAATATTGAGTTTGAAAAGACGCCGTTTTACGTCAATACCCAGGTCAAAGATTGGCCGGGTCATCAAAACGGTGTCCGGCGTGCGGCGGTGAGTTCCTTTGGCTACAGTGGCACCAATGCGTATATGGTGGTGGAAGCGTTCGTGGAGACGAGCCCGCGCGCGGTCGGGCAGCAGGGACCTGCATTAATTGTCTTGTCGGCTAGGCATGAGGTGCGACTCAAAGAGCTGGCCAGCAATCTCATGGCCTATTTGAAGCGGTATGGCTTGAATCCGGATCGCCCGATTCAGCTCGAAGATATGGCGTATACGCTTCAGGTTGGCAGACAGGCCATGTCAGAGCGTCTGGCGTTTGTGGCGGACAGCGTGGCGGATGTCGTCAAACATTTAGCCACATTTGTTGACGGCGAGGCCAATGCCCAGGAACTTTACCGGGGGCAAGTTAAACCGTTCGGCGATAAGAGCGATTTGCTTTTGGAGGGCGAGGCGGGTCAGGCTTTTCTCAACACGATTTTAAGACAGCAGGATTACCGCAAATTAGCCGCCCTGTGGGTGGCGGGTACAGACTTGGACTGGAATTTACTCTACGACGGTGAAAACCGTGCCCGTCGCATTTCGCTACCGACCTATCCTTTTGCTAGGGAAACGTATTGGTTGGATGAGGGGATAGGGAGCAATGAAAAAGAGCTTCTAAGAGATCAGACTCAAAAAGAGTTACGTGATCGTGATCGTGAGCAAACTACGGAACTCATGACATTTGAAGAGATATGGCAGGAGGCGTCCTTAAACAATCATTCGGATTCCATCAAGTATAAAAGCATCGTTTGTTTTCTTTCCGGATCAGAACATCAGCAAGAAATGCGAACTGCCATGCAGGCGATTGATCCGGCTATCCATCTTACGATGATTGCTCAAGGCCATGGTTACACAAAGCACTCATCTGATCGTTACACAGTAGACCCCGCCGATATACAGAGCTTTCGTGAAGCTTTCCTCGATATCAGCCAGACTCATGGCGAGGTCGACGCGCTGCTTTATCTATGGCCAACCGAGGATTGGCGTCTCTTGTATGATCCATCCGCCGTCGTTTATATGTTGCAGGCTCTGGTCAAGAGTGAGCTAAAACCTTCCCGCTGCTTGCTGGTTGCTGCTTTTTCCACTGCTTTGGAGCGTTGTTACCTGGAATCCTGGATTGGCTTCGAGCGCTCGTTAAAGCTCATCATGCCTGGTTTCCAGGTCGCGGGACTGTTTCAGGAACATGCGGGGCCGGACCAGACGATTTCAATGACACATTGGAGTCAACACATTGTCTCTGAACTCAAAGCGCCTAAAGCACAGACGGTGCTGATACAAAATCACCGGCGCTACGTCAATCAGATTCAAAAAACCGAACTGGCCGCGCAAGGCGCTTCGGTTGCATCGGCCGTCAAACAGGGCGGTACTTACCTGATTACCGGTGGCTGTGGGGGATTAGGTTTTTTGGTCGCCCAGCACCTGGCAGAACACCTTGGGCAACCGGCAGCCTCAGCCTCGGGAAAAACGGTGCATTTAATTCTGACGGGTCGATCATCTCCCGATGACGCGATACAAAGCAAAATCACGCAACTGGAAGCATTAGGGGCAAAGGTTGGTTACGTTCAAGCGGATGTTGCCGATGCAGTCGCCATGAGACGTGGCCTTGCCCAGATGAAAAATCGCTTTGGCGACATACACGGTATTTTTCATATCGCTGGGATCGCCCCCAGCGAGAGTCTCCTCAATAAAGATATCGACGCCTTTCAAAACGTACTGGGGCCTAAAATTGCGGGCACGTTGATGCTTGACGATCTCTGTCGTGATGAACCGCTTGATGTTATCTGTTATTTTTCCTCCTCTGCCGCGATTTTAGGGGATTTTGGCGCCTGTGACTACGCGATTGGCAATCGTTTTCAGATGGCTTATGCCGCTTATCGCAACCATCTGCTGCAGCAGGGGATGCGACAGGGTAAGGCGTTGGTGATTAATTGGCCGCTTTGGCAAGAAGGCGGCATGGGGTTTCATCAAGACGAAAATACCAAGATGTACTTGAGCTCCAGCGGGCAGCGGGTTCTGGAAACTCAGGAAGCCTTGACGGTATTGGATCACGTCCTTAACCAGGACAAAACACAGCATTTGGTCCTGGTGGGGCAGCCAGGTCGGGTGTATGGCTTTTTAGGGTTGACTGAGGCGCCTATGACTCAGATGCCAGTGACTGAAGCGCCAGTGACGCAGACATCCACACGGCCAGAGTTGAGAGGCTTGAGTACGGAGCAGTCGGTATTATGGGATTTAAGAAATCTCATCGTCCAGCAACTCAAAGTGCCCTGGGAGCAGCTTGGGCGAGATCACAATCTCGCTGATTTCGGTTTTGATTCAATAAGCTTGTTGAGTTTTGCCAATCGTCTCAGCGAGCATTATCAACTTGACATTACACCTGCCTTGTTTTTTGGGTATTCGACTCTAGAGCAACTCACGCAGTACTTTTTAAGCGAGCATTGCGATTTTATCAACGCCTTTTATAAGGAACCCGAAAAATCGGAAATCCCTGTAAAAAAGGAAGCCGTTGAAGAGCGTGCTCCTATCCGGATTGTTTCTGAAGAAACCCGCCCAGAAAAAATAGATAATGCAAAAGATGAGCCCATTGCCATTATTGGCATGAGTGGCAGATTTCCCAAAGCTTACGATGTTGAACAAATGTGGCAGCTCTTGGCATCGGGTGAATGTGCGGTAGAAGAAATTTCACCACATTACTTTGATTGGCGCAGATACTTTGGAGAGCCGAGCCAGGAGGCTAACAAAACCAATGGAAAATGGTGTGCTAATATTCCTGGCGTTGCCGAATTCGACCCCCTGTTTTTCCAAATTTCCCCGAGAGAAGCGCCAAACATTGATCCTCGTCAACGGCACTTATTGCAAGAGTCTTGGAATGCTTTAGAACATGCCGGATACGGGCCGCATCAACTGAATAGCCAGAAGATCGGCACCTTTGTCGGGGCTGAAGAAGGGGATTATTATCAACGTGTCAAAGAGGGCAACATCACCTCCAATCACTCGGGCATTCTCGCCGCTCGTCTGGCCTATTTCTTAAACTTAAAAGGCCCGACCATGGCGATTAATACCGCGTGTTCCTCCTCACTGGTCGCGGCTCATCAGGCTTGTCTGAGTTTACGGCAGGGGGAATGTGATACGGCCATCGCGGCAGGGGTCAATCTAATGCTCACCCCTTACGGATATATCAGTATGGGCCGAGCAGGTATGCTCTCTGAGGATGGCCACTGTTATGCCTTTGATGAACGCGCCAATGGCTTAGTACCAGGTGAAGCCGTGGTCGTCGTGGTATTAAAGCGCCTTAGCCGAGCGCTTGCTGACGGTGATCCTATTCACGCGTTGATCTTGGCTAGCGGTGTTAACTATGATGGCAAAACCAATGGTATCACTGCACCAAATGGTGTTTCGCAGGCCGAGTTGGTGAGGGAGGTTCACCAACGAGCCGGGGTTCATCCGCAGGATATTGATTATATTGTGACACACGGTACGGGTACCCGGCTAGGTGACCCCGTGGAGGTCAACGCCCTTAACGAAGTCTTTAGGGACAGCCAACACCTTTGTGCGATTACATCCAGTAAAACCAATTTTGGCCATACGTTTTCCGCTTCGGGGCTGCTCAGTCTTGTCAATCTGGTACAGGCGCTTCGTCATGAGACCATTCCGAAAAGCCTGCATTTTGCTCAGCCAAACAAATTTATGACATGGGATCAAGGCCCTCTCTATGTCAATACGGCCAATAAGCCCTGGCTCGAAAAGCCGGGCGAAAAACGCATTGGCGGGGTGAGTGCGTTTGGAATGAGTGGCACCAATGCCCATATGCTGATTCAAGACTACCAGCTTCACAGAAAAGAACCACGTGCGGTCCCGCCTTATGCGCTGCTTGTGTTGTCTGCAAAAACGGCAGAGGCACTGCATCTCAAGGTCAAAGCCATGGTCGCGTTTTTGCAAGAAGGGCTTGCAGACACTGCCACCCTAGCGGATATCAGTTATACATTGTTTGAAGGCCGACACCACCTTCAATACCGTTTGGCTATTGTGGTGCAGGATATGACTGAGGCCATGTGTTGTTGGACACAAGCCGGGCAGCCAGATAAGAAACCCAATATTTTTCAGGGAAAAGTGCCTACCGAATTTAGTGGTCAAAAGGTCACACAGAATTATATTAACCAATTAGTAGAACAGCTTGATCGCTCTACCGGCGATGATGACGTATACCGAGAACGTCTCTTGGGTTTAGCTGATTTTTATTGTCAGGGGTATGATGTCCCTTGGTCTAGGCTATACGGTGATACACGGCCACGCCGTATAAGTCTGCCTGGGTATCCGTTTGCTAAACAACAATTTTGGCTGGATTTCTCTCCGAAGGATCATGGCGAACAAGAAAATGTCGAACTTCCTATTGGCAAGATGCAGAGACAAGTTCTAAATGAAAAAAACACGCTTGAAACATTAAGCTACATTCACAAATGGGAACAGCAGGATAAAGCTGAAGTCAAGATAGAAATCAGCCAGGTTTGCTTACTAGTTTACTTTGAATCTGCATCGCAATTTGAAAAAACGCTGGCAAGCTTCTTCTTGCAGCAGGGTGCATCTCAGGTGATCGAGATTCAATTGGGACTCGAAACCAAACCGGTGTCCGAACATAAATGGCGCTGCAATGTCAATGACGTCGACGCTTTTCAGCGTTGCCTTCAAGCCTATGCACAGACAATCAATAGCGTTTACTTTCTCTGTGTCGATACCCTCCAGCAGGGCATGGAAGAAAGCGAAATGCAGTTGCTACGGCTGGTCAAAGCCTTAAAATCACGTATGCAGAGCCATGCCTTTATCGATTTCACCCTTCTGACTCTGGATAATCACCGCGTCGATAACAGCGCGACAAGTCCCAACCACGGGGGGCTTAGCGGTCTTGGGTACTCGGTGGCGCAGAGCGATCACCGCTTCCGGGTTCGAAATATCGATTTGTCGCGGGAAGATCTGGTGAGCGCCGAACAACAATGCACCCTGCCAGGCATGATCGTCAGCGAAGCCCCGTCGGACCGAGGCGAGGTGGTCAAGTTGCAGGCAGGTTTGCGCTACAAGCAGCGCTTTTTCAAGCTCGACTGGCAGACGCTGCAAGCGGCACAGCCAGAGGCGGCGGGTTTGAAAACCGGTGGGGTCTATGTGTTGTTGGGTGGCGCGGGAACCGTTGGTGCGATTATAACCCGCTATCTCATCCAAAAATATCAGGCCAATGTGGTTTGGCTGGGGCGTCGTGCGCTGACATCGCCTGCCGTGCAGGAACAACTACACGCGTTCCGGAGCGTGGACGAAGGGTGTGTGCCACTCTATATTCAGGCCGATGTGACGGATCAGGCTTCCATGACTCAAGCGGTCAAAGAGATCAAGCAACATCACCCTTGCATCCATGGCGCGATTTTCTCCGCACTGGTCTTTAAGTTGGATAACTCAATTGCTAAGACTAGCGAGGAAGACTTTAATGAGGTTTTGGATACCAAGAAAAAGGGTGCGCAGTATTTTTATCATGCATTCAAAGATGAAAACTTAGATTTTATGTGTTATTTCTCGTCGGTCCAATCTTTTTTCTTTATCTCCTCTCGAGAGAGTGCAGGGTATGCAACCGGTATTACCAGCGCTGACACCTTTGTACATGCCATCGATCACGATAGCACCTTTCCTGTCGGTATCATCAATTGGGGTTACTGGGAGGCCTCTCTGGCGGGAACCGAAGCCGAGAAGCGTTTGCCCGGTCATTATGACTTAATCTCTGATCATGATGGATGTCAGTTTTTTGACGGATTTGTACCTATGCTTAGATCAGGCCTTATCAAACAGGCCGTTTGTTTAGGTGTGTCAAAAGCGATAGAGGATTTCATGGGCTGTGACGCCACGCAGATGATCACGGTGAACAAGCTTGAGGCTGATTCTTTGATTTTTAGCCTTTTTAATGAAAATGAGTGCGGCCAAGCTACGTGTGAGGAAACTGAAATCGAGCGCCTTTTGGATAAAGATTTCAACAATGAACTTAAGCAATGGTTGCCGCGGCTGCTATTTTCACAGCTGCAACAACTGGGGATCTTTTTAAATCGTGGTGAGCAGAGAGATTGTACGACGTGGCAACAACAAGCTGGTGTGATCAAAAAATATGAACGCTGGTGGCGAGAGTGTTGCTTAGGGCTGCTGGAGACCTCCGGCTACGTACAATGTGAAGGTGAGAGGGTTGAGGTCACTCACCATAGTCCGGCAGACGAGGCGGATCAACTCTGGCAAGGCTGGGAGAGCTTCCAAAATTTATTCCTCGACAAGCCGGAAAGAAAACCTGTGCTCGACTTATTGGAGAGCTGTCTGAGAAGCCTGACGCAAATCCTGTGCGGTGACATCCTGGCCACCGATATTCTTTTTCCAAAATCGTCAATGGAAAAAGTAGAAAATATATACCAGCGGAATGCCCTATCCGACTATTGTAATACCTTTGTCGCGAAAGGTATCGAAGCTTACATTCATCAGCGGATTCAGGCAGAGCCTCAGGCAAGGATCCGGATATTGGAAGTCGGTGCAGGTACTGGAGGTACCACCGCATTGGTCCTGCCACAACTGCGTCAGGTGCAGCATGCGATAGACGAGTATTGTTATACAGACATTTCCAAAGCCTTCTTGATACATGCAGAAAAGACTTATGGGCCGGATTATAACTATCTAGATTATAAGCTACTCAATCTCGAACAACCGTTAGCGCCACAAGGAATAGAGCCTGGCTCCTATGATATGGTAATCGCTACCAACGTGTTGCACGCTACAGAGAATATCAGACAAACCCTTCGCCATACTAAAACTGCTCTAAAACGTCATGGATTATTAGTGATCAATGAAGTGGTTGAGAAATCTATTGTCGGTATCTTAACCTTCGGGTTGTTAGACGGCTGGTGGCTCTACCAAGACGAATCATTACGCATCCCAGGCTCTCCGCTGATCACGCTGGATACCTGGCGTAAAATTTTAAAAGAAGAGGGCTTTGCCAGGGTCTTGTTGCCAATGCGAGCCGCATCTAAGTTGGGTCAGCAAGTGATGGTGGCGGAAAGTGACGGTCTGGTTAGACGGGAGAGAGAAGACTTGCCGGACGAGGACGAATCGGCTGTGACTGATAAAACGTCCGTGGTACAGGGCATGACTTTGACTCCGGAACAGCGAATTGCGCAAACACCGTCTGTACGGGAGCTGTCGTCCGAAACACTACGAGAACAGGTTGCCGAGCTTATTTTGACAGGATTGGCCGAAACATTAGGCATGGCGCAAGAAAATATTGACCCACTAGTTTCATTTTCTGACTATGGTATTGATTCTATTCTTGGTGTCGGTTTTATTGGTCAGCTTACTAAATCCTTCGGCATCACCATCAATACCGCTATATTGTATGATTATACCAATGTAGTGCGTCTTAGTGATTATCTGGTAGAAATCTATGCAGAGGACATACAAAACAAAATTCAAAACAACCGCATGTCTCCAGTTGAGAAAGATGCTGTTCTATATACAGAGACACAACTAGAAACAACAGTCGATCGTAATCCGGAAAAAAGTCAGCTTGAAAACTCAGTTCCTAATATGACCTCTGGCGAGAATAAGTCCGCCAAATGCCAGGAGATCGCTGTTATTGGTATGTCAGGGCAGTTCCCTAGAGCAAAAGACCTTGACGCCTTCTGGCAAAATCTGATTCAGGGACGGGATGGTGTTGTAGAGCTACCCGCGAATTATCTCAATCCGGCTTTGTTTAGCCCGCACAAACAAGCGGGAACAACCGATTGTAAATGGGGTGGCATTTTAGAGCAGCGTGATTGTTTTGACCCACTTTTTTTCAACCTTACGCCCAGGGAAGCGGAGTCGATGAACCCGCATCAGCGTCTCATTCTGAGTGAGAGCTGGAAAGCGCTGGAAGATGCCGGCTACAATCCCAAAGAGCTGGATAATACTCGCGTTAGCGTGTTTATTGGCGCGGAACCTACCGACTATTACCATGAAACCTTTACCGGCTCTTCTGATGCTATTGTTGCCTCCCGCTTATCCTACTACCTCAACCTCAAGGGACCGGCTTTGGTGGTCAATACGGGTTGTTCGTCTTCTGCTTTGGCGATTCACTTGGCCTGCGAAAGTTTACGCCGTGGCGAGTCTTCAATGGCCCTGACAGGTGGCATTTTTGCTGCAATGCATGAAGAAGCACTGGTTAAACTAGCCCAGATTGATATGCTTAGTGCCACCGGTCGCTGCCGTACATTTGATCAATTCTGCGATGGTACCGTATTGTCTGAAGGTGTTGGGGTGGTTGTGTTAAAACGGCTTGACGATGCCGTCAGGGACAACGACCCCATCTATGGCGTGATTCAAGCCTCTGGGGCAAATCAGGACGGTGCCAGCAATGGGATAACTGCGCCTAGTGGTTTGTCGCAGGAAGAACTCCTGACGTCTGTCTACCGGCAATATGACATCAATCCGGAAACGATCACGTATATTGAAGCTCATGGAACTGGTACCTCACTTGGAGATACCGTTGAGGCTAATGCGTTAAAGCGGGCCTTTAAACAGTTTACGGATAAAAAACAATTCTGTGCACTTGGCAGCGCAAAATCTCATATCGGCCATACAGGAGCTGCTGCTGGCGTTATTGGTTTAATCAAAGTTTTGTTGTCGATGCGCTATCATCAGCTGCCTAAACTGTTGCACTTCGAAGAACTCAATCCATCAATCGAATTGGAAGATTCTGCATTTTATATCAATCAACAGCAAATGGAATGGACGGGGCAGGGCGTGCCATTAACCGCAGGGCTGAATTCTTTTGGCCACAGTGGTACGAACGTTCACCTCGTGGTTCGGGAATACCTGCCGTTATCTGAGACGAAAGCCGAAATGGAGGCTGTACTGATTCCATTGTCTGCCAAAACCCTCGAATCCCTTAGAACCTATGCTGAAAGTTTATCGACGTTTCTGGAAAATGGGCATTCTGGTCATGGTGTTAGCCTCACCGATTTAGCCTTTACCCTCCAGCTTGGACGCGAAGCGATGCGGGAGCGCTGTATTTTCTTGGCTGGAAATGTCCCGGATTTGGTAGCCCAATTAAAGGCTTTTGCGAATGACAAGACGCTCAACAATGTGGGTTGGTACGGCCGGGTTGGACGCAGCAAGAACAGCCATTCCTTCAATGATCATGAGTCTCGGCAAATGATCACTCAATGGTTGCAACAAGGAAAATTGGATAAAATTGCCGCCGCTTGGGTACAGGGCCTGAGCATTGACTGGGCAGCCCTTTATCGCGAGCTCACAGCTCGTAAAATCCATGCGCCAACCTATCCTTTTGCCCAGGAACATTATTGGAAACCCGAACAGCAGAGTATGGTTCAGAAGCCCGTTGCGCCGGAAACACAGCCTGAGACCTTCGGAACACTGATGTTGCAGCCCTGTTGGATAGATCAACCCCTTGAACATTCATAA", "orf_prot_sequence": "MLRTGMKTDSPNHPENQAINVNHYLMVLSAKTKERLQTVVENLLDYAKANRRLIESRLADVAFTLQTGREEMEARLAFVVSDYHDLMGQLSGYLEDAPNANTIFRGQVDLFDQSAPVRQHRAAQERDCERMIRTHDLPGLAELFVQGVPIDWRRLYVQGRPRRIALPSYPFAPERHWVARREPDHLAADMPAVRQPHSLLDGRDDRMSLESGVVFRKLLRINDGVLQDHQVNETPVFPGVAYIEMACEALAQLSFSDPEVLRKTVLNQMVWLQALAVTEAEHEILLCLEKDTHGLAFEVKDHQTLYAKGRFDQSDDLSQGHQYLELETIKGDCPHEKHRSVIYHDFRLLGLNYGPWFQGLEHTWFSIDSAEGEGEALGYFNMPLICESEFSAYTFHPGLLDAALQVVASVPGYADSGLLLPYAVEKLEWFHPFPACGYSHVRKLAKHRYDVTICDEQGKVCAKFSDLSVRPSRVAGSEPSLNQLTYRARWSHQELGERRSPAGRPEETGVVFIIHTPEQQALVQELSSVLADMHGDHRVRRMCLNANDWDFKSLGNWNHRIRAVQDLRDIYFLAAMEHTVSSGQAHVDPLSFTNRQEHGLLSLFRLLKALDQNQLLLQPLSLKVLTTGNYRVLPSDTICPLSAGLPGFCRSIAQEYPLLALSCIDLGCPDGDAMQPSSLKKLAQFIVAEPAHQPHETVGIRELRRYTRKLVPVRFPEPGGQRAFKSRGVYMIVGGAGGIGMVLAQYLAERVQARLVLVGRSALDEEKKQNLSTLTAAGGEALYIQADISRLYSMKDAVAQARQRFGNINGVVHSAMVLNDQSLARMSEEGLRASLAPKVEGCIVLQQAMAGEPLDFMLFFSSAISFSGNAGQSNYAAASTFKDAFAHYLTQVEAYPVFNINWGYWGCVGVVANAAYRERWAARGVHSIDPEQGLQVIESILTNHIDQVAAVNVEPSFLERLGVELSQTQTVLPPRRSSLIAKLNALPLPETGGFQDNVNRLEIVSAFRWAEVFKHMLDMSSTQGMYARSDLKRQLQISSEHDQLFDVLISMLIQEGYLHQQGKNLTPTPYLNGEFFQQQREQVALLESELSQTDNAYLNLLSRCLDHYPAMLRGEVAATDVIFPQGSMEWVEGIYRSHASADYFNQQLAQRLVAYVEARLPSLGANESIHILEIGAGTGGTSAIVLQALQPYAARLRYTYSDISPGFLNYGRKTFGDAYPFVEFRHLNIEHNGEAQGYQAGEYDLVLAANVLHATRHIGNTLARVKFFMKRHGWLLLNEATQVRHFGTLTFGLLKGWWLFQDAENRLDGSPLLSTTAWQRLLSEEGFKHTLSLCDAVEEESIFQDVIVAESDGVIQMNQSDSPVQPREPVDVSVDVHHVDDMMEPGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVDSITGVDFIHQINSRLGIVLRTTALFDHATIFDLSRFIDESHGAAIDEQRQRLRSTPLTSSDTKPAERVAPPDEALPHIERGCHQAVVLEKPSQIEHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLLCVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGHSTLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGEKVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIAMVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQLISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPDGMMDNQVGQRMVPESSTVEDYRVGNATVEQVAVKQPADMDEPIAVVGMSGRFPGANNLEQFWLNLIGGNNAITEVPADRWDVHQWYDPDPAVLDKTHCRWGGFLRDIDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSVPGEPQSFWGNSSSLIASRIAYFLNLKGPSITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGIIRGSGSNQDGRTYGITAPSAASQTELEQSVYRQAELDPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFIKVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPRRAAVSSFGFSGTNAHILLEEYQHHEDEAQALGDDKDVLIVLSAKNQERLKKAAENLHHFLESRVSYKLSDIAYTLQVGREAMEARVAFMVVSVLDLQQKLVSLLHDPTDEQDMYWGEVRDGEGPAGVAAFEDVALALANKQLDQLAQWWVSGVEIDWTQLARVVKVRLVPLPTYPFSPDRYWFDSVGPATVVHAEHSASALYPLLNRIAPQASTQIANGCVFETCLKSSDPLLAQHLIDGQAVFPAVGFLEMVIAGLREIQPDKAARLENVFWLRPLDVMDEQRVHLVFEVKQDRFQYRIVPAESHGDGAYFRGQGYWSNDMNPAIPMDIDRLKSRMRQQPLLNESSPRVRLGRLYQGATEGWTDGEQALIAFELPTAQPYRDGSPDQKSYPFHPAAFVAALQAYHWIHEAPKRLGMPFAVQKVELWRHRDQPAYAYVALDEHGNADVHILDAGGQVCVCYRGMALQTLNNAHHDGRQESTQKDELGKLLFVPVWKRLDTKHGRAHGMHALARGTGVLLVYTHENGVEAEQLMQRYREEQCELLSVCLSAADRALDTLAARLKHLQSPLRHVCFLDRHQAALDPADKQIDERLREPQTLTGFLALVRTLSELGYDEQPLQWLVLTSSACAVNQADPINPYAAAIVGLASCLAQEHRYWQVSVCDRGKGTSFTTIANHGETLRVIAERSGYSYVRHIKELELPPPRQSRLRHKGVYVLVGGAGYVGTLLSRYLVQTYQAKVIWLGRREQDEQIEQNIALIATLGSRPQYLSLKTGSDDELHRAFAQIKAENGLIHGVFNLVMVAQSTPMRSLSEAQFRAGSFNSKVNSAQALYRILKKEALDFMVFFSSMQSFAQQLNFMSANMSSYVAGCMFQDAFVHQINCELSYPVKTINWGYWSQESSESEKAKWYETYIADKGIYSLNVGEAMQALEYILAHEPEQVIVTKVSHRVLSDMGFVQDDSENVDLQPVIDSNDDNTQLEDLIVNGILKTFETLDVLQVFDSACNLDVSRLQAHVPDKYRRLWRELLLILVQAGKMAPQGAGFALRESYTSLASQLRLMDLDREAGLLRERHPTLASKLALLVPCLKDMAEVLTARKPATEVLFEHASLSRVEGIYRGNPTTDYFNQRVADIVKAAVQQALPSLSVGKKVRILEIGAGTGGTSAYLFQALNTYADQLHYIYTDISKRFLIHADETFCEQYSFIETKLLNIEQDVAGQGFDPASIDIVVAANVLHATRNISKTLQHVKDLLKNDGLLVLNELADVSPFLTVTFGLLDGWWLYDDEAIRQPGSPGLSAKNWQLVLKNQRFHNISLNDEKALTSEQQIIIAQNESKESVPVSSTVLLGTELIASVEASLIAQLSQCIKIEQNRLNTYTTFSDYGVDSILMLAYVDQINGDLGIDLNPSELFNYTTVERLTKFIVDYHGKEIISAKESVERSLLQNQESKFDLNDIDVITKAGNEAPEMARSLLFDNVLQVPSGNVHHHQSDKARPDIAVIGMSGQFPGATNVQQFWQNLSAGVDSVSELPESRLDRQLYSPQPEAGKCYCQWGGILEEQASFDPLFFEISPKEAAEMNPSQRVFMQEAYRALEDAGLVNAGLSQLHCGIYVGCEPNGYTKQGFTGASEAIVASRISYFLNLQGPALVINSGCSSSLVAIHLACESLRHGENDIALAGGVFTNLNNELLVCLSSIEMLSFSGKCHAFDEAANGTVLCEGVSVLVLKRLQDALDDGDVIYGVIKGSGMNQDGRSNGITAPNGLAQENLIKRIYQDYNIDASKISYIEAHGTGTKLGDPVEANAXKNVFSSRNTGLDFRCGIGSVKSNIGHAAAAAGVIGLVKVLLCMQHRQLPGLVHFNKLNPLIDFNDTGLYIVEQLQNWEPASGEPLMAGINSFGHSGTNAHLVIQEPPVRPVRDSENPFHLICLSAKTEEALKQKISDLSAYLRRKEEPPTLGAISYTLNTGRAHFRKRCAFVVDSLEALQNALMGALDGLVGNAERLSPQEQAFCKKAFDLIIKDLHDVENLESRADQTIYKDNLLALTGLYLKGFDLDWQRVYKGQSYHRVSLPTYPFSRDTYWIDEPKQISFTEPGTDKPGNTSRNHQQDQKDEDVLGGQFYIPQWKRLDQTQSYASLSDHGKLTIASDPVVIFYPPTMTSLKDDIQTCYEQLPASQVASFELGCTPSSEVDVRDPRAFERIFVSPRQALEELLEQGRTLTIYFILPEPDQNPDSGCNLECLEESLSLGLISLFRLIQALLAHHGYASELTLKIVTQQTQVCKASERIVPYGADVVGFVQSLAKEYELWQISCVDINRQTWWTPAQSKNFAEALIALKPPADGRALCWRDGYVYHRVLTPANLVGVQGSAFKTRGVYLIIGGAGGLGLVLSQYLLEHVQAKLVWVGRRSLEALAPDALRLFNTPGAHVLYEQADLCDPEALQRALQQAKGRFGYIDGVIHSALILEDRAIADMDEKTLRKVLAPKVQGNVVLQQVLADEPLDFLLYFSAGQSFMSHAGQSNYAAACTFEDAWALCQDQRQNYPIKIINWGYWGEVGIVATADYRKQMARQGVLSIHPQEGMEAVERCLASCATQAAYFKVEPRALSRLGLDGTGILHASRNRVPPQLIHVVIDATQAWSISMPYAQRYQQSLKKLDRLGCYLLLRVFQAMGVFSQPHEHYEKQELASRLAISKGYHHLYQECLNLLDTSGFIAINGSHIEVQDVLPEEHDEHHSWLQPYPELAAHEKLLRICLQAFPDIIRGSVAATDIIFPDASVELVEGIYQGNPATDALNTKAKDAVVAYVKARLADCQEQIIFLEVGAGTGGMSHEVLKGLAPYGQYIEYYYTDVSEHFIQYARRRYGQDYPFVRFQRLDIEQEHSALSEGLLSACDVVLAANVLHATQSVRNTIQHVKALLKRHGLLILNEATTLESFATLTFGLLEGWWRYQDAGDRLPGGPLLSASMWHRLLEEEGFDQVVSLGEPGEGDMLGQHLIVGRSDGWSLHQSARDDETRSAPVSPVAASDVIQGNRNDKPAELIKHVEAQIVQTLSAALDIAAARVERDVSFSEYGVDSILSVAIINQLNQRLGIRLKRPDLFNYTTTESMAAHIVATFADHLTAALVEEAEPPTPVTVASPQPIKAAGQQDVLQQNLQTQPQVSQGVWQTKPEPIAVIGMSACVPGADHVGAFWDNLVAGTDSVTRIPHERWQREAVNELPGGPDTSQRKAGFMDNIAEFDPLFFAISPQEAQWMDPTQRLFLQQAWAALEDAGYNPRALAGASCAVMVGCAATGYGVKEGERTGYVSYAMTNSEAILPARISYFLDLKGPSIPINTACSSSLVAIHLACEQLRSGQSDMALAGGASALIGSALHIGLNGVGMLSPEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKTPFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTNAYMVVEAFVETSPRAVGQQGPALIVLSARHEVRLKELASNLMAYLKRYGLNPDRPIQLEDMAYTLQVGRQAMSERLAFVADSVADVVKHLATFVDGEANAQELYRGQVKPFGDKSDLLLEGEAGQAFLNTILRQQDYRKLAALWVAGTDLDWNLLYDGENRARRISLPTYPFARETYWLDEGIGSNEKELLRDQTQKELRDRDREQTTELMTFEEIWQEASLNNHSDSIKYKSIVCFLSGSEHQQEMRTAMQAIDPAIHLTMIAQGHGYTKHSSDRYTVDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVAAFSTALERCYLESWIGFERSLKLIMPGFQVAGLFQEHAGPDQTISMTHWSQHIVSELKAPKAQTVLIQNHRRYVNQIQKTELAAQGASVASAVKQGGTYLITGGCGGLGFLVAQHLAEHLGQPAASASGKTVHLILTGRSSPDDAIQSKITQLEALGAKVGYVQADVADAVAMRRGLAQMKNRFGDIHGIFHIAGIAPSESLLNKDIDAFQNVLGPKIAGTLMLDDLCRDEPLDVICYFSSSAAILGDFGACDYAIGNRFQMAYAAYRNHLLQQGMRQGKALVINWPLWQEGGMGFHQDENTKMYLSSSGQRVLETQEALTVLDHVLNQDKTQHLVLVGQPGRVYGFLGLTEAPMTQMPVTEAPVTQTSTRPELRGLSTEQSVLWDLRNLIVQQLKVPWEQLGRDHNLADFGFDSISLLSFANRLSEHYQLDITPALFFGYSTLEQLTQYFLSEHCDFINAFYKEPEKSEIPVKKEAVEERAPIRIVSEETRPEKIDNAKDEPIAIIGMSGRFPKAYDVEQMWQLLASGECAVEEISPHYFDWRRYFGEPSQEANKTNGKWCANIPGVAEFDPLFFQISPREAPNIDPRQRHLLQESWNALEHAGYGPHQLNSQKIGTFVGAEEGDYYQRVKEGNITSNHSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGVNLMLTPYGYISMGRAGMLSEDGHCYAFDERANGLVPGEAVVVVVLKRLSRALADGDPIHALILASGVNYDGKTNGITAPNGVSQAELVREVHQRAGVHPQDIDYIVTHGTGTRLGDPVEVNALNEVFRDSQHLCAITSSKTNFGHTFSASGLLSLVNLVQALRHETIPKSLHFAQPNKFMTWDQGPLYVNTANKPWLEKPGEKRIGGVSAFGMSGTNAHMLIQDYQLHRKEPRAVPPYALLVLSAKTAEALHLKVKAMVAFLQEGLADTATLADISYTLFEGRHHLQYRLAIVVQDMTEAMCCWTQAGQPDKKPNIFQGKVPTEFSGQKVTQNYINQLVEQLDRSTGDDDVYRERLLGLADFYCQGYDVPWSRLYGDTRPRRISLPGYPFAKQQFWLDFSPKDHGEQENVELPIGKMQRQVLNEKNTLETLSYIHKWEQQDKAEVKIEISQVCLLVYFESASQFEKTLASFFLQQGASQVIEIQLGLETKPVSEHKWRCNVNDVDAFQRCLQAYAQTINSVYFLCVDTLQQGMEESEMQLLRLVKALKSRMQSHAFIDFTLLTLDNHRVDNSATSPNHGGLSGLGYSVAQSDHRFRVRNIDLSREDLVSAEQQCTLPGMIVSEAPSDRGEVVKLQAGLRYKQRFFKLDWQTLQAAQPEAAGLKTGGVYVLLGGAGTVGAIITRYLIQKYQANVVWLGRRALTSPAVQEQLHAFRSVDEGCVPLYIQADVTDQASMTQAVKEIKQHHPCIHGAIFSALVFKLDNSIAKTSEEDFNEVLDTKKKGAQYFYHAFKDENLDFMCYFSSVQSFFFISSRESAGYATGITSADTFVHAIDHDSTFPVGIINWGYWEASLAGTEAEKRLPGHYDLISDHDGCQFFDGFVPMLRSGLIKQAVCLGVSKAIEDFMGCDATQMITVNKLEADSLIFSLFNENECGQATCEETEIERLLDKDFNNELKQWLPRLLFSQLQQLGIFLNRGEQRDCTTWQQQAGVIKKYERWWRECCLGLLETSGYVQCEGERVEVTHHSPADEADQLWQGWESFQNLFLDKPERKPVLDLLESCLRSLTQILCGDILATDILFPKSSMEKVENIYQRNALSDYCNTFVAKGIEAYIHQRIQAEPQARIRILEVGAGTGGTTALVLPQLRQVQHAIDEYCYTDISKAFLIHAEKTYGPDYNYLDYKLLNLEQPLAPQGIEPGSYDMVIATNVLHATENIRQTLRHTKTALKRHGLLVINEVVEKSIVGILTFGLLDGWWLYQDESLRIPGSPLITLDTWRKILKEEGFARVLLPMRAASKLGQQVMVAESDGLVRREREDLPDEDESAVTDKTSVVQGMTLTPEQRIAQTPSVRELSSETLREQVAELILTGLAETLGMAQENIDPLVSFSDYGIDSILGVGFIGQLTKSFGITINTAILYDYTNVVRLSDYLVEIYAEDIQNKIQNNRMSPVEKDAVLYTETQLETTVDRNPEKSQLENSVPNMTSGENKSAKCQEIAVIGMSGQFPRAKDLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGGILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIGAEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVNTGCSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATGRCRTFDQFCDGTVLSEGVGVVVLKRLDDAVRDNDPIYGVIQASGANQDGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMRYHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREYLPLSETKAEMEAVLIPLSAKTLESLRTYAESLSTFLENGHSGHGVSLTDLAFTLQLGREAMRERCIFLAGNVPDLVAQLKAFANDKTLNNVGWYGRVGRSKNSHSFNDHESRQMITQWLQQGKLDKIAAAWVQGLSIDWAALYRELTARKIHAPTYPFAQEHYWKPEQQSMVQKPVAPETQPETFGTLMLQPCWIDQPLEHS", "perc_identity": 25.56}, "gnl|BL_ORD_ID|1855|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 33035, "orf_end": 60031, "orf_from": "BGC0001186.1|Misakinolide_16 ", "model_name": "Erm(41)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "225", "model_id": "2013", "ARO_accession": "3000603", "ARO_name": "Erm(41)", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35946": {"category_aro_accession": "0000027", "category_aro_cvterm_id": "35946", "category_aro_name": "roxithromycin", "category_aro_description": "Roxithromycin is a semi-synthetic, 14-carbon ring macrolide antibiotic derived from erythromycin. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35974": {"category_aro_accession": "0000057", "category_aro_cvterm_id": "35974", "category_aro_name": "telithromycin", "category_aro_description": "Telithromycin is a semi-synthetic derivative of erythromycin. It is a 14-membered macrolide and is the first ketolide antibiotic to be used in clinics. Telithromycin binds the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35982": {"category_aro_accession": "0000065", "category_aro_cvterm_id": "35982", "category_aro_name": "clarithromycin", "category_aro_description": "Clarithromycin is a methyl derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome and is used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), and skin structure infections.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "36315": {"category_aro_accession": "3000176", "category_aro_cvterm_id": "36315", "category_aro_name": "dirithromycin", "category_aro_description": "Dirithromycin is an oxazine derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome to inhibit bacterial protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36722": {"category_aro_accession": "3000583", "category_aro_cvterm_id": "36722", "category_aro_name": "pristinamycin IA", "category_aro_description": "Pristinamycin IA is a type B streptogramin antibiotic produced by Streptomyces pristinaespiralis. It binds to the P site of the 50S subunit of the bacterial ribosome, preventing the extension of protein chains.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37016": {"category_aro_accession": "3000672", "category_aro_cvterm_id": "37016", "category_aro_name": "madumycin II", "category_aro_description": "Madumycin II is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37017": {"category_aro_accession": "3000673", "category_aro_cvterm_id": "37017", "category_aro_name": "griseoviridin", "category_aro_description": "Griseoviridin is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "37019": {"category_aro_accession": "3000675", "category_aro_cvterm_id": "37019", "category_aro_name": "pristinamycin IB", "category_aro_description": "Pristinamycin IB is a class B streptogramin similar to pristinamycin IA, the former containing a N-methyl-4-(methylamino)phenylalanine instead of a N-methyl-4-(dimethylamino)phenylalanine in its class A streptogramin counterpart (one less methyl group).", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37022": {"category_aro_accession": "3000678", "category_aro_cvterm_id": "37022", "category_aro_name": "pristinamycin IC", "category_aro_description": "Pristinamycin IC is a class B streptogramin derived from virginiamycin S1.", "category_aro_class_name": "Antibiotic"}, "37023": {"category_aro_accession": "3000679", "category_aro_cvterm_id": "37023", "category_aro_name": "vernamycin C", "category_aro_description": "Vernamycin C is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37024": {"category_aro_accession": "3000680", "category_aro_cvterm_id": "37024", "category_aro_name": "patricin A", "category_aro_description": "Patricin A is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37025": {"category_aro_accession": "3000681", "category_aro_cvterm_id": "37025", "category_aro_name": "patricin B", "category_aro_description": "Patricin B is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37026": {"category_aro_accession": "3000682", "category_aro_cvterm_id": "37026", "category_aro_name": "ostreogrycin B3", "category_aro_description": "Ostreogrycin B3 is a derivative of pristinamycin IA, with an additional 3-hydroxy group on its 4-oxopipecolic acid.", "category_aro_class_name": "Antibiotic"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.85368, "max_identities": 19, "bit_score": 30.0314, "cvterm_id": "36888", "query": "VDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVA", "match": "+ P   +  R  F +      E D L + WP   +R++  P   V    AL++S L P   LL A", "sequence_from_db": "LHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPFRVVASPPYQVT--SALIRSLLTPESRLLAA", "sequence_from_broadstreet": "MDLGAGHGALTAHLVAAGARVLAVELHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPFRVVASPPYQVTSALIRSLLTPESRLLAADLVLQRGAVHKHAKRAPVRHWTLRAGITLPRSAFHHPPQVDSSVLVIRRR", "dna_sequence_from_broadstreet": "GTGGATCTGGGCGCAGGACACGGCGCGCTGACGGCACATCTGGTTGCCGCTGGCGCCAGGGTGCTAGCCGTCGAGCTGCATCCGGGGCGGGCTCGACACCTTCGTTCACGGTTTGCCGAGGAAGATGTCCGGGTAGCGGAAGCGGACCTACTCGCCTTCCGGTGGCCGCGACGGCCATTTCGGGTGGTGGCGAGCCCGCCCTACCAAGTCACCAGCGCACTGATCCGGAGTCTCTTGACGCCGGAATCCCGGCTGCTGGCTGCCGACCTGGTGCTGCAGCGCGGGGCTGTGCACAAACATGCGAAGCGAGCACCTGTTCGCCATTGGACGCTACGGGCCGGAATCACATTGCCGCGAAGCGCTTTCCATCATCCACCGCAGGTGGATTCGTCGGTGCTGGTGATCAGGCGGCGCTGA", "partial": "0", "query_start": 51440, "query_end": 51634, "hit_start": 75, "hit_end": 264, "orf_dna_sequence": "ATGTTGAGGACCGGCATGAAGACAGATAGCCCGAATCATCCAGAAAACCAAGCGATCAATGTCAATCACTATTTAATGGTTTTGTCGGCCAAAACGAAAGAGCGCCTGCAAACGGTGGTTGAAAATCTACTTGACTACGCCAAAGCCAATCGTCGTCTCATCGAGTCCCGCCTTGCGGATGTCGCCTTTACCTTGCAAACGGGCCGCGAGGAGATGGAAGCGCGTTTGGCCTTCGTGGTATCGGATTATCATGATCTGATGGGTCAGTTAAGCGGTTATCTGGAGGATGCGCCCAACGCGAACACGATTTTCCGCGGACAGGTGGATCTGTTTGACCAATCTGCGCCGGTTCGTCAACATCGCGCGGCACAAGAGCGCGACTGCGAACGCATGATACGGACCCACGACCTGCCGGGCTTGGCCGAACTTTTTGTTCAGGGCGTGCCGATTGACTGGCGCCGTTTATATGTGCAGGGTCGCCCCAGGCGCATCGCGCTGCCCAGCTACCCCTTTGCCCCAGAGCGTCACTGGGTGGCGCGCCGGGAGCCTGACCATCTGGCTGCCGATATGCCCGCCGTTCGGCAGCCACACTCGCTGCTTGATGGACGTGATGATCGAATGAGTCTTGAGTCCGGCGTCGTGTTTCGAAAGCTGTTGCGCATTAACGATGGTGTCCTTCAGGATCATCAAGTCAATGAAACACCCGTATTCCCAGGCGTGGCCTATATAGAGATGGCCTGCGAAGCTTTGGCGCAGTTGTCGTTTTCTGATCCGGAGGTGTTGCGGAAGACCGTATTGAACCAAATGGTTTGGCTACAAGCCCTCGCCGTGACAGAGGCCGAGCATGAAATTTTGCTATGCTTGGAAAAAGATACACATGGTCTAGCATTTGAAGTCAAAGATCATCAAACGCTTTATGCCAAGGGCCGTTTCGATCAGTCGGATGACTTGAGTCAAGGCCATCAATACCTGGAACTGGAAACTATAAAAGGTGATTGTCCGCACGAAAAGCATCGCTCGGTCATTTACCATGACTTCCGCCTCTTAGGGCTAAATTATGGACCTTGGTTCCAGGGCTTAGAGCATACTTGGTTCAGTATAGATAGTGCTGAAGGGGAGGGTGAAGCGCTCGGCTATTTTAACATGCCGTTGATTTGCGAGTCGGAATTCTCCGCTTATACCTTTCATCCTGGCCTGTTGGATGCGGCATTGCAAGTCGTTGCCAGCGTGCCCGGATACGCTGACTCTGGCTTATTACTTCCCTATGCGGTAGAAAAGCTGGAGTGGTTCCACCCGTTTCCTGCTTGCGGATATTCCCATGTTCGCAAGCTGGCGAAGCATCGCTACGATGTCACCATCTGCGATGAACAAGGCAAGGTCTGCGCTAAATTTTCTGATCTTAGTGTTAGGCCCAGCCGAGTCGCAGGCTCAGAGCCCAGCCTGAATCAGCTGACCTACCGGGCGCGCTGGTCGCACCAAGAACTTGGGGAAAGACGATCGCCAGCAGGCCGTCCCGAAGAAACCGGAGTCGTGTTCATCATTCACACTCCGGAACAGCAGGCATTGGTACAAGAGCTAAGCAGCGTTTTAGCAGACATGCATGGCGATCATCGAGTACGACGGATGTGCCTAAATGCAAACGACTGGGATTTTAAATCGTTAGGGAATTGGAATCACCGTATTCGCGCCGTTCAGGACTTGCGCGATATCTATTTTCTTGCTGCTATGGAGCATACCGTTTCGAGCGGACAGGCCCATGTGGATCCTCTCTCTTTTACCAACCGACAGGAGCATGGGCTGCTCTCTTTATTCCGCTTGCTCAAAGCGCTGGATCAGAACCAGTTACTACTGCAACCGCTGTCGTTAAAAGTCCTAACGACAGGAAATTATCGCGTTTTGCCAAGCGATACGATTTGCCCTTTGAGTGCCGGTTTACCAGGTTTTTGCCGCTCCATTGCTCAGGAATACCCCTTGCTCGCTCTCAGTTGTATCGATCTCGGATGCCCGGATGGCGACGCCATGCAGCCATCCTCGCTTAAAAAACTGGCGCAGTTCATCGTTGCTGAGCCCGCGCATCAGCCTCATGAAACCGTCGGCATACGTGAACTCCGGCGCTATACTCGCAAGCTTGTTCCCGTTCGTTTTCCCGAACCCGGAGGGCAAAGAGCTTTTAAATCCCGAGGCGTCTACATGATCGTTGGCGGAGCTGGGGGCATTGGGATGGTGCTGGCCCAGTACCTGGCCGAGCGTGTTCAGGCGCGTCTGGTCTTGGTGGGCAGAAGTGCTTTGGATGAGGAGAAAAAGCAAAACCTTTCGACGCTCACTGCCGCCGGTGGAGAAGCCCTATATATCCAGGCAGATATCAGTCGTCTGTACAGCATGAAAGATGCCGTCGCCCAAGCCCGTCAGCGTTTTGGCAACATCAACGGTGTGGTGCATTCCGCCATGGTTTTAAATGACCAAAGCTTGGCCCGTATGAGTGAAGAGGGGTTGCGGGCCAGCCTGGCGCCAAAAGTCGAAGGCTGTATCGTGTTGCAGCAGGCGATGGCCGGTGAGCCACTGGATTTTATGTTGTTCTTTTCTTCGGCAATCTCCTTTAGCGGCAACGCCGGACAAAGTAACTATGCAGCAGCTAGTACATTTAAGGATGCCTTTGCCCATTATCTGACGCAAGTGGAAGCTTATCCCGTATTTAACATCAACTGGGGATATTGGGGGTGTGTTGGTGTGGTTGCGAATGCAGCTTACCGTGAACGTTGGGCAGCTCGAGGAGTCCATTCTATTGACCCAGAACAGGGTCTGCAAGTCATTGAATCGATCCTGACTAACCATATTGATCAAGTCGCTGCGGTGAATGTCGAGCCGTCTTTTCTAGAGCGCCTGGGCGTAGAACTGTCTCAAACACAAACTGTACTCCCACCACGTCGCTCGTCGCTGATTGCAAAACTTAATGCGTTGCCACTGCCGGAAACCGGGGGTTTTCAAGATAATGTTAATCGCCTAGAGATCGTGAGTGCATTCCGCTGGGCTGAAGTGTTTAAGCATATGCTTGATATGTCTAGCACTCAGGGAATGTATGCTCGCTCTGATCTTAAACGACAATTACAGATTAGCTCTGAACACGATCAGTTGTTTGATGTTCTCATTTCTATGCTCATTCAAGAGGGCTATCTCCATCAGCAGGGCAAAAATCTGACGCCTACACCTTACTTGAATGGCGAGTTTTTCCAGCAGCAGAGAGAACAAGTCGCATTGCTGGAAAGTGAGCTGTCGCAAACGGATAATGCCTATTTAAACTTGTTATCTCGCTGTCTGGATCACTATCCCGCTATGTTGCGCGGTGAAGTGGCGGCAACTGATGTGATATTCCCACAGGGCTCGATGGAATGGGTGGAAGGTATCTACCGCAGCCATGCTTCAGCCGACTATTTTAATCAGCAATTGGCCCAACGCCTCGTTGCCTATGTTGAGGCCCGCTTGCCTTCCCTGGGTGCGAATGAATCGATTCATATCCTAGAAATTGGCGCCGGCACCGGCGGCACCAGCGCCATTGTATTACAGGCGCTCCAGCCTTATGCAGCTCGCCTGCGTTATACCTACTCCGATATCTCGCCTGGTTTCCTCAATTACGGGCGCAAAACCTTTGGCGACGCGTATCCGTTTGTCGAATTCAGACACTTAAATATTGAACACAATGGCGAAGCTCAGGGCTATCAAGCAGGCGAGTACGATTTGGTCCTGGCGGCCAATGTGTTGCACGCTACCCGTCACATTGGCAACACCTTGGCCCGGGTTAAGTTTTTCATGAAACGCCATGGCTGGCTGTTATTGAATGAAGCCACCCAAGTGCGCCATTTTGGGACGTTGACCTTTGGTTTGCTAAAAGGTTGGTGGTTGTTTCAAGACGCTGAAAACCGGCTTGACGGATCGCCTTTGCTGTCAACCACTGCCTGGCAGCGGTTACTGTCGGAAGAGGGGTTCAAGCACACGCTTAGTTTGTGCGACGCGGTTGAAGAAGAGTCAATTTTTCAGGATGTCATTGTTGCTGAAAGTGATGGTGTCATTCAAATGAATCAGTCGGATTCACCTGTGCAGCCGCGTGAGCCTGTGGATGTGTCTGTGGATGTCCATCATGTCGATGACATGATGGAGCCTGGGCAAGTGGCGGATGTGGTTGAGTCACGACATGATTTTATCGTCAATAGCGTCAGCCAATGTATGGCTCAGTCTTTAGGTGTGGCGTTTACCGACATTCACATCAATCGTCCATTTAGCCTTTATGGTGTGGATTCGATCACGGGAGTTGATTTTATTCATCAGATCAATTCCCGTTTAGGGATCGTTTTGCGAACGACGGCCTTATTTGATCACGCGACGATTTTTGATTTATCCCGTTTTATCGACGAGAGCCACGGCGCGGCGATTGACGAGCAGCGTCAGCGCTTGAGGTCAACACCGTTGACCTCAAGCGATACGAAGCCAGCGGAGCGTGTCGCCCCGCCGGATGAAGCGCTTCCCCATATCGAAAGGGGCTGTCACCAGGCGGTCGTACTGGAAAAACCCAGCCAGATCGAGCACCTTCGCTTCCATCCCGTGAAAACCCGGGAACCTGCGGCGCATGAGGTGCAAATTGCAGTTCGCGCTTTTTCGCTCAACTTCGGGGATTTGCTATGCGTGACCGGGCTCTATCCCACCATGCCGGCGTATCCATTTACACCGGGCTTTGAAGTGTCCGGGCACGTCGCCAACGTGGGAGCGGCGGTCAGCCACGTTGCGGTGGGCGACGAGGTCATTGCCCTAGCGGGCCAGCAGTTGGGCGGCCACAGTACGCTGTTGACCACTGCAGGACACTTGGTGGTTCACAAACCGCGTCAGGTCAGCCACGAGGAAGCTTGCGCGTTTCCCGGCGTTTTTCTGACCGTCTACCATGCGTTTCAAAGCGCCAATATTCAAGCTGGGGAAAAAGTTTTGATTCAAGGCGCGGCCGGGGGAACGGGCTTAATTGCTGTACAAATGGCCCAGGCGGTGGGAGCGGAAATTTATGCCACAGCCGGTTCGCCCCAAAAACTGGATTATCTGCGTGAACGAGGCGTGCCGCATCTGATCAATTACCAGACGGACGATTTCGCCGAGGTCATTTTAGCAGATACAAACGGTTATGGCGTGGACGTGATCTTCAATACAGCAGCCGGGGACGCCATGCAAAAAGGGCTGGACATTCTGGCTCCCAATGGACGCTATTTGGAAATTGCGATGGTCGCCCTGAAGCGTTCGCGGTCGGTTGATTTATCTCATTTGGTTGATAATCAGGTGTTTTATAGCATCGATATGAGAAAGCTGATCGCTGGAAACCCACAGCTGATCAGCCGCTATCTGAATCGCATGGTGGAGCATCTGGCAGAAGGGCACGTGCAGCCGACGATAGGCGCAAGATTTGCGCTTGATGATATTCAAAGCGCCTACCGGCTGCTACACGACCGGCAAAATATTGGCAAAGTTGTTGTCAGTATCCCCGATGGGATGATGGACAATCAGGTCGGCCAAAGGATGGTGCCGGAATCCTCAACGGTTGAGGACTATCGCGTTGGAAACGCCACGGTTGAACAGGTTGCGGTAAAACAACCGGCGGACATGGATGAGCCGATTGCCGTTGTCGGTATGTCCGGCCGTTTTCCCGGGGCAAACAACTTGGAGCAGTTCTGGTTGAATCTTATAGGTGGCAACAACGCGATCACCGAAGTTCCCGCTGACCGCTGGGATGTCCATCAGTGGTATGACCCCGACCCGGCAGTCCTTGATAAGACCCATTGCAGATGGGGCGGTTTTCTGCGAGATATTGACAAATTTGATGCGCTGTTTTTTAAACTCTCAGGCCGGGAAGCCGAGTTGACTGACCCGCAACAGCGTTTATTTCTGGAGGTCGCTTGGGCCGCACTTGAAGATGCGGGGCATGCGAACCGCGCGATTTCCAATGCCCGCTGCGGGGTTTTTGTCGGAGCCGGTCCGAGCGATTACGTCACGTTAATGCGTGAACGGAGCGTGCCCGGCGAGCCCCAGTCATTCTGGGGCAATTCCAGCTCGCTAATCGCGTCGCGCATTGCCTATTTTTTAAACCTGAAAGGGCCGAGTATCACCATTGATACGGCCTGTTCCTCATCTCTGGTCGCCTTGCATTTAGGCTGCGAAAGTATTCGGCGTGGCGAATGCGACATGGTCATTGCCGGTGGCGTGTATATTGGGGTCACACCACACTTACATGTTATTGCTAGCAACGCCGGCATGCTCTCACCCGATGGCCAGTGTAAAGCCTTTGATCAAGGTGCAGATGGCTTTGTCCCGGGTGAAGGCGTTGGCGCGGTGGTCTTAAAACCACTGTCAGTGGCACGTCAAGCCGGTAATTTTATTTATGGGATTATTCGTGGCTCAGGTTCAAATCAAGATGGGCGAACTTATGGTATTACCGCGCCCAGCGCTGCTTCTCAAACAGAGCTAGAGCAAAGTGTCTACCGACAGGCCGAACTCGACCCGGCAAGCATTGGCTATGTTGAAGCTCACGGTACAGGTACCAAACTTGGTGATCCCATTGAGATTGATGCGCTGAATCGTGCCTTCCAAAGTGACGCGAAAAAGCAGCACTCTTGTGCCATTGGATCGGTTAAAACAAATATTGGACACGCTGGTGCGGCTGCCGGTATTGCTGGATTCATTAAGGTCTTATTGTGCCTGCAACATCAACAATTGGTGCCTTCGTTAAATTATCACACGTGTAATGAACATATCGATTTGGACAATAGCCCGTTCTATGTGAATACAGAATCAAAGGATTGGTTCGTCGCTCAGGGTGAGCCGAGACGGGCTGCGGTCAGCAGCTTTGGCTTTAGTGGTACTAATGCGCATATTTTGTTAGAAGAATACCAACACCATGAGGACGAGGCCCAGGCACTTGGAGATGACAAGGATGTGTTGATCGTCCTTTCAGCCAAGAATCAAGAACGTCTCAAAAAAGCGGCTGAAAATCTTCACCATTTTTTAGAAAGCAGAGTCTCCTATAAATTGTCCGACATTGCCTATACGTTGCAGGTTGGCCGTGAGGCGATGGAGGCGCGAGTTGCTTTTATGGTGGTCTCAGTCCTTGACTTACAACAAAAGCTTGTGTCATTGCTTCATGACCCAACAGACGAACAAGACATGTATTGGGGGGAGGTGCGCGATGGCGAGGGGCCTGCTGGAGTGGCTGCTTTTGAAGACGTCGCACTTGCCTTGGCTAACAAGCAGTTGGATCAGCTTGCCCAGTGGTGGGTGTCTGGGGTTGAAATAGACTGGACCCAGCTTGCACGCGTGGTGAAAGTCCGTCTCGTTCCTCTGCCTACGTATCCGTTTTCGCCTGATCGTTACTGGTTTGATTCGGTAGGTCCGGCGACGGTTGTACATGCCGAGCATTCAGCCTCTGCTCTGTATCCCCTATTGAATCGTATCGCTCCGCAGGCGAGCACTCAAATCGCGAACGGCTGCGTGTTTGAGACGTGCTTGAAATCCAGTGACCCTCTGTTGGCGCAACATCTCATTGACGGCCAGGCGGTGTTTCCGGCAGTGGGATTTCTGGAGATGGTCATAGCTGGCCTGCGCGAAATCCAGCCAGATAAAGCAGCGCGGTTGGAGAATGTGTTTTGGCTCCGGCCTCTTGATGTCATGGATGAACAACGCGTTCATCTGGTGTTTGAGGTGAAACAGGATCGTTTTCAATATCGAATTGTACCCGCAGAGTCTCACGGGGACGGGGCCTATTTTCGTGGCCAAGGCTACTGGTCAAACGATATGAATCCTGCGATTCCGATGGATATTGATCGCCTGAAAAGCCGTATGCGCCAACAGCCCTTGCTCAACGAATCCAGCCCCCGAGTCCGCCTGGGCCGCTTGTATCAAGGCGCGACTGAGGGGTGGACGGATGGTGAGCAAGCACTGATCGCCTTTGAGTTGCCAACGGCGCAACCGTATCGAGACGGGTCCCCCGATCAAAAATCATACCCATTTCACCCTGCAGCTTTTGTCGCGGCTTTGCAAGCCTATCACTGGATTCATGAGGCGCCTAAGCGTCTGGGGATGCCTTTTGCCGTGCAAAAAGTGGAGCTGTGGCGCCATCGTGATCAACCCGCTTATGCTTACGTTGCACTAGATGAGCATGGCAACGCGGACGTGCACATCCTGGATGCAGGCGGTCAGGTATGCGTCTGTTATCGTGGCATGGCCCTGCAGACCTTGAACAATGCGCACCACGATGGGAGACAAGAAAGCACTCAAAAAGATGAGCTTGGAAAATTGCTTTTTGTCCCTGTCTGGAAGCGTCTTGATACGAAACATGGGCGTGCACATGGCATGCATGCGCTTGCTCGCGGAACGGGCGTCTTACTGGTGTACACACACGAAAATGGGGTAGAGGCCGAGCAGCTCATGCAGCGTTATCGCGAAGAGCAATGTGAGTTACTCTCGGTTTGCTTATCTGCGGCGGATAGAGCACTGGACACCCTGGCGGCGCGTCTAAAGCATCTGCAGTCGCCACTGCGCCATGTCTGTTTTCTTGATCGTCATCAGGCCGCGCTTGATCCGGCTGACAAGCAGATTGACGAGCGATTGCGTGAACCCCAGACCCTCACAGGCTTTTTGGCATTAGTGAGAACCCTGAGCGAGCTTGGCTATGATGAACAGCCCCTACAATGGCTTGTGCTTACCTCTAGCGCATGTGCCGTCAATCAAGCAGACCCCATTAACCCGTATGCCGCTGCGATTGTCGGACTTGCCTCTTGTCTGGCGCAAGAGCATAGGTATTGGCAGGTGAGTGTCTGTGATCGGGGCAAAGGCACATCTTTCACAACGATTGCGAATCACGGGGAAACCTTGCGCGTTATTGCTGAGCGCAGTGGATACAGTTATGTGAGGCACATCAAAGAATTAGAGCTGCCCCCTCCCCGGCAGAGCCGTTTGCGTCACAAGGGCGTATATGTCTTGGTTGGCGGTGCCGGTTACGTGGGGACCTTGCTTAGCCGCTATCTGGTTCAGACCTATCAGGCAAAGGTGATATGGCTAGGTAGACGTGAGCAAGATGAGCAGATAGAGCAAAACATAGCCCTGATCGCTACCTTGGGATCGCGTCCGCAGTATCTGAGCCTGAAAACCGGATCAGACGACGAGCTACACCGTGCATTTGCGCAGATTAAGGCAGAAAACGGTTTGATCCACGGTGTGTTTAACCTGGTGATGGTCGCGCAGAGTACCCCGATGCGCAGCCTGAGCGAAGCACAATTTCGAGCTGGCTCCTTTAATTCCAAAGTGAACTCCGCGCAAGCCTTATACCGTATTCTGAAAAAGGAAGCTCTAGACTTTATGGTGTTCTTCTCTTCGATGCAAAGCTTTGCGCAGCAGCTCAATTTTATGTCAGCGAATATGAGTAGTTATGTTGCAGGTTGCATGTTTCAAGATGCTTTTGTGCATCAGATCAATTGCGAGTTATCTTATCCTGTAAAAACTATTAACTGGGGTTATTGGTCACAAGAGAGTTCAGAGAGCGAAAAGGCGAAGTGGTACGAGACTTATATCGCGGATAAAGGTATTTACAGTCTCAATGTTGGGGAGGCGATGCAAGCGTTGGAGTATATTTTGGCTCACGAACCAGAACAAGTGATCGTGACCAAAGTATCACATCGGGTTCTCAGCGACATGGGCTTTGTGCAAGATGACTCAGAGAACGTCGACCTACAGCCTGTTATTGACTCGAACGATGACAATACCCAGCTTGAGGACTTGATCGTTAATGGTATTCTCAAAACCTTTGAAACGCTCGATGTATTGCAGGTATTTGATAGCGCCTGTAATCTCGATGTTTCGAGATTACAGGCGCATGTGCCCGATAAATATCGCCGCCTGTGGCGTGAACTGCTTCTGATTTTGGTTCAGGCTGGAAAGATGGCACCACAGGGTGCTGGGTTTGCTCTACGAGAAAGCTATACCAGTTTGGCGAGCCAGCTTCGCTTAATGGATCTCGATCGGGAGGCTGGGCTATTGCGCGAGCGCCATCCCACCTTAGCCTCGAAACTTGCCTTGCTCGTACCCTGTCTGAAGGATATGGCCGAGGTGTTAACGGCTCGCAAACCAGCAACAGAAGTGTTGTTCGAACACGCTTCGCTGTCACGGGTTGAAGGGATTTATAGAGGAAATCCCACCACAGACTACTTTAACCAGCGTGTCGCTGACATTGTGAAGGCCGCAGTACAGCAGGCACTGCCCAGCCTGAGTGTAGGGAAAAAAGTACGCATTTTGGAAATCGGCGCGGGCACCGGTGGTACCAGTGCCTACTTGTTTCAAGCACTTAATACATATGCAGATCAGTTGCACTACATCTATACGGATATCTCTAAACGATTCTTAATTCATGCAGATGAAACTTTCTGTGAGCAGTATTCCTTTATAGAGACAAAATTGTTGAATATCGAACAAGATGTGGCAGGCCAGGGGTTCGATCCTGCTAGTATTGATATCGTGGTGGCAGCCAATGTTTTGCACGCCACACGCAACATTAGTAAAACTTTGCAACATGTTAAAGACTTACTCAAGAACGATGGGCTTCTGGTGTTAAATGAATTAGCGGACGTTTCGCCTTTCCTCACCGTGACCTTTGGTCTGTTAGATGGATGGTGGTTGTATGATGATGAAGCCATTCGCCAACCAGGCTCACCTGGCCTATCAGCAAAAAATTGGCAGCTTGTGTTGAAAAATCAGCGTTTTCACAATATTAGTCTCAACGATGAAAAAGCTCTGACGTCAGAGCAGCAAATTATTATCGCGCAAAACGAGAGTAAAGAGAGTGTGCCGGTCTCATCCACAGTATTATTAGGAACAGAACTTATCGCCTCAGTCGAAGCCAGTCTGATCGCACAATTGAGTCAGTGCATAAAAATCGAGCAAAACCGTCTCAATACCTATACCACGTTTTCAGATTATGGTGTGGATTCAATTTTGATGCTCGCCTATGTTGATCAAATTAATGGTGATCTTGGAATTGACCTCAATCCTTCAGAACTATTTAATTATACCACTGTTGAGCGTCTTACTAAGTTTATCGTTGATTATCATGGGAAAGAGATCATTTCAGCAAAAGAAAGCGTTGAGAGATCATTACTTCAGAATCAAGAAAGCAAATTTGACCTCAATGACATAGATGTCATCACAAAGGCAGGGAACGAAGCTCCGGAGATGGCGCGCAGCCTTCTCTTTGATAACGTTTTGCAAGTGCCGTCCGGTAACGTGCATCATCACCAGAGCGATAAGGCGCGACCTGATATTGCGGTTATTGGCATGTCGGGGCAATTCCCAGGTGCGACGAATGTTCAGCAGTTTTGGCAAAATCTGAGCGCCGGCGTCGATAGTGTGAGCGAGCTGCCTGAAAGCCGCCTGGATCGTCAGCTGTACAGTCCGCAGCCAGAGGCGGGAAAATGTTATTGCCAATGGGGCGGTATCTTAGAGGAACAGGCCTCTTTTGATCCACTGTTTTTTGAAATCTCTCCCAAAGAAGCCGCCGAGATGAATCCTTCTCAGCGGGTGTTTATGCAGGAGGCTTATCGAGCCCTGGAAGATGCGGGGCTGGTCAACGCAGGTCTCTCGCAACTGCATTGTGGCATTTATGTCGGTTGTGAGCCAAACGGCTATACCAAACAAGGTTTCACCGGCGCCTCCGAAGCCATTGTCGCTTCCAGAATCTCCTATTTTCTCAATTTGCAGGGACCGGCTCTGGTGATTAATTCCGGCTGCTCCTCTTCCTTGGTCGCCATTCATCTGGCTTGTGAAAGCCTTCGCCATGGCGAAAACGATATTGCCCTCGCCGGAGGCGTTTTTACGAATCTGAATAACGAGTTGCTCGTCTGTCTGTCGTCCATTGAGATGTTGTCATTCTCCGGTAAATGTCACGCCTTTGACGAAGCCGCCAATGGCACGGTGCTGTGTGAAGGTGTCAGCGTGCTGGTGTTGAAACGATTACAGGACGCGCTAGATGATGGCGATGTCATTTATGGCGTGATCAAAGGCAGTGGCATGAATCAGGACGGAAGAAGTAATGGCATCACTGCACCCAACGGACTTGCACAAGAAAATTTGATCAAGCGCATTTATCAGGATTACAACATTGATGCCAGCAAAATCAGCTACATAGAAGCCCATGGTACTGGAACGAAATTGGGTGACCCCGTTGAGGCGAATGCGNTGAAGAACGTATTTTCTTCAAGAAACACGGGTTTGGACTTTCGTTGCGGAATCGGTTCAGTTAAATCGAATATAGGACATGCGGCTGCAGCTGCGGGTGTGATCGGTCTGGTCAAGGTCTTATTATGCATGCAACACCGTCAGTTACCAGGGCTGGTGCATTTTAACAAACTCAACCCTCTAATCGATTTTAACGACACAGGTTTGTACATCGTTGAGCAATTGCAAAACTGGGAGCCAGCGTCTGGTGAGCCGTTGATGGCAGGCATCAACTCGTTCGGCCATAGCGGCACCAATGCCCATCTCGTGATTCAGGAACCCCCTGTGCGACCTGTCCGCGACAGCGAGAACCCATTCCATTTAATCTGTCTATCTGCCAAAACAGAGGAAGCGCTTAAACAAAAAATTAGCGATTTGAGTGCATATCTAAGGCGCAAAGAAGAGCCGCCAACTCTAGGAGCCATCAGTTATACCTTGAATACCGGCCGTGCTCACTTTAGAAAACGCTGCGCTTTCGTCGTGGATTCGCTGGAGGCTTTGCAAAATGCTCTCATGGGAGCTTTAGATGGTCTTGTTGGCAATGCAGAAAGGTTAAGTCCACAAGAACAGGCATTTTGTAAAAAAGCATTTGATTTGATTATCAAGGATTTACACGATGTAGAGAATCTTGAAAGTAGGGCTGATCAAACAATCTATAAAGATAACCTACTGGCTCTGACCGGACTTTATCTAAAAGGTTTTGACCTAGACTGGCAACGGGTGTACAAAGGTCAGAGCTATCACCGGGTATCCCTGCCGACATATCCTTTTTCCAGAGATACATACTGGATTGACGAGCCAAAACAAATTAGCTTCACCGAGCCTGGTACCGACAAGCCTGGAAACACCAGCAGGAATCATCAGCAGGATCAAAAAGATGAGGATGTGTTGGGTGGACAGTTTTATATACCGCAGTGGAAACGGCTTGATCAAACACAATCCTATGCCAGTTTAAGCGATCATGGGAAGTTGACCATCGCATCTGACCCTGTTGTCATTTTTTATCCGCCGACCATGACAAGTTTAAAAGATGATATTCAAACATGCTATGAGCAATTACCGGCAAGCCAAGTCGCTAGCTTCGAGCTTGGCTGCACACCTTCGTCTGAGGTCGATGTTCGCGATCCCCGTGCCTTTGAACGCATCTTTGTATCCCCTAGGCAGGCATTGGAAGAGCTGCTTGAGCAAGGTCGAACGTTAACGATCTACTTTATCCTGCCTGAACCGGATCAAAACCCGGACTCAGGGTGCAACCTCGAATGCCTTGAGGAATCCCTGTCACTCGGGCTGATCTCGTTGTTCCGTTTGATACAAGCGCTGTTGGCCCATCACGGCTATGCCAGCGAGCTGACCCTCAAAATCGTGACCCAGCAAACCCAGGTCTGTAAAGCTTCTGAGCGCATTGTGCCCTATGGCGCAGATGTGGTGGGTTTTGTGCAGTCGTTAGCGAAGGAATACGAGCTCTGGCAAATCAGTTGCGTGGATATTAATCGGCAGACATGGTGGACGCCCGCGCAAAGCAAAAACTTTGCCGAGGCGCTGATTGCCCTGAAGCCACCGGCGGACGGGCGCGCTCTATGTTGGCGGGACGGGTATGTTTATCACCGTGTTTTAACCCCGGCTAATCTCGTTGGCGTTCAGGGAAGTGCATTCAAGACGCGCGGTGTCTACCTAATTATTGGTGGCGCTGGAGGGTTGGGATTGGTGCTCAGCCAGTATCTGCTTGAACACGTGCAAGCGAAACTGGTATGGGTGGGGCGGCGCAGCCTCGAGGCGTTGGCGCCGGATGCGTTGCGGTTATTCAACACTCCGGGCGCCCACGTGCTATACGAGCAAGCGGATCTGTGTGATCCGGAAGCGCTGCAGCGCGCGCTGCAGCAAGCCAAAGGACGTTTTGGATACATTGATGGTGTCATCCATTCGGCTTTGATTCTAGAGGACCGAGCGATCGCCGACATGGATGAGAAAACGCTACGCAAAGTTCTCGCGCCCAAAGTACAGGGCAACGTGGTACTCCAGCAAGTGCTGGCCGATGAGCCTTTAGATTTTCTGTTGTATTTCTCCGCCGGACAGTCTTTTATGAGTCATGCTGGGCAGAGCAATTACGCCGCTGCCTGTACCTTTGAAGATGCCTGGGCGCTGTGCCAGGACCAGCGGCAAAACTATCCGATCAAAATTATCAACTGGGGCTATTGGGGCGAGGTGGGCATTGTCGCCACGGCTGACTACCGTAAACAAATGGCCAGGCAAGGCGTGCTATCGATTCATCCGCAAGAGGGCATGGAAGCGGTAGAGCGTTGTCTGGCGTCGTGCGCCACCCAGGCCGCTTATTTTAAAGTGGAACCCCGCGCCTTGAGCCGATTGGGCTTGGACGGCACTGGAATCTTGCATGCGAGCCGGAACCGTGTTCCACCTCAATTGATTCATGTCGTGATTGATGCCACCCAGGCGTGGTCAATCTCGATGCCGTACGCACAGCGCTATCAACAATCCCTTAAAAAGTTGGATCGGCTTGGTTGCTATCTCCTTCTGCGTGTATTCCAGGCTATGGGAGTGTTTAGTCAGCCTCATGAACACTATGAAAAACAGGAATTGGCCAGTAGATTAGCCATTTCAAAAGGCTATCATCACCTCTATCAAGAATGCTTGAACTTGCTAGATACGTCCGGTTTTATTGCAATCAATGGTTCGCACATTGAAGTCCAAGACGTGCTACCGGAAGAACATGACGAACACCACAGCTGGTTACAACCCTATCCCGAATTGGCCGCGCATGAAAAATTGTTGCGCATCTGCCTACAAGCTTTTCCGGATATCATCCGGGGATCGGTTGCCGCGACGGATATCATATTTCCGGATGCGTCTGTGGAATTGGTAGAAGGTATTTATCAGGGCAATCCCGCCACCGATGCGCTGAATACCAAAGCGAAAGATGCTGTGGTTGCCTACGTCAAAGCCCGCCTGGCAGACTGTCAGGAACAAATCATCTTTTTAGAAGTCGGAGCGGGAACCGGCGGCATGAGTCATGAGGTGTTGAAGGGGCTGGCCCCCTATGGGCAGTATATCGAGTATTATTACACCGATGTCTCCGAGCATTTTATCCAGTACGCTCGCCGCCGTTATGGTCAGGATTACCCCTTTGTCCGGTTTCAACGTTTAGACATTGAACAGGAGCATAGCGCGCTAAGTGAGGGGCTGCTCAGTGCCTGCGATGTCGTATTAGCCGCGAATGTTCTGCACGCCACCCAAAGCGTTCGCAATACCATCCAGCATGTCAAAGCCCTGCTAAAACGGCACGGCTTGTTAATCTTAAACGAAGCTACGACTTTGGAAAGCTTTGCCACATTGACATTCGGATTGTTAGAGGGCTGGTGGCGCTACCAGGATGCCGGAGACCGCCTACCTGGCGGGCCTTTGTTAAGCGCGTCCATGTGGCATCGCTTGCTCGAAGAAGAAGGTTTTGACCAGGTGGTGTCCCTGGGTGAGCCAGGCGAAGGCGACATGTTGGGACAGCATCTCATTGTCGGTCGAAGTGATGGCTGGAGCTTGCATCAATCTGCGAGGGACGATGAAACCCGTTCGGCCCCTGTTAGCCCTGTGGCGGCGAGCGACGTTATCCAAGGCAATCGAAATGACAAGCCCGCAGAGCTTATCAAACACGTTGAAGCGCAGATTGTGCAAACCCTTTCAGCCGCACTGGATATTGCTGCGGCTCGAGTGGAACGCGATGTGTCGTTTTCCGAGTATGGGGTGGATTCGATTCTGTCCGTTGCGATTATTAACCAATTAAACCAGCGCCTAGGGATTCGTCTGAAACGTCCGGATTTGTTTAATTACACCACCACAGAAAGCATGGCGGCGCATATTGTCGCAACCTTTGCTGACCACTTGACGGCGGCCTTAGTCGAAGAAGCTGAACCACCAACGCCAGTAACCGTAGCAAGTCCTCAACCGATAAAAGCGGCGGGGCAGCAGGATGTTCTTCAGCAAAACTTGCAAACCCAGCCTCAAGTCTCGCAAGGCGTTTGGCAAACCAAGCCGGAACCCATTGCTGTCATCGGCATGTCTGCCTGCGTGCCAGGGGCGGATCATGTGGGTGCGTTTTGGGACAACTTGGTTGCCGGCACAGATTCCGTCACCCGGATTCCCCATGAGCGTTGGCAGCGGGAGGCCGTCAATGAGCTGCCCGGCGGGCCGGATACCTCCCAGCGCAAAGCCGGATTTATGGACAATATTGCCGAATTTGACCCGCTTTTTTTTGCCATCTCTCCGCAAGAGGCGCAGTGGATGGACCCGACGCAGCGGCTGTTCTTACAGCAGGCTTGGGCCGCGTTGGAAGATGCCGGATACAATCCGCGAGCCTTAGCCGGCGCTTCATGTGCGGTGATGGTTGGCTGTGCGGCGACTGGCTATGGTGTGAAAGAGGGCGAGCGCACGGGGTATGTGTCCTATGCTATGACCAATAGCGAGGCCATCTTACCCGCGAGAATCTCCTATTTTCTCGACTTAAAAGGCCCGAGTATTCCCATTAACACCGCCTGCTCTTCGTCTTTAGTGGCGATTCATCTGGCCTGCGAACAACTTCGCTCCGGGCAAAGCGACATGGCGTTGGCTGGCGGTGCTTCCGCACTGATTGGTTCCGCGTTGCACATCGGACTCAATGGCGTTGGGATGCTATCTCCCGAGGGCGCATGCAAAGCATTTGATAAGGAGGCCAATGGCTTTGTGCTTGGCGAAGCGGTTGGCGTTGTCGTTCTCAAACCGTTGTCCAAGGCCGTGGCTGATGGCGATTCGATACATGGTTTAATTATTGGCTCGGCGATTAACCAGGACGGCAAAACCAATGGTATCATGGCGCCGAACGGTCCGTCTCAGACGGCATTAATTGAATCGGTGTACCGGAAATTCGAGATCGATCCTAAAACGATTAGCTATATCGAAACCCATGGCACCGGCACCCAACTCGGCGACCCAATAGAAGTCAACGCCTTGGCTGCTGCCTATGAAAATTTCACCACCTCGCAAACTCAGTACTGCGCCATCGGATCGGTAAAAACCAATATTGGTCACACCACCACTGCTGCCGGTGTCTGTGGATTGATTAAGACTTTATTATGTCTCAAACACCAAAAACTTGTCCCATCCCTGCACTATAAGGAGCCCAACGAAAATATTGAGTTTGAAAAGACGCCGTTTTACGTCAATACCCAGGTCAAAGATTGGCCGGGTCATCAAAACGGTGTCCGGCGTGCGGCGGTGAGTTCCTTTGGCTACAGTGGCACCAATGCGTATATGGTGGTGGAAGCGTTCGTGGAGACGAGCCCGCGCGCGGTCGGGCAGCAGGGACCTGCATTAATTGTCTTGTCGGCTAGGCATGAGGTGCGACTCAAAGAGCTGGCCAGCAATCTCATGGCCTATTTGAAGCGGTATGGCTTGAATCCGGATCGCCCGATTCAGCTCGAAGATATGGCGTATACGCTTCAGGTTGGCAGACAGGCCATGTCAGAGCGTCTGGCGTTTGTGGCGGACAGCGTGGCGGATGTCGTCAAACATTTAGCCACATTTGTTGACGGCGAGGCCAATGCCCAGGAACTTTACCGGGGGCAAGTTAAACCGTTCGGCGATAAGAGCGATTTGCTTTTGGAGGGCGAGGCGGGTCAGGCTTTTCTCAACACGATTTTAAGACAGCAGGATTACCGCAAATTAGCCGCCCTGTGGGTGGCGGGTACAGACTTGGACTGGAATTTACTCTACGACGGTGAAAACCGTGCCCGTCGCATTTCGCTACCGACCTATCCTTTTGCTAGGGAAACGTATTGGTTGGATGAGGGGATAGGGAGCAATGAAAAAGAGCTTCTAAGAGATCAGACTCAAAAAGAGTTACGTGATCGTGATCGTGAGCAAACTACGGAACTCATGACATTTGAAGAGATATGGCAGGAGGCGTCCTTAAACAATCATTCGGATTCCATCAAGTATAAAAGCATCGTTTGTTTTCTTTCCGGATCAGAACATCAGCAAGAAATGCGAACTGCCATGCAGGCGATTGATCCGGCTATCCATCTTACGATGATTGCTCAAGGCCATGGTTACACAAAGCACTCATCTGATCGTTACACAGTAGACCCCGCCGATATACAGAGCTTTCGTGAAGCTTTCCTCGATATCAGCCAGACTCATGGCGAGGTCGACGCGCTGCTTTATCTATGGCCAACCGAGGATTGGCGTCTCTTGTATGATCCATCCGCCGTCGTTTATATGTTGCAGGCTCTGGTCAAGAGTGAGCTAAAACCTTCCCGCTGCTTGCTGGTTGCTGCTTTTTCCACTGCTTTGGAGCGTTGTTACCTGGAATCCTGGATTGGCTTCGAGCGCTCGTTAAAGCTCATCATGCCTGGTTTCCAGGTCGCGGGACTGTTTCAGGAACATGCGGGGCCGGACCAGACGATTTCAATGACACATTGGAGTCAACACATTGTCTCTGAACTCAAAGCGCCTAAAGCACAGACGGTGCTGATACAAAATCACCGGCGCTACGTCAATCAGATTCAAAAAACCGAACTGGCCGCGCAAGGCGCTTCGGTTGCATCGGCCGTCAAACAGGGCGGTACTTACCTGATTACCGGTGGCTGTGGGGGATTAGGTTTTTTGGTCGCCCAGCACCTGGCAGAACACCTTGGGCAACCGGCAGCCTCAGCCTCGGGAAAAACGGTGCATTTAATTCTGACGGGTCGATCATCTCCCGATGACGCGATACAAAGCAAAATCACGCAACTGGAAGCATTAGGGGCAAAGGTTGGTTACGTTCAAGCGGATGTTGCCGATGCAGTCGCCATGAGACGTGGCCTTGCCCAGATGAAAAATCGCTTTGGCGACATACACGGTATTTTTCATATCGCTGGGATCGCCCCCAGCGAGAGTCTCCTCAATAAAGATATCGACGCCTTTCAAAACGTACTGGGGCCTAAAATTGCGGGCACGTTGATGCTTGACGATCTCTGTCGTGATGAACCGCTTGATGTTATCTGTTATTTTTCCTCCTCTGCCGCGATTTTAGGGGATTTTGGCGCCTGTGACTACGCGATTGGCAATCGTTTTCAGATGGCTTATGCCGCTTATCGCAACCATCTGCTGCAGCAGGGGATGCGACAGGGTAAGGCGTTGGTGATTAATTGGCCGCTTTGGCAAGAAGGCGGCATGGGGTTTCATCAAGACGAAAATACCAAGATGTACTTGAGCTCCAGCGGGCAGCGGGTTCTGGAAACTCAGGAAGCCTTGACGGTATTGGATCACGTCCTTAACCAGGACAAAACACAGCATTTGGTCCTGGTGGGGCAGCCAGGTCGGGTGTATGGCTTTTTAGGGTTGACTGAGGCGCCTATGACTCAGATGCCAGTGACTGAAGCGCCAGTGACGCAGACATCCACACGGCCAGAGTTGAGAGGCTTGAGTACGGAGCAGTCGGTATTATGGGATTTAAGAAATCTCATCGTCCAGCAACTCAAAGTGCCCTGGGAGCAGCTTGGGCGAGATCACAATCTCGCTGATTTCGGTTTTGATTCAATAAGCTTGTTGAGTTTTGCCAATCGTCTCAGCGAGCATTATCAACTTGACATTACACCTGCCTTGTTTTTTGGGTATTCGACTCTAGAGCAACTCACGCAGTACTTTTTAAGCGAGCATTGCGATTTTATCAACGCCTTTTATAAGGAACCCGAAAAATCGGAAATCCCTGTAAAAAAGGAAGCCGTTGAAGAGCGTGCTCCTATCCGGATTGTTTCTGAAGAAACCCGCCCAGAAAAAATAGATAATGCAAAAGATGAGCCCATTGCCATTATTGGCATGAGTGGCAGATTTCCCAAAGCTTACGATGTTGAACAAATGTGGCAGCTCTTGGCATCGGGTGAATGTGCGGTAGAAGAAATTTCACCACATTACTTTGATTGGCGCAGATACTTTGGAGAGCCGAGCCAGGAGGCTAACAAAACCAATGGAAAATGGTGTGCTAATATTCCTGGCGTTGCCGAATTCGACCCCCTGTTTTTCCAAATTTCCCCGAGAGAAGCGCCAAACATTGATCCTCGTCAACGGCACTTATTGCAAGAGTCTTGGAATGCTTTAGAACATGCCGGATACGGGCCGCATCAACTGAATAGCCAGAAGATCGGCACCTTTGTCGGGGCTGAAGAAGGGGATTATTATCAACGTGTCAAAGAGGGCAACATCACCTCCAATCACTCGGGCATTCTCGCCGCTCGTCTGGCCTATTTCTTAAACTTAAAAGGCCCGACCATGGCGATTAATACCGCGTGTTCCTCCTCACTGGTCGCGGCTCATCAGGCTTGTCTGAGTTTACGGCAGGGGGAATGTGATACGGCCATCGCGGCAGGGGTCAATCTAATGCTCACCCCTTACGGATATATCAGTATGGGCCGAGCAGGTATGCTCTCTGAGGATGGCCACTGTTATGCCTTTGATGAACGCGCCAATGGCTTAGTACCAGGTGAAGCCGTGGTCGTCGTGGTATTAAAGCGCCTTAGCCGAGCGCTTGCTGACGGTGATCCTATTCACGCGTTGATCTTGGCTAGCGGTGTTAACTATGATGGCAAAACCAATGGTATCACTGCACCAAATGGTGTTTCGCAGGCCGAGTTGGTGAGGGAGGTTCACCAACGAGCCGGGGTTCATCCGCAGGATATTGATTATATTGTGACACACGGTACGGGTACCCGGCTAGGTGACCCCGTGGAGGTCAACGCCCTTAACGAAGTCTTTAGGGACAGCCAACACCTTTGTGCGATTACATCCAGTAAAACCAATTTTGGCCATACGTTTTCCGCTTCGGGGCTGCTCAGTCTTGTCAATCTGGTACAGGCGCTTCGTCATGAGACCATTCCGAAAAGCCTGCATTTTGCTCAGCCAAACAAATTTATGACATGGGATCAAGGCCCTCTCTATGTCAATACGGCCAATAAGCCCTGGCTCGAAAAGCCGGGCGAAAAACGCATTGGCGGGGTGAGTGCGTTTGGAATGAGTGGCACCAATGCCCATATGCTGATTCAAGACTACCAGCTTCACAGAAAAGAACCACGTGCGGTCCCGCCTTATGCGCTGCTTGTGTTGTCTGCAAAAACGGCAGAGGCACTGCATCTCAAGGTCAAAGCCATGGTCGCGTTTTTGCAAGAAGGGCTTGCAGACACTGCCACCCTAGCGGATATCAGTTATACATTGTTTGAAGGCCGACACCACCTTCAATACCGTTTGGCTATTGTGGTGCAGGATATGACTGAGGCCATGTGTTGTTGGACACAAGCCGGGCAGCCAGATAAGAAACCCAATATTTTTCAGGGAAAAGTGCCTACCGAATTTAGTGGTCAAAAGGTCACACAGAATTATATTAACCAATTAGTAGAACAGCTTGATCGCTCTACCGGCGATGATGACGTATACCGAGAACGTCTCTTGGGTTTAGCTGATTTTTATTGTCAGGGGTATGATGTCCCTTGGTCTAGGCTATACGGTGATACACGGCCACGCCGTATAAGTCTGCCTGGGTATCCGTTTGCTAAACAACAATTTTGGCTGGATTTCTCTCCGAAGGATCATGGCGAACAAGAAAATGTCGAACTTCCTATTGGCAAGATGCAGAGACAAGTTCTAAATGAAAAAAACACGCTTGAAACATTAAGCTACATTCACAAATGGGAACAGCAGGATAAAGCTGAAGTCAAGATAGAAATCAGCCAGGTTTGCTTACTAGTTTACTTTGAATCTGCATCGCAATTTGAAAAAACGCTGGCAAGCTTCTTCTTGCAGCAGGGTGCATCTCAGGTGATCGAGATTCAATTGGGACTCGAAACCAAACCGGTGTCCGAACATAAATGGCGCTGCAATGTCAATGACGTCGACGCTTTTCAGCGTTGCCTTCAAGCCTATGCACAGACAATCAATAGCGTTTACTTTCTCTGTGTCGATACCCTCCAGCAGGGCATGGAAGAAAGCGAAATGCAGTTGCTACGGCTGGTCAAAGCCTTAAAATCACGTATGCAGAGCCATGCCTTTATCGATTTCACCCTTCTGACTCTGGATAATCACCGCGTCGATAACAGCGCGACAAGTCCCAACCACGGGGGGCTTAGCGGTCTTGGGTACTCGGTGGCGCAGAGCGATCACCGCTTCCGGGTTCGAAATATCGATTTGTCGCGGGAAGATCTGGTGAGCGCCGAACAACAATGCACCCTGCCAGGCATGATCGTCAGCGAAGCCCCGTCGGACCGAGGCGAGGTGGTCAAGTTGCAGGCAGGTTTGCGCTACAAGCAGCGCTTTTTCAAGCTCGACTGGCAGACGCTGCAAGCGGCACAGCCAGAGGCGGCGGGTTTGAAAACCGGTGGGGTCTATGTGTTGTTGGGTGGCGCGGGAACCGTTGGTGCGATTATAACCCGCTATCTCATCCAAAAATATCAGGCCAATGTGGTTTGGCTGGGGCGTCGTGCGCTGACATCGCCTGCCGTGCAGGAACAACTACACGCGTTCCGGAGCGTGGACGAAGGGTGTGTGCCACTCTATATTCAGGCCGATGTGACGGATCAGGCTTCCATGACTCAAGCGGTCAAAGAGATCAAGCAACATCACCCTTGCATCCATGGCGCGATTTTCTCCGCACTGGTCTTTAAGTTGGATAACTCAATTGCTAAGACTAGCGAGGAAGACTTTAATGAGGTTTTGGATACCAAGAAAAAGGGTGCGCAGTATTTTTATCATGCATTCAAAGATGAAAACTTAGATTTTATGTGTTATTTCTCGTCGGTCCAATCTTTTTTCTTTATCTCCTCTCGAGAGAGTGCAGGGTATGCAACCGGTATTACCAGCGCTGACACCTTTGTACATGCCATCGATCACGATAGCACCTTTCCTGTCGGTATCATCAATTGGGGTTACTGGGAGGCCTCTCTGGCGGGAACCGAAGCCGAGAAGCGTTTGCCCGGTCATTATGACTTAATCTCTGATCATGATGGATGTCAGTTTTTTGACGGATTTGTACCTATGCTTAGATCAGGCCTTATCAAACAGGCCGTTTGTTTAGGTGTGTCAAAAGCGATAGAGGATTTCATGGGCTGTGACGCCACGCAGATGATCACGGTGAACAAGCTTGAGGCTGATTCTTTGATTTTTAGCCTTTTTAATGAAAATGAGTGCGGCCAAGCTACGTGTGAGGAAACTGAAATCGAGCGCCTTTTGGATAAAGATTTCAACAATGAACTTAAGCAATGGTTGCCGCGGCTGCTATTTTCACAGCTGCAACAACTGGGGATCTTTTTAAATCGTGGTGAGCAGAGAGATTGTACGACGTGGCAACAACAAGCTGGTGTGATCAAAAAATATGAACGCTGGTGGCGAGAGTGTTGCTTAGGGCTGCTGGAGACCTCCGGCTACGTACAATGTGAAGGTGAGAGGGTTGAGGTCACTCACCATAGTCCGGCAGACGAGGCGGATCAACTCTGGCAAGGCTGGGAGAGCTTCCAAAATTTATTCCTCGACAAGCCGGAAAGAAAACCTGTGCTCGACTTATTGGAGAGCTGTCTGAGAAGCCTGACGCAAATCCTGTGCGGTGACATCCTGGCCACCGATATTCTTTTTCCAAAATCGTCAATGGAAAAAGTAGAAAATATATACCAGCGGAATGCCCTATCCGACTATTGTAATACCTTTGTCGCGAAAGGTATCGAAGCTTACATTCATCAGCGGATTCAGGCAGAGCCTCAGGCAAGGATCCGGATATTGGAAGTCGGTGCAGGTACTGGAGGTACCACCGCATTGGTCCTGCCACAACTGCGTCAGGTGCAGCATGCGATAGACGAGTATTGTTATACAGACATTTCCAAAGCCTTCTTGATACATGCAGAAAAGACTTATGGGCCGGATTATAACTATCTAGATTATAAGCTACTCAATCTCGAACAACCGTTAGCGCCACAAGGAATAGAGCCTGGCTCCTATGATATGGTAATCGCTACCAACGTGTTGCACGCTACAGAGAATATCAGACAAACCCTTCGCCATACTAAAACTGCTCTAAAACGTCATGGATTATTAGTGATCAATGAAGTGGTTGAGAAATCTATTGTCGGTATCTTAACCTTCGGGTTGTTAGACGGCTGGTGGCTCTACCAAGACGAATCATTACGCATCCCAGGCTCTCCGCTGATCACGCTGGATACCTGGCGTAAAATTTTAAAAGAAGAGGGCTTTGCCAGGGTCTTGTTGCCAATGCGAGCCGCATCTAAGTTGGGTCAGCAAGTGATGGTGGCGGAAAGTGACGGTCTGGTTAGACGGGAGAGAGAAGACTTGCCGGACGAGGACGAATCGGCTGTGACTGATAAAACGTCCGTGGTACAGGGCATGACTTTGACTCCGGAACAGCGAATTGCGCAAACACCGTCTGTACGGGAGCTGTCGTCCGAAACACTACGAGAACAGGTTGCCGAGCTTATTTTGACAGGATTGGCCGAAACATTAGGCATGGCGCAAGAAAATATTGACCCACTAGTTTCATTTTCTGACTATGGTATTGATTCTATTCTTGGTGTCGGTTTTATTGGTCAGCTTACTAAATCCTTCGGCATCACCATCAATACCGCTATATTGTATGATTATACCAATGTAGTGCGTCTTAGTGATTATCTGGTAGAAATCTATGCAGAGGACATACAAAACAAAATTCAAAACAACCGCATGTCTCCAGTTGAGAAAGATGCTGTTCTATATACAGAGACACAACTAGAAACAACAGTCGATCGTAATCCGGAAAAAAGTCAGCTTGAAAACTCAGTTCCTAATATGACCTCTGGCGAGAATAAGTCCGCCAAATGCCAGGAGATCGCTGTTATTGGTATGTCAGGGCAGTTCCCTAGAGCAAAAGACCTTGACGCCTTCTGGCAAAATCTGATTCAGGGACGGGATGGTGTTGTAGAGCTACCCGCGAATTATCTCAATCCGGCTTTGTTTAGCCCGCACAAACAAGCGGGAACAACCGATTGTAAATGGGGTGGCATTTTAGAGCAGCGTGATTGTTTTGACCCACTTTTTTTCAACCTTACGCCCAGGGAAGCGGAGTCGATGAACCCGCATCAGCGTCTCATTCTGAGTGAGAGCTGGAAAGCGCTGGAAGATGCCGGCTACAATCCCAAAGAGCTGGATAATACTCGCGTTAGCGTGTTTATTGGCGCGGAACCTACCGACTATTACCATGAAACCTTTACCGGCTCTTCTGATGCTATTGTTGCCTCCCGCTTATCCTACTACCTCAACCTCAAGGGACCGGCTTTGGTGGTCAATACGGGTTGTTCGTCTTCTGCTTTGGCGATTCACTTGGCCTGCGAAAGTTTACGCCGTGGCGAGTCTTCAATGGCCCTGACAGGTGGCATTTTTGCTGCAATGCATGAAGAAGCACTGGTTAAACTAGCCCAGATTGATATGCTTAGTGCCACCGGTCGCTGCCGTACATTTGATCAATTCTGCGATGGTACCGTATTGTCTGAAGGTGTTGGGGTGGTTGTGTTAAAACGGCTTGACGATGCCGTCAGGGACAACGACCCCATCTATGGCGTGATTCAAGCCTCTGGGGCAAATCAGGACGGTGCCAGCAATGGGATAACTGCGCCTAGTGGTTTGTCGCAGGAAGAACTCCTGACGTCTGTCTACCGGCAATATGACATCAATCCGGAAACGATCACGTATATTGAAGCTCATGGAACTGGTACCTCACTTGGAGATACCGTTGAGGCTAATGCGTTAAAGCGGGCCTTTAAACAGTTTACGGATAAAAAACAATTCTGTGCACTTGGCAGCGCAAAATCTCATATCGGCCATACAGGAGCTGCTGCTGGCGTTATTGGTTTAATCAAAGTTTTGTTGTCGATGCGCTATCATCAGCTGCCTAAACTGTTGCACTTCGAAGAACTCAATCCATCAATCGAATTGGAAGATTCTGCATTTTATATCAATCAACAGCAAATGGAATGGACGGGGCAGGGCGTGCCATTAACCGCAGGGCTGAATTCTTTTGGCCACAGTGGTACGAACGTTCACCTCGTGGTTCGGGAATACCTGCCGTTATCTGAGACGAAAGCCGAAATGGAGGCTGTACTGATTCCATTGTCTGCCAAAACCCTCGAATCCCTTAGAACCTATGCTGAAAGTTTATCGACGTTTCTGGAAAATGGGCATTCTGGTCATGGTGTTAGCCTCACCGATTTAGCCTTTACCCTCCAGCTTGGACGCGAAGCGATGCGGGAGCGCTGTATTTTCTTGGCTGGAAATGTCCCGGATTTGGTAGCCCAATTAAAGGCTTTTGCGAATGACAAGACGCTCAACAATGTGGGTTGGTACGGCCGGGTTGGACGCAGCAAGAACAGCCATTCCTTCAATGATCATGAGTCTCGGCAAATGATCACTCAATGGTTGCAACAAGGAAAATTGGATAAAATTGCCGCCGCTTGGGTACAGGGCCTGAGCATTGACTGGGCAGCCCTTTATCGCGAGCTCACAGCTCGTAAAATCCATGCGCCAACCTATCCTTTTGCCCAGGAACATTATTGGAAACCCGAACAGCAGAGTATGGTTCAGAAGCCCGTTGCGCCGGAAACACAGCCTGAGACCTTCGGAACACTGATGTTGCAGCCCTGTTGGATAGATCAACCCCTTGAACATTCATAA", "orf_prot_sequence": "MLRTGMKTDSPNHPENQAINVNHYLMVLSAKTKERLQTVVENLLDYAKANRRLIESRLADVAFTLQTGREEMEARLAFVVSDYHDLMGQLSGYLEDAPNANTIFRGQVDLFDQSAPVRQHRAAQERDCERMIRTHDLPGLAELFVQGVPIDWRRLYVQGRPRRIALPSYPFAPERHWVARREPDHLAADMPAVRQPHSLLDGRDDRMSLESGVVFRKLLRINDGVLQDHQVNETPVFPGVAYIEMACEALAQLSFSDPEVLRKTVLNQMVWLQALAVTEAEHEILLCLEKDTHGLAFEVKDHQTLYAKGRFDQSDDLSQGHQYLELETIKGDCPHEKHRSVIYHDFRLLGLNYGPWFQGLEHTWFSIDSAEGEGEALGYFNMPLICESEFSAYTFHPGLLDAALQVVASVPGYADSGLLLPYAVEKLEWFHPFPACGYSHVRKLAKHRYDVTICDEQGKVCAKFSDLSVRPSRVAGSEPSLNQLTYRARWSHQELGERRSPAGRPEETGVVFIIHTPEQQALVQELSSVLADMHGDHRVRRMCLNANDWDFKSLGNWNHRIRAVQDLRDIYFLAAMEHTVSSGQAHVDPLSFTNRQEHGLLSLFRLLKALDQNQLLLQPLSLKVLTTGNYRVLPSDTICPLSAGLPGFCRSIAQEYPLLALSCIDLGCPDGDAMQPSSLKKLAQFIVAEPAHQPHETVGIRELRRYTRKLVPVRFPEPGGQRAFKSRGVYMIVGGAGGIGMVLAQYLAERVQARLVLVGRSALDEEKKQNLSTLTAAGGEALYIQADISRLYSMKDAVAQARQRFGNINGVVHSAMVLNDQSLARMSEEGLRASLAPKVEGCIVLQQAMAGEPLDFMLFFSSAISFSGNAGQSNYAAASTFKDAFAHYLTQVEAYPVFNINWGYWGCVGVVANAAYRERWAARGVHSIDPEQGLQVIESILTNHIDQVAAVNVEPSFLERLGVELSQTQTVLPPRRSSLIAKLNALPLPETGGFQDNVNRLEIVSAFRWAEVFKHMLDMSSTQGMYARSDLKRQLQISSEHDQLFDVLISMLIQEGYLHQQGKNLTPTPYLNGEFFQQQREQVALLESELSQTDNAYLNLLSRCLDHYPAMLRGEVAATDVIFPQGSMEWVEGIYRSHASADYFNQQLAQRLVAYVEARLPSLGANESIHILEIGAGTGGTSAIVLQALQPYAARLRYTYSDISPGFLNYGRKTFGDAYPFVEFRHLNIEHNGEAQGYQAGEYDLVLAANVLHATRHIGNTLARVKFFMKRHGWLLLNEATQVRHFGTLTFGLLKGWWLFQDAENRLDGSPLLSTTAWQRLLSEEGFKHTLSLCDAVEEESIFQDVIVAESDGVIQMNQSDSPVQPREPVDVSVDVHHVDDMMEPGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVDSITGVDFIHQINSRLGIVLRTTALFDHATIFDLSRFIDESHGAAIDEQRQRLRSTPLTSSDTKPAERVAPPDEALPHIERGCHQAVVLEKPSQIEHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLLCVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGHSTLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGEKVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIAMVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQLISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPDGMMDNQVGQRMVPESSTVEDYRVGNATVEQVAVKQPADMDEPIAVVGMSGRFPGANNLEQFWLNLIGGNNAITEVPADRWDVHQWYDPDPAVLDKTHCRWGGFLRDIDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSVPGEPQSFWGNSSSLIASRIAYFLNLKGPSITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGIIRGSGSNQDGRTYGITAPSAASQTELEQSVYRQAELDPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFIKVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPRRAAVSSFGFSGTNAHILLEEYQHHEDEAQALGDDKDVLIVLSAKNQERLKKAAENLHHFLESRVSYKLSDIAYTLQVGREAMEARVAFMVVSVLDLQQKLVSLLHDPTDEQDMYWGEVRDGEGPAGVAAFEDVALALANKQLDQLAQWWVSGVEIDWTQLARVVKVRLVPLPTYPFSPDRYWFDSVGPATVVHAEHSASALYPLLNRIAPQASTQIANGCVFETCLKSSDPLLAQHLIDGQAVFPAVGFLEMVIAGLREIQPDKAARLENVFWLRPLDVMDEQRVHLVFEVKQDRFQYRIVPAESHGDGAYFRGQGYWSNDMNPAIPMDIDRLKSRMRQQPLLNESSPRVRLGRLYQGATEGWTDGEQALIAFELPTAQPYRDGSPDQKSYPFHPAAFVAALQAYHWIHEAPKRLGMPFAVQKVELWRHRDQPAYAYVALDEHGNADVHILDAGGQVCVCYRGMALQTLNNAHHDGRQESTQKDELGKLLFVPVWKRLDTKHGRAHGMHALARGTGVLLVYTHENGVEAEQLMQRYREEQCELLSVCLSAADRALDTLAARLKHLQSPLRHVCFLDRHQAALDPADKQIDERLREPQTLTGFLALVRTLSELGYDEQPLQWLVLTSSACAVNQADPINPYAAAIVGLASCLAQEHRYWQVSVCDRGKGTSFTTIANHGETLRVIAERSGYSYVRHIKELELPPPRQSRLRHKGVYVLVGGAGYVGTLLSRYLVQTYQAKVIWLGRREQDEQIEQNIALIATLGSRPQYLSLKTGSDDELHRAFAQIKAENGLIHGVFNLVMVAQSTPMRSLSEAQFRAGSFNSKVNSAQALYRILKKEALDFMVFFSSMQSFAQQLNFMSANMSSYVAGCMFQDAFVHQINCELSYPVKTINWGYWSQESSESEKAKWYETYIADKGIYSLNVGEAMQALEYILAHEPEQVIVTKVSHRVLSDMGFVQDDSENVDLQPVIDSNDDNTQLEDLIVNGILKTFETLDVLQVFDSACNLDVSRLQAHVPDKYRRLWRELLLILVQAGKMAPQGAGFALRESYTSLASQLRLMDLDREAGLLRERHPTLASKLALLVPCLKDMAEVLTARKPATEVLFEHASLSRVEGIYRGNPTTDYFNQRVADIVKAAVQQALPSLSVGKKVRILEIGAGTGGTSAYLFQALNTYADQLHYIYTDISKRFLIHADETFCEQYSFIETKLLNIEQDVAGQGFDPASIDIVVAANVLHATRNISKTLQHVKDLLKNDGLLVLNELADVSPFLTVTFGLLDGWWLYDDEAIRQPGSPGLSAKNWQLVLKNQRFHNISLNDEKALTSEQQIIIAQNESKESVPVSSTVLLGTELIASVEASLIAQLSQCIKIEQNRLNTYTTFSDYGVDSILMLAYVDQINGDLGIDLNPSELFNYTTVERLTKFIVDYHGKEIISAKESVERSLLQNQESKFDLNDIDVITKAGNEAPEMARSLLFDNVLQVPSGNVHHHQSDKARPDIAVIGMSGQFPGATNVQQFWQNLSAGVDSVSELPESRLDRQLYSPQPEAGKCYCQWGGILEEQASFDPLFFEISPKEAAEMNPSQRVFMQEAYRALEDAGLVNAGLSQLHCGIYVGCEPNGYTKQGFTGASEAIVASRISYFLNLQGPALVINSGCSSSLVAIHLACESLRHGENDIALAGGVFTNLNNELLVCLSSIEMLSFSGKCHAFDEAANGTVLCEGVSVLVLKRLQDALDDGDVIYGVIKGSGMNQDGRSNGITAPNGLAQENLIKRIYQDYNIDASKISYIEAHGTGTKLGDPVEANAXKNVFSSRNTGLDFRCGIGSVKSNIGHAAAAAGVIGLVKVLLCMQHRQLPGLVHFNKLNPLIDFNDTGLYIVEQLQNWEPASGEPLMAGINSFGHSGTNAHLVIQEPPVRPVRDSENPFHLICLSAKTEEALKQKISDLSAYLRRKEEPPTLGAISYTLNTGRAHFRKRCAFVVDSLEALQNALMGALDGLVGNAERLSPQEQAFCKKAFDLIIKDLHDVENLESRADQTIYKDNLLALTGLYLKGFDLDWQRVYKGQSYHRVSLPTYPFSRDTYWIDEPKQISFTEPGTDKPGNTSRNHQQDQKDEDVLGGQFYIPQWKRLDQTQSYASLSDHGKLTIASDPVVIFYPPTMTSLKDDIQTCYEQLPASQVASFELGCTPSSEVDVRDPRAFERIFVSPRQALEELLEQGRTLTIYFILPEPDQNPDSGCNLECLEESLSLGLISLFRLIQALLAHHGYASELTLKIVTQQTQVCKASERIVPYGADVVGFVQSLAKEYELWQISCVDINRQTWWTPAQSKNFAEALIALKPPADGRALCWRDGYVYHRVLTPANLVGVQGSAFKTRGVYLIIGGAGGLGLVLSQYLLEHVQAKLVWVGRRSLEALAPDALRLFNTPGAHVLYEQADLCDPEALQRALQQAKGRFGYIDGVIHSALILEDRAIADMDEKTLRKVLAPKVQGNVVLQQVLADEPLDFLLYFSAGQSFMSHAGQSNYAAACTFEDAWALCQDQRQNYPIKIINWGYWGEVGIVATADYRKQMARQGVLSIHPQEGMEAVERCLASCATQAAYFKVEPRALSRLGLDGTGILHASRNRVPPQLIHVVIDATQAWSISMPYAQRYQQSLKKLDRLGCYLLLRVFQAMGVFSQPHEHYEKQELASRLAISKGYHHLYQECLNLLDTSGFIAINGSHIEVQDVLPEEHDEHHSWLQPYPELAAHEKLLRICLQAFPDIIRGSVAATDIIFPDASVELVEGIYQGNPATDALNTKAKDAVVAYVKARLADCQEQIIFLEVGAGTGGMSHEVLKGLAPYGQYIEYYYTDVSEHFIQYARRRYGQDYPFVRFQRLDIEQEHSALSEGLLSACDVVLAANVLHATQSVRNTIQHVKALLKRHGLLILNEATTLESFATLTFGLLEGWWRYQDAGDRLPGGPLLSASMWHRLLEEEGFDQVVSLGEPGEGDMLGQHLIVGRSDGWSLHQSARDDETRSAPVSPVAASDVIQGNRNDKPAELIKHVEAQIVQTLSAALDIAAARVERDVSFSEYGVDSILSVAIINQLNQRLGIRLKRPDLFNYTTTESMAAHIVATFADHLTAALVEEAEPPTPVTVASPQPIKAAGQQDVLQQNLQTQPQVSQGVWQTKPEPIAVIGMSACVPGADHVGAFWDNLVAGTDSVTRIPHERWQREAVNELPGGPDTSQRKAGFMDNIAEFDPLFFAISPQEAQWMDPTQRLFLQQAWAALEDAGYNPRALAGASCAVMVGCAATGYGVKEGERTGYVSYAMTNSEAILPARISYFLDLKGPSIPINTACSSSLVAIHLACEQLRSGQSDMALAGGASALIGSALHIGLNGVGMLSPEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKTPFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTNAYMVVEAFVETSPRAVGQQGPALIVLSARHEVRLKELASNLMAYLKRYGLNPDRPIQLEDMAYTLQVGRQAMSERLAFVADSVADVVKHLATFVDGEANAQELYRGQVKPFGDKSDLLLEGEAGQAFLNTILRQQDYRKLAALWVAGTDLDWNLLYDGENRARRISLPTYPFARETYWLDEGIGSNEKELLRDQTQKELRDRDREQTTELMTFEEIWQEASLNNHSDSIKYKSIVCFLSGSEHQQEMRTAMQAIDPAIHLTMIAQGHGYTKHSSDRYTVDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVAAFSTALERCYLESWIGFERSLKLIMPGFQVAGLFQEHAGPDQTISMTHWSQHIVSELKAPKAQTVLIQNHRRYVNQIQKTELAAQGASVASAVKQGGTYLITGGCGGLGFLVAQHLAEHLGQPAASASGKTVHLILTGRSSPDDAIQSKITQLEALGAKVGYVQADVADAVAMRRGLAQMKNRFGDIHGIFHIAGIAPSESLLNKDIDAFQNVLGPKIAGTLMLDDLCRDEPLDVICYFSSSAAILGDFGACDYAIGNRFQMAYAAYRNHLLQQGMRQGKALVINWPLWQEGGMGFHQDENTKMYLSSSGQRVLETQEALTVLDHVLNQDKTQHLVLVGQPGRVYGFLGLTEAPMTQMPVTEAPVTQTSTRPELRGLSTEQSVLWDLRNLIVQQLKVPWEQLGRDHNLADFGFDSISLLSFANRLSEHYQLDITPALFFGYSTLEQLTQYFLSEHCDFINAFYKEPEKSEIPVKKEAVEERAPIRIVSEETRPEKIDNAKDEPIAIIGMSGRFPKAYDVEQMWQLLASGECAVEEISPHYFDWRRYFGEPSQEANKTNGKWCANIPGVAEFDPLFFQISPREAPNIDPRQRHLLQESWNALEHAGYGPHQLNSQKIGTFVGAEEGDYYQRVKEGNITSNHSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGVNLMLTPYGYISMGRAGMLSEDGHCYAFDERANGLVPGEAVVVVVLKRLSRALADGDPIHALILASGVNYDGKTNGITAPNGVSQAELVREVHQRAGVHPQDIDYIVTHGTGTRLGDPVEVNALNEVFRDSQHLCAITSSKTNFGHTFSASGLLSLVNLVQALRHETIPKSLHFAQPNKFMTWDQGPLYVNTANKPWLEKPGEKRIGGVSAFGMSGTNAHMLIQDYQLHRKEPRAVPPYALLVLSAKTAEALHLKVKAMVAFLQEGLADTATLADISYTLFEGRHHLQYRLAIVVQDMTEAMCCWTQAGQPDKKPNIFQGKVPTEFSGQKVTQNYINQLVEQLDRSTGDDDVYRERLLGLADFYCQGYDVPWSRLYGDTRPRRISLPGYPFAKQQFWLDFSPKDHGEQENVELPIGKMQRQVLNEKNTLETLSYIHKWEQQDKAEVKIEISQVCLLVYFESASQFEKTLASFFLQQGASQVIEIQLGLETKPVSEHKWRCNVNDVDAFQRCLQAYAQTINSVYFLCVDTLQQGMEESEMQLLRLVKALKSRMQSHAFIDFTLLTLDNHRVDNSATSPNHGGLSGLGYSVAQSDHRFRVRNIDLSREDLVSAEQQCTLPGMIVSEAPSDRGEVVKLQAGLRYKQRFFKLDWQTLQAAQPEAAGLKTGGVYVLLGGAGTVGAIITRYLIQKYQANVVWLGRRALTSPAVQEQLHAFRSVDEGCVPLYIQADVTDQASMTQAVKEIKQHHPCIHGAIFSALVFKLDNSIAKTSEEDFNEVLDTKKKGAQYFYHAFKDENLDFMCYFSSVQSFFFISSRESAGYATGITSADTFVHAIDHDSTFPVGIINWGYWEASLAGTEAEKRLPGHYDLISDHDGCQFFDGFVPMLRSGLIKQAVCLGVSKAIEDFMGCDATQMITVNKLEADSLIFSLFNENECGQATCEETEIERLLDKDFNNELKQWLPRLLFSQLQQLGIFLNRGEQRDCTTWQQQAGVIKKYERWWRECCLGLLETSGYVQCEGERVEVTHHSPADEADQLWQGWESFQNLFLDKPERKPVLDLLESCLRSLTQILCGDILATDILFPKSSMEKVENIYQRNALSDYCNTFVAKGIEAYIHQRIQAEPQARIRILEVGAGTGGTTALVLPQLRQVQHAIDEYCYTDISKAFLIHAEKTYGPDYNYLDYKLLNLEQPLAPQGIEPGSYDMVIATNVLHATENIRQTLRHTKTALKRHGLLVINEVVEKSIVGILTFGLLDGWWLYQDESLRIPGSPLITLDTWRKILKEEGFARVLLPMRAASKLGQQVMVAESDGLVRREREDLPDEDESAVTDKTSVVQGMTLTPEQRIAQTPSVRELSSETLREQVAELILTGLAETLGMAQENIDPLVSFSDYGIDSILGVGFIGQLTKSFGITINTAILYDYTNVVRLSDYLVEIYAEDIQNKIQNNRMSPVEKDAVLYTETQLETTVDRNPEKSQLENSVPNMTSGENKSAKCQEIAVIGMSGQFPRAKDLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGGILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIGAEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVNTGCSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATGRCRTFDQFCDGTVLSEGVGVVVLKRLDDAVRDNDPIYGVIQASGANQDGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMRYHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREYLPLSETKAEMEAVLIPLSAKTLESLRTYAESLSTFLENGHSGHGVSLTDLAFTLQLGREAMRERCIFLAGNVPDLVAQLKAFANDKTLNNVGWYGRVGRSKNSHSFNDHESRQMITQWLQQGKLDKIAAAWVQGLSIDWAALYRELTARKIHAPTYPFAQEHYWKPEQQSMVQKPVAPETQPETFGTLMLQPCWIDQPLEHS", "perc_identity": 29.23}, "gnl|BL_ORD_ID|1968|hsp_num:0": {"type_match": "Loose", "snp": {"original": "G", "change": "D", "position": 387}, "query_snp": {"original": "G", "change": "D", "position": 214}, "orf_strand": "+", "orf_start": 33035, "orf_end": 60031, "orf_from": "BGC0001186.1|Misakinolide_16 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.1764e-16, "bit_score": 83.9593, "max_identities": 70, "cvterm_id": "39507", "query": "TACSSSLVAIHLACEQLRSGQSDMALAGGASALIGSALHIGLNGVGMLS-----PEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKTPFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTN", "match": "+ACSS   AI  A  Q+  G +D+A+ GG    I +      + +  +S     PE A + FDK+ +GFV GEA  +++++    A A G      ++G+ I  D       A +G      +        + P  I ++  HGT T +GD  E NA+  A            A+ + K+ +GH+  A G    + T+L L+   + P+L+Y+ P+  I+ +         V   P + +  R A  +SFG+ G N", "sequence_from_db": "SACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVA-------GCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLD--------VVAGEPRYGD-YRYAVNNSFGFGGHN", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 49853, "query_end": 50605, "hit_start": 504, "hit_end": 1224, "orf_dna_sequence": "ATGTTGAGGACCGGCATGAAGACAGATAGCCCGAATCATCCAGAAAACCAAGCGATCAATGTCAATCACTATTTAATGGTTTTGTCGGCCAAAACGAAAGAGCGCCTGCAAACGGTGGTTGAAAATCTACTTGACTACGCCAAAGCCAATCGTCGTCTCATCGAGTCCCGCCTTGCGGATGTCGCCTTTACCTTGCAAACGGGCCGCGAGGAGATGGAAGCGCGTTTGGCCTTCGTGGTATCGGATTATCATGATCTGATGGGTCAGTTAAGCGGTTATCTGGAGGATGCGCCCAACGCGAACACGATTTTCCGCGGACAGGTGGATCTGTTTGACCAATCTGCGCCGGTTCGTCAACATCGCGCGGCACAAGAGCGCGACTGCGAACGCATGATACGGACCCACGACCTGCCGGGCTTGGCCGAACTTTTTGTTCAGGGCGTGCCGATTGACTGGCGCCGTTTATATGTGCAGGGTCGCCCCAGGCGCATCGCGCTGCCCAGCTACCCCTTTGCCCCAGAGCGTCACTGGGTGGCGCGCCGGGAGCCTGACCATCTGGCTGCCGATATGCCCGCCGTTCGGCAGCCACACTCGCTGCTTGATGGACGTGATGATCGAATGAGTCTTGAGTCCGGCGTCGTGTTTCGAAAGCTGTTGCGCATTAACGATGGTGTCCTTCAGGATCATCAAGTCAATGAAACACCCGTATTCCCAGGCGTGGCCTATATAGAGATGGCCTGCGAAGCTTTGGCGCAGTTGTCGTTTTCTGATCCGGAGGTGTTGCGGAAGACCGTATTGAACCAAATGGTTTGGCTACAAGCCCTCGCCGTGACAGAGGCCGAGCATGAAATTTTGCTATGCTTGGAAAAAGATACACATGGTCTAGCATTTGAAGTCAAAGATCATCAAACGCTTTATGCCAAGGGCCGTTTCGATCAGTCGGATGACTTGAGTCAAGGCCATCAATACCTGGAACTGGAAACTATAAAAGGTGATTGTCCGCACGAAAAGCATCGCTCGGTCATTTACCATGACTTCCGCCTCTTAGGGCTAAATTATGGACCTTGGTTCCAGGGCTTAGAGCATACTTGGTTCAGTATAGATAGTGCTGAAGGGGAGGGTGAAGCGCTCGGCTATTTTAACATGCCGTTGATTTGCGAGTCGGAATTCTCCGCTTATACCTTTCATCCTGGCCTGTTGGATGCGGCATTGCAAGTCGTTGCCAGCGTGCCCGGATACGCTGACTCTGGCTTATTACTTCCCTATGCGGTAGAAAAGCTGGAGTGGTTCCACCCGTTTCCTGCTTGCGGATATTCCCATGTTCGCAAGCTGGCGAAGCATCGCTACGATGTCACCATCTGCGATGAACAAGGCAAGGTCTGCGCTAAATTTTCTGATCTTAGTGTTAGGCCCAGCCGAGTCGCAGGCTCAGAGCCCAGCCTGAATCAGCTGACCTACCGGGCGCGCTGGTCGCACCAAGAACTTGGGGAAAGACGATCGCCAGCAGGCCGTCCCGAAGAAACCGGAGTCGTGTTCATCATTCACACTCCGGAACAGCAGGCATTGGTACAAGAGCTAAGCAGCGTTTTAGCAGACATGCATGGCGATCATCGAGTACGACGGATGTGCCTAAATGCAAACGACTGGGATTTTAAATCGTTAGGGAATTGGAATCACCGTATTCGCGCCGTTCAGGACTTGCGCGATATCTATTTTCTTGCTGCTATGGAGCATACCGTTTCGAGCGGACAGGCCCATGTGGATCCTCTCTCTTTTACCAACCGACAGGAGCATGGGCTGCTCTCTTTATTCCGCTTGCTCAAAGCGCTGGATCAGAACCAGTTACTACTGCAACCGCTGTCGTTAAAAGTCCTAACGACAGGAAATTATCGCGTTTTGCCAAGCGATACGATTTGCCCTTTGAGTGCCGGTTTACCAGGTTTTTGCCGCTCCATTGCTCAGGAATACCCCTTGCTCGCTCTCAGTTGTATCGATCTCGGATGCCCGGATGGCGACGCCATGCAGCCATCCTCGCTTAAAAAACTGGCGCAGTTCATCGTTGCTGAGCCCGCGCATCAGCCTCATGAAACCGTCGGCATACGTGAACTCCGGCGCTATACTCGCAAGCTTGTTCCCGTTCGTTTTCCCGAACCCGGAGGGCAAAGAGCTTTTAAATCCCGAGGCGTCTACATGATCGTTGGCGGAGCTGGGGGCATTGGGATGGTGCTGGCCCAGTACCTGGCCGAGCGTGTTCAGGCGCGTCTGGTCTTGGTGGGCAGAAGTGCTTTGGATGAGGAGAAAAAGCAAAACCTTTCGACGCTCACTGCCGCCGGTGGAGAAGCCCTATATATCCAGGCAGATATCAGTCGTCTGTACAGCATGAAAGATGCCGTCGCCCAAGCCCGTCAGCGTTTTGGCAACATCAACGGTGTGGTGCATTCCGCCATGGTTTTAAATGACCAAAGCTTGGCCCGTATGAGTGAAGAGGGGTTGCGGGCCAGCCTGGCGCCAAAAGTCGAAGGCTGTATCGTGTTGCAGCAGGCGATGGCCGGTGAGCCACTGGATTTTATGTTGTTCTTTTCTTCGGCAATCTCCTTTAGCGGCAACGCCGGACAAAGTAACTATGCAGCAGCTAGTACATTTAAGGATGCCTTTGCCCATTATCTGACGCAAGTGGAAGCTTATCCCGTATTTAACATCAACTGGGGATATTGGGGGTGTGTTGGTGTGGTTGCGAATGCAGCTTACCGTGAACGTTGGGCAGCTCGAGGAGTCCATTCTATTGACCCAGAACAGGGTCTGCAAGTCATTGAATCGATCCTGACTAACCATATTGATCAAGTCGCTGCGGTGAATGTCGAGCCGTCTTTTCTAGAGCGCCTGGGCGTAGAACTGTCTCAAACACAAACTGTACTCCCACCACGTCGCTCGTCGCTGATTGCAAAACTTAATGCGTTGCCACTGCCGGAAACCGGGGGTTTTCAAGATAATGTTAATCGCCTAGAGATCGTGAGTGCATTCCGCTGGGCTGAAGTGTTTAAGCATATGCTTGATATGTCTAGCACTCAGGGAATGTATGCTCGCTCTGATCTTAAACGACAATTACAGATTAGCTCTGAACACGATCAGTTGTTTGATGTTCTCATTTCTATGCTCATTCAAGAGGGCTATCTCCATCAGCAGGGCAAAAATCTGACGCCTACACCTTACTTGAATGGCGAGTTTTTCCAGCAGCAGAGAGAACAAGTCGCATTGCTGGAAAGTGAGCTGTCGCAAACGGATAATGCCTATTTAAACTTGTTATCTCGCTGTCTGGATCACTATCCCGCTATGTTGCGCGGTGAAGTGGCGGCAACTGATGTGATATTCCCACAGGGCTCGATGGAATGGGTGGAAGGTATCTACCGCAGCCATGCTTCAGCCGACTATTTTAATCAGCAATTGGCCCAACGCCTCGTTGCCTATGTTGAGGCCCGCTTGCCTTCCCTGGGTGCGAATGAATCGATTCATATCCTAGAAATTGGCGCCGGCACCGGCGGCACCAGCGCCATTGTATTACAGGCGCTCCAGCCTTATGCAGCTCGCCTGCGTTATACCTACTCCGATATCTCGCCTGGTTTCCTCAATTACGGGCGCAAAACCTTTGGCGACGCGTATCCGTTTGTCGAATTCAGACACTTAAATATTGAACACAATGGCGAAGCTCAGGGCTATCAAGCAGGCGAGTACGATTTGGTCCTGGCGGCCAATGTGTTGCACGCTACCCGTCACATTGGCAACACCTTGGCCCGGGTTAAGTTTTTCATGAAACGCCATGGCTGGCTGTTATTGAATGAAGCCACCCAAGTGCGCCATTTTGGGACGTTGACCTTTGGTTTGCTAAAAGGTTGGTGGTTGTTTCAAGACGCTGAAAACCGGCTTGACGGATCGCCTTTGCTGTCAACCACTGCCTGGCAGCGGTTACTGTCGGAAGAGGGGTTCAAGCACACGCTTAGTTTGTGCGACGCGGTTGAAGAAGAGTCAATTTTTCAGGATGTCATTGTTGCTGAAAGTGATGGTGTCATTCAAATGAATCAGTCGGATTCACCTGTGCAGCCGCGTGAGCCTGTGGATGTGTCTGTGGATGTCCATCATGTCGATGACATGATGGAGCCTGGGCAAGTGGCGGATGTGGTTGAGTCACGACATGATTTTATCGTCAATAGCGTCAGCCAATGTATGGCTCAGTCTTTAGGTGTGGCGTTTACCGACATTCACATCAATCGTCCATTTAGCCTTTATGGTGTGGATTCGATCACGGGAGTTGATTTTATTCATCAGATCAATTCCCGTTTAGGGATCGTTTTGCGAACGACGGCCTTATTTGATCACGCGACGATTTTTGATTTATCCCGTTTTATCGACGAGAGCCACGGCGCGGCGATTGACGAGCAGCGTCAGCGCTTGAGGTCAACACCGTTGACCTCAAGCGATACGAAGCCAGCGGAGCGTGTCGCCCCGCCGGATGAAGCGCTTCCCCATATCGAAAGGGGCTGTCACCAGGCGGTCGTACTGGAAAAACCCAGCCAGATCGAGCACCTTCGCTTCCATCCCGTGAAAACCCGGGAACCTGCGGCGCATGAGGTGCAAATTGCAGTTCGCGCTTTTTCGCTCAACTTCGGGGATTTGCTATGCGTGACCGGGCTCTATCCCACCATGCCGGCGTATCCATTTACACCGGGCTTTGAAGTGTCCGGGCACGTCGCCAACGTGGGAGCGGCGGTCAGCCACGTTGCGGTGGGCGACGAGGTCATTGCCCTAGCGGGCCAGCAGTTGGGCGGCCACAGTACGCTGTTGACCACTGCAGGACACTTGGTGGTTCACAAACCGCGTCAGGTCAGCCACGAGGAAGCTTGCGCGTTTCCCGGCGTTTTTCTGACCGTCTACCATGCGTTTCAAAGCGCCAATATTCAAGCTGGGGAAAAAGTTTTGATTCAAGGCGCGGCCGGGGGAACGGGCTTAATTGCTGTACAAATGGCCCAGGCGGTGGGAGCGGAAATTTATGCCACAGCCGGTTCGCCCCAAAAACTGGATTATCTGCGTGAACGAGGCGTGCCGCATCTGATCAATTACCAGACGGACGATTTCGCCGAGGTCATTTTAGCAGATACAAACGGTTATGGCGTGGACGTGATCTTCAATACAGCAGCCGGGGACGCCATGCAAAAAGGGCTGGACATTCTGGCTCCCAATGGACGCTATTTGGAAATTGCGATGGTCGCCCTGAAGCGTTCGCGGTCGGTTGATTTATCTCATTTGGTTGATAATCAGGTGTTTTATAGCATCGATATGAGAAAGCTGATCGCTGGAAACCCACAGCTGATCAGCCGCTATCTGAATCGCATGGTGGAGCATCTGGCAGAAGGGCACGTGCAGCCGACGATAGGCGCAAGATTTGCGCTTGATGATATTCAAAGCGCCTACCGGCTGCTACACGACCGGCAAAATATTGGCAAAGTTGTTGTCAGTATCCCCGATGGGATGATGGACAATCAGGTCGGCCAAAGGATGGTGCCGGAATCCTCAACGGTTGAGGACTATCGCGTTGGAAACGCCACGGTTGAACAGGTTGCGGTAAAACAACCGGCGGACATGGATGAGCCGATTGCCGTTGTCGGTATGTCCGGCCGTTTTCCCGGGGCAAACAACTTGGAGCAGTTCTGGTTGAATCTTATAGGTGGCAACAACGCGATCACCGAAGTTCCCGCTGACCGCTGGGATGTCCATCAGTGGTATGACCCCGACCCGGCAGTCCTTGATAAGACCCATTGCAGATGGGGCGGTTTTCTGCGAGATATTGACAAATTTGATGCGCTGTTTTTTAAACTCTCAGGCCGGGAAGCCGAGTTGACTGACCCGCAACAGCGTTTATTTCTGGAGGTCGCTTGGGCCGCACTTGAAGATGCGGGGCATGCGAACCGCGCGATTTCCAATGCCCGCTGCGGGGTTTTTGTCGGAGCCGGTCCGAGCGATTACGTCACGTTAATGCGTGAACGGAGCGTGCCCGGCGAGCCCCAGTCATTCTGGGGCAATTCCAGCTCGCTAATCGCGTCGCGCATTGCCTATTTTTTAAACCTGAAAGGGCCGAGTATCACCATTGATACGGCCTGTTCCTCATCTCTGGTCGCCTTGCATTTAGGCTGCGAAAGTATTCGGCGTGGCGAATGCGACATGGTCATTGCCGGTGGCGTGTATATTGGGGTCACACCACACTTACATGTTATTGCTAGCAACGCCGGCATGCTCTCACCCGATGGCCAGTGTAAAGCCTTTGATCAAGGTGCAGATGGCTTTGTCCCGGGTGAAGGCGTTGGCGCGGTGGTCTTAAAACCACTGTCAGTGGCACGTCAAGCCGGTAATTTTATTTATGGGATTATTCGTGGCTCAGGTTCAAATCAAGATGGGCGAACTTATGGTATTACCGCGCCCAGCGCTGCTTCTCAAACAGAGCTAGAGCAAAGTGTCTACCGACAGGCCGAACTCGACCCGGCAAGCATTGGCTATGTTGAAGCTCACGGTACAGGTACCAAACTTGGTGATCCCATTGAGATTGATGCGCTGAATCGTGCCTTCCAAAGTGACGCGAAAAAGCAGCACTCTTGTGCCATTGGATCGGTTAAAACAAATATTGGACACGCTGGTGCGGCTGCCGGTATTGCTGGATTCATTAAGGTCTTATTGTGCCTGCAACATCAACAATTGGTGCCTTCGTTAAATTATCACACGTGTAATGAACATATCGATTTGGACAATAGCCCGTTCTATGTGAATACAGAATCAAAGGATTGGTTCGTCGCTCAGGGTGAGCCGAGACGGGCTGCGGTCAGCAGCTTTGGCTTTAGTGGTACTAATGCGCATATTTTGTTAGAAGAATACCAACACCATGAGGACGAGGCCCAGGCACTTGGAGATGACAAGGATGTGTTGATCGTCCTTTCAGCCAAGAATCAAGAACGTCTCAAAAAAGCGGCTGAAAATCTTCACCATTTTTTAGAAAGCAGAGTCTCCTATAAATTGTCCGACATTGCCTATACGTTGCAGGTTGGCCGTGAGGCGATGGAGGCGCGAGTTGCTTTTATGGTGGTCTCAGTCCTTGACTTACAACAAAAGCTTGTGTCATTGCTTCATGACCCAACAGACGAACAAGACATGTATTGGGGGGAGGTGCGCGATGGCGAGGGGCCTGCTGGAGTGGCTGCTTTTGAAGACGTCGCACTTGCCTTGGCTAACAAGCAGTTGGATCAGCTTGCCCAGTGGTGGGTGTCTGGGGTTGAAATAGACTGGACCCAGCTTGCACGCGTGGTGAAAGTCCGTCTCGTTCCTCTGCCTACGTATCCGTTTTCGCCTGATCGTTACTGGTTTGATTCGGTAGGTCCGGCGACGGTTGTACATGCCGAGCATTCAGCCTCTGCTCTGTATCCCCTATTGAATCGTATCGCTCCGCAGGCGAGCACTCAAATCGCGAACGGCTGCGTGTTTGAGACGTGCTTGAAATCCAGTGACCCTCTGTTGGCGCAACATCTCATTGACGGCCAGGCGGTGTTTCCGGCAGTGGGATTTCTGGAGATGGTCATAGCTGGCCTGCGCGAAATCCAGCCAGATAAAGCAGCGCGGTTGGAGAATGTGTTTTGGCTCCGGCCTCTTGATGTCATGGATGAACAACGCGTTCATCTGGTGTTTGAGGTGAAACAGGATCGTTTTCAATATCGAATTGTACCCGCAGAGTCTCACGGGGACGGGGCCTATTTTCGTGGCCAAGGCTACTGGTCAAACGATATGAATCCTGCGATTCCGATGGATATTGATCGCCTGAAAAGCCGTATGCGCCAACAGCCCTTGCTCAACGAATCCAGCCCCCGAGTCCGCCTGGGCCGCTTGTATCAAGGCGCGACTGAGGGGTGGACGGATGGTGAGCAAGCACTGATCGCCTTTGAGTTGCCAACGGCGCAACCGTATCGAGACGGGTCCCCCGATCAAAAATCATACCCATTTCACCCTGCAGCTTTTGTCGCGGCTTTGCAAGCCTATCACTGGATTCATGAGGCGCCTAAGCGTCTGGGGATGCCTTTTGCCGTGCAAAAAGTGGAGCTGTGGCGCCATCGTGATCAACCCGCTTATGCTTACGTTGCACTAGATGAGCATGGCAACGCGGACGTGCACATCCTGGATGCAGGCGGTCAGGTATGCGTCTGTTATCGTGGCATGGCCCTGCAGACCTTGAACAATGCGCACCACGATGGGAGACAAGAAAGCACTCAAAAAGATGAGCTTGGAAAATTGCTTTTTGTCCCTGTCTGGAAGCGTCTTGATACGAAACATGGGCGTGCACATGGCATGCATGCGCTTGCTCGCGGAACGGGCGTCTTACTGGTGTACACACACGAAAATGGGGTAGAGGCCGAGCAGCTCATGCAGCGTTATCGCGAAGAGCAATGTGAGTTACTCTCGGTTTGCTTATCTGCGGCGGATAGAGCACTGGACACCCTGGCGGCGCGTCTAAAGCATCTGCAGTCGCCACTGCGCCATGTCTGTTTTCTTGATCGTCATCAGGCCGCGCTTGATCCGGCTGACAAGCAGATTGACGAGCGATTGCGTGAACCCCAGACCCTCACAGGCTTTTTGGCATTAGTGAGAACCCTGAGCGAGCTTGGCTATGATGAACAGCCCCTACAATGGCTTGTGCTTACCTCTAGCGCATGTGCCGTCAATCAAGCAGACCCCATTAACCCGTATGCCGCTGCGATTGTCGGACTTGCCTCTTGTCTGGCGCAAGAGCATAGGTATTGGCAGGTGAGTGTCTGTGATCGGGGCAAAGGCACATCTTTCACAACGATTGCGAATCACGGGGAAACCTTGCGCGTTATTGCTGAGCGCAGTGGATACAGTTATGTGAGGCACATCAAAGAATTAGAGCTGCCCCCTCCCCGGCAGAGCCGTTTGCGTCACAAGGGCGTATATGTCTTGGTTGGCGGTGCCGGTTACGTGGGGACCTTGCTTAGCCGCTATCTGGTTCAGACCTATCAGGCAAAGGTGATATGGCTAGGTAGACGTGAGCAAGATGAGCAGATAGAGCAAAACATAGCCCTGATCGCTACCTTGGGATCGCGTCCGCAGTATCTGAGCCTGAAAACCGGATCAGACGACGAGCTACACCGTGCATTTGCGCAGATTAAGGCAGAAAACGGTTTGATCCACGGTGTGTTTAACCTGGTGATGGTCGCGCAGAGTACCCCGATGCGCAGCCTGAGCGAAGCACAATTTCGAGCTGGCTCCTTTAATTCCAAAGTGAACTCCGCGCAAGCCTTATACCGTATTCTGAAAAAGGAAGCTCTAGACTTTATGGTGTTCTTCTCTTCGATGCAAAGCTTTGCGCAGCAGCTCAATTTTATGTCAGCGAATATGAGTAGTTATGTTGCAGGTTGCATGTTTCAAGATGCTTTTGTGCATCAGATCAATTGCGAGTTATCTTATCCTGTAAAAACTATTAACTGGGGTTATTGGTCACAAGAGAGTTCAGAGAGCGAAAAGGCGAAGTGGTACGAGACTTATATCGCGGATAAAGGTATTTACAGTCTCAATGTTGGGGAGGCGATGCAAGCGTTGGAGTATATTTTGGCTCACGAACCAGAACAAGTGATCGTGACCAAAGTATCACATCGGGTTCTCAGCGACATGGGCTTTGTGCAAGATGACTCAGAGAACGTCGACCTACAGCCTGTTATTGACTCGAACGATGACAATACCCAGCTTGAGGACTTGATCGTTAATGGTATTCTCAAAACCTTTGAAACGCTCGATGTATTGCAGGTATTTGATAGCGCCTGTAATCTCGATGTTTCGAGATTACAGGCGCATGTGCCCGATAAATATCGCCGCCTGTGGCGTGAACTGCTTCTGATTTTGGTTCAGGCTGGAAAGATGGCACCACAGGGTGCTGGGTTTGCTCTACGAGAAAGCTATACCAGTTTGGCGAGCCAGCTTCGCTTAATGGATCTCGATCGGGAGGCTGGGCTATTGCGCGAGCGCCATCCCACCTTAGCCTCGAAACTTGCCTTGCTCGTACCCTGTCTGAAGGATATGGCCGAGGTGTTAACGGCTCGCAAACCAGCAACAGAAGTGTTGTTCGAACACGCTTCGCTGTCACGGGTTGAAGGGATTTATAGAGGAAATCCCACCACAGACTACTTTAACCAGCGTGTCGCTGACATTGTGAAGGCCGCAGTACAGCAGGCACTGCCCAGCCTGAGTGTAGGGAAAAAAGTACGCATTTTGGAAATCGGCGCGGGCACCGGTGGTACCAGTGCCTACTTGTTTCAAGCACTTAATACATATGCAGATCAGTTGCACTACATCTATACGGATATCTCTAAACGATTCTTAATTCATGCAGATGAAACTTTCTGTGAGCAGTATTCCTTTATAGAGACAAAATTGTTGAATATCGAACAAGATGTGGCAGGCCAGGGGTTCGATCCTGCTAGTATTGATATCGTGGTGGCAGCCAATGTTTTGCACGCCACACGCAACATTAGTAAAACTTTGCAACATGTTAAAGACTTACTCAAGAACGATGGGCTTCTGGTGTTAAATGAATTAGCGGACGTTTCGCCTTTCCTCACCGTGACCTTTGGTCTGTTAGATGGATGGTGGTTGTATGATGATGAAGCCATTCGCCAACCAGGCTCACCTGGCCTATCAGCAAAAAATTGGCAGCTTGTGTTGAAAAATCAGCGTTTTCACAATATTAGTCTCAACGATGAAAAAGCTCTGACGTCAGAGCAGCAAATTATTATCGCGCAAAACGAGAGTAAAGAGAGTGTGCCGGTCTCATCCACAGTATTATTAGGAACAGAACTTATCGCCTCAGTCGAAGCCAGTCTGATCGCACAATTGAGTCAGTGCATAAAAATCGAGCAAAACCGTCTCAATACCTATACCACGTTTTCAGATTATGGTGTGGATTCAATTTTGATGCTCGCCTATGTTGATCAAATTAATGGTGATCTTGGAATTGACCTCAATCCTTCAGAACTATTTAATTATACCACTGTTGAGCGTCTTACTAAGTTTATCGTTGATTATCATGGGAAAGAGATCATTTCAGCAAAAGAAAGCGTTGAGAGATCATTACTTCAGAATCAAGAAAGCAAATTTGACCTCAATGACATAGATGTCATCACAAAGGCAGGGAACGAAGCTCCGGAGATGGCGCGCAGCCTTCTCTTTGATAACGTTTTGCAAGTGCCGTCCGGTAACGTGCATCATCACCAGAGCGATAAGGCGCGACCTGATATTGCGGTTATTGGCATGTCGGGGCAATTCCCAGGTGCGACGAATGTTCAGCAGTTTTGGCAAAATCTGAGCGCCGGCGTCGATAGTGTGAGCGAGCTGCCTGAAAGCCGCCTGGATCGTCAGCTGTACAGTCCGCAGCCAGAGGCGGGAAAATGTTATTGCCAATGGGGCGGTATCTTAGAGGAACAGGCCTCTTTTGATCCACTGTTTTTTGAAATCTCTCCCAAAGAAGCCGCCGAGATGAATCCTTCTCAGCGGGTGTTTATGCAGGAGGCTTATCGAGCCCTGGAAGATGCGGGGCTGGTCAACGCAGGTCTCTCGCAACTGCATTGTGGCATTTATGTCGGTTGTGAGCCAAACGGCTATACCAAACAAGGTTTCACCGGCGCCTCCGAAGCCATTGTCGCTTCCAGAATCTCCTATTTTCTCAATTTGCAGGGACCGGCTCTGGTGATTAATTCCGGCTGCTCCTCTTCCTTGGTCGCCATTCATCTGGCTTGTGAAAGCCTTCGCCATGGCGAAAACGATATTGCCCTCGCCGGAGGCGTTTTTACGAATCTGAATAACGAGTTGCTCGTCTGTCTGTCGTCCATTGAGATGTTGTCATTCTCCGGTAAATGTCACGCCTTTGACGAAGCCGCCAATGGCACGGTGCTGTGTGAAGGTGTCAGCGTGCTGGTGTTGAAACGATTACAGGACGCGCTAGATGATGGCGATGTCATTTATGGCGTGATCAAAGGCAGTGGCATGAATCAGGACGGAAGAAGTAATGGCATCACTGCACCCAACGGACTTGCACAAGAAAATTTGATCAAGCGCATTTATCAGGATTACAACATTGATGCCAGCAAAATCAGCTACATAGAAGCCCATGGTACTGGAACGAAATTGGGTGACCCCGTTGAGGCGAATGCGNTGAAGAACGTATTTTCTTCAAGAAACACGGGTTTGGACTTTCGTTGCGGAATCGGTTCAGTTAAATCGAATATAGGACATGCGGCTGCAGCTGCGGGTGTGATCGGTCTGGTCAAGGTCTTATTATGCATGCAACACCGTCAGTTACCAGGGCTGGTGCATTTTAACAAACTCAACCCTCTAATCGATTTTAACGACACAGGTTTGTACATCGTTGAGCAATTGCAAAACTGGGAGCCAGCGTCTGGTGAGCCGTTGATGGCAGGCATCAACTCGTTCGGCCATAGCGGCACCAATGCCCATCTCGTGATTCAGGAACCCCCTGTGCGACCTGTCCGCGACAGCGAGAACCCATTCCATTTAATCTGTCTATCTGCCAAAACAGAGGAAGCGCTTAAACAAAAAATTAGCGATTTGAGTGCATATCTAAGGCGCAAAGAAGAGCCGCCAACTCTAGGAGCCATCAGTTATACCTTGAATACCGGCCGTGCTCACTTTAGAAAACGCTGCGCTTTCGTCGTGGATTCGCTGGAGGCTTTGCAAAATGCTCTCATGGGAGCTTTAGATGGTCTTGTTGGCAATGCAGAAAGGTTAAGTCCACAAGAACAGGCATTTTGTAAAAAAGCATTTGATTTGATTATCAAGGATTTACACGATGTAGAGAATCTTGAAAGTAGGGCTGATCAAACAATCTATAAAGATAACCTACTGGCTCTGACCGGACTTTATCTAAAAGGTTTTGACCTAGACTGGCAACGGGTGTACAAAGGTCAGAGCTATCACCGGGTATCCCTGCCGACATATCCTTTTTCCAGAGATACATACTGGATTGACGAGCCAAAACAAATTAGCTTCACCGAGCCTGGTACCGACAAGCCTGGAAACACCAGCAGGAATCATCAGCAGGATCAAAAAGATGAGGATGTGTTGGGTGGACAGTTTTATATACCGCAGTGGAAACGGCTTGATCAAACACAATCCTATGCCAGTTTAAGCGATCATGGGAAGTTGACCATCGCATCTGACCCTGTTGTCATTTTTTATCCGCCGACCATGACAAGTTTAAAAGATGATATTCAAACATGCTATGAGCAATTACCGGCAAGCCAAGTCGCTAGCTTCGAGCTTGGCTGCACACCTTCGTCTGAGGTCGATGTTCGCGATCCCCGTGCCTTTGAACGCATCTTTGTATCCCCTAGGCAGGCATTGGAAGAGCTGCTTGAGCAAGGTCGAACGTTAACGATCTACTTTATCCTGCCTGAACCGGATCAAAACCCGGACTCAGGGTGCAACCTCGAATGCCTTGAGGAATCCCTGTCACTCGGGCTGATCTCGTTGTTCCGTTTGATACAAGCGCTGTTGGCCCATCACGGCTATGCCAGCGAGCTGACCCTCAAAATCGTGACCCAGCAAACCCAGGTCTGTAAAGCTTCTGAGCGCATTGTGCCCTATGGCGCAGATGTGGTGGGTTTTGTGCAGTCGTTAGCGAAGGAATACGAGCTCTGGCAAATCAGTTGCGTGGATATTAATCGGCAGACATGGTGGACGCCCGCGCAAAGCAAAAACTTTGCCGAGGCGCTGATTGCCCTGAAGCCACCGGCGGACGGGCGCGCTCTATGTTGGCGGGACGGGTATGTTTATCACCGTGTTTTAACCCCGGCTAATCTCGTTGGCGTTCAGGGAAGTGCATTCAAGACGCGCGGTGTCTACCTAATTATTGGTGGCGCTGGAGGGTTGGGATTGGTGCTCAGCCAGTATCTGCTTGAACACGTGCAAGCGAAACTGGTATGGGTGGGGCGGCGCAGCCTCGAGGCGTTGGCGCCGGATGCGTTGCGGTTATTCAACACTCCGGGCGCCCACGTGCTATACGAGCAAGCGGATCTGTGTGATCCGGAAGCGCTGCAGCGCGCGCTGCAGCAAGCCAAAGGACGTTTTGGATACATTGATGGTGTCATCCATTCGGCTTTGATTCTAGAGGACCGAGCGATCGCCGACATGGATGAGAAAACGCTACGCAAAGTTCTCGCGCCCAAAGTACAGGGCAACGTGGTACTCCAGCAAGTGCTGGCCGATGAGCCTTTAGATTTTCTGTTGTATTTCTCCGCCGGACAGTCTTTTATGAGTCATGCTGGGCAGAGCAATTACGCCGCTGCCTGTACCTTTGAAGATGCCTGGGCGCTGTGCCAGGACCAGCGGCAAAACTATCCGATCAAAATTATCAACTGGGGCTATTGGGGCGAGGTGGGCATTGTCGCCACGGCTGACTACCGTAAACAAATGGCCAGGCAAGGCGTGCTATCGATTCATCCGCAAGAGGGCATGGAAGCGGTAGAGCGTTGTCTGGCGTCGTGCGCCACCCAGGCCGCTTATTTTAAAGTGGAACCCCGCGCCTTGAGCCGATTGGGCTTGGACGGCACTGGAATCTTGCATGCGAGCCGGAACCGTGTTCCACCTCAATTGATTCATGTCGTGATTGATGCCACCCAGGCGTGGTCAATCTCGATGCCGTACGCACAGCGCTATCAACAATCCCTTAAAAAGTTGGATCGGCTTGGTTGCTATCTCCTTCTGCGTGTATTCCAGGCTATGGGAGTGTTTAGTCAGCCTCATGAACACTATGAAAAACAGGAATTGGCCAGTAGATTAGCCATTTCAAAAGGCTATCATCACCTCTATCAAGAATGCTTGAACTTGCTAGATACGTCCGGTTTTATTGCAATCAATGGTTCGCACATTGAAGTCCAAGACGTGCTACCGGAAGAACATGACGAACACCACAGCTGGTTACAACCCTATCCCGAATTGGCCGCGCATGAAAAATTGTTGCGCATCTGCCTACAAGCTTTTCCGGATATCATCCGGGGATCGGTTGCCGCGACGGATATCATATTTCCGGATGCGTCTGTGGAATTGGTAGAAGGTATTTATCAGGGCAATCCCGCCACCGATGCGCTGAATACCAAAGCGAAAGATGCTGTGGTTGCCTACGTCAAAGCCCGCCTGGCAGACTGTCAGGAACAAATCATCTTTTTAGAAGTCGGAGCGGGAACCGGCGGCATGAGTCATGAGGTGTTGAAGGGGCTGGCCCCCTATGGGCAGTATATCGAGTATTATTACACCGATGTCTCCGAGCATTTTATCCAGTACGCTCGCCGCCGTTATGGTCAGGATTACCCCTTTGTCCGGTTTCAACGTTTAGACATTGAACAGGAGCATAGCGCGCTAAGTGAGGGGCTGCTCAGTGCCTGCGATGTCGTATTAGCCGCGAATGTTCTGCACGCCACCCAAAGCGTTCGCAATACCATCCAGCATGTCAAAGCCCTGCTAAAACGGCACGGCTTGTTAATCTTAAACGAAGCTACGACTTTGGAAAGCTTTGCCACATTGACATTCGGATTGTTAGAGGGCTGGTGGCGCTACCAGGATGCCGGAGACCGCCTACCTGGCGGGCCTTTGTTAAGCGCGTCCATGTGGCATCGCTTGCTCGAAGAAGAAGGTTTTGACCAGGTGGTGTCCCTGGGTGAGCCAGGCGAAGGCGACATGTTGGGACAGCATCTCATTGTCGGTCGAAGTGATGGCTGGAGCTTGCATCAATCTGCGAGGGACGATGAAACCCGTTCGGCCCCTGTTAGCCCTGTGGCGGCGAGCGACGTTATCCAAGGCAATCGAAATGACAAGCCCGCAGAGCTTATCAAACACGTTGAAGCGCAGATTGTGCAAACCCTTTCAGCCGCACTGGATATTGCTGCGGCTCGAGTGGAACGCGATGTGTCGTTTTCCGAGTATGGGGTGGATTCGATTCTGTCCGTTGCGATTATTAACCAATTAAACCAGCGCCTAGGGATTCGTCTGAAACGTCCGGATTTGTTTAATTACACCACCACAGAAAGCATGGCGGCGCATATTGTCGCAACCTTTGCTGACCACTTGACGGCGGCCTTAGTCGAAGAAGCTGAACCACCAACGCCAGTAACCGTAGCAAGTCCTCAACCGATAAAAGCGGCGGGGCAGCAGGATGTTCTTCAGCAAAACTTGCAAACCCAGCCTCAAGTCTCGCAAGGCGTTTGGCAAACCAAGCCGGAACCCATTGCTGTCATCGGCATGTCTGCCTGCGTGCCAGGGGCGGATCATGTGGGTGCGTTTTGGGACAACTTGGTTGCCGGCACAGATTCCGTCACCCGGATTCCCCATGAGCGTTGGCAGCGGGAGGCCGTCAATGAGCTGCCCGGCGGGCCGGATACCTCCCAGCGCAAAGCCGGATTTATGGACAATATTGCCGAATTTGACCCGCTTTTTTTTGCCATCTCTCCGCAAGAGGCGCAGTGGATGGACCCGACGCAGCGGCTGTTCTTACAGCAGGCTTGGGCCGCGTTGGAAGATGCCGGATACAATCCGCGAGCCTTAGCCGGCGCTTCATGTGCGGTGATGGTTGGCTGTGCGGCGACTGGCTATGGTGTGAAAGAGGGCGAGCGCACGGGGTATGTGTCCTATGCTATGACCAATAGCGAGGCCATCTTACCCGCGAGAATCTCCTATTTTCTCGACTTAAAAGGCCCGAGTATTCCCATTAACACCGCCTGCTCTTCGTCTTTAGTGGCGATTCATCTGGCCTGCGAACAACTTCGCTCCGGGCAAAGCGACATGGCGTTGGCTGGCGGTGCTTCCGCACTGATTGGTTCCGCGTTGCACATCGGACTCAATGGCGTTGGGATGCTATCTCCCGAGGGCGCATGCAAAGCATTTGATAAGGAGGCCAATGGCTTTGTGCTTGGCGAAGCGGTTGGCGTTGTCGTTCTCAAACCGTTGTCCAAGGCCGTGGCTGATGGCGATTCGATACATGGTTTAATTATTGGCTCGGCGATTAACCAGGACGGCAAAACCAATGGTATCATGGCGCCGAACGGTCCGTCTCAGACGGCATTAATTGAATCGGTGTACCGGAAATTCGAGATCGATCCTAAAACGATTAGCTATATCGAAACCCATGGCACCGGCACCCAACTCGGCGACCCAATAGAAGTCAACGCCTTGGCTGCTGCCTATGAAAATTTCACCACCTCGCAAACTCAGTACTGCGCCATCGGATCGGTAAAAACCAATATTGGTCACACCACCACTGCTGCCGGTGTCTGTGGATTGATTAAGACTTTATTATGTCTCAAACACCAAAAACTTGTCCCATCCCTGCACTATAAGGAGCCCAACGAAAATATTGAGTTTGAAAAGACGCCGTTTTACGTCAATACCCAGGTCAAAGATTGGCCGGGTCATCAAAACGGTGTCCGGCGTGCGGCGGTGAGTTCCTTTGGCTACAGTGGCACCAATGCGTATATGGTGGTGGAAGCGTTCGTGGAGACGAGCCCGCGCGCGGTCGGGCAGCAGGGACCTGCATTAATTGTCTTGTCGGCTAGGCATGAGGTGCGACTCAAAGAGCTGGCCAGCAATCTCATGGCCTATTTGAAGCGGTATGGCTTGAATCCGGATCGCCCGATTCAGCTCGAAGATATGGCGTATACGCTTCAGGTTGGCAGACAGGCCATGTCAGAGCGTCTGGCGTTTGTGGCGGACAGCGTGGCGGATGTCGTCAAACATTTAGCCACATTTGTTGACGGCGAGGCCAATGCCCAGGAACTTTACCGGGGGCAAGTTAAACCGTTCGGCGATAAGAGCGATTTGCTTTTGGAGGGCGAGGCGGGTCAGGCTTTTCTCAACACGATTTTAAGACAGCAGGATTACCGCAAATTAGCCGCCCTGTGGGTGGCGGGTACAGACTTGGACTGGAATTTACTCTACGACGGTGAAAACCGTGCCCGTCGCATTTCGCTACCGACCTATCCTTTTGCTAGGGAAACGTATTGGTTGGATGAGGGGATAGGGAGCAATGAAAAAGAGCTTCTAAGAGATCAGACTCAAAAAGAGTTACGTGATCGTGATCGTGAGCAAACTACGGAACTCATGACATTTGAAGAGATATGGCAGGAGGCGTCCTTAAACAATCATTCGGATTCCATCAAGTATAAAAGCATCGTTTGTTTTCTTTCCGGATCAGAACATCAGCAAGAAATGCGAACTGCCATGCAGGCGATTGATCCGGCTATCCATCTTACGATGATTGCTCAAGGCCATGGTTACACAAAGCACTCATCTGATCGTTACACAGTAGACCCCGCCGATATACAGAGCTTTCGTGAAGCTTTCCTCGATATCAGCCAGACTCATGGCGAGGTCGACGCGCTGCTTTATCTATGGCCAACCGAGGATTGGCGTCTCTTGTATGATCCATCCGCCGTCGTTTATATGTTGCAGGCTCTGGTCAAGAGTGAGCTAAAACCTTCCCGCTGCTTGCTGGTTGCTGCTTTTTCCACTGCTTTGGAGCGTTGTTACCTGGAATCCTGGATTGGCTTCGAGCGCTCGTTAAAGCTCATCATGCCTGGTTTCCAGGTCGCGGGACTGTTTCAGGAACATGCGGGGCCGGACCAGACGATTTCAATGACACATTGGAGTCAACACATTGTCTCTGAACTCAAAGCGCCTAAAGCACAGACGGTGCTGATACAAAATCACCGGCGCTACGTCAATCAGATTCAAAAAACCGAACTGGCCGCGCAAGGCGCTTCGGTTGCATCGGCCGTCAAACAGGGCGGTACTTACCTGATTACCGGTGGCTGTGGGGGATTAGGTTTTTTGGTCGCCCAGCACCTGGCAGAACACCTTGGGCAACCGGCAGCCTCAGCCTCGGGAAAAACGGTGCATTTAATTCTGACGGGTCGATCATCTCCCGATGACGCGATACAAAGCAAAATCACGCAACTGGAAGCATTAGGGGCAAAGGTTGGTTACGTTCAAGCGGATGTTGCCGATGCAGTCGCCATGAGACGTGGCCTTGCCCAGATGAAAAATCGCTTTGGCGACATACACGGTATTTTTCATATCGCTGGGATCGCCCCCAGCGAGAGTCTCCTCAATAAAGATATCGACGCCTTTCAAAACGTACTGGGGCCTAAAATTGCGGGCACGTTGATGCTTGACGATCTCTGTCGTGATGAACCGCTTGATGTTATCTGTTATTTTTCCTCCTCTGCCGCGATTTTAGGGGATTTTGGCGCCTGTGACTACGCGATTGGCAATCGTTTTCAGATGGCTTATGCCGCTTATCGCAACCATCTGCTGCAGCAGGGGATGCGACAGGGTAAGGCGTTGGTGATTAATTGGCCGCTTTGGCAAGAAGGCGGCATGGGGTTTCATCAAGACGAAAATACCAAGATGTACTTGAGCTCCAGCGGGCAGCGGGTTCTGGAAACTCAGGAAGCCTTGACGGTATTGGATCACGTCCTTAACCAGGACAAAACACAGCATTTGGTCCTGGTGGGGCAGCCAGGTCGGGTGTATGGCTTTTTAGGGTTGACTGAGGCGCCTATGACTCAGATGCCAGTGACTGAAGCGCCAGTGACGCAGACATCCACACGGCCAGAGTTGAGAGGCTTGAGTACGGAGCAGTCGGTATTATGGGATTTAAGAAATCTCATCGTCCAGCAACTCAAAGTGCCCTGGGAGCAGCTTGGGCGAGATCACAATCTCGCTGATTTCGGTTTTGATTCAATAAGCTTGTTGAGTTTTGCCAATCGTCTCAGCGAGCATTATCAACTTGACATTACACCTGCCTTGTTTTTTGGGTATTCGACTCTAGAGCAACTCACGCAGTACTTTTTAAGCGAGCATTGCGATTTTATCAACGCCTTTTATAAGGAACCCGAAAAATCGGAAATCCCTGTAAAAAAGGAAGCCGTTGAAGAGCGTGCTCCTATCCGGATTGTTTCTGAAGAAACCCGCCCAGAAAAAATAGATAATGCAAAAGATGAGCCCATTGCCATTATTGGCATGAGTGGCAGATTTCCCAAAGCTTACGATGTTGAACAAATGTGGCAGCTCTTGGCATCGGGTGAATGTGCGGTAGAAGAAATTTCACCACATTACTTTGATTGGCGCAGATACTTTGGAGAGCCGAGCCAGGAGGCTAACAAAACCAATGGAAAATGGTGTGCTAATATTCCTGGCGTTGCCGAATTCGACCCCCTGTTTTTCCAAATTTCCCCGAGAGAAGCGCCAAACATTGATCCTCGTCAACGGCACTTATTGCAAGAGTCTTGGAATGCTTTAGAACATGCCGGATACGGGCCGCATCAACTGAATAGCCAGAAGATCGGCACCTTTGTCGGGGCTGAAGAAGGGGATTATTATCAACGTGTCAAAGAGGGCAACATCACCTCCAATCACTCGGGCATTCTCGCCGCTCGTCTGGCCTATTTCTTAAACTTAAAAGGCCCGACCATGGCGATTAATACCGCGTGTTCCTCCTCACTGGTCGCGGCTCATCAGGCTTGTCTGAGTTTACGGCAGGGGGAATGTGATACGGCCATCGCGGCAGGGGTCAATCTAATGCTCACCCCTTACGGATATATCAGTATGGGCCGAGCAGGTATGCTCTCTGAGGATGGCCACTGTTATGCCTTTGATGAACGCGCCAATGGCTTAGTACCAGGTGAAGCCGTGGTCGTCGTGGTATTAAAGCGCCTTAGCCGAGCGCTTGCTGACGGTGATCCTATTCACGCGTTGATCTTGGCTAGCGGTGTTAACTATGATGGCAAAACCAATGGTATCACTGCACCAAATGGTGTTTCGCAGGCCGAGTTGGTGAGGGAGGTTCACCAACGAGCCGGGGTTCATCCGCAGGATATTGATTATATTGTGACACACGGTACGGGTACCCGGCTAGGTGACCCCGTGGAGGTCAACGCCCTTAACGAAGTCTTTAGGGACAGCCAACACCTTTGTGCGATTACATCCAGTAAAACCAATTTTGGCCATACGTTTTCCGCTTCGGGGCTGCTCAGTCTTGTCAATCTGGTACAGGCGCTTCGTCATGAGACCATTCCGAAAAGCCTGCATTTTGCTCAGCCAAACAAATTTATGACATGGGATCAAGGCCCTCTCTATGTCAATACGGCCAATAAGCCCTGGCTCGAAAAGCCGGGCGAAAAACGCATTGGCGGGGTGAGTGCGTTTGGAATGAGTGGCACCAATGCCCATATGCTGATTCAAGACTACCAGCTTCACAGAAAAGAACCACGTGCGGTCCCGCCTTATGCGCTGCTTGTGTTGTCTGCAAAAACGGCAGAGGCACTGCATCTCAAGGTCAAAGCCATGGTCGCGTTTTTGCAAGAAGGGCTTGCAGACACTGCCACCCTAGCGGATATCAGTTATACATTGTTTGAAGGCCGACACCACCTTCAATACCGTTTGGCTATTGTGGTGCAGGATATGACTGAGGCCATGTGTTGTTGGACACAAGCCGGGCAGCCAGATAAGAAACCCAATATTTTTCAGGGAAAAGTGCCTACCGAATTTAGTGGTCAAAAGGTCACACAGAATTATATTAACCAATTAGTAGAACAGCTTGATCGCTCTACCGGCGATGATGACGTATACCGAGAACGTCTCTTGGGTTTAGCTGATTTTTATTGTCAGGGGTATGATGTCCCTTGGTCTAGGCTATACGGTGATACACGGCCACGCCGTATAAGTCTGCCTGGGTATCCGTTTGCTAAACAACAATTTTGGCTGGATTTCTCTCCGAAGGATCATGGCGAACAAGAAAATGTCGAACTTCCTATTGGCAAGATGCAGAGACAAGTTCTAAATGAAAAAAACACGCTTGAAACATTAAGCTACATTCACAAATGGGAACAGCAGGATAAAGCTGAAGTCAAGATAGAAATCAGCCAGGTTTGCTTACTAGTTTACTTTGAATCTGCATCGCAATTTGAAAAAACGCTGGCAAGCTTCTTCTTGCAGCAGGGTGCATCTCAGGTGATCGAGATTCAATTGGGACTCGAAACCAAACCGGTGTCCGAACATAAATGGCGCTGCAATGTCAATGACGTCGACGCTTTTCAGCGTTGCCTTCAAGCCTATGCACAGACAATCAATAGCGTTTACTTTCTCTGTGTCGATACCCTCCAGCAGGGCATGGAAGAAAGCGAAATGCAGTTGCTACGGCTGGTCAAAGCCTTAAAATCACGTATGCAGAGCCATGCCTTTATCGATTTCACCCTTCTGACTCTGGATAATCACCGCGTCGATAACAGCGCGACAAGTCCCAACCACGGGGGGCTTAGCGGTCTTGGGTACTCGGTGGCGCAGAGCGATCACCGCTTCCGGGTTCGAAATATCGATTTGTCGCGGGAAGATCTGGTGAGCGCCGAACAACAATGCACCCTGCCAGGCATGATCGTCAGCGAAGCCCCGTCGGACCGAGGCGAGGTGGTCAAGTTGCAGGCAGGTTTGCGCTACAAGCAGCGCTTTTTCAAGCTCGACTGGCAGACGCTGCAAGCGGCACAGCCAGAGGCGGCGGGTTTGAAAACCGGTGGGGTCTATGTGTTGTTGGGTGGCGCGGGAACCGTTGGTGCGATTATAACCCGCTATCTCATCCAAAAATATCAGGCCAATGTGGTTTGGCTGGGGCGTCGTGCGCTGACATCGCCTGCCGTGCAGGAACAACTACACGCGTTCCGGAGCGTGGACGAAGGGTGTGTGCCACTCTATATTCAGGCCGATGTGACGGATCAGGCTTCCATGACTCAAGCGGTCAAAGAGATCAAGCAACATCACCCTTGCATCCATGGCGCGATTTTCTCCGCACTGGTCTTTAAGTTGGATAACTCAATTGCTAAGACTAGCGAGGAAGACTTTAATGAGGTTTTGGATACCAAGAAAAAGGGTGCGCAGTATTTTTATCATGCATTCAAAGATGAAAACTTAGATTTTATGTGTTATTTCTCGTCGGTCCAATCTTTTTTCTTTATCTCCTCTCGAGAGAGTGCAGGGTATGCAACCGGTATTACCAGCGCTGACACCTTTGTACATGCCATCGATCACGATAGCACCTTTCCTGTCGGTATCATCAATTGGGGTTACTGGGAGGCCTCTCTGGCGGGAACCGAAGCCGAGAAGCGTTTGCCCGGTCATTATGACTTAATCTCTGATCATGATGGATGTCAGTTTTTTGACGGATTTGTACCTATGCTTAGATCAGGCCTTATCAAACAGGCCGTTTGTTTAGGTGTGTCAAAAGCGATAGAGGATTTCATGGGCTGTGACGCCACGCAGATGATCACGGTGAACAAGCTTGAGGCTGATTCTTTGATTTTTAGCCTTTTTAATGAAAATGAGTGCGGCCAAGCTACGTGTGAGGAAACTGAAATCGAGCGCCTTTTGGATAAAGATTTCAACAATGAACTTAAGCAATGGTTGCCGCGGCTGCTATTTTCACAGCTGCAACAACTGGGGATCTTTTTAAATCGTGGTGAGCAGAGAGATTGTACGACGTGGCAACAACAAGCTGGTGTGATCAAAAAATATGAACGCTGGTGGCGAGAGTGTTGCTTAGGGCTGCTGGAGACCTCCGGCTACGTACAATGTGAAGGTGAGAGGGTTGAGGTCACTCACCATAGTCCGGCAGACGAGGCGGATCAACTCTGGCAAGGCTGGGAGAGCTTCCAAAATTTATTCCTCGACAAGCCGGAAAGAAAACCTGTGCTCGACTTATTGGAGAGCTGTCTGAGAAGCCTGACGCAAATCCTGTGCGGTGACATCCTGGCCACCGATATTCTTTTTCCAAAATCGTCAATGGAAAAAGTAGAAAATATATACCAGCGGAATGCCCTATCCGACTATTGTAATACCTTTGTCGCGAAAGGTATCGAAGCTTACATTCATCAGCGGATTCAGGCAGAGCCTCAGGCAAGGATCCGGATATTGGAAGTCGGTGCAGGTACTGGAGGTACCACCGCATTGGTCCTGCCACAACTGCGTCAGGTGCAGCATGCGATAGACGAGTATTGTTATACAGACATTTCCAAAGCCTTCTTGATACATGCAGAAAAGACTTATGGGCCGGATTATAACTATCTAGATTATAAGCTACTCAATCTCGAACAACCGTTAGCGCCACAAGGAATAGAGCCTGGCTCCTATGATATGGTAATCGCTACCAACGTGTTGCACGCTACAGAGAATATCAGACAAACCCTTCGCCATACTAAAACTGCTCTAAAACGTCATGGATTATTAGTGATCAATGAAGTGGTTGAGAAATCTATTGTCGGTATCTTAACCTTCGGGTTGTTAGACGGCTGGTGGCTCTACCAAGACGAATCATTACGCATCCCAGGCTCTCCGCTGATCACGCTGGATACCTGGCGTAAAATTTTAAAAGAAGAGGGCTTTGCCAGGGTCTTGTTGCCAATGCGAGCCGCATCTAAGTTGGGTCAGCAAGTGATGGTGGCGGAAAGTGACGGTCTGGTTAGACGGGAGAGAGAAGACTTGCCGGACGAGGACGAATCGGCTGTGACTGATAAAACGTCCGTGGTACAGGGCATGACTTTGACTCCGGAACAGCGAATTGCGCAAACACCGTCTGTACGGGAGCTGTCGTCCGAAACACTACGAGAACAGGTTGCCGAGCTTATTTTGACAGGATTGGCCGAAACATTAGGCATGGCGCAAGAAAATATTGACCCACTAGTTTCATTTTCTGACTATGGTATTGATTCTATTCTTGGTGTCGGTTTTATTGGTCAGCTTACTAAATCCTTCGGCATCACCATCAATACCGCTATATTGTATGATTATACCAATGTAGTGCGTCTTAGTGATTATCTGGTAGAAATCTATGCAGAGGACATACAAAACAAAATTCAAAACAACCGCATGTCTCCAGTTGAGAAAGATGCTGTTCTATATACAGAGACACAACTAGAAACAACAGTCGATCGTAATCCGGAAAAAAGTCAGCTTGAAAACTCAGTTCCTAATATGACCTCTGGCGAGAATAAGTCCGCCAAATGCCAGGAGATCGCTGTTATTGGTATGTCAGGGCAGTTCCCTAGAGCAAAAGACCTTGACGCCTTCTGGCAAAATCTGATTCAGGGACGGGATGGTGTTGTAGAGCTACCCGCGAATTATCTCAATCCGGCTTTGTTTAGCCCGCACAAACAAGCGGGAACAACCGATTGTAAATGGGGTGGCATTTTAGAGCAGCGTGATTGTTTTGACCCACTTTTTTTCAACCTTACGCCCAGGGAAGCGGAGTCGATGAACCCGCATCAGCGTCTCATTCTGAGTGAGAGCTGGAAAGCGCTGGAAGATGCCGGCTACAATCCCAAAGAGCTGGATAATACTCGCGTTAGCGTGTTTATTGGCGCGGAACCTACCGACTATTACCATGAAACCTTTACCGGCTCTTCTGATGCTATTGTTGCCTCCCGCTTATCCTACTACCTCAACCTCAAGGGACCGGCTTTGGTGGTCAATACGGGTTGTTCGTCTTCTGCTTTGGCGATTCACTTGGCCTGCGAAAGTTTACGCCGTGGCGAGTCTTCAATGGCCCTGACAGGTGGCATTTTTGCTGCAATGCATGAAGAAGCACTGGTTAAACTAGCCCAGATTGATATGCTTAGTGCCACCGGTCGCTGCCGTACATTTGATCAATTCTGCGATGGTACCGTATTGTCTGAAGGTGTTGGGGTGGTTGTGTTAAAACGGCTTGACGATGCCGTCAGGGACAACGACCCCATCTATGGCGTGATTCAAGCCTCTGGGGCAAATCAGGACGGTGCCAGCAATGGGATAACTGCGCCTAGTGGTTTGTCGCAGGAAGAACTCCTGACGTCTGTCTACCGGCAATATGACATCAATCCGGAAACGATCACGTATATTGAAGCTCATGGAACTGGTACCTCACTTGGAGATACCGTTGAGGCTAATGCGTTAAAGCGGGCCTTTAAACAGTTTACGGATAAAAAACAATTCTGTGCACTTGGCAGCGCAAAATCTCATATCGGCCATACAGGAGCTGCTGCTGGCGTTATTGGTTTAATCAAAGTTTTGTTGTCGATGCGCTATCATCAGCTGCCTAAACTGTTGCACTTCGAAGAACTCAATCCATCAATCGAATTGGAAGATTCTGCATTTTATATCAATCAACAGCAAATGGAATGGACGGGGCAGGGCGTGCCATTAACCGCAGGGCTGAATTCTTTTGGCCACAGTGGTACGAACGTTCACCTCGTGGTTCGGGAATACCTGCCGTTATCTGAGACGAAAGCCGAAATGGAGGCTGTACTGATTCCATTGTCTGCCAAAACCCTCGAATCCCTTAGAACCTATGCTGAAAGTTTATCGACGTTTCTGGAAAATGGGCATTCTGGTCATGGTGTTAGCCTCACCGATTTAGCCTTTACCCTCCAGCTTGGACGCGAAGCGATGCGGGAGCGCTGTATTTTCTTGGCTGGAAATGTCCCGGATTTGGTAGCCCAATTAAAGGCTTTTGCGAATGACAAGACGCTCAACAATGTGGGTTGGTACGGCCGGGTTGGACGCAGCAAGAACAGCCATTCCTTCAATGATCATGAGTCTCGGCAAATGATCACTCAATGGTTGCAACAAGGAAAATTGGATAAAATTGCCGCCGCTTGGGTACAGGGCCTGAGCATTGACTGGGCAGCCCTTTATCGCGAGCTCACAGCTCGTAAAATCCATGCGCCAACCTATCCTTTTGCCCAGGAACATTATTGGAAACCCGAACAGCAGAGTATGGTTCAGAAGCCCGTTGCGCCGGAAACACAGCCTGAGACCTTCGGAACACTGATGTTGCAGCCCTGTTGGATAGATCAACCCCTTGAACATTCATAA", "orf_prot_sequence": "MLRTGMKTDSPNHPENQAINVNHYLMVLSAKTKERLQTVVENLLDYAKANRRLIESRLADVAFTLQTGREEMEARLAFVVSDYHDLMGQLSGYLEDAPNANTIFRGQVDLFDQSAPVRQHRAAQERDCERMIRTHDLPGLAELFVQGVPIDWRRLYVQGRPRRIALPSYPFAPERHWVARREPDHLAADMPAVRQPHSLLDGRDDRMSLESGVVFRKLLRINDGVLQDHQVNETPVFPGVAYIEMACEALAQLSFSDPEVLRKTVLNQMVWLQALAVTEAEHEILLCLEKDTHGLAFEVKDHQTLYAKGRFDQSDDLSQGHQYLELETIKGDCPHEKHRSVIYHDFRLLGLNYGPWFQGLEHTWFSIDSAEGEGEALGYFNMPLICESEFSAYTFHPGLLDAALQVVASVPGYADSGLLLPYAVEKLEWFHPFPACGYSHVRKLAKHRYDVTICDEQGKVCAKFSDLSVRPSRVAGSEPSLNQLTYRARWSHQELGERRSPAGRPEETGVVFIIHTPEQQALVQELSSVLADMHGDHRVRRMCLNANDWDFKSLGNWNHRIRAVQDLRDIYFLAAMEHTVSSGQAHVDPLSFTNRQEHGLLSLFRLLKALDQNQLLLQPLSLKVLTTGNYRVLPSDTICPLSAGLPGFCRSIAQEYPLLALSCIDLGCPDGDAMQPSSLKKLAQFIVAEPAHQPHETVGIRELRRYTRKLVPVRFPEPGGQRAFKSRGVYMIVGGAGGIGMVLAQYLAERVQARLVLVGRSALDEEKKQNLSTLTAAGGEALYIQADISRLYSMKDAVAQARQRFGNINGVVHSAMVLNDQSLARMSEEGLRASLAPKVEGCIVLQQAMAGEPLDFMLFFSSAISFSGNAGQSNYAAASTFKDAFAHYLTQVEAYPVFNINWGYWGCVGVVANAAYRERWAARGVHSIDPEQGLQVIESILTNHIDQVAAVNVEPSFLERLGVELSQTQTVLPPRRSSLIAKLNALPLPETGGFQDNVNRLEIVSAFRWAEVFKHMLDMSSTQGMYARSDLKRQLQISSEHDQLFDVLISMLIQEGYLHQQGKNLTPTPYLNGEFFQQQREQVALLESELSQTDNAYLNLLSRCLDHYPAMLRGEVAATDVIFPQGSMEWVEGIYRSHASADYFNQQLAQRLVAYVEARLPSLGANESIHILEIGAGTGGTSAIVLQALQPYAARLRYTYSDISPGFLNYGRKTFGDAYPFVEFRHLNIEHNGEAQGYQAGEYDLVLAANVLHATRHIGNTLARVKFFMKRHGWLLLNEATQVRHFGTLTFGLLKGWWLFQDAENRLDGSPLLSTTAWQRLLSEEGFKHTLSLCDAVEEESIFQDVIVAESDGVIQMNQSDSPVQPREPVDVSVDVHHVDDMMEPGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVDSITGVDFIHQINSRLGIVLRTTALFDHATIFDLSRFIDESHGAAIDEQRQRLRSTPLTSSDTKPAERVAPPDEALPHIERGCHQAVVLEKPSQIEHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLLCVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGHSTLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGEKVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIAMVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQLISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPDGMMDNQVGQRMVPESSTVEDYRVGNATVEQVAVKQPADMDEPIAVVGMSGRFPGANNLEQFWLNLIGGNNAITEVPADRWDVHQWYDPDPAVLDKTHCRWGGFLRDIDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSVPGEPQSFWGNSSSLIASRIAYFLNLKGPSITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGIIRGSGSNQDGRTYGITAPSAASQTELEQSVYRQAELDPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFIKVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPRRAAVSSFGFSGTNAHILLEEYQHHEDEAQALGDDKDVLIVLSAKNQERLKKAAENLHHFLESRVSYKLSDIAYTLQVGREAMEARVAFMVVSVLDLQQKLVSLLHDPTDEQDMYWGEVRDGEGPAGVAAFEDVALALANKQLDQLAQWWVSGVEIDWTQLARVVKVRLVPLPTYPFSPDRYWFDSVGPATVVHAEHSASALYPLLNRIAPQASTQIANGCVFETCLKSSDPLLAQHLIDGQAVFPAVGFLEMVIAGLREIQPDKAARLENVFWLRPLDVMDEQRVHLVFEVKQDRFQYRIVPAESHGDGAYFRGQGYWSNDMNPAIPMDIDRLKSRMRQQPLLNESSPRVRLGRLYQGATEGWTDGEQALIAFELPTAQPYRDGSPDQKSYPFHPAAFVAALQAYHWIHEAPKRLGMPFAVQKVELWRHRDQPAYAYVALDEHGNADVHILDAGGQVCVCYRGMALQTLNNAHHDGRQESTQKDELGKLLFVPVWKRLDTKHGRAHGMHALARGTGVLLVYTHENGVEAEQLMQRYREEQCELLSVCLSAADRALDTLAARLKHLQSPLRHVCFLDRHQAALDPADKQIDERLREPQTLTGFLALVRTLSELGYDEQPLQWLVLTSSACAVNQADPINPYAAAIVGLASCLAQEHRYWQVSVCDRGKGTSFTTIANHGETLRVIAERSGYSYVRHIKELELPPPRQSRLRHKGVYVLVGGAGYVGTLLSRYLVQTYQAKVIWLGRREQDEQIEQNIALIATLGSRPQYLSLKTGSDDELHRAFAQIKAENGLIHGVFNLVMVAQSTPMRSLSEAQFRAGSFNSKVNSAQALYRILKKEALDFMVFFSSMQSFAQQLNFMSANMSSYVAGCMFQDAFVHQINCELSYPVKTINWGYWSQESSESEKAKWYETYIADKGIYSLNVGEAMQALEYILAHEPEQVIVTKVSHRVLSDMGFVQDDSENVDLQPVIDSNDDNTQLEDLIVNGILKTFETLDVLQVFDSACNLDVSRLQAHVPDKYRRLWRELLLILVQAGKMAPQGAGFALRESYTSLASQLRLMDLDREAGLLRERHPTLASKLALLVPCLKDMAEVLTARKPATEVLFEHASLSRVEGIYRGNPTTDYFNQRVADIVKAAVQQALPSLSVGKKVRILEIGAGTGGTSAYLFQALNTYADQLHYIYTDISKRFLIHADETFCEQYSFIETKLLNIEQDVAGQGFDPASIDIVVAANVLHATRNISKTLQHVKDLLKNDGLLVLNELADVSPFLTVTFGLLDGWWLYDDEAIRQPGSPGLSAKNWQLVLKNQRFHNISLNDEKALTSEQQIIIAQNESKESVPVSSTVLLGTELIASVEASLIAQLSQCIKIEQNRLNTYTTFSDYGVDSILMLAYVDQINGDLGIDLNPSELFNYTTVERLTKFIVDYHGKEIISAKESVERSLLQNQESKFDLNDIDVITKAGNEAPEMARSLLFDNVLQVPSGNVHHHQSDKARPDIAVIGMSGQFPGATNVQQFWQNLSAGVDSVSELPESRLDRQLYSPQPEAGKCYCQWGGILEEQASFDPLFFEISPKEAAEMNPSQRVFMQEAYRALEDAGLVNAGLSQLHCGIYVGCEPNGYTKQGFTGASEAIVASRISYFLNLQGPALVINSGCSSSLVAIHLACESLRHGENDIALAGGVFTNLNNELLVCLSSIEMLSFSGKCHAFDEAANGTVLCEGVSVLVLKRLQDALDDGDVIYGVIKGSGMNQDGRSNGITAPNGLAQENLIKRIYQDYNIDASKISYIEAHGTGTKLGDPVEANAXKNVFSSRNTGLDFRCGIGSVKSNIGHAAAAAGVIGLVKVLLCMQHRQLPGLVHFNKLNPLIDFNDTGLYIVEQLQNWEPASGEPLMAGINSFGHSGTNAHLVIQEPPVRPVRDSENPFHLICLSAKTEEALKQKISDLSAYLRRKEEPPTLGAISYTLNTGRAHFRKRCAFVVDSLEALQNALMGALDGLVGNAERLSPQEQAFCKKAFDLIIKDLHDVENLESRADQTIYKDNLLALTGLYLKGFDLDWQRVYKGQSYHRVSLPTYPFSRDTYWIDEPKQISFTEPGTDKPGNTSRNHQQDQKDEDVLGGQFYIPQWKRLDQTQSYASLSDHGKLTIASDPVVIFYPPTMTSLKDDIQTCYEQLPASQVASFELGCTPSSEVDVRDPRAFERIFVSPRQALEELLEQGRTLTIYFILPEPDQNPDSGCNLECLEESLSLGLISLFRLIQALLAHHGYASELTLKIVTQQTQVCKASERIVPYGADVVGFVQSLAKEYELWQISCVDINRQTWWTPAQSKNFAEALIALKPPADGRALCWRDGYVYHRVLTPANLVGVQGSAFKTRGVYLIIGGAGGLGLVLSQYLLEHVQAKLVWVGRRSLEALAPDALRLFNTPGAHVLYEQADLCDPEALQRALQQAKGRFGYIDGVIHSALILEDRAIADMDEKTLRKVLAPKVQGNVVLQQVLADEPLDFLLYFSAGQSFMSHAGQSNYAAACTFEDAWALCQDQRQNYPIKIINWGYWGEVGIVATADYRKQMARQGVLSIHPQEGMEAVERCLASCATQAAYFKVEPRALSRLGLDGTGILHASRNRVPPQLIHVVIDATQAWSISMPYAQRYQQSLKKLDRLGCYLLLRVFQAMGVFSQPHEHYEKQELASRLAISKGYHHLYQECLNLLDTSGFIAINGSHIEVQDVLPEEHDEHHSWLQPYPELAAHEKLLRICLQAFPDIIRGSVAATDIIFPDASVELVEGIYQGNPATDALNTKAKDAVVAYVKARLADCQEQIIFLEVGAGTGGMSHEVLKGLAPYGQYIEYYYTDVSEHFIQYARRRYGQDYPFVRFQRLDIEQEHSALSEGLLSACDVVLAANVLHATQSVRNTIQHVKALLKRHGLLILNEATTLESFATLTFGLLEGWWRYQDAGDRLPGGPLLSASMWHRLLEEEGFDQVVSLGEPGEGDMLGQHLIVGRSDGWSLHQSARDDETRSAPVSPVAASDVIQGNRNDKPAELIKHVEAQIVQTLSAALDIAAARVERDVSFSEYGVDSILSVAIINQLNQRLGIRLKRPDLFNYTTTESMAAHIVATFADHLTAALVEEAEPPTPVTVASPQPIKAAGQQDVLQQNLQTQPQVSQGVWQTKPEPIAVIGMSACVPGADHVGAFWDNLVAGTDSVTRIPHERWQREAVNELPGGPDTSQRKAGFMDNIAEFDPLFFAISPQEAQWMDPTQRLFLQQAWAALEDAGYNPRALAGASCAVMVGCAATGYGVKEGERTGYVSYAMTNSEAILPARISYFLDLKGPSIPINTACSSSLVAIHLACEQLRSGQSDMALAGGASALIGSALHIGLNGVGMLSPEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKTPFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTNAYMVVEAFVETSPRAVGQQGPALIVLSARHEVRLKELASNLMAYLKRYGLNPDRPIQLEDMAYTLQVGRQAMSERLAFVADSVADVVKHLATFVDGEANAQELYRGQVKPFGDKSDLLLEGEAGQAFLNTILRQQDYRKLAALWVAGTDLDWNLLYDGENRARRISLPTYPFARETYWLDEGIGSNEKELLRDQTQKELRDRDREQTTELMTFEEIWQEASLNNHSDSIKYKSIVCFLSGSEHQQEMRTAMQAIDPAIHLTMIAQGHGYTKHSSDRYTVDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVAAFSTALERCYLESWIGFERSLKLIMPGFQVAGLFQEHAGPDQTISMTHWSQHIVSELKAPKAQTVLIQNHRRYVNQIQKTELAAQGASVASAVKQGGTYLITGGCGGLGFLVAQHLAEHLGQPAASASGKTVHLILTGRSSPDDAIQSKITQLEALGAKVGYVQADVADAVAMRRGLAQMKNRFGDIHGIFHIAGIAPSESLLNKDIDAFQNVLGPKIAGTLMLDDLCRDEPLDVICYFSSSAAILGDFGACDYAIGNRFQMAYAAYRNHLLQQGMRQGKALVINWPLWQEGGMGFHQDENTKMYLSSSGQRVLETQEALTVLDHVLNQDKTQHLVLVGQPGRVYGFLGLTEAPMTQMPVTEAPVTQTSTRPELRGLSTEQSVLWDLRNLIVQQLKVPWEQLGRDHNLADFGFDSISLLSFANRLSEHYQLDITPALFFGYSTLEQLTQYFLSEHCDFINAFYKEPEKSEIPVKKEAVEERAPIRIVSEETRPEKIDNAKDEPIAIIGMSGRFPKAYDVEQMWQLLASGECAVEEISPHYFDWRRYFGEPSQEANKTNGKWCANIPGVAEFDPLFFQISPREAPNIDPRQRHLLQESWNALEHAGYGPHQLNSQKIGTFVGAEEGDYYQRVKEGNITSNHSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGVNLMLTPYGYISMGRAGMLSEDGHCYAFDERANGLVPGEAVVVVVLKRLSRALADGDPIHALILASGVNYDGKTNGITAPNGVSQAELVREVHQRAGVHPQDIDYIVTHGTGTRLGDPVEVNALNEVFRDSQHLCAITSSKTNFGHTFSASGLLSLVNLVQALRHETIPKSLHFAQPNKFMTWDQGPLYVNTANKPWLEKPGEKRIGGVSAFGMSGTNAHMLIQDYQLHRKEPRAVPPYALLVLSAKTAEALHLKVKAMVAFLQEGLADTATLADISYTLFEGRHHLQYRLAIVVQDMTEAMCCWTQAGQPDKKPNIFQGKVPTEFSGQKVTQNYINQLVEQLDRSTGDDDVYRERLLGLADFYCQGYDVPWSRLYGDTRPRRISLPGYPFAKQQFWLDFSPKDHGEQENVELPIGKMQRQVLNEKNTLETLSYIHKWEQQDKAEVKIEISQVCLLVYFESASQFEKTLASFFLQQGASQVIEIQLGLETKPVSEHKWRCNVNDVDAFQRCLQAYAQTINSVYFLCVDTLQQGMEESEMQLLRLVKALKSRMQSHAFIDFTLLTLDNHRVDNSATSPNHGGLSGLGYSVAQSDHRFRVRNIDLSREDLVSAEQQCTLPGMIVSEAPSDRGEVVKLQAGLRYKQRFFKLDWQTLQAAQPEAAGLKTGGVYVLLGGAGTVGAIITRYLIQKYQANVVWLGRRALTSPAVQEQLHAFRSVDEGCVPLYIQADVTDQASMTQAVKEIKQHHPCIHGAIFSALVFKLDNSIAKTSEEDFNEVLDTKKKGAQYFYHAFKDENLDFMCYFSSVQSFFFISSRESAGYATGITSADTFVHAIDHDSTFPVGIINWGYWEASLAGTEAEKRLPGHYDLISDHDGCQFFDGFVPMLRSGLIKQAVCLGVSKAIEDFMGCDATQMITVNKLEADSLIFSLFNENECGQATCEETEIERLLDKDFNNELKQWLPRLLFSQLQQLGIFLNRGEQRDCTTWQQQAGVIKKYERWWRECCLGLLETSGYVQCEGERVEVTHHSPADEADQLWQGWESFQNLFLDKPERKPVLDLLESCLRSLTQILCGDILATDILFPKSSMEKVENIYQRNALSDYCNTFVAKGIEAYIHQRIQAEPQARIRILEVGAGTGGTTALVLPQLRQVQHAIDEYCYTDISKAFLIHAEKTYGPDYNYLDYKLLNLEQPLAPQGIEPGSYDMVIATNVLHATENIRQTLRHTKTALKRHGLLVINEVVEKSIVGILTFGLLDGWWLYQDESLRIPGSPLITLDTWRKILKEEGFARVLLPMRAASKLGQQVMVAESDGLVRREREDLPDEDESAVTDKTSVVQGMTLTPEQRIAQTPSVRELSSETLREQVAELILTGLAETLGMAQENIDPLVSFSDYGIDSILGVGFIGQLTKSFGITINTAILYDYTNVVRLSDYLVEIYAEDIQNKIQNNRMSPVEKDAVLYTETQLETTVDRNPEKSQLENSVPNMTSGENKSAKCQEIAVIGMSGQFPRAKDLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGGILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIGAEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVNTGCSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATGRCRTFDQFCDGTVLSEGVGVVVLKRLDDAVRDNDPIYGVIQASGANQDGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMRYHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREYLPLSETKAEMEAVLIPLSAKTLESLRTYAESLSTFLENGHSGHGVSLTDLAFTLQLGREAMRERCIFLAGNVPDLVAQLKAFANDKTLNNVGWYGRVGRSKNSHSFNDHESRQMITQWLQQGKLDKIAAAWVQGLSIDWAALYRELTARKIHAPTYPFAQEHYWKPEQQSMVQKPVAPETQPETFGTLMLQPCWIDQPLEHS", "perc_identity": 27.34}, "gnl|BL_ORD_ID|1968|hsp_num:1": {"type_match": "Loose", "snp": {"original": "F", "change": "L", "position": 413}, "query_snp": {"original": "F", "change": "L", "position": 368}, "orf_strand": "+", "orf_start": 33035, "orf_end": 60031, "orf_from": "BGC0001186.1|Misakinolide_16 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.23071e-16, "bit_score": 82.8037, "max_identities": 111, "cvterm_id": "39507", "query": "NLEQFWLNLIGGNNAITEVPAD---RWDVHQWYDPDPAVLDKTHCRWGGFLRDIDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSV--PGEPQSFWGNSSSLI-----ASRIAYFLNLKGPSITIDTACSSSLVALHLGCESIRRGECDMVIAGGV-----YIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGIIRGSGSNQDGRTYGITAPSAASQTELEQSVYRQAEL---DPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFIKVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPR----RAAV-SSFGFSGTNAHILLEEY", "match": "++E  W  L+ G + I  +  +   +WD+                + GG L+D    D+   +L  R         +L     W   E AG     +   R  V VG G      ++    +   G P+     +  +I     A+ I   L  +   +T  +ACSS   A+      I  G+ D+ + GGV      + +     + A +     P+   + FD+  DGFV GE    ++++    A+  G      + G+G   D   + + AP AA      +++ R  EL    PA I +V AHGT T +GD  E +A+  A    A      A+ + K+ +GH+  A G    +  +L L+   + P+LNY T +  IDLD              V  GEPR    R AV +SFGF G N  +    Y", "sequence_from_db": "DIESTWKGLLAGESGIHALEDEFVTKWDLA--------------VKIGGHLKD--PVDSHMGRLDMRRMSYVQRMGKLLGGQLW---ESAGSPE--VDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSD--AFHMVAP-AADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQA------AVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLD--------------VVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 38720, "query_end": 39949, "hit_start": 81, "hit_end": 1248, "orf_dna_sequence": "ATGTTGAGGACCGGCATGAAGACAGATAGCCCGAATCATCCAGAAAACCAAGCGATCAATGTCAATCACTATTTAATGGTTTTGTCGGCCAAAACGAAAGAGCGCCTGCAAACGGTGGTTGAAAATCTACTTGACTACGCCAAAGCCAATCGTCGTCTCATCGAGTCCCGCCTTGCGGATGTCGCCTTTACCTTGCAAACGGGCCGCGAGGAGATGGAAGCGCGTTTGGCCTTCGTGGTATCGGATTATCATGATCTGATGGGTCAGTTAAGCGGTTATCTGGAGGATGCGCCCAACGCGAACACGATTTTCCGCGGACAGGTGGATCTGTTTGACCAATCTGCGCCGGTTCGTCAACATCGCGCGGCACAAGAGCGCGACTGCGAACGCATGATACGGACCCACGACCTGCCGGGCTTGGCCGAACTTTTTGTTCAGGGCGTGCCGATTGACTGGCGCCGTTTATATGTGCAGGGTCGCCCCAGGCGCATCGCGCTGCCCAGCTACCCCTTTGCCCCAGAGCGTCACTGGGTGGCGCGCCGGGAGCCTGACCATCTGGCTGCCGATATGCCCGCCGTTCGGCAGCCACACTCGCTGCTTGATGGACGTGATGATCGAATGAGTCTTGAGTCCGGCGTCGTGTTTCGAAAGCTGTTGCGCATTAACGATGGTGTCCTTCAGGATCATCAAGTCAATGAAACACCCGTATTCCCAGGCGTGGCCTATATAGAGATGGCCTGCGAAGCTTTGGCGCAGTTGTCGTTTTCTGATCCGGAGGTGTTGCGGAAGACCGTATTGAACCAAATGGTTTGGCTACAAGCCCTCGCCGTGACAGAGGCCGAGCATGAAATTTTGCTATGCTTGGAAAAAGATACACATGGTCTAGCATTTGAAGTCAAAGATCATCAAACGCTTTATGCCAAGGGCCGTTTCGATCAGTCGGATGACTTGAGTCAAGGCCATCAATACCTGGAACTGGAAACTATAAAAGGTGATTGTCCGCACGAAAAGCATCGCTCGGTCATTTACCATGACTTCCGCCTCTTAGGGCTAAATTATGGACCTTGGTTCCAGGGCTTAGAGCATACTTGGTTCAGTATAGATAGTGCTGAAGGGGAGGGTGAAGCGCTCGGCTATTTTAACATGCCGTTGATTTGCGAGTCGGAATTCTCCGCTTATACCTTTCATCCTGGCCTGTTGGATGCGGCATTGCAAGTCGTTGCCAGCGTGCCCGGATACGCTGACTCTGGCTTATTACTTCCCTATGCGGTAGAAAAGCTGGAGTGGTTCCACCCGTTTCCTGCTTGCGGATATTCCCATGTTCGCAAGCTGGCGAAGCATCGCTACGATGTCACCATCTGCGATGAACAAGGCAAGGTCTGCGCTAAATTTTCTGATCTTAGTGTTAGGCCCAGCCGAGTCGCAGGCTCAGAGCCCAGCCTGAATCAGCTGACCTACCGGGCGCGCTGGTCGCACCAAGAACTTGGGGAAAGACGATCGCCAGCAGGCCGTCCCGAAGAAACCGGAGTCGTGTTCATCATTCACACTCCGGAACAGCAGGCATTGGTACAAGAGCTAAGCAGCGTTTTAGCAGACATGCATGGCGATCATCGAGTACGACGGATGTGCCTAAATGCAAACGACTGGGATTTTAAATCGTTAGGGAATTGGAATCACCGTATTCGCGCCGTTCAGGACTTGCGCGATATCTATTTTCTTGCTGCTATGGAGCATACCGTTTCGAGCGGACAGGCCCATGTGGATCCTCTCTCTTTTACCAACCGACAGGAGCATGGGCTGCTCTCTTTATTCCGCTTGCTCAAAGCGCTGGATCAGAACCAGTTACTACTGCAACCGCTGTCGTTAAAAGTCCTAACGACAGGAAATTATCGCGTTTTGCCAAGCGATACGATTTGCCCTTTGAGTGCCGGTTTACCAGGTTTTTGCCGCTCCATTGCTCAGGAATACCCCTTGCTCGCTCTCAGTTGTATCGATCTCGGATGCCCGGATGGCGACGCCATGCAGCCATCCTCGCTTAAAAAACTGGCGCAGTTCATCGTTGCTGAGCCCGCGCATCAGCCTCATGAAACCGTCGGCATACGTGAACTCCGGCGCTATACTCGCAAGCTTGTTCCCGTTCGTTTTCCCGAACCCGGAGGGCAAAGAGCTTTTAAATCCCGAGGCGTCTACATGATCGTTGGCGGAGCTGGGGGCATTGGGATGGTGCTGGCCCAGTACCTGGCCGAGCGTGTTCAGGCGCGTCTGGTCTTGGTGGGCAGAAGTGCTTTGGATGAGGAGAAAAAGCAAAACCTTTCGACGCTCACTGCCGCCGGTGGAGAAGCCCTATATATCCAGGCAGATATCAGTCGTCTGTACAGCATGAAAGATGCCGTCGCCCAAGCCCGTCAGCGTTTTGGCAACATCAACGGTGTGGTGCATTCCGCCATGGTTTTAAATGACCAAAGCTTGGCCCGTATGAGTGAAGAGGGGTTGCGGGCCAGCCTGGCGCCAAAAGTCGAAGGCTGTATCGTGTTGCAGCAGGCGATGGCCGGTGAGCCACTGGATTTTATGTTGTTCTTTTCTTCGGCAATCTCCTTTAGCGGCAACGCCGGACAAAGTAACTATGCAGCAGCTAGTACATTTAAGGATGCCTTTGCCCATTATCTGACGCAAGTGGAAGCTTATCCCGTATTTAACATCAACTGGGGATATTGGGGGTGTGTTGGTGTGGTTGCGAATGCAGCTTACCGTGAACGTTGGGCAGCTCGAGGAGTCCATTCTATTGACCCAGAACAGGGTCTGCAAGTCATTGAATCGATCCTGACTAACCATATTGATCAAGTCGCTGCGGTGAATGTCGAGCCGTCTTTTCTAGAGCGCCTGGGCGTAGAACTGTCTCAAACACAAACTGTACTCCCACCACGTCGCTCGTCGCTGATTGCAAAACTTAATGCGTTGCCACTGCCGGAAACCGGGGGTTTTCAAGATAATGTTAATCGCCTAGAGATCGTGAGTGCATTCCGCTGGGCTGAAGTGTTTAAGCATATGCTTGATATGTCTAGCACTCAGGGAATGTATGCTCGCTCTGATCTTAAACGACAATTACAGATTAGCTCTGAACACGATCAGTTGTTTGATGTTCTCATTTCTATGCTCATTCAAGAGGGCTATCTCCATCAGCAGGGCAAAAATCTGACGCCTACACCTTACTTGAATGGCGAGTTTTTCCAGCAGCAGAGAGAACAAGTCGCATTGCTGGAAAGTGAGCTGTCGCAAACGGATAATGCCTATTTAAACTTGTTATCTCGCTGTCTGGATCACTATCCCGCTATGTTGCGCGGTGAAGTGGCGGCAACTGATGTGATATTCCCACAGGGCTCGATGGAATGGGTGGAAGGTATCTACCGCAGCCATGCTTCAGCCGACTATTTTAATCAGCAATTGGCCCAACGCCTCGTTGCCTATGTTGAGGCCCGCTTGCCTTCCCTGGGTGCGAATGAATCGATTCATATCCTAGAAATTGGCGCCGGCACCGGCGGCACCAGCGCCATTGTATTACAGGCGCTCCAGCCTTATGCAGCTCGCCTGCGTTATACCTACTCCGATATCTCGCCTGGTTTCCTCAATTACGGGCGCAAAACCTTTGGCGACGCGTATCCGTTTGTCGAATTCAGACACTTAAATATTGAACACAATGGCGAAGCTCAGGGCTATCAAGCAGGCGAGTACGATTTGGTCCTGGCGGCCAATGTGTTGCACGCTACCCGTCACATTGGCAACACCTTGGCCCGGGTTAAGTTTTTCATGAAACGCCATGGCTGGCTGTTATTGAATGAAGCCACCCAAGTGCGCCATTTTGGGACGTTGACCTTTGGTTTGCTAAAAGGTTGGTGGTTGTTTCAAGACGCTGAAAACCGGCTTGACGGATCGCCTTTGCTGTCAACCACTGCCTGGCAGCGGTTACTGTCGGAAGAGGGGTTCAAGCACACGCTTAGTTTGTGCGACGCGGTTGAAGAAGAGTCAATTTTTCAGGATGTCATTGTTGCTGAAAGTGATGGTGTCATTCAAATGAATCAGTCGGATTCACCTGTGCAGCCGCGTGAGCCTGTGGATGTGTCTGTGGATGTCCATCATGTCGATGACATGATGGAGCCTGGGCAAGTGGCGGATGTGGTTGAGTCACGACATGATTTTATCGTCAATAGCGTCAGCCAATGTATGGCTCAGTCTTTAGGTGTGGCGTTTACCGACATTCACATCAATCGTCCATTTAGCCTTTATGGTGTGGATTCGATCACGGGAGTTGATTTTATTCATCAGATCAATTCCCGTTTAGGGATCGTTTTGCGAACGACGGCCTTATTTGATCACGCGACGATTTTTGATTTATCCCGTTTTATCGACGAGAGCCACGGCGCGGCGATTGACGAGCAGCGTCAGCGCTTGAGGTCAACACCGTTGACCTCAAGCGATACGAAGCCAGCGGAGCGTGTCGCCCCGCCGGATGAAGCGCTTCCCCATATCGAAAGGGGCTGTCACCAGGCGGTCGTACTGGAAAAACCCAGCCAGATCGAGCACCTTCGCTTCCATCCCGTGAAAACCCGGGAACCTGCGGCGCATGAGGTGCAAATTGCAGTTCGCGCTTTTTCGCTCAACTTCGGGGATTTGCTATGCGTGACCGGGCTCTATCCCACCATGCCGGCGTATCCATTTACACCGGGCTTTGAAGTGTCCGGGCACGTCGCCAACGTGGGAGCGGCGGTCAGCCACGTTGCGGTGGGCGACGAGGTCATTGCCCTAGCGGGCCAGCAGTTGGGCGGCCACAGTACGCTGTTGACCACTGCAGGACACTTGGTGGTTCACAAACCGCGTCAGGTCAGCCACGAGGAAGCTTGCGCGTTTCCCGGCGTTTTTCTGACCGTCTACCATGCGTTTCAAAGCGCCAATATTCAAGCTGGGGAAAAAGTTTTGATTCAAGGCGCGGCCGGGGGAACGGGCTTAATTGCTGTACAAATGGCCCAGGCGGTGGGAGCGGAAATTTATGCCACAGCCGGTTCGCCCCAAAAACTGGATTATCTGCGTGAACGAGGCGTGCCGCATCTGATCAATTACCAGACGGACGATTTCGCCGAGGTCATTTTAGCAGATACAAACGGTTATGGCGTGGACGTGATCTTCAATACAGCAGCCGGGGACGCCATGCAAAAAGGGCTGGACATTCTGGCTCCCAATGGACGCTATTTGGAAATTGCGATGGTCGCCCTGAAGCGTTCGCGGTCGGTTGATTTATCTCATTTGGTTGATAATCAGGTGTTTTATAGCATCGATATGAGAAAGCTGATCGCTGGAAACCCACAGCTGATCAGCCGCTATCTGAATCGCATGGTGGAGCATCTGGCAGAAGGGCACGTGCAGCCGACGATAGGCGCAAGATTTGCGCTTGATGATATTCAAAGCGCCTACCGGCTGCTACACGACCGGCAAAATATTGGCAAAGTTGTTGTCAGTATCCCCGATGGGATGATGGACAATCAGGTCGGCCAAAGGATGGTGCCGGAATCCTCAACGGTTGAGGACTATCGCGTTGGAAACGCCACGGTTGAACAGGTTGCGGTAAAACAACCGGCGGACATGGATGAGCCGATTGCCGTTGTCGGTATGTCCGGCCGTTTTCCCGGGGCAAACAACTTGGAGCAGTTCTGGTTGAATCTTATAGGTGGCAACAACGCGATCACCGAAGTTCCCGCTGACCGCTGGGATGTCCATCAGTGGTATGACCCCGACCCGGCAGTCCTTGATAAGACCCATTGCAGATGGGGCGGTTTTCTGCGAGATATTGACAAATTTGATGCGCTGTTTTTTAAACTCTCAGGCCGGGAAGCCGAGTTGACTGACCCGCAACAGCGTTTATTTCTGGAGGTCGCTTGGGCCGCACTTGAAGATGCGGGGCATGCGAACCGCGCGATTTCCAATGCCCGCTGCGGGGTTTTTGTCGGAGCCGGTCCGAGCGATTACGTCACGTTAATGCGTGAACGGAGCGTGCCCGGCGAGCCCCAGTCATTCTGGGGCAATTCCAGCTCGCTAATCGCGTCGCGCATTGCCTATTTTTTAAACCTGAAAGGGCCGAGTATCACCATTGATACGGCCTGTTCCTCATCTCTGGTCGCCTTGCATTTAGGCTGCGAAAGTATTCGGCGTGGCGAATGCGACATGGTCATTGCCGGTGGCGTGTATATTGGGGTCACACCACACTTACATGTTATTGCTAGCAACGCCGGCATGCTCTCACCCGATGGCCAGTGTAAAGCCTTTGATCAAGGTGCAGATGGCTTTGTCCCGGGTGAAGGCGTTGGCGCGGTGGTCTTAAAACCACTGTCAGTGGCACGTCAAGCCGGTAATTTTATTTATGGGATTATTCGTGGCTCAGGTTCAAATCAAGATGGGCGAACTTATGGTATTACCGCGCCCAGCGCTGCTTCTCAAACAGAGCTAGAGCAAAGTGTCTACCGACAGGCCGAACTCGACCCGGCAAGCATTGGCTATGTTGAAGCTCACGGTACAGGTACCAAACTTGGTGATCCCATTGAGATTGATGCGCTGAATCGTGCCTTCCAAAGTGACGCGAAAAAGCAGCACTCTTGTGCCATTGGATCGGTTAAAACAAATATTGGACACGCTGGTGCGGCTGCCGGTATTGCTGGATTCATTAAGGTCTTATTGTGCCTGCAACATCAACAATTGGTGCCTTCGTTAAATTATCACACGTGTAATGAACATATCGATTTGGACAATAGCCCGTTCTATGTGAATACAGAATCAAAGGATTGGTTCGTCGCTCAGGGTGAGCCGAGACGGGCTGCGGTCAGCAGCTTTGGCTTTAGTGGTACTAATGCGCATATTTTGTTAGAAGAATACCAACACCATGAGGACGAGGCCCAGGCACTTGGAGATGACAAGGATGTGTTGATCGTCCTTTCAGCCAAGAATCAAGAACGTCTCAAAAAAGCGGCTGAAAATCTTCACCATTTTTTAGAAAGCAGAGTCTCCTATAAATTGTCCGACATTGCCTATACGTTGCAGGTTGGCCGTGAGGCGATGGAGGCGCGAGTTGCTTTTATGGTGGTCTCAGTCCTTGACTTACAACAAAAGCTTGTGTCATTGCTTCATGACCCAACAGACGAACAAGACATGTATTGGGGGGAGGTGCGCGATGGCGAGGGGCCTGCTGGAGTGGCTGCTTTTGAAGACGTCGCACTTGCCTTGGCTAACAAGCAGTTGGATCAGCTTGCCCAGTGGTGGGTGTCTGGGGTTGAAATAGACTGGACCCAGCTTGCACGCGTGGTGAAAGTCCGTCTCGTTCCTCTGCCTACGTATCCGTTTTCGCCTGATCGTTACTGGTTTGATTCGGTAGGTCCGGCGACGGTTGTACATGCCGAGCATTCAGCCTCTGCTCTGTATCCCCTATTGAATCGTATCGCTCCGCAGGCGAGCACTCAAATCGCGAACGGCTGCGTGTTTGAGACGTGCTTGAAATCCAGTGACCCTCTGTTGGCGCAACATCTCATTGACGGCCAGGCGGTGTTTCCGGCAGTGGGATTTCTGGAGATGGTCATAGCTGGCCTGCGCGAAATCCAGCCAGATAAAGCAGCGCGGTTGGAGAATGTGTTTTGGCTCCGGCCTCTTGATGTCATGGATGAACAACGCGTTCATCTGGTGTTTGAGGTGAAACAGGATCGTTTTCAATATCGAATTGTACCCGCAGAGTCTCACGGGGACGGGGCCTATTTTCGTGGCCAAGGCTACTGGTCAAACGATATGAATCCTGCGATTCCGATGGATATTGATCGCCTGAAAAGCCGTATGCGCCAACAGCCCTTGCTCAACGAATCCAGCCCCCGAGTCCGCCTGGGCCGCTTGTATCAAGGCGCGACTGAGGGGTGGACGGATGGTGAGCAAGCACTGATCGCCTTTGAGTTGCCAACGGCGCAACCGTATCGAGACGGGTCCCCCGATCAAAAATCATACCCATTTCACCCTGCAGCTTTTGTCGCGGCTTTGCAAGCCTATCACTGGATTCATGAGGCGCCTAAGCGTCTGGGGATGCCTTTTGCCGTGCAAAAAGTGGAGCTGTGGCGCCATCGTGATCAACCCGCTTATGCTTACGTTGCACTAGATGAGCATGGCAACGCGGACGTGCACATCCTGGATGCAGGCGGTCAGGTATGCGTCTGTTATCGTGGCATGGCCCTGCAGACCTTGAACAATGCGCACCACGATGGGAGACAAGAAAGCACTCAAAAAGATGAGCTTGGAAAATTGCTTTTTGTCCCTGTCTGGAAGCGTCTTGATACGAAACATGGGCGTGCACATGGCATGCATGCGCTTGCTCGCGGAACGGGCGTCTTACTGGTGTACACACACGAAAATGGGGTAGAGGCCGAGCAGCTCATGCAGCGTTATCGCGAAGAGCAATGTGAGTTACTCTCGGTTTGCTTATCTGCGGCGGATAGAGCACTGGACACCCTGGCGGCGCGTCTAAAGCATCTGCAGTCGCCACTGCGCCATGTCTGTTTTCTTGATCGTCATCAGGCCGCGCTTGATCCGGCTGACAAGCAGATTGACGAGCGATTGCGTGAACCCCAGACCCTCACAGGCTTTTTGGCATTAGTGAGAACCCTGAGCGAGCTTGGCTATGATGAACAGCCCCTACAATGGCTTGTGCTTACCTCTAGCGCATGTGCCGTCAATCAAGCAGACCCCATTAACCCGTATGCCGCTGCGATTGTCGGACTTGCCTCTTGTCTGGCGCAAGAGCATAGGTATTGGCAGGTGAGTGTCTGTGATCGGGGCAAAGGCACATCTTTCACAACGATTGCGAATCACGGGGAAACCTTGCGCGTTATTGCTGAGCGCAGTGGATACAGTTATGTGAGGCACATCAAAGAATTAGAGCTGCCCCCTCCCCGGCAGAGCCGTTTGCGTCACAAGGGCGTATATGTCTTGGTTGGCGGTGCCGGTTACGTGGGGACCTTGCTTAGCCGCTATCTGGTTCAGACCTATCAGGCAAAGGTGATATGGCTAGGTAGACGTGAGCAAGATGAGCAGATAGAGCAAAACATAGCCCTGATCGCTACCTTGGGATCGCGTCCGCAGTATCTGAGCCTGAAAACCGGATCAGACGACGAGCTACACCGTGCATTTGCGCAGATTAAGGCAGAAAACGGTTTGATCCACGGTGTGTTTAACCTGGTGATGGTCGCGCAGAGTACCCCGATGCGCAGCCTGAGCGAAGCACAATTTCGAGCTGGCTCCTTTAATTCCAAAGTGAACTCCGCGCAAGCCTTATACCGTATTCTGAAAAAGGAAGCTCTAGACTTTATGGTGTTCTTCTCTTCGATGCAAAGCTTTGCGCAGCAGCTCAATTTTATGTCAGCGAATATGAGTAGTTATGTTGCAGGTTGCATGTTTCAAGATGCTTTTGTGCATCAGATCAATTGCGAGTTATCTTATCCTGTAAAAACTATTAACTGGGGTTATTGGTCACAAGAGAGTTCAGAGAGCGAAAAGGCGAAGTGGTACGAGACTTATATCGCGGATAAAGGTATTTACAGTCTCAATGTTGGGGAGGCGATGCAAGCGTTGGAGTATATTTTGGCTCACGAACCAGAACAAGTGATCGTGACCAAAGTATCACATCGGGTTCTCAGCGACATGGGCTTTGTGCAAGATGACTCAGAGAACGTCGACCTACAGCCTGTTATTGACTCGAACGATGACAATACCCAGCTTGAGGACTTGATCGTTAATGGTATTCTCAAAACCTTTGAAACGCTCGATGTATTGCAGGTATTTGATAGCGCCTGTAATCTCGATGTTTCGAGATTACAGGCGCATGTGCCCGATAAATATCGCCGCCTGTGGCGTGAACTGCTTCTGATTTTGGTTCAGGCTGGAAAGATGGCACCACAGGGTGCTGGGTTTGCTCTACGAGAAAGCTATACCAGTTTGGCGAGCCAGCTTCGCTTAATGGATCTCGATCGGGAGGCTGGGCTATTGCGCGAGCGCCATCCCACCTTAGCCTCGAAACTTGCCTTGCTCGTACCCTGTCTGAAGGATATGGCCGAGGTGTTAACGGCTCGCAAACCAGCAACAGAAGTGTTGTTCGAACACGCTTCGCTGTCACGGGTTGAAGGGATTTATAGAGGAAATCCCACCACAGACTACTTTAACCAGCGTGTCGCTGACATTGTGAAGGCCGCAGTACAGCAGGCACTGCCCAGCCTGAGTGTAGGGAAAAAAGTACGCATTTTGGAAATCGGCGCGGGCACCGGTGGTACCAGTGCCTACTTGTTTCAAGCACTTAATACATATGCAGATCAGTTGCACTACATCTATACGGATATCTCTAAACGATTCTTAATTCATGCAGATGAAACTTTCTGTGAGCAGTATTCCTTTATAGAGACAAAATTGTTGAATATCGAACAAGATGTGGCAGGCCAGGGGTTCGATCCTGCTAGTATTGATATCGTGGTGGCAGCCAATGTTTTGCACGCCACACGCAACATTAGTAAAACTTTGCAACATGTTAAAGACTTACTCAAGAACGATGGGCTTCTGGTGTTAAATGAATTAGCGGACGTTTCGCCTTTCCTCACCGTGACCTTTGGTCTGTTAGATGGATGGTGGTTGTATGATGATGAAGCCATTCGCCAACCAGGCTCACCTGGCCTATCAGCAAAAAATTGGCAGCTTGTGTTGAAAAATCAGCGTTTTCACAATATTAGTCTCAACGATGAAAAAGCTCTGACGTCAGAGCAGCAAATTATTATCGCGCAAAACGAGAGTAAAGAGAGTGTGCCGGTCTCATCCACAGTATTATTAGGAACAGAACTTATCGCCTCAGTCGAAGCCAGTCTGATCGCACAATTGAGTCAGTGCATAAAAATCGAGCAAAACCGTCTCAATACCTATACCACGTTTTCAGATTATGGTGTGGATTCAATTTTGATGCTCGCCTATGTTGATCAAATTAATGGTGATCTTGGAATTGACCTCAATCCTTCAGAACTATTTAATTATACCACTGTTGAGCGTCTTACTAAGTTTATCGTTGATTATCATGGGAAAGAGATCATTTCAGCAAAAGAAAGCGTTGAGAGATCATTACTTCAGAATCAAGAAAGCAAATTTGACCTCAATGACATAGATGTCATCACAAAGGCAGGGAACGAAGCTCCGGAGATGGCGCGCAGCCTTCTCTTTGATAACGTTTTGCAAGTGCCGTCCGGTAACGTGCATCATCACCAGAGCGATAAGGCGCGACCTGATATTGCGGTTATTGGCATGTCGGGGCAATTCCCAGGTGCGACGAATGTTCAGCAGTTTTGGCAAAATCTGAGCGCCGGCGTCGATAGTGTGAGCGAGCTGCCTGAAAGCCGCCTGGATCGTCAGCTGTACAGTCCGCAGCCAGAGGCGGGAAAATGTTATTGCCAATGGGGCGGTATCTTAGAGGAACAGGCCTCTTTTGATCCACTGTTTTTTGAAATCTCTCCCAAAGAAGCCGCCGAGATGAATCCTTCTCAGCGGGTGTTTATGCAGGAGGCTTATCGAGCCCTGGAAGATGCGGGGCTGGTCAACGCAGGTCTCTCGCAACTGCATTGTGGCATTTATGTCGGTTGTGAGCCAAACGGCTATACCAAACAAGGTTTCACCGGCGCCTCCGAAGCCATTGTCGCTTCCAGAATCTCCTATTTTCTCAATTTGCAGGGACCGGCTCTGGTGATTAATTCCGGCTGCTCCTCTTCCTTGGTCGCCATTCATCTGGCTTGTGAAAGCCTTCGCCATGGCGAAAACGATATTGCCCTCGCCGGAGGCGTTTTTACGAATCTGAATAACGAGTTGCTCGTCTGTCTGTCGTCCATTGAGATGTTGTCATTCTCCGGTAAATGTCACGCCTTTGACGAAGCCGCCAATGGCACGGTGCTGTGTGAAGGTGTCAGCGTGCTGGTGTTGAAACGATTACAGGACGCGCTAGATGATGGCGATGTCATTTATGGCGTGATCAAAGGCAGTGGCATGAATCAGGACGGAAGAAGTAATGGCATCACTGCACCCAACGGACTTGCACAAGAAAATTTGATCAAGCGCATTTATCAGGATTACAACATTGATGCCAGCAAAATCAGCTACATAGAAGCCCATGGTACTGGAACGAAATTGGGTGACCCCGTTGAGGCGAATGCGNTGAAGAACGTATTTTCTTCAAGAAACACGGGTTTGGACTTTCGTTGCGGAATCGGTTCAGTTAAATCGAATATAGGACATGCGGCTGCAGCTGCGGGTGTGATCGGTCTGGTCAAGGTCTTATTATGCATGCAACACCGTCAGTTACCAGGGCTGGTGCATTTTAACAAACTCAACCCTCTAATCGATTTTAACGACACAGGTTTGTACATCGTTGAGCAATTGCAAAACTGGGAGCCAGCGTCTGGTGAGCCGTTGATGGCAGGCATCAACTCGTTCGGCCATAGCGGCACCAATGCCCATCTCGTGATTCAGGAACCCCCTGTGCGACCTGTCCGCGACAGCGAGAACCCATTCCATTTAATCTGTCTATCTGCCAAAACAGAGGAAGCGCTTAAACAAAAAATTAGCGATTTGAGTGCATATCTAAGGCGCAAAGAAGAGCCGCCAACTCTAGGAGCCATCAGTTATACCTTGAATACCGGCCGTGCTCACTTTAGAAAACGCTGCGCTTTCGTCGTGGATTCGCTGGAGGCTTTGCAAAATGCTCTCATGGGAGCTTTAGATGGTCTTGTTGGCAATGCAGAAAGGTTAAGTCCACAAGAACAGGCATTTTGTAAAAAAGCATTTGATTTGATTATCAAGGATTTACACGATGTAGAGAATCTTGAAAGTAGGGCTGATCAAACAATCTATAAAGATAACCTACTGGCTCTGACCGGACTTTATCTAAAAGGTTTTGACCTAGACTGGCAACGGGTGTACAAAGGTCAGAGCTATCACCGGGTATCCCTGCCGACATATCCTTTTTCCAGAGATACATACTGGATTGACGAGCCAAAACAAATTAGCTTCACCGAGCCTGGTACCGACAAGCCTGGAAACACCAGCAGGAATCATCAGCAGGATCAAAAAGATGAGGATGTGTTGGGTGGACAGTTTTATATACCGCAGTGGAAACGGCTTGATCAAACACAATCCTATGCCAGTTTAAGCGATCATGGGAAGTTGACCATCGCATCTGACCCTGTTGTCATTTTTTATCCGCCGACCATGACAAGTTTAAAAGATGATATTCAAACATGCTATGAGCAATTACCGGCAAGCCAAGTCGCTAGCTTCGAGCTTGGCTGCACACCTTCGTCTGAGGTCGATGTTCGCGATCCCCGTGCCTTTGAACGCATCTTTGTATCCCCTAGGCAGGCATTGGAAGAGCTGCTTGAGCAAGGTCGAACGTTAACGATCTACTTTATCCTGCCTGAACCGGATCAAAACCCGGACTCAGGGTGCAACCTCGAATGCCTTGAGGAATCCCTGTCACTCGGGCTGATCTCGTTGTTCCGTTTGATACAAGCGCTGTTGGCCCATCACGGCTATGCCAGCGAGCTGACCCTCAAAATCGTGACCCAGCAAACCCAGGTCTGTAAAGCTTCTGAGCGCATTGTGCCCTATGGCGCAGATGTGGTGGGTTTTGTGCAGTCGTTAGCGAAGGAATACGAGCTCTGGCAAATCAGTTGCGTGGATATTAATCGGCAGACATGGTGGACGCCCGCGCAAAGCAAAAACTTTGCCGAGGCGCTGATTGCCCTGAAGCCACCGGCGGACGGGCGCGCTCTATGTTGGCGGGACGGGTATGTTTATCACCGTGTTTTAACCCCGGCTAATCTCGTTGGCGTTCAGGGAAGTGCATTCAAGACGCGCGGTGTCTACCTAATTATTGGTGGCGCTGGAGGGTTGGGATTGGTGCTCAGCCAGTATCTGCTTGAACACGTGCAAGCGAAACTGGTATGGGTGGGGCGGCGCAGCCTCGAGGCGTTGGCGCCGGATGCGTTGCGGTTATTCAACACTCCGGGCGCCCACGTGCTATACGAGCAAGCGGATCTGTGTGATCCGGAAGCGCTGCAGCGCGCGCTGCAGCAAGCCAAAGGACGTTTTGGATACATTGATGGTGTCATCCATTCGGCTTTGATTCTAGAGGACCGAGCGATCGCCGACATGGATGAGAAAACGCTACGCAAAGTTCTCGCGCCCAAAGTACAGGGCAACGTGGTACTCCAGCAAGTGCTGGCCGATGAGCCTTTAGATTTTCTGTTGTATTTCTCCGCCGGACAGTCTTTTATGAGTCATGCTGGGCAGAGCAATTACGCCGCTGCCTGTACCTTTGAAGATGCCTGGGCGCTGTGCCAGGACCAGCGGCAAAACTATCCGATCAAAATTATCAACTGGGGCTATTGGGGCGAGGTGGGCATTGTCGCCACGGCTGACTACCGTAAACAAATGGCCAGGCAAGGCGTGCTATCGATTCATCCGCAAGAGGGCATGGAAGCGGTAGAGCGTTGTCTGGCGTCGTGCGCCACCCAGGCCGCTTATTTTAAAGTGGAACCCCGCGCCTTGAGCCGATTGGGCTTGGACGGCACTGGAATCTTGCATGCGAGCCGGAACCGTGTTCCACCTCAATTGATTCATGTCGTGATTGATGCCACCCAGGCGTGGTCAATCTCGATGCCGTACGCACAGCGCTATCAACAATCCCTTAAAAAGTTGGATCGGCTTGGTTGCTATCTCCTTCTGCGTGTATTCCAGGCTATGGGAGTGTTTAGTCAGCCTCATGAACACTATGAAAAACAGGAATTGGCCAGTAGATTAGCCATTTCAAAAGGCTATCATCACCTCTATCAAGAATGCTTGAACTTGCTAGATACGTCCGGTTTTATTGCAATCAATGGTTCGCACATTGAAGTCCAAGACGTGCTACCGGAAGAACATGACGAACACCACAGCTGGTTACAACCCTATCCCGAATTGGCCGCGCATGAAAAATTGTTGCGCATCTGCCTACAAGCTTTTCCGGATATCATCCGGGGATCGGTTGCCGCGACGGATATCATATTTCCGGATGCGTCTGTGGAATTGGTAGAAGGTATTTATCAGGGCAATCCCGCCACCGATGCGCTGAATACCAAAGCGAAAGATGCTGTGGTTGCCTACGTCAAAGCCCGCCTGGCAGACTGTCAGGAACAAATCATCTTTTTAGAAGTCGGAGCGGGAACCGGCGGCATGAGTCATGAGGTGTTGAAGGGGCTGGCCCCCTATGGGCAGTATATCGAGTATTATTACACCGATGTCTCCGAGCATTTTATCCAGTACGCTCGCCGCCGTTATGGTCAGGATTACCCCTTTGTCCGGTTTCAACGTTTAGACATTGAACAGGAGCATAGCGCGCTAAGTGAGGGGCTGCTCAGTGCCTGCGATGTCGTATTAGCCGCGAATGTTCTGCACGCCACCCAAAGCGTTCGCAATACCATCCAGCATGTCAAAGCCCTGCTAAAACGGCACGGCTTGTTAATCTTAAACGAAGCTACGACTTTGGAAAGCTTTGCCACATTGACATTCGGATTGTTAGAGGGCTGGTGGCGCTACCAGGATGCCGGAGACCGCCTACCTGGCGGGCCTTTGTTAAGCGCGTCCATGTGGCATCGCTTGCTCGAAGAAGAAGGTTTTGACCAGGTGGTGTCCCTGGGTGAGCCAGGCGAAGGCGACATGTTGGGACAGCATCTCATTGTCGGTCGAAGTGATGGCTGGAGCTTGCATCAATCTGCGAGGGACGATGAAACCCGTTCGGCCCCTGTTAGCCCTGTGGCGGCGAGCGACGTTATCCAAGGCAATCGAAATGACAAGCCCGCAGAGCTTATCAAACACGTTGAAGCGCAGATTGTGCAAACCCTTTCAGCCGCACTGGATATTGCTGCGGCTCGAGTGGAACGCGATGTGTCGTTTTCCGAGTATGGGGTGGATTCGATTCTGTCCGTTGCGATTATTAACCAATTAAACCAGCGCCTAGGGATTCGTCTGAAACGTCCGGATTTGTTTAATTACACCACCACAGAAAGCATGGCGGCGCATATTGTCGCAACCTTTGCTGACCACTTGACGGCGGCCTTAGTCGAAGAAGCTGAACCACCAACGCCAGTAACCGTAGCAAGTCCTCAACCGATAAAAGCGGCGGGGCAGCAGGATGTTCTTCAGCAAAACTTGCAAACCCAGCCTCAAGTCTCGCAAGGCGTTTGGCAAACCAAGCCGGAACCCATTGCTGTCATCGGCATGTCTGCCTGCGTGCCAGGGGCGGATCATGTGGGTGCGTTTTGGGACAACTTGGTTGCCGGCACAGATTCCGTCACCCGGATTCCCCATGAGCGTTGGCAGCGGGAGGCCGTCAATGAGCTGCCCGGCGGGCCGGATACCTCCCAGCGCAAAGCCGGATTTATGGACAATATTGCCGAATTTGACCCGCTTTTTTTTGCCATCTCTCCGCAAGAGGCGCAGTGGATGGACCCGACGCAGCGGCTGTTCTTACAGCAGGCTTGGGCCGCGTTGGAAGATGCCGGATACAATCCGCGAGCCTTAGCCGGCGCTTCATGTGCGGTGATGGTTGGCTGTGCGGCGACTGGCTATGGTGTGAAAGAGGGCGAGCGCACGGGGTATGTGTCCTATGCTATGACCAATAGCGAGGCCATCTTACCCGCGAGAATCTCCTATTTTCTCGACTTAAAAGGCCCGAGTATTCCCATTAACACCGCCTGCTCTTCGTCTTTAGTGGCGATTCATCTGGCCTGCGAACAACTTCGCTCCGGGCAAAGCGACATGGCGTTGGCTGGCGGTGCTTCCGCACTGATTGGTTCCGCGTTGCACATCGGACTCAATGGCGTTGGGATGCTATCTCCCGAGGGCGCATGCAAAGCATTTGATAAGGAGGCCAATGGCTTTGTGCTTGGCGAAGCGGTTGGCGTTGTCGTTCTCAAACCGTTGTCCAAGGCCGTGGCTGATGGCGATTCGATACATGGTTTAATTATTGGCTCGGCGATTAACCAGGACGGCAAAACCAATGGTATCATGGCGCCGAACGGTCCGTCTCAGACGGCATTAATTGAATCGGTGTACCGGAAATTCGAGATCGATCCTAAAACGATTAGCTATATCGAAACCCATGGCACCGGCACCCAACTCGGCGACCCAATAGAAGTCAACGCCTTGGCTGCTGCCTATGAAAATTTCACCACCTCGCAAACTCAGTACTGCGCCATCGGATCGGTAAAAACCAATATTGGTCACACCACCACTGCTGCCGGTGTCTGTGGATTGATTAAGACTTTATTATGTCTCAAACACCAAAAACTTGTCCCATCCCTGCACTATAAGGAGCCCAACGAAAATATTGAGTTTGAAAAGACGCCGTTTTACGTCAATACCCAGGTCAAAGATTGGCCGGGTCATCAAAACGGTGTCCGGCGTGCGGCGGTGAGTTCCTTTGGCTACAGTGGCACCAATGCGTATATGGTGGTGGAAGCGTTCGTGGAGACGAGCCCGCGCGCGGTCGGGCAGCAGGGACCTGCATTAATTGTCTTGTCGGCTAGGCATGAGGTGCGACTCAAAGAGCTGGCCAGCAATCTCATGGCCTATTTGAAGCGGTATGGCTTGAATCCGGATCGCCCGATTCAGCTCGAAGATATGGCGTATACGCTTCAGGTTGGCAGACAGGCCATGTCAGAGCGTCTGGCGTTTGTGGCGGACAGCGTGGCGGATGTCGTCAAACATTTAGCCACATTTGTTGACGGCGAGGCCAATGCCCAGGAACTTTACCGGGGGCAAGTTAAACCGTTCGGCGATAAGAGCGATTTGCTTTTGGAGGGCGAGGCGGGTCAGGCTTTTCTCAACACGATTTTAAGACAGCAGGATTACCGCAAATTAGCCGCCCTGTGGGTGGCGGGTACAGACTTGGACTGGAATTTACTCTACGACGGTGAAAACCGTGCCCGTCGCATTTCGCTACCGACCTATCCTTTTGCTAGGGAAACGTATTGGTTGGATGAGGGGATAGGGAGCAATGAAAAAGAGCTTCTAAGAGATCAGACTCAAAAAGAGTTACGTGATCGTGATCGTGAGCAAACTACGGAACTCATGACATTTGAAGAGATATGGCAGGAGGCGTCCTTAAACAATCATTCGGATTCCATCAAGTATAAAAGCATCGTTTGTTTTCTTTCCGGATCAGAACATCAGCAAGAAATGCGAACTGCCATGCAGGCGATTGATCCGGCTATCCATCTTACGATGATTGCTCAAGGCCATGGTTACACAAAGCACTCATCTGATCGTTACACAGTAGACCCCGCCGATATACAGAGCTTTCGTGAAGCTTTCCTCGATATCAGCCAGACTCATGGCGAGGTCGACGCGCTGCTTTATCTATGGCCAACCGAGGATTGGCGTCTCTTGTATGATCCATCCGCCGTCGTTTATATGTTGCAGGCTCTGGTCAAGAGTGAGCTAAAACCTTCCCGCTGCTTGCTGGTTGCTGCTTTTTCCACTGCTTTGGAGCGTTGTTACCTGGAATCCTGGATTGGCTTCGAGCGCTCGTTAAAGCTCATCATGCCTGGTTTCCAGGTCGCGGGACTGTTTCAGGAACATGCGGGGCCGGACCAGACGATTTCAATGACACATTGGAGTCAACACATTGTCTCTGAACTCAAAGCGCCTAAAGCACAGACGGTGCTGATACAAAATCACCGGCGCTACGTCAATCAGATTCAAAAAACCGAACTGGCCGCGCAAGGCGCTTCGGTTGCATCGGCCGTCAAACAGGGCGGTACTTACCTGATTACCGGTGGCTGTGGGGGATTAGGTTTTTTGGTCGCCCAGCACCTGGCAGAACACCTTGGGCAACCGGCAGCCTCAGCCTCGGGAAAAACGGTGCATTTAATTCTGACGGGTCGATCATCTCCCGATGACGCGATACAAAGCAAAATCACGCAACTGGAAGCATTAGGGGCAAAGGTTGGTTACGTTCAAGCGGATGTTGCCGATGCAGTCGCCATGAGACGTGGCCTTGCCCAGATGAAAAATCGCTTTGGCGACATACACGGTATTTTTCATATCGCTGGGATCGCCCCCAGCGAGAGTCTCCTCAATAAAGATATCGACGCCTTTCAAAACGTACTGGGGCCTAAAATTGCGGGCACGTTGATGCTTGACGATCTCTGTCGTGATGAACCGCTTGATGTTATCTGTTATTTTTCCTCCTCTGCCGCGATTTTAGGGGATTTTGGCGCCTGTGACTACGCGATTGGCAATCGTTTTCAGATGGCTTATGCCGCTTATCGCAACCATCTGCTGCAGCAGGGGATGCGACAGGGTAAGGCGTTGGTGATTAATTGGCCGCTTTGGCAAGAAGGCGGCATGGGGTTTCATCAAGACGAAAATACCAAGATGTACTTGAGCTCCAGCGGGCAGCGGGTTCTGGAAACTCAGGAAGCCTTGACGGTATTGGATCACGTCCTTAACCAGGACAAAACACAGCATTTGGTCCTGGTGGGGCAGCCAGGTCGGGTGTATGGCTTTTTAGGGTTGACTGAGGCGCCTATGACTCAGATGCCAGTGACTGAAGCGCCAGTGACGCAGACATCCACACGGCCAGAGTTGAGAGGCTTGAGTACGGAGCAGTCGGTATTATGGGATTTAAGAAATCTCATCGTCCAGCAACTCAAAGTGCCCTGGGAGCAGCTTGGGCGAGATCACAATCTCGCTGATTTCGGTTTTGATTCAATAAGCTTGTTGAGTTTTGCCAATCGTCTCAGCGAGCATTATCAACTTGACATTACACCTGCCTTGTTTTTTGGGTATTCGACTCTAGAGCAACTCACGCAGTACTTTTTAAGCGAGCATTGCGATTTTATCAACGCCTTTTATAAGGAACCCGAAAAATCGGAAATCCCTGTAAAAAAGGAAGCCGTTGAAGAGCGTGCTCCTATCCGGATTGTTTCTGAAGAAACCCGCCCAGAAAAAATAGATAATGCAAAAGATGAGCCCATTGCCATTATTGGCATGAGTGGCAGATTTCCCAAAGCTTACGATGTTGAACAAATGTGGCAGCTCTTGGCATCGGGTGAATGTGCGGTAGAAGAAATTTCACCACATTACTTTGATTGGCGCAGATACTTTGGAGAGCCGAGCCAGGAGGCTAACAAAACCAATGGAAAATGGTGTGCTAATATTCCTGGCGTTGCCGAATTCGACCCCCTGTTTTTCCAAATTTCCCCGAGAGAAGCGCCAAACATTGATCCTCGTCAACGGCACTTATTGCAAGAGTCTTGGAATGCTTTAGAACATGCCGGATACGGGCCGCATCAACTGAATAGCCAGAAGATCGGCACCTTTGTCGGGGCTGAAGAAGGGGATTATTATCAACGTGTCAAAGAGGGCAACATCACCTCCAATCACTCGGGCATTCTCGCCGCTCGTCTGGCCTATTTCTTAAACTTAAAAGGCCCGACCATGGCGATTAATACCGCGTGTTCCTCCTCACTGGTCGCGGCTCATCAGGCTTGTCTGAGTTTACGGCAGGGGGAATGTGATACGGCCATCGCGGCAGGGGTCAATCTAATGCTCACCCCTTACGGATATATCAGTATGGGCCGAGCAGGTATGCTCTCTGAGGATGGCCACTGTTATGCCTTTGATGAACGCGCCAATGGCTTAGTACCAGGTGAAGCCGTGGTCGTCGTGGTATTAAAGCGCCTTAGCCGAGCGCTTGCTGACGGTGATCCTATTCACGCGTTGATCTTGGCTAGCGGTGTTAACTATGATGGCAAAACCAATGGTATCACTGCACCAAATGGTGTTTCGCAGGCCGAGTTGGTGAGGGAGGTTCACCAACGAGCCGGGGTTCATCCGCAGGATATTGATTATATTGTGACACACGGTACGGGTACCCGGCTAGGTGACCCCGTGGAGGTCAACGCCCTTAACGAAGTCTTTAGGGACAGCCAACACCTTTGTGCGATTACATCCAGTAAAACCAATTTTGGCCATACGTTTTCCGCTTCGGGGCTGCTCAGTCTTGTCAATCTGGTACAGGCGCTTCGTCATGAGACCATTCCGAAAAGCCTGCATTTTGCTCAGCCAAACAAATTTATGACATGGGATCAAGGCCCTCTCTATGTCAATACGGCCAATAAGCCCTGGCTCGAAAAGCCGGGCGAAAAACGCATTGGCGGGGTGAGTGCGTTTGGAATGAGTGGCACCAATGCCCATATGCTGATTCAAGACTACCAGCTTCACAGAAAAGAACCACGTGCGGTCCCGCCTTATGCGCTGCTTGTGTTGTCTGCAAAAACGGCAGAGGCACTGCATCTCAAGGTCAAAGCCATGGTCGCGTTTTTGCAAGAAGGGCTTGCAGACACTGCCACCCTAGCGGATATCAGTTATACATTGTTTGAAGGCCGACACCACCTTCAATACCGTTTGGCTATTGTGGTGCAGGATATGACTGAGGCCATGTGTTGTTGGACACAAGCCGGGCAGCCAGATAAGAAACCCAATATTTTTCAGGGAAAAGTGCCTACCGAATTTAGTGGTCAAAAGGTCACACAGAATTATATTAACCAATTAGTAGAACAGCTTGATCGCTCTACCGGCGATGATGACGTATACCGAGAACGTCTCTTGGGTTTAGCTGATTTTTATTGTCAGGGGTATGATGTCCCTTGGTCTAGGCTATACGGTGATACACGGCCACGCCGTATAAGTCTGCCTGGGTATCCGTTTGCTAAACAACAATTTTGGCTGGATTTCTCTCCGAAGGATCATGGCGAACAAGAAAATGTCGAACTTCCTATTGGCAAGATGCAGAGACAAGTTCTAAATGAAAAAAACACGCTTGAAACATTAAGCTACATTCACAAATGGGAACAGCAGGATAAAGCTGAAGTCAAGATAGAAATCAGCCAGGTTTGCTTACTAGTTTACTTTGAATCTGCATCGCAATTTGAAAAAACGCTGGCAAGCTTCTTCTTGCAGCAGGGTGCATCTCAGGTGATCGAGATTCAATTGGGACTCGAAACCAAACCGGTGTCCGAACATAAATGGCGCTGCAATGTCAATGACGTCGACGCTTTTCAGCGTTGCCTTCAAGCCTATGCACAGACAATCAATAGCGTTTACTTTCTCTGTGTCGATACCCTCCAGCAGGGCATGGAAGAAAGCGAAATGCAGTTGCTACGGCTGGTCAAAGCCTTAAAATCACGTATGCAGAGCCATGCCTTTATCGATTTCACCCTTCTGACTCTGGATAATCACCGCGTCGATAACAGCGCGACAAGTCCCAACCACGGGGGGCTTAGCGGTCTTGGGTACTCGGTGGCGCAGAGCGATCACCGCTTCCGGGTTCGAAATATCGATTTGTCGCGGGAAGATCTGGTGAGCGCCGAACAACAATGCACCCTGCCAGGCATGATCGTCAGCGAAGCCCCGTCGGACCGAGGCGAGGTGGTCAAGTTGCAGGCAGGTTTGCGCTACAAGCAGCGCTTTTTCAAGCTCGACTGGCAGACGCTGCAAGCGGCACAGCCAGAGGCGGCGGGTTTGAAAACCGGTGGGGTCTATGTGTTGTTGGGTGGCGCGGGAACCGTTGGTGCGATTATAACCCGCTATCTCATCCAAAAATATCAGGCCAATGTGGTTTGGCTGGGGCGTCGTGCGCTGACATCGCCTGCCGTGCAGGAACAACTACACGCGTTCCGGAGCGTGGACGAAGGGTGTGTGCCACTCTATATTCAGGCCGATGTGACGGATCAGGCTTCCATGACTCAAGCGGTCAAAGAGATCAAGCAACATCACCCTTGCATCCATGGCGCGATTTTCTCCGCACTGGTCTTTAAGTTGGATAACTCAATTGCTAAGACTAGCGAGGAAGACTTTAATGAGGTTTTGGATACCAAGAAAAAGGGTGCGCAGTATTTTTATCATGCATTCAAAGATGAAAACTTAGATTTTATGTGTTATTTCTCGTCGGTCCAATCTTTTTTCTTTATCTCCTCTCGAGAGAGTGCAGGGTATGCAACCGGTATTACCAGCGCTGACACCTTTGTACATGCCATCGATCACGATAGCACCTTTCCTGTCGGTATCATCAATTGGGGTTACTGGGAGGCCTCTCTGGCGGGAACCGAAGCCGAGAAGCGTTTGCCCGGTCATTATGACTTAATCTCTGATCATGATGGATGTCAGTTTTTTGACGGATTTGTACCTATGCTTAGATCAGGCCTTATCAAACAGGCCGTTTGTTTAGGTGTGTCAAAAGCGATAGAGGATTTCATGGGCTGTGACGCCACGCAGATGATCACGGTGAACAAGCTTGAGGCTGATTCTTTGATTTTTAGCCTTTTTAATGAAAATGAGTGCGGCCAAGCTACGTGTGAGGAAACTGAAATCGAGCGCCTTTTGGATAAAGATTTCAACAATGAACTTAAGCAATGGTTGCCGCGGCTGCTATTTTCACAGCTGCAACAACTGGGGATCTTTTTAAATCGTGGTGAGCAGAGAGATTGTACGACGTGGCAACAACAAGCTGGTGTGATCAAAAAATATGAACGCTGGTGGCGAGAGTGTTGCTTAGGGCTGCTGGAGACCTCCGGCTACGTACAATGTGAAGGTGAGAGGGTTGAGGTCACTCACCATAGTCCGGCAGACGAGGCGGATCAACTCTGGCAAGGCTGGGAGAGCTTCCAAAATTTATTCCTCGACAAGCCGGAAAGAAAACCTGTGCTCGACTTATTGGAGAGCTGTCTGAGAAGCCTGACGCAAATCCTGTGCGGTGACATCCTGGCCACCGATATTCTTTTTCCAAAATCGTCAATGGAAAAAGTAGAAAATATATACCAGCGGAATGCCCTATCCGACTATTGTAATACCTTTGTCGCGAAAGGTATCGAAGCTTACATTCATCAGCGGATTCAGGCAGAGCCTCAGGCAAGGATCCGGATATTGGAAGTCGGTGCAGGTACTGGAGGTACCACCGCATTGGTCCTGCCACAACTGCGTCAGGTGCAGCATGCGATAGACGAGTATTGTTATACAGACATTTCCAAAGCCTTCTTGATACATGCAGAAAAGACTTATGGGCCGGATTATAACTATCTAGATTATAAGCTACTCAATCTCGAACAACCGTTAGCGCCACAAGGAATAGAGCCTGGCTCCTATGATATGGTAATCGCTACCAACGTGTTGCACGCTACAGAGAATATCAGACAAACCCTTCGCCATACTAAAACTGCTCTAAAACGTCATGGATTATTAGTGATCAATGAAGTGGTTGAGAAATCTATTGTCGGTATCTTAACCTTCGGGTTGTTAGACGGCTGGTGGCTCTACCAAGACGAATCATTACGCATCCCAGGCTCTCCGCTGATCACGCTGGATACCTGGCGTAAAATTTTAAAAGAAGAGGGCTTTGCCAGGGTCTTGTTGCCAATGCGAGCCGCATCTAAGTTGGGTCAGCAAGTGATGGTGGCGGAAAGTGACGGTCTGGTTAGACGGGAGAGAGAAGACTTGCCGGACGAGGACGAATCGGCTGTGACTGATAAAACGTCCGTGGTACAGGGCATGACTTTGACTCCGGAACAGCGAATTGCGCAAACACCGTCTGTACGGGAGCTGTCGTCCGAAACACTACGAGAACAGGTTGCCGAGCTTATTTTGACAGGATTGGCCGAAACATTAGGCATGGCGCAAGAAAATATTGACCCACTAGTTTCATTTTCTGACTATGGTATTGATTCTATTCTTGGTGTCGGTTTTATTGGTCAGCTTACTAAATCCTTCGGCATCACCATCAATACCGCTATATTGTATGATTATACCAATGTAGTGCGTCTTAGTGATTATCTGGTAGAAATCTATGCAGAGGACATACAAAACAAAATTCAAAACAACCGCATGTCTCCAGTTGAGAAAGATGCTGTTCTATATACAGAGACACAACTAGAAACAACAGTCGATCGTAATCCGGAAAAAAGTCAGCTTGAAAACTCAGTTCCTAATATGACCTCTGGCGAGAATAAGTCCGCCAAATGCCAGGAGATCGCTGTTATTGGTATGTCAGGGCAGTTCCCTAGAGCAAAAGACCTTGACGCCTTCTGGCAAAATCTGATTCAGGGACGGGATGGTGTTGTAGAGCTACCCGCGAATTATCTCAATCCGGCTTTGTTTAGCCCGCACAAACAAGCGGGAACAACCGATTGTAAATGGGGTGGCATTTTAGAGCAGCGTGATTGTTTTGACCCACTTTTTTTCAACCTTACGCCCAGGGAAGCGGAGTCGATGAACCCGCATCAGCGTCTCATTCTGAGTGAGAGCTGGAAAGCGCTGGAAGATGCCGGCTACAATCCCAAAGAGCTGGATAATACTCGCGTTAGCGTGTTTATTGGCGCGGAACCTACCGACTATTACCATGAAACCTTTACCGGCTCTTCTGATGCTATTGTTGCCTCCCGCTTATCCTACTACCTCAACCTCAAGGGACCGGCTTTGGTGGTCAATACGGGTTGTTCGTCTTCTGCTTTGGCGATTCACTTGGCCTGCGAAAGTTTACGCCGTGGCGAGTCTTCAATGGCCCTGACAGGTGGCATTTTTGCTGCAATGCATGAAGAAGCACTGGTTAAACTAGCCCAGATTGATATGCTTAGTGCCACCGGTCGCTGCCGTACATTTGATCAATTCTGCGATGGTACCGTATTGTCTGAAGGTGTTGGGGTGGTTGTGTTAAAACGGCTTGACGATGCCGTCAGGGACAACGACCCCATCTATGGCGTGATTCAAGCCTCTGGGGCAAATCAGGACGGTGCCAGCAATGGGATAACTGCGCCTAGTGGTTTGTCGCAGGAAGAACTCCTGACGTCTGTCTACCGGCAATATGACATCAATCCGGAAACGATCACGTATATTGAAGCTCATGGAACTGGTACCTCACTTGGAGATACCGTTGAGGCTAATGCGTTAAAGCGGGCCTTTAAACAGTTTACGGATAAAAAACAATTCTGTGCACTTGGCAGCGCAAAATCTCATATCGGCCATACAGGAGCTGCTGCTGGCGTTATTGGTTTAATCAAAGTTTTGTTGTCGATGCGCTATCATCAGCTGCCTAAACTGTTGCACTTCGAAGAACTCAATCCATCAATCGAATTGGAAGATTCTGCATTTTATATCAATCAACAGCAAATGGAATGGACGGGGCAGGGCGTGCCATTAACCGCAGGGCTGAATTCTTTTGGCCACAGTGGTACGAACGTTCACCTCGTGGTTCGGGAATACCTGCCGTTATCTGAGACGAAAGCCGAAATGGAGGCTGTACTGATTCCATTGTCTGCCAAAACCCTCGAATCCCTTAGAACCTATGCTGAAAGTTTATCGACGTTTCTGGAAAATGGGCATTCTGGTCATGGTGTTAGCCTCACCGATTTAGCCTTTACCCTCCAGCTTGGACGCGAAGCGATGCGGGAGCGCTGTATTTTCTTGGCTGGAAATGTCCCGGATTTGGTAGCCCAATTAAAGGCTTTTGCGAATGACAAGACGCTCAACAATGTGGGTTGGTACGGCCGGGTTGGACGCAGCAAGAACAGCCATTCCTTCAATGATCATGAGTCTCGGCAAATGATCACTCAATGGTTGCAACAAGGAAAATTGGATAAAATTGCCGCCGCTTGGGTACAGGGCCTGAGCATTGACTGGGCAGCCCTTTATCGCGAGCTCACAGCTCGTAAAATCCATGCGCCAACCTATCCTTTTGCCCAGGAACATTATTGGAAACCCGAACAGCAGAGTATGGTTCAGAAGCCCGTTGCGCCGGAAACACAGCCTGAGACCTTCGGAACACTGATGTTGCAGCCCTGTTGGATAGATCAACCCCTTGAACATTCATAA", "orf_prot_sequence": "MLRTGMKTDSPNHPENQAINVNHYLMVLSAKTKERLQTVVENLLDYAKANRRLIESRLADVAFTLQTGREEMEARLAFVVSDYHDLMGQLSGYLEDAPNANTIFRGQVDLFDQSAPVRQHRAAQERDCERMIRTHDLPGLAELFVQGVPIDWRRLYVQGRPRRIALPSYPFAPERHWVARREPDHLAADMPAVRQPHSLLDGRDDRMSLESGVVFRKLLRINDGVLQDHQVNETPVFPGVAYIEMACEALAQLSFSDPEVLRKTVLNQMVWLQALAVTEAEHEILLCLEKDTHGLAFEVKDHQTLYAKGRFDQSDDLSQGHQYLELETIKGDCPHEKHRSVIYHDFRLLGLNYGPWFQGLEHTWFSIDSAEGEGEALGYFNMPLICESEFSAYTFHPGLLDAALQVVASVPGYADSGLLLPYAVEKLEWFHPFPACGYSHVRKLAKHRYDVTICDEQGKVCAKFSDLSVRPSRVAGSEPSLNQLTYRARWSHQELGERRSPAGRPEETGVVFIIHTPEQQALVQELSSVLADMHGDHRVRRMCLNANDWDFKSLGNWNHRIRAVQDLRDIYFLAAMEHTVSSGQAHVDPLSFTNRQEHGLLSLFRLLKALDQNQLLLQPLSLKVLTTGNYRVLPSDTICPLSAGLPGFCRSIAQEYPLLALSCIDLGCPDGDAMQPSSLKKLAQFIVAEPAHQPHETVGIRELRRYTRKLVPVRFPEPGGQRAFKSRGVYMIVGGAGGIGMVLAQYLAERVQARLVLVGRSALDEEKKQNLSTLTAAGGEALYIQADISRLYSMKDAVAQARQRFGNINGVVHSAMVLNDQSLARMSEEGLRASLAPKVEGCIVLQQAMAGEPLDFMLFFSSAISFSGNAGQSNYAAASTFKDAFAHYLTQVEAYPVFNINWGYWGCVGVVANAAYRERWAARGVHSIDPEQGLQVIESILTNHIDQVAAVNVEPSFLERLGVELSQTQTVLPPRRSSLIAKLNALPLPETGGFQDNVNRLEIVSAFRWAEVFKHMLDMSSTQGMYARSDLKRQLQISSEHDQLFDVLISMLIQEGYLHQQGKNLTPTPYLNGEFFQQQREQVALLESELSQTDNAYLNLLSRCLDHYPAMLRGEVAATDVIFPQGSMEWVEGIYRSHASADYFNQQLAQRLVAYVEARLPSLGANESIHILEIGAGTGGTSAIVLQALQPYAARLRYTYSDISPGFLNYGRKTFGDAYPFVEFRHLNIEHNGEAQGYQAGEYDLVLAANVLHATRHIGNTLARVKFFMKRHGWLLLNEATQVRHFGTLTFGLLKGWWLFQDAENRLDGSPLLSTTAWQRLLSEEGFKHTLSLCDAVEEESIFQDVIVAESDGVIQMNQSDSPVQPREPVDVSVDVHHVDDMMEPGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVDSITGVDFIHQINSRLGIVLRTTALFDHATIFDLSRFIDESHGAAIDEQRQRLRSTPLTSSDTKPAERVAPPDEALPHIERGCHQAVVLEKPSQIEHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLLCVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGHSTLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGEKVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIAMVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQLISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPDGMMDNQVGQRMVPESSTVEDYRVGNATVEQVAVKQPADMDEPIAVVGMSGRFPGANNLEQFWLNLIGGNNAITEVPADRWDVHQWYDPDPAVLDKTHCRWGGFLRDIDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSVPGEPQSFWGNSSSLIASRIAYFLNLKGPSITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGIIRGSGSNQDGRTYGITAPSAASQTELEQSVYRQAELDPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFIKVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPRRAAVSSFGFSGTNAHILLEEYQHHEDEAQALGDDKDVLIVLSAKNQERLKKAAENLHHFLESRVSYKLSDIAYTLQVGREAMEARVAFMVVSVLDLQQKLVSLLHDPTDEQDMYWGEVRDGEGPAGVAAFEDVALALANKQLDQLAQWWVSGVEIDWTQLARVVKVRLVPLPTYPFSPDRYWFDSVGPATVVHAEHSASALYPLLNRIAPQASTQIANGCVFETCLKSSDPLLAQHLIDGQAVFPAVGFLEMVIAGLREIQPDKAARLENVFWLRPLDVMDEQRVHLVFEVKQDRFQYRIVPAESHGDGAYFRGQGYWSNDMNPAIPMDIDRLKSRMRQQPLLNESSPRVRLGRLYQGATEGWTDGEQALIAFELPTAQPYRDGSPDQKSYPFHPAAFVAALQAYHWIHEAPKRLGMPFAVQKVELWRHRDQPAYAYVALDEHGNADVHILDAGGQVCVCYRGMALQTLNNAHHDGRQESTQKDELGKLLFVPVWKRLDTKHGRAHGMHALARGTGVLLVYTHENGVEAEQLMQRYREEQCELLSVCLSAADRALDTLAARLKHLQSPLRHVCFLDRHQAALDPADKQIDERLREPQTLTGFLALVRTLSELGYDEQPLQWLVLTSSACAVNQADPINPYAAAIVGLASCLAQEHRYWQVSVCDRGKGTSFTTIANHGETLRVIAERSGYSYVRHIKELELPPPRQSRLRHKGVYVLVGGAGYVGTLLSRYLVQTYQAKVIWLGRREQDEQIEQNIALIATLGSRPQYLSLKTGSDDELHRAFAQIKAENGLIHGVFNLVMVAQSTPMRSLSEAQFRAGSFNSKVNSAQALYRILKKEALDFMVFFSSMQSFAQQLNFMSANMSSYVAGCMFQDAFVHQINCELSYPVKTINWGYWSQESSESEKAKWYETYIADKGIYSLNVGEAMQALEYILAHEPEQVIVTKVSHRVLSDMGFVQDDSENVDLQPVIDSNDDNTQLEDLIVNGILKTFETLDVLQVFDSACNLDVSRLQAHVPDKYRRLWRELLLILVQAGKMAPQGAGFALRESYTSLASQLRLMDLDREAGLLRERHPTLASKLALLVPCLKDMAEVLTARKPATEVLFEHASLSRVEGIYRGNPTTDYFNQRVADIVKAAVQQALPSLSVGKKVRILEIGAGTGGTSAYLFQALNTYADQLHYIYTDISKRFLIHADETFCEQYSFIETKLLNIEQDVAGQGFDPASIDIVVAANVLHATRNISKTLQHVKDLLKNDGLLVLNELADVSPFLTVTFGLLDGWWLYDDEAIRQPGSPGLSAKNWQLVLKNQRFHNISLNDEKALTSEQQIIIAQNESKESVPVSSTVLLGTELIASVEASLIAQLSQCIKIEQNRLNTYTTFSDYGVDSILMLAYVDQINGDLGIDLNPSELFNYTTVERLTKFIVDYHGKEIISAKESVERSLLQNQESKFDLNDIDVITKAGNEAPEMARSLLFDNVLQVPSGNVHHHQSDKARPDIAVIGMSGQFPGATNVQQFWQNLSAGVDSVSELPESRLDRQLYSPQPEAGKCYCQWGGILEEQASFDPLFFEISPKEAAEMNPSQRVFMQEAYRALEDAGLVNAGLSQLHCGIYVGCEPNGYTKQGFTGASEAIVASRISYFLNLQGPALVINSGCSSSLVAIHLACESLRHGENDIALAGGVFTNLNNELLVCLSSIEMLSFSGKCHAFDEAANGTVLCEGVSVLVLKRLQDALDDGDVIYGVIKGSGMNQDGRSNGITAPNGLAQENLIKRIYQDYNIDASKISYIEAHGTGTKLGDPVEANAXKNVFSSRNTGLDFRCGIGSVKSNIGHAAAAAGVIGLVKVLLCMQHRQLPGLVHFNKLNPLIDFNDTGLYIVEQLQNWEPASGEPLMAGINSFGHSGTNAHLVIQEPPVRPVRDSENPFHLICLSAKTEEALKQKISDLSAYLRRKEEPPTLGAISYTLNTGRAHFRKRCAFVVDSLEALQNALMGALDGLVGNAERLSPQEQAFCKKAFDLIIKDLHDVENLESRADQTIYKDNLLALTGLYLKGFDLDWQRVYKGQSYHRVSLPTYPFSRDTYWIDEPKQISFTEPGTDKPGNTSRNHQQDQKDEDVLGGQFYIPQWKRLDQTQSYASLSDHGKLTIASDPVVIFYPPTMTSLKDDIQTCYEQLPASQVASFELGCTPSSEVDVRDPRAFERIFVSPRQALEELLEQGRTLTIYFILPEPDQNPDSGCNLECLEESLSLGLISLFRLIQALLAHHGYASELTLKIVTQQTQVCKASERIVPYGADVVGFVQSLAKEYELWQISCVDINRQTWWTPAQSKNFAEALIALKPPADGRALCWRDGYVYHRVLTPANLVGVQGSAFKTRGVYLIIGGAGGLGLVLSQYLLEHVQAKLVWVGRRSLEALAPDALRLFNTPGAHVLYEQADLCDPEALQRALQQAKGRFGYIDGVIHSALILEDRAIADMDEKTLRKVLAPKVQGNVVLQQVLADEPLDFLLYFSAGQSFMSHAGQSNYAAACTFEDAWALCQDQRQNYPIKIINWGYWGEVGIVATADYRKQMARQGVLSIHPQEGMEAVERCLASCATQAAYFKVEPRALSRLGLDGTGILHASRNRVPPQLIHVVIDATQAWSISMPYAQRYQQSLKKLDRLGCYLLLRVFQAMGVFSQPHEHYEKQELASRLAISKGYHHLYQECLNLLDTSGFIAINGSHIEVQDVLPEEHDEHHSWLQPYPELAAHEKLLRICLQAFPDIIRGSVAATDIIFPDASVELVEGIYQGNPATDALNTKAKDAVVAYVKARLADCQEQIIFLEVGAGTGGMSHEVLKGLAPYGQYIEYYYTDVSEHFIQYARRRYGQDYPFVRFQRLDIEQEHSALSEGLLSACDVVLAANVLHATQSVRNTIQHVKALLKRHGLLILNEATTLESFATLTFGLLEGWWRYQDAGDRLPGGPLLSASMWHRLLEEEGFDQVVSLGEPGEGDMLGQHLIVGRSDGWSLHQSARDDETRSAPVSPVAASDVIQGNRNDKPAELIKHVEAQIVQTLSAALDIAAARVERDVSFSEYGVDSILSVAIINQLNQRLGIRLKRPDLFNYTTTESMAAHIVATFADHLTAALVEEAEPPTPVTVASPQPIKAAGQQDVLQQNLQTQPQVSQGVWQTKPEPIAVIGMSACVPGADHVGAFWDNLVAGTDSVTRIPHERWQREAVNELPGGPDTSQRKAGFMDNIAEFDPLFFAISPQEAQWMDPTQRLFLQQAWAALEDAGYNPRALAGASCAVMVGCAATGYGVKEGERTGYVSYAMTNSEAILPARISYFLDLKGPSIPINTACSSSLVAIHLACEQLRSGQSDMALAGGASALIGSALHIGLNGVGMLSPEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKTPFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTNAYMVVEAFVETSPRAVGQQGPALIVLSARHEVRLKELASNLMAYLKRYGLNPDRPIQLEDMAYTLQVGRQAMSERLAFVADSVADVVKHLATFVDGEANAQELYRGQVKPFGDKSDLLLEGEAGQAFLNTILRQQDYRKLAALWVAGTDLDWNLLYDGENRARRISLPTYPFARETYWLDEGIGSNEKELLRDQTQKELRDRDREQTTELMTFEEIWQEASLNNHSDSIKYKSIVCFLSGSEHQQEMRTAMQAIDPAIHLTMIAQGHGYTKHSSDRYTVDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVAAFSTALERCYLESWIGFERSLKLIMPGFQVAGLFQEHAGPDQTISMTHWSQHIVSELKAPKAQTVLIQNHRRYVNQIQKTELAAQGASVASAVKQGGTYLITGGCGGLGFLVAQHLAEHLGQPAASASGKTVHLILTGRSSPDDAIQSKITQLEALGAKVGYVQADVADAVAMRRGLAQMKNRFGDIHGIFHIAGIAPSESLLNKDIDAFQNVLGPKIAGTLMLDDLCRDEPLDVICYFSSSAAILGDFGACDYAIGNRFQMAYAAYRNHLLQQGMRQGKALVINWPLWQEGGMGFHQDENTKMYLSSSGQRVLETQEALTVLDHVLNQDKTQHLVLVGQPGRVYGFLGLTEAPMTQMPVTEAPVTQTSTRPELRGLSTEQSVLWDLRNLIVQQLKVPWEQLGRDHNLADFGFDSISLLSFANRLSEHYQLDITPALFFGYSTLEQLTQYFLSEHCDFINAFYKEPEKSEIPVKKEAVEERAPIRIVSEETRPEKIDNAKDEPIAIIGMSGRFPKAYDVEQMWQLLASGECAVEEISPHYFDWRRYFGEPSQEANKTNGKWCANIPGVAEFDPLFFQISPREAPNIDPRQRHLLQESWNALEHAGYGPHQLNSQKIGTFVGAEEGDYYQRVKEGNITSNHSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGVNLMLTPYGYISMGRAGMLSEDGHCYAFDERANGLVPGEAVVVVVLKRLSRALADGDPIHALILASGVNYDGKTNGITAPNGVSQAELVREVHQRAGVHPQDIDYIVTHGTGTRLGDPVEVNALNEVFRDSQHLCAITSSKTNFGHTFSASGLLSLVNLVQALRHETIPKSLHFAQPNKFMTWDQGPLYVNTANKPWLEKPGEKRIGGVSAFGMSGTNAHMLIQDYQLHRKEPRAVPPYALLVLSAKTAEALHLKVKAMVAFLQEGLADTATLADISYTLFEGRHHLQYRLAIVVQDMTEAMCCWTQAGQPDKKPNIFQGKVPTEFSGQKVTQNYINQLVEQLDRSTGDDDVYRERLLGLADFYCQGYDVPWSRLYGDTRPRRISLPGYPFAKQQFWLDFSPKDHGEQENVELPIGKMQRQVLNEKNTLETLSYIHKWEQQDKAEVKIEISQVCLLVYFESASQFEKTLASFFLQQGASQVIEIQLGLETKPVSEHKWRCNVNDVDAFQRCLQAYAQTINSVYFLCVDTLQQGMEESEMQLLRLVKALKSRMQSHAFIDFTLLTLDNHRVDNSATSPNHGGLSGLGYSVAQSDHRFRVRNIDLSREDLVSAEQQCTLPGMIVSEAPSDRGEVVKLQAGLRYKQRFFKLDWQTLQAAQPEAAGLKTGGVYVLLGGAGTVGAIITRYLIQKYQANVVWLGRRALTSPAVQEQLHAFRSVDEGCVPLYIQADVTDQASMTQAVKEIKQHHPCIHGAIFSALVFKLDNSIAKTSEEDFNEVLDTKKKGAQYFYHAFKDENLDFMCYFSSVQSFFFISSRESAGYATGITSADTFVHAIDHDSTFPVGIINWGYWEASLAGTEAEKRLPGHYDLISDHDGCQFFDGFVPMLRSGLIKQAVCLGVSKAIEDFMGCDATQMITVNKLEADSLIFSLFNENECGQATCEETEIERLLDKDFNNELKQWLPRLLFSQLQQLGIFLNRGEQRDCTTWQQQAGVIKKYERWWRECCLGLLETSGYVQCEGERVEVTHHSPADEADQLWQGWESFQNLFLDKPERKPVLDLLESCLRSLTQILCGDILATDILFPKSSMEKVENIYQRNALSDYCNTFVAKGIEAYIHQRIQAEPQARIRILEVGAGTGGTTALVLPQLRQVQHAIDEYCYTDISKAFLIHAEKTYGPDYNYLDYKLLNLEQPLAPQGIEPGSYDMVIATNVLHATENIRQTLRHTKTALKRHGLLVINEVVEKSIVGILTFGLLDGWWLYQDESLRIPGSPLITLDTWRKILKEEGFARVLLPMRAASKLGQQVMVAESDGLVRREREDLPDEDESAVTDKTSVVQGMTLTPEQRIAQTPSVRELSSETLREQVAELILTGLAETLGMAQENIDPLVSFSDYGIDSILGVGFIGQLTKSFGITINTAILYDYTNVVRLSDYLVEIYAEDIQNKIQNNRMSPVEKDAVLYTETQLETTVDRNPEKSQLENSVPNMTSGENKSAKCQEIAVIGMSGQFPRAKDLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGGILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIGAEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVNTGCSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATGRCRTFDQFCDGTVLSEGVGVVVLKRLDDAVRDNDPIYGVIQASGANQDGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMRYHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREYLPLSETKAEMEAVLIPLSAKTLESLRTYAESLSTFLENGHSGHGVSLTDLAFTLQLGREAMRERCIFLAGNVPDLVAQLKAFANDKTLNNVGWYGRVGRSKNSHSFNDHESRQMITQWLQQGKLDKIAAAWVQGLSIDWAALYRELTARKIHAPTYPFAQEHYWKPEQQSMVQKPVAPETQPETFGTLMLQPCWIDQPLEHS", "perc_identity": 25.64}, "gnl|BL_ORD_ID|1968|hsp_num:2": {"type_match": "Loose", "snp": {"original": "G", "change": "S", "position": 269}, "query_snp": {"original": "G", "change": "S", "position": 218}, "orf_strand": "+", "orf_start": 33035, "orf_end": 60031, "orf_from": "BGC0001186.1|Misakinolide_16 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.96707e-15, "bit_score": 78.1814, "max_identities": 97, "cvterm_id": "39507", "query": "DLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGGILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIG-----AEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVN-------------TGCSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATG-----RCRTFDQFCDGTVLSEGVGVVVLKRLDDA-VRDNDPIYGVIQASGANQDGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMRYHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREY", "match": "D+++ W+ L+ G  G+  L   ++     +          K GG L  +D  D     L  R    +    +L+  + W   E AG    E+D  R +V +G     AE     ++         V+      +   G A V+              + CSS + AI  A   +  G++ +A+ GG+   +    +   + +  +S          R FD+  DG V  E   +++++  + A  R   P+  ++ A G   D       A  G+     +T       ++P  I ++ AHGT T +GD  EANA++ A     D+    A+ + KS +GH+  A G +  +  +L++R   +P  L++E  +P I+L+  A         +           NSFG  G NV L    Y", "sequence_from_db": "DIESTWKGLLAGESGIHALEDEFVTKWDLA---------VKIGGHL--KDPVDSHMGRLDMRRMSYVQRMGKLLGGQLW---ESAGS--PEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGA-GITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVA---GCDQ---AAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVN--------NSFGFGGHNVALAFGRY", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 58235, "query_end": 59422, "hit_start": 81, "hit_end": 1248, "orf_dna_sequence": "ATGTTGAGGACCGGCATGAAGACAGATAGCCCGAATCATCCAGAAAACCAAGCGATCAATGTCAATCACTATTTAATGGTTTTGTCGGCCAAAACGAAAGAGCGCCTGCAAACGGTGGTTGAAAATCTACTTGACTACGCCAAAGCCAATCGTCGTCTCATCGAGTCCCGCCTTGCGGATGTCGCCTTTACCTTGCAAACGGGCCGCGAGGAGATGGAAGCGCGTTTGGCCTTCGTGGTATCGGATTATCATGATCTGATGGGTCAGTTAAGCGGTTATCTGGAGGATGCGCCCAACGCGAACACGATTTTCCGCGGACAGGTGGATCTGTTTGACCAATCTGCGCCGGTTCGTCAACATCGCGCGGCACAAGAGCGCGACTGCGAACGCATGATACGGACCCACGACCTGCCGGGCTTGGCCGAACTTTTTGTTCAGGGCGTGCCGATTGACTGGCGCCGTTTATATGTGCAGGGTCGCCCCAGGCGCATCGCGCTGCCCAGCTACCCCTTTGCCCCAGAGCGTCACTGGGTGGCGCGCCGGGAGCCTGACCATCTGGCTGCCGATATGCCCGCCGTTCGGCAGCCACACTCGCTGCTTGATGGACGTGATGATCGAATGAGTCTTGAGTCCGGCGTCGTGTTTCGAAAGCTGTTGCGCATTAACGATGGTGTCCTTCAGGATCATCAAGTCAATGAAACACCCGTATTCCCAGGCGTGGCCTATATAGAGATGGCCTGCGAAGCTTTGGCGCAGTTGTCGTTTTCTGATCCGGAGGTGTTGCGGAAGACCGTATTGAACCAAATGGTTTGGCTACAAGCCCTCGCCGTGACAGAGGCCGAGCATGAAATTTTGCTATGCTTGGAAAAAGATACACATGGTCTAGCATTTGAAGTCAAAGATCATCAAACGCTTTATGCCAAGGGCCGTTTCGATCAGTCGGATGACTTGAGTCAAGGCCATCAATACCTGGAACTGGAAACTATAAAAGGTGATTGTCCGCACGAAAAGCATCGCTCGGTCATTTACCATGACTTCCGCCTCTTAGGGCTAAATTATGGACCTTGGTTCCAGGGCTTAGAGCATACTTGGTTCAGTATAGATAGTGCTGAAGGGGAGGGTGAAGCGCTCGGCTATTTTAACATGCCGTTGATTTGCGAGTCGGAATTCTCCGCTTATACCTTTCATCCTGGCCTGTTGGATGCGGCATTGCAAGTCGTTGCCAGCGTGCCCGGATACGCTGACTCTGGCTTATTACTTCCCTATGCGGTAGAAAAGCTGGAGTGGTTCCACCCGTTTCCTGCTTGCGGATATTCCCATGTTCGCAAGCTGGCGAAGCATCGCTACGATGTCACCATCTGCGATGAACAAGGCAAGGTCTGCGCTAAATTTTCTGATCTTAGTGTTAGGCCCAGCCGAGTCGCAGGCTCAGAGCCCAGCCTGAATCAGCTGACCTACCGGGCGCGCTGGTCGCACCAAGAACTTGGGGAAAGACGATCGCCAGCAGGCCGTCCCGAAGAAACCGGAGTCGTGTTCATCATTCACACTCCGGAACAGCAGGCATTGGTACAAGAGCTAAGCAGCGTTTTAGCAGACATGCATGGCGATCATCGAGTACGACGGATGTGCCTAAATGCAAACGACTGGGATTTTAAATCGTTAGGGAATTGGAATCACCGTATTCGCGCCGTTCAGGACTTGCGCGATATCTATTTTCTTGCTGCTATGGAGCATACCGTTTCGAGCGGACAGGCCCATGTGGATCCTCTCTCTTTTACCAACCGACAGGAGCATGGGCTGCTCTCTTTATTCCGCTTGCTCAAAGCGCTGGATCAGAACCAGTTACTACTGCAACCGCTGTCGTTAAAAGTCCTAACGACAGGAAATTATCGCGTTTTGCCAAGCGATACGATTTGCCCTTTGAGTGCCGGTTTACCAGGTTTTTGCCGCTCCATTGCTCAGGAATACCCCTTGCTCGCTCTCAGTTGTATCGATCTCGGATGCCCGGATGGCGACGCCATGCAGCCATCCTCGCTTAAAAAACTGGCGCAGTTCATCGTTGCTGAGCCCGCGCATCAGCCTCATGAAACCGTCGGCATACGTGAACTCCGGCGCTATACTCGCAAGCTTGTTCCCGTTCGTTTTCCCGAACCCGGAGGGCAAAGAGCTTTTAAATCCCGAGGCGTCTACATGATCGTTGGCGGAGCTGGGGGCATTGGGATGGTGCTGGCCCAGTACCTGGCCGAGCGTGTTCAGGCGCGTCTGGTCTTGGTGGGCAGAAGTGCTTTGGATGAGGAGAAAAAGCAAAACCTTTCGACGCTCACTGCCGCCGGTGGAGAAGCCCTATATATCCAGGCAGATATCAGTCGTCTGTACAGCATGAAAGATGCCGTCGCCCAAGCCCGTCAGCGTTTTGGCAACATCAACGGTGTGGTGCATTCCGCCATGGTTTTAAATGACCAAAGCTTGGCCCGTATGAGTGAAGAGGGGTTGCGGGCCAGCCTGGCGCCAAAAGTCGAAGGCTGTATCGTGTTGCAGCAGGCGATGGCCGGTGAGCCACTGGATTTTATGTTGTTCTTTTCTTCGGCAATCTCCTTTAGCGGCAACGCCGGACAAAGTAACTATGCAGCAGCTAGTACATTTAAGGATGCCTTTGCCCATTATCTGACGCAAGTGGAAGCTTATCCCGTATTTAACATCAACTGGGGATATTGGGGGTGTGTTGGTGTGGTTGCGAATGCAGCTTACCGTGAACGTTGGGCAGCTCGAGGAGTCCATTCTATTGACCCAGAACAGGGTCTGCAAGTCATTGAATCGATCCTGACTAACCATATTGATCAAGTCGCTGCGGTGAATGTCGAGCCGTCTTTTCTAGAGCGCCTGGGCGTAGAACTGTCTCAAACACAAACTGTACTCCCACCACGTCGCTCGTCGCTGATTGCAAAACTTAATGCGTTGCCACTGCCGGAAACCGGGGGTTTTCAAGATAATGTTAATCGCCTAGAGATCGTGAGTGCATTCCGCTGGGCTGAAGTGTTTAAGCATATGCTTGATATGTCTAGCACTCAGGGAATGTATGCTCGCTCTGATCTTAAACGACAATTACAGATTAGCTCTGAACACGATCAGTTGTTTGATGTTCTCATTTCTATGCTCATTCAAGAGGGCTATCTCCATCAGCAGGGCAAAAATCTGACGCCTACACCTTACTTGAATGGCGAGTTTTTCCAGCAGCAGAGAGAACAAGTCGCATTGCTGGAAAGTGAGCTGTCGCAAACGGATAATGCCTATTTAAACTTGTTATCTCGCTGTCTGGATCACTATCCCGCTATGTTGCGCGGTGAAGTGGCGGCAACTGATGTGATATTCCCACAGGGCTCGATGGAATGGGTGGAAGGTATCTACCGCAGCCATGCTTCAGCCGACTATTTTAATCAGCAATTGGCCCAACGCCTCGTTGCCTATGTTGAGGCCCGCTTGCCTTCCCTGGGTGCGAATGAATCGATTCATATCCTAGAAATTGGCGCCGGCACCGGCGGCACCAGCGCCATTGTATTACAGGCGCTCCAGCCTTATGCAGCTCGCCTGCGTTATACCTACTCCGATATCTCGCCTGGTTTCCTCAATTACGGGCGCAAAACCTTTGGCGACGCGTATCCGTTTGTCGAATTCAGACACTTAAATATTGAACACAATGGCGAAGCTCAGGGCTATCAAGCAGGCGAGTACGATTTGGTCCTGGCGGCCAATGTGTTGCACGCTACCCGTCACATTGGCAACACCTTGGCCCGGGTTAAGTTTTTCATGAAACGCCATGGCTGGCTGTTATTGAATGAAGCCACCCAAGTGCGCCATTTTGGGACGTTGACCTTTGGTTTGCTAAAAGGTTGGTGGTTGTTTCAAGACGCTGAAAACCGGCTTGACGGATCGCCTTTGCTGTCAACCACTGCCTGGCAGCGGTTACTGTCGGAAGAGGGGTTCAAGCACACGCTTAGTTTGTGCGACGCGGTTGAAGAAGAGTCAATTTTTCAGGATGTCATTGTTGCTGAAAGTGATGGTGTCATTCAAATGAATCAGTCGGATTCACCTGTGCAGCCGCGTGAGCCTGTGGATGTGTCTGTGGATGTCCATCATGTCGATGACATGATGGAGCCTGGGCAAGTGGCGGATGTGGTTGAGTCACGACATGATTTTATCGTCAATAGCGTCAGCCAATGTATGGCTCAGTCTTTAGGTGTGGCGTTTACCGACATTCACATCAATCGTCCATTTAGCCTTTATGGTGTGGATTCGATCACGGGAGTTGATTTTATTCATCAGATCAATTCCCGTTTAGGGATCGTTTTGCGAACGACGGCCTTATTTGATCACGCGACGATTTTTGATTTATCCCGTTTTATCGACGAGAGCCACGGCGCGGCGATTGACGAGCAGCGTCAGCGCTTGAGGTCAACACCGTTGACCTCAAGCGATACGAAGCCAGCGGAGCGTGTCGCCCCGCCGGATGAAGCGCTTCCCCATATCGAAAGGGGCTGTCACCAGGCGGTCGTACTGGAAAAACCCAGCCAGATCGAGCACCTTCGCTTCCATCCCGTGAAAACCCGGGAACCTGCGGCGCATGAGGTGCAAATTGCAGTTCGCGCTTTTTCGCTCAACTTCGGGGATTTGCTATGCGTGACCGGGCTCTATCCCACCATGCCGGCGTATCCATTTACACCGGGCTTTGAAGTGTCCGGGCACGTCGCCAACGTGGGAGCGGCGGTCAGCCACGTTGCGGTGGGCGACGAGGTCATTGCCCTAGCGGGCCAGCAGTTGGGCGGCCACAGTACGCTGTTGACCACTGCAGGACACTTGGTGGTTCACAAACCGCGTCAGGTCAGCCACGAGGAAGCTTGCGCGTTTCCCGGCGTTTTTCTGACCGTCTACCATGCGTTTCAAAGCGCCAATATTCAAGCTGGGGAAAAAGTTTTGATTCAAGGCGCGGCCGGGGGAACGGGCTTAATTGCTGTACAAATGGCCCAGGCGGTGGGAGCGGAAATTTATGCCACAGCCGGTTCGCCCCAAAAACTGGATTATCTGCGTGAACGAGGCGTGCCGCATCTGATCAATTACCAGACGGACGATTTCGCCGAGGTCATTTTAGCAGATACAAACGGTTATGGCGTGGACGTGATCTTCAATACAGCAGCCGGGGACGCCATGCAAAAAGGGCTGGACATTCTGGCTCCCAATGGACGCTATTTGGAAATTGCGATGGTCGCCCTGAAGCGTTCGCGGTCGGTTGATTTATCTCATTTGGTTGATAATCAGGTGTTTTATAGCATCGATATGAGAAAGCTGATCGCTGGAAACCCACAGCTGATCAGCCGCTATCTGAATCGCATGGTGGAGCATCTGGCAGAAGGGCACGTGCAGCCGACGATAGGCGCAAGATTTGCGCTTGATGATATTCAAAGCGCCTACCGGCTGCTACACGACCGGCAAAATATTGGCAAAGTTGTTGTCAGTATCCCCGATGGGATGATGGACAATCAGGTCGGCCAAAGGATGGTGCCGGAATCCTCAACGGTTGAGGACTATCGCGTTGGAAACGCCACGGTTGAACAGGTTGCGGTAAAACAACCGGCGGACATGGATGAGCCGATTGCCGTTGTCGGTATGTCCGGCCGTTTTCCCGGGGCAAACAACTTGGAGCAGTTCTGGTTGAATCTTATAGGTGGCAACAACGCGATCACCGAAGTTCCCGCTGACCGCTGGGATGTCCATCAGTGGTATGACCCCGACCCGGCAGTCCTTGATAAGACCCATTGCAGATGGGGCGGTTTTCTGCGAGATATTGACAAATTTGATGCGCTGTTTTTTAAACTCTCAGGCCGGGAAGCCGAGTTGACTGACCCGCAACAGCGTTTATTTCTGGAGGTCGCTTGGGCCGCACTTGAAGATGCGGGGCATGCGAACCGCGCGATTTCCAATGCCCGCTGCGGGGTTTTTGTCGGAGCCGGTCCGAGCGATTACGTCACGTTAATGCGTGAACGGAGCGTGCCCGGCGAGCCCCAGTCATTCTGGGGCAATTCCAGCTCGCTAATCGCGTCGCGCATTGCCTATTTTTTAAACCTGAAAGGGCCGAGTATCACCATTGATACGGCCTGTTCCTCATCTCTGGTCGCCTTGCATTTAGGCTGCGAAAGTATTCGGCGTGGCGAATGCGACATGGTCATTGCCGGTGGCGTGTATATTGGGGTCACACCACACTTACATGTTATTGCTAGCAACGCCGGCATGCTCTCACCCGATGGCCAGTGTAAAGCCTTTGATCAAGGTGCAGATGGCTTTGTCCCGGGTGAAGGCGTTGGCGCGGTGGTCTTAAAACCACTGTCAGTGGCACGTCAAGCCGGTAATTTTATTTATGGGATTATTCGTGGCTCAGGTTCAAATCAAGATGGGCGAACTTATGGTATTACCGCGCCCAGCGCTGCTTCTCAAACAGAGCTAGAGCAAAGTGTCTACCGACAGGCCGAACTCGACCCGGCAAGCATTGGCTATGTTGAAGCTCACGGTACAGGTACCAAACTTGGTGATCCCATTGAGATTGATGCGCTGAATCGTGCCTTCCAAAGTGACGCGAAAAAGCAGCACTCTTGTGCCATTGGATCGGTTAAAACAAATATTGGACACGCTGGTGCGGCTGCCGGTATTGCTGGATTCATTAAGGTCTTATTGTGCCTGCAACATCAACAATTGGTGCCTTCGTTAAATTATCACACGTGTAATGAACATATCGATTTGGACAATAGCCCGTTCTATGTGAATACAGAATCAAAGGATTGGTTCGTCGCTCAGGGTGAGCCGAGACGGGCTGCGGTCAGCAGCTTTGGCTTTAGTGGTACTAATGCGCATATTTTGTTAGAAGAATACCAACACCATGAGGACGAGGCCCAGGCACTTGGAGATGACAAGGATGTGTTGATCGTCCTTTCAGCCAAGAATCAAGAACGTCTCAAAAAAGCGGCTGAAAATCTTCACCATTTTTTAGAAAGCAGAGTCTCCTATAAATTGTCCGACATTGCCTATACGTTGCAGGTTGGCCGTGAGGCGATGGAGGCGCGAGTTGCTTTTATGGTGGTCTCAGTCCTTGACTTACAACAAAAGCTTGTGTCATTGCTTCATGACCCAACAGACGAACAAGACATGTATTGGGGGGAGGTGCGCGATGGCGAGGGGCCTGCTGGAGTGGCTGCTTTTGAAGACGTCGCACTTGCCTTGGCTAACAAGCAGTTGGATCAGCTTGCCCAGTGGTGGGTGTCTGGGGTTGAAATAGACTGGACCCAGCTTGCACGCGTGGTGAAAGTCCGTCTCGTTCCTCTGCCTACGTATCCGTTTTCGCCTGATCGTTACTGGTTTGATTCGGTAGGTCCGGCGACGGTTGTACATGCCGAGCATTCAGCCTCTGCTCTGTATCCCCTATTGAATCGTATCGCTCCGCAGGCGAGCACTCAAATCGCGAACGGCTGCGTGTTTGAGACGTGCTTGAAATCCAGTGACCCTCTGTTGGCGCAACATCTCATTGACGGCCAGGCGGTGTTTCCGGCAGTGGGATTTCTGGAGATGGTCATAGCTGGCCTGCGCGAAATCCAGCCAGATAAAGCAGCGCGGTTGGAGAATGTGTTTTGGCTCCGGCCTCTTGATGTCATGGATGAACAACGCGTTCATCTGGTGTTTGAGGTGAAACAGGATCGTTTTCAATATCGAATTGTACCCGCAGAGTCTCACGGGGACGGGGCCTATTTTCGTGGCCAAGGCTACTGGTCAAACGATATGAATCCTGCGATTCCGATGGATATTGATCGCCTGAAAAGCCGTATGCGCCAACAGCCCTTGCTCAACGAATCCAGCCCCCGAGTCCGCCTGGGCCGCTTGTATCAAGGCGCGACTGAGGGGTGGACGGATGGTGAGCAAGCACTGATCGCCTTTGAGTTGCCAACGGCGCAACCGTATCGAGACGGGTCCCCCGATCAAAAATCATACCCATTTCACCCTGCAGCTTTTGTCGCGGCTTTGCAAGCCTATCACTGGATTCATGAGGCGCCTAAGCGTCTGGGGATGCCTTTTGCCGTGCAAAAAGTGGAGCTGTGGCGCCATCGTGATCAACCCGCTTATGCTTACGTTGCACTAGATGAGCATGGCAACGCGGACGTGCACATCCTGGATGCAGGCGGTCAGGTATGCGTCTGTTATCGTGGCATGGCCCTGCAGACCTTGAACAATGCGCACCACGATGGGAGACAAGAAAGCACTCAAAAAGATGAGCTTGGAAAATTGCTTTTTGTCCCTGTCTGGAAGCGTCTTGATACGAAACATGGGCGTGCACATGGCATGCATGCGCTTGCTCGCGGAACGGGCGTCTTACTGGTGTACACACACGAAAATGGGGTAGAGGCCGAGCAGCTCATGCAGCGTTATCGCGAAGAGCAATGTGAGTTACTCTCGGTTTGCTTATCTGCGGCGGATAGAGCACTGGACACCCTGGCGGCGCGTCTAAAGCATCTGCAGTCGCCACTGCGCCATGTCTGTTTTCTTGATCGTCATCAGGCCGCGCTTGATCCGGCTGACAAGCAGATTGACGAGCGATTGCGTGAACCCCAGACCCTCACAGGCTTTTTGGCATTAGTGAGAACCCTGAGCGAGCTTGGCTATGATGAACAGCCCCTACAATGGCTTGTGCTTACCTCTAGCGCATGTGCCGTCAATCAAGCAGACCCCATTAACCCGTATGCCGCTGCGATTGTCGGACTTGCCTCTTGTCTGGCGCAAGAGCATAGGTATTGGCAGGTGAGTGTCTGTGATCGGGGCAAAGGCACATCTTTCACAACGATTGCGAATCACGGGGAAACCTTGCGCGTTATTGCTGAGCGCAGTGGATACAGTTATGTGAGGCACATCAAAGAATTAGAGCTGCCCCCTCCCCGGCAGAGCCGTTTGCGTCACAAGGGCGTATATGTCTTGGTTGGCGGTGCCGGTTACGTGGGGACCTTGCTTAGCCGCTATCTGGTTCAGACCTATCAGGCAAAGGTGATATGGCTAGGTAGACGTGAGCAAGATGAGCAGATAGAGCAAAACATAGCCCTGATCGCTACCTTGGGATCGCGTCCGCAGTATCTGAGCCTGAAAACCGGATCAGACGACGAGCTACACCGTGCATTTGCGCAGATTAAGGCAGAAAACGGTTTGATCCACGGTGTGTTTAACCTGGTGATGGTCGCGCAGAGTACCCCGATGCGCAGCCTGAGCGAAGCACAATTTCGAGCTGGCTCCTTTAATTCCAAAGTGAACTCCGCGCAAGCCTTATACCGTATTCTGAAAAAGGAAGCTCTAGACTTTATGGTGTTCTTCTCTTCGATGCAAAGCTTTGCGCAGCAGCTCAATTTTATGTCAGCGAATATGAGTAGTTATGTTGCAGGTTGCATGTTTCAAGATGCTTTTGTGCATCAGATCAATTGCGAGTTATCTTATCCTGTAAAAACTATTAACTGGGGTTATTGGTCACAAGAGAGTTCAGAGAGCGAAAAGGCGAAGTGGTACGAGACTTATATCGCGGATAAAGGTATTTACAGTCTCAATGTTGGGGAGGCGATGCAAGCGTTGGAGTATATTTTGGCTCACGAACCAGAACAAGTGATCGTGACCAAAGTATCACATCGGGTTCTCAGCGACATGGGCTTTGTGCAAGATGACTCAGAGAACGTCGACCTACAGCCTGTTATTGACTCGAACGATGACAATACCCAGCTTGAGGACTTGATCGTTAATGGTATTCTCAAAACCTTTGAAACGCTCGATGTATTGCAGGTATTTGATAGCGCCTGTAATCTCGATGTTTCGAGATTACAGGCGCATGTGCCCGATAAATATCGCCGCCTGTGGCGTGAACTGCTTCTGATTTTGGTTCAGGCTGGAAAGATGGCACCACAGGGTGCTGGGTTTGCTCTACGAGAAAGCTATACCAGTTTGGCGAGCCAGCTTCGCTTAATGGATCTCGATCGGGAGGCTGGGCTATTGCGCGAGCGCCATCCCACCTTAGCCTCGAAACTTGCCTTGCTCGTACCCTGTCTGAAGGATATGGCCGAGGTGTTAACGGCTCGCAAACCAGCAACAGAAGTGTTGTTCGAACACGCTTCGCTGTCACGGGTTGAAGGGATTTATAGAGGAAATCCCACCACAGACTACTTTAACCAGCGTGTCGCTGACATTGTGAAGGCCGCAGTACAGCAGGCACTGCCCAGCCTGAGTGTAGGGAAAAAAGTACGCATTTTGGAAATCGGCGCGGGCACCGGTGGTACCAGTGCCTACTTGTTTCAAGCACTTAATACATATGCAGATCAGTTGCACTACATCTATACGGATATCTCTAAACGATTCTTAATTCATGCAGATGAAACTTTCTGTGAGCAGTATTCCTTTATAGAGACAAAATTGTTGAATATCGAACAAGATGTGGCAGGCCAGGGGTTCGATCCTGCTAGTATTGATATCGTGGTGGCAGCCAATGTTTTGCACGCCACACGCAACATTAGTAAAACTTTGCAACATGTTAAAGACTTACTCAAGAACGATGGGCTTCTGGTGTTAAATGAATTAGCGGACGTTTCGCCTTTCCTCACCGTGACCTTTGGTCTGTTAGATGGATGGTGGTTGTATGATGATGAAGCCATTCGCCAACCAGGCTCACCTGGCCTATCAGCAAAAAATTGGCAGCTTGTGTTGAAAAATCAGCGTTTTCACAATATTAGTCTCAACGATGAAAAAGCTCTGACGTCAGAGCAGCAAATTATTATCGCGCAAAACGAGAGTAAAGAGAGTGTGCCGGTCTCATCCACAGTATTATTAGGAACAGAACTTATCGCCTCAGTCGAAGCCAGTCTGATCGCACAATTGAGTCAGTGCATAAAAATCGAGCAAAACCGTCTCAATACCTATACCACGTTTTCAGATTATGGTGTGGATTCAATTTTGATGCTCGCCTATGTTGATCAAATTAATGGTGATCTTGGAATTGACCTCAATCCTTCAGAACTATTTAATTATACCACTGTTGAGCGTCTTACTAAGTTTATCGTTGATTATCATGGGAAAGAGATCATTTCAGCAAAAGAAAGCGTTGAGAGATCATTACTTCAGAATCAAGAAAGCAAATTTGACCTCAATGACATAGATGTCATCACAAAGGCAGGGAACGAAGCTCCGGAGATGGCGCGCAGCCTTCTCTTTGATAACGTTTTGCAAGTGCCGTCCGGTAACGTGCATCATCACCAGAGCGATAAGGCGCGACCTGATATTGCGGTTATTGGCATGTCGGGGCAATTCCCAGGTGCGACGAATGTTCAGCAGTTTTGGCAAAATCTGAGCGCCGGCGTCGATAGTGTGAGCGAGCTGCCTGAAAGCCGCCTGGATCGTCAGCTGTACAGTCCGCAGCCAGAGGCGGGAAAATGTTATTGCCAATGGGGCGGTATCTTAGAGGAACAGGCCTCTTTTGATCCACTGTTTTTTGAAATCTCTCCCAAAGAAGCCGCCGAGATGAATCCTTCTCAGCGGGTGTTTATGCAGGAGGCTTATCGAGCCCTGGAAGATGCGGGGCTGGTCAACGCAGGTCTCTCGCAACTGCATTGTGGCATTTATGTCGGTTGTGAGCCAAACGGCTATACCAAACAAGGTTTCACCGGCGCCTCCGAAGCCATTGTCGCTTCCAGAATCTCCTATTTTCTCAATTTGCAGGGACCGGCTCTGGTGATTAATTCCGGCTGCTCCTCTTCCTTGGTCGCCATTCATCTGGCTTGTGAAAGCCTTCGCCATGGCGAAAACGATATTGCCCTCGCCGGAGGCGTTTTTACGAATCTGAATAACGAGTTGCTCGTCTGTCTGTCGTCCATTGAGATGTTGTCATTCTCCGGTAAATGTCACGCCTTTGACGAAGCCGCCAATGGCACGGTGCTGTGTGAAGGTGTCAGCGTGCTGGTGTTGAAACGATTACAGGACGCGCTAGATGATGGCGATGTCATTTATGGCGTGATCAAAGGCAGTGGCATGAATCAGGACGGAAGAAGTAATGGCATCACTGCACCCAACGGACTTGCACAAGAAAATTTGATCAAGCGCATTTATCAGGATTACAACATTGATGCCAGCAAAATCAGCTACATAGAAGCCCATGGTACTGGAACGAAATTGGGTGACCCCGTTGAGGCGAATGCGNTGAAGAACGTATTTTCTTCAAGAAACACGGGTTTGGACTTTCGTTGCGGAATCGGTTCAGTTAAATCGAATATAGGACATGCGGCTGCAGCTGCGGGTGTGATCGGTCTGGTCAAGGTCTTATTATGCATGCAACACCGTCAGTTACCAGGGCTGGTGCATTTTAACAAACTCAACCCTCTAATCGATTTTAACGACACAGGTTTGTACATCGTTGAGCAATTGCAAAACTGGGAGCCAGCGTCTGGTGAGCCGTTGATGGCAGGCATCAACTCGTTCGGCCATAGCGGCACCAATGCCCATCTCGTGATTCAGGAACCCCCTGTGCGACCTGTCCGCGACAGCGAGAACCCATTCCATTTAATCTGTCTATCTGCCAAAACAGAGGAAGCGCTTAAACAAAAAATTAGCGATTTGAGTGCATATCTAAGGCGCAAAGAAGAGCCGCCAACTCTAGGAGCCATCAGTTATACCTTGAATACCGGCCGTGCTCACTTTAGAAAACGCTGCGCTTTCGTCGTGGATTCGCTGGAGGCTTTGCAAAATGCTCTCATGGGAGCTTTAGATGGTCTTGTTGGCAATGCAGAAAGGTTAAGTCCACAAGAACAGGCATTTTGTAAAAAAGCATTTGATTTGATTATCAAGGATTTACACGATGTAGAGAATCTTGAAAGTAGGGCTGATCAAACAATCTATAAAGATAACCTACTGGCTCTGACCGGACTTTATCTAAAAGGTTTTGACCTAGACTGGCAACGGGTGTACAAAGGTCAGAGCTATCACCGGGTATCCCTGCCGACATATCCTTTTTCCAGAGATACATACTGGATTGACGAGCCAAAACAAATTAGCTTCACCGAGCCTGGTACCGACAAGCCTGGAAACACCAGCAGGAATCATCAGCAGGATCAAAAAGATGAGGATGTGTTGGGTGGACAGTTTTATATACCGCAGTGGAAACGGCTTGATCAAACACAATCCTATGCCAGTTTAAGCGATCATGGGAAGTTGACCATCGCATCTGACCCTGTTGTCATTTTTTATCCGCCGACCATGACAAGTTTAAAAGATGATATTCAAACATGCTATGAGCAATTACCGGCAAGCCAAGTCGCTAGCTTCGAGCTTGGCTGCACACCTTCGTCTGAGGTCGATGTTCGCGATCCCCGTGCCTTTGAACGCATCTTTGTATCCCCTAGGCAGGCATTGGAAGAGCTGCTTGAGCAAGGTCGAACGTTAACGATCTACTTTATCCTGCCTGAACCGGATCAAAACCCGGACTCAGGGTGCAACCTCGAATGCCTTGAGGAATCCCTGTCACTCGGGCTGATCTCGTTGTTCCGTTTGATACAAGCGCTGTTGGCCCATCACGGCTATGCCAGCGAGCTGACCCTCAAAATCGTGACCCAGCAAACCCAGGTCTGTAAAGCTTCTGAGCGCATTGTGCCCTATGGCGCAGATGTGGTGGGTTTTGTGCAGTCGTTAGCGAAGGAATACGAGCTCTGGCAAATCAGTTGCGTGGATATTAATCGGCAGACATGGTGGACGCCCGCGCAAAGCAAAAACTTTGCCGAGGCGCTGATTGCCCTGAAGCCACCGGCGGACGGGCGCGCTCTATGTTGGCGGGACGGGTATGTTTATCACCGTGTTTTAACCCCGGCTAATCTCGTTGGCGTTCAGGGAAGTGCATTCAAGACGCGCGGTGTCTACCTAATTATTGGTGGCGCTGGAGGGTTGGGATTGGTGCTCAGCCAGTATCTGCTTGAACACGTGCAAGCGAAACTGGTATGGGTGGGGCGGCGCAGCCTCGAGGCGTTGGCGCCGGATGCGTTGCGGTTATTCAACACTCCGGGCGCCCACGTGCTATACGAGCAAGCGGATCTGTGTGATCCGGAAGCGCTGCAGCGCGCGCTGCAGCAAGCCAAAGGACGTTTTGGATACATTGATGGTGTCATCCATTCGGCTTTGATTCTAGAGGACCGAGCGATCGCCGACATGGATGAGAAAACGCTACGCAAAGTTCTCGCGCCCAAAGTACAGGGCAACGTGGTACTCCAGCAAGTGCTGGCCGATGAGCCTTTAGATTTTCTGTTGTATTTCTCCGCCGGACAGTCTTTTATGAGTCATGCTGGGCAGAGCAATTACGCCGCTGCCTGTACCTTTGAAGATGCCTGGGCGCTGTGCCAGGACCAGCGGCAAAACTATCCGATCAAAATTATCAACTGGGGCTATTGGGGCGAGGTGGGCATTGTCGCCACGGCTGACTACCGTAAACAAATGGCCAGGCAAGGCGTGCTATCGATTCATCCGCAAGAGGGCATGGAAGCGGTAGAGCGTTGTCTGGCGTCGTGCGCCACCCAGGCCGCTTATTTTAAAGTGGAACCCCGCGCCTTGAGCCGATTGGGCTTGGACGGCACTGGAATCTTGCATGCGAGCCGGAACCGTGTTCCACCTCAATTGATTCATGTCGTGATTGATGCCACCCAGGCGTGGTCAATCTCGATGCCGTACGCACAGCGCTATCAACAATCCCTTAAAAAGTTGGATCGGCTTGGTTGCTATCTCCTTCTGCGTGTATTCCAGGCTATGGGAGTGTTTAGTCAGCCTCATGAACACTATGAAAAACAGGAATTGGCCAGTAGATTAGCCATTTCAAAAGGCTATCATCACCTCTATCAAGAATGCTTGAACTTGCTAGATACGTCCGGTTTTATTGCAATCAATGGTTCGCACATTGAAGTCCAAGACGTGCTACCGGAAGAACATGACGAACACCACAGCTGGTTACAACCCTATCCCGAATTGGCCGCGCATGAAAAATTGTTGCGCATCTGCCTACAAGCTTTTCCGGATATCATCCGGGGATCGGTTGCCGCGACGGATATCATATTTCCGGATGCGTCTGTGGAATTGGTAGAAGGTATTTATCAGGGCAATCCCGCCACCGATGCGCTGAATACCAAAGCGAAAGATGCTGTGGTTGCCTACGTCAAAGCCCGCCTGGCAGACTGTCAGGAACAAATCATCTTTTTAGAAGTCGGAGCGGGAACCGGCGGCATGAGTCATGAGGTGTTGAAGGGGCTGGCCCCCTATGGGCAGTATATCGAGTATTATTACACCGATGTCTCCGAGCATTTTATCCAGTACGCTCGCCGCCGTTATGGTCAGGATTACCCCTTTGTCCGGTTTCAACGTTTAGACATTGAACAGGAGCATAGCGCGCTAAGTGAGGGGCTGCTCAGTGCCTGCGATGTCGTATTAGCCGCGAATGTTCTGCACGCCACCCAAAGCGTTCGCAATACCATCCAGCATGTCAAAGCCCTGCTAAAACGGCACGGCTTGTTAATCTTAAACGAAGCTACGACTTTGGAAAGCTTTGCCACATTGACATTCGGATTGTTAGAGGGCTGGTGGCGCTACCAGGATGCCGGAGACCGCCTACCTGGCGGGCCTTTGTTAAGCGCGTCCATGTGGCATCGCTTGCTCGAAGAAGAAGGTTTTGACCAGGTGGTGTCCCTGGGTGAGCCAGGCGAAGGCGACATGTTGGGACAGCATCTCATTGTCGGTCGAAGTGATGGCTGGAGCTTGCATCAATCTGCGAGGGACGATGAAACCCGTTCGGCCCCTGTTAGCCCTGTGGCGGCGAGCGACGTTATCCAAGGCAATCGAAATGACAAGCCCGCAGAGCTTATCAAACACGTTGAAGCGCAGATTGTGCAAACCCTTTCAGCCGCACTGGATATTGCTGCGGCTCGAGTGGAACGCGATGTGTCGTTTTCCGAGTATGGGGTGGATTCGATTCTGTCCGTTGCGATTATTAACCAATTAAACCAGCGCCTAGGGATTCGTCTGAAACGTCCGGATTTGTTTAATTACACCACCACAGAAAGCATGGCGGCGCATATTGTCGCAACCTTTGCTGACCACTTGACGGCGGCCTTAGTCGAAGAAGCTGAACCACCAACGCCAGTAACCGTAGCAAGTCCTCAACCGATAAAAGCGGCGGGGCAGCAGGATGTTCTTCAGCAAAACTTGCAAACCCAGCCTCAAGTCTCGCAAGGCGTTTGGCAAACCAAGCCGGAACCCATTGCTGTCATCGGCATGTCTGCCTGCGTGCCAGGGGCGGATCATGTGGGTGCGTTTTGGGACAACTTGGTTGCCGGCACAGATTCCGTCACCCGGATTCCCCATGAGCGTTGGCAGCGGGAGGCCGTCAATGAGCTGCCCGGCGGGCCGGATACCTCCCAGCGCAAAGCCGGATTTATGGACAATATTGCCGAATTTGACCCGCTTTTTTTTGCCATCTCTCCGCAAGAGGCGCAGTGGATGGACCCGACGCAGCGGCTGTTCTTACAGCAGGCTTGGGCCGCGTTGGAAGATGCCGGATACAATCCGCGAGCCTTAGCCGGCGCTTCATGTGCGGTGATGGTTGGCTGTGCGGCGACTGGCTATGGTGTGAAAGAGGGCGAGCGCACGGGGTATGTGTCCTATGCTATGACCAATAGCGAGGCCATCTTACCCGCGAGAATCTCCTATTTTCTCGACTTAAAAGGCCCGAGTATTCCCATTAACACCGCCTGCTCTTCGTCTTTAGTGGCGATTCATCTGGCCTGCGAACAACTTCGCTCCGGGCAAAGCGACATGGCGTTGGCTGGCGGTGCTTCCGCACTGATTGGTTCCGCGTTGCACATCGGACTCAATGGCGTTGGGATGCTATCTCCCGAGGGCGCATGCAAAGCATTTGATAAGGAGGCCAATGGCTTTGTGCTTGGCGAAGCGGTTGGCGTTGTCGTTCTCAAACCGTTGTCCAAGGCCGTGGCTGATGGCGATTCGATACATGGTTTAATTATTGGCTCGGCGATTAACCAGGACGGCAAAACCAATGGTATCATGGCGCCGAACGGTCCGTCTCAGACGGCATTAATTGAATCGGTGTACCGGAAATTCGAGATCGATCCTAAAACGATTAGCTATATCGAAACCCATGGCACCGGCACCCAACTCGGCGACCCAATAGAAGTCAACGCCTTGGCTGCTGCCTATGAAAATTTCACCACCTCGCAAACTCAGTACTGCGCCATCGGATCGGTAAAAACCAATATTGGTCACACCACCACTGCTGCCGGTGTCTGTGGATTGATTAAGACTTTATTATGTCTCAAACACCAAAAACTTGTCCCATCCCTGCACTATAAGGAGCCCAACGAAAATATTGAGTTTGAAAAGACGCCGTTTTACGTCAATACCCAGGTCAAAGATTGGCCGGGTCATCAAAACGGTGTCCGGCGTGCGGCGGTGAGTTCCTTTGGCTACAGTGGCACCAATGCGTATATGGTGGTGGAAGCGTTCGTGGAGACGAGCCCGCGCGCGGTCGGGCAGCAGGGACCTGCATTAATTGTCTTGTCGGCTAGGCATGAGGTGCGACTCAAAGAGCTGGCCAGCAATCTCATGGCCTATTTGAAGCGGTATGGCTTGAATCCGGATCGCCCGATTCAGCTCGAAGATATGGCGTATACGCTTCAGGTTGGCAGACAGGCCATGTCAGAGCGTCTGGCGTTTGTGGCGGACAGCGTGGCGGATGTCGTCAAACATTTAGCCACATTTGTTGACGGCGAGGCCAATGCCCAGGAACTTTACCGGGGGCAAGTTAAACCGTTCGGCGATAAGAGCGATTTGCTTTTGGAGGGCGAGGCGGGTCAGGCTTTTCTCAACACGATTTTAAGACAGCAGGATTACCGCAAATTAGCCGCCCTGTGGGTGGCGGGTACAGACTTGGACTGGAATTTACTCTACGACGGTGAAAACCGTGCCCGTCGCATTTCGCTACCGACCTATCCTTTTGCTAGGGAAACGTATTGGTTGGATGAGGGGATAGGGAGCAATGAAAAAGAGCTTCTAAGAGATCAGACTCAAAAAGAGTTACGTGATCGTGATCGTGAGCAAACTACGGAACTCATGACATTTGAAGAGATATGGCAGGAGGCGTCCTTAAACAATCATTCGGATTCCATCAAGTATAAAAGCATCGTTTGTTTTCTTTCCGGATCAGAACATCAGCAAGAAATGCGAACTGCCATGCAGGCGATTGATCCGGCTATCCATCTTACGATGATTGCTCAAGGCCATGGTTACACAAAGCACTCATCTGATCGTTACACAGTAGACCCCGCCGATATACAGAGCTTTCGTGAAGCTTTCCTCGATATCAGCCAGACTCATGGCGAGGTCGACGCGCTGCTTTATCTATGGCCAACCGAGGATTGGCGTCTCTTGTATGATCCATCCGCCGTCGTTTATATGTTGCAGGCTCTGGTCAAGAGTGAGCTAAAACCTTCCCGCTGCTTGCTGGTTGCTGCTTTTTCCACTGCTTTGGAGCGTTGTTACCTGGAATCCTGGATTGGCTTCGAGCGCTCGTTAAAGCTCATCATGCCTGGTTTCCAGGTCGCGGGACTGTTTCAGGAACATGCGGGGCCGGACCAGACGATTTCAATGACACATTGGAGTCAACACATTGTCTCTGAACTCAAAGCGCCTAAAGCACAGACGGTGCTGATACAAAATCACCGGCGCTACGTCAATCAGATTCAAAAAACCGAACTGGCCGCGCAAGGCGCTTCGGTTGCATCGGCCGTCAAACAGGGCGGTACTTACCTGATTACCGGTGGCTGTGGGGGATTAGGTTTTTTGGTCGCCCAGCACCTGGCAGAACACCTTGGGCAACCGGCAGCCTCAGCCTCGGGAAAAACGGTGCATTTAATTCTGACGGGTCGATCATCTCCCGATGACGCGATACAAAGCAAAATCACGCAACTGGAAGCATTAGGGGCAAAGGTTGGTTACGTTCAAGCGGATGTTGCCGATGCAGTCGCCATGAGACGTGGCCTTGCCCAGATGAAAAATCGCTTTGGCGACATACACGGTATTTTTCATATCGCTGGGATCGCCCCCAGCGAGAGTCTCCTCAATAAAGATATCGACGCCTTTCAAAACGTACTGGGGCCTAAAATTGCGGGCACGTTGATGCTTGACGATCTCTGTCGTGATGAACCGCTTGATGTTATCTGTTATTTTTCCTCCTCTGCCGCGATTTTAGGGGATTTTGGCGCCTGTGACTACGCGATTGGCAATCGTTTTCAGATGGCTTATGCCGCTTATCGCAACCATCTGCTGCAGCAGGGGATGCGACAGGGTAAGGCGTTGGTGATTAATTGGCCGCTTTGGCAAGAAGGCGGCATGGGGTTTCATCAAGACGAAAATACCAAGATGTACTTGAGCTCCAGCGGGCAGCGGGTTCTGGAAACTCAGGAAGCCTTGACGGTATTGGATCACGTCCTTAACCAGGACAAAACACAGCATTTGGTCCTGGTGGGGCAGCCAGGTCGGGTGTATGGCTTTTTAGGGTTGACTGAGGCGCCTATGACTCAGATGCCAGTGACTGAAGCGCCAGTGACGCAGACATCCACACGGCCAGAGTTGAGAGGCTTGAGTACGGAGCAGTCGGTATTATGGGATTTAAGAAATCTCATCGTCCAGCAACTCAAAGTGCCCTGGGAGCAGCTTGGGCGAGATCACAATCTCGCTGATTTCGGTTTTGATTCAATAAGCTTGTTGAGTTTTGCCAATCGTCTCAGCGAGCATTATCAACTTGACATTACACCTGCCTTGTTTTTTGGGTATTCGACTCTAGAGCAACTCACGCAGTACTTTTTAAGCGAGCATTGCGATTTTATCAACGCCTTTTATAAGGAACCCGAAAAATCGGAAATCCCTGTAAAAAAGGAAGCCGTTGAAGAGCGTGCTCCTATCCGGATTGTTTCTGAAGAAACCCGCCCAGAAAAAATAGATAATGCAAAAGATGAGCCCATTGCCATTATTGGCATGAGTGGCAGATTTCCCAAAGCTTACGATGTTGAACAAATGTGGCAGCTCTTGGCATCGGGTGAATGTGCGGTAGAAGAAATTTCACCACATTACTTTGATTGGCGCAGATACTTTGGAGAGCCGAGCCAGGAGGCTAACAAAACCAATGGAAAATGGTGTGCTAATATTCCTGGCGTTGCCGAATTCGACCCCCTGTTTTTCCAAATTTCCCCGAGAGAAGCGCCAAACATTGATCCTCGTCAACGGCACTTATTGCAAGAGTCTTGGAATGCTTTAGAACATGCCGGATACGGGCCGCATCAACTGAATAGCCAGAAGATCGGCACCTTTGTCGGGGCTGAAGAAGGGGATTATTATCAACGTGTCAAAGAGGGCAACATCACCTCCAATCACTCGGGCATTCTCGCCGCTCGTCTGGCCTATTTCTTAAACTTAAAAGGCCCGACCATGGCGATTAATACCGCGTGTTCCTCCTCACTGGTCGCGGCTCATCAGGCTTGTCTGAGTTTACGGCAGGGGGAATGTGATACGGCCATCGCGGCAGGGGTCAATCTAATGCTCACCCCTTACGGATATATCAGTATGGGCCGAGCAGGTATGCTCTCTGAGGATGGCCACTGTTATGCCTTTGATGAACGCGCCAATGGCTTAGTACCAGGTGAAGCCGTGGTCGTCGTGGTATTAAAGCGCCTTAGCCGAGCGCTTGCTGACGGTGATCCTATTCACGCGTTGATCTTGGCTAGCGGTGTTAACTATGATGGCAAAACCAATGGTATCACTGCACCAAATGGTGTTTCGCAGGCCGAGTTGGTGAGGGAGGTTCACCAACGAGCCGGGGTTCATCCGCAGGATATTGATTATATTGTGACACACGGTACGGGTACCCGGCTAGGTGACCCCGTGGAGGTCAACGCCCTTAACGAAGTCTTTAGGGACAGCCAACACCTTTGTGCGATTACATCCAGTAAAACCAATTTTGGCCATACGTTTTCCGCTTCGGGGCTGCTCAGTCTTGTCAATCTGGTACAGGCGCTTCGTCATGAGACCATTCCGAAAAGCCTGCATTTTGCTCAGCCAAACAAATTTATGACATGGGATCAAGGCCCTCTCTATGTCAATACGGCCAATAAGCCCTGGCTCGAAAAGCCGGGCGAAAAACGCATTGGCGGGGTGAGTGCGTTTGGAATGAGTGGCACCAATGCCCATATGCTGATTCAAGACTACCAGCTTCACAGAAAAGAACCACGTGCGGTCCCGCCTTATGCGCTGCTTGTGTTGTCTGCAAAAACGGCAGAGGCACTGCATCTCAAGGTCAAAGCCATGGTCGCGTTTTTGCAAGAAGGGCTTGCAGACACTGCCACCCTAGCGGATATCAGTTATACATTGTTTGAAGGCCGACACCACCTTCAATACCGTTTGGCTATTGTGGTGCAGGATATGACTGAGGCCATGTGTTGTTGGACACAAGCCGGGCAGCCAGATAAGAAACCCAATATTTTTCAGGGAAAAGTGCCTACCGAATTTAGTGGTCAAAAGGTCACACAGAATTATATTAACCAATTAGTAGAACAGCTTGATCGCTCTACCGGCGATGATGACGTATACCGAGAACGTCTCTTGGGTTTAGCTGATTTTTATTGTCAGGGGTATGATGTCCCTTGGTCTAGGCTATACGGTGATACACGGCCACGCCGTATAAGTCTGCCTGGGTATCCGTTTGCTAAACAACAATTTTGGCTGGATTTCTCTCCGAAGGATCATGGCGAACAAGAAAATGTCGAACTTCCTATTGGCAAGATGCAGAGACAAGTTCTAAATGAAAAAAACACGCTTGAAACATTAAGCTACATTCACAAATGGGAACAGCAGGATAAAGCTGAAGTCAAGATAGAAATCAGCCAGGTTTGCTTACTAGTTTACTTTGAATCTGCATCGCAATTTGAAAAAACGCTGGCAAGCTTCTTCTTGCAGCAGGGTGCATCTCAGGTGATCGAGATTCAATTGGGACTCGAAACCAAACCGGTGTCCGAACATAAATGGCGCTGCAATGTCAATGACGTCGACGCTTTTCAGCGTTGCCTTCAAGCCTATGCACAGACAATCAATAGCGTTTACTTTCTCTGTGTCGATACCCTCCAGCAGGGCATGGAAGAAAGCGAAATGCAGTTGCTACGGCTGGTCAAAGCCTTAAAATCACGTATGCAGAGCCATGCCTTTATCGATTTCACCCTTCTGACTCTGGATAATCACCGCGTCGATAACAGCGCGACAAGTCCCAACCACGGGGGGCTTAGCGGTCTTGGGTACTCGGTGGCGCAGAGCGATCACCGCTTCCGGGTTCGAAATATCGATTTGTCGCGGGAAGATCTGGTGAGCGCCGAACAACAATGCACCCTGCCAGGCATGATCGTCAGCGAAGCCCCGTCGGACCGAGGCGAGGTGGTCAAGTTGCAGGCAGGTTTGCGCTACAAGCAGCGCTTTTTCAAGCTCGACTGGCAGACGCTGCAAGCGGCACAGCCAGAGGCGGCGGGTTTGAAAACCGGTGGGGTCTATGTGTTGTTGGGTGGCGCGGGAACCGTTGGTGCGATTATAACCCGCTATCTCATCCAAAAATATCAGGCCAATGTGGTTTGGCTGGGGCGTCGTGCGCTGACATCGCCTGCCGTGCAGGAACAACTACACGCGTTCCGGAGCGTGGACGAAGGGTGTGTGCCACTCTATATTCAGGCCGATGTGACGGATCAGGCTTCCATGACTCAAGCGGTCAAAGAGATCAAGCAACATCACCCTTGCATCCATGGCGCGATTTTCTCCGCACTGGTCTTTAAGTTGGATAACTCAATTGCTAAGACTAGCGAGGAAGACTTTAATGAGGTTTTGGATACCAAGAAAAAGGGTGCGCAGTATTTTTATCATGCATTCAAAGATGAAAACTTAGATTTTATGTGTTATTTCTCGTCGGTCCAATCTTTTTTCTTTATCTCCTCTCGAGAGAGTGCAGGGTATGCAACCGGTATTACCAGCGCTGACACCTTTGTACATGCCATCGATCACGATAGCACCTTTCCTGTCGGTATCATCAATTGGGGTTACTGGGAGGCCTCTCTGGCGGGAACCGAAGCCGAGAAGCGTTTGCCCGGTCATTATGACTTAATCTCTGATCATGATGGATGTCAGTTTTTTGACGGATTTGTACCTATGCTTAGATCAGGCCTTATCAAACAGGCCGTTTGTTTAGGTGTGTCAAAAGCGATAGAGGATTTCATGGGCTGTGACGCCACGCAGATGATCACGGTGAACAAGCTTGAGGCTGATTCTTTGATTTTTAGCCTTTTTAATGAAAATGAGTGCGGCCAAGCTACGTGTGAGGAAACTGAAATCGAGCGCCTTTTGGATAAAGATTTCAACAATGAACTTAAGCAATGGTTGCCGCGGCTGCTATTTTCACAGCTGCAACAACTGGGGATCTTTTTAAATCGTGGTGAGCAGAGAGATTGTACGACGTGGCAACAACAAGCTGGTGTGATCAAAAAATATGAACGCTGGTGGCGAGAGTGTTGCTTAGGGCTGCTGGAGACCTCCGGCTACGTACAATGTGAAGGTGAGAGGGTTGAGGTCACTCACCATAGTCCGGCAGACGAGGCGGATCAACTCTGGCAAGGCTGGGAGAGCTTCCAAAATTTATTCCTCGACAAGCCGGAAAGAAAACCTGTGCTCGACTTATTGGAGAGCTGTCTGAGAAGCCTGACGCAAATCCTGTGCGGTGACATCCTGGCCACCGATATTCTTTTTCCAAAATCGTCAATGGAAAAAGTAGAAAATATATACCAGCGGAATGCCCTATCCGACTATTGTAATACCTTTGTCGCGAAAGGTATCGAAGCTTACATTCATCAGCGGATTCAGGCAGAGCCTCAGGCAAGGATCCGGATATTGGAAGTCGGTGCAGGTACTGGAGGTACCACCGCATTGGTCCTGCCACAACTGCGTCAGGTGCAGCATGCGATAGACGAGTATTGTTATACAGACATTTCCAAAGCCTTCTTGATACATGCAGAAAAGACTTATGGGCCGGATTATAACTATCTAGATTATAAGCTACTCAATCTCGAACAACCGTTAGCGCCACAAGGAATAGAGCCTGGCTCCTATGATATGGTAATCGCTACCAACGTGTTGCACGCTACAGAGAATATCAGACAAACCCTTCGCCATACTAAAACTGCTCTAAAACGTCATGGATTATTAGTGATCAATGAAGTGGTTGAGAAATCTATTGTCGGTATCTTAACCTTCGGGTTGTTAGACGGCTGGTGGCTCTACCAAGACGAATCATTACGCATCCCAGGCTCTCCGCTGATCACGCTGGATACCTGGCGTAAAATTTTAAAAGAAGAGGGCTTTGCCAGGGTCTTGTTGCCAATGCGAGCCGCATCTAAGTTGGGTCAGCAAGTGATGGTGGCGGAAAGTGACGGTCTGGTTAGACGGGAGAGAGAAGACTTGCCGGACGAGGACGAATCGGCTGTGACTGATAAAACGTCCGTGGTACAGGGCATGACTTTGACTCCGGAACAGCGAATTGCGCAAACACCGTCTGTACGGGAGCTGTCGTCCGAAACACTACGAGAACAGGTTGCCGAGCTTATTTTGACAGGATTGGCCGAAACATTAGGCATGGCGCAAGAAAATATTGACCCACTAGTTTCATTTTCTGACTATGGTATTGATTCTATTCTTGGTGTCGGTTTTATTGGTCAGCTTACTAAATCCTTCGGCATCACCATCAATACCGCTATATTGTATGATTATACCAATGTAGTGCGTCTTAGTGATTATCTGGTAGAAATCTATGCAGAGGACATACAAAACAAAATTCAAAACAACCGCATGTCTCCAGTTGAGAAAGATGCTGTTCTATATACAGAGACACAACTAGAAACAACAGTCGATCGTAATCCGGAAAAAAGTCAGCTTGAAAACTCAGTTCCTAATATGACCTCTGGCGAGAATAAGTCCGCCAAATGCCAGGAGATCGCTGTTATTGGTATGTCAGGGCAGTTCCCTAGAGCAAAAGACCTTGACGCCTTCTGGCAAAATCTGATTCAGGGACGGGATGGTGTTGTAGAGCTACCCGCGAATTATCTCAATCCGGCTTTGTTTAGCCCGCACAAACAAGCGGGAACAACCGATTGTAAATGGGGTGGCATTTTAGAGCAGCGTGATTGTTTTGACCCACTTTTTTTCAACCTTACGCCCAGGGAAGCGGAGTCGATGAACCCGCATCAGCGTCTCATTCTGAGTGAGAGCTGGAAAGCGCTGGAAGATGCCGGCTACAATCCCAAAGAGCTGGATAATACTCGCGTTAGCGTGTTTATTGGCGCGGAACCTACCGACTATTACCATGAAACCTTTACCGGCTCTTCTGATGCTATTGTTGCCTCCCGCTTATCCTACTACCTCAACCTCAAGGGACCGGCTTTGGTGGTCAATACGGGTTGTTCGTCTTCTGCTTTGGCGATTCACTTGGCCTGCGAAAGTTTACGCCGTGGCGAGTCTTCAATGGCCCTGACAGGTGGCATTTTTGCTGCAATGCATGAAGAAGCACTGGTTAAACTAGCCCAGATTGATATGCTTAGTGCCACCGGTCGCTGCCGTACATTTGATCAATTCTGCGATGGTACCGTATTGTCTGAAGGTGTTGGGGTGGTTGTGTTAAAACGGCTTGACGATGCCGTCAGGGACAACGACCCCATCTATGGCGTGATTCAAGCCTCTGGGGCAAATCAGGACGGTGCCAGCAATGGGATAACTGCGCCTAGTGGTTTGTCGCAGGAAGAACTCCTGACGTCTGTCTACCGGCAATATGACATCAATCCGGAAACGATCACGTATATTGAAGCTCATGGAACTGGTACCTCACTTGGAGATACCGTTGAGGCTAATGCGTTAAAGCGGGCCTTTAAACAGTTTACGGATAAAAAACAATTCTGTGCACTTGGCAGCGCAAAATCTCATATCGGCCATACAGGAGCTGCTGCTGGCGTTATTGGTTTAATCAAAGTTTTGTTGTCGATGCGCTATCATCAGCTGCCTAAACTGTTGCACTTCGAAGAACTCAATCCATCAATCGAATTGGAAGATTCTGCATTTTATATCAATCAACAGCAAATGGAATGGACGGGGCAGGGCGTGCCATTAACCGCAGGGCTGAATTCTTTTGGCCACAGTGGTACGAACGTTCACCTCGTGGTTCGGGAATACCTGCCGTTATCTGAGACGAAAGCCGAAATGGAGGCTGTACTGATTCCATTGTCTGCCAAAACCCTCGAATCCCTTAGAACCTATGCTGAAAGTTTATCGACGTTTCTGGAAAATGGGCATTCTGGTCATGGTGTTAGCCTCACCGATTTAGCCTTTACCCTCCAGCTTGGACGCGAAGCGATGCGGGAGCGCTGTATTTTCTTGGCTGGAAATGTCCCGGATTTGGTAGCCCAATTAAAGGCTTTTGCGAATGACAAGACGCTCAACAATGTGGGTTGGTACGGCCGGGTTGGACGCAGCAAGAACAGCCATTCCTTCAATGATCATGAGTCTCGGCAAATGATCACTCAATGGTTGCAACAAGGAAAATTGGATAAAATTGCCGCCGCTTGGGTACAGGGCCTGAGCATTGACTGGGCAGCCCTTTATCGCGAGCTCACAGCTCGTAAAATCCATGCGCCAACCTATCCTTTTGCCCAGGAACATTATTGGAAACCCGAACAGCAGAGTATGGTTCAGAAGCCCGTTGCGCCGGAAACACAGCCTGAGACCTTCGGAACACTGATGTTGCAGCCCTGTTGGATAGATCAACCCCTTGAACATTCATAA", "orf_prot_sequence": "MLRTGMKTDSPNHPENQAINVNHYLMVLSAKTKERLQTVVENLLDYAKANRRLIESRLADVAFTLQTGREEMEARLAFVVSDYHDLMGQLSGYLEDAPNANTIFRGQVDLFDQSAPVRQHRAAQERDCERMIRTHDLPGLAELFVQGVPIDWRRLYVQGRPRRIALPSYPFAPERHWVARREPDHLAADMPAVRQPHSLLDGRDDRMSLESGVVFRKLLRINDGVLQDHQVNETPVFPGVAYIEMACEALAQLSFSDPEVLRKTVLNQMVWLQALAVTEAEHEILLCLEKDTHGLAFEVKDHQTLYAKGRFDQSDDLSQGHQYLELETIKGDCPHEKHRSVIYHDFRLLGLNYGPWFQGLEHTWFSIDSAEGEGEALGYFNMPLICESEFSAYTFHPGLLDAALQVVASVPGYADSGLLLPYAVEKLEWFHPFPACGYSHVRKLAKHRYDVTICDEQGKVCAKFSDLSVRPSRVAGSEPSLNQLTYRARWSHQELGERRSPAGRPEETGVVFIIHTPEQQALVQELSSVLADMHGDHRVRRMCLNANDWDFKSLGNWNHRIRAVQDLRDIYFLAAMEHTVSSGQAHVDPLSFTNRQEHGLLSLFRLLKALDQNQLLLQPLSLKVLTTGNYRVLPSDTICPLSAGLPGFCRSIAQEYPLLALSCIDLGCPDGDAMQPSSLKKLAQFIVAEPAHQPHETVGIRELRRYTRKLVPVRFPEPGGQRAFKSRGVYMIVGGAGGIGMVLAQYLAERVQARLVLVGRSALDEEKKQNLSTLTAAGGEALYIQADISRLYSMKDAVAQARQRFGNINGVVHSAMVLNDQSLARMSEEGLRASLAPKVEGCIVLQQAMAGEPLDFMLFFSSAISFSGNAGQSNYAAASTFKDAFAHYLTQVEAYPVFNINWGYWGCVGVVANAAYRERWAARGVHSIDPEQGLQVIESILTNHIDQVAAVNVEPSFLERLGVELSQTQTVLPPRRSSLIAKLNALPLPETGGFQDNVNRLEIVSAFRWAEVFKHMLDMSSTQGMYARSDLKRQLQISSEHDQLFDVLISMLIQEGYLHQQGKNLTPTPYLNGEFFQQQREQVALLESELSQTDNAYLNLLSRCLDHYPAMLRGEVAATDVIFPQGSMEWVEGIYRSHASADYFNQQLAQRLVAYVEARLPSLGANESIHILEIGAGTGGTSAIVLQALQPYAARLRYTYSDISPGFLNYGRKTFGDAYPFVEFRHLNIEHNGEAQGYQAGEYDLVLAANVLHATRHIGNTLARVKFFMKRHGWLLLNEATQVRHFGTLTFGLLKGWWLFQDAENRLDGSPLLSTTAWQRLLSEEGFKHTLSLCDAVEEESIFQDVIVAESDGVIQMNQSDSPVQPREPVDVSVDVHHVDDMMEPGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVDSITGVDFIHQINSRLGIVLRTTALFDHATIFDLSRFIDESHGAAIDEQRQRLRSTPLTSSDTKPAERVAPPDEALPHIERGCHQAVVLEKPSQIEHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLLCVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGHSTLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGEKVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIAMVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQLISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPDGMMDNQVGQRMVPESSTVEDYRVGNATVEQVAVKQPADMDEPIAVVGMSGRFPGANNLEQFWLNLIGGNNAITEVPADRWDVHQWYDPDPAVLDKTHCRWGGFLRDIDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSVPGEPQSFWGNSSSLIASRIAYFLNLKGPSITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGIIRGSGSNQDGRTYGITAPSAASQTELEQSVYRQAELDPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFIKVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPRRAAVSSFGFSGTNAHILLEEYQHHEDEAQALGDDKDVLIVLSAKNQERLKKAAENLHHFLESRVSYKLSDIAYTLQVGREAMEARVAFMVVSVLDLQQKLVSLLHDPTDEQDMYWGEVRDGEGPAGVAAFEDVALALANKQLDQLAQWWVSGVEIDWTQLARVVKVRLVPLPTYPFSPDRYWFDSVGPATVVHAEHSASALYPLLNRIAPQASTQIANGCVFETCLKSSDPLLAQHLIDGQAVFPAVGFLEMVIAGLREIQPDKAARLENVFWLRPLDVMDEQRVHLVFEVKQDRFQYRIVPAESHGDGAYFRGQGYWSNDMNPAIPMDIDRLKSRMRQQPLLNESSPRVRLGRLYQGATEGWTDGEQALIAFELPTAQPYRDGSPDQKSYPFHPAAFVAALQAYHWIHEAPKRLGMPFAVQKVELWRHRDQPAYAYVALDEHGNADVHILDAGGQVCVCYRGMALQTLNNAHHDGRQESTQKDELGKLLFVPVWKRLDTKHGRAHGMHALARGTGVLLVYTHENGVEAEQLMQRYREEQCELLSVCLSAADRALDTLAARLKHLQSPLRHVCFLDRHQAALDPADKQIDERLREPQTLTGFLALVRTLSELGYDEQPLQWLVLTSSACAVNQADPINPYAAAIVGLASCLAQEHRYWQVSVCDRGKGTSFTTIANHGETLRVIAERSGYSYVRHIKELELPPPRQSRLRHKGVYVLVGGAGYVGTLLSRYLVQTYQAKVIWLGRREQDEQIEQNIALIATLGSRPQYLSLKTGSDDELHRAFAQIKAENGLIHGVFNLVMVAQSTPMRSLSEAQFRAGSFNSKVNSAQALYRILKKEALDFMVFFSSMQSFAQQLNFMSANMSSYVAGCMFQDAFVHQINCELSYPVKTINWGYWSQESSESEKAKWYETYIADKGIYSLNVGEAMQALEYILAHEPEQVIVTKVSHRVLSDMGFVQDDSENVDLQPVIDSNDDNTQLEDLIVNGILKTFETLDVLQVFDSACNLDVSRLQAHVPDKYRRLWRELLLILVQAGKMAPQGAGFALRESYTSLASQLRLMDLDREAGLLRERHPTLASKLALLVPCLKDMAEVLTARKPATEVLFEHASLSRVEGIYRGNPTTDYFNQRVADIVKAAVQQALPSLSVGKKVRILEIGAGTGGTSAYLFQALNTYADQLHYIYTDISKRFLIHADETFCEQYSFIETKLLNIEQDVAGQGFDPASIDIVVAANVLHATRNISKTLQHVKDLLKNDGLLVLNELADVSPFLTVTFGLLDGWWLYDDEAIRQPGSPGLSAKNWQLVLKNQRFHNISLNDEKALTSEQQIIIAQNESKESVPVSSTVLLGTELIASVEASLIAQLSQCIKIEQNRLNTYTTFSDYGVDSILMLAYVDQINGDLGIDLNPSELFNYTTVERLTKFIVDYHGKEIISAKESVERSLLQNQESKFDLNDIDVITKAGNEAPEMARSLLFDNVLQVPSGNVHHHQSDKARPDIAVIGMSGQFPGATNVQQFWQNLSAGVDSVSELPESRLDRQLYSPQPEAGKCYCQWGGILEEQASFDPLFFEISPKEAAEMNPSQRVFMQEAYRALEDAGLVNAGLSQLHCGIYVGCEPNGYTKQGFTGASEAIVASRISYFLNLQGPALVINSGCSSSLVAIHLACESLRHGENDIALAGGVFTNLNNELLVCLSSIEMLSFSGKCHAFDEAANGTVLCEGVSVLVLKRLQDALDDGDVIYGVIKGSGMNQDGRSNGITAPNGLAQENLIKRIYQDYNIDASKISYIEAHGTGTKLGDPVEANAXKNVFSSRNTGLDFRCGIGSVKSNIGHAAAAAGVIGLVKVLLCMQHRQLPGLVHFNKLNPLIDFNDTGLYIVEQLQNWEPASGEPLMAGINSFGHSGTNAHLVIQEPPVRPVRDSENPFHLICLSAKTEEALKQKISDLSAYLRRKEEPPTLGAISYTLNTGRAHFRKRCAFVVDSLEALQNALMGALDGLVGNAERLSPQEQAFCKKAFDLIIKDLHDVENLESRADQTIYKDNLLALTGLYLKGFDLDWQRVYKGQSYHRVSLPTYPFSRDTYWIDEPKQISFTEPGTDKPGNTSRNHQQDQKDEDVLGGQFYIPQWKRLDQTQSYASLSDHGKLTIASDPVVIFYPPTMTSLKDDIQTCYEQLPASQVASFELGCTPSSEVDVRDPRAFERIFVSPRQALEELLEQGRTLTIYFILPEPDQNPDSGCNLECLEESLSLGLISLFRLIQALLAHHGYASELTLKIVTQQTQVCKASERIVPYGADVVGFVQSLAKEYELWQISCVDINRQTWWTPAQSKNFAEALIALKPPADGRALCWRDGYVYHRVLTPANLVGVQGSAFKTRGVYLIIGGAGGLGLVLSQYLLEHVQAKLVWVGRRSLEALAPDALRLFNTPGAHVLYEQADLCDPEALQRALQQAKGRFGYIDGVIHSALILEDRAIADMDEKTLRKVLAPKVQGNVVLQQVLADEPLDFLLYFSAGQSFMSHAGQSNYAAACTFEDAWALCQDQRQNYPIKIINWGYWGEVGIVATADYRKQMARQGVLSIHPQEGMEAVERCLASCATQAAYFKVEPRALSRLGLDGTGILHASRNRVPPQLIHVVIDATQAWSISMPYAQRYQQSLKKLDRLGCYLLLRVFQAMGVFSQPHEHYEKQELASRLAISKGYHHLYQECLNLLDTSGFIAINGSHIEVQDVLPEEHDEHHSWLQPYPELAAHEKLLRICLQAFPDIIRGSVAATDIIFPDASVELVEGIYQGNPATDALNTKAKDAVVAYVKARLADCQEQIIFLEVGAGTGGMSHEVLKGLAPYGQYIEYYYTDVSEHFIQYARRRYGQDYPFVRFQRLDIEQEHSALSEGLLSACDVVLAANVLHATQSVRNTIQHVKALLKRHGLLILNEATTLESFATLTFGLLEGWWRYQDAGDRLPGGPLLSASMWHRLLEEEGFDQVVSLGEPGEGDMLGQHLIVGRSDGWSLHQSARDDETRSAPVSPVAASDVIQGNRNDKPAELIKHVEAQIVQTLSAALDIAAARVERDVSFSEYGVDSILSVAIINQLNQRLGIRLKRPDLFNYTTTESMAAHIVATFADHLTAALVEEAEPPTPVTVASPQPIKAAGQQDVLQQNLQTQPQVSQGVWQTKPEPIAVIGMSACVPGADHVGAFWDNLVAGTDSVTRIPHERWQREAVNELPGGPDTSQRKAGFMDNIAEFDPLFFAISPQEAQWMDPTQRLFLQQAWAALEDAGYNPRALAGASCAVMVGCAATGYGVKEGERTGYVSYAMTNSEAILPARISYFLDLKGPSIPINTACSSSLVAIHLACEQLRSGQSDMALAGGASALIGSALHIGLNGVGMLSPEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKTPFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTNAYMVVEAFVETSPRAVGQQGPALIVLSARHEVRLKELASNLMAYLKRYGLNPDRPIQLEDMAYTLQVGRQAMSERLAFVADSVADVVKHLATFVDGEANAQELYRGQVKPFGDKSDLLLEGEAGQAFLNTILRQQDYRKLAALWVAGTDLDWNLLYDGENRARRISLPTYPFARETYWLDEGIGSNEKELLRDQTQKELRDRDREQTTELMTFEEIWQEASLNNHSDSIKYKSIVCFLSGSEHQQEMRTAMQAIDPAIHLTMIAQGHGYTKHSSDRYTVDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVAAFSTALERCYLESWIGFERSLKLIMPGFQVAGLFQEHAGPDQTISMTHWSQHIVSELKAPKAQTVLIQNHRRYVNQIQKTELAAQGASVASAVKQGGTYLITGGCGGLGFLVAQHLAEHLGQPAASASGKTVHLILTGRSSPDDAIQSKITQLEALGAKVGYVQADVADAVAMRRGLAQMKNRFGDIHGIFHIAGIAPSESLLNKDIDAFQNVLGPKIAGTLMLDDLCRDEPLDVICYFSSSAAILGDFGACDYAIGNRFQMAYAAYRNHLLQQGMRQGKALVINWPLWQEGGMGFHQDENTKMYLSSSGQRVLETQEALTVLDHVLNQDKTQHLVLVGQPGRVYGFLGLTEAPMTQMPVTEAPVTQTSTRPELRGLSTEQSVLWDLRNLIVQQLKVPWEQLGRDHNLADFGFDSISLLSFANRLSEHYQLDITPALFFGYSTLEQLTQYFLSEHCDFINAFYKEPEKSEIPVKKEAVEERAPIRIVSEETRPEKIDNAKDEPIAIIGMSGRFPKAYDVEQMWQLLASGECAVEEISPHYFDWRRYFGEPSQEANKTNGKWCANIPGVAEFDPLFFQISPREAPNIDPRQRHLLQESWNALEHAGYGPHQLNSQKIGTFVGAEEGDYYQRVKEGNITSNHSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGVNLMLTPYGYISMGRAGMLSEDGHCYAFDERANGLVPGEAVVVVVLKRLSRALADGDPIHALILASGVNYDGKTNGITAPNGVSQAELVREVHQRAGVHPQDIDYIVTHGTGTRLGDPVEVNALNEVFRDSQHLCAITSSKTNFGHTFSASGLLSLVNLVQALRHETIPKSLHFAQPNKFMTWDQGPLYVNTANKPWLEKPGEKRIGGVSAFGMSGTNAHMLIQDYQLHRKEPRAVPPYALLVLSAKTAEALHLKVKAMVAFLQEGLADTATLADISYTLFEGRHHLQYRLAIVVQDMTEAMCCWTQAGQPDKKPNIFQGKVPTEFSGQKVTQNYINQLVEQLDRSTGDDDVYRERLLGLADFYCQGYDVPWSRLYGDTRPRRISLPGYPFAKQQFWLDFSPKDHGEQENVELPIGKMQRQVLNEKNTLETLSYIHKWEQQDKAEVKIEISQVCLLVYFESASQFEKTLASFFLQQGASQVIEIQLGLETKPVSEHKWRCNVNDVDAFQRCLQAYAQTINSVYFLCVDTLQQGMEESEMQLLRLVKALKSRMQSHAFIDFTLLTLDNHRVDNSATSPNHGGLSGLGYSVAQSDHRFRVRNIDLSREDLVSAEQQCTLPGMIVSEAPSDRGEVVKLQAGLRYKQRFFKLDWQTLQAAQPEAAGLKTGGVYVLLGGAGTVGAIITRYLIQKYQANVVWLGRRALTSPAVQEQLHAFRSVDEGCVPLYIQADVTDQASMTQAVKEIKQHHPCIHGAIFSALVFKLDNSIAKTSEEDFNEVLDTKKKGAQYFYHAFKDENLDFMCYFSSVQSFFFISSRESAGYATGITSADTFVHAIDHDSTFPVGIINWGYWEASLAGTEAEKRLPGHYDLISDHDGCQFFDGFVPMLRSGLIKQAVCLGVSKAIEDFMGCDATQMITVNKLEADSLIFSLFNENECGQATCEETEIERLLDKDFNNELKQWLPRLLFSQLQQLGIFLNRGEQRDCTTWQQQAGVIKKYERWWRECCLGLLETSGYVQCEGERVEVTHHSPADEADQLWQGWESFQNLFLDKPERKPVLDLLESCLRSLTQILCGDILATDILFPKSSMEKVENIYQRNALSDYCNTFVAKGIEAYIHQRIQAEPQARIRILEVGAGTGGTTALVLPQLRQVQHAIDEYCYTDISKAFLIHAEKTYGPDYNYLDYKLLNLEQPLAPQGIEPGSYDMVIATNVLHATENIRQTLRHTKTALKRHGLLVINEVVEKSIVGILTFGLLDGWWLYQDESLRIPGSPLITLDTWRKILKEEGFARVLLPMRAASKLGQQVMVAESDGLVRREREDLPDEDESAVTDKTSVVQGMTLTPEQRIAQTPSVRELSSETLREQVAELILTGLAETLGMAQENIDPLVSFSDYGIDSILGVGFIGQLTKSFGITINTAILYDYTNVVRLSDYLVEIYAEDIQNKIQNNRMSPVEKDAVLYTETQLETTVDRNPEKSQLENSVPNMTSGENKSAKCQEIAVIGMSGQFPRAKDLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGGILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIGAEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVNTGCSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATGRCRTFDQFCDGTVLSEGVGVVVLKRLDDAVRDNDPIYGVIQASGANQDGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMRYHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREYLPLSETKAEMEAVLIPLSAKTLESLRTYAESLSTFLENGHSGHGVSLTDLAFTLQLGREAMRERCIFLAGNVPDLVAQLKAFANDKTLNNVGWYGRVGRSKNSHSFNDHESRQMITQWLQQGKLDKIAAAWVQGLSIDWAALYRELTARKIHAPTYPFAQEHYWKPEQQSMVQKPVAPETQPETFGTLMLQPCWIDQPLEHS", "perc_identity": 23.1}, "gnl|BL_ORD_ID|1039|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 33035, "orf_end": 60031, "orf_from": "BGC0001186.1|Misakinolide_16 ", "model_name": "MexS", "model_type": "protein overexpression model", "model_type_id": 41091, "pass_evalue": "n/a", "pass_bitscore": "660", "model_id": "1041", "ARO_accession": "3000813", "ARO_name": "MexS", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.35085e-21, "max_identities": 80, "bit_score": 95.9005, "cvterm_id": "39594", "query": "EHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLLCVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGH----STLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGEKVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIAMVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQL--------ISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPD", "match": "E L+   + T  PAA EV + V+A  +++ D+L    L P   A P   GFE++G V  VGA V  + +G  V +        +      +L     L V+       E +  + G+ +  +     A ++AG+ VLI  AA   G +++Q+A+A+GA + A+  S ++ ++LRE+G   ++     D    +   T G GV+VI +   G  M    D+ A  G+ +         S     +    +  FY   +     G+P++        +S+ L  + +   +  ++P +   F  D +  A+R +      G+VV+ + D", "sequence_from_db": "EVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDF-TGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD", "sequence_from_broadstreet": "MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD", "dna_sequence_from_broadstreet": "ATGTCCCGAGTGATCCGTTTTCATCAGTTTGGCCCGCCAGAGGTCCTCAAATGCGAAGAGCTGCCGACCCCGGCGCCGGCCGCAGGGGAAGTCCTGGTGCGTGTCCAGGCGATCGGCGTGAGCTGGAAGGATGTGCTCTGGCGTCAGAACCTGGCCCCGGAGCAGGCTGCGCTGCCGTCCGGTCTCGGCTTCGAACTGGCCGGCGAGGTGCTGGCGGTCGGCGCCGGCGTCGGCGACCTGCCGCTGGGTTCCCGCGTGGCCAGTTTCCCCGCCCATACCCCCGATCATTATCCGGCCTATGGCGACGTGGTGCTGATGCCGCGCGCGGCCCTGGCGGTCTACCCCGAGGTACTCACCCCGGTGGAGGCCAGCGTCTACTACACCGGCCTGCTGGTGGCCTATTTCGGCCTGGTCGACCTGGCCGGGTTGAAGGCCGGGCAGACCGTGCTGATCACCGAGGCGGCGCGCATGTACGGGCCGGTCTCGATCCAGTTGGCCAAGGCTCTCGGCGCGCGGGTGATCGCTTCCACCAAGTCCGCCGAGGAGCGCGAGTTCCTCCGCGAGCAGGGCGCCGACAAGGTGGTGGTGACCGACGAGCAGGACCTGGTCCTGGAAGTCGAGCGCTTCACCGAGGGCAAGGGCGTCAATGTCATCCTCGACGAATTGGGCGGTCCGCAGATGACCCTGCTCGGCGATGTCTCCGCCACCCGCGGCAAGCTGGTGCTGTATGGCTGCAACGGCGGCAACGAGTCGGCGTTCCCGGCCTGCGCCGCGTTCAAGAAGCACCTGCAGTTCTACCGCCACTGCCTGATGGATTTCACCGGTCATCCGGAGATGGGCCTGGAACGCAACGACGAGTCGGTGAGCAAGGCCCTCGCGCACATCGAGCAACTGACCCGCGATCGCCTGCTCAAACCGGTGGTCGACCGGGTATTCGAGTTCGACCAGGTGGTCGAGGCGCACCGCTACATGGAAACCTGTCCAAAGCGCGGCCGGGTGGTGATCCACGTCGCCGATTGA", "partial": "0", "query_start": 37607, "query_end": 38551, "hit_start": 39, "hit_end": 1017, "orf_dna_sequence": "ATGTTGAGGACCGGCATGAAGACAGATAGCCCGAATCATCCAGAAAACCAAGCGATCAATGTCAATCACTATTTAATGGTTTTGTCGGCCAAAACGAAAGAGCGCCTGCAAACGGTGGTTGAAAATCTACTTGACTACGCCAAAGCCAATCGTCGTCTCATCGAGTCCCGCCTTGCGGATGTCGCCTTTACCTTGCAAACGGGCCGCGAGGAGATGGAAGCGCGTTTGGCCTTCGTGGTATCGGATTATCATGATCTGATGGGTCAGTTAAGCGGTTATCTGGAGGATGCGCCCAACGCGAACACGATTTTCCGCGGACAGGTGGATCTGTTTGACCAATCTGCGCCGGTTCGTCAACATCGCGCGGCACAAGAGCGCGACTGCGAACGCATGATACGGACCCACGACCTGCCGGGCTTGGCCGAACTTTTTGTTCAGGGCGTGCCGATTGACTGGCGCCGTTTATATGTGCAGGGTCGCCCCAGGCGCATCGCGCTGCCCAGCTACCCCTTTGCCCCAGAGCGTCACTGGGTGGCGCGCCGGGAGCCTGACCATCTGGCTGCCGATATGCCCGCCGTTCGGCAGCCACACTCGCTGCTTGATGGACGTGATGATCGAATGAGTCTTGAGTCCGGCGTCGTGTTTCGAAAGCTGTTGCGCATTAACGATGGTGTCCTTCAGGATCATCAAGTCAATGAAACACCCGTATTCCCAGGCGTGGCCTATATAGAGATGGCCTGCGAAGCTTTGGCGCAGTTGTCGTTTTCTGATCCGGAGGTGTTGCGGAAGACCGTATTGAACCAAATGGTTTGGCTACAAGCCCTCGCCGTGACAGAGGCCGAGCATGAAATTTTGCTATGCTTGGAAAAAGATACACATGGTCTAGCATTTGAAGTCAAAGATCATCAAACGCTTTATGCCAAGGGCCGTTTCGATCAGTCGGATGACTTGAGTCAAGGCCATCAATACCTGGAACTGGAAACTATAAAAGGTGATTGTCCGCACGAAAAGCATCGCTCGGTCATTTACCATGACTTCCGCCTCTTAGGGCTAAATTATGGACCTTGGTTCCAGGGCTTAGAGCATACTTGGTTCAGTATAGATAGTGCTGAAGGGGAGGGTGAAGCGCTCGGCTATTTTAACATGCCGTTGATTTGCGAGTCGGAATTCTCCGCTTATACCTTTCATCCTGGCCTGTTGGATGCGGCATTGCAAGTCGTTGCCAGCGTGCCCGGATACGCTGACTCTGGCTTATTACTTCCCTATGCGGTAGAAAAGCTGGAGTGGTTCCACCCGTTTCCTGCTTGCGGATATTCCCATGTTCGCAAGCTGGCGAAGCATCGCTACGATGTCACCATCTGCGATGAACAAGGCAAGGTCTGCGCTAAATTTTCTGATCTTAGTGTTAGGCCCAGCCGAGTCGCAGGCTCAGAGCCCAGCCTGAATCAGCTGACCTACCGGGCGCGCTGGTCGCACCAAGAACTTGGGGAAAGACGATCGCCAGCAGGCCGTCCCGAAGAAACCGGAGTCGTGTTCATCATTCACACTCCGGAACAGCAGGCATTGGTACAAGAGCTAAGCAGCGTTTTAGCAGACATGCATGGCGATCATCGAGTACGACGGATGTGCCTAAATGCAAACGACTGGGATTTTAAATCGTTAGGGAATTGGAATCACCGTATTCGCGCCGTTCAGGACTTGCGCGATATCTATTTTCTTGCTGCTATGGAGCATACCGTTTCGAGCGGACAGGCCCATGTGGATCCTCTCTCTTTTACCAACCGACAGGAGCATGGGCTGCTCTCTTTATTCCGCTTGCTCAAAGCGCTGGATCAGAACCAGTTACTACTGCAACCGCTGTCGTTAAAAGTCCTAACGACAGGAAATTATCGCGTTTTGCCAAGCGATACGATTTGCCCTTTGAGTGCCGGTTTACCAGGTTTTTGCCGCTCCATTGCTCAGGAATACCCCTTGCTCGCTCTCAGTTGTATCGATCTCGGATGCCCGGATGGCGACGCCATGCAGCCATCCTCGCTTAAAAAACTGGCGCAGTTCATCGTTGCTGAGCCCGCGCATCAGCCTCATGAAACCGTCGGCATACGTGAACTCCGGCGCTATACTCGCAAGCTTGTTCCCGTTCGTTTTCCCGAACCCGGAGGGCAAAGAGCTTTTAAATCCCGAGGCGTCTACATGATCGTTGGCGGAGCTGGGGGCATTGGGATGGTGCTGGCCCAGTACCTGGCCGAGCGTGTTCAGGCGCGTCTGGTCTTGGTGGGCAGAAGTGCTTTGGATGAGGAGAAAAAGCAAAACCTTTCGACGCTCACTGCCGCCGGTGGAGAAGCCCTATATATCCAGGCAGATATCAGTCGTCTGTACAGCATGAAAGATGCCGTCGCCCAAGCCCGTCAGCGTTTTGGCAACATCAACGGTGTGGTGCATTCCGCCATGGTTTTAAATGACCAAAGCTTGGCCCGTATGAGTGAAGAGGGGTTGCGGGCCAGCCTGGCGCCAAAAGTCGAAGGCTGTATCGTGTTGCAGCAGGCGATGGCCGGTGAGCCACTGGATTTTATGTTGTTCTTTTCTTCGGCAATCTCCTTTAGCGGCAACGCCGGACAAAGTAACTATGCAGCAGCTAGTACATTTAAGGATGCCTTTGCCCATTATCTGACGCAAGTGGAAGCTTATCCCGTATTTAACATCAACTGGGGATATTGGGGGTGTGTTGGTGTGGTTGCGAATGCAGCTTACCGTGAACGTTGGGCAGCTCGAGGAGTCCATTCTATTGACCCAGAACAGGGTCTGCAAGTCATTGAATCGATCCTGACTAACCATATTGATCAAGTCGCTGCGGTGAATGTCGAGCCGTCTTTTCTAGAGCGCCTGGGCGTAGAACTGTCTCAAACACAAACTGTACTCCCACCACGTCGCTCGTCGCTGATTGCAAAACTTAATGCGTTGCCACTGCCGGAAACCGGGGGTTTTCAAGATAATGTTAATCGCCTAGAGATCGTGAGTGCATTCCGCTGGGCTGAAGTGTTTAAGCATATGCTTGATATGTCTAGCACTCAGGGAATGTATGCTCGCTCTGATCTTAAACGACAATTACAGATTAGCTCTGAACACGATCAGTTGTTTGATGTTCTCATTTCTATGCTCATTCAAGAGGGCTATCTCCATCAGCAGGGCAAAAATCTGACGCCTACACCTTACTTGAATGGCGAGTTTTTCCAGCAGCAGAGAGAACAAGTCGCATTGCTGGAAAGTGAGCTGTCGCAAACGGATAATGCCTATTTAAACTTGTTATCTCGCTGTCTGGATCACTATCCCGCTATGTTGCGCGGTGAAGTGGCGGCAACTGATGTGATATTCCCACAGGGCTCGATGGAATGGGTGGAAGGTATCTACCGCAGCCATGCTTCAGCCGACTATTTTAATCAGCAATTGGCCCAACGCCTCGTTGCCTATGTTGAGGCCCGCTTGCCTTCCCTGGGTGCGAATGAATCGATTCATATCCTAGAAATTGGCGCCGGCACCGGCGGCACCAGCGCCATTGTATTACAGGCGCTCCAGCCTTATGCAGCTCGCCTGCGTTATACCTACTCCGATATCTCGCCTGGTTTCCTCAATTACGGGCGCAAAACCTTTGGCGACGCGTATCCGTTTGTCGAATTCAGACACTTAAATATTGAACACAATGGCGAAGCTCAGGGCTATCAAGCAGGCGAGTACGATTTGGTCCTGGCGGCCAATGTGTTGCACGCTACCCGTCACATTGGCAACACCTTGGCCCGGGTTAAGTTTTTCATGAAACGCCATGGCTGGCTGTTATTGAATGAAGCCACCCAAGTGCGCCATTTTGGGACGTTGACCTTTGGTTTGCTAAAAGGTTGGTGGTTGTTTCAAGACGCTGAAAACCGGCTTGACGGATCGCCTTTGCTGTCAACCACTGCCTGGCAGCGGTTACTGTCGGAAGAGGGGTTCAAGCACACGCTTAGTTTGTGCGACGCGGTTGAAGAAGAGTCAATTTTTCAGGATGTCATTGTTGCTGAAAGTGATGGTGTCATTCAAATGAATCAGTCGGATTCACCTGTGCAGCCGCGTGAGCCTGTGGATGTGTCTGTGGATGTCCATCATGTCGATGACATGATGGAGCCTGGGCAAGTGGCGGATGTGGTTGAGTCACGACATGATTTTATCGTCAATAGCGTCAGCCAATGTATGGCTCAGTCTTTAGGTGTGGCGTTTACCGACATTCACATCAATCGTCCATTTAGCCTTTATGGTGTGGATTCGATCACGGGAGTTGATTTTATTCATCAGATCAATTCCCGTTTAGGGATCGTTTTGCGAACGACGGCCTTATTTGATCACGCGACGATTTTTGATTTATCCCGTTTTATCGACGAGAGCCACGGCGCGGCGATTGACGAGCAGCGTCAGCGCTTGAGGTCAACACCGTTGACCTCAAGCGATACGAAGCCAGCGGAGCGTGTCGCCCCGCCGGATGAAGCGCTTCCCCATATCGAAAGGGGCTGTCACCAGGCGGTCGTACTGGAAAAACCCAGCCAGATCGAGCACCTTCGCTTCCATCCCGTGAAAACCCGGGAACCTGCGGCGCATGAGGTGCAAATTGCAGTTCGCGCTTTTTCGCTCAACTTCGGGGATTTGCTATGCGTGACCGGGCTCTATCCCACCATGCCGGCGTATCCATTTACACCGGGCTTTGAAGTGTCCGGGCACGTCGCCAACGTGGGAGCGGCGGTCAGCCACGTTGCGGTGGGCGACGAGGTCATTGCCCTAGCGGGCCAGCAGTTGGGCGGCCACAGTACGCTGTTGACCACTGCAGGACACTTGGTGGTTCACAAACCGCGTCAGGTCAGCCACGAGGAAGCTTGCGCGTTTCCCGGCGTTTTTCTGACCGTCTACCATGCGTTTCAAAGCGCCAATATTCAAGCTGGGGAAAAAGTTTTGATTCAAGGCGCGGCCGGGGGAACGGGCTTAATTGCTGTACAAATGGCCCAGGCGGTGGGAGCGGAAATTTATGCCACAGCCGGTTCGCCCCAAAAACTGGATTATCTGCGTGAACGAGGCGTGCCGCATCTGATCAATTACCAGACGGACGATTTCGCCGAGGTCATTTTAGCAGATACAAACGGTTATGGCGTGGACGTGATCTTCAATACAGCAGCCGGGGACGCCATGCAAAAAGGGCTGGACATTCTGGCTCCCAATGGACGCTATTTGGAAATTGCGATGGTCGCCCTGAAGCGTTCGCGGTCGGTTGATTTATCTCATTTGGTTGATAATCAGGTGTTTTATAGCATCGATATGAGAAAGCTGATCGCTGGAAACCCACAGCTGATCAGCCGCTATCTGAATCGCATGGTGGAGCATCTGGCAGAAGGGCACGTGCAGCCGACGATAGGCGCAAGATTTGCGCTTGATGATATTCAAAGCGCCTACCGGCTGCTACACGACCGGCAAAATATTGGCAAAGTTGTTGTCAGTATCCCCGATGGGATGATGGACAATCAGGTCGGCCAAAGGATGGTGCCGGAATCCTCAACGGTTGAGGACTATCGCGTTGGAAACGCCACGGTTGAACAGGTTGCGGTAAAACAACCGGCGGACATGGATGAGCCGATTGCCGTTGTCGGTATGTCCGGCCGTTTTCCCGGGGCAAACAACTTGGAGCAGTTCTGGTTGAATCTTATAGGTGGCAACAACGCGATCACCGAAGTTCCCGCTGACCGCTGGGATGTCCATCAGTGGTATGACCCCGACCCGGCAGTCCTTGATAAGACCCATTGCAGATGGGGCGGTTTTCTGCGAGATATTGACAAATTTGATGCGCTGTTTTTTAAACTCTCAGGCCGGGAAGCCGAGTTGACTGACCCGCAACAGCGTTTATTTCTGGAGGTCGCTTGGGCCGCACTTGAAGATGCGGGGCATGCGAACCGCGCGATTTCCAATGCCCGCTGCGGGGTTTTTGTCGGAGCCGGTCCGAGCGATTACGTCACGTTAATGCGTGAACGGAGCGTGCCCGGCGAGCCCCAGTCATTCTGGGGCAATTCCAGCTCGCTAATCGCGTCGCGCATTGCCTATTTTTTAAACCTGAAAGGGCCGAGTATCACCATTGATACGGCCTGTTCCTCATCTCTGGTCGCCTTGCATTTAGGCTGCGAAAGTATTCGGCGTGGCGAATGCGACATGGTCATTGCCGGTGGCGTGTATATTGGGGTCACACCACACTTACATGTTATTGCTAGCAACGCCGGCATGCTCTCACCCGATGGCCAGTGTAAAGCCTTTGATCAAGGTGCAGATGGCTTTGTCCCGGGTGAAGGCGTTGGCGCGGTGGTCTTAAAACCACTGTCAGTGGCACGTCAAGCCGGTAATTTTATTTATGGGATTATTCGTGGCTCAGGTTCAAATCAAGATGGGCGAACTTATGGTATTACCGCGCCCAGCGCTGCTTCTCAAACAGAGCTAGAGCAAAGTGTCTACCGACAGGCCGAACTCGACCCGGCAAGCATTGGCTATGTTGAAGCTCACGGTACAGGTACCAAACTTGGTGATCCCATTGAGATTGATGCGCTGAATCGTGCCTTCCAAAGTGACGCGAAAAAGCAGCACTCTTGTGCCATTGGATCGGTTAAAACAAATATTGGACACGCTGGTGCGGCTGCCGGTATTGCTGGATTCATTAAGGTCTTATTGTGCCTGCAACATCAACAATTGGTGCCTTCGTTAAATTATCACACGTGTAATGAACATATCGATTTGGACAATAGCCCGTTCTATGTGAATACAGAATCAAAGGATTGGTTCGTCGCTCAGGGTGAGCCGAGACGGGCTGCGGTCAGCAGCTTTGGCTTTAGTGGTACTAATGCGCATATTTTGTTAGAAGAATACCAACACCATGAGGACGAGGCCCAGGCACTTGGAGATGACAAGGATGTGTTGATCGTCCTTTCAGCCAAGAATCAAGAACGTCTCAAAAAAGCGGCTGAAAATCTTCACCATTTTTTAGAAAGCAGAGTCTCCTATAAATTGTCCGACATTGCCTATACGTTGCAGGTTGGCCGTGAGGCGATGGAGGCGCGAGTTGCTTTTATGGTGGTCTCAGTCCTTGACTTACAACAAAAGCTTGTGTCATTGCTTCATGACCCAACAGACGAACAAGACATGTATTGGGGGGAGGTGCGCGATGGCGAGGGGCCTGCTGGAGTGGCTGCTTTTGAAGACGTCGCACTTGCCTTGGCTAACAAGCAGTTGGATCAGCTTGCCCAGTGGTGGGTGTCTGGGGTTGAAATAGACTGGACCCAGCTTGCACGCGTGGTGAAAGTCCGTCTCGTTCCTCTGCCTACGTATCCGTTTTCGCCTGATCGTTACTGGTTTGATTCGGTAGGTCCGGCGACGGTTGTACATGCCGAGCATTCAGCCTCTGCTCTGTATCCCCTATTGAATCGTATCGCTCCGCAGGCGAGCACTCAAATCGCGAACGGCTGCGTGTTTGAGACGTGCTTGAAATCCAGTGACCCTCTGTTGGCGCAACATCTCATTGACGGCCAGGCGGTGTTTCCGGCAGTGGGATTTCTGGAGATGGTCATAGCTGGCCTGCGCGAAATCCAGCCAGATAAAGCAGCGCGGTTGGAGAATGTGTTTTGGCTCCGGCCTCTTGATGTCATGGATGAACAACGCGTTCATCTGGTGTTTGAGGTGAAACAGGATCGTTTTCAATATCGAATTGTACCCGCAGAGTCTCACGGGGACGGGGCCTATTTTCGTGGCCAAGGCTACTGGTCAAACGATATGAATCCTGCGATTCCGATGGATATTGATCGCCTGAAAAGCCGTATGCGCCAACAGCCCTTGCTCAACGAATCCAGCCCCCGAGTCCGCCTGGGCCGCTTGTATCAAGGCGCGACTGAGGGGTGGACGGATGGTGAGCAAGCACTGATCGCCTTTGAGTTGCCAACGGCGCAACCGTATCGAGACGGGTCCCCCGATCAAAAATCATACCCATTTCACCCTGCAGCTTTTGTCGCGGCTTTGCAAGCCTATCACTGGATTCATGAGGCGCCTAAGCGTCTGGGGATGCCTTTTGCCGTGCAAAAAGTGGAGCTGTGGCGCCATCGTGATCAACCCGCTTATGCTTACGTTGCACTAGATGAGCATGGCAACGCGGACGTGCACATCCTGGATGCAGGCGGTCAGGTATGCGTCTGTTATCGTGGCATGGCCCTGCAGACCTTGAACAATGCGCACCACGATGGGAGACAAGAAAGCACTCAAAAAGATGAGCTTGGAAAATTGCTTTTTGTCCCTGTCTGGAAGCGTCTTGATACGAAACATGGGCGTGCACATGGCATGCATGCGCTTGCTCGCGGAACGGGCGTCTTACTGGTGTACACACACGAAAATGGGGTAGAGGCCGAGCAGCTCATGCAGCGTTATCGCGAAGAGCAATGTGAGTTACTCTCGGTTTGCTTATCTGCGGCGGATAGAGCACTGGACACCCTGGCGGCGCGTCTAAAGCATCTGCAGTCGCCACTGCGCCATGTCTGTTTTCTTGATCGTCATCAGGCCGCGCTTGATCCGGCTGACAAGCAGATTGACGAGCGATTGCGTGAACCCCAGACCCTCACAGGCTTTTTGGCATTAGTGAGAACCCTGAGCGAGCTTGGCTATGATGAACAGCCCCTACAATGGCTTGTGCTTACCTCTAGCGCATGTGCCGTCAATCAAGCAGACCCCATTAACCCGTATGCCGCTGCGATTGTCGGACTTGCCTCTTGTCTGGCGCAAGAGCATAGGTATTGGCAGGTGAGTGTCTGTGATCGGGGCAAAGGCACATCTTTCACAACGATTGCGAATCACGGGGAAACCTTGCGCGTTATTGCTGAGCGCAGTGGATACAGTTATGTGAGGCACATCAAAGAATTAGAGCTGCCCCCTCCCCGGCAGAGCCGTTTGCGTCACAAGGGCGTATATGTCTTGGTTGGCGGTGCCGGTTACGTGGGGACCTTGCTTAGCCGCTATCTGGTTCAGACCTATCAGGCAAAGGTGATATGGCTAGGTAGACGTGAGCAAGATGAGCAGATAGAGCAAAACATAGCCCTGATCGCTACCTTGGGATCGCGTCCGCAGTATCTGAGCCTGAAAACCGGATCAGACGACGAGCTACACCGTGCATTTGCGCAGATTAAGGCAGAAAACGGTTTGATCCACGGTGTGTTTAACCTGGTGATGGTCGCGCAGAGTACCCCGATGCGCAGCCTGAGCGAAGCACAATTTCGAGCTGGCTCCTTTAATTCCAAAGTGAACTCCGCGCAAGCCTTATACCGTATTCTGAAAAAGGAAGCTCTAGACTTTATGGTGTTCTTCTCTTCGATGCAAAGCTTTGCGCAGCAGCTCAATTTTATGTCAGCGAATATGAGTAGTTATGTTGCAGGTTGCATGTTTCAAGATGCTTTTGTGCATCAGATCAATTGCGAGTTATCTTATCCTGTAAAAACTATTAACTGGGGTTATTGGTCACAAGAGAGTTCAGAGAGCGAAAAGGCGAAGTGGTACGAGACTTATATCGCGGATAAAGGTATTTACAGTCTCAATGTTGGGGAGGCGATGCAAGCGTTGGAGTATATTTTGGCTCACGAACCAGAACAAGTGATCGTGACCAAAGTATCACATCGGGTTCTCAGCGACATGGGCTTTGTGCAAGATGACTCAGAGAACGTCGACCTACAGCCTGTTATTGACTCGAACGATGACAATACCCAGCTTGAGGACTTGATCGTTAATGGTATTCTCAAAACCTTTGAAACGCTCGATGTATTGCAGGTATTTGATAGCGCCTGTAATCTCGATGTTTCGAGATTACAGGCGCATGTGCCCGATAAATATCGCCGCCTGTGGCGTGAACTGCTTCTGATTTTGGTTCAGGCTGGAAAGATGGCACCACAGGGTGCTGGGTTTGCTCTACGAGAAAGCTATACCAGTTTGGCGAGCCAGCTTCGCTTAATGGATCTCGATCGGGAGGCTGGGCTATTGCGCGAGCGCCATCCCACCTTAGCCTCGAAACTTGCCTTGCTCGTACCCTGTCTGAAGGATATGGCCGAGGTGTTAACGGCTCGCAAACCAGCAACAGAAGTGTTGTTCGAACACGCTTCGCTGTCACGGGTTGAAGGGATTTATAGAGGAAATCCCACCACAGACTACTTTAACCAGCGTGTCGCTGACATTGTGAAGGCCGCAGTACAGCAGGCACTGCCCAGCCTGAGTGTAGGGAAAAAAGTACGCATTTTGGAAATCGGCGCGGGCACCGGTGGTACCAGTGCCTACTTGTTTCAAGCACTTAATACATATGCAGATCAGTTGCACTACATCTATACGGATATCTCTAAACGATTCTTAATTCATGCAGATGAAACTTTCTGTGAGCAGTATTCCTTTATAGAGACAAAATTGTTGAATATCGAACAAGATGTGGCAGGCCAGGGGTTCGATCCTGCTAGTATTGATATCGTGGTGGCAGCCAATGTTTTGCACGCCACACGCAACATTAGTAAAACTTTGCAACATGTTAAAGACTTACTCAAGAACGATGGGCTTCTGGTGTTAAATGAATTAGCGGACGTTTCGCCTTTCCTCACCGTGACCTTTGGTCTGTTAGATGGATGGTGGTTGTATGATGATGAAGCCATTCGCCAACCAGGCTCACCTGGCCTATCAGCAAAAAATTGGCAGCTTGTGTTGAAAAATCAGCGTTTTCACAATATTAGTCTCAACGATGAAAAAGCTCTGACGTCAGAGCAGCAAATTATTATCGCGCAAAACGAGAGTAAAGAGAGTGTGCCGGTCTCATCCACAGTATTATTAGGAACAGAACTTATCGCCTCAGTCGAAGCCAGTCTGATCGCACAATTGAGTCAGTGCATAAAAATCGAGCAAAACCGTCTCAATACCTATACCACGTTTTCAGATTATGGTGTGGATTCAATTTTGATGCTCGCCTATGTTGATCAAATTAATGGTGATCTTGGAATTGACCTCAATCCTTCAGAACTATTTAATTATACCACTGTTGAGCGTCTTACTAAGTTTATCGTTGATTATCATGGGAAAGAGATCATTTCAGCAAAAGAAAGCGTTGAGAGATCATTACTTCAGAATCAAGAAAGCAAATTTGACCTCAATGACATAGATGTCATCACAAAGGCAGGGAACGAAGCTCCGGAGATGGCGCGCAGCCTTCTCTTTGATAACGTTTTGCAAGTGCCGTCCGGTAACGTGCATCATCACCAGAGCGATAAGGCGCGACCTGATATTGCGGTTATTGGCATGTCGGGGCAATTCCCAGGTGCGACGAATGTTCAGCAGTTTTGGCAAAATCTGAGCGCCGGCGTCGATAGTGTGAGCGAGCTGCCTGAAAGCCGCCTGGATCGTCAGCTGTACAGTCCGCAGCCAGAGGCGGGAAAATGTTATTGCCAATGGGGCGGTATCTTAGAGGAACAGGCCTCTTTTGATCCACTGTTTTTTGAAATCTCTCCCAAAGAAGCCGCCGAGATGAATCCTTCTCAGCGGGTGTTTATGCAGGAGGCTTATCGAGCCCTGGAAGATGCGGGGCTGGTCAACGCAGGTCTCTCGCAACTGCATTGTGGCATTTATGTCGGTTGTGAGCCAAACGGCTATACCAAACAAGGTTTCACCGGCGCCTCCGAAGCCATTGTCGCTTCCAGAATCTCCTATTTTCTCAATTTGCAGGGACCGGCTCTGGTGATTAATTCCGGCTGCTCCTCTTCCTTGGTCGCCATTCATCTGGCTTGTGAAAGCCTTCGCCATGGCGAAAACGATATTGCCCTCGCCGGAGGCGTTTTTACGAATCTGAATAACGAGTTGCTCGTCTGTCTGTCGTCCATTGAGATGTTGTCATTCTCCGGTAAATGTCACGCCTTTGACGAAGCCGCCAATGGCACGGTGCTGTGTGAAGGTGTCAGCGTGCTGGTGTTGAAACGATTACAGGACGCGCTAGATGATGGCGATGTCATTTATGGCGTGATCAAAGGCAGTGGCATGAATCAGGACGGAAGAAGTAATGGCATCACTGCACCCAACGGACTTGCACAAGAAAATTTGATCAAGCGCATTTATCAGGATTACAACATTGATGCCAGCAAAATCAGCTACATAGAAGCCCATGGTACTGGAACGAAATTGGGTGACCCCGTTGAGGCGAATGCGNTGAAGAACGTATTTTCTTCAAGAAACACGGGTTTGGACTTTCGTTGCGGAATCGGTTCAGTTAAATCGAATATAGGACATGCGGCTGCAGCTGCGGGTGTGATCGGTCTGGTCAAGGTCTTATTATGCATGCAACACCGTCAGTTACCAGGGCTGGTGCATTTTAACAAACTCAACCCTCTAATCGATTTTAACGACACAGGTTTGTACATCGTTGAGCAATTGCAAAACTGGGAGCCAGCGTCTGGTGAGCCGTTGATGGCAGGCATCAACTCGTTCGGCCATAGCGGCACCAATGCCCATCTCGTGATTCAGGAACCCCCTGTGCGACCTGTCCGCGACAGCGAGAACCCATTCCATTTAATCTGTCTATCTGCCAAAACAGAGGAAGCGCTTAAACAAAAAATTAGCGATTTGAGTGCATATCTAAGGCGCAAAGAAGAGCCGCCAACTCTAGGAGCCATCAGTTATACCTTGAATACCGGCCGTGCTCACTTTAGAAAACGCTGCGCTTTCGTCGTGGATTCGCTGGAGGCTTTGCAAAATGCTCTCATGGGAGCTTTAGATGGTCTTGTTGGCAATGCAGAAAGGTTAAGTCCACAAGAACAGGCATTTTGTAAAAAAGCATTTGATTTGATTATCAAGGATTTACACGATGTAGAGAATCTTGAAAGTAGGGCTGATCAAACAATCTATAAAGATAACCTACTGGCTCTGACCGGACTTTATCTAAAAGGTTTTGACCTAGACTGGCAACGGGTGTACAAAGGTCAGAGCTATCACCGGGTATCCCTGCCGACATATCCTTTTTCCAGAGATACATACTGGATTGACGAGCCAAAACAAATTAGCTTCACCGAGCCTGGTACCGACAAGCCTGGAAACACCAGCAGGAATCATCAGCAGGATCAAAAAGATGAGGATGTGTTGGGTGGACAGTTTTATATACCGCAGTGGAAACGGCTTGATCAAACACAATCCTATGCCAGTTTAAGCGATCATGGGAAGTTGACCATCGCATCTGACCCTGTTGTCATTTTTTATCCGCCGACCATGACAAGTTTAAAAGATGATATTCAAACATGCTATGAGCAATTACCGGCAAGCCAAGTCGCTAGCTTCGAGCTTGGCTGCACACCTTCGTCTGAGGTCGATGTTCGCGATCCCCGTGCCTTTGAACGCATCTTTGTATCCCCTAGGCAGGCATTGGAAGAGCTGCTTGAGCAAGGTCGAACGTTAACGATCTACTTTATCCTGCCTGAACCGGATCAAAACCCGGACTCAGGGTGCAACCTCGAATGCCTTGAGGAATCCCTGTCACTCGGGCTGATCTCGTTGTTCCGTTTGATACAAGCGCTGTTGGCCCATCACGGCTATGCCAGCGAGCTGACCCTCAAAATCGTGACCCAGCAAACCCAGGTCTGTAAAGCTTCTGAGCGCATTGTGCCCTATGGCGCAGATGTGGTGGGTTTTGTGCAGTCGTTAGCGAAGGAATACGAGCTCTGGCAAATCAGTTGCGTGGATATTAATCGGCAGACATGGTGGACGCCCGCGCAAAGCAAAAACTTTGCCGAGGCGCTGATTGCCCTGAAGCCACCGGCGGACGGGCGCGCTCTATGTTGGCGGGACGGGTATGTTTATCACCGTGTTTTAACCCCGGCTAATCTCGTTGGCGTTCAGGGAAGTGCATTCAAGACGCGCGGTGTCTACCTAATTATTGGTGGCGCTGGAGGGTTGGGATTGGTGCTCAGCCAGTATCTGCTTGAACACGTGCAAGCGAAACTGGTATGGGTGGGGCGGCGCAGCCTCGAGGCGTTGGCGCCGGATGCGTTGCGGTTATTCAACACTCCGGGCGCCCACGTGCTATACGAGCAAGCGGATCTGTGTGATCCGGAAGCGCTGCAGCGCGCGCTGCAGCAAGCCAAAGGACGTTTTGGATACATTGATGGTGTCATCCATTCGGCTTTGATTCTAGAGGACCGAGCGATCGCCGACATGGATGAGAAAACGCTACGCAAAGTTCTCGCGCCCAAAGTACAGGGCAACGTGGTACTCCAGCAAGTGCTGGCCGATGAGCCTTTAGATTTTCTGTTGTATTTCTCCGCCGGACAGTCTTTTATGAGTCATGCTGGGCAGAGCAATTACGCCGCTGCCTGTACCTTTGAAGATGCCTGGGCGCTGTGCCAGGACCAGCGGCAAAACTATCCGATCAAAATTATCAACTGGGGCTATTGGGGCGAGGTGGGCATTGTCGCCACGGCTGACTACCGTAAACAAATGGCCAGGCAAGGCGTGCTATCGATTCATCCGCAAGAGGGCATGGAAGCGGTAGAGCGTTGTCTGGCGTCGTGCGCCACCCAGGCCGCTTATTTTAAAGTGGAACCCCGCGCCTTGAGCCGATTGGGCTTGGACGGCACTGGAATCTTGCATGCGAGCCGGAACCGTGTTCCACCTCAATTGATTCATGTCGTGATTGATGCCACCCAGGCGTGGTCAATCTCGATGCCGTACGCACAGCGCTATCAACAATCCCTTAAAAAGTTGGATCGGCTTGGTTGCTATCTCCTTCTGCGTGTATTCCAGGCTATGGGAGTGTTTAGTCAGCCTCATGAACACTATGAAAAACAGGAATTGGCCAGTAGATTAGCCATTTCAAAAGGCTATCATCACCTCTATCAAGAATGCTTGAACTTGCTAGATACGTCCGGTTTTATTGCAATCAATGGTTCGCACATTGAAGTCCAAGACGTGCTACCGGAAGAACATGACGAACACCACAGCTGGTTACAACCCTATCCCGAATTGGCCGCGCATGAAAAATTGTTGCGCATCTGCCTACAAGCTTTTCCGGATATCATCCGGGGATCGGTTGCCGCGACGGATATCATATTTCCGGATGCGTCTGTGGAATTGGTAGAAGGTATTTATCAGGGCAATCCCGCCACCGATGCGCTGAATACCAAAGCGAAAGATGCTGTGGTTGCCTACGTCAAAGCCCGCCTGGCAGACTGTCAGGAACAAATCATCTTTTTAGAAGTCGGAGCGGGAACCGGCGGCATGAGTCATGAGGTGTTGAAGGGGCTGGCCCCCTATGGGCAGTATATCGAGTATTATTACACCGATGTCTCCGAGCATTTTATCCAGTACGCTCGCCGCCGTTATGGTCAGGATTACCCCTTTGTCCGGTTTCAACGTTTAGACATTGAACAGGAGCATAGCGCGCTAAGTGAGGGGCTGCTCAGTGCCTGCGATGTCGTATTAGCCGCGAATGTTCTGCACGCCACCCAAAGCGTTCGCAATACCATCCAGCATGTCAAAGCCCTGCTAAAACGGCACGGCTTGTTAATCTTAAACGAAGCTACGACTTTGGAAAGCTTTGCCACATTGACATTCGGATTGTTAGAGGGCTGGTGGCGCTACCAGGATGCCGGAGACCGCCTACCTGGCGGGCCTTTGTTAAGCGCGTCCATGTGGCATCGCTTGCTCGAAGAAGAAGGTTTTGACCAGGTGGTGTCCCTGGGTGAGCCAGGCGAAGGCGACATGTTGGGACAGCATCTCATTGTCGGTCGAAGTGATGGCTGGAGCTTGCATCAATCTGCGAGGGACGATGAAACCCGTTCGGCCCCTGTTAGCCCTGTGGCGGCGAGCGACGTTATCCAAGGCAATCGAAATGACAAGCCCGCAGAGCTTATCAAACACGTTGAAGCGCAGATTGTGCAAACCCTTTCAGCCGCACTGGATATTGCTGCGGCTCGAGTGGAACGCGATGTGTCGTTTTCCGAGTATGGGGTGGATTCGATTCTGTCCGTTGCGATTATTAACCAATTAAACCAGCGCCTAGGGATTCGTCTGAAACGTCCGGATTTGTTTAATTACACCACCACAGAAAGCATGGCGGCGCATATTGTCGCAACCTTTGCTGACCACTTGACGGCGGCCTTAGTCGAAGAAGCTGAACCACCAACGCCAGTAACCGTAGCAAGTCCTCAACCGATAAAAGCGGCGGGGCAGCAGGATGTTCTTCAGCAAAACTTGCAAACCCAGCCTCAAGTCTCGCAAGGCGTTTGGCAAACCAAGCCGGAACCCATTGCTGTCATCGGCATGTCTGCCTGCGTGCCAGGGGCGGATCATGTGGGTGCGTTTTGGGACAACTTGGTTGCCGGCACAGATTCCGTCACCCGGATTCCCCATGAGCGTTGGCAGCGGGAGGCCGTCAATGAGCTGCCCGGCGGGCCGGATACCTCCCAGCGCAAAGCCGGATTTATGGACAATATTGCCGAATTTGACCCGCTTTTTTTTGCCATCTCTCCGCAAGAGGCGCAGTGGATGGACCCGACGCAGCGGCTGTTCTTACAGCAGGCTTGGGCCGCGTTGGAAGATGCCGGATACAATCCGCGAGCCTTAGCCGGCGCTTCATGTGCGGTGATGGTTGGCTGTGCGGCGACTGGCTATGGTGTGAAAGAGGGCGAGCGCACGGGGTATGTGTCCTATGCTATGACCAATAGCGAGGCCATCTTACCCGCGAGAATCTCCTATTTTCTCGACTTAAAAGGCCCGAGTATTCCCATTAACACCGCCTGCTCTTCGTCTTTAGTGGCGATTCATCTGGCCTGCGAACAACTTCGCTCCGGGCAAAGCGACATGGCGTTGGCTGGCGGTGCTTCCGCACTGATTGGTTCCGCGTTGCACATCGGACTCAATGGCGTTGGGATGCTATCTCCCGAGGGCGCATGCAAAGCATTTGATAAGGAGGCCAATGGCTTTGTGCTTGGCGAAGCGGTTGGCGTTGTCGTTCTCAAACCGTTGTCCAAGGCCGTGGCTGATGGCGATTCGATACATGGTTTAATTATTGGCTCGGCGATTAACCAGGACGGCAAAACCAATGGTATCATGGCGCCGAACGGTCCGTCTCAGACGGCATTAATTGAATCGGTGTACCGGAAATTCGAGATCGATCCTAAAACGATTAGCTATATCGAAACCCATGGCACCGGCACCCAACTCGGCGACCCAATAGAAGTCAACGCCTTGGCTGCTGCCTATGAAAATTTCACCACCTCGCAAACTCAGTACTGCGCCATCGGATCGGTAAAAACCAATATTGGTCACACCACCACTGCTGCCGGTGTCTGTGGATTGATTAAGACTTTATTATGTCTCAAACACCAAAAACTTGTCCCATCCCTGCACTATAAGGAGCCCAACGAAAATATTGAGTTTGAAAAGACGCCGTTTTACGTCAATACCCAGGTCAAAGATTGGCCGGGTCATCAAAACGGTGTCCGGCGTGCGGCGGTGAGTTCCTTTGGCTACAGTGGCACCAATGCGTATATGGTGGTGGAAGCGTTCGTGGAGACGAGCCCGCGCGCGGTCGGGCAGCAGGGACCTGCATTAATTGTCTTGTCGGCTAGGCATGAGGTGCGACTCAAAGAGCTGGCCAGCAATCTCATGGCCTATTTGAAGCGGTATGGCTTGAATCCGGATCGCCCGATTCAGCTCGAAGATATGGCGTATACGCTTCAGGTTGGCAGACAGGCCATGTCAGAGCGTCTGGCGTTTGTGGCGGACAGCGTGGCGGATGTCGTCAAACATTTAGCCACATTTGTTGACGGCGAGGCCAATGCCCAGGAACTTTACCGGGGGCAAGTTAAACCGTTCGGCGATAAGAGCGATTTGCTTTTGGAGGGCGAGGCGGGTCAGGCTTTTCTCAACACGATTTTAAGACAGCAGGATTACCGCAAATTAGCCGCCCTGTGGGTGGCGGGTACAGACTTGGACTGGAATTTACTCTACGACGGTGAAAACCGTGCCCGTCGCATTTCGCTACCGACCTATCCTTTTGCTAGGGAAACGTATTGGTTGGATGAGGGGATAGGGAGCAATGAAAAAGAGCTTCTAAGAGATCAGACTCAAAAAGAGTTACGTGATCGTGATCGTGAGCAAACTACGGAACTCATGACATTTGAAGAGATATGGCAGGAGGCGTCCTTAAACAATCATTCGGATTCCATCAAGTATAAAAGCATCGTTTGTTTTCTTTCCGGATCAGAACATCAGCAAGAAATGCGAACTGCCATGCAGGCGATTGATCCGGCTATCCATCTTACGATGATTGCTCAAGGCCATGGTTACACAAAGCACTCATCTGATCGTTACACAGTAGACCCCGCCGATATACAGAGCTTTCGTGAAGCTTTCCTCGATATCAGCCAGACTCATGGCGAGGTCGACGCGCTGCTTTATCTATGGCCAACCGAGGATTGGCGTCTCTTGTATGATCCATCCGCCGTCGTTTATATGTTGCAGGCTCTGGTCAAGAGTGAGCTAAAACCTTCCCGCTGCTTGCTGGTTGCTGCTTTTTCCACTGCTTTGGAGCGTTGTTACCTGGAATCCTGGATTGGCTTCGAGCGCTCGTTAAAGCTCATCATGCCTGGTTTCCAGGTCGCGGGACTGTTTCAGGAACATGCGGGGCCGGACCAGACGATTTCAATGACACATTGGAGTCAACACATTGTCTCTGAACTCAAAGCGCCTAAAGCACAGACGGTGCTGATACAAAATCACCGGCGCTACGTCAATCAGATTCAAAAAACCGAACTGGCCGCGCAAGGCGCTTCGGTTGCATCGGCCGTCAAACAGGGCGGTACTTACCTGATTACCGGTGGCTGTGGGGGATTAGGTTTTTTGGTCGCCCAGCACCTGGCAGAACACCTTGGGCAACCGGCAGCCTCAGCCTCGGGAAAAACGGTGCATTTAATTCTGACGGGTCGATCATCTCCCGATGACGCGATACAAAGCAAAATCACGCAACTGGAAGCATTAGGGGCAAAGGTTGGTTACGTTCAAGCGGATGTTGCCGATGCAGTCGCCATGAGACGTGGCCTTGCCCAGATGAAAAATCGCTTTGGCGACATACACGGTATTTTTCATATCGCTGGGATCGCCCCCAGCGAGAGTCTCCTCAATAAAGATATCGACGCCTTTCAAAACGTACTGGGGCCTAAAATTGCGGGCACGTTGATGCTTGACGATCTCTGTCGTGATGAACCGCTTGATGTTATCTGTTATTTTTCCTCCTCTGCCGCGATTTTAGGGGATTTTGGCGCCTGTGACTACGCGATTGGCAATCGTTTTCAGATGGCTTATGCCGCTTATCGCAACCATCTGCTGCAGCAGGGGATGCGACAGGGTAAGGCGTTGGTGATTAATTGGCCGCTTTGGCAAGAAGGCGGCATGGGGTTTCATCAAGACGAAAATACCAAGATGTACTTGAGCTCCAGCGGGCAGCGGGTTCTGGAAACTCAGGAAGCCTTGACGGTATTGGATCACGTCCTTAACCAGGACAAAACACAGCATTTGGTCCTGGTGGGGCAGCCAGGTCGGGTGTATGGCTTTTTAGGGTTGACTGAGGCGCCTATGACTCAGATGCCAGTGACTGAAGCGCCAGTGACGCAGACATCCACACGGCCAGAGTTGAGAGGCTTGAGTACGGAGCAGTCGGTATTATGGGATTTAAGAAATCTCATCGTCCAGCAACTCAAAGTGCCCTGGGAGCAGCTTGGGCGAGATCACAATCTCGCTGATTTCGGTTTTGATTCAATAAGCTTGTTGAGTTTTGCCAATCGTCTCAGCGAGCATTATCAACTTGACATTACACCTGCCTTGTTTTTTGGGTATTCGACTCTAGAGCAACTCACGCAGTACTTTTTAAGCGAGCATTGCGATTTTATCAACGCCTTTTATAAGGAACCCGAAAAATCGGAAATCCCTGTAAAAAAGGAAGCCGTTGAAGAGCGTGCTCCTATCCGGATTGTTTCTGAAGAAACCCGCCCAGAAAAAATAGATAATGCAAAAGATGAGCCCATTGCCATTATTGGCATGAGTGGCAGATTTCCCAAAGCTTACGATGTTGAACAAATGTGGCAGCTCTTGGCATCGGGTGAATGTGCGGTAGAAGAAATTTCACCACATTACTTTGATTGGCGCAGATACTTTGGAGAGCCGAGCCAGGAGGCTAACAAAACCAATGGAAAATGGTGTGCTAATATTCCTGGCGTTGCCGAATTCGACCCCCTGTTTTTCCAAATTTCCCCGAGAGAAGCGCCAAACATTGATCCTCGTCAACGGCACTTATTGCAAGAGTCTTGGAATGCTTTAGAACATGCCGGATACGGGCCGCATCAACTGAATAGCCAGAAGATCGGCACCTTTGTCGGGGCTGAAGAAGGGGATTATTATCAACGTGTCAAAGAGGGCAACATCACCTCCAATCACTCGGGCATTCTCGCCGCTCGTCTGGCCTATTTCTTAAACTTAAAAGGCCCGACCATGGCGATTAATACCGCGTGTTCCTCCTCACTGGTCGCGGCTCATCAGGCTTGTCTGAGTTTACGGCAGGGGGAATGTGATACGGCCATCGCGGCAGGGGTCAATCTAATGCTCACCCCTTACGGATATATCAGTATGGGCCGAGCAGGTATGCTCTCTGAGGATGGCCACTGTTATGCCTTTGATGAACGCGCCAATGGCTTAGTACCAGGTGAAGCCGTGGTCGTCGTGGTATTAAAGCGCCTTAGCCGAGCGCTTGCTGACGGTGATCCTATTCACGCGTTGATCTTGGCTAGCGGTGTTAACTATGATGGCAAAACCAATGGTATCACTGCACCAAATGGTGTTTCGCAGGCCGAGTTGGTGAGGGAGGTTCACCAACGAGCCGGGGTTCATCCGCAGGATATTGATTATATTGTGACACACGGTACGGGTACCCGGCTAGGTGACCCCGTGGAGGTCAACGCCCTTAACGAAGTCTTTAGGGACAGCCAACACCTTTGTGCGATTACATCCAGTAAAACCAATTTTGGCCATACGTTTTCCGCTTCGGGGCTGCTCAGTCTTGTCAATCTGGTACAGGCGCTTCGTCATGAGACCATTCCGAAAAGCCTGCATTTTGCTCAGCCAAACAAATTTATGACATGGGATCAAGGCCCTCTCTATGTCAATACGGCCAATAAGCCCTGGCTCGAAAAGCCGGGCGAAAAACGCATTGGCGGGGTGAGTGCGTTTGGAATGAGTGGCACCAATGCCCATATGCTGATTCAAGACTACCAGCTTCACAGAAAAGAACCACGTGCGGTCCCGCCTTATGCGCTGCTTGTGTTGTCTGCAAAAACGGCAGAGGCACTGCATCTCAAGGTCAAAGCCATGGTCGCGTTTTTGCAAGAAGGGCTTGCAGACACTGCCACCCTAGCGGATATCAGTTATACATTGTTTGAAGGCCGACACCACCTTCAATACCGTTTGGCTATTGTGGTGCAGGATATGACTGAGGCCATGTGTTGTTGGACACAAGCCGGGCAGCCAGATAAGAAACCCAATATTTTTCAGGGAAAAGTGCCTACCGAATTTAGTGGTCAAAAGGTCACACAGAATTATATTAACCAATTAGTAGAACAGCTTGATCGCTCTACCGGCGATGATGACGTATACCGAGAACGTCTCTTGGGTTTAGCTGATTTTTATTGTCAGGGGTATGATGTCCCTTGGTCTAGGCTATACGGTGATACACGGCCACGCCGTATAAGTCTGCCTGGGTATCCGTTTGCTAAACAACAATTTTGGCTGGATTTCTCTCCGAAGGATCATGGCGAACAAGAAAATGTCGAACTTCCTATTGGCAAGATGCAGAGACAAGTTCTAAATGAAAAAAACACGCTTGAAACATTAAGCTACATTCACAAATGGGAACAGCAGGATAAAGCTGAAGTCAAGATAGAAATCAGCCAGGTTTGCTTACTAGTTTACTTTGAATCTGCATCGCAATTTGAAAAAACGCTGGCAAGCTTCTTCTTGCAGCAGGGTGCATCTCAGGTGATCGAGATTCAATTGGGACTCGAAACCAAACCGGTGTCCGAACATAAATGGCGCTGCAATGTCAATGACGTCGACGCTTTTCAGCGTTGCCTTCAAGCCTATGCACAGACAATCAATAGCGTTTACTTTCTCTGTGTCGATACCCTCCAGCAGGGCATGGAAGAAAGCGAAATGCAGTTGCTACGGCTGGTCAAAGCCTTAAAATCACGTATGCAGAGCCATGCCTTTATCGATTTCACCCTTCTGACTCTGGATAATCACCGCGTCGATAACAGCGCGACAAGTCCCAACCACGGGGGGCTTAGCGGTCTTGGGTACTCGGTGGCGCAGAGCGATCACCGCTTCCGGGTTCGAAATATCGATTTGTCGCGGGAAGATCTGGTGAGCGCCGAACAACAATGCACCCTGCCAGGCATGATCGTCAGCGAAGCCCCGTCGGACCGAGGCGAGGTGGTCAAGTTGCAGGCAGGTTTGCGCTACAAGCAGCGCTTTTTCAAGCTCGACTGGCAGACGCTGCAAGCGGCACAGCCAGAGGCGGCGGGTTTGAAAACCGGTGGGGTCTATGTGTTGTTGGGTGGCGCGGGAACCGTTGGTGCGATTATAACCCGCTATCTCATCCAAAAATATCAGGCCAATGTGGTTTGGCTGGGGCGTCGTGCGCTGACATCGCCTGCCGTGCAGGAACAACTACACGCGTTCCGGAGCGTGGACGAAGGGTGTGTGCCACTCTATATTCAGGCCGATGTGACGGATCAGGCTTCCATGACTCAAGCGGTCAAAGAGATCAAGCAACATCACCCTTGCATCCATGGCGCGATTTTCTCCGCACTGGTCTTTAAGTTGGATAACTCAATTGCTAAGACTAGCGAGGAAGACTTTAATGAGGTTTTGGATACCAAGAAAAAGGGTGCGCAGTATTTTTATCATGCATTCAAAGATGAAAACTTAGATTTTATGTGTTATTTCTCGTCGGTCCAATCTTTTTTCTTTATCTCCTCTCGAGAGAGTGCAGGGTATGCAACCGGTATTACCAGCGCTGACACCTTTGTACATGCCATCGATCACGATAGCACCTTTCCTGTCGGTATCATCAATTGGGGTTACTGGGAGGCCTCTCTGGCGGGAACCGAAGCCGAGAAGCGTTTGCCCGGTCATTATGACTTAATCTCTGATCATGATGGATGTCAGTTTTTTGACGGATTTGTACCTATGCTTAGATCAGGCCTTATCAAACAGGCCGTTTGTTTAGGTGTGTCAAAAGCGATAGAGGATTTCATGGGCTGTGACGCCACGCAGATGATCACGGTGAACAAGCTTGAGGCTGATTCTTTGATTTTTAGCCTTTTTAATGAAAATGAGTGCGGCCAAGCTACGTGTGAGGAAACTGAAATCGAGCGCCTTTTGGATAAAGATTTCAACAATGAACTTAAGCAATGGTTGCCGCGGCTGCTATTTTCACAGCTGCAACAACTGGGGATCTTTTTAAATCGTGGTGAGCAGAGAGATTGTACGACGTGGCAACAACAAGCTGGTGTGATCAAAAAATATGAACGCTGGTGGCGAGAGTGTTGCTTAGGGCTGCTGGAGACCTCCGGCTACGTACAATGTGAAGGTGAGAGGGTTGAGGTCACTCACCATAGTCCGGCAGACGAGGCGGATCAACTCTGGCAAGGCTGGGAGAGCTTCCAAAATTTATTCCTCGACAAGCCGGAAAGAAAACCTGTGCTCGACTTATTGGAGAGCTGTCTGAGAAGCCTGACGCAAATCCTGTGCGGTGACATCCTGGCCACCGATATTCTTTTTCCAAAATCGTCAATGGAAAAAGTAGAAAATATATACCAGCGGAATGCCCTATCCGACTATTGTAATACCTTTGTCGCGAAAGGTATCGAAGCTTACATTCATCAGCGGATTCAGGCAGAGCCTCAGGCAAGGATCCGGATATTGGAAGTCGGTGCAGGTACTGGAGGTACCACCGCATTGGTCCTGCCACAACTGCGTCAGGTGCAGCATGCGATAGACGAGTATTGTTATACAGACATTTCCAAAGCCTTCTTGATACATGCAGAAAAGACTTATGGGCCGGATTATAACTATCTAGATTATAAGCTACTCAATCTCGAACAACCGTTAGCGCCACAAGGAATAGAGCCTGGCTCCTATGATATGGTAATCGCTACCAACGTGTTGCACGCTACAGAGAATATCAGACAAACCCTTCGCCATACTAAAACTGCTCTAAAACGTCATGGATTATTAGTGATCAATGAAGTGGTTGAGAAATCTATTGTCGGTATCTTAACCTTCGGGTTGTTAGACGGCTGGTGGCTCTACCAAGACGAATCATTACGCATCCCAGGCTCTCCGCTGATCACGCTGGATACCTGGCGTAAAATTTTAAAAGAAGAGGGCTTTGCCAGGGTCTTGTTGCCAATGCGAGCCGCATCTAAGTTGGGTCAGCAAGTGATGGTGGCGGAAAGTGACGGTCTGGTTAGACGGGAGAGAGAAGACTTGCCGGACGAGGACGAATCGGCTGTGACTGATAAAACGTCCGTGGTACAGGGCATGACTTTGACTCCGGAACAGCGAATTGCGCAAACACCGTCTGTACGGGAGCTGTCGTCCGAAACACTACGAGAACAGGTTGCCGAGCTTATTTTGACAGGATTGGCCGAAACATTAGGCATGGCGCAAGAAAATATTGACCCACTAGTTTCATTTTCTGACTATGGTATTGATTCTATTCTTGGTGTCGGTTTTATTGGTCAGCTTACTAAATCCTTCGGCATCACCATCAATACCGCTATATTGTATGATTATACCAATGTAGTGCGTCTTAGTGATTATCTGGTAGAAATCTATGCAGAGGACATACAAAACAAAATTCAAAACAACCGCATGTCTCCAGTTGAGAAAGATGCTGTTCTATATACAGAGACACAACTAGAAACAACAGTCGATCGTAATCCGGAAAAAAGTCAGCTTGAAAACTCAGTTCCTAATATGACCTCTGGCGAGAATAAGTCCGCCAAATGCCAGGAGATCGCTGTTATTGGTATGTCAGGGCAGTTCCCTAGAGCAAAAGACCTTGACGCCTTCTGGCAAAATCTGATTCAGGGACGGGATGGTGTTGTAGAGCTACCCGCGAATTATCTCAATCCGGCTTTGTTTAGCCCGCACAAACAAGCGGGAACAACCGATTGTAAATGGGGTGGCATTTTAGAGCAGCGTGATTGTTTTGACCCACTTTTTTTCAACCTTACGCCCAGGGAAGCGGAGTCGATGAACCCGCATCAGCGTCTCATTCTGAGTGAGAGCTGGAAAGCGCTGGAAGATGCCGGCTACAATCCCAAAGAGCTGGATAATACTCGCGTTAGCGTGTTTATTGGCGCGGAACCTACCGACTATTACCATGAAACCTTTACCGGCTCTTCTGATGCTATTGTTGCCTCCCGCTTATCCTACTACCTCAACCTCAAGGGACCGGCTTTGGTGGTCAATACGGGTTGTTCGTCTTCTGCTTTGGCGATTCACTTGGCCTGCGAAAGTTTACGCCGTGGCGAGTCTTCAATGGCCCTGACAGGTGGCATTTTTGCTGCAATGCATGAAGAAGCACTGGTTAAACTAGCCCAGATTGATATGCTTAGTGCCACCGGTCGCTGCCGTACATTTGATCAATTCTGCGATGGTACCGTATTGTCTGAAGGTGTTGGGGTGGTTGTGTTAAAACGGCTTGACGATGCCGTCAGGGACAACGACCCCATCTATGGCGTGATTCAAGCCTCTGGGGCAAATCAGGACGGTGCCAGCAATGGGATAACTGCGCCTAGTGGTTTGTCGCAGGAAGAACTCCTGACGTCTGTCTACCGGCAATATGACATCAATCCGGAAACGATCACGTATATTGAAGCTCATGGAACTGGTACCTCACTTGGAGATACCGTTGAGGCTAATGCGTTAAAGCGGGCCTTTAAACAGTTTACGGATAAAAAACAATTCTGTGCACTTGGCAGCGCAAAATCTCATATCGGCCATACAGGAGCTGCTGCTGGCGTTATTGGTTTAATCAAAGTTTTGTTGTCGATGCGCTATCATCAGCTGCCTAAACTGTTGCACTTCGAAGAACTCAATCCATCAATCGAATTGGAAGATTCTGCATTTTATATCAATCAACAGCAAATGGAATGGACGGGGCAGGGCGTGCCATTAACCGCAGGGCTGAATTCTTTTGGCCACAGTGGTACGAACGTTCACCTCGTGGTTCGGGAATACCTGCCGTTATCTGAGACGAAAGCCGAAATGGAGGCTGTACTGATTCCATTGTCTGCCAAAACCCTCGAATCCCTTAGAACCTATGCTGAAAGTTTATCGACGTTTCTGGAAAATGGGCATTCTGGTCATGGTGTTAGCCTCACCGATTTAGCCTTTACCCTCCAGCTTGGACGCGAAGCGATGCGGGAGCGCTGTATTTTCTTGGCTGGAAATGTCCCGGATTTGGTAGCCCAATTAAAGGCTTTTGCGAATGACAAGACGCTCAACAATGTGGGTTGGTACGGCCGGGTTGGACGCAGCAAGAACAGCCATTCCTTCAATGATCATGAGTCTCGGCAAATGATCACTCAATGGTTGCAACAAGGAAAATTGGATAAAATTGCCGCCGCTTGGGTACAGGGCCTGAGCATTGACTGGGCAGCCCTTTATCGCGAGCTCACAGCTCGTAAAATCCATGCGCCAACCTATCCTTTTGCCCAGGAACATTATTGGAAACCCGAACAGCAGAGTATGGTTCAGAAGCCCGTTGCGCCGGAAACACAGCCTGAGACCTTCGGAACACTGATGTTGCAGCCCTGTTGGATAGATCAACCCCTTGAACATTCATAA", "orf_prot_sequence": "MLRTGMKTDSPNHPENQAINVNHYLMVLSAKTKERLQTVVENLLDYAKANRRLIESRLADVAFTLQTGREEMEARLAFVVSDYHDLMGQLSGYLEDAPNANTIFRGQVDLFDQSAPVRQHRAAQERDCERMIRTHDLPGLAELFVQGVPIDWRRLYVQGRPRRIALPSYPFAPERHWVARREPDHLAADMPAVRQPHSLLDGRDDRMSLESGVVFRKLLRINDGVLQDHQVNETPVFPGVAYIEMACEALAQLSFSDPEVLRKTVLNQMVWLQALAVTEAEHEILLCLEKDTHGLAFEVKDHQTLYAKGRFDQSDDLSQGHQYLELETIKGDCPHEKHRSVIYHDFRLLGLNYGPWFQGLEHTWFSIDSAEGEGEALGYFNMPLICESEFSAYTFHPGLLDAALQVVASVPGYADSGLLLPYAVEKLEWFHPFPACGYSHVRKLAKHRYDVTICDEQGKVCAKFSDLSVRPSRVAGSEPSLNQLTYRARWSHQELGERRSPAGRPEETGVVFIIHTPEQQALVQELSSVLADMHGDHRVRRMCLNANDWDFKSLGNWNHRIRAVQDLRDIYFLAAMEHTVSSGQAHVDPLSFTNRQEHGLLSLFRLLKALDQNQLLLQPLSLKVLTTGNYRVLPSDTICPLSAGLPGFCRSIAQEYPLLALSCIDLGCPDGDAMQPSSLKKLAQFIVAEPAHQPHETVGIRELRRYTRKLVPVRFPEPGGQRAFKSRGVYMIVGGAGGIGMVLAQYLAERVQARLVLVGRSALDEEKKQNLSTLTAAGGEALYIQADISRLYSMKDAVAQARQRFGNINGVVHSAMVLNDQSLARMSEEGLRASLAPKVEGCIVLQQAMAGEPLDFMLFFSSAISFSGNAGQSNYAAASTFKDAFAHYLTQVEAYPVFNINWGYWGCVGVVANAAYRERWAARGVHSIDPEQGLQVIESILTNHIDQVAAVNVEPSFLERLGVELSQTQTVLPPRRSSLIAKLNALPLPETGGFQDNVNRLEIVSAFRWAEVFKHMLDMSSTQGMYARSDLKRQLQISSEHDQLFDVLISMLIQEGYLHQQGKNLTPTPYLNGEFFQQQREQVALLESELSQTDNAYLNLLSRCLDHYPAMLRGEVAATDVIFPQGSMEWVEGIYRSHASADYFNQQLAQRLVAYVEARLPSLGANESIHILEIGAGTGGTSAIVLQALQPYAARLRYTYSDISPGFLNYGRKTFGDAYPFVEFRHLNIEHNGEAQGYQAGEYDLVLAANVLHATRHIGNTLARVKFFMKRHGWLLLNEATQVRHFGTLTFGLLKGWWLFQDAENRLDGSPLLSTTAWQRLLSEEGFKHTLSLCDAVEEESIFQDVIVAESDGVIQMNQSDSPVQPREPVDVSVDVHHVDDMMEPGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVDSITGVDFIHQINSRLGIVLRTTALFDHATIFDLSRFIDESHGAAIDEQRQRLRSTPLTSSDTKPAERVAPPDEALPHIERGCHQAVVLEKPSQIEHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLLCVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGHSTLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGEKVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIAMVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQLISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPDGMMDNQVGQRMVPESSTVEDYRVGNATVEQVAVKQPADMDEPIAVVGMSGRFPGANNLEQFWLNLIGGNNAITEVPADRWDVHQWYDPDPAVLDKTHCRWGGFLRDIDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSVPGEPQSFWGNSSSLIASRIAYFLNLKGPSITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGIIRGSGSNQDGRTYGITAPSAASQTELEQSVYRQAELDPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFIKVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPRRAAVSSFGFSGTNAHILLEEYQHHEDEAQALGDDKDVLIVLSAKNQERLKKAAENLHHFLESRVSYKLSDIAYTLQVGREAMEARVAFMVVSVLDLQQKLVSLLHDPTDEQDMYWGEVRDGEGPAGVAAFEDVALALANKQLDQLAQWWVSGVEIDWTQLARVVKVRLVPLPTYPFSPDRYWFDSVGPATVVHAEHSASALYPLLNRIAPQASTQIANGCVFETCLKSSDPLLAQHLIDGQAVFPAVGFLEMVIAGLREIQPDKAARLENVFWLRPLDVMDEQRVHLVFEVKQDRFQYRIVPAESHGDGAYFRGQGYWSNDMNPAIPMDIDRLKSRMRQQPLLNESSPRVRLGRLYQGATEGWTDGEQALIAFELPTAQPYRDGSPDQKSYPFHPAAFVAALQAYHWIHEAPKRLGMPFAVQKVELWRHRDQPAYAYVALDEHGNADVHILDAGGQVCVCYRGMALQTLNNAHHDGRQESTQKDELGKLLFVPVWKRLDTKHGRAHGMHALARGTGVLLVYTHENGVEAEQLMQRYREEQCELLSVCLSAADRALDTLAARLKHLQSPLRHVCFLDRHQAALDPADKQIDERLREPQTLTGFLALVRTLSELGYDEQPLQWLVLTSSACAVNQADPINPYAAAIVGLASCLAQEHRYWQVSVCDRGKGTSFTTIANHGETLRVIAERSGYSYVRHIKELELPPPRQSRLRHKGVYVLVGGAGYVGTLLSRYLVQTYQAKVIWLGRREQDEQIEQNIALIATLGSRPQYLSLKTGSDDELHRAFAQIKAENGLIHGVFNLVMVAQSTPMRSLSEAQFRAGSFNSKVNSAQALYRILKKEALDFMVFFSSMQSFAQQLNFMSANMSSYVAGCMFQDAFVHQINCELSYPVKTINWGYWSQESSESEKAKWYETYIADKGIYSLNVGEAMQALEYILAHEPEQVIVTKVSHRVLSDMGFVQDDSENVDLQPVIDSNDDNTQLEDLIVNGILKTFETLDVLQVFDSACNLDVSRLQAHVPDKYRRLWRELLLILVQAGKMAPQGAGFALRESYTSLASQLRLMDLDREAGLLRERHPTLASKLALLVPCLKDMAEVLTARKPATEVLFEHASLSRVEGIYRGNPTTDYFNQRVADIVKAAVQQALPSLSVGKKVRILEIGAGTGGTSAYLFQALNTYADQLHYIYTDISKRFLIHADETFCEQYSFIETKLLNIEQDVAGQGFDPASIDIVVAANVLHATRNISKTLQHVKDLLKNDGLLVLNELADVSPFLTVTFGLLDGWWLYDDEAIRQPGSPGLSAKNWQLVLKNQRFHNISLNDEKALTSEQQIIIAQNESKESVPVSSTVLLGTELIASVEASLIAQLSQCIKIEQNRLNTYTTFSDYGVDSILMLAYVDQINGDLGIDLNPSELFNYTTVERLTKFIVDYHGKEIISAKESVERSLLQNQESKFDLNDIDVITKAGNEAPEMARSLLFDNVLQVPSGNVHHHQSDKARPDIAVIGMSGQFPGATNVQQFWQNLSAGVDSVSELPESRLDRQLYSPQPEAGKCYCQWGGILEEQASFDPLFFEISPKEAAEMNPSQRVFMQEAYRALEDAGLVNAGLSQLHCGIYVGCEPNGYTKQGFTGASEAIVASRISYFLNLQGPALVINSGCSSSLVAIHLACESLRHGENDIALAGGVFTNLNNELLVCLSSIEMLSFSGKCHAFDEAANGTVLCEGVSVLVLKRLQDALDDGDVIYGVIKGSGMNQDGRSNGITAPNGLAQENLIKRIYQDYNIDASKISYIEAHGTGTKLGDPVEANAXKNVFSSRNTGLDFRCGIGSVKSNIGHAAAAAGVIGLVKVLLCMQHRQLPGLVHFNKLNPLIDFNDTGLYIVEQLQNWEPASGEPLMAGINSFGHSGTNAHLVIQEPPVRPVRDSENPFHLICLSAKTEEALKQKISDLSAYLRRKEEPPTLGAISYTLNTGRAHFRKRCAFVVDSLEALQNALMGALDGLVGNAERLSPQEQAFCKKAFDLIIKDLHDVENLESRADQTIYKDNLLALTGLYLKGFDLDWQRVYKGQSYHRVSLPTYPFSRDTYWIDEPKQISFTEPGTDKPGNTSRNHQQDQKDEDVLGGQFYIPQWKRLDQTQSYASLSDHGKLTIASDPVVIFYPPTMTSLKDDIQTCYEQLPASQVASFELGCTPSSEVDVRDPRAFERIFVSPRQALEELLEQGRTLTIYFILPEPDQNPDSGCNLECLEESLSLGLISLFRLIQALLAHHGYASELTLKIVTQQTQVCKASERIVPYGADVVGFVQSLAKEYELWQISCVDINRQTWWTPAQSKNFAEALIALKPPADGRALCWRDGYVYHRVLTPANLVGVQGSAFKTRGVYLIIGGAGGLGLVLSQYLLEHVQAKLVWVGRRSLEALAPDALRLFNTPGAHVLYEQADLCDPEALQRALQQAKGRFGYIDGVIHSALILEDRAIADMDEKTLRKVLAPKVQGNVVLQQVLADEPLDFLLYFSAGQSFMSHAGQSNYAAACTFEDAWALCQDQRQNYPIKIINWGYWGEVGIVATADYRKQMARQGVLSIHPQEGMEAVERCLASCATQAAYFKVEPRALSRLGLDGTGILHASRNRVPPQLIHVVIDATQAWSISMPYAQRYQQSLKKLDRLGCYLLLRVFQAMGVFSQPHEHYEKQELASRLAISKGYHHLYQECLNLLDTSGFIAINGSHIEVQDVLPEEHDEHHSWLQPYPELAAHEKLLRICLQAFPDIIRGSVAATDIIFPDASVELVEGIYQGNPATDALNTKAKDAVVAYVKARLADCQEQIIFLEVGAGTGGMSHEVLKGLAPYGQYIEYYYTDVSEHFIQYARRRYGQDYPFVRFQRLDIEQEHSALSEGLLSACDVVLAANVLHATQSVRNTIQHVKALLKRHGLLILNEATTLESFATLTFGLLEGWWRYQDAGDRLPGGPLLSASMWHRLLEEEGFDQVVSLGEPGEGDMLGQHLIVGRSDGWSLHQSARDDETRSAPVSPVAASDVIQGNRNDKPAELIKHVEAQIVQTLSAALDIAAARVERDVSFSEYGVDSILSVAIINQLNQRLGIRLKRPDLFNYTTTESMAAHIVATFADHLTAALVEEAEPPTPVTVASPQPIKAAGQQDVLQQNLQTQPQVSQGVWQTKPEPIAVIGMSACVPGADHVGAFWDNLVAGTDSVTRIPHERWQREAVNELPGGPDTSQRKAGFMDNIAEFDPLFFAISPQEAQWMDPTQRLFLQQAWAALEDAGYNPRALAGASCAVMVGCAATGYGVKEGERTGYVSYAMTNSEAILPARISYFLDLKGPSIPINTACSSSLVAIHLACEQLRSGQSDMALAGGASALIGSALHIGLNGVGMLSPEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKTPFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTNAYMVVEAFVETSPRAVGQQGPALIVLSARHEVRLKELASNLMAYLKRYGLNPDRPIQLEDMAYTLQVGRQAMSERLAFVADSVADVVKHLATFVDGEANAQELYRGQVKPFGDKSDLLLEGEAGQAFLNTILRQQDYRKLAALWVAGTDLDWNLLYDGENRARRISLPTYPFARETYWLDEGIGSNEKELLRDQTQKELRDRDREQTTELMTFEEIWQEASLNNHSDSIKYKSIVCFLSGSEHQQEMRTAMQAIDPAIHLTMIAQGHGYTKHSSDRYTVDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVAAFSTALERCYLESWIGFERSLKLIMPGFQVAGLFQEHAGPDQTISMTHWSQHIVSELKAPKAQTVLIQNHRRYVNQIQKTELAAQGASVASAVKQGGTYLITGGCGGLGFLVAQHLAEHLGQPAASASGKTVHLILTGRSSPDDAIQSKITQLEALGAKVGYVQADVADAVAMRRGLAQMKNRFGDIHGIFHIAGIAPSESLLNKDIDAFQNVLGPKIAGTLMLDDLCRDEPLDVICYFSSSAAILGDFGACDYAIGNRFQMAYAAYRNHLLQQGMRQGKALVINWPLWQEGGMGFHQDENTKMYLSSSGQRVLETQEALTVLDHVLNQDKTQHLVLVGQPGRVYGFLGLTEAPMTQMPVTEAPVTQTSTRPELRGLSTEQSVLWDLRNLIVQQLKVPWEQLGRDHNLADFGFDSISLLSFANRLSEHYQLDITPALFFGYSTLEQLTQYFLSEHCDFINAFYKEPEKSEIPVKKEAVEERAPIRIVSEETRPEKIDNAKDEPIAIIGMSGRFPKAYDVEQMWQLLASGECAVEEISPHYFDWRRYFGEPSQEANKTNGKWCANIPGVAEFDPLFFQISPREAPNIDPRQRHLLQESWNALEHAGYGPHQLNSQKIGTFVGAEEGDYYQRVKEGNITSNHSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGVNLMLTPYGYISMGRAGMLSEDGHCYAFDERANGLVPGEAVVVVVLKRLSRALADGDPIHALILASGVNYDGKTNGITAPNGVSQAELVREVHQRAGVHPQDIDYIVTHGTGTRLGDPVEVNALNEVFRDSQHLCAITSSKTNFGHTFSASGLLSLVNLVQALRHETIPKSLHFAQPNKFMTWDQGPLYVNTANKPWLEKPGEKRIGGVSAFGMSGTNAHMLIQDYQLHRKEPRAVPPYALLVLSAKTAEALHLKVKAMVAFLQEGLADTATLADISYTLFEGRHHLQYRLAIVVQDMTEAMCCWTQAGQPDKKPNIFQGKVPTEFSGQKVTQNYINQLVEQLDRSTGDDDVYRERLLGLADFYCQGYDVPWSRLYGDTRPRRISLPGYPFAKQQFWLDFSPKDHGEQENVELPIGKMQRQVLNEKNTLETLSYIHKWEQQDKAEVKIEISQVCLLVYFESASQFEKTLASFFLQQGASQVIEIQLGLETKPVSEHKWRCNVNDVDAFQRCLQAYAQTINSVYFLCVDTLQQGMEESEMQLLRLVKALKSRMQSHAFIDFTLLTLDNHRVDNSATSPNHGGLSGLGYSVAQSDHRFRVRNIDLSREDLVSAEQQCTLPGMIVSEAPSDRGEVVKLQAGLRYKQRFFKLDWQTLQAAQPEAAGLKTGGVYVLLGGAGTVGAIITRYLIQKYQANVVWLGRRALTSPAVQEQLHAFRSVDEGCVPLYIQADVTDQASMTQAVKEIKQHHPCIHGAIFSALVFKLDNSIAKTSEEDFNEVLDTKKKGAQYFYHAFKDENLDFMCYFSSVQSFFFISSRESAGYATGITSADTFVHAIDHDSTFPVGIINWGYWEASLAGTEAEKRLPGHYDLISDHDGCQFFDGFVPMLRSGLIKQAVCLGVSKAIEDFMGCDATQMITVNKLEADSLIFSLFNENECGQATCEETEIERLLDKDFNNELKQWLPRLLFSQLQQLGIFLNRGEQRDCTTWQQQAGVIKKYERWWRECCLGLLETSGYVQCEGERVEVTHHSPADEADQLWQGWESFQNLFLDKPERKPVLDLLESCLRSLTQILCGDILATDILFPKSSMEKVENIYQRNALSDYCNTFVAKGIEAYIHQRIQAEPQARIRILEVGAGTGGTTALVLPQLRQVQHAIDEYCYTDISKAFLIHAEKTYGPDYNYLDYKLLNLEQPLAPQGIEPGSYDMVIATNVLHATENIRQTLRHTKTALKRHGLLVINEVVEKSIVGILTFGLLDGWWLYQDESLRIPGSPLITLDTWRKILKEEGFARVLLPMRAASKLGQQVMVAESDGLVRREREDLPDEDESAVTDKTSVVQGMTLTPEQRIAQTPSVRELSSETLREQVAELILTGLAETLGMAQENIDPLVSFSDYGIDSILGVGFIGQLTKSFGITINTAILYDYTNVVRLSDYLVEIYAEDIQNKIQNNRMSPVEKDAVLYTETQLETTVDRNPEKSQLENSVPNMTSGENKSAKCQEIAVIGMSGQFPRAKDLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGGILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIGAEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVNTGCSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATGRCRTFDQFCDGTVLSEGVGVVVLKRLDDAVRDNDPIYGVIQASGANQDGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMRYHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREYLPLSETKAEMEAVLIPLSAKTLESLRTYAESLSTFLENGHSGHGVSLTDLAFTLQLGREAMRERCIFLAGNVPDLVAQLKAFANDKTLNNVGWYGRVGRSKNSHSFNDHESRQMITQWLQQGKLDKIAAAWVQGLSIDWAALYRELTARKIHAPTYPFAQEHYWKPEQQSMVQKPVAPETQPETFGTLMLQPCWIDQPLEHS", "perc_identity": 24.46}}, "BGC0001186.1|Misakinolide_17 # 60103 # 73629 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.505": {"gnl|BL_ORD_ID|1570|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 60103, "orf_end": 73629, "orf_from": "BGC0001186.1|Misakinolide_17 ", "model_name": "AQU-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "1711", "ARO_accession": "3002993", "ARO_name": "AQU-1", "ARO_category": {"39426": {"category_aro_accession": "3002992", "category_aro_cvterm_id": "39426", "category_aro_name": "AQU beta-lactamase", "category_aro_description": "AQU beta-lactamases are chromosomal class C beta-lactamases that confer resistance to cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.5022, "max_identities": 16, "bit_score": 30.8018, "cvterm_id": "39651", "query": "QMCALRMLSKDGQCKAFGQGGNGFVPGEGAGVVLLK----PLSEAIREGDNI", "match": "+M + R+ +K G    FG     FVP +G G+V+L     P+ E ++   +I", "sequence_from_db": "EMGSQRLFNKTGSTNGFG-AYVAFVPAKGVGIVMLANRNYPIQERVKAAHSI", "sequence_from_broadstreet": "MKQTSPLSSLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPHYFNYGVAELATGKKVSEQTLFEIGSVSKTYTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLADEAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSEQTLLAGNSVQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYPIQERVKAAHSILSKLAP", "dna_sequence_from_broadstreet": "ATGAAGCAAACCTCACCCTTGTCGTCGCTGGCGCTGAGCGCCCTGCTGCTGTCGCCCCTCACCCAGGCCGCTCCCGCCGATCCGCTGGTCGGGGTAGTGGATGAGGTCATTCGTCCGCTGGTGAAAGAGCACAGGATCCCGGGCATGGCGGTAGCCGTGTTCAAAGAGGGGCAACCCCACTACTTCAACTACGGGGTTGCCGAGCTGGCGACGGGGAAGAAGGTCAGCGAGCAGACCCTGTTCGAGATTGGCTCGGTCAGCAAAACCTATACCGCCACCCTGGGGGCCTACGCCGTGGTCAAGGGGAGCATTGGGCTGGATGACAAGGTGAGCCGGCACGCTCCCTGGCTCAAGGGCTCCGCCTTTGATGGCATCACCATGGCCGAGCTTGCCACTTACAGTGCCGGGGGTCTGCCGCTGCAATTCCCCGACGAGGTGGAATCGCTCGAGCAGATGCAGGCTTACTATCGCCAGTGGACGCCGGCCTATCAACCAGGCAGCCATCGCCAGTACTCCAACCCCAGTATCGGCCTGTTCGGCTATCTGGCGGCGAGCAGTCTGCAGCAGCCGTTTGCCCAGTTGATGGAGCAGACCCTGCTGCCCGGGCTCGGCCTGCATCACACCTATATCAATGTGCCGAAGCAGGCGATGGCGAACTACGCCTATGGCTATTCGAAAGAGGACAAGCCCATCAGGGTCACGCCAGGGGTGCTGGCGGACGAGGCCTACGGCATCAAGACCAGCTCGGCGGATCTGCTCGCCTTCGTGAAGGCCAACATCAACGGGGTGGATGACAAGGGATTGCAGCAGGCCATCGCTTTGACCCACCAGGGGCGCTACTCGGTAGGCGAGATGACCCAGGGGCTGGGCTGGGAGAGTTACCCCTATCCGGTCAGCGAGCAGACGCTGCTGGCGGGCAACTCGGTCCAGGTGATCATGAAGGCCAATCCGACGACGGCCGCGCCGAAGGAGATGGGGAGCCAGCGGCTCTTCAACAAGACCGGCTCGACCAACGGCTTTGGCGCCTATGTGGCCTTCGTGCCGGCCAAGGGAGTGGGCATCGTCATGCTGGCCAACCGCAACTACCCCATCCAGGAGAGGGTAAAGGCGGCCCACTCCATCCTGAGCAAGCTGGCTCCCTGA", "partial": "0", "query_start": 69229, "query_end": 69372, "hit_start": 969, "hit_end": 1122, "orf_dna_sequence": "GTGAGTGCGTCCGAACATGCAGGCTCAACCATCCAGTACGGCCGACATTTGGTGATTCTCTGCGAGCCCGATGGAATAACGCAGGAAAGTATTGCCAGCAGGATGGCGGCGGTGGATTGTCTCGTTTATCAATCACGATCGGAAAATATTGCTGAACGTTTCCAGGACTATGCGTTGCGACTATTTACAGAAATTCAACAGCTCCTCACAGCGAGAGCGGAGGCTAAAATCCTGCTTCAATTCGTCATTCGTGATTTGCTGGAGCAGCAACTTTTTGCTGGTTTGGCTGGCTTGTTGAAGACCGCTCACCTGGAAAACCCAAATCTGATGGGCCAGCTTCTCTGCGTCGCTCCGGGTGATGATGCGGAACATCTTGTGGCAACACTCAAGGTGAATGCGCAAACACCCTTAGACCAACGTGTTGCCTATCGCAACGGAAAGCGCCGAATTGCCGCATGGAAAGAAGTACCGATTGCTAATGATGAGGATGTGAGCATTCCCTGGAAGGAAAACGGTACGTATCTGATTACCGGTGGTCTAGGGGGGTTGGGTCTGCTGTTCACTAAGGAAATTGCCCAACAGATCCGCTCCGGAACGGTCATGCTGACTGGCCGCTCACCACTCGATGAGTCAAAACGGCAGATGTTGCAAACCTTGCAGCAATTCTGCGGGCAGAGCCGCGTACACCTTGAATATCGTCAGGTCGACGTTTGCGAGCCGCAAGGTGTTGCGAGTTTAATTCAGGAGATAAATCACCATGTTGGTCCTCTCGACGGCGTGATTCACGCTGCGGGTGTGATTCACGATAACTTCATTATTAAAAAGACGCCGCAAGAGTTGGAAAATGTGCTTGCGCCTAAAGTCAAGGGCTTGGTGAATCTTGATGAGGCCACGAAAGACCAGCCGTTGGACTTTTTCTTTTTCTGTTCCTCACTAGCGGGCGGTATCGGTAATGTCGGGCAGGCGGATTACGCTTGTGCCAATGCCTTCATGGATTGCTATGCGCGATATCGTAACCAACTCTTGCAATCGCATCAGCGTCAGGGACGCACGTTGTCGATCAACTGGCCCTTATGGCAAGAGGGTGGCATGCGGGTTGATGCAGCGAGCGAGAACATGATGGCGCAAAGTATCGGCTTGCTTGCCATGCCGACCTCTGCCGGCATGCGGGCCTTGTACAAAGCCATTGCCAGTCAGCAGGATCAGGTGATGGTGGTAGAGGGTGATCTTGCCAAACTTAGACAAACTTTTTTGAGCTTGCCGGAAAAAACAGCTCAACCTGAAATAGGTGATGTTGAGGCCGCGCTGGATACGGGGCAACTGCAACACAAAACGCTTGAAAAATTAAAGTCGTTATTTGCCGAAATGACGAAGTTGCCTCTAGAGAGGGTTAACGAAGAAGAGCCACTGGATAGTTATGGTATTGATTCTGTCATGATTGCTCAGTTGAATCAAAAATTGACTGCAGAGCTCGGCCCTGTATCCAAAACACTATTATATGAATTTCATACGCTAGAAGAGTTGGCACATCATTTAGTTAAGGCTTATTTTGATCGTTGCGTTAACTGGACTCAACTCAATAGCACACTCAATTTTTCTGAAGTAAGCGTTGAGACTCGCAATCATAAATCTGAAAAAGGCAGGTATTCAAACGAATACGATATGCAAATGCCGGATGATACCGCCCAACAACCCATTGCCATTATTGGGCTGAGTGGCCGTTATCCCAAAGCGAAAACGATAGCTGAATTTTGGCAGAATCTGAAACACGGAGAAGCATGCATCAGTGAAATTCCGCGCCAACGCTGGGATTGGAAGCGTTATTATCATGCCGATCCCAACGAGGCGGTTAAATCGGGCAAGAGCTATAGCAAATGGGGTGGGTTTTTAGAGGATTTTGATCAGTTTGATCCCATGTTTTTCAACATGACCCCGCGCGAGGCGGAAAATATTGATCCGCAGGAACGCATCTTCCTACAAGAAAGTTGGAAGGCGCTGGAAGACGCCGGCTACTCTCCCTCCAATCTGTCGGCTGATTTGCGCCAGAGAATTGGCGTTTTCGCGGGTATCACCAAACAAGGCTTTAATTTATACCGCATGGAATCCGGGCCGGATCGTCAACTCGCGTGCCCTGCCACATCATTTGCCTCTTTGGTGAACCGAGTTTCGTATGTTCTCAATCTCCAAGGCCCCAGTTTTCCGGTCGATACGATGTGCTCTTCTTCCTTCGTCGCAATACACGAGGCATGTGCGTATATTCGCTCTGGCCAAGGGGACATGGCCGTCGTTGGGGGCGTCAACTTATATGCCCACCCCTCGTCTTATCTGGAGCTATCGTTGGGGCGATTTGTCTCGAATGGCTCGACGTGCGCTGCGTTTGAAAAAGATGCCGATGGCTTTGTTCCCGGAGAAGGGGTTGGCGTTGTCATCCTCAAAGCTTATGACCAGGCGCTAAAGGATCGCGATAGCATTTACGCCCTGATTCGGGGGAGCGCGGTCAATCACGATGGCAAGACAAATGGCTATAAAACCCCGAACCCTGGACCAAAAGCGGCCGTGATTCGTCAGGCCTTGCAACAAAGTGGCATTGATGCGCGAAGCATCAGCTACATCGAAGCCGCGGCTCAAGGTTCGGATGTGGGCGATGCCATCGAAGCCAGTGCATTGACCGATGTATTCAGCGGCCGCAACCATGTTGAGGGGGCCTATCGCATTGGCTCAGTGAAACCCAATATTGGCCACAGCGAATCGGCGTCGGGCATGTCCCAGCTCACCAAAGTGATTTTATCGTTAAACCATCAAACGCTACCACCCACGTTGCGTTCGAGAGCGCTCAGCCCCTCTATTGATTTTGATCAACTGCCTTTTGAGTTGCAGCAAGAGCTCAGCGAGTGGCAACCGGTTCGTGTCGATGGCATTGAGGTGCCACGAAGAGCTGGGATGATGAATATTGGCGCTGGCGGAGTAAATGCTCACATCATTGTCGAAGAGCCTCCGCCTCATGAAGAGCCGGTTCATGACGGGCATGGGCCTGTGCTGTTTGTTTTATCAGCAAAAAATGAAGAGCGCCTGGAGCGCTACGTACAAGACTGGCTGATCTATATCACCAATGGTCCAATTCTCGATTTACCATCGATCGCTTACACCTTGCAGGTCGGACGGGAAAGCATGGCCTGCCGCCTGGCCTTTGTGGTGAACCAATCAGAGGAGCTTGCGACGTATCTGACGCGTTGGCTTAAAACGCGTGAACTGGGCGACGTTGGCTTTTATGGGGATGTGACGCAGGAAAGAGTTAAGAACTCAGAGGCGGTGAGTACGCTCGTAAAAGCAGGGGATGCCAGTCATGCTCGTGAGCTGGCTGCACTGTGGGTGCAAGGCAATGCCATCGCATGGGACAAATGGCATCGCGGCACAACCTTGGGCAGACGCAGTGGCTTGCCGACTTATCCCTTTGCGAACAGGACTTGTTGGATCGCTCGCGATGACCATGATTGTTCAGAGGATGATCGCGGCGAGGAAAAGAGCGATGTCGAGCCGCGTATCGATCACACTCTGGATGAAAATAAGGCGGTTGAATTTTACACCCGAATGACACAAGACTGTGACGAGGCGTTTCAGGAAGAGTATTTGACGTTTGGCGCTTTCCCCAGAAGAATTCCTGGCTTCTCGATGACCCGTGTCGCAATGAATGCGGAGAGGTATCCGGAAGAACTGGAAATGATTAAGGAAAGCCAGCGGGAGTTGCGCCAGGTTCTGTTTTGTCGCGAAGATTTTGATCGTGTTCACACGTTCCTCGATATTGGTTGCGGTCACGGCACGGATGTGATTCAGGTGGCCGCGCTCTATCCGCATATACAAACCCATGGTTTTACCATTACCGAGTCACAAGCAATCTTGGGCAATCGACGTATTGAGCATATGAATTTGGGCTCTCGTGCGCGAATTTATCATAAAGATAGTTCAAAAGAACCATTCCCAGACAACTGTGATATGATTCTGGGTATCGAGGTTACCTTCCACATTCGCGACAAAGATGCCTTGCTTCAGAAGATGGCGGATGCGCTCAGTGATGATGGCAAAATCTTACTTATGGATTATATTGCTAATCTGAGAGGCAGTATTGTCGACCCCAATGTCGAAATTAGTATTCCTACTCAGTCGCAGTGGATTGATCTGTTATCTCAGCACGATCTCATTATTGATGAAATTATCGATGTATCGACCGAAGTTTCGAACTATCTTTATGACCCTGAGCATGCTGAACATACTAAGCACTTGCCAAAAGTAAGCCAGGATAGCTATCGCAACTACGCCAATCAGGCCATCGCTTTAGAAAAAGGTTGGATTACATATTGCTTGTTAAAATTGCAAAGAGACACTCAGCGTAGTGAACAAGAGCGACGCGAGTATAATGCTTGGAAAATTGCCAATCAAACACCATATGCCCAGGCTCTGGAAGACATGCTGCGTGTCGGGCGTATGCCTTATCCGCTGAGCGGGGGGCTCAAAATGGCTGTCCAGCCGATGGACGGTCAGCCACCCTCCACCCTTGATGAAAGCGTGCCTGACTTAGGACAAATCCAGACCGCTCTGGCGGGGATCTTTGTCGCCATTTTAGGTTTTGAAACACGCGAACTCGACTTCATTGATCAGCTACCGCTCACGGAGTTGGGAATTAGCTCCGTGAATGCCGTGGAATTACTGGAAGCCATTAACACCGAATTTGACCTGCATTTGCCCACCAGTCTGGTCTTTGAGTGTCATCGTTTGGAGGATTTAGCTGGCCATATACAGGTTGAACTAGGGCGGAAACCCATCGCACCTGCCATGTCAAATGCGTCAGTAGCCGTGCAAGCTGAGGCTGAATCCAGGCAAAAAACCACTGTGCCGGTAGAAGAAAAAGCGCCGATAGCAAACGAGGAGACTGCCATCATTGGACTCTCCTGCCGTTGTGCCGGCGCTAAAGATCAAGAGCAATTTTGGCAAGTGGTCAGTCAGGGTAAAGATTGTATTGAAGACCTGAAGGAACCTCAGTGGCTCGACTACATTGCCGAGCATGGTTCAGAAACGTTTCCCATTCGCTATGGCGTTATGCCGGAACGGGATGATTTTGACCCGCTGTTTTTTCACATCTCGCCCCGAGAAGCTGAGGCCATGGACGCAACCCAACGCGTGCTGTTGGAGGAATGTTACCGAGCCCTGGAAGACGCGGGTTATAACCCTTCGTCATTAAAGCAACAAGCAGTGGGCACCTATATTGGTGCGATGGGAAGCGCTTCTCTACGTAAGGGGTTTTCGCATCTTGACATGTTGGGTTCGGAAACGAGTATCCTCTCTGCTCGCACGGCCTATTTCCTGGACTTAACAGGCCCTGCACTGACGATCAATACGGCCTGTTCTTCATCCCTGGTTGCCATTGAGGTGGCCAGTCAGGCGTTAAAGAGTGGCGAGATTAATCTGGCGATTGCCGGTGGGGTGACGCTCTATCAGCATCCCGGCACTTTTATTGCGATGCACAATGCGAGCATGCTCTCTCCAACCGGCCAGTGCCGGCCCTTTGATGACGATGCCGATGGCATCGTTGTCGGAGACGGGGTTGGCGTCGTTATTTTAAAGCGTTTGCGTGAAGCGGAGCGCGATGGCGATTCCATTTATGGCATTATCCGCGGCTGTGGCATGAATCAGGACGGCCAAACCGCCAGCATGACCGTCCCCAGCTTCCTGGCGCAAAGTGAGCTAGAGAGCGCCGTCTATCAAAAAGCGAATATTGATATTGAAGACCTTCAATACATTGAAGCTCATGGAACGGCTACCAAACTAGGCGACCCGATTGAAATTCATGCGTTGAATAAAAGCTTTCAGGCGTTGACCTCAAAACAGAAATTCTGCGCTATCGGTTCGTTAAAAGCGAATGTGGGCCATACGACCGCCGCTGCTGGAGTATTAGGTGTCATTAAAGTCTTACTTGGTATGAAGTATCAACAACTGCCACCGTCCATCCACTTTAACGAGGGTAACAGGCATATTGATTTTGACAACAGTCCTGTCTACGTTAACACCACCTTGAAACCTTGGCCAAAAAATGCAAAGGACTCCCGACTGGCCGCTATTAGTTCATTTGGTTTTAGTGGAACTAATGCACACTTGGTTCTGGAACAGTATATGCCTCTGCCGGACACGGATAGCGGCGTATTTATACCTCTAGTACTGCTACTTTCAGCAGAAAGCGATGACGCATTACAGCACTATGCTCACAATGTAAAATGTTATCTCGAAGATCATCCGGCTATTCAATATGGGCATTTTCTATATACGTTTCAAGTTGGACGGGATGCCTTCGCCTATCGTTTAGCCATCATCGCTGAGAATCAGCAGGAGTTGATACAAAAGCTGGAGCAATGGCTTACAACTGGAGGCCCGGTAACAGACATTCACAACAAGCCAGATATTGGAAACCGTGAAGAAGAAAAAGCATCTCTTCAAAGCCTGATATCCGGTCGGAAAGTGGAGCCGCTTGCTCAATTATGGGAGCAGGGCGCCTCGGTGGATTGGCATGCGTTTTATCCGGACGGACGATGCCGTCGGTTGGCTGGTTTGCCTACTTACCCTTTTGCTCGTGAGTATTTTGGTGCTCCTCAGGATGAAGAATGCCAATATGGTGAAGCGAAACAAGCGCCCAGCGAAGATTGTGAAGGAACGATAGCACGATCTTCAACGGAAACCCTAATTGCCTGTCCCTATTGGAAAGAAAAGTCCGTTGCAGGCGCTACTGAATCGTTTGCATATTCCCGGCATCTGGTGTTGTTATGCGGTATGGAACATATCTCGGCGGCGAAGCTACAGGCACAAATACCGGGTGTGGAATGTGTGCATTTATCCTCTGTTAACCGTTTTCATCGCAGTACACATGTAGAAACCATTTATCAGGATGAGTTTACCCAGGTTTTTGAAATGATTCAGGACGTTCTGGCCAGTAAAACCAGAGGCAACATATTGATTCAATGTGTGGTTCCCCAGCAGCCGAACCAACCATGCCTGTCGGCTATTTCCGGCATGCTCAAAACAGCACAGCTGGAAAACCCTAAAGTATCAGGGCAGCTGATTGAGGTGCTTGCCGACGAGACGGAAGTGAGTTTGCTGAGCAAAATTCATGAAAATGGCCGATGCCCTGAGGACAAACAGATTCGGTATGACCAGGGGCAGCGTGTTGTGCAGGCATGGCAAGAACTTGTCGTTTCCGATCGCGCTTGCAAAACCCCTTGGCGAGAAGGAGGCGTATATCTCATTACGGGTGGTGCCGGTGGTTTGGGTCTGATGGTTGCCGAAGAAATCGCCAGTCAAACCCAGCGTTCTACGCTGATCTTAAGTGGCCGATCAAGCTTAAGTCCGGAAGAGGTCGCATCATTTTCGTATGGACTACAAGCACTCGGCACGAGGGTCGAATACCAGCCGGCTGATATCAGCAATCCATACGATGTTGACACGCTCATCCAGCGTATTTCAAAAGCGTACGGCTCGCTGCACGGTATCCTGCATTGTGCGGGTATTGTGCGGGATAATTTCGTGATCAACAAAACATCGGCTGAGTTTCAGGCGGTGTTGGCCCCGAAAGTGGCGGGTGTCGTTTATGTAGACGCGGCCAGCAAAGATTTGAATCTCGATTTCTTTGTGCTGTTTTCTTCAATCGCAGGCGCAATGGGCAATGCGGGCCAGGCTGATTATGCGACCGCCAATGCCTTTATGGATGCATTTGCAACCTATCGTAATGATCTGGTCCGCATCGGGCAACGACATGGACAAACCCTGTCGATTAACTGGCCGCTTTGGCGAGCAGGCGGTATGCAAGTGACAGCTCACCAAGAGGCCGCTATGAGGCAGAGCGTGGGCCTGGAAATGCTCGATACGGCGCGAGGGATGCAAGCCTTGGTCAAGGGGCTGGCCTCGGGGCAGAGTCAGATCTTGGTGGCTGCGGGCCATCTTCCCACGCTGAGAGGGTGGTTGTTCCAGGAACCATTAGCGCCGAGTACATCAGACCAGCCACTGGCCAATGTCCATCGAGTTGGCCGCCAACCCTCACTGGCATCCGTGGACAAACAGAGACTTTATGAAGAAACCTTGGTTCAGCTTAAAGGGCTGTTAGGCACTGTTTTCCGTTTGTCGCCAAATCGCATTAAAATGCATGACGCGTTTGAGCGCTACGGTATCGACTCCGTGATGATCGTGCAATTAAATCAGGAAATGGAAGCGGTTTTTCCGGAACTCTCAAAGACCGTGTTTTTCGAATACCAAACATCGCATGAGCTGGTTGCCTACCTGCTTGATGAGTATCCGCAGGAATGTATGGTATGGACTGGGCTTGGGGCTGAATCTGACATTGATCATGGAAATGGAGAGTCTTCTTGGCCCGAACGTGCATGGCGCCCTAAACACAGTTTAGCGACGTCTGTAGATCGTGACTTGGCGCAAGCGCAAAACCCGCAGATTCAGGAAGCAATTGCGATTATTGGCGTTAGCGCTCGCTTTGCCCAGGCTGAAACCCTGCAAGCATATTGGCAAAATCTGCAAGCCGGCAAAGACTGCATTGGCGAAATTCCTACCAATCGGTGGTCATTGGACGGCTTTTTTGTTGACGACATCGACGAAGCCATCGCCCAGCGGAAAAGTTATAGCAAATGGGGTAGTTTTCTGGAGAGCTTTGCGGATTTCGACCCTCTGTTTTTTGGCATTCCCCCGCGCGATGTCTTAAGTATTGATCCGCATGAACGCTTGTTTCTCCAATCCTCGTGGGAGGCGCTCGAAGACGCTGGCTATACCCGCGACACATTGCGTGAGAGATATCAACAGCAGGTCGGTGTGTTCGCAGGCGTCACCAAAACCGGTTTTGACTTGTATGGCCCTGAGTTATGGAAACGCGGTGAACAGGCCTTTCCGCACACTTCTTTCAGCTCCGTTGCCAATCGGACATCGTATTTTTTGAATCTGCAAGGCCCGAGTATGCCAATTGATACGATGTGCTCATCGGCTCTAACCGCCGTGCACGAAGCGTGCGAACATTTACGCCGAAGAGATTGCCGACTCGCCTTGGCGGGCGGTGTCAACTTATACCTGCACCCTTCCAATTATGTTCAGATGTGCGCGCTACGTATGTTATCGAAAGACGGTCAGTGTAAAGCTTTTGGCCAAGGTGGCAATGGTTTTGTGCCCGGTGAGGGCGCGGGCGTGGTCTTGCTGAAACCCCTGTCCGAGGCCATTCGAGAGGGCGACAATATCTACGCCGTGATTCGCGCAAGCCATGTGAATCACGGCGGAAAAACCAATAGCTACACCGTACCCAACCCCGGTGCACAAGCGGATTTGATTCGTCAAACACTTGACAAAGCAGGGATTGAGGCGCGCAGCATCAGCTATATAGAAGCCCACGGCACGGGAACGGCATTGGGAGATCCAATCGAAATTACCGGTCTGACTCAGGCCTTTAAAACAGATACTGATGATACTGGCTTTTGTGCGATCGGTTCTGCAAAATCCAATCTAGGGCACTTGGAAGCGGCATCAGGTATGGCGGGGCTGTTCAAGGTTCTTCTGCAACTGAAGCACCGCCAGCTTGTTCCGAGTTTACATGCAGGAAGTTTAAACCCTAATATCGCTTTTGAAAAAACCCCCTTTGTGGTGCAGCAGGCCCTTTCAGAGTGGAAAAGACCCATCGTGGAAAGCAGCGGTGAGGTCAAGGAATACCCCAGGAGAGCGGGCATCTCCTCATTTGGTGCCGGGGGTTCGAATGCACATTTGATTGTTGAAGAGTATGAAGCAAATGACGAACCGTATGCCGAGAAAGCGGTTGATGAGTCCGTGATGATTGTATTGTCGGCCAAAAATACGGATCAGCTCATTCAACTGGCTCGTAACTTAAGGCGTTTTATTGCCGAGACCGAAACCAAGCCGCCCCGTCTGGAAGATATCGCATACACGCTTCAGACCGGGCGCGAGGCAATGGAGGAGCGTCTAGCGCTTATTGTTGGGAGTCTAGAGGAGCTTGAAGAAAAGCTGCACGCCTTTGTTGAGGGACAGGAGCCTATTGCGTCGCTTTATCGTGGGGACCTCAAACAGGACTTGAACTTACTGTCGGATTTTGCCACGGAGGAAGAGCTTTCGAATACCATTGATGACTGGATGATGTCGAAACAAATAAATAAGCTACTCAGTCTGTGGGTTAAAGGTCTCACCATTAATTGGCAGAAATTTTATATTTATATTTATCATAAGCCCAGATCGAGACGTATTAGTCTTCCTACCTATCCCTTTGCCAAAGAATTCTATTGGTTTGAGCCGCAGGCTTTTAATCATGGTATCTCGACTCACTCGCAAAAGCCAGCTGAAAATCAGACTTCCTCGCGAAGCATTCAGTATCTGCAAAAGCAGTGGCTGCTGGATGAGTCCGAACCTGATGAGTCCTATGCTAAACAAGTGGTGGCGCGAAAAATTGCGATTCTAAGCGGTCCGCAAACCCGGTTGCTTGCGTCCCTGTTGGAAGAGGAATTCCCAAACAGCCAAATTATTGAACACGATAACATCAAGGAACACTTGGAACAGAGCCATGCAGATTGGCAGACGCATGGCGGATGCATCGATCTGGCGGGTTGTAGTCGTGACGAAGAAGCCGGAGATGCGCTTGACTGGATGCTGTGGCTCCAGCGCCTGATCGAAAATGGCTCAAAAACCGGTCTCACCCTGCTTGGCGTCACCCGAGGCTTAGAGTTCTTTCAGAACAGCGAGGTGAACCTATCGGGTGCCTCTCGTGTCGGGCTTTATCGCATGCTTCAGAGCGAGTATGCCCATATTCAATCTCGTCATATCGATACCGATCCCAGCCTTAAGACATCAGCGTTGGCCGAGCAGATTGCTCGCGAGTTTGTGTTGAACGATGAGAACTGTGAAATTTGTTACCGCGATCACAAGCGCTACCGTGCATATTTGGCAGCGTCTTCGCTAAAAGCGGCAAAGATATCAGACACAGACCTTCAGTTTGCTCAAGAAGATGTTCTCCTGATTACCGGAGGAACGGGTGGGCTGGGGCTTTTGTGTGCTCAGCATTTTGTAGAGCATTACGGGGTGAAGCGCTTGGTGCTTACCGGGCGGGAAGCGTTGCCATCGCGTGAGCAATGGGCTGATCCGCAAAGTGATAAGGTCAAGCAAAAGATAGACGTCATTCAGTCCTTGGAGCGTCAAGGCGTTAAGGTACAAGTATTGCCGATGGTGTTAAGTGATCATGATGCGGTGCGAGAAACTCTGGGTCAAGTTACAAAGAACTTTGGACCTATTCGTGGTTTGCTTCATTGTTCTGGAGCTGTCGATTCAGAAACGCCTGCCTTTGTTCGTAAGCCGATAGCAAAGGTGTCGCAGGTTTTAGAGCCTAAAGTGTCGGGACTTCAAACGCTGTTGGCGCAATGCAGACCACAGTCATTAAAATTCGCGGTCTTGTTTTCCTCTGTGGCTGCCACGATTCCCCGTCTGGCCAGCGGCCTGAGTGACTATGCTATGGCTAACGCGTATATGGATTATGTGGCCCAAGCCACGGGCGGTAAGTTGGTGAGTATTCAATGGCCAAGCTGGCAGGAGACCGGGATGGGCGCCGCGAACAGCAGGGCGTATCATGAAACGGGTTTGCTTCGTCACAACAATCAAGAAGGTCTCCGGCTCTTAGATGATATCCTTTCTCAACAAACCGAACCTGTGATACTGCCTGCTGTTGTCGATTCTGCGTTGTGGGCGCCGCAACAATTGATGAAGCATCAGAGCAGGCGAGAGAGCATTTCACCCGTCTTGCATCACCACCCTCAGACGCCAATGCATATTGAGCCCGCTACACCGAACATGGCATCAAGCCAGTTGACTCTGAACGATTTAGTTGCCTTATTTTCTCAGGAACTTGGCATTCCTACACAAAATCTGGCGCTGGACAAATCATTTGCGGATTATGGCCTGGATTCGATATGGCTGGCTCAGCTCGCAAGCAAAATCAATCAACAGCTTGTTGAGCCACTGGACCCTTCTATCTTGTACGAGTATTCTTCGTTAAATGCACTGGCGTCTTGGCTGGCTAGCGAACAGGCGCCAGCTCTTAAATCACAGGCCCATGATAGAGACGTTGAGCAGAAGATCGATCCGAAAAATGCCGCGGATAGCGTTGTACCCCGCTCTTCAAAAAAGCAGGCGTTGGATATCGCTGTGGTTGGCATGTCCTGCCGTTTTCCGGATGCCAATAATCTAGACGAGTATTGGTCTTTATTATCGGAAGGCAAGCAAGCTATCCGCCCTGTTCCAGCGGACCGCTGGTCGAGACCAACGCCGTTTTATGCAGGCTTGATCGAAAATAGCAGCCATTTTGATCCCGCCTTTTTCCTGATTCCACCAGAGGACGCGAAGGTGCTGGATCCTCAGGCGCTATTGCTGTTGGAAGAATGCCTGAACTTGTTTTATCACGCGGGTTACACCCTAGACGAGATGAAAGGCAGGGCCATCGGGGTCTATTTAGGTGGGCGCAGTCAGCATCGCATTGATGAAGCCGATCTTGGTCAAGCTCGAAATCCGATCGTGGCCGCGCAGAATTATCTGGCCACACATCTCTCACAGTTTTTTGATCTGAATGGTCCAAGTCTGGTCATTGACACAGCCTGTTCCTCGGCTCTGGTGGGGATGAATTTTGCCGTTCAGTCCCTGCTCAGTGGCGAGATTGACTCGGCGGTCGTTGGAGGCGTCAGTCTCCTGGCCGACGAAGATGCCCATCGTATCTTTCAGCAGCGCGATCTGTTGAACCGGGACGCCTCGTTTCATATCTTTGATCAGCGGGCCTCCGGCATCACGTTGGGCGAAGGGGCGGGTTTGGTGTTTTTAAAAACCCTGCCGCAGGCGCAACGCGATGGCGATCAGATTTACGCCGTCATTAAGGGACTGGTCATCAATAACGACGGTCGCACGGCCGGTCCGGCGACACCGAATTTTGAGGCGCTCAAATCTGTTATGCAGCGCGCCTTGAAGCAAAGTTGTCAACAGCCGCAAGATATTGTTCATATTGAAGCTAACGGCTCAGGCTCCGAGGTGACCGATCTACTCGAGCTTAAAGCGATGGAAGCGGTTTATCGTAGCGACAATAAGGCACCTTGCAGCTTAGGATCAATTAAGCCCAATATGGGGCATCCGTTATGTGCCGAAGGTATTGCTAGTTTTATAAAACTGGTGTGTATGTTGAAATATCAGCAGCAAGTACCTTTTTTATCTGGTCAAGTGCCATTAACACATTATGATTTAGACGCTTCGCCCTTTTATTTCTGTCGTCAGTCAACAAAATGGACAGAACACTCCCCCCTTCTGGTGGCGCTCAACTGTTTTGCGGATGGTGGGACCAATGCACATGTGATTATGGAAGCCTGGACGCAGGCAGAATCTCACCAGCAACGGCAGCCCATACCACCACCCGCGCTAAACCGAGTGAATATCCGCGGTGCAGTCAGCCAGCATCCCTGGTGGTGA", "orf_prot_sequence": "MSASEHAGSTIQYGRHLVILCEPDGITQESIASRMAAVDCLVYQSRSENIAERFQDYALRLFTEIQQLLTARAEAKILLQFVIRDLLEQQLFAGLAGLLKTAHLENPNLMGQLLCVAPGDDAEHLVATLKVNAQTPLDQRVAYRNGKRRIAAWKEVPIANDEDVSIPWKENGTYLITGGLGGLGLLFTKEIAQQIRSGTVMLTGRSPLDESKRQMLQTLQQFCGQSRVHLEYRQVDVCEPQGVASLIQEINHHVGPLDGVIHAAGVIHDNFIIKKTPQELENVLAPKVKGLVNLDEATKDQPLDFFFFCSSLAGGIGNVGQADYACANAFMDCYARYRNQLLQSHQRQGRTLSINWPLWQEGGMRVDAASENMMAQSIGLLAMPTSAGMRALYKAIASQQDQVMVVEGDLAKLRQTFLSLPEKTAQPEIGDVEAALDTGQLQHKTLEKLKSLFAEMTKLPLERVNEEEPLDSYGIDSVMIAQLNQKLTAELGPVSKTLLYEFHTLEELAHHLVKAYFDRCVNWTQLNSTLNFSEVSVETRNHKSEKGRYSNEYDMQMPDDTAQQPIAIIGLSGRYPKAKTIAEFWQNLKHGEACISEIPRQRWDWKRYYHADPNEAVKSGKSYSKWGGFLEDFDQFDPMFFNMTPREAENIDPQERIFLQESWKALEDAGYSPSNLSADLRQRIGVFAGITKQGFNLYRMESGPDRQLACPATSFASLVNRVSYVLNLQGPSFPVDTMCSSSFVAIHEACAYIRSGQGDMAVVGGVNLYAHPSSYLELSLGRFVSNGSTCAAFEKDADGFVPGEGVGVVILKAYDQALKDRDSIYALIRGSAVNHDGKTNGYKTPNPGPKAAVIRQALQQSGIDARSISYIEAAAQGSDVGDAIEASALTDVFSGRNHVEGAYRIGSVKPNIGHSESASGMSQLTKVILSLNHQTLPPTLRSRALSPSIDFDQLPFELQQELSEWQPVRVDGIEVPRRAGMMNIGAGGVNAHIIVEEPPPHEEPVHDGHGPVLFVLSAKNEERLERYVQDWLIYITNGPILDLPSIAYTLQVGRESMACRLAFVVNQSEELATYLTRWLKTRELGDVGFYGDVTQERVKNSEAVSTLVKAGDASHARELAALWVQGNAIAWDKWHRGTTLGRRSGLPTYPFANRTCWIARDDHDCSEDDRGEEKSDVEPRIDHTLDENKAVEFYTRMTQDCDEAFQEEYLTFGAFPRRIPGFSMTRVAMNAERYPEELEMIKESQRELRQVLFCREDFDRVHTFLDIGCGHGTDVIQVAALYPHIQTHGFTITESQAILGNRRIEHMNLGSRARIYHKDSSKEPFPDNCDMILGIEVTFHIRDKDALLQKMADALSDDGKILLMDYIANLRGSIVDPNVEISIPTQSQWIDLLSQHDLIIDEIIDVSTEVSNYLYDPEHAEHTKHLPKVSQDSYRNYANQAIALEKGWITYCLLKLQRDTQRSEQERREYNAWKIANQTPYAQALEDMLRVGRMPYPLSGGLKMAVQPMDGQPPSTLDESVPDLGQIQTALAGIFVAILGFETRELDFIDQLPLTELGISSVNAVELLEAINTEFDLHLPTSLVFECHRLEDLAGHIQVELGRKPIAPAMSNASVAVQAEAESRQKTTVPVEEKAPIANEETAIIGLSCRCAGAKDQEQFWQVVSQGKDCIEDLKEPQWLDYIAEHGSETFPIRYGVMPERDDFDPLFFHISPREAEAMDATQRVLLEECYRALEDAGYNPSSLKQQAVGTYIGAMGSASLRKGFSHLDMLGSETSILSARTAYFLDLTGPALTINTACSSSLVAIEVASQALKSGEINLAIAGGVTLYQHPGTFIAMHNASMLSPTGQCRPFDDDADGIVVGDGVGVVILKRLREAERDGDSIYGIIRGCGMNQDGQTASMTVPSFLAQSELESAVYQKANIDIEDLQYIEAHGTATKLGDPIEIHALNKSFQALTSKQKFCAIGSLKANVGHTTAAAGVLGVIKVLLGMKYQQLPPSIHFNEGNRHIDFDNSPVYVNTTLKPWPKNAKDSRLAAISSFGFSGTNAHLVLEQYMPLPDTDSGVFIPLVLLLSAESDDALQHYAHNVKCYLEDHPAIQYGHFLYTFQVGRDAFAYRLAIIAENQQELIQKLEQWLTTGGPVTDIHNKPDIGNREEEKASLQSLISGRKVEPLAQLWEQGASVDWHAFYPDGRCRRLAGLPTYPFAREYFGAPQDEECQYGEAKQAPSEDCEGTIARSSTETLIACPYWKEKSVAGATESFAYSRHLVLLCGMEHISAAKLQAQIPGVECVHLSSVNRFHRSTHVETIYQDEFTQVFEMIQDVLASKTRGNILIQCVVPQQPNQPCLSAISGMLKTAQLENPKVSGQLIEVLADETEVSLLSKIHENGRCPEDKQIRYDQGQRVVQAWQELVVSDRACKTPWREGGVYLITGGAGGLGLMVAEEIASQTQRSTLILSGRSSLSPEEVASFSYGLQALGTRVEYQPADISNPYDVDTLIQRISKAYGSLHGILHCAGIVRDNFVINKTSAEFQAVLAPKVAGVVYVDAASKDLNLDFFVLFSSIAGAMGNAGQADYATANAFMDAFATYRNDLVRIGQRHGQTLSINWPLWRAGGMQVTAHQEAAMRQSVGLEMLDTARGMQALVKGLASGQSQILVAAGHLPTLRGWLFQEPLAPSTSDQPLANVHRVGRQPSLASVDKQRLYEETLVQLKGLLGTVFRLSPNRIKMHDAFERYGIDSVMIVQLNQEMEAVFPELSKTVFFEYQTSHELVAYLLDEYPQECMVWTGLGAESDIDHGNGESSWPERAWRPKHSLATSVDRDLAQAQNPQIQEAIAIIGVSARFAQAETLQAYWQNLQAGKDCIGEIPTNRWSLDGFFVDDIDEAIAQRKSYSKWGSFLESFADFDPLFFGIPPRDVLSIDPHERLFLQSSWEALEDAGYTRDTLRERYQQQVGVFAGVTKTGFDLYGPELWKRGEQAFPHTSFSSVANRTSYFLNLQGPSMPIDTMCSSALTAVHEACEHLRRRDCRLALAGGVNLYLHPSNYVQMCALRMLSKDGQCKAFGQGGNGFVPGEGAGVVLLKPLSEAIREGDNIYAVIRASHVNHGGKTNSYTVPNPGAQADLIRQTLDKAGIEARSISYIEAHGTGTALGDPIEITGLTQAFKTDTDDTGFCAIGSAKSNLGHLEAASGMAGLFKVLLQLKHRQLVPSLHAGSLNPNIAFEKTPFVVQQALSEWKRPIVESSGEVKEYPRRAGISSFGAGGSNAHLIVEEYEANDEPYAEKAVDESVMIVLSAKNTDQLIQLARNLRRFIAETETKPPRLEDIAYTLQTGREAMEERLALIVGSLEELEEKLHAFVEGQEPIASLYRGDLKQDLNLLSDFATEEELSNTIDDWMMSKQINKLLSLWVKGLTINWQKFYIYIYHKPRSRRISLPTYPFAKEFYWFEPQAFNHGISTHSQKPAENQTSSRSIQYLQKQWLLDESEPDESYAKQVVARKIAILSGPQTRLLASLLEEEFPNSQIIEHDNIKEHLEQSHADWQTHGGCIDLAGCSRDEEAGDALDWMLWLQRLIENGSKTGLTLLGVTRGLEFFQNSEVNLSGASRVGLYRMLQSEYAHIQSRHIDTDPSLKTSALAEQIAREFVLNDENCEICYRDHKRYRAYLAASSLKAAKISDTDLQFAQEDVLLITGGTGGLGLLCAQHFVEHYGVKRLVLTGREALPSREQWADPQSDKVKQKIDVIQSLERQGVKVQVLPMVLSDHDAVRETLGQVTKNFGPIRGLLHCSGAVDSETPAFVRKPIAKVSQVLEPKVSGLQTLLAQCRPQSLKFAVLFSSVAATIPRLASGLSDYAMANAYMDYVAQATGGKLVSIQWPSWQETGMGAANSRAYHETGLLRHNNQEGLRLLDDILSQQTEPVILPAVVDSALWAPQQLMKHQSRRESISPVLHHHPQTPMHIEPATPNMASSQLTLNDLVALFSQELGIPTQNLALDKSFADYGLDSIWLAQLASKINQQLVEPLDPSILYEYSSLNALASWLASEQAPALKSQAHDRDVEQKIDPKNAADSVVPRSSKKQALDIAVVGMSCRFPDANNLDEYWSLLSEGKQAIRPVPADRWSRPTPFYAGLIENSSHFDPAFFLIPPEDAKVLDPQALLLLEECLNLFYHAGYTLDEMKGRAIGVYLGGRSQHRIDEADLGQARNPIVAAQNYLATHLSQFFDLNGPSLVIDTACSSALVGMNFAVQSLLSGEIDSAVVGGVSLLADEDAHRIFQQRDLLNRDASFHIFDQRASGITLGEGAGLVFLKTLPQAQRDGDQIYAVIKGLVINNDGRTAGPATPNFEALKSVMQRALKQSCQQPQDIVHIEANGSGSEVTDLLELKAMEAVYRSDNKAPCSLGSIKPNMGHPLCAEGIASFIKLVCMLKYQQQVPFLSGQVPLTHYDLDASPFYFCRQSTKWTEHSPLLVALNCFADGGTNAHVIMEAWTQAESHQQRQPIPPPALNRVNIRGAVSQHPWW", "perc_identity": 30.77}, "gnl|BL_ORD_ID|2125|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 60103, "orf_end": 73629, "orf_from": "BGC0001186.1|Misakinolide_17 ", "model_name": "AQU-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3346", "ARO_accession": "3004647", "ARO_name": "AQU-2", "ARO_category": {"39426": {"category_aro_accession": "3002992", "category_aro_cvterm_id": "39426", "category_aro_name": "AQU beta-lactamase", "category_aro_description": "AQU beta-lactamases are chromosomal class C beta-lactamases that confer resistance to cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.22815, "max_identities": 16, "bit_score": 30.0314, "cvterm_id": "36810", "query": "QMCALRMLSKDGQCKAFGQGGNGFVPGEGAGVVLLK----PLSEAIREGDNI", "match": "+M + R+ +K G    FG     FVP +G G+V+L     P+ E ++    I", "sequence_from_db": "EMGSQRLFNKTGSTNGFG-AYVAFVPAKGVGIVMLANRNYPIQERVKAAHAI", "sequence_from_broadstreet": "MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPHYFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLADEAYGIKTSSADLLAFVQANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSEQTLLAGNSAQVIMKANPTTAAPXEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYPIQERVKAAHAILSKLAP", "dna_sequence_from_broadstreet": "ATGAAGCAAACCTCACCCTTGTCGTTGCTGGCGCTGAGCGCCCTGCTGCTGTCGCCCCTCACCCAGGCCGCTCCCGCCGATCCGCTGGTCGGGGTAGTGGATGACGTCATTCGTCCGCTGGTGAAAGAGCACAGGATCCCGGGCATGGCGGTAGCCGTGTTCAAAGAGGGGCAACCCCACTACTTCAACTACGGGGTTGCCGAGCTGGCGACGGGGAAGAAGGTCAGCGAGCAGACCCTGTTCGAGATTGGCTCGGTCAGCAAGACCCTGACCGCGACCCTGGGGGCCTACGCCGTGGTCAAGGGGAGCATTGGGCTGGATGACAAGGTGAGCCGGCACGCTCCCTGGCTCAAGGGCTCCGCCTTTGATGGCATTACCATGGCCGAGCTTGCCACTTACAGTGCCGGGGGTCTGCCGCTGCAATTCCCCGACGAGGTGGAATCGCTCGAGCAGATGCAGGCTTACTATCGCCAGTGGACGCCGGCCTATCAACCAGGCAGCCATCGCCAGTACTCCAACCCCAGTATCGGCCTGTTCGGCTATCTGGCGGCGAGCAGTCTGCAGCAGCCGTTTGCCCAGTTGATGGAGCAGACCCTGCTGCCCGGGCTCGGCCTGCATCACACCTATATCAATGTGCCGAAGCAGGCCATGGCGAACTACGCCTATGGCTATTCGAAAGAGGACAAGCCCATCAGGGTCAATCCCGGCATGCTGGCCGACGAGGCCTACGGCATCAAGACTAGCTCGGCGGATCTGCTCGCCTTCGTGCAGGCCAACATCAACGGGGTGGATGACAAGGGGTTGCAGCAGGCCATCGCTTTGACCCACCAGGGGCACTACTCGGTAGGCGGGATGACTCAGGGGCTGGGCTGGGAGAGTTACCCCTATCCGGTCAGCGAGCAGACGCTGCTGGCGGGCAACTCGGCCCAGGTGATCATGAARGCCAATCCGACGACGGCCGCGCCGAAKGAGATGGGGAGCCAGCGGCTCTTCAACAAGACTGGCTCGACCAACGGCTTTGGCGCCTATGTGGCCTTCGTGCCGGCCAAGGGAGTGGGCATCGTCATGCTGGCCAACCGCAACTACCCCATCCAGGAGAGGGTAAAGGCGGCCCACGCCATCCTGAGCAAGCTGGCTCCCTGA", "partial": "0", "query_start": 69229, "query_end": 69372, "hit_start": 969, "hit_end": 1122, "orf_dna_sequence": "GTGAGTGCGTCCGAACATGCAGGCTCAACCATCCAGTACGGCCGACATTTGGTGATTCTCTGCGAGCCCGATGGAATAACGCAGGAAAGTATTGCCAGCAGGATGGCGGCGGTGGATTGTCTCGTTTATCAATCACGATCGGAAAATATTGCTGAACGTTTCCAGGACTATGCGTTGCGACTATTTACAGAAATTCAACAGCTCCTCACAGCGAGAGCGGAGGCTAAAATCCTGCTTCAATTCGTCATTCGTGATTTGCTGGAGCAGCAACTTTTTGCTGGTTTGGCTGGCTTGTTGAAGACCGCTCACCTGGAAAACCCAAATCTGATGGGCCAGCTTCTCTGCGTCGCTCCGGGTGATGATGCGGAACATCTTGTGGCAACACTCAAGGTGAATGCGCAAACACCCTTAGACCAACGTGTTGCCTATCGCAACGGAAAGCGCCGAATTGCCGCATGGAAAGAAGTACCGATTGCTAATGATGAGGATGTGAGCATTCCCTGGAAGGAAAACGGTACGTATCTGATTACCGGTGGTCTAGGGGGGTTGGGTCTGCTGTTCACTAAGGAAATTGCCCAACAGATCCGCTCCGGAACGGTCATGCTGACTGGCCGCTCACCACTCGATGAGTCAAAACGGCAGATGTTGCAAACCTTGCAGCAATTCTGCGGGCAGAGCCGCGTACACCTTGAATATCGTCAGGTCGACGTTTGCGAGCCGCAAGGTGTTGCGAGTTTAATTCAGGAGATAAATCACCATGTTGGTCCTCTCGACGGCGTGATTCACGCTGCGGGTGTGATTCACGATAACTTCATTATTAAAAAGACGCCGCAAGAGTTGGAAAATGTGCTTGCGCCTAAAGTCAAGGGCTTGGTGAATCTTGATGAGGCCACGAAAGACCAGCCGTTGGACTTTTTCTTTTTCTGTTCCTCACTAGCGGGCGGTATCGGTAATGTCGGGCAGGCGGATTACGCTTGTGCCAATGCCTTCATGGATTGCTATGCGCGATATCGTAACCAACTCTTGCAATCGCATCAGCGTCAGGGACGCACGTTGTCGATCAACTGGCCCTTATGGCAAGAGGGTGGCATGCGGGTTGATGCAGCGAGCGAGAACATGATGGCGCAAAGTATCGGCTTGCTTGCCATGCCGACCTCTGCCGGCATGCGGGCCTTGTACAAAGCCATTGCCAGTCAGCAGGATCAGGTGATGGTGGTAGAGGGTGATCTTGCCAAACTTAGACAAACTTTTTTGAGCTTGCCGGAAAAAACAGCTCAACCTGAAATAGGTGATGTTGAGGCCGCGCTGGATACGGGGCAACTGCAACACAAAACGCTTGAAAAATTAAAGTCGTTATTTGCCGAAATGACGAAGTTGCCTCTAGAGAGGGTTAACGAAGAAGAGCCACTGGATAGTTATGGTATTGATTCTGTCATGATTGCTCAGTTGAATCAAAAATTGACTGCAGAGCTCGGCCCTGTATCCAAAACACTATTATATGAATTTCATACGCTAGAAGAGTTGGCACATCATTTAGTTAAGGCTTATTTTGATCGTTGCGTTAACTGGACTCAACTCAATAGCACACTCAATTTTTCTGAAGTAAGCGTTGAGACTCGCAATCATAAATCTGAAAAAGGCAGGTATTCAAACGAATACGATATGCAAATGCCGGATGATACCGCCCAACAACCCATTGCCATTATTGGGCTGAGTGGCCGTTATCCCAAAGCGAAAACGATAGCTGAATTTTGGCAGAATCTGAAACACGGAGAAGCATGCATCAGTGAAATTCCGCGCCAACGCTGGGATTGGAAGCGTTATTATCATGCCGATCCCAACGAGGCGGTTAAATCGGGCAAGAGCTATAGCAAATGGGGTGGGTTTTTAGAGGATTTTGATCAGTTTGATCCCATGTTTTTCAACATGACCCCGCGCGAGGCGGAAAATATTGATCCGCAGGAACGCATCTTCCTACAAGAAAGTTGGAAGGCGCTGGAAGACGCCGGCTACTCTCCCTCCAATCTGTCGGCTGATTTGCGCCAGAGAATTGGCGTTTTCGCGGGTATCACCAAACAAGGCTTTAATTTATACCGCATGGAATCCGGGCCGGATCGTCAACTCGCGTGCCCTGCCACATCATTTGCCTCTTTGGTGAACCGAGTTTCGTATGTTCTCAATCTCCAAGGCCCCAGTTTTCCGGTCGATACGATGTGCTCTTCTTCCTTCGTCGCAATACACGAGGCATGTGCGTATATTCGCTCTGGCCAAGGGGACATGGCCGTCGTTGGGGGCGTCAACTTATATGCCCACCCCTCGTCTTATCTGGAGCTATCGTTGGGGCGATTTGTCTCGAATGGCTCGACGTGCGCTGCGTTTGAAAAAGATGCCGATGGCTTTGTTCCCGGAGAAGGGGTTGGCGTTGTCATCCTCAAAGCTTATGACCAGGCGCTAAAGGATCGCGATAGCATTTACGCCCTGATTCGGGGGAGCGCGGTCAATCACGATGGCAAGACAAATGGCTATAAAACCCCGAACCCTGGACCAAAAGCGGCCGTGATTCGTCAGGCCTTGCAACAAAGTGGCATTGATGCGCGAAGCATCAGCTACATCGAAGCCGCGGCTCAAGGTTCGGATGTGGGCGATGCCATCGAAGCCAGTGCATTGACCGATGTATTCAGCGGCCGCAACCATGTTGAGGGGGCCTATCGCATTGGCTCAGTGAAACCCAATATTGGCCACAGCGAATCGGCGTCGGGCATGTCCCAGCTCACCAAAGTGATTTTATCGTTAAACCATCAAACGCTACCACCCACGTTGCGTTCGAGAGCGCTCAGCCCCTCTATTGATTTTGATCAACTGCCTTTTGAGTTGCAGCAAGAGCTCAGCGAGTGGCAACCGGTTCGTGTCGATGGCATTGAGGTGCCACGAAGAGCTGGGATGATGAATATTGGCGCTGGCGGAGTAAATGCTCACATCATTGTCGAAGAGCCTCCGCCTCATGAAGAGCCGGTTCATGACGGGCATGGGCCTGTGCTGTTTGTTTTATCAGCAAAAAATGAAGAGCGCCTGGAGCGCTACGTACAAGACTGGCTGATCTATATCACCAATGGTCCAATTCTCGATTTACCATCGATCGCTTACACCTTGCAGGTCGGACGGGAAAGCATGGCCTGCCGCCTGGCCTTTGTGGTGAACCAATCAGAGGAGCTTGCGACGTATCTGACGCGTTGGCTTAAAACGCGTGAACTGGGCGACGTTGGCTTTTATGGGGATGTGACGCAGGAAAGAGTTAAGAACTCAGAGGCGGTGAGTACGCTCGTAAAAGCAGGGGATGCCAGTCATGCTCGTGAGCTGGCTGCACTGTGGGTGCAAGGCAATGCCATCGCATGGGACAAATGGCATCGCGGCACAACCTTGGGCAGACGCAGTGGCTTGCCGACTTATCCCTTTGCGAACAGGACTTGTTGGATCGCTCGCGATGACCATGATTGTTCAGAGGATGATCGCGGCGAGGAAAAGAGCGATGTCGAGCCGCGTATCGATCACACTCTGGATGAAAATAAGGCGGTTGAATTTTACACCCGAATGACACAAGACTGTGACGAGGCGTTTCAGGAAGAGTATTTGACGTTTGGCGCTTTCCCCAGAAGAATTCCTGGCTTCTCGATGACCCGTGTCGCAATGAATGCGGAGAGGTATCCGGAAGAACTGGAAATGATTAAGGAAAGCCAGCGGGAGTTGCGCCAGGTTCTGTTTTGTCGCGAAGATTTTGATCGTGTTCACACGTTCCTCGATATTGGTTGCGGTCACGGCACGGATGTGATTCAGGTGGCCGCGCTCTATCCGCATATACAAACCCATGGTTTTACCATTACCGAGTCACAAGCAATCTTGGGCAATCGACGTATTGAGCATATGAATTTGGGCTCTCGTGCGCGAATTTATCATAAAGATAGTTCAAAAGAACCATTCCCAGACAACTGTGATATGATTCTGGGTATCGAGGTTACCTTCCACATTCGCGACAAAGATGCCTTGCTTCAGAAGATGGCGGATGCGCTCAGTGATGATGGCAAAATCTTACTTATGGATTATATTGCTAATCTGAGAGGCAGTATTGTCGACCCCAATGTCGAAATTAGTATTCCTACTCAGTCGCAGTGGATTGATCTGTTATCTCAGCACGATCTCATTATTGATGAAATTATCGATGTATCGACCGAAGTTTCGAACTATCTTTATGACCCTGAGCATGCTGAACATACTAAGCACTTGCCAAAAGTAAGCCAGGATAGCTATCGCAACTACGCCAATCAGGCCATCGCTTTAGAAAAAGGTTGGATTACATATTGCTTGTTAAAATTGCAAAGAGACACTCAGCGTAGTGAACAAGAGCGACGCGAGTATAATGCTTGGAAAATTGCCAATCAAACACCATATGCCCAGGCTCTGGAAGACATGCTGCGTGTCGGGCGTATGCCTTATCCGCTGAGCGGGGGGCTCAAAATGGCTGTCCAGCCGATGGACGGTCAGCCACCCTCCACCCTTGATGAAAGCGTGCCTGACTTAGGACAAATCCAGACCGCTCTGGCGGGGATCTTTGTCGCCATTTTAGGTTTTGAAACACGCGAACTCGACTTCATTGATCAGCTACCGCTCACGGAGTTGGGAATTAGCTCCGTGAATGCCGTGGAATTACTGGAAGCCATTAACACCGAATTTGACCTGCATTTGCCCACCAGTCTGGTCTTTGAGTGTCATCGTTTGGAGGATTTAGCTGGCCATATACAGGTTGAACTAGGGCGGAAACCCATCGCACCTGCCATGTCAAATGCGTCAGTAGCCGTGCAAGCTGAGGCTGAATCCAGGCAAAAAACCACTGTGCCGGTAGAAGAAAAAGCGCCGATAGCAAACGAGGAGACTGCCATCATTGGACTCTCCTGCCGTTGTGCCGGCGCTAAAGATCAAGAGCAATTTTGGCAAGTGGTCAGTCAGGGTAAAGATTGTATTGAAGACCTGAAGGAACCTCAGTGGCTCGACTACATTGCCGAGCATGGTTCAGAAACGTTTCCCATTCGCTATGGCGTTATGCCGGAACGGGATGATTTTGACCCGCTGTTTTTTCACATCTCGCCCCGAGAAGCTGAGGCCATGGACGCAACCCAACGCGTGCTGTTGGAGGAATGTTACCGAGCCCTGGAAGACGCGGGTTATAACCCTTCGTCATTAAAGCAACAAGCAGTGGGCACCTATATTGGTGCGATGGGAAGCGCTTCTCTACGTAAGGGGTTTTCGCATCTTGACATGTTGGGTTCGGAAACGAGTATCCTCTCTGCTCGCACGGCCTATTTCCTGGACTTAACAGGCCCTGCACTGACGATCAATACGGCCTGTTCTTCATCCCTGGTTGCCATTGAGGTGGCCAGTCAGGCGTTAAAGAGTGGCGAGATTAATCTGGCGATTGCCGGTGGGGTGACGCTCTATCAGCATCCCGGCACTTTTATTGCGATGCACAATGCGAGCATGCTCTCTCCAACCGGCCAGTGCCGGCCCTTTGATGACGATGCCGATGGCATCGTTGTCGGAGACGGGGTTGGCGTCGTTATTTTAAAGCGTTTGCGTGAAGCGGAGCGCGATGGCGATTCCATTTATGGCATTATCCGCGGCTGTGGCATGAATCAGGACGGCCAAACCGCCAGCATGACCGTCCCCAGCTTCCTGGCGCAAAGTGAGCTAGAGAGCGCCGTCTATCAAAAAGCGAATATTGATATTGAAGACCTTCAATACATTGAAGCTCATGGAACGGCTACCAAACTAGGCGACCCGATTGAAATTCATGCGTTGAATAAAAGCTTTCAGGCGTTGACCTCAAAACAGAAATTCTGCGCTATCGGTTCGTTAAAAGCGAATGTGGGCCATACGACCGCCGCTGCTGGAGTATTAGGTGTCATTAAAGTCTTACTTGGTATGAAGTATCAACAACTGCCACCGTCCATCCACTTTAACGAGGGTAACAGGCATATTGATTTTGACAACAGTCCTGTCTACGTTAACACCACCTTGAAACCTTGGCCAAAAAATGCAAAGGACTCCCGACTGGCCGCTATTAGTTCATTTGGTTTTAGTGGAACTAATGCACACTTGGTTCTGGAACAGTATATGCCTCTGCCGGACACGGATAGCGGCGTATTTATACCTCTAGTACTGCTACTTTCAGCAGAAAGCGATGACGCATTACAGCACTATGCTCACAATGTAAAATGTTATCTCGAAGATCATCCGGCTATTCAATATGGGCATTTTCTATATACGTTTCAAGTTGGACGGGATGCCTTCGCCTATCGTTTAGCCATCATCGCTGAGAATCAGCAGGAGTTGATACAAAAGCTGGAGCAATGGCTTACAACTGGAGGCCCGGTAACAGACATTCACAACAAGCCAGATATTGGAAACCGTGAAGAAGAAAAAGCATCTCTTCAAAGCCTGATATCCGGTCGGAAAGTGGAGCCGCTTGCTCAATTATGGGAGCAGGGCGCCTCGGTGGATTGGCATGCGTTTTATCCGGACGGACGATGCCGTCGGTTGGCTGGTTTGCCTACTTACCCTTTTGCTCGTGAGTATTTTGGTGCTCCTCAGGATGAAGAATGCCAATATGGTGAAGCGAAACAAGCGCCCAGCGAAGATTGTGAAGGAACGATAGCACGATCTTCAACGGAAACCCTAATTGCCTGTCCCTATTGGAAAGAAAAGTCCGTTGCAGGCGCTACTGAATCGTTTGCATATTCCCGGCATCTGGTGTTGTTATGCGGTATGGAACATATCTCGGCGGCGAAGCTACAGGCACAAATACCGGGTGTGGAATGTGTGCATTTATCCTCTGTTAACCGTTTTCATCGCAGTACACATGTAGAAACCATTTATCAGGATGAGTTTACCCAGGTTTTTGAAATGATTCAGGACGTTCTGGCCAGTAAAACCAGAGGCAACATATTGATTCAATGTGTGGTTCCCCAGCAGCCGAACCAACCATGCCTGTCGGCTATTTCCGGCATGCTCAAAACAGCACAGCTGGAAAACCCTAAAGTATCAGGGCAGCTGATTGAGGTGCTTGCCGACGAGACGGAAGTGAGTTTGCTGAGCAAAATTCATGAAAATGGCCGATGCCCTGAGGACAAACAGATTCGGTATGACCAGGGGCAGCGTGTTGTGCAGGCATGGCAAGAACTTGTCGTTTCCGATCGCGCTTGCAAAACCCCTTGGCGAGAAGGAGGCGTATATCTCATTACGGGTGGTGCCGGTGGTTTGGGTCTGATGGTTGCCGAAGAAATCGCCAGTCAAACCCAGCGTTCTACGCTGATCTTAAGTGGCCGATCAAGCTTAAGTCCGGAAGAGGTCGCATCATTTTCGTATGGACTACAAGCACTCGGCACGAGGGTCGAATACCAGCCGGCTGATATCAGCAATCCATACGATGTTGACACGCTCATCCAGCGTATTTCAAAAGCGTACGGCTCGCTGCACGGTATCCTGCATTGTGCGGGTATTGTGCGGGATAATTTCGTGATCAACAAAACATCGGCTGAGTTTCAGGCGGTGTTGGCCCCGAAAGTGGCGGGTGTCGTTTATGTAGACGCGGCCAGCAAAGATTTGAATCTCGATTTCTTTGTGCTGTTTTCTTCAATCGCAGGCGCAATGGGCAATGCGGGCCAGGCTGATTATGCGACCGCCAATGCCTTTATGGATGCATTTGCAACCTATCGTAATGATCTGGTCCGCATCGGGCAACGACATGGACAAACCCTGTCGATTAACTGGCCGCTTTGGCGAGCAGGCGGTATGCAAGTGACAGCTCACCAAGAGGCCGCTATGAGGCAGAGCGTGGGCCTGGAAATGCTCGATACGGCGCGAGGGATGCAAGCCTTGGTCAAGGGGCTGGCCTCGGGGCAGAGTCAGATCTTGGTGGCTGCGGGCCATCTTCCCACGCTGAGAGGGTGGTTGTTCCAGGAACCATTAGCGCCGAGTACATCAGACCAGCCACTGGCCAATGTCCATCGAGTTGGCCGCCAACCCTCACTGGCATCCGTGGACAAACAGAGACTTTATGAAGAAACCTTGGTTCAGCTTAAAGGGCTGTTAGGCACTGTTTTCCGTTTGTCGCCAAATCGCATTAAAATGCATGACGCGTTTGAGCGCTACGGTATCGACTCCGTGATGATCGTGCAATTAAATCAGGAAATGGAAGCGGTTTTTCCGGAACTCTCAAAGACCGTGTTTTTCGAATACCAAACATCGCATGAGCTGGTTGCCTACCTGCTTGATGAGTATCCGCAGGAATGTATGGTATGGACTGGGCTTGGGGCTGAATCTGACATTGATCATGGAAATGGAGAGTCTTCTTGGCCCGAACGTGCATGGCGCCCTAAACACAGTTTAGCGACGTCTGTAGATCGTGACTTGGCGCAAGCGCAAAACCCGCAGATTCAGGAAGCAATTGCGATTATTGGCGTTAGCGCTCGCTTTGCCCAGGCTGAAACCCTGCAAGCATATTGGCAAAATCTGCAAGCCGGCAAAGACTGCATTGGCGAAATTCCTACCAATCGGTGGTCATTGGACGGCTTTTTTGTTGACGACATCGACGAAGCCATCGCCCAGCGGAAAAGTTATAGCAAATGGGGTAGTTTTCTGGAGAGCTTTGCGGATTTCGACCCTCTGTTTTTTGGCATTCCCCCGCGCGATGTCTTAAGTATTGATCCGCATGAACGCTTGTTTCTCCAATCCTCGTGGGAGGCGCTCGAAGACGCTGGCTATACCCGCGACACATTGCGTGAGAGATATCAACAGCAGGTCGGTGTGTTCGCAGGCGTCACCAAAACCGGTTTTGACTTGTATGGCCCTGAGTTATGGAAACGCGGTGAACAGGCCTTTCCGCACACTTCTTTCAGCTCCGTTGCCAATCGGACATCGTATTTTTTGAATCTGCAAGGCCCGAGTATGCCAATTGATACGATGTGCTCATCGGCTCTAACCGCCGTGCACGAAGCGTGCGAACATTTACGCCGAAGAGATTGCCGACTCGCCTTGGCGGGCGGTGTCAACTTATACCTGCACCCTTCCAATTATGTTCAGATGTGCGCGCTACGTATGTTATCGAAAGACGGTCAGTGTAAAGCTTTTGGCCAAGGTGGCAATGGTTTTGTGCCCGGTGAGGGCGCGGGCGTGGTCTTGCTGAAACCCCTGTCCGAGGCCATTCGAGAGGGCGACAATATCTACGCCGTGATTCGCGCAAGCCATGTGAATCACGGCGGAAAAACCAATAGCTACACCGTACCCAACCCCGGTGCACAAGCGGATTTGATTCGTCAAACACTTGACAAAGCAGGGATTGAGGCGCGCAGCATCAGCTATATAGAAGCCCACGGCACGGGAACGGCATTGGGAGATCCAATCGAAATTACCGGTCTGACTCAGGCCTTTAAAACAGATACTGATGATACTGGCTTTTGTGCGATCGGTTCTGCAAAATCCAATCTAGGGCACTTGGAAGCGGCATCAGGTATGGCGGGGCTGTTCAAGGTTCTTCTGCAACTGAAGCACCGCCAGCTTGTTCCGAGTTTACATGCAGGAAGTTTAAACCCTAATATCGCTTTTGAAAAAACCCCCTTTGTGGTGCAGCAGGCCCTTTCAGAGTGGAAAAGACCCATCGTGGAAAGCAGCGGTGAGGTCAAGGAATACCCCAGGAGAGCGGGCATCTCCTCATTTGGTGCCGGGGGTTCGAATGCACATTTGATTGTTGAAGAGTATGAAGCAAATGACGAACCGTATGCCGAGAAAGCGGTTGATGAGTCCGTGATGATTGTATTGTCGGCCAAAAATACGGATCAGCTCATTCAACTGGCTCGTAACTTAAGGCGTTTTATTGCCGAGACCGAAACCAAGCCGCCCCGTCTGGAAGATATCGCATACACGCTTCAGACCGGGCGCGAGGCAATGGAGGAGCGTCTAGCGCTTATTGTTGGGAGTCTAGAGGAGCTTGAAGAAAAGCTGCACGCCTTTGTTGAGGGACAGGAGCCTATTGCGTCGCTTTATCGTGGGGACCTCAAACAGGACTTGAACTTACTGTCGGATTTTGCCACGGAGGAAGAGCTTTCGAATACCATTGATGACTGGATGATGTCGAAACAAATAAATAAGCTACTCAGTCTGTGGGTTAAAGGTCTCACCATTAATTGGCAGAAATTTTATATTTATATTTATCATAAGCCCAGATCGAGACGTATTAGTCTTCCTACCTATCCCTTTGCCAAAGAATTCTATTGGTTTGAGCCGCAGGCTTTTAATCATGGTATCTCGACTCACTCGCAAAAGCCAGCTGAAAATCAGACTTCCTCGCGAAGCATTCAGTATCTGCAAAAGCAGTGGCTGCTGGATGAGTCCGAACCTGATGAGTCCTATGCTAAACAAGTGGTGGCGCGAAAAATTGCGATTCTAAGCGGTCCGCAAACCCGGTTGCTTGCGTCCCTGTTGGAAGAGGAATTCCCAAACAGCCAAATTATTGAACACGATAACATCAAGGAACACTTGGAACAGAGCCATGCAGATTGGCAGACGCATGGCGGATGCATCGATCTGGCGGGTTGTAGTCGTGACGAAGAAGCCGGAGATGCGCTTGACTGGATGCTGTGGCTCCAGCGCCTGATCGAAAATGGCTCAAAAACCGGTCTCACCCTGCTTGGCGTCACCCGAGGCTTAGAGTTCTTTCAGAACAGCGAGGTGAACCTATCGGGTGCCTCTCGTGTCGGGCTTTATCGCATGCTTCAGAGCGAGTATGCCCATATTCAATCTCGTCATATCGATACCGATCCCAGCCTTAAGACATCAGCGTTGGCCGAGCAGATTGCTCGCGAGTTTGTGTTGAACGATGAGAACTGTGAAATTTGTTACCGCGATCACAAGCGCTACCGTGCATATTTGGCAGCGTCTTCGCTAAAAGCGGCAAAGATATCAGACACAGACCTTCAGTTTGCTCAAGAAGATGTTCTCCTGATTACCGGAGGAACGGGTGGGCTGGGGCTTTTGTGTGCTCAGCATTTTGTAGAGCATTACGGGGTGAAGCGCTTGGTGCTTACCGGGCGGGAAGCGTTGCCATCGCGTGAGCAATGGGCTGATCCGCAAAGTGATAAGGTCAAGCAAAAGATAGACGTCATTCAGTCCTTGGAGCGTCAAGGCGTTAAGGTACAAGTATTGCCGATGGTGTTAAGTGATCATGATGCGGTGCGAGAAACTCTGGGTCAAGTTACAAAGAACTTTGGACCTATTCGTGGTTTGCTTCATTGTTCTGGAGCTGTCGATTCAGAAACGCCTGCCTTTGTTCGTAAGCCGATAGCAAAGGTGTCGCAGGTTTTAGAGCCTAAAGTGTCGGGACTTCAAACGCTGTTGGCGCAATGCAGACCACAGTCATTAAAATTCGCGGTCTTGTTTTCCTCTGTGGCTGCCACGATTCCCCGTCTGGCCAGCGGCCTGAGTGACTATGCTATGGCTAACGCGTATATGGATTATGTGGCCCAAGCCACGGGCGGTAAGTTGGTGAGTATTCAATGGCCAAGCTGGCAGGAGACCGGGATGGGCGCCGCGAACAGCAGGGCGTATCATGAAACGGGTTTGCTTCGTCACAACAATCAAGAAGGTCTCCGGCTCTTAGATGATATCCTTTCTCAACAAACCGAACCTGTGATACTGCCTGCTGTTGTCGATTCTGCGTTGTGGGCGCCGCAACAATTGATGAAGCATCAGAGCAGGCGAGAGAGCATTTCACCCGTCTTGCATCACCACCCTCAGACGCCAATGCATATTGAGCCCGCTACACCGAACATGGCATCAAGCCAGTTGACTCTGAACGATTTAGTTGCCTTATTTTCTCAGGAACTTGGCATTCCTACACAAAATCTGGCGCTGGACAAATCATTTGCGGATTATGGCCTGGATTCGATATGGCTGGCTCAGCTCGCAAGCAAAATCAATCAACAGCTTGTTGAGCCACTGGACCCTTCTATCTTGTACGAGTATTCTTCGTTAAATGCACTGGCGTCTTGGCTGGCTAGCGAACAGGCGCCAGCTCTTAAATCACAGGCCCATGATAGAGACGTTGAGCAGAAGATCGATCCGAAAAATGCCGCGGATAGCGTTGTACCCCGCTCTTCAAAAAAGCAGGCGTTGGATATCGCTGTGGTTGGCATGTCCTGCCGTTTTCCGGATGCCAATAATCTAGACGAGTATTGGTCTTTATTATCGGAAGGCAAGCAAGCTATCCGCCCTGTTCCAGCGGACCGCTGGTCGAGACCAACGCCGTTTTATGCAGGCTTGATCGAAAATAGCAGCCATTTTGATCCCGCCTTTTTCCTGATTCCACCAGAGGACGCGAAGGTGCTGGATCCTCAGGCGCTATTGCTGTTGGAAGAATGCCTGAACTTGTTTTATCACGCGGGTTACACCCTAGACGAGATGAAAGGCAGGGCCATCGGGGTCTATTTAGGTGGGCGCAGTCAGCATCGCATTGATGAAGCCGATCTTGGTCAAGCTCGAAATCCGATCGTGGCCGCGCAGAATTATCTGGCCACACATCTCTCACAGTTTTTTGATCTGAATGGTCCAAGTCTGGTCATTGACACAGCCTGTTCCTCGGCTCTGGTGGGGATGAATTTTGCCGTTCAGTCCCTGCTCAGTGGCGAGATTGACTCGGCGGTCGTTGGAGGCGTCAGTCTCCTGGCCGACGAAGATGCCCATCGTATCTTTCAGCAGCGCGATCTGTTGAACCGGGACGCCTCGTTTCATATCTTTGATCAGCGGGCCTCCGGCATCACGTTGGGCGAAGGGGCGGGTTTGGTGTTTTTAAAAACCCTGCCGCAGGCGCAACGCGATGGCGATCAGATTTACGCCGTCATTAAGGGACTGGTCATCAATAACGACGGTCGCACGGCCGGTCCGGCGACACCGAATTTTGAGGCGCTCAAATCTGTTATGCAGCGCGCCTTGAAGCAAAGTTGTCAACAGCCGCAAGATATTGTTCATATTGAAGCTAACGGCTCAGGCTCCGAGGTGACCGATCTACTCGAGCTTAAAGCGATGGAAGCGGTTTATCGTAGCGACAATAAGGCACCTTGCAGCTTAGGATCAATTAAGCCCAATATGGGGCATCCGTTATGTGCCGAAGGTATTGCTAGTTTTATAAAACTGGTGTGTATGTTGAAATATCAGCAGCAAGTACCTTTTTTATCTGGTCAAGTGCCATTAACACATTATGATTTAGACGCTTCGCCCTTTTATTTCTGTCGTCAGTCAACAAAATGGACAGAACACTCCCCCCTTCTGGTGGCGCTCAACTGTTTTGCGGATGGTGGGACCAATGCACATGTGATTATGGAAGCCTGGACGCAGGCAGAATCTCACCAGCAACGGCAGCCCATACCACCACCCGCGCTAAACCGAGTGAATATCCGCGGTGCAGTCAGCCAGCATCCCTGGTGGTGA", "orf_prot_sequence": "MSASEHAGSTIQYGRHLVILCEPDGITQESIASRMAAVDCLVYQSRSENIAERFQDYALRLFTEIQQLLTARAEAKILLQFVIRDLLEQQLFAGLAGLLKTAHLENPNLMGQLLCVAPGDDAEHLVATLKVNAQTPLDQRVAYRNGKRRIAAWKEVPIANDEDVSIPWKENGTYLITGGLGGLGLLFTKEIAQQIRSGTVMLTGRSPLDESKRQMLQTLQQFCGQSRVHLEYRQVDVCEPQGVASLIQEINHHVGPLDGVIHAAGVIHDNFIIKKTPQELENVLAPKVKGLVNLDEATKDQPLDFFFFCSSLAGGIGNVGQADYACANAFMDCYARYRNQLLQSHQRQGRTLSINWPLWQEGGMRVDAASENMMAQSIGLLAMPTSAGMRALYKAIASQQDQVMVVEGDLAKLRQTFLSLPEKTAQPEIGDVEAALDTGQLQHKTLEKLKSLFAEMTKLPLERVNEEEPLDSYGIDSVMIAQLNQKLTAELGPVSKTLLYEFHTLEELAHHLVKAYFDRCVNWTQLNSTLNFSEVSVETRNHKSEKGRYSNEYDMQMPDDTAQQPIAIIGLSGRYPKAKTIAEFWQNLKHGEACISEIPRQRWDWKRYYHADPNEAVKSGKSYSKWGGFLEDFDQFDPMFFNMTPREAENIDPQERIFLQESWKALEDAGYSPSNLSADLRQRIGVFAGITKQGFNLYRMESGPDRQLACPATSFASLVNRVSYVLNLQGPSFPVDTMCSSSFVAIHEACAYIRSGQGDMAVVGGVNLYAHPSSYLELSLGRFVSNGSTCAAFEKDADGFVPGEGVGVVILKAYDQALKDRDSIYALIRGSAVNHDGKTNGYKTPNPGPKAAVIRQALQQSGIDARSISYIEAAAQGSDVGDAIEASALTDVFSGRNHVEGAYRIGSVKPNIGHSESASGMSQLTKVILSLNHQTLPPTLRSRALSPSIDFDQLPFELQQELSEWQPVRVDGIEVPRRAGMMNIGAGGVNAHIIVEEPPPHEEPVHDGHGPVLFVLSAKNEERLERYVQDWLIYITNGPILDLPSIAYTLQVGRESMACRLAFVVNQSEELATYLTRWLKTRELGDVGFYGDVTQERVKNSEAVSTLVKAGDASHARELAALWVQGNAIAWDKWHRGTTLGRRSGLPTYPFANRTCWIARDDHDCSEDDRGEEKSDVEPRIDHTLDENKAVEFYTRMTQDCDEAFQEEYLTFGAFPRRIPGFSMTRVAMNAERYPEELEMIKESQRELRQVLFCREDFDRVHTFLDIGCGHGTDVIQVAALYPHIQTHGFTITESQAILGNRRIEHMNLGSRARIYHKDSSKEPFPDNCDMILGIEVTFHIRDKDALLQKMADALSDDGKILLMDYIANLRGSIVDPNVEISIPTQSQWIDLLSQHDLIIDEIIDVSTEVSNYLYDPEHAEHTKHLPKVSQDSYRNYANQAIALEKGWITYCLLKLQRDTQRSEQERREYNAWKIANQTPYAQALEDMLRVGRMPYPLSGGLKMAVQPMDGQPPSTLDESVPDLGQIQTALAGIFVAILGFETRELDFIDQLPLTELGISSVNAVELLEAINTEFDLHLPTSLVFECHRLEDLAGHIQVELGRKPIAPAMSNASVAVQAEAESRQKTTVPVEEKAPIANEETAIIGLSCRCAGAKDQEQFWQVVSQGKDCIEDLKEPQWLDYIAEHGSETFPIRYGVMPERDDFDPLFFHISPREAEAMDATQRVLLEECYRALEDAGYNPSSLKQQAVGTYIGAMGSASLRKGFSHLDMLGSETSILSARTAYFLDLTGPALTINTACSSSLVAIEVASQALKSGEINLAIAGGVTLYQHPGTFIAMHNASMLSPTGQCRPFDDDADGIVVGDGVGVVILKRLREAERDGDSIYGIIRGCGMNQDGQTASMTVPSFLAQSELESAVYQKANIDIEDLQYIEAHGTATKLGDPIEIHALNKSFQALTSKQKFCAIGSLKANVGHTTAAAGVLGVIKVLLGMKYQQLPPSIHFNEGNRHIDFDNSPVYVNTTLKPWPKNAKDSRLAAISSFGFSGTNAHLVLEQYMPLPDTDSGVFIPLVLLLSAESDDALQHYAHNVKCYLEDHPAIQYGHFLYTFQVGRDAFAYRLAIIAENQQELIQKLEQWLTTGGPVTDIHNKPDIGNREEEKASLQSLISGRKVEPLAQLWEQGASVDWHAFYPDGRCRRLAGLPTYPFAREYFGAPQDEECQYGEAKQAPSEDCEGTIARSSTETLIACPYWKEKSVAGATESFAYSRHLVLLCGMEHISAAKLQAQIPGVECVHLSSVNRFHRSTHVETIYQDEFTQVFEMIQDVLASKTRGNILIQCVVPQQPNQPCLSAISGMLKTAQLENPKVSGQLIEVLADETEVSLLSKIHENGRCPEDKQIRYDQGQRVVQAWQELVVSDRACKTPWREGGVYLITGGAGGLGLMVAEEIASQTQRSTLILSGRSSLSPEEVASFSYGLQALGTRVEYQPADISNPYDVDTLIQRISKAYGSLHGILHCAGIVRDNFVINKTSAEFQAVLAPKVAGVVYVDAASKDLNLDFFVLFSSIAGAMGNAGQADYATANAFMDAFATYRNDLVRIGQRHGQTLSINWPLWRAGGMQVTAHQEAAMRQSVGLEMLDTARGMQALVKGLASGQSQILVAAGHLPTLRGWLFQEPLAPSTSDQPLANVHRVGRQPSLASVDKQRLYEETLVQLKGLLGTVFRLSPNRIKMHDAFERYGIDSVMIVQLNQEMEAVFPELSKTVFFEYQTSHELVAYLLDEYPQECMVWTGLGAESDIDHGNGESSWPERAWRPKHSLATSVDRDLAQAQNPQIQEAIAIIGVSARFAQAETLQAYWQNLQAGKDCIGEIPTNRWSLDGFFVDDIDEAIAQRKSYSKWGSFLESFADFDPLFFGIPPRDVLSIDPHERLFLQSSWEALEDAGYTRDTLRERYQQQVGVFAGVTKTGFDLYGPELWKRGEQAFPHTSFSSVANRTSYFLNLQGPSMPIDTMCSSALTAVHEACEHLRRRDCRLALAGGVNLYLHPSNYVQMCALRMLSKDGQCKAFGQGGNGFVPGEGAGVVLLKPLSEAIREGDNIYAVIRASHVNHGGKTNSYTVPNPGAQADLIRQTLDKAGIEARSISYIEAHGTGTALGDPIEITGLTQAFKTDTDDTGFCAIGSAKSNLGHLEAASGMAGLFKVLLQLKHRQLVPSLHAGSLNPNIAFEKTPFVVQQALSEWKRPIVESSGEVKEYPRRAGISSFGAGGSNAHLIVEEYEANDEPYAEKAVDESVMIVLSAKNTDQLIQLARNLRRFIAETETKPPRLEDIAYTLQTGREAMEERLALIVGSLEELEEKLHAFVEGQEPIASLYRGDLKQDLNLLSDFATEEELSNTIDDWMMSKQINKLLSLWVKGLTINWQKFYIYIYHKPRSRRISLPTYPFAKEFYWFEPQAFNHGISTHSQKPAENQTSSRSIQYLQKQWLLDESEPDESYAKQVVARKIAILSGPQTRLLASLLEEEFPNSQIIEHDNIKEHLEQSHADWQTHGGCIDLAGCSRDEEAGDALDWMLWLQRLIENGSKTGLTLLGVTRGLEFFQNSEVNLSGASRVGLYRMLQSEYAHIQSRHIDTDPSLKTSALAEQIAREFVLNDENCEICYRDHKRYRAYLAASSLKAAKISDTDLQFAQEDVLLITGGTGGLGLLCAQHFVEHYGVKRLVLTGREALPSREQWADPQSDKVKQKIDVIQSLERQGVKVQVLPMVLSDHDAVRETLGQVTKNFGPIRGLLHCSGAVDSETPAFVRKPIAKVSQVLEPKVSGLQTLLAQCRPQSLKFAVLFSSVAATIPRLASGLSDYAMANAYMDYVAQATGGKLVSIQWPSWQETGMGAANSRAYHETGLLRHNNQEGLRLLDDILSQQTEPVILPAVVDSALWAPQQLMKHQSRRESISPVLHHHPQTPMHIEPATPNMASSQLTLNDLVALFSQELGIPTQNLALDKSFADYGLDSIWLAQLASKINQQLVEPLDPSILYEYSSLNALASWLASEQAPALKSQAHDRDVEQKIDPKNAADSVVPRSSKKQALDIAVVGMSCRFPDANNLDEYWSLLSEGKQAIRPVPADRWSRPTPFYAGLIENSSHFDPAFFLIPPEDAKVLDPQALLLLEECLNLFYHAGYTLDEMKGRAIGVYLGGRSQHRIDEADLGQARNPIVAAQNYLATHLSQFFDLNGPSLVIDTACSSALVGMNFAVQSLLSGEIDSAVVGGVSLLADEDAHRIFQQRDLLNRDASFHIFDQRASGITLGEGAGLVFLKTLPQAQRDGDQIYAVIKGLVINNDGRTAGPATPNFEALKSVMQRALKQSCQQPQDIVHIEANGSGSEVTDLLELKAMEAVYRSDNKAPCSLGSIKPNMGHPLCAEGIASFIKLVCMLKYQQQVPFLSGQVPLTHYDLDASPFYFCRQSTKWTEHSPLLVALNCFADGGTNAHVIMEAWTQAESHQQRQPIPPPALNRVNIRGAVSQHPWW", "perc_identity": 30.77}, "gnl|BL_ORD_ID|2411|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 60103, "orf_end": 73629, "orf_from": "BGC0001186.1|Misakinolide_17 ", "model_name": "AxyY", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1700", "model_id": "2799", "ARO_accession": "3004144", "ARO_name": "AxyY", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35976": {"category_aro_accession": "0000059", "category_aro_cvterm_id": "35976", "category_aro_name": "cefepime", "category_aro_description": "Cefepime (INN) is a fourth-generation cephalosporin antibiotic developed in 1994. It contains an aminothiazolyl group that decreases its affinity with beta-lactamases. Cefepime shows high binding affinity with penicillin-binding proteins and has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.43645, "max_identities": 14, "bit_score": 30.0314, "cvterm_id": "41271", "query": "LPDTDSGVFIPLVLLLSAESDDALQHYAHNVKCYLEDHPAIQYGHFLYTF", "match": "LPD D G F+ +V+L              +V+ Y+ +H  +QY + +  F", "sequence_from_db": "LPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGF", "sequence_from_broadstreet": "MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP", "dna_sequence_from_broadstreet": "ATGGCGCGTTTCTTTATCGATCGCCCCGTTTTCGCGTGGGTGATCTCGCTGCTCATCGCGCTGGTCGGCCTGTTGTCGATCCGCGCGCTGCCGGTGGCGCAGTATCCGGACATCGCTCCGCCCGTCGTCAACATCGGCGCCAGCTATCCCGGCGCCTCGGCCAAGGTGGTCGAGGAAGCCGTCACCGCCATCATCGAACGCGAGATGAACGGCGCCCCGGGCCTGATGTACACCTCGTCCAGCAGCGATTCGACCGGCTGGGCCAGCATCAACCTGACCTTCAAGCAGGGCACCAACCCCGACATCGCGGCGGTGGAAGTGCAGAACCGCCTGAAGGCGGTCGAGCCTCGCCTGCCCGAATCGGTGCGGCGCGATGGCGTGCGCGTGGAAAAGGCGGCCGACAACATCCAGCTGGTGGTGTCGTTGAAGTCGGACGGCAGCCTGGACGACATGCAACTGGGCGAGCTGGCCGCCTCCAATGTGCTGCAGGCGCTGCGGCGGGTCGAAGGCGTGGGCAAGGTGCAGTCGTTCGGCGCGGAAGCGGCGATGCGCATCTGGCCGGACCCGGCCAAGCTCACCGCCCTGTCGCTGACGCCGGGCGACATCGTCTCGGCGCTGCGCAGCCACAACGCGCGCGTCACCATCGGCGAACTGGGCAACCAGGCCGTGCCCAAGGACGCGCCGCTGAACGCCAGCATCGTGGCGGGCGAATCGCTGCACACGCCGGAACAGTTCGCCAACATCCCGCTGCGGGCGCTGCCGGACGGCGCCACGCTGCGCCTGAAGGACGTGGCGCGGGTGGAGCTGGGCGGCACCGACTACATGTACCTGTCGCGCGTCAACGGCCTGACCGGCACCGGCCTGGGCATCAAGCTGGCGCCCGGCTCCAACGCCGTCGAAACCACCCGCCGCATCCGCGAGACCATGCGCGAGCTGGCGCAATACTTCCCGCCGGGCGTGACCTGGGACATTCCGTACGAGACCTCCACCTTCGTCGAGATCTCGATCAAGAAGGTCCTGATGACGCTGCTGGAGGCGGTGGCGCTGGTGTTCTGCGTGATGTACCTGTTCATGCAGAACCTGCGCGCCACGCTGATCCCGACCCTGGTGGTGCCGGTGGCGCTGCTGGGCACGCTGGGGGTGATGCTGGGGCTGGGCTATTCGATCAACGTGCTGACGATGTTCGGCATGGTGCTGGCCATCGGCATCCTGGTGGACGACGCCATCGTGGTGGTCGAGAACGTCGAGCGCATCATGGCCGAGGAAGGCCTGTCGCCGCATGACGCCACGGTCAAGGCCATGGGCCAGATCAGCGGCGCCATCGTCGGCATCACCGTGGTGCTGGTGTCGGTGTTCGTGCCGATGGCGTTCTTCGACGGCGCGGTGGGCAACATCTACCGCCAGTTCGCCGTGACGCTGGCGGTGTCGATCGCCTTCTCGGCCTTCCTGGCGCTGTCGCTGACGCCGGCGCTGTGCGCCAGCCTGCTCAAACCCGTCCCGGCCGGCCACCACGAGAAGCGCGGCTTCTTCGGCTGGTTCAACCGCGCCTTCGCGCGCCTGACCACGCGCTATACGGCGCGGGTGGCCGGCGTGCTGGCGCGGCCGGTACGCTTCGGCCTGGCCTATGCGCTGGTGATCGGCGTGGCGGCGTTGCTGTTCGCGCGGCTGCCATCGTCGTTCCTGCCGGACGAGGACCAGGGCAGCTTCATGGCCATGGTGATCCTGCCGCAGGGCTCGCCGCAGGCCGAGACCATGGCGGTGGTCAAGGACGTCGAACGCTACATGATGGAGCACGAGCCGGTGCAGTACGTGTATTCGGTCAACGGCTTCAGCCAGTACGGCAGCGGCCCGAACTCCGCCATGTTCTTCGTCACGCTGAAGGACTGGAAGGAACGCCGCGATGCCTCGCAACACGTGGACGCGGTGGTCAAGCGCATCAACAAGGCGTTCGCGGATCGCAAGAACCTGATGGTGTTCGCGCTGAACTCGCCGCCGCTGCCTGACCTGGGCTCGACCTCGGGCTTCGACTTCCGGCTGCAGGATCGCGGCGGCCTCGGCTACGAAGCCCTGACGCAGGCGCGCCAGAAGCTGCTGGCCAAGGCGGCCGAGCATCCCGCGCTGACGGACGTGGTGTTCGCCGGCCAGGAAGAGGCGCCGCAGCTGCAACTGCGCGTCGACCGCGACAAGGCGCAGGCCATGGGCGTGCCGATCGACGAGATCAACACCGCGCTGGCTGTGATGTACGGCTCGGACTACATCGGCGACTTCATGCTCAACGGCCAGGTTCGGCGCGTGATGGTGCAGGCCGACGGCAAGCGCCGCGTGGACGTGGACGACATCTCGCGCCTGCACGTGCGCAACCTGCAGGGCCAGATGGTGCCGCTGTCGGCGTTCGCCACGCTGACGTGGTCGATGGGGCCGCCGCAGCTGAACCGCTACAACGGCTTCCCGTCGTTCACCATCAACGGCTCGGCGGCGCGCGGCCACAGCAGCGGCGAGGCCATGCGCGCCATGGAGACGCTGGCGGCCGAGCTGCCGCGCGGCATCGGCTTCGACTGGTCGGGCCAATCGTACGAAGAGCGGCTGTCCGGCAACCAGGCGCCGGTGCTGTTCGCGCTGTCGGTGCTGATCGTGTTCCTGGCGCTGGCGGCGCTGTATGAAAGCTGGTCGATTCCGCTGGCGGTGATCCTGGTGGTGCCGCTGGGCGTGATCGGCGCGCTGCTGGGGGTGACCGTGCGCGGCATGCCCAACGACATCTACTTCAAGGTCGGCCTGATCGCCACCATCGGCCTGTCCGCCAAGAACGCGATCCTGATCGTGGAAGTGGCCAAGGACCTGGTGCGCGACGGCCAGGGCATCCTGTCCGCCACGCTGGAAGCGGCGCGGCTGCGGCTGCGGCCGATCGTGATGACCTCGCTGGCCTTTGGCGTGGGCGTGCTGCCGCTGGCGCTGGCCACTGGCGCCGCCTCGGGCGCGCAGGCCGCCATCGGCACCGGCGTGCTGGGCGGGATCATCACGGCGACCGTGCTGGCGGTGTTCCTGGTGCCGCTGTTCTTTCTCATCGTGGGACGCATGGTCGGCATGCGCGCCCGCCCCGCGCGCCCCGACGGCCGCGAACCGCTGGAGACGACGCCATGA", "partial": "0", "query_start": 66271, "query_end": 66420, "hit_start": 1680, "hit_end": 1830, "orf_dna_sequence": "GTGAGTGCGTCCGAACATGCAGGCTCAACCATCCAGTACGGCCGACATTTGGTGATTCTCTGCGAGCCCGATGGAATAACGCAGGAAAGTATTGCCAGCAGGATGGCGGCGGTGGATTGTCTCGTTTATCAATCACGATCGGAAAATATTGCTGAACGTTTCCAGGACTATGCGTTGCGACTATTTACAGAAATTCAACAGCTCCTCACAGCGAGAGCGGAGGCTAAAATCCTGCTTCAATTCGTCATTCGTGATTTGCTGGAGCAGCAACTTTTTGCTGGTTTGGCTGGCTTGTTGAAGACCGCTCACCTGGAAAACCCAAATCTGATGGGCCAGCTTCTCTGCGTCGCTCCGGGTGATGATGCGGAACATCTTGTGGCAACACTCAAGGTGAATGCGCAAACACCCTTAGACCAACGTGTTGCCTATCGCAACGGAAAGCGCCGAATTGCCGCATGGAAAGAAGTACCGATTGCTAATGATGAGGATGTGAGCATTCCCTGGAAGGAAAACGGTACGTATCTGATTACCGGTGGTCTAGGGGGGTTGGGTCTGCTGTTCACTAAGGAAATTGCCCAACAGATCCGCTCCGGAACGGTCATGCTGACTGGCCGCTCACCACTCGATGAGTCAAAACGGCAGATGTTGCAAACCTTGCAGCAATTCTGCGGGCAGAGCCGCGTACACCTTGAATATCGTCAGGTCGACGTTTGCGAGCCGCAAGGTGTTGCGAGTTTAATTCAGGAGATAAATCACCATGTTGGTCCTCTCGACGGCGTGATTCACGCTGCGGGTGTGATTCACGATAACTTCATTATTAAAAAGACGCCGCAAGAGTTGGAAAATGTGCTTGCGCCTAAAGTCAAGGGCTTGGTGAATCTTGATGAGGCCACGAAAGACCAGCCGTTGGACTTTTTCTTTTTCTGTTCCTCACTAGCGGGCGGTATCGGTAATGTCGGGCAGGCGGATTACGCTTGTGCCAATGCCTTCATGGATTGCTATGCGCGATATCGTAACCAACTCTTGCAATCGCATCAGCGTCAGGGACGCACGTTGTCGATCAACTGGCCCTTATGGCAAGAGGGTGGCATGCGGGTTGATGCAGCGAGCGAGAACATGATGGCGCAAAGTATCGGCTTGCTTGCCATGCCGACCTCTGCCGGCATGCGGGCCTTGTACAAAGCCATTGCCAGTCAGCAGGATCAGGTGATGGTGGTAGAGGGTGATCTTGCCAAACTTAGACAAACTTTTTTGAGCTTGCCGGAAAAAACAGCTCAACCTGAAATAGGTGATGTTGAGGCCGCGCTGGATACGGGGCAACTGCAACACAAAACGCTTGAAAAATTAAAGTCGTTATTTGCCGAAATGACGAAGTTGCCTCTAGAGAGGGTTAACGAAGAAGAGCCACTGGATAGTTATGGTATTGATTCTGTCATGATTGCTCAGTTGAATCAAAAATTGACTGCAGAGCTCGGCCCTGTATCCAAAACACTATTATATGAATTTCATACGCTAGAAGAGTTGGCACATCATTTAGTTAAGGCTTATTTTGATCGTTGCGTTAACTGGACTCAACTCAATAGCACACTCAATTTTTCTGAAGTAAGCGTTGAGACTCGCAATCATAAATCTGAAAAAGGCAGGTATTCAAACGAATACGATATGCAAATGCCGGATGATACCGCCCAACAACCCATTGCCATTATTGGGCTGAGTGGCCGTTATCCCAAAGCGAAAACGATAGCTGAATTTTGGCAGAATCTGAAACACGGAGAAGCATGCATCAGTGAAATTCCGCGCCAACGCTGGGATTGGAAGCGTTATTATCATGCCGATCCCAACGAGGCGGTTAAATCGGGCAAGAGCTATAGCAAATGGGGTGGGTTTTTAGAGGATTTTGATCAGTTTGATCCCATGTTTTTCAACATGACCCCGCGCGAGGCGGAAAATATTGATCCGCAGGAACGCATCTTCCTACAAGAAAGTTGGAAGGCGCTGGAAGACGCCGGCTACTCTCCCTCCAATCTGTCGGCTGATTTGCGCCAGAGAATTGGCGTTTTCGCGGGTATCACCAAACAAGGCTTTAATTTATACCGCATGGAATCCGGGCCGGATCGTCAACTCGCGTGCCCTGCCACATCATTTGCCTCTTTGGTGAACCGAGTTTCGTATGTTCTCAATCTCCAAGGCCCCAGTTTTCCGGTCGATACGATGTGCTCTTCTTCCTTCGTCGCAATACACGAGGCATGTGCGTATATTCGCTCTGGCCAAGGGGACATGGCCGTCGTTGGGGGCGTCAACTTATATGCCCACCCCTCGTCTTATCTGGAGCTATCGTTGGGGCGATTTGTCTCGAATGGCTCGACGTGCGCTGCGTTTGAAAAAGATGCCGATGGCTTTGTTCCCGGAGAAGGGGTTGGCGTTGTCATCCTCAAAGCTTATGACCAGGCGCTAAAGGATCGCGATAGCATTTACGCCCTGATTCGGGGGAGCGCGGTCAATCACGATGGCAAGACAAATGGCTATAAAACCCCGAACCCTGGACCAAAAGCGGCCGTGATTCGTCAGGCCTTGCAACAAAGTGGCATTGATGCGCGAAGCATCAGCTACATCGAAGCCGCGGCTCAAGGTTCGGATGTGGGCGATGCCATCGAAGCCAGTGCATTGACCGATGTATTCAGCGGCCGCAACCATGTTGAGGGGGCCTATCGCATTGGCTCAGTGAAACCCAATATTGGCCACAGCGAATCGGCGTCGGGCATGTCCCAGCTCACCAAAGTGATTTTATCGTTAAACCATCAAACGCTACCACCCACGTTGCGTTCGAGAGCGCTCAGCCCCTCTATTGATTTTGATCAACTGCCTTTTGAGTTGCAGCAAGAGCTCAGCGAGTGGCAACCGGTTCGTGTCGATGGCATTGAGGTGCCACGAAGAGCTGGGATGATGAATATTGGCGCTGGCGGAGTAAATGCTCACATCATTGTCGAAGAGCCTCCGCCTCATGAAGAGCCGGTTCATGACGGGCATGGGCCTGTGCTGTTTGTTTTATCAGCAAAAAATGAAGAGCGCCTGGAGCGCTACGTACAAGACTGGCTGATCTATATCACCAATGGTCCAATTCTCGATTTACCATCGATCGCTTACACCTTGCAGGTCGGACGGGAAAGCATGGCCTGCCGCCTGGCCTTTGTGGTGAACCAATCAGAGGAGCTTGCGACGTATCTGACGCGTTGGCTTAAAACGCGTGAACTGGGCGACGTTGGCTTTTATGGGGATGTGACGCAGGAAAGAGTTAAGAACTCAGAGGCGGTGAGTACGCTCGTAAAAGCAGGGGATGCCAGTCATGCTCGTGAGCTGGCTGCACTGTGGGTGCAAGGCAATGCCATCGCATGGGACAAATGGCATCGCGGCACAACCTTGGGCAGACGCAGTGGCTTGCCGACTTATCCCTTTGCGAACAGGACTTGTTGGATCGCTCGCGATGACCATGATTGTTCAGAGGATGATCGCGGCGAGGAAAAGAGCGATGTCGAGCCGCGTATCGATCACACTCTGGATGAAAATAAGGCGGTTGAATTTTACACCCGAATGACACAAGACTGTGACGAGGCGTTTCAGGAAGAGTATTTGACGTTTGGCGCTTTCCCCAGAAGAATTCCTGGCTTCTCGATGACCCGTGTCGCAATGAATGCGGAGAGGTATCCGGAAGAACTGGAAATGATTAAGGAAAGCCAGCGGGAGTTGCGCCAGGTTCTGTTTTGTCGCGAAGATTTTGATCGTGTTCACACGTTCCTCGATATTGGTTGCGGTCACGGCACGGATGTGATTCAGGTGGCCGCGCTCTATCCGCATATACAAACCCATGGTTTTACCATTACCGAGTCACAAGCAATCTTGGGCAATCGACGTATTGAGCATATGAATTTGGGCTCTCGTGCGCGAATTTATCATAAAGATAGTTCAAAAGAACCATTCCCAGACAACTGTGATATGATTCTGGGTATCGAGGTTACCTTCCACATTCGCGACAAAGATGCCTTGCTTCAGAAGATGGCGGATGCGCTCAGTGATGATGGCAAAATCTTACTTATGGATTATATTGCTAATCTGAGAGGCAGTATTGTCGACCCCAATGTCGAAATTAGTATTCCTACTCAGTCGCAGTGGATTGATCTGTTATCTCAGCACGATCTCATTATTGATGAAATTATCGATGTATCGACCGAAGTTTCGAACTATCTTTATGACCCTGAGCATGCTGAACATACTAAGCACTTGCCAAAAGTAAGCCAGGATAGCTATCGCAACTACGCCAATCAGGCCATCGCTTTAGAAAAAGGTTGGATTACATATTGCTTGTTAAAATTGCAAAGAGACACTCAGCGTAGTGAACAAGAGCGACGCGAGTATAATGCTTGGAAAATTGCCAATCAAACACCATATGCCCAGGCTCTGGAAGACATGCTGCGTGTCGGGCGTATGCCTTATCCGCTGAGCGGGGGGCTCAAAATGGCTGTCCAGCCGATGGACGGTCAGCCACCCTCCACCCTTGATGAAAGCGTGCCTGACTTAGGACAAATCCAGACCGCTCTGGCGGGGATCTTTGTCGCCATTTTAGGTTTTGAAACACGCGAACTCGACTTCATTGATCAGCTACCGCTCACGGAGTTGGGAATTAGCTCCGTGAATGCCGTGGAATTACTGGAAGCCATTAACACCGAATTTGACCTGCATTTGCCCACCAGTCTGGTCTTTGAGTGTCATCGTTTGGAGGATTTAGCTGGCCATATACAGGTTGAACTAGGGCGGAAACCCATCGCACCTGCCATGTCAAATGCGTCAGTAGCCGTGCAAGCTGAGGCTGAATCCAGGCAAAAAACCACTGTGCCGGTAGAAGAAAAAGCGCCGATAGCAAACGAGGAGACTGCCATCATTGGACTCTCCTGCCGTTGTGCCGGCGCTAAAGATCAAGAGCAATTTTGGCAAGTGGTCAGTCAGGGTAAAGATTGTATTGAAGACCTGAAGGAACCTCAGTGGCTCGACTACATTGCCGAGCATGGTTCAGAAACGTTTCCCATTCGCTATGGCGTTATGCCGGAACGGGATGATTTTGACCCGCTGTTTTTTCACATCTCGCCCCGAGAAGCTGAGGCCATGGACGCAACCCAACGCGTGCTGTTGGAGGAATGTTACCGAGCCCTGGAAGACGCGGGTTATAACCCTTCGTCATTAAAGCAACAAGCAGTGGGCACCTATATTGGTGCGATGGGAAGCGCTTCTCTACGTAAGGGGTTTTCGCATCTTGACATGTTGGGTTCGGAAACGAGTATCCTCTCTGCTCGCACGGCCTATTTCCTGGACTTAACAGGCCCTGCACTGACGATCAATACGGCCTGTTCTTCATCCCTGGTTGCCATTGAGGTGGCCAGTCAGGCGTTAAAGAGTGGCGAGATTAATCTGGCGATTGCCGGTGGGGTGACGCTCTATCAGCATCCCGGCACTTTTATTGCGATGCACAATGCGAGCATGCTCTCTCCAACCGGCCAGTGCCGGCCCTTTGATGACGATGCCGATGGCATCGTTGTCGGAGACGGGGTTGGCGTCGTTATTTTAAAGCGTTTGCGTGAAGCGGAGCGCGATGGCGATTCCATTTATGGCATTATCCGCGGCTGTGGCATGAATCAGGACGGCCAAACCGCCAGCATGACCGTCCCCAGCTTCCTGGCGCAAAGTGAGCTAGAGAGCGCCGTCTATCAAAAAGCGAATATTGATATTGAAGACCTTCAATACATTGAAGCTCATGGAACGGCTACCAAACTAGGCGACCCGATTGAAATTCATGCGTTGAATAAAAGCTTTCAGGCGTTGACCTCAAAACAGAAATTCTGCGCTATCGGTTCGTTAAAAGCGAATGTGGGCCATACGACCGCCGCTGCTGGAGTATTAGGTGTCATTAAAGTCTTACTTGGTATGAAGTATCAACAACTGCCACCGTCCATCCACTTTAACGAGGGTAACAGGCATATTGATTTTGACAACAGTCCTGTCTACGTTAACACCACCTTGAAACCTTGGCCAAAAAATGCAAAGGACTCCCGACTGGCCGCTATTAGTTCATTTGGTTTTAGTGGAACTAATGCACACTTGGTTCTGGAACAGTATATGCCTCTGCCGGACACGGATAGCGGCGTATTTATACCTCTAGTACTGCTACTTTCAGCAGAAAGCGATGACGCATTACAGCACTATGCTCACAATGTAAAATGTTATCTCGAAGATCATCCGGCTATTCAATATGGGCATTTTCTATATACGTTTCAAGTTGGACGGGATGCCTTCGCCTATCGTTTAGCCATCATCGCTGAGAATCAGCAGGAGTTGATACAAAAGCTGGAGCAATGGCTTACAACTGGAGGCCCGGTAACAGACATTCACAACAAGCCAGATATTGGAAACCGTGAAGAAGAAAAAGCATCTCTTCAAAGCCTGATATCCGGTCGGAAAGTGGAGCCGCTTGCTCAATTATGGGAGCAGGGCGCCTCGGTGGATTGGCATGCGTTTTATCCGGACGGACGATGCCGTCGGTTGGCTGGTTTGCCTACTTACCCTTTTGCTCGTGAGTATTTTGGTGCTCCTCAGGATGAAGAATGCCAATATGGTGAAGCGAAACAAGCGCCCAGCGAAGATTGTGAAGGAACGATAGCACGATCTTCAACGGAAACCCTAATTGCCTGTCCCTATTGGAAAGAAAAGTCCGTTGCAGGCGCTACTGAATCGTTTGCATATTCCCGGCATCTGGTGTTGTTATGCGGTATGGAACATATCTCGGCGGCGAAGCTACAGGCACAAATACCGGGTGTGGAATGTGTGCATTTATCCTCTGTTAACCGTTTTCATCGCAGTACACATGTAGAAACCATTTATCAGGATGAGTTTACCCAGGTTTTTGAAATGATTCAGGACGTTCTGGCCAGTAAAACCAGAGGCAACATATTGATTCAATGTGTGGTTCCCCAGCAGCCGAACCAACCATGCCTGTCGGCTATTTCCGGCATGCTCAAAACAGCACAGCTGGAAAACCCTAAAGTATCAGGGCAGCTGATTGAGGTGCTTGCCGACGAGACGGAAGTGAGTTTGCTGAGCAAAATTCATGAAAATGGCCGATGCCCTGAGGACAAACAGATTCGGTATGACCAGGGGCAGCGTGTTGTGCAGGCATGGCAAGAACTTGTCGTTTCCGATCGCGCTTGCAAAACCCCTTGGCGAGAAGGAGGCGTATATCTCATTACGGGTGGTGCCGGTGGTTTGGGTCTGATGGTTGCCGAAGAAATCGCCAGTCAAACCCAGCGTTCTACGCTGATCTTAAGTGGCCGATCAAGCTTAAGTCCGGAAGAGGTCGCATCATTTTCGTATGGACTACAAGCACTCGGCACGAGGGTCGAATACCAGCCGGCTGATATCAGCAATCCATACGATGTTGACACGCTCATCCAGCGTATTTCAAAAGCGTACGGCTCGCTGCACGGTATCCTGCATTGTGCGGGTATTGTGCGGGATAATTTCGTGATCAACAAAACATCGGCTGAGTTTCAGGCGGTGTTGGCCCCGAAAGTGGCGGGTGTCGTTTATGTAGACGCGGCCAGCAAAGATTTGAATCTCGATTTCTTTGTGCTGTTTTCTTCAATCGCAGGCGCAATGGGCAATGCGGGCCAGGCTGATTATGCGACCGCCAATGCCTTTATGGATGCATTTGCAACCTATCGTAATGATCTGGTCCGCATCGGGCAACGACATGGACAAACCCTGTCGATTAACTGGCCGCTTTGGCGAGCAGGCGGTATGCAAGTGACAGCTCACCAAGAGGCCGCTATGAGGCAGAGCGTGGGCCTGGAAATGCTCGATACGGCGCGAGGGATGCAAGCCTTGGTCAAGGGGCTGGCCTCGGGGCAGAGTCAGATCTTGGTGGCTGCGGGCCATCTTCCCACGCTGAGAGGGTGGTTGTTCCAGGAACCATTAGCGCCGAGTACATCAGACCAGCCACTGGCCAATGTCCATCGAGTTGGCCGCCAACCCTCACTGGCATCCGTGGACAAACAGAGACTTTATGAAGAAACCTTGGTTCAGCTTAAAGGGCTGTTAGGCACTGTTTTCCGTTTGTCGCCAAATCGCATTAAAATGCATGACGCGTTTGAGCGCTACGGTATCGACTCCGTGATGATCGTGCAATTAAATCAGGAAATGGAAGCGGTTTTTCCGGAACTCTCAAAGACCGTGTTTTTCGAATACCAAACATCGCATGAGCTGGTTGCCTACCTGCTTGATGAGTATCCGCAGGAATGTATGGTATGGACTGGGCTTGGGGCTGAATCTGACATTGATCATGGAAATGGAGAGTCTTCTTGGCCCGAACGTGCATGGCGCCCTAAACACAGTTTAGCGACGTCTGTAGATCGTGACTTGGCGCAAGCGCAAAACCCGCAGATTCAGGAAGCAATTGCGATTATTGGCGTTAGCGCTCGCTTTGCCCAGGCTGAAACCCTGCAAGCATATTGGCAAAATCTGCAAGCCGGCAAAGACTGCATTGGCGAAATTCCTACCAATCGGTGGTCATTGGACGGCTTTTTTGTTGACGACATCGACGAAGCCATCGCCCAGCGGAAAAGTTATAGCAAATGGGGTAGTTTTCTGGAGAGCTTTGCGGATTTCGACCCTCTGTTTTTTGGCATTCCCCCGCGCGATGTCTTAAGTATTGATCCGCATGAACGCTTGTTTCTCCAATCCTCGTGGGAGGCGCTCGAAGACGCTGGCTATACCCGCGACACATTGCGTGAGAGATATCAACAGCAGGTCGGTGTGTTCGCAGGCGTCACCAAAACCGGTTTTGACTTGTATGGCCCTGAGTTATGGAAACGCGGTGAACAGGCCTTTCCGCACACTTCTTTCAGCTCCGTTGCCAATCGGACATCGTATTTTTTGAATCTGCAAGGCCCGAGTATGCCAATTGATACGATGTGCTCATCGGCTCTAACCGCCGTGCACGAAGCGTGCGAACATTTACGCCGAAGAGATTGCCGACTCGCCTTGGCGGGCGGTGTCAACTTATACCTGCACCCTTCCAATTATGTTCAGATGTGCGCGCTACGTATGTTATCGAAAGACGGTCAGTGTAAAGCTTTTGGCCAAGGTGGCAATGGTTTTGTGCCCGGTGAGGGCGCGGGCGTGGTCTTGCTGAAACCCCTGTCCGAGGCCATTCGAGAGGGCGACAATATCTACGCCGTGATTCGCGCAAGCCATGTGAATCACGGCGGAAAAACCAATAGCTACACCGTACCCAACCCCGGTGCACAAGCGGATTTGATTCGTCAAACACTTGACAAAGCAGGGATTGAGGCGCGCAGCATCAGCTATATAGAAGCCCACGGCACGGGAACGGCATTGGGAGATCCAATCGAAATTACCGGTCTGACTCAGGCCTTTAAAACAGATACTGATGATACTGGCTTTTGTGCGATCGGTTCTGCAAAATCCAATCTAGGGCACTTGGAAGCGGCATCAGGTATGGCGGGGCTGTTCAAGGTTCTTCTGCAACTGAAGCACCGCCAGCTTGTTCCGAGTTTACATGCAGGAAGTTTAAACCCTAATATCGCTTTTGAAAAAACCCCCTTTGTGGTGCAGCAGGCCCTTTCAGAGTGGAAAAGACCCATCGTGGAAAGCAGCGGTGAGGTCAAGGAATACCCCAGGAGAGCGGGCATCTCCTCATTTGGTGCCGGGGGTTCGAATGCACATTTGATTGTTGAAGAGTATGAAGCAAATGACGAACCGTATGCCGAGAAAGCGGTTGATGAGTCCGTGATGATTGTATTGTCGGCCAAAAATACGGATCAGCTCATTCAACTGGCTCGTAACTTAAGGCGTTTTATTGCCGAGACCGAAACCAAGCCGCCCCGTCTGGAAGATATCGCATACACGCTTCAGACCGGGCGCGAGGCAATGGAGGAGCGTCTAGCGCTTATTGTTGGGAGTCTAGAGGAGCTTGAAGAAAAGCTGCACGCCTTTGTTGAGGGACAGGAGCCTATTGCGTCGCTTTATCGTGGGGACCTCAAACAGGACTTGAACTTACTGTCGGATTTTGCCACGGAGGAAGAGCTTTCGAATACCATTGATGACTGGATGATGTCGAAACAAATAAATAAGCTACTCAGTCTGTGGGTTAAAGGTCTCACCATTAATTGGCAGAAATTTTATATTTATATTTATCATAAGCCCAGATCGAGACGTATTAGTCTTCCTACCTATCCCTTTGCCAAAGAATTCTATTGGTTTGAGCCGCAGGCTTTTAATCATGGTATCTCGACTCACTCGCAAAAGCCAGCTGAAAATCAGACTTCCTCGCGAAGCATTCAGTATCTGCAAAAGCAGTGGCTGCTGGATGAGTCCGAACCTGATGAGTCCTATGCTAAACAAGTGGTGGCGCGAAAAATTGCGATTCTAAGCGGTCCGCAAACCCGGTTGCTTGCGTCCCTGTTGGAAGAGGAATTCCCAAACAGCCAAATTATTGAACACGATAACATCAAGGAACACTTGGAACAGAGCCATGCAGATTGGCAGACGCATGGCGGATGCATCGATCTGGCGGGTTGTAGTCGTGACGAAGAAGCCGGAGATGCGCTTGACTGGATGCTGTGGCTCCAGCGCCTGATCGAAAATGGCTCAAAAACCGGTCTCACCCTGCTTGGCGTCACCCGAGGCTTAGAGTTCTTTCAGAACAGCGAGGTGAACCTATCGGGTGCCTCTCGTGTCGGGCTTTATCGCATGCTTCAGAGCGAGTATGCCCATATTCAATCTCGTCATATCGATACCGATCCCAGCCTTAAGACATCAGCGTTGGCCGAGCAGATTGCTCGCGAGTTTGTGTTGAACGATGAGAACTGTGAAATTTGTTACCGCGATCACAAGCGCTACCGTGCATATTTGGCAGCGTCTTCGCTAAAAGCGGCAAAGATATCAGACACAGACCTTCAGTTTGCTCAAGAAGATGTTCTCCTGATTACCGGAGGAACGGGTGGGCTGGGGCTTTTGTGTGCTCAGCATTTTGTAGAGCATTACGGGGTGAAGCGCTTGGTGCTTACCGGGCGGGAAGCGTTGCCATCGCGTGAGCAATGGGCTGATCCGCAAAGTGATAAGGTCAAGCAAAAGATAGACGTCATTCAGTCCTTGGAGCGTCAAGGCGTTAAGGTACAAGTATTGCCGATGGTGTTAAGTGATCATGATGCGGTGCGAGAAACTCTGGGTCAAGTTACAAAGAACTTTGGACCTATTCGTGGTTTGCTTCATTGTTCTGGAGCTGTCGATTCAGAAACGCCTGCCTTTGTTCGTAAGCCGATAGCAAAGGTGTCGCAGGTTTTAGAGCCTAAAGTGTCGGGACTTCAAACGCTGTTGGCGCAATGCAGACCACAGTCATTAAAATTCGCGGTCTTGTTTTCCTCTGTGGCTGCCACGATTCCCCGTCTGGCCAGCGGCCTGAGTGACTATGCTATGGCTAACGCGTATATGGATTATGTGGCCCAAGCCACGGGCGGTAAGTTGGTGAGTATTCAATGGCCAAGCTGGCAGGAGACCGGGATGGGCGCCGCGAACAGCAGGGCGTATCATGAAACGGGTTTGCTTCGTCACAACAATCAAGAAGGTCTCCGGCTCTTAGATGATATCCTTTCTCAACAAACCGAACCTGTGATACTGCCTGCTGTTGTCGATTCTGCGTTGTGGGCGCCGCAACAATTGATGAAGCATCAGAGCAGGCGAGAGAGCATTTCACCCGTCTTGCATCACCACCCTCAGACGCCAATGCATATTGAGCCCGCTACACCGAACATGGCATCAAGCCAGTTGACTCTGAACGATTTAGTTGCCTTATTTTCTCAGGAACTTGGCATTCCTACACAAAATCTGGCGCTGGACAAATCATTTGCGGATTATGGCCTGGATTCGATATGGCTGGCTCAGCTCGCAAGCAAAATCAATCAACAGCTTGTTGAGCCACTGGACCCTTCTATCTTGTACGAGTATTCTTCGTTAAATGCACTGGCGTCTTGGCTGGCTAGCGAACAGGCGCCAGCTCTTAAATCACAGGCCCATGATAGAGACGTTGAGCAGAAGATCGATCCGAAAAATGCCGCGGATAGCGTTGTACCCCGCTCTTCAAAAAAGCAGGCGTTGGATATCGCTGTGGTTGGCATGTCCTGCCGTTTTCCGGATGCCAATAATCTAGACGAGTATTGGTCTTTATTATCGGAAGGCAAGCAAGCTATCCGCCCTGTTCCAGCGGACCGCTGGTCGAGACCAACGCCGTTTTATGCAGGCTTGATCGAAAATAGCAGCCATTTTGATCCCGCCTTTTTCCTGATTCCACCAGAGGACGCGAAGGTGCTGGATCCTCAGGCGCTATTGCTGTTGGAAGAATGCCTGAACTTGTTTTATCACGCGGGTTACACCCTAGACGAGATGAAAGGCAGGGCCATCGGGGTCTATTTAGGTGGGCGCAGTCAGCATCGCATTGATGAAGCCGATCTTGGTCAAGCTCGAAATCCGATCGTGGCCGCGCAGAATTATCTGGCCACACATCTCTCACAGTTTTTTGATCTGAATGGTCCAAGTCTGGTCATTGACACAGCCTGTTCCTCGGCTCTGGTGGGGATGAATTTTGCCGTTCAGTCCCTGCTCAGTGGCGAGATTGACTCGGCGGTCGTTGGAGGCGTCAGTCTCCTGGCCGACGAAGATGCCCATCGTATCTTTCAGCAGCGCGATCTGTTGAACCGGGACGCCTCGTTTCATATCTTTGATCAGCGGGCCTCCGGCATCACGTTGGGCGAAGGGGCGGGTTTGGTGTTTTTAAAAACCCTGCCGCAGGCGCAACGCGATGGCGATCAGATTTACGCCGTCATTAAGGGACTGGTCATCAATAACGACGGTCGCACGGCCGGTCCGGCGACACCGAATTTTGAGGCGCTCAAATCTGTTATGCAGCGCGCCTTGAAGCAAAGTTGTCAACAGCCGCAAGATATTGTTCATATTGAAGCTAACGGCTCAGGCTCCGAGGTGACCGATCTACTCGAGCTTAAAGCGATGGAAGCGGTTTATCGTAGCGACAATAAGGCACCTTGCAGCTTAGGATCAATTAAGCCCAATATGGGGCATCCGTTATGTGCCGAAGGTATTGCTAGTTTTATAAAACTGGTGTGTATGTTGAAATATCAGCAGCAAGTACCTTTTTTATCTGGTCAAGTGCCATTAACACATTATGATTTAGACGCTTCGCCCTTTTATTTCTGTCGTCAGTCAACAAAATGGACAGAACACTCCCCCCTTCTGGTGGCGCTCAACTGTTTTGCGGATGGTGGGACCAATGCACATGTGATTATGGAAGCCTGGACGCAGGCAGAATCTCACCAGCAACGGCAGCCCATACCACCACCCGCGCTAAACCGAGTGAATATCCGCGGTGCAGTCAGCCAGCATCCCTGGTGGTGA", "orf_prot_sequence": "MSASEHAGSTIQYGRHLVILCEPDGITQESIASRMAAVDCLVYQSRSENIAERFQDYALRLFTEIQQLLTARAEAKILLQFVIRDLLEQQLFAGLAGLLKTAHLENPNLMGQLLCVAPGDDAEHLVATLKVNAQTPLDQRVAYRNGKRRIAAWKEVPIANDEDVSIPWKENGTYLITGGLGGLGLLFTKEIAQQIRSGTVMLTGRSPLDESKRQMLQTLQQFCGQSRVHLEYRQVDVCEPQGVASLIQEINHHVGPLDGVIHAAGVIHDNFIIKKTPQELENVLAPKVKGLVNLDEATKDQPLDFFFFCSSLAGGIGNVGQADYACANAFMDCYARYRNQLLQSHQRQGRTLSINWPLWQEGGMRVDAASENMMAQSIGLLAMPTSAGMRALYKAIASQQDQVMVVEGDLAKLRQTFLSLPEKTAQPEIGDVEAALDTGQLQHKTLEKLKSLFAEMTKLPLERVNEEEPLDSYGIDSVMIAQLNQKLTAELGPVSKTLLYEFHTLEELAHHLVKAYFDRCVNWTQLNSTLNFSEVSVETRNHKSEKGRYSNEYDMQMPDDTAQQPIAIIGLSGRYPKAKTIAEFWQNLKHGEACISEIPRQRWDWKRYYHADPNEAVKSGKSYSKWGGFLEDFDQFDPMFFNMTPREAENIDPQERIFLQESWKALEDAGYSPSNLSADLRQRIGVFAGITKQGFNLYRMESGPDRQLACPATSFASLVNRVSYVLNLQGPSFPVDTMCSSSFVAIHEACAYIRSGQGDMAVVGGVNLYAHPSSYLELSLGRFVSNGSTCAAFEKDADGFVPGEGVGVVILKAYDQALKDRDSIYALIRGSAVNHDGKTNGYKTPNPGPKAAVIRQALQQSGIDARSISYIEAAAQGSDVGDAIEASALTDVFSGRNHVEGAYRIGSVKPNIGHSESASGMSQLTKVILSLNHQTLPPTLRSRALSPSIDFDQLPFELQQELSEWQPVRVDGIEVPRRAGMMNIGAGGVNAHIIVEEPPPHEEPVHDGHGPVLFVLSAKNEERLERYVQDWLIYITNGPILDLPSIAYTLQVGRESMACRLAFVVNQSEELATYLTRWLKTRELGDVGFYGDVTQERVKNSEAVSTLVKAGDASHARELAALWVQGNAIAWDKWHRGTTLGRRSGLPTYPFANRTCWIARDDHDCSEDDRGEEKSDVEPRIDHTLDENKAVEFYTRMTQDCDEAFQEEYLTFGAFPRRIPGFSMTRVAMNAERYPEELEMIKESQRELRQVLFCREDFDRVHTFLDIGCGHGTDVIQVAALYPHIQTHGFTITESQAILGNRRIEHMNLGSRARIYHKDSSKEPFPDNCDMILGIEVTFHIRDKDALLQKMADALSDDGKILLMDYIANLRGSIVDPNVEISIPTQSQWIDLLSQHDLIIDEIIDVSTEVSNYLYDPEHAEHTKHLPKVSQDSYRNYANQAIALEKGWITYCLLKLQRDTQRSEQERREYNAWKIANQTPYAQALEDMLRVGRMPYPLSGGLKMAVQPMDGQPPSTLDESVPDLGQIQTALAGIFVAILGFETRELDFIDQLPLTELGISSVNAVELLEAINTEFDLHLPTSLVFECHRLEDLAGHIQVELGRKPIAPAMSNASVAVQAEAESRQKTTVPVEEKAPIANEETAIIGLSCRCAGAKDQEQFWQVVSQGKDCIEDLKEPQWLDYIAEHGSETFPIRYGVMPERDDFDPLFFHISPREAEAMDATQRVLLEECYRALEDAGYNPSSLKQQAVGTYIGAMGSASLRKGFSHLDMLGSETSILSARTAYFLDLTGPALTINTACSSSLVAIEVASQALKSGEINLAIAGGVTLYQHPGTFIAMHNASMLSPTGQCRPFDDDADGIVVGDGVGVVILKRLREAERDGDSIYGIIRGCGMNQDGQTASMTVPSFLAQSELESAVYQKANIDIEDLQYIEAHGTATKLGDPIEIHALNKSFQALTSKQKFCAIGSLKANVGHTTAAAGVLGVIKVLLGMKYQQLPPSIHFNEGNRHIDFDNSPVYVNTTLKPWPKNAKDSRLAAISSFGFSGTNAHLVLEQYMPLPDTDSGVFIPLVLLLSAESDDALQHYAHNVKCYLEDHPAIQYGHFLYTFQVGRDAFAYRLAIIAENQQELIQKLEQWLTTGGPVTDIHNKPDIGNREEEKASLQSLISGRKVEPLAQLWEQGASVDWHAFYPDGRCRRLAGLPTYPFAREYFGAPQDEECQYGEAKQAPSEDCEGTIARSSTETLIACPYWKEKSVAGATESFAYSRHLVLLCGMEHISAAKLQAQIPGVECVHLSSVNRFHRSTHVETIYQDEFTQVFEMIQDVLASKTRGNILIQCVVPQQPNQPCLSAISGMLKTAQLENPKVSGQLIEVLADETEVSLLSKIHENGRCPEDKQIRYDQGQRVVQAWQELVVSDRACKTPWREGGVYLITGGAGGLGLMVAEEIASQTQRSTLILSGRSSLSPEEVASFSYGLQALGTRVEYQPADISNPYDVDTLIQRISKAYGSLHGILHCAGIVRDNFVINKTSAEFQAVLAPKVAGVVYVDAASKDLNLDFFVLFSSIAGAMGNAGQADYATANAFMDAFATYRNDLVRIGQRHGQTLSINWPLWRAGGMQVTAHQEAAMRQSVGLEMLDTARGMQALVKGLASGQSQILVAAGHLPTLRGWLFQEPLAPSTSDQPLANVHRVGRQPSLASVDKQRLYEETLVQLKGLLGTVFRLSPNRIKMHDAFERYGIDSVMIVQLNQEMEAVFPELSKTVFFEYQTSHELVAYLLDEYPQECMVWTGLGAESDIDHGNGESSWPERAWRPKHSLATSVDRDLAQAQNPQIQEAIAIIGVSARFAQAETLQAYWQNLQAGKDCIGEIPTNRWSLDGFFVDDIDEAIAQRKSYSKWGSFLESFADFDPLFFGIPPRDVLSIDPHERLFLQSSWEALEDAGYTRDTLRERYQQQVGVFAGVTKTGFDLYGPELWKRGEQAFPHTSFSSVANRTSYFLNLQGPSMPIDTMCSSALTAVHEACEHLRRRDCRLALAGGVNLYLHPSNYVQMCALRMLSKDGQCKAFGQGGNGFVPGEGAGVVLLKPLSEAIREGDNIYAVIRASHVNHGGKTNSYTVPNPGAQADLIRQTLDKAGIEARSISYIEAHGTGTALGDPIEITGLTQAFKTDTDDTGFCAIGSAKSNLGHLEAASGMAGLFKVLLQLKHRQLVPSLHAGSLNPNIAFEKTPFVVQQALSEWKRPIVESSGEVKEYPRRAGISSFGAGGSNAHLIVEEYEANDEPYAEKAVDESVMIVLSAKNTDQLIQLARNLRRFIAETETKPPRLEDIAYTLQTGREAMEERLALIVGSLEELEEKLHAFVEGQEPIASLYRGDLKQDLNLLSDFATEEELSNTIDDWMMSKQINKLLSLWVKGLTINWQKFYIYIYHKPRSRRISLPTYPFAKEFYWFEPQAFNHGISTHSQKPAENQTSSRSIQYLQKQWLLDESEPDESYAKQVVARKIAILSGPQTRLLASLLEEEFPNSQIIEHDNIKEHLEQSHADWQTHGGCIDLAGCSRDEEAGDALDWMLWLQRLIENGSKTGLTLLGVTRGLEFFQNSEVNLSGASRVGLYRMLQSEYAHIQSRHIDTDPSLKTSALAEQIAREFVLNDENCEICYRDHKRYRAYLAASSLKAAKISDTDLQFAQEDVLLITGGTGGLGLLCAQHFVEHYGVKRLVLTGREALPSREQWADPQSDKVKQKIDVIQSLERQGVKVQVLPMVLSDHDAVRETLGQVTKNFGPIRGLLHCSGAVDSETPAFVRKPIAKVSQVLEPKVSGLQTLLAQCRPQSLKFAVLFSSVAATIPRLASGLSDYAMANAYMDYVAQATGGKLVSIQWPSWQETGMGAANSRAYHETGLLRHNNQEGLRLLDDILSQQTEPVILPAVVDSALWAPQQLMKHQSRRESISPVLHHHPQTPMHIEPATPNMASSQLTLNDLVALFSQELGIPTQNLALDKSFADYGLDSIWLAQLASKINQQLVEPLDPSILYEYSSLNALASWLASEQAPALKSQAHDRDVEQKIDPKNAADSVVPRSSKKQALDIAVVGMSCRFPDANNLDEYWSLLSEGKQAIRPVPADRWSRPTPFYAGLIENSSHFDPAFFLIPPEDAKVLDPQALLLLEECLNLFYHAGYTLDEMKGRAIGVYLGGRSQHRIDEADLGQARNPIVAAQNYLATHLSQFFDLNGPSLVIDTACSSALVGMNFAVQSLLSGEIDSAVVGGVSLLADEDAHRIFQQRDLLNRDASFHIFDQRASGITLGEGAGLVFLKTLPQAQRDGDQIYAVIKGLVINNDGRTAGPATPNFEALKSVMQRALKQSCQQPQDIVHIEANGSGSEVTDLLELKAMEAVYRSDNKAPCSLGSIKPNMGHPLCAEGIASFIKLVCMLKYQQQVPFLSGQVPLTHYDLDASPFYFCRQSTKWTEHSPLLVALNCFADGGTNAHVIMEAWTQAESHQQRQPIPPPALNRVNIRGAVSQHPWW", "perc_identity": 28.0}, "gnl|BL_ORD_ID|1968|hsp_num:0": {"type_match": "Loose", "snp": {"original": "F", "change": "L", "position": 413}, "query_snp": {"original": "F", "change": "L", "position": 238}, "orf_strand": "+", "orf_start": 60103, "orf_end": 73629, "orf_from": "BGC0001186.1|Misakinolide_17 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.72975e-16, "bit_score": 82.4185, "max_identities": 69, "cvterm_id": "39507", "query": "LTINTACSSSLVAIEVASQALKSGEINLAIAGGVTLYQHPGTFIAMHNASML--------SPTGQCRPFDDDADGIVVGDGVGVVILKRLREAERDGDSIYGIIRGCGMNQDGQTASMTVPSFLAQSELESAVYQKANIDIEDLQYIEAHGTATKLGDPIEIHALNKSFQALTSKQKFCAIGSLKANVGHTTAAAGVLGVIKVLLGMKYQQLPPSIHFNEGNRHIDFD---NSPVYVNTTLKPWPKNAKDSRLAAISSFGFSGTNAHLVLEQY", "match": "+T  +ACSS   AI  A + +  G+ ++A+ GGV   + P   + +   SM+         P    RPFD D DG V G+   +++++    A+  G      + G G+  D           +      +   + A +   D+ ++ AHGTAT +GD  E +A+        +     A+ + K+ +GH+  A G L  +  +L ++   +PP++++   +  ID D     P Y             D R A  +SFGF G N  L   +Y", "sequence_from_db": "MTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGV---EGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIR------VAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRY------------GDYRYAVNNSFGFGGHNVALAFGRY", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 65479, "query_end": 66264, "hit_start": 492, "hit_end": 1248, "orf_dna_sequence": "GTGAGTGCGTCCGAACATGCAGGCTCAACCATCCAGTACGGCCGACATTTGGTGATTCTCTGCGAGCCCGATGGAATAACGCAGGAAAGTATTGCCAGCAGGATGGCGGCGGTGGATTGTCTCGTTTATCAATCACGATCGGAAAATATTGCTGAACGTTTCCAGGACTATGCGTTGCGACTATTTACAGAAATTCAACAGCTCCTCACAGCGAGAGCGGAGGCTAAAATCCTGCTTCAATTCGTCATTCGTGATTTGCTGGAGCAGCAACTTTTTGCTGGTTTGGCTGGCTTGTTGAAGACCGCTCACCTGGAAAACCCAAATCTGATGGGCCAGCTTCTCTGCGTCGCTCCGGGTGATGATGCGGAACATCTTGTGGCAACACTCAAGGTGAATGCGCAAACACCCTTAGACCAACGTGTTGCCTATCGCAACGGAAAGCGCCGAATTGCCGCATGGAAAGAAGTACCGATTGCTAATGATGAGGATGTGAGCATTCCCTGGAAGGAAAACGGTACGTATCTGATTACCGGTGGTCTAGGGGGGTTGGGTCTGCTGTTCACTAAGGAAATTGCCCAACAGATCCGCTCCGGAACGGTCATGCTGACTGGCCGCTCACCACTCGATGAGTCAAAACGGCAGATGTTGCAAACCTTGCAGCAATTCTGCGGGCAGAGCCGCGTACACCTTGAATATCGTCAGGTCGACGTTTGCGAGCCGCAAGGTGTTGCGAGTTTAATTCAGGAGATAAATCACCATGTTGGTCCTCTCGACGGCGTGATTCACGCTGCGGGTGTGATTCACGATAACTTCATTATTAAAAAGACGCCGCAAGAGTTGGAAAATGTGCTTGCGCCTAAAGTCAAGGGCTTGGTGAATCTTGATGAGGCCACGAAAGACCAGCCGTTGGACTTTTTCTTTTTCTGTTCCTCACTAGCGGGCGGTATCGGTAATGTCGGGCAGGCGGATTACGCTTGTGCCAATGCCTTCATGGATTGCTATGCGCGATATCGTAACCAACTCTTGCAATCGCATCAGCGTCAGGGACGCACGTTGTCGATCAACTGGCCCTTATGGCAAGAGGGTGGCATGCGGGTTGATGCAGCGAGCGAGAACATGATGGCGCAAAGTATCGGCTTGCTTGCCATGCCGACCTCTGCCGGCATGCGGGCCTTGTACAAAGCCATTGCCAGTCAGCAGGATCAGGTGATGGTGGTAGAGGGTGATCTTGCCAAACTTAGACAAACTTTTTTGAGCTTGCCGGAAAAAACAGCTCAACCTGAAATAGGTGATGTTGAGGCCGCGCTGGATACGGGGCAACTGCAACACAAAACGCTTGAAAAATTAAAGTCGTTATTTGCCGAAATGACGAAGTTGCCTCTAGAGAGGGTTAACGAAGAAGAGCCACTGGATAGTTATGGTATTGATTCTGTCATGATTGCTCAGTTGAATCAAAAATTGACTGCAGAGCTCGGCCCTGTATCCAAAACACTATTATATGAATTTCATACGCTAGAAGAGTTGGCACATCATTTAGTTAAGGCTTATTTTGATCGTTGCGTTAACTGGACTCAACTCAATAGCACACTCAATTTTTCTGAAGTAAGCGTTGAGACTCGCAATCATAAATCTGAAAAAGGCAGGTATTCAAACGAATACGATATGCAAATGCCGGATGATACCGCCCAACAACCCATTGCCATTATTGGGCTGAGTGGCCGTTATCCCAAAGCGAAAACGATAGCTGAATTTTGGCAGAATCTGAAACACGGAGAAGCATGCATCAGTGAAATTCCGCGCCAACGCTGGGATTGGAAGCGTTATTATCATGCCGATCCCAACGAGGCGGTTAAATCGGGCAAGAGCTATAGCAAATGGGGTGGGTTTTTAGAGGATTTTGATCAGTTTGATCCCATGTTTTTCAACATGACCCCGCGCGAGGCGGAAAATATTGATCCGCAGGAACGCATCTTCCTACAAGAAAGTTGGAAGGCGCTGGAAGACGCCGGCTACTCTCCCTCCAATCTGTCGGCTGATTTGCGCCAGAGAATTGGCGTTTTCGCGGGTATCACCAAACAAGGCTTTAATTTATACCGCATGGAATCCGGGCCGGATCGTCAACTCGCGTGCCCTGCCACATCATTTGCCTCTTTGGTGAACCGAGTTTCGTATGTTCTCAATCTCCAAGGCCCCAGTTTTCCGGTCGATACGATGTGCTCTTCTTCCTTCGTCGCAATACACGAGGCATGTGCGTATATTCGCTCTGGCCAAGGGGACATGGCCGTCGTTGGGGGCGTCAACTTATATGCCCACCCCTCGTCTTATCTGGAGCTATCGTTGGGGCGATTTGTCTCGAATGGCTCGACGTGCGCTGCGTTTGAAAAAGATGCCGATGGCTTTGTTCCCGGAGAAGGGGTTGGCGTTGTCATCCTCAAAGCTTATGACCAGGCGCTAAAGGATCGCGATAGCATTTACGCCCTGATTCGGGGGAGCGCGGTCAATCACGATGGCAAGACAAATGGCTATAAAACCCCGAACCCTGGACCAAAAGCGGCCGTGATTCGTCAGGCCTTGCAACAAAGTGGCATTGATGCGCGAAGCATCAGCTACATCGAAGCCGCGGCTCAAGGTTCGGATGTGGGCGATGCCATCGAAGCCAGTGCATTGACCGATGTATTCAGCGGCCGCAACCATGTTGAGGGGGCCTATCGCATTGGCTCAGTGAAACCCAATATTGGCCACAGCGAATCGGCGTCGGGCATGTCCCAGCTCACCAAAGTGATTTTATCGTTAAACCATCAAACGCTACCACCCACGTTGCGTTCGAGAGCGCTCAGCCCCTCTATTGATTTTGATCAACTGCCTTTTGAGTTGCAGCAAGAGCTCAGCGAGTGGCAACCGGTTCGTGTCGATGGCATTGAGGTGCCACGAAGAGCTGGGATGATGAATATTGGCGCTGGCGGAGTAAATGCTCACATCATTGTCGAAGAGCCTCCGCCTCATGAAGAGCCGGTTCATGACGGGCATGGGCCTGTGCTGTTTGTTTTATCAGCAAAAAATGAAGAGCGCCTGGAGCGCTACGTACAAGACTGGCTGATCTATATCACCAATGGTCCAATTCTCGATTTACCATCGATCGCTTACACCTTGCAGGTCGGACGGGAAAGCATGGCCTGCCGCCTGGCCTTTGTGGTGAACCAATCAGAGGAGCTTGCGACGTATCTGACGCGTTGGCTTAAAACGCGTGAACTGGGCGACGTTGGCTTTTATGGGGATGTGACGCAGGAAAGAGTTAAGAACTCAGAGGCGGTGAGTACGCTCGTAAAAGCAGGGGATGCCAGTCATGCTCGTGAGCTGGCTGCACTGTGGGTGCAAGGCAATGCCATCGCATGGGACAAATGGCATCGCGGCACAACCTTGGGCAGACGCAGTGGCTTGCCGACTTATCCCTTTGCGAACAGGACTTGTTGGATCGCTCGCGATGACCATGATTGTTCAGAGGATGATCGCGGCGAGGAAAAGAGCGATGTCGAGCCGCGTATCGATCACACTCTGGATGAAAATAAGGCGGTTGAATTTTACACCCGAATGACACAAGACTGTGACGAGGCGTTTCAGGAAGAGTATTTGACGTTTGGCGCTTTCCCCAGAAGAATTCCTGGCTTCTCGATGACCCGTGTCGCAATGAATGCGGAGAGGTATCCGGAAGAACTGGAAATGATTAAGGAAAGCCAGCGGGAGTTGCGCCAGGTTCTGTTTTGTCGCGAAGATTTTGATCGTGTTCACACGTTCCTCGATATTGGTTGCGGTCACGGCACGGATGTGATTCAGGTGGCCGCGCTCTATCCGCATATACAAACCCATGGTTTTACCATTACCGAGTCACAAGCAATCTTGGGCAATCGACGTATTGAGCATATGAATTTGGGCTCTCGTGCGCGAATTTATCATAAAGATAGTTCAAAAGAACCATTCCCAGACAACTGTGATATGATTCTGGGTATCGAGGTTACCTTCCACATTCGCGACAAAGATGCCTTGCTTCAGAAGATGGCGGATGCGCTCAGTGATGATGGCAAAATCTTACTTATGGATTATATTGCTAATCTGAGAGGCAGTATTGTCGACCCCAATGTCGAAATTAGTATTCCTACTCAGTCGCAGTGGATTGATCTGTTATCTCAGCACGATCTCATTATTGATGAAATTATCGATGTATCGACCGAAGTTTCGAACTATCTTTATGACCCTGAGCATGCTGAACATACTAAGCACTTGCCAAAAGTAAGCCAGGATAGCTATCGCAACTACGCCAATCAGGCCATCGCTTTAGAAAAAGGTTGGATTACATATTGCTTGTTAAAATTGCAAAGAGACACTCAGCGTAGTGAACAAGAGCGACGCGAGTATAATGCTTGGAAAATTGCCAATCAAACACCATATGCCCAGGCTCTGGAAGACATGCTGCGTGTCGGGCGTATGCCTTATCCGCTGAGCGGGGGGCTCAAAATGGCTGTCCAGCCGATGGACGGTCAGCCACCCTCCACCCTTGATGAAAGCGTGCCTGACTTAGGACAAATCCAGACCGCTCTGGCGGGGATCTTTGTCGCCATTTTAGGTTTTGAAACACGCGAACTCGACTTCATTGATCAGCTACCGCTCACGGAGTTGGGAATTAGCTCCGTGAATGCCGTGGAATTACTGGAAGCCATTAACACCGAATTTGACCTGCATTTGCCCACCAGTCTGGTCTTTGAGTGTCATCGTTTGGAGGATTTAGCTGGCCATATACAGGTTGAACTAGGGCGGAAACCCATCGCACCTGCCATGTCAAATGCGTCAGTAGCCGTGCAAGCTGAGGCTGAATCCAGGCAAAAAACCACTGTGCCGGTAGAAGAAAAAGCGCCGATAGCAAACGAGGAGACTGCCATCATTGGACTCTCCTGCCGTTGTGCCGGCGCTAAAGATCAAGAGCAATTTTGGCAAGTGGTCAGTCAGGGTAAAGATTGTATTGAAGACCTGAAGGAACCTCAGTGGCTCGACTACATTGCCGAGCATGGTTCAGAAACGTTTCCCATTCGCTATGGCGTTATGCCGGAACGGGATGATTTTGACCCGCTGTTTTTTCACATCTCGCCCCGAGAAGCTGAGGCCATGGACGCAACCCAACGCGTGCTGTTGGAGGAATGTTACCGAGCCCTGGAAGACGCGGGTTATAACCCTTCGTCATTAAAGCAACAAGCAGTGGGCACCTATATTGGTGCGATGGGAAGCGCTTCTCTACGTAAGGGGTTTTCGCATCTTGACATGTTGGGTTCGGAAACGAGTATCCTCTCTGCTCGCACGGCCTATTTCCTGGACTTAACAGGCCCTGCACTGACGATCAATACGGCCTGTTCTTCATCCCTGGTTGCCATTGAGGTGGCCAGTCAGGCGTTAAAGAGTGGCGAGATTAATCTGGCGATTGCCGGTGGGGTGACGCTCTATCAGCATCCCGGCACTTTTATTGCGATGCACAATGCGAGCATGCTCTCTCCAACCGGCCAGTGCCGGCCCTTTGATGACGATGCCGATGGCATCGTTGTCGGAGACGGGGTTGGCGTCGTTATTTTAAAGCGTTTGCGTGAAGCGGAGCGCGATGGCGATTCCATTTATGGCATTATCCGCGGCTGTGGCATGAATCAGGACGGCCAAACCGCCAGCATGACCGTCCCCAGCTTCCTGGCGCAAAGTGAGCTAGAGAGCGCCGTCTATCAAAAAGCGAATATTGATATTGAAGACCTTCAATACATTGAAGCTCATGGAACGGCTACCAAACTAGGCGACCCGATTGAAATTCATGCGTTGAATAAAAGCTTTCAGGCGTTGACCTCAAAACAGAAATTCTGCGCTATCGGTTCGTTAAAAGCGAATGTGGGCCATACGACCGCCGCTGCTGGAGTATTAGGTGTCATTAAAGTCTTACTTGGTATGAAGTATCAACAACTGCCACCGTCCATCCACTTTAACGAGGGTAACAGGCATATTGATTTTGACAACAGTCCTGTCTACGTTAACACCACCTTGAAACCTTGGCCAAAAAATGCAAAGGACTCCCGACTGGCCGCTATTAGTTCATTTGGTTTTAGTGGAACTAATGCACACTTGGTTCTGGAACAGTATATGCCTCTGCCGGACACGGATAGCGGCGTATTTATACCTCTAGTACTGCTACTTTCAGCAGAAAGCGATGACGCATTACAGCACTATGCTCACAATGTAAAATGTTATCTCGAAGATCATCCGGCTATTCAATATGGGCATTTTCTATATACGTTTCAAGTTGGACGGGATGCCTTCGCCTATCGTTTAGCCATCATCGCTGAGAATCAGCAGGAGTTGATACAAAAGCTGGAGCAATGGCTTACAACTGGAGGCCCGGTAACAGACATTCACAACAAGCCAGATATTGGAAACCGTGAAGAAGAAAAAGCATCTCTTCAAAGCCTGATATCCGGTCGGAAAGTGGAGCCGCTTGCTCAATTATGGGAGCAGGGCGCCTCGGTGGATTGGCATGCGTTTTATCCGGACGGACGATGCCGTCGGTTGGCTGGTTTGCCTACTTACCCTTTTGCTCGTGAGTATTTTGGTGCTCCTCAGGATGAAGAATGCCAATATGGTGAAGCGAAACAAGCGCCCAGCGAAGATTGTGAAGGAACGATAGCACGATCTTCAACGGAAACCCTAATTGCCTGTCCCTATTGGAAAGAAAAGTCCGTTGCAGGCGCTACTGAATCGTTTGCATATTCCCGGCATCTGGTGTTGTTATGCGGTATGGAACATATCTCGGCGGCGAAGCTACAGGCACAAATACCGGGTGTGGAATGTGTGCATTTATCCTCTGTTAACCGTTTTCATCGCAGTACACATGTAGAAACCATTTATCAGGATGAGTTTACCCAGGTTTTTGAAATGATTCAGGACGTTCTGGCCAGTAAAACCAGAGGCAACATATTGATTCAATGTGTGGTTCCCCAGCAGCCGAACCAACCATGCCTGTCGGCTATTTCCGGCATGCTCAAAACAGCACAGCTGGAAAACCCTAAAGTATCAGGGCAGCTGATTGAGGTGCTTGCCGACGAGACGGAAGTGAGTTTGCTGAGCAAAATTCATGAAAATGGCCGATGCCCTGAGGACAAACAGATTCGGTATGACCAGGGGCAGCGTGTTGTGCAGGCATGGCAAGAACTTGTCGTTTCCGATCGCGCTTGCAAAACCCCTTGGCGAGAAGGAGGCGTATATCTCATTACGGGTGGTGCCGGTGGTTTGGGTCTGATGGTTGCCGAAGAAATCGCCAGTCAAACCCAGCGTTCTACGCTGATCTTAAGTGGCCGATCAAGCTTAAGTCCGGAAGAGGTCGCATCATTTTCGTATGGACTACAAGCACTCGGCACGAGGGTCGAATACCAGCCGGCTGATATCAGCAATCCATACGATGTTGACACGCTCATCCAGCGTATTTCAAAAGCGTACGGCTCGCTGCACGGTATCCTGCATTGTGCGGGTATTGTGCGGGATAATTTCGTGATCAACAAAACATCGGCTGAGTTTCAGGCGGTGTTGGCCCCGAAAGTGGCGGGTGTCGTTTATGTAGACGCGGCCAGCAAAGATTTGAATCTCGATTTCTTTGTGCTGTTTTCTTCAATCGCAGGCGCAATGGGCAATGCGGGCCAGGCTGATTATGCGACCGCCAATGCCTTTATGGATGCATTTGCAACCTATCGTAATGATCTGGTCCGCATCGGGCAACGACATGGACAAACCCTGTCGATTAACTGGCCGCTTTGGCGAGCAGGCGGTATGCAAGTGACAGCTCACCAAGAGGCCGCTATGAGGCAGAGCGTGGGCCTGGAAATGCTCGATACGGCGCGAGGGATGCAAGCCTTGGTCAAGGGGCTGGCCTCGGGGCAGAGTCAGATCTTGGTGGCTGCGGGCCATCTTCCCACGCTGAGAGGGTGGTTGTTCCAGGAACCATTAGCGCCGAGTACATCAGACCAGCCACTGGCCAATGTCCATCGAGTTGGCCGCCAACCCTCACTGGCATCCGTGGACAAACAGAGACTTTATGAAGAAACCTTGGTTCAGCTTAAAGGGCTGTTAGGCACTGTTTTCCGTTTGTCGCCAAATCGCATTAAAATGCATGACGCGTTTGAGCGCTACGGTATCGACTCCGTGATGATCGTGCAATTAAATCAGGAAATGGAAGCGGTTTTTCCGGAACTCTCAAAGACCGTGTTTTTCGAATACCAAACATCGCATGAGCTGGTTGCCTACCTGCTTGATGAGTATCCGCAGGAATGTATGGTATGGACTGGGCTTGGGGCTGAATCTGACATTGATCATGGAAATGGAGAGTCTTCTTGGCCCGAACGTGCATGGCGCCCTAAACACAGTTTAGCGACGTCTGTAGATCGTGACTTGGCGCAAGCGCAAAACCCGCAGATTCAGGAAGCAATTGCGATTATTGGCGTTAGCGCTCGCTTTGCCCAGGCTGAAACCCTGCAAGCATATTGGCAAAATCTGCAAGCCGGCAAAGACTGCATTGGCGAAATTCCTACCAATCGGTGGTCATTGGACGGCTTTTTTGTTGACGACATCGACGAAGCCATCGCCCAGCGGAAAAGTTATAGCAAATGGGGTAGTTTTCTGGAGAGCTTTGCGGATTTCGACCCTCTGTTTTTTGGCATTCCCCCGCGCGATGTCTTAAGTATTGATCCGCATGAACGCTTGTTTCTCCAATCCTCGTGGGAGGCGCTCGAAGACGCTGGCTATACCCGCGACACATTGCGTGAGAGATATCAACAGCAGGTCGGTGTGTTCGCAGGCGTCACCAAAACCGGTTTTGACTTGTATGGCCCTGAGTTATGGAAACGCGGTGAACAGGCCTTTCCGCACACTTCTTTCAGCTCCGTTGCCAATCGGACATCGTATTTTTTGAATCTGCAAGGCCCGAGTATGCCAATTGATACGATGTGCTCATCGGCTCTAACCGCCGTGCACGAAGCGTGCGAACATTTACGCCGAAGAGATTGCCGACTCGCCTTGGCGGGCGGTGTCAACTTATACCTGCACCCTTCCAATTATGTTCAGATGTGCGCGCTACGTATGTTATCGAAAGACGGTCAGTGTAAAGCTTTTGGCCAAGGTGGCAATGGTTTTGTGCCCGGTGAGGGCGCGGGCGTGGTCTTGCTGAAACCCCTGTCCGAGGCCATTCGAGAGGGCGACAATATCTACGCCGTGATTCGCGCAAGCCATGTGAATCACGGCGGAAAAACCAATAGCTACACCGTACCCAACCCCGGTGCACAAGCGGATTTGATTCGTCAAACACTTGACAAAGCAGGGATTGAGGCGCGCAGCATCAGCTATATAGAAGCCCACGGCACGGGAACGGCATTGGGAGATCCAATCGAAATTACCGGTCTGACTCAGGCCTTTAAAACAGATACTGATGATACTGGCTTTTGTGCGATCGGTTCTGCAAAATCCAATCTAGGGCACTTGGAAGCGGCATCAGGTATGGCGGGGCTGTTCAAGGTTCTTCTGCAACTGAAGCACCGCCAGCTTGTTCCGAGTTTACATGCAGGAAGTTTAAACCCTAATATCGCTTTTGAAAAAACCCCCTTTGTGGTGCAGCAGGCCCTTTCAGAGTGGAAAAGACCCATCGTGGAAAGCAGCGGTGAGGTCAAGGAATACCCCAGGAGAGCGGGCATCTCCTCATTTGGTGCCGGGGGTTCGAATGCACATTTGATTGTTGAAGAGTATGAAGCAAATGACGAACCGTATGCCGAGAAAGCGGTTGATGAGTCCGTGATGATTGTATTGTCGGCCAAAAATACGGATCAGCTCATTCAACTGGCTCGTAACTTAAGGCGTTTTATTGCCGAGACCGAAACCAAGCCGCCCCGTCTGGAAGATATCGCATACACGCTTCAGACCGGGCGCGAGGCAATGGAGGAGCGTCTAGCGCTTATTGTTGGGAGTCTAGAGGAGCTTGAAGAAAAGCTGCACGCCTTTGTTGAGGGACAGGAGCCTATTGCGTCGCTTTATCGTGGGGACCTCAAACAGGACTTGAACTTACTGTCGGATTTTGCCACGGAGGAAGAGCTTTCGAATACCATTGATGACTGGATGATGTCGAAACAAATAAATAAGCTACTCAGTCTGTGGGTTAAAGGTCTCACCATTAATTGGCAGAAATTTTATATTTATATTTATCATAAGCCCAGATCGAGACGTATTAGTCTTCCTACCTATCCCTTTGCCAAAGAATTCTATTGGTTTGAGCCGCAGGCTTTTAATCATGGTATCTCGACTCACTCGCAAAAGCCAGCTGAAAATCAGACTTCCTCGCGAAGCATTCAGTATCTGCAAAAGCAGTGGCTGCTGGATGAGTCCGAACCTGATGAGTCCTATGCTAAACAAGTGGTGGCGCGAAAAATTGCGATTCTAAGCGGTCCGCAAACCCGGTTGCTTGCGTCCCTGTTGGAAGAGGAATTCCCAAACAGCCAAATTATTGAACACGATAACATCAAGGAACACTTGGAACAGAGCCATGCAGATTGGCAGACGCATGGCGGATGCATCGATCTGGCGGGTTGTAGTCGTGACGAAGAAGCCGGAGATGCGCTTGACTGGATGCTGTGGCTCCAGCGCCTGATCGAAAATGGCTCAAAAACCGGTCTCACCCTGCTTGGCGTCACCCGAGGCTTAGAGTTCTTTCAGAACAGCGAGGTGAACCTATCGGGTGCCTCTCGTGTCGGGCTTTATCGCATGCTTCAGAGCGAGTATGCCCATATTCAATCTCGTCATATCGATACCGATCCCAGCCTTAAGACATCAGCGTTGGCCGAGCAGATTGCTCGCGAGTTTGTGTTGAACGATGAGAACTGTGAAATTTGTTACCGCGATCACAAGCGCTACCGTGCATATTTGGCAGCGTCTTCGCTAAAAGCGGCAAAGATATCAGACACAGACCTTCAGTTTGCTCAAGAAGATGTTCTCCTGATTACCGGAGGAACGGGTGGGCTGGGGCTTTTGTGTGCTCAGCATTTTGTAGAGCATTACGGGGTGAAGCGCTTGGTGCTTACCGGGCGGGAAGCGTTGCCATCGCGTGAGCAATGGGCTGATCCGCAAAGTGATAAGGTCAAGCAAAAGATAGACGTCATTCAGTCCTTGGAGCGTCAAGGCGTTAAGGTACAAGTATTGCCGATGGTGTTAAGTGATCATGATGCGGTGCGAGAAACTCTGGGTCAAGTTACAAAGAACTTTGGACCTATTCGTGGTTTGCTTCATTGTTCTGGAGCTGTCGATTCAGAAACGCCTGCCTTTGTTCGTAAGCCGATAGCAAAGGTGTCGCAGGTTTTAGAGCCTAAAGTGTCGGGACTTCAAACGCTGTTGGCGCAATGCAGACCACAGTCATTAAAATTCGCGGTCTTGTTTTCCTCTGTGGCTGCCACGATTCCCCGTCTGGCCAGCGGCCTGAGTGACTATGCTATGGCTAACGCGTATATGGATTATGTGGCCCAAGCCACGGGCGGTAAGTTGGTGAGTATTCAATGGCCAAGCTGGCAGGAGACCGGGATGGGCGCCGCGAACAGCAGGGCGTATCATGAAACGGGTTTGCTTCGTCACAACAATCAAGAAGGTCTCCGGCTCTTAGATGATATCCTTTCTCAACAAACCGAACCTGTGATACTGCCTGCTGTTGTCGATTCTGCGTTGTGGGCGCCGCAACAATTGATGAAGCATCAGAGCAGGCGAGAGAGCATTTCACCCGTCTTGCATCACCACCCTCAGACGCCAATGCATATTGAGCCCGCTACACCGAACATGGCATCAAGCCAGTTGACTCTGAACGATTTAGTTGCCTTATTTTCTCAGGAACTTGGCATTCCTACACAAAATCTGGCGCTGGACAAATCATTTGCGGATTATGGCCTGGATTCGATATGGCTGGCTCAGCTCGCAAGCAAAATCAATCAACAGCTTGTTGAGCCACTGGACCCTTCTATCTTGTACGAGTATTCTTCGTTAAATGCACTGGCGTCTTGGCTGGCTAGCGAACAGGCGCCAGCTCTTAAATCACAGGCCCATGATAGAGACGTTGAGCAGAAGATCGATCCGAAAAATGCCGCGGATAGCGTTGTACCCCGCTCTTCAAAAAAGCAGGCGTTGGATATCGCTGTGGTTGGCATGTCCTGCCGTTTTCCGGATGCCAATAATCTAGACGAGTATTGGTCTTTATTATCGGAAGGCAAGCAAGCTATCCGCCCTGTTCCAGCGGACCGCTGGTCGAGACCAACGCCGTTTTATGCAGGCTTGATCGAAAATAGCAGCCATTTTGATCCCGCCTTTTTCCTGATTCCACCAGAGGACGCGAAGGTGCTGGATCCTCAGGCGCTATTGCTGTTGGAAGAATGCCTGAACTTGTTTTATCACGCGGGTTACACCCTAGACGAGATGAAAGGCAGGGCCATCGGGGTCTATTTAGGTGGGCGCAGTCAGCATCGCATTGATGAAGCCGATCTTGGTCAAGCTCGAAATCCGATCGTGGCCGCGCAGAATTATCTGGCCACACATCTCTCACAGTTTTTTGATCTGAATGGTCCAAGTCTGGTCATTGACACAGCCTGTTCCTCGGCTCTGGTGGGGATGAATTTTGCCGTTCAGTCCCTGCTCAGTGGCGAGATTGACTCGGCGGTCGTTGGAGGCGTCAGTCTCCTGGCCGACGAAGATGCCCATCGTATCTTTCAGCAGCGCGATCTGTTGAACCGGGACGCCTCGTTTCATATCTTTGATCAGCGGGCCTCCGGCATCACGTTGGGCGAAGGGGCGGGTTTGGTGTTTTTAAAAACCCTGCCGCAGGCGCAACGCGATGGCGATCAGATTTACGCCGTCATTAAGGGACTGGTCATCAATAACGACGGTCGCACGGCCGGTCCGGCGACACCGAATTTTGAGGCGCTCAAATCTGTTATGCAGCGCGCCTTGAAGCAAAGTTGTCAACAGCCGCAAGATATTGTTCATATTGAAGCTAACGGCTCAGGCTCCGAGGTGACCGATCTACTCGAGCTTAAAGCGATGGAAGCGGTTTATCGTAGCGACAATAAGGCACCTTGCAGCTTAGGATCAATTAAGCCCAATATGGGGCATCCGTTATGTGCCGAAGGTATTGCTAGTTTTATAAAACTGGTGTGTATGTTGAAATATCAGCAGCAAGTACCTTTTTTATCTGGTCAAGTGCCATTAACACATTATGATTTAGACGCTTCGCCCTTTTATTTCTGTCGTCAGTCAACAAAATGGACAGAACACTCCCCCCTTCTGGTGGCGCTCAACTGTTTTGCGGATGGTGGGACCAATGCACATGTGATTATGGAAGCCTGGACGCAGGCAGAATCTCACCAGCAACGGCAGCCCATACCACCACCCGCGCTAAACCGAGTGAATATCCGCGGTGCAGTCAGCCAGCATCCCTGGTGGTGA", "orf_prot_sequence": "MSASEHAGSTIQYGRHLVILCEPDGITQESIASRMAAVDCLVYQSRSENIAERFQDYALRLFTEIQQLLTARAEAKILLQFVIRDLLEQQLFAGLAGLLKTAHLENPNLMGQLLCVAPGDDAEHLVATLKVNAQTPLDQRVAYRNGKRRIAAWKEVPIANDEDVSIPWKENGTYLITGGLGGLGLLFTKEIAQQIRSGTVMLTGRSPLDESKRQMLQTLQQFCGQSRVHLEYRQVDVCEPQGVASLIQEINHHVGPLDGVIHAAGVIHDNFIIKKTPQELENVLAPKVKGLVNLDEATKDQPLDFFFFCSSLAGGIGNVGQADYACANAFMDCYARYRNQLLQSHQRQGRTLSINWPLWQEGGMRVDAASENMMAQSIGLLAMPTSAGMRALYKAIASQQDQVMVVEGDLAKLRQTFLSLPEKTAQPEIGDVEAALDTGQLQHKTLEKLKSLFAEMTKLPLERVNEEEPLDSYGIDSVMIAQLNQKLTAELGPVSKTLLYEFHTLEELAHHLVKAYFDRCVNWTQLNSTLNFSEVSVETRNHKSEKGRYSNEYDMQMPDDTAQQPIAIIGLSGRYPKAKTIAEFWQNLKHGEACISEIPRQRWDWKRYYHADPNEAVKSGKSYSKWGGFLEDFDQFDPMFFNMTPREAENIDPQERIFLQESWKALEDAGYSPSNLSADLRQRIGVFAGITKQGFNLYRMESGPDRQLACPATSFASLVNRVSYVLNLQGPSFPVDTMCSSSFVAIHEACAYIRSGQGDMAVVGGVNLYAHPSSYLELSLGRFVSNGSTCAAFEKDADGFVPGEGVGVVILKAYDQALKDRDSIYALIRGSAVNHDGKTNGYKTPNPGPKAAVIRQALQQSGIDARSISYIEAAAQGSDVGDAIEASALTDVFSGRNHVEGAYRIGSVKPNIGHSESASGMSQLTKVILSLNHQTLPPTLRSRALSPSIDFDQLPFELQQELSEWQPVRVDGIEVPRRAGMMNIGAGGVNAHIIVEEPPPHEEPVHDGHGPVLFVLSAKNEERLERYVQDWLIYITNGPILDLPSIAYTLQVGRESMACRLAFVVNQSEELATYLTRWLKTRELGDVGFYGDVTQERVKNSEAVSTLVKAGDASHARELAALWVQGNAIAWDKWHRGTTLGRRSGLPTYPFANRTCWIARDDHDCSEDDRGEEKSDVEPRIDHTLDENKAVEFYTRMTQDCDEAFQEEYLTFGAFPRRIPGFSMTRVAMNAERYPEELEMIKESQRELRQVLFCREDFDRVHTFLDIGCGHGTDVIQVAALYPHIQTHGFTITESQAILGNRRIEHMNLGSRARIYHKDSSKEPFPDNCDMILGIEVTFHIRDKDALLQKMADALSDDGKILLMDYIANLRGSIVDPNVEISIPTQSQWIDLLSQHDLIIDEIIDVSTEVSNYLYDPEHAEHTKHLPKVSQDSYRNYANQAIALEKGWITYCLLKLQRDTQRSEQERREYNAWKIANQTPYAQALEDMLRVGRMPYPLSGGLKMAVQPMDGQPPSTLDESVPDLGQIQTALAGIFVAILGFETRELDFIDQLPLTELGISSVNAVELLEAINTEFDLHLPTSLVFECHRLEDLAGHIQVELGRKPIAPAMSNASVAVQAEAESRQKTTVPVEEKAPIANEETAIIGLSCRCAGAKDQEQFWQVVSQGKDCIEDLKEPQWLDYIAEHGSETFPIRYGVMPERDDFDPLFFHISPREAEAMDATQRVLLEECYRALEDAGYNPSSLKQQAVGTYIGAMGSASLRKGFSHLDMLGSETSILSARTAYFLDLTGPALTINTACSSSLVAIEVASQALKSGEINLAIAGGVTLYQHPGTFIAMHNASMLSPTGQCRPFDDDADGIVVGDGVGVVILKRLREAERDGDSIYGIIRGCGMNQDGQTASMTVPSFLAQSELESAVYQKANIDIEDLQYIEAHGTATKLGDPIEIHALNKSFQALTSKQKFCAIGSLKANVGHTTAAAGVLGVIKVLLGMKYQQLPPSIHFNEGNRHIDFDNSPVYVNTTLKPWPKNAKDSRLAAISSFGFSGTNAHLVLEQYMPLPDTDSGVFIPLVLLLSAESDDALQHYAHNVKCYLEDHPAIQYGHFLYTFQVGRDAFAYRLAIIAENQQELIQKLEQWLTTGGPVTDIHNKPDIGNREEEKASLQSLISGRKVEPLAQLWEQGASVDWHAFYPDGRCRRLAGLPTYPFAREYFGAPQDEECQYGEAKQAPSEDCEGTIARSSTETLIACPYWKEKSVAGATESFAYSRHLVLLCGMEHISAAKLQAQIPGVECVHLSSVNRFHRSTHVETIYQDEFTQVFEMIQDVLASKTRGNILIQCVVPQQPNQPCLSAISGMLKTAQLENPKVSGQLIEVLADETEVSLLSKIHENGRCPEDKQIRYDQGQRVVQAWQELVVSDRACKTPWREGGVYLITGGAGGLGLMVAEEIASQTQRSTLILSGRSSLSPEEVASFSYGLQALGTRVEYQPADISNPYDVDTLIQRISKAYGSLHGILHCAGIVRDNFVINKTSAEFQAVLAPKVAGVVYVDAASKDLNLDFFVLFSSIAGAMGNAGQADYATANAFMDAFATYRNDLVRIGQRHGQTLSINWPLWRAGGMQVTAHQEAAMRQSVGLEMLDTARGMQALVKGLASGQSQILVAAGHLPTLRGWLFQEPLAPSTSDQPLANVHRVGRQPSLASVDKQRLYEETLVQLKGLLGTVFRLSPNRIKMHDAFERYGIDSVMIVQLNQEMEAVFPELSKTVFFEYQTSHELVAYLLDEYPQECMVWTGLGAESDIDHGNGESSWPERAWRPKHSLATSVDRDLAQAQNPQIQEAIAIIGVSARFAQAETLQAYWQNLQAGKDCIGEIPTNRWSLDGFFVDDIDEAIAQRKSYSKWGSFLESFADFDPLFFGIPPRDVLSIDPHERLFLQSSWEALEDAGYTRDTLRERYQQQVGVFAGVTKTGFDLYGPELWKRGEQAFPHTSFSSVANRTSYFLNLQGPSMPIDTMCSSALTAVHEACEHLRRRDCRLALAGGVNLYLHPSNYVQMCALRMLSKDGQCKAFGQGGNGFVPGEGAGVVLLKPLSEAIREGDNIYAVIRASHVNHGGKTNSYTVPNPGAQADLIRQTLDKAGIEARSISYIEAHGTGTALGDPIEITGLTQAFKTDTDDTGFCAIGSAKSNLGHLEAASGMAGLFKVLLQLKHRQLVPSLHAGSLNPNIAFEKTPFVVQQALSEWKRPIVESSGEVKEYPRRAGISSFGAGGSNAHLIVEEYEANDEPYAEKAVDESVMIVLSAKNTDQLIQLARNLRRFIAETETKPPRLEDIAYTLQTGREAMEERLALIVGSLEELEEKLHAFVEGQEPIASLYRGDLKQDLNLLSDFATEEELSNTIDDWMMSKQINKLLSLWVKGLTINWQKFYIYIYHKPRSRRISLPTYPFAKEFYWFEPQAFNHGISTHSQKPAENQTSSRSIQYLQKQWLLDESEPDESYAKQVVARKIAILSGPQTRLLASLLEEEFPNSQIIEHDNIKEHLEQSHADWQTHGGCIDLAGCSRDEEAGDALDWMLWLQRLIENGSKTGLTLLGVTRGLEFFQNSEVNLSGASRVGLYRMLQSEYAHIQSRHIDTDPSLKTSALAEQIAREFVLNDENCEICYRDHKRYRAYLAASSLKAAKISDTDLQFAQEDVLLITGGTGGLGLLCAQHFVEHYGVKRLVLTGREALPSREQWADPQSDKVKQKIDVIQSLERQGVKVQVLPMVLSDHDAVRETLGQVTKNFGPIRGLLHCSGAVDSETPAFVRKPIAKVSQVLEPKVSGLQTLLAQCRPQSLKFAVLFSSVAATIPRLASGLSDYAMANAYMDYVAQATGGKLVSIQWPSWQETGMGAANSRAYHETGLLRHNNQEGLRLLDDILSQQTEPVILPAVVDSALWAPQQLMKHQSRRESISPVLHHHPQTPMHIEPATPNMASSQLTLNDLVALFSQELGIPTQNLALDKSFADYGLDSIWLAQLASKINQQLVEPLDPSILYEYSSLNALASWLASEQAPALKSQAHDRDVEQKIDPKNAADSVVPRSSKKQALDIAVVGMSCRFPDANNLDEYWSLLSEGKQAIRPVPADRWSRPTPFYAGLIENSSHFDPAFFLIPPEDAKVLDPQALLLLEECLNLFYHAGYTLDEMKGRAIGVYLGGRSQHRIDEADLGQARNPIVAAQNYLATHLSQFFDLNGPSLVIDTACSSALVGMNFAVQSLLSGEIDSAVVGGVSLLADEDAHRIFQQRDLLNRDASFHIFDQRASGITLGEGAGLVFLKTLPQAQRDGDQIYAVIKGLVINNDGRTAGPATPNFEALKSVMQRALKQSCQQPQDIVHIEANGSGSEVTDLLELKAMEAVYRSDNKAPCSLGSIKPNMGHPLCAEGIASFIKLVCMLKYQQQVPFLSGQVPLTHYDLDASPFYFCRQSTKWTEHSPLLVALNCFADGGTNAHVIMEAWTQAESHQQRQPIPPPALNRVNIRGAVSQHPWW", "perc_identity": 25.27}}, "BGC0001186.1|Misakinolide_18 # 73695 # 97673 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.504": {"gnl|BL_ORD_ID|1774|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 73695, "orf_end": 97673, "orf_from": "BGC0001186.1|Misakinolide_18 ", "model_name": "vanM", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "1924", "ARO_accession": "3002911", "ARO_name": "vanM", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "39340": {"category_aro_accession": "3002906", "category_aro_cvterm_id": "39340", "category_aro_name": "Van ligase", "category_aro_description": "Van ligases synthesize alternative substrates for peptidoglycan synthesis that reduce vancomycin binding affinity.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "35948": {"category_aro_accession": "0000029", "category_aro_cvterm_id": "35948", "category_aro_name": "teicoplanin", "category_aro_description": "Teicoplanin is a glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria. Teicoplanin has a unique acyl-aliphatic chain, and binds to cell wall precursors to inhibit transglycosylation  and transpeptidation.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.04659, "max_identities": 17, "bit_score": 31.187, "cvterm_id": "36779", "query": "AQPAEGVEQ-RLPVLIPLSAKNEERLKEAARNFYHYL", "match": "A+P +G E   + V   LSA+  ER+KEAA+N Y  L", "sequence_from_db": "AEPEKGSENATITVPAELSAEERERIKEAAKNIYKAL", "sequence_from_broadstreet": "MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWDNEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYVGCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYGVNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGIFRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGRIVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVKE", "dna_sequence_from_broadstreet": "ATGAATAGATTGAAAATAGCCATCCTGTTTGGGGGTTGCTCAGAAGAGCATAATGTATCGGTAAAATCAGCGGCAGAGATTGCCAACAACATTGATATAGGAAAATATGAACCAATATACATCGGAATAACCCAATCTGGCGTTTGGAAAACATGCGAAAAACCATGTATAGATTGGGATAATGAACACTGTCGCTCGGCAGTACTTTCTCCGGATAAAAAAATGCATGGGTTGCTTATTATGCAAGATAAAGGATATCAAATACAGCGTATAGATGTAGTCTTTTCAGTGTTGCACGGAAAATCGGGTGAAGACGGCGCCATACAAGGATTATTTGAATTGTCTGGTATACCTTATGTAGGCTGTGATATTCAAAGTTCGGCGGTTTGTATGGACAAATCACTGGCATATATTATTGCGAAAAACGCTGGCATAGCTACTCCTGAATTTCAGGTCATTTATAAAGACGATAAGCCAGCGGCAGATTCGTTTACCTATCCCGTTTTTGTTAAGCCAGCACGTTCAGGTTCCTCCTATGGTGTGAATAAAGTTAATAGTGCGGATGAATTGGACTCCGCAATTGACTTGGCAAGACAATATGACAGCAAAATCCTAATTGAGCAGGGTGTTTTAGGTTATGAGGTCGGTTGTGCCGTATTGGGAAACAGTTTCGACTTGATTGTTGGTGAAGTGGATCAAATCAGACTGCAACACGGTATTTTTCGTATTCATCAGGAAGCCGAGCCGGAAAAAGGTTCTGAAAACGCAACTATAACCGTTCCCGCAGAACTATCGGCAGAGGAGCGAGAACGGATAAAAGAAGCGGCAAAAAATATATATAAGGCGCTCGGGTGTAGAGGTCTTTCTCGTGTTGATATGTTTTTACAAGATAACGGCCGCATTGTACTAAATGAAGTCAATACCATGCCTGGTTTCACGTCATACAGCCGTTATCCACGTATGATGGTCTCAGCAGGTATAACAATTCCCGAACTGATTGACCATCTGATTGTATTAGCTGTAAAGGAGTGA", "partial": "0", "query_start": 76269, "query_end": 76376, "hit_start": 738, "hit_end": 849, "orf_dna_sequence": "GTGAAAAAAGAATTTCATATACATGCAAGCCACCCCATTGTGAAACATCACCAGGCCTATGGCCAGGCGTTGTTGCCGGGGCTGGCTTATATTGATTTGCTGTACCAGTTTTTTCGCGAGCAAGGGTATGAGTTTGCAGCTTTAGAACTTCGCAACCTGTCAATTTATCGCCCTTTGTTGGTTGGGGAAGATGATGGTATTCAGCTTTTGCTGCAAGCAGATGACATGGCCGAGGGGCTGTGGTCGGTTCAACTGTTAGACGGGGAGCAACGCGGTGCCCCGGAGTCTAAAGCGCAACAACTCTATATCAAGGCGGAAATGTATCACCACCGTGAAGCGCCTGTATTTGATGACGTGCTAGATTTTCAGGCCCTGCAAGCCGTCAGTCATACGCAAATCCCTTTGAATGATATCTATGCCCAGTGCCGTTCTCAGGGACTGGTTCACTCGGGGATGATGAAAGCGGAAGGGACGGCTTACACGCTGGATGACGCCCAAATCATCGAGGTGGCTTTGCCAGACGAAGCCGCTTCTTCTGCGGCCGGCTTTATGTTTCATCCTGCCCTTATCGACGGTAGTGGCGTGGGTTCATCCAATTTGTTTGCCGCGCTGGTAGAAGGTGAACAGCGTTTGTTTCTACCGTTATTCTATGAGCGTTTTCGCGCATCTGCACGGTTTGAGCGAACGTGCCTTGTCAGAGTTAAGACGGCTTCCGTGTGGCGAAAAAACGATATGATGTATATGGATATAGAGTTCTTTAATGAGTCTGGAGAAAAAATTGCGGAACTGAAAAACTTTGTCAATAAGCTGGTGCGAGAGGCCGCATTAATTAATCCGAATCTTAAGCCAGCAAGCCAGGCTCAATCGTCCAAACTCAAGCCGTATGAGGAAGCGTCTAGCGAGTCGCAAGCCAATCCGCCTCGGCTCGATAAGTCTGAGGCTTTAGAGGGCATGGAAGACCTGCTTAAGGAGATCATTGCGCCGTATGTGGATGGCTCGCCAGAGCAACTTGATCCGGAGGCTGGTTATTACGAACTCGGTCTGGACTCGGCAATCCTGCTGCAGGTGGTCACGGCACTGGAGAAACGATTCGACGCCAAACTCATGCCCACGTTGTTATTTGAATACACCACCATCGAAGAGCTCGCCGCTTATTTTGTCAATGAGAATTTTGCCACGAAACATGTGGCCAAAGAGCCGGCCACGCCTCTAGCGCCTGTCTTGCCTGGGCCCATACAGACCGGCCACGAGGATGACATCGCCATTATCGGTATTTCCGGTCGTTACCCAGGAGCCAATAATATCAATGAGTTTTGGCAAAATTTAGTTGTAGGCAAAGACTGTATTAGCGACGTGCCAGAAGAGCGATGGGACTGGCGCAGCGTGGCCAAGCACAAATCACCGTCGGGTAAAAGCGTCTCAAAATGGGGAGGATTTATCCAGGACCCCGATTGTTTTGACCATCAATTTTTTCGAATTTCTCCACGGGAAGCCGAGGTGCTCGATCCGCAGGAACGCCTGTTTTTGCAGACCTGCTGGGAATGTATTGAGGACGCTGGCTATACCCCAGAAACGTTGGTCACCCGGCAGCAAGCCCCGCATCGCCGGCAGAGTGTGGGCGTGTTTGTCGGGGTGATGCATAAAGATTACGTCTTTCTCGGCATGGAAGCCATTGCGCGCGGTGAGCAGTTTCATTTGTCAATTAACAATGCGCCGATTGCCAACCGGGTTTCCTATTTTTGTGATTTCCATGGCCCCTCCATGGTCATCGATACGGTGTGTTCGTCCTCACTCACCGCCATACACTTGGCTTTGGAAAGCATTCGGCACGGAGAAAGCGATATTGCGCTGGCTGGAGGCGTCAACCTATCGTTGCACCCGAACAAATATCTGACCTATGGCCTACTCGATATGTATTCTAGCGATGGGCGTTGCCGGGCGTTTGGCCGCGGCGGGGATGGTTATGTGTCAGGGGAAGGGGTCGGGGCTGTCGTGTTGAAACCGTTGGCGCAGGCCATTCAAGATCGGGATCATATTTATGCGGTGGTCAAAGGCAGCATGATCAATCATGTGGGAAAAGTGACCGGAATCAGCGTGCCGAATCCGGTGGCGCAGAGCGACATGATTTTACAGTGTCTGGAAAAAACCGGCATTCACCCACGGACGCTTAGCTATGTCGAAGCTCATGGCACGGGCACGTCGCTTGGCGACCCCATCGAGATACAGGGTTTGTGCAAAGCATTTCAAACGCACACCAACGATACCCAATTTTGTGCCATCGGATCGGTTAAATCCAATATTGGCCATACGGAGTCGGCTGCTGGCATTAGTGGTTTGAGCAAAGTGGCCTTGCAACTGCACTATCAAACCCTGGTGCCATCGCTACATTCCGAAGCCATCAATCCTCATCTTGATTTAGAGGCGTCGCCCTTTTTTGTGCAGCGTCAAACCCAGCATTGGGAGCGGACCTCAGACCATCCACGACGAGCGGGTTTAAGCTCGTTTGGTGCAACCGGCTCAAATGCGCATGTGATTCTGGAGGAGTATATACCCGAGCAGAGCGAAACCGACCTGGCACAGCCCGCAGAGGGTGTAGAGCAACGTCTACCTGTGTTGATTCCGCTATCCGCCAAAAATGAAGAGCGTCTTAAAGAGGCTGCGCGAAACTTCTATCACTATCTCATCTCAAAGCCCGAAGATGTCGCAGGGCATCAGGTGGCGAGACTCAGCGATATCGCCTACACCTTACAAGTCGGCCGAAGGGCGATGGAAACACGGGCTATTTTTCTCGTTGATCATCAACAGCAGTTGGTTGAAAGTCTCCAAGCTTTTTTGGATGACGATCATACAAAGGGAAATAGTTGGCTAGGCAAGCAGGTCAAGCAGCAAAGACACGCTAGACGTGGCGAATATAGCGAGGCAATGCTACAGCAATGGATGGTTCAGGGCAGACTCGATCAGCTTGCTCAGGCGTGGAGCGAAGGTGTTCCCTTGAATTGGGACGCCCTTTATTCGCCGGAGAGCGGTGTCGCAAAACCAAGCCGCGTCAGTTTACCGACTTACCCCTTTGCCAAAGCACGTCATTGGGTACCAATGGAAGTGAAGGCGGTGACACCATTTGCTGCACTTCACCCCTTGCTGCACCGCAACACCTCTACGCTGGGTGAACAGCGTTTTAGTTCGACGTTTAGTGGGGAAGAATTCTTCCTCGCTGATCATCGGGTGCATGGCCAAAAAATGTTGCCGGGGGTTGCTTATCTCGAAATGGCGCGAGCCGCCGTTGCTCTGGCCACCTCAGCCGGGGAGGCCCAGGCGATACGATTTAAGAACATCATCTGGCAACAACCGCTCGTTATAGATGGGACGGAAAAAACGATTCATATTGGCTTGTATGCGAAAGCAAATTCGCAAGTCGATTTTACCATTTATACCGGAGACGAGCATGGCTCGGACGCTCCCTTTCCCGATGAACAAAACCGCCGTGTTCACTGCCGCGGCATTGCCATGTTAACGTTGTCGGATCGTGAGCGTGAAACTTACCTGGATCTTGATCATTTGCAGTCCCAAACAGGACAAAACGATTTTACCCCGGAGCAGTGTTATCAGGCCTTTGCGGCGATGGGTATTGATTACCGCGATGGACATCAAGGCATTGCCGCAGTTCATGCCGGGGCTGATCAGATATTGGCAGAACTCAGCCTGCCTGCCTCCGTTTTGGCCCATCGTGAACCGTTTGTGCTCCATCCCAGTATGATGGATTCAGCGTTACAAGCGGCAATTGGTTTTGCACTTAGCGCGCAAGTTGCCGGCGCACAACAACCGGCTTCTTTACCTTATGCTTTGGAATCGCTTGACGTAAGAGCTGCTTGCACCCCTTCCATGTGGGTTTGGATACGCTATGCCGACAACAATAGCGCAGGTAGTCCGGTGCAAAAATTTGATTTGGACCTGTGCGATGATCGTGGCAAAATCTGTGTGCTGATGAGAGGCTTTTCTTCTCGTATCTTTCATGCCCAGGCCTCGCCTTGTTTTGCTGAAACGTTATTGCCTTCTCAGCTGCATCCCTTATTGCATCAACATGTTCCCTCAGAAAACCCAGTGCATGATCAGTTTATCGCTCAATTTACGGGAGAAGAGTTTTTTCTACGTGACCACCAGCAAGTGATGCTGGGTATGGCCTATCTCGAAATGGCCCACCGTGCCGGACAGCATCGCGCGAGTCAGAAGATTTTGGGGCTCAAAAATGTCGTCTGGAGCCAGCTTCTCTTTATTGCCGGACAAGCTCGTGAGGTATCTGTTCATGTACAGAATGAAGTCCTTCAGCATCGTTTTCGTATAACGACACAGAATGAGGATTCGCTGCAAAACATACATTGCCAGGGTATGCTGGTTGTTGACCAGGCTTTGTACCCGGAGAGACCTGACCAACTTAATATTCAAGATATTCAATCCCGCTGTTCAGCGAGCATCGAAACTACTGAGTGCGATCAACTGCTACAATACACCCATGGCCCCAGCCTGCTGACGATCAAACAATTGTGGCACAACGAACATGAAGCCTTGGCTTTGCTTCAATTGCCCGATGGTATGCGCTCGGGACGTGAAGATTATACACTTCACCCGAGCATGATGAACGGCGCGATCCTCACCAGTGTACTCTTTTCTTTGCTCAATGGGCCGCAAGAACACCTGCCCATGCCTTTTGCCTTGGACGAGCTTTGGATGTACCAGGAGATGCCTGAGCGTGCCTACGCTTATGTGAGTATGAGTTCGGCGAACAATCATGATATCGAACTGGTGGACATAACGGGCAAATGTATTGTTTTGTTTAAAGGTTTTACTGCTGCCATTCAAGGGGCATGGCAAAGCCAGGCGCCGCAAAACAATGTGATTTATGCGAGCACACAATGGCGAGAAAGCGTGTTGTCCGGTGACGAGCATGCGAACACGGCCGCATCTGCACCGATTGTGATGCTTGCACAAGACAATCCGGAGCTTGCCGGTTTATTACGCCAGAGATGGCCAGAAGCCAGCATTGAAATGCTGGCGCCCATCGGTGAGGATATCGCCAAAACAGTTCAGGCAAACTTCCTGCAGGTGTTTGATCGAGTCAAAACCTGTATCTTAGAACAGCCTCAACGCATTCAGCCAATTGTCGTCCTTCTACCTGAAAATGAAAACGATTATCTGCACGACGGTCTTGCTGCCTTGTTCAAAACGGCAAGGTTTGAGTATAGAAAAATAGTAGGGAAATTAATTCGCTATACGATTGATATAGATATAGAAGAACTTGCTAAATCTATTTTGATGGAAGTGTCTCATGATGATCAACATGTGGATGTCTATTACAGTCAAACAGGTACCAGAAAGGTTAAAACGCTAAACGAAATATACGACTTTGAAAAGAGCCATGCGCACCTTCTTGTTGAGGCCGATTTATTGCATGAAGGTGATGTGGTTTGGATCACTGGCGGCTTGGGCGGTTTAGGGCAGATTTTTACTAGGCACCTTAGTCATACCAAAGGCTTGAAGTTGATTTTGAGCGGGCGTTCGCCCTTGAATGCGGCTAGCGAAAAAGTGTTGCGCGAACTTCAGCAGTCTGACGTTGAGATGAGTTACTTGAGTTGCGATATCAGCGATCAACAAGCTGTGGCGACGCTTGTCCAAAGTATTCTGAACAAATATGGCAAATTAAATGGCGTCATTCATAGTGCTGGGTTGACCCGGGATGCCTATATTCACAATAAAACGCGTGAAGAAATGATCGCTGTGCTGCGCCCTAAAATGGCGGGCATTTTGGCAATTGAGGCGGCTTGTCAAGATATTCAACTGAATTTTATGGTGTTATTTTCTTCCATTGCAGGTGTTTTTGGCAGTATTGGCCAAGCGGATTACGCCATGGCAAATGCTTTTCTTGACAGCTTTGCCGAGGCGAGGAATCGTCGCGTTCAGCAAGGGAAATGCTTTGGTAGAACGCTTTCCATCAATTGGCCCCTGTGGCGCAACGGTGGTATGGGGGTGGATGCGCAGAATGAAACCCTGATGCAGCGCAATACCGGCATGATTGCGTTAGAAACCCGTGCGGGCCTAAATGCGTTTGAGCTGGCTTTGTCTTCTGAATATAGCCACATCTTGGTGGCTCAGGGGGAAACCGAAAAAATTCGTTCTCGTTTGTTGTCGCCTCGGTTCGTAGAGGAAAACCTGAGCTCGGTTGAAGCAGATACAACGGAGCCATTGGAACATCAAAATCAGAGCGAGCCAAGCAAAGCCGAGCAGGACCAGCGGGCATGGCTCATTCGGTTGCTGCTCAAGGATCTCGCGGCTTTTGTCTGTCGCCTTCAGAAAGTGCAACCTGAAGAGATTGACCTAGAAGCCGAGTTTTCCGTCTATGGATTTGACTCTATAGGTTTTATGAGTTTTGTCAATCATTTGAACGACATGTACGACTTGGAATTAATGCCGACGCTATTTTTTGAGCATTCCAGTTTGCGTGCGCTTGCCGACGCGCTGATCGAGAAGCATCAGGAAGCTTTACTGAAAAAATATGAGTCCCCGAAAACAGCTGCTCAGCCAAGCCAGGATCGCATGCCAATTCAAGCTCGTGCAGTCGAGATGGACAAACGCCAACACCCTGTATCTGCAACGATGACACCTGTTGAATCGGAAACGACTCAAGGGAATCCGACGCCAGAGAGTTTATCTACAACTGACCCGATTGCCATTATTGGTATGAGCGGCAAATTTCCCGGATCGGAAAACCTGACGGCGTTTTGGCAGCACCTAGAGGCTAATCGTGATCTTGTCAGTGAAATCCCTGAAGACCGTTGGGACTGGCGGGATTACTACGGTGATCACCTGAGCGAAAGCGGCAAGACGAAGATTAAGTGGGGTGGCTTTATAGAGGGCATCGATCATTTCGATCCCCTGTTTTTCGGCATTTCCCCAGTGGAAGCCGAAATCATGGACCCTCAATTTCGTCTCTTTTTGCAAACGGTTTGGGCCACGATTGAAGATGCAGGCTATCGTGCCAGTGCGCTGTCGGGTAGCAAAACCGGGGTTTATGTGGGCGTGACCACCACGGATTATAAAGATTTAATGCAGCAGGCGCGGGCGAGGGAAAACTCCCAGGAATACCATGGTATGTTTCCATTTATGCTGGCCAATCGCGTCTCCTATTTGTTCAATTTTCGTGGCCCTAGTGAGGCGATCGATACAGCTTGCTCCAGCTCCTTAGTGGCGATTCATCGTGCGACCGAAAGCATACGCCAAGGAAGCTGTGAGATGGCGGTAGCAGGTGGGGTGAACATTATTGCGAACCCGCAATTGGTTCTTTCAGCGACTCAAGGTGGTATGTTGAGTGAAGATGGGCGCTGCAAGACCTTTGATCAAAGTGCCAATGGCTATGTCAGAGGTGAGGGGGTTGGCGCGATTTTGTTAAAACCCTTGGCAAGAGCGATCGAGGACCATGATCCGATCTGCGGTGTGATTCGGGGTTCGGCGGAAAATCACGGCGGCAAAGCCACATCGCCCACCGCCCCAAATCCGGTGGCGCAGCAGGAATTGCTGGTTTCGGCTTACGCCCAAGCCGGTATCACCCCGGAAACCGTGGGTTATATTGAAGCTCACGGAACGGGTACGCCGCTCGGTGATCCGATTGAAATCAATGGACTCAAAAGCGCATTTGCCCAGCTTTATGAGCAAATCGGCCGGCCTCCCGCCAACGAGCCCCATTGTGCCTTGGGCTCTGTAAAAACCAATATCGGACATGCGGAAGCGGCTGCGGGCATTTCAGGTGTTCTCAAAGTCCTCTTGATGATGAAGCATCAAAAAATTCCCGGAAATCCACATCTCAAGGAGCCAAATCCCTATTTACAATTGACCGGTAGCCCTTTTCATTTGGCGCAGGATACGCAGGACTGGAGGGCGTTACACGACGAGGTTCACAACCCGATACCCCGGCGCGCTGGGGTGAGCAGTTTTGGCATTGGCGGTAGCAATGCCCATCTGGTGCTGGAAGAATATACTGCCGAGCCTGCCGCTGAGCCCGTGGTCTGCGGCGAAGCCTCGTTAATAATTTTATCAGCGAAAAATAGAGCGTGTCTGGTTGAGGCTGCCGGGAATCTCTATCGATTTCTCATCGATAACCGTGAATCCTCCCGAGGAGAGCTGTTGCGTCTTGCTGATATTGCCTACACGCTTCAGGTGGGACGCGAGGAGATGGCGCATCGTTTAGGATTTGTGGCTTCATCTCTTACAGAACTCGAAGAAAGACTTCAGACTTTCATCAATGTCCAAGGTGAAAATCAAGACTTATATGAGGGGCACACGAAGGGTAATCGGAGTACCTTAGAAGCTTTTGAGTCTGATGATGATTTACAGGAGATGCTTACAAAGTGGGTTGAAGGCAGGAGATTTGAGCAAATTTTAAAGCTTTGGGTCAAAGGGCTTGCTGTGAACTGGGAGAGCCTCTACCGCGGAATACAGCCTCGGCGTATCAGCCTACCAAGCTATCCCTTTGCACGTGAACGTTACTGGATTCCTGCATCGGCTGAATCTTTGCCCGTACCGGCTGCATCGCCGGTATCTCCCATACAGGTCGATAACGCTGCCGGGGTATTGATGTGCCACCCGGTCTGGGAAGAAAAAGCCGCTCCGGTTCAGGTCGGCTCCTTTGATCCTGCTTCGCTGCATGATTGTCAGCACCTGATTCTGTTTTGTCATATGGATGTCCCTTTGGGTTTACAGGACCGTTTCGGCACAAGTAGCGTTTGTCGTGTGTTTCAGGCCCAGAGTGACGATGTGGCGCTAGGTTATTCGTATCTTTGCGAGCAGGTTTTGACGTGTCTCAAAGAGATTCTGGAAAACAAACCGAGAGACCGGGTATTCGTGCAGATTGTGATTCCTGGTCCCGAGACGAGCGAGGCCGAAGGTGCGAGCGGCCTGTTGCATGGTCTCTCTGCGTTGCTTAAAACCGCGCATTTGGAAAATCCAAAAGTTCTCGGGCAACTTATCGAAGTGGGTCCGCGCCACACGGGTGATGCGTTGATCCGGTGCGTGCAGGAAAATTGTCAATCGCCAGACGATGTCCAGGTCAGATACCGCCATGGGCGGCGTGAAGTGATGGCCTGGGAAGAGCTTCCAGTGTCAGAACCGAACGCCGCTCCTATGCCCTGGAAAGAAAGGGGGGTGTATTTAATAACTGGCGGTGCGGGGGGCTTGGGGTTCATTGTTGCAAGAGAAATTGCTCGCCGTGTCAAAGCCCCAATTCTTATTCTGGCCGGACGTTCCCATTTAAGCCAGGCAAAACGGGATGAATTGCAGCAAGAAGCCCAACGCTTGGGGGTGCAGATCGAATATCGACAGGCTGATGTTAGTCAACCACAAGAGGTCAATGACCTCATTCGGAGTATTCTGCGCGACTTCACGAAGCTCAATGGCATTTTGCACGCCGCTGGCCTGATTCGCGACAGCTTTATGATTCGGAAGACAGTCGATCAGTTGCATCAGGTACTGGCGCCAAAAGTATTTGGCACGGTGTACCTGGATGAGGCAAGCAAGGATGTCGACCTGGATTTCTTTCTTTTATTTTCCTCGGGCGCTGCAGCACTGGGTAATGCGGGGCAAGCAGACTACGCTGCCGCCAATGCCTTTATGGATGCTTACGCCGAGTATCGTCATGCACTGTTCGCGTCAAAGCAACGTTTTGGCCGGAGTCTTTCGATCAACTGGCCGCTCTGGCAAGAGGGCGGTATGCAAGTGGATGAGCCGACCCTGACCGCGTTAGAGCAATACGCGGGCATCAGGGCACTGCAAACCGGTAGCGGATTAGATGCGCTGTACCGTGCGCTTAGCGTAACGCCGAACCAAATCATGGTACTAGAAGGCGATCTGGCCAAAATCCGTCAGGGGTTGTTTTCTGCCTCCACAGAACCGTATCGCAACGAATCTTCAAGGGTTGAGGTTGATGAGGAACGCTTGCTCGCCAGGACCTTGCACCAGTGTAAAACACTTTTTGGCGGCATTATCAAATTAGCCGCAGATCGAGTCGAGGCAGAAGAAGCGCTGGAGCACTATGGTATTGACTCCGTAATCATTGCCCAAATGAATCTGCGTTTGGAAGAGGTTTTTGGCGAGGTCTCTAAAACTTTGCTCTATGAATACCAGACGCTGGGGGAACTGGCTAGTTATTTAGCAACCGAGTACCGAGACGCATGCATGACGTGGACAGGCTTAACAGCTATCCCCACAAGTGACATGACAACAGTTCCGGACGACGCGATTCCGGCCAAGCCTCAAATCACTTCGGAGCCTCGGCGATCATCGGGGGTTGATGTTCATGCCCTGACGCCAAAAGCACCCGCGCCGTCGCAAGATGAGCCCATTGCGATCATCGGCCTGGCTGGCCGATATGCACAAGCCGATACGCCGCGCGCTTACTGGGAAAATTTGCAGTCAGGAACAGACTGTGTGACGGAAATTCCTCCGGATCGCTGGTCCCTGTCGGGCTTTTATCACGAGGATCTCGAAGAGGCCATTGCCCAGGGTAAGAGTTATAGCAAATGGGGAAGCTTCCTAAACGGTTTTGCCGATTTTGACCCGCTGTTCTTTTCGATGTCGCCTCGTGAAGCCATTGGCATTGACCCACAAGAGCGCCTGTTTCTGCAAAGTTCCTGGGAGGCGATGGAAGATGCCGGCTACACCAGAGAGACCCTTCGAGATCAGTTTCAGCAGCGAGTCGGGGTGTTTGTCGGTATTACCAAAACAGGTTTTAGCCTATACGGTCCAGAGCTGTGGCAGCGTGGTGACATTGTCTATCCGACCACCTCCTTCAGCTCGGTGGCCAATCGCATTTCTTATCTATTCAATCTGCGCGGCCCGAGTTTACCGATCGATACCATGTGCTCCTCTTCGCTAACGGCCATTCACGAAGCCTGCGAACATATACGCCGCGGTGAATGTGAGTTGGCCATTGCGGGTGGCGTCAACTTATATTTGCATCCCTCTACCTATGTGCAAATGTGCGCAGCCCATTTGCTGTCGCAAGATGGAAAATGTAAAAGCTTTGGCGAAGGCGGCAACGGTTTTGTCCCCGGTGAGGGCGTAGGTACGATCGTGCTGAAGCCGCTCACCCAAGCGATTGACGATCACGATCATATCTATGCCGTCATTCGTGCGTCGAGTGTGAACCACGGCGGCAAAACCAATGGCTATACGGTGCCCAACCCAAATGCGCAAGCCGCTCTGATTGAGGACGCGCTGGACAAAGCCGGGGTGGATGCGCGTACGCTTACATATATTGAAGCACACGGGACGGGAACCGAATTAGGTGATCCGATCGAAATTCGTGGTTTGACTCAGGCTTTTCAGAAACATACTATCGATACGGCGTTTTGCGCCGTGGGATCGGCTAAATCCAATTTGGGGCACCTGGAAGCGGCCGCCGGTATTGCCGGGCTGACGAAAATTATTCTGCAGTTGCAACATGCAAAAATTGCCCCGAGTCTGCATGCCTCGACATTAAACCCAAATATTAATTTTGCCAAAACCCCCTTTGTGGTGCCGCAAGCACTTTCAGAGTGGAAAAGACCCATTGTCGACATGCACGGCGAGGTCAAAGAATACCCCAGAAGAACGGGTATTTCCTCCTTTGGTGCCGGTGGGTCGAATGCCCACTTGATTGTTGAAGAGTATGTGAAGGGGACCTCGGTTGGAGAAACGAGGGCAAGTCATCATCACGATGTGATTCGCAACGAGGCCCAAGTCATTTTACTGTCAGCGAAAAATGAAGATCGTCTCCACTGTGTGGCAAAAGATTTACATGATTATCTCAACGCGGAGCAAGGCGCAAACTTAAGCCTGCGTGACATCGCCTATACGCTCCAGTTGGGCCGTGAGGCCATGGATGAACGTTTGGGGCTGGTTGTCTATTCGTTGGATGAGTTGCGACAAAAGCTTAACGGCTTTATTGCAGGAGAGAGTGGTATTGAAGATGTGTATCGCGGACAGGTTCAAGGTCATAAAAAAGCACTAGCGTTATTTACTGAAGATGATGAACTTCAAGAAGCGATTGAAAAATGGATGCAACGCGGAAAATTCGCCAGGTTGGTCGAGCTTTGGAGTCAGGGCCTGGCGGTTGATTGGAACAAACTATATTGCGATCGCGAAGTCATACCTTATCGCGTCAGCCTGCCAACATATCCCTTTGAGCAACATCGATACTGGATCGAAGACACGTTGCATGCCTCACCCAAGCCGGTGGCTGAGTCAGTGGGGCAAAGTGCGGTCAAACTACATCCGTTGATCCACGAAAACACTTCCAACTTTCTCGCGCAACGCTTCCGCTCATGTTTTCGTGGCGACGAGTTTTTCTTGGCCGATCATCTGGTGCAAGGTCGGCGCGTTTTGCCGGGCGTTGCTTATCTGGAAATGGTTCGCATGGCAGTCTCACTGGCGATGGATACGCAAATCGAGGGGTATGATTTACGTTTTGAGAATGTGGTTTGGGCAAGACCTATTATCGTGGACGGTCAGCCGCTCAATATGCATACCGTATTACAGGTAGAGGACAGCACTACCATTAGCTTTGAAATATACTCCCAGGTAGATACCGAGGAAAACGATGCCGATGTCTTACATTGCCAGGGCTCAGTTGAGATTTGCGTTTTAGAAAAAGAGCAAGAGTTAGAGGTGTCCCATTTACTAGGCGAGTGTCAGAAACACCATCTTTCTGCTGCCCAATGTTATGAAGTCTTTGAATCTGCTGGTATTCAATATGGCCCGGGGCACCGAGGCCTTGATACCGTCTATGTGGGAGATCAGCAGGTTCTGGCAAAATTGCTTTTGCCGCCATCGGTTGCAAGCACAGCGGAACAATTTATTTTACATCCGAGCTTGATGGATGCTGCCTTGCAGGCGTCGCTTGGCCTGGCCGTAGGCGGTGTTGGGTCCGAGCCCACCCCCTCCTTGCCCTATGCGTTGGAAACGCTTGATCTCTGCGACGCGGGGGCCAGACCAAGTTGGGCCTGGATTCGTGAATCCAACCAAAGCAGCGGGGAGATTCAAAAACTTGATATTGACCTGTGCGACGATCAAGGCCGCATCTGTGTTCGGATGCGAGGGTTTTCGTCACGTGTGCTCGAGCGGGCATGGGGCTCGCAAGAAGACCGTTTGACCCTGCTGAGTCCGGTATGGAATGTCATATCAGACCCGCCAACAGAAGGCGAGCGCGATGATGTTGCCAGTGAGCAGGTGATCATCGCCGGGGGTAGCGACCTGCAAAGAGATATCCTTGGGCAGGTTCACCCCGGTGCGGTGTGGTTACCAGCAGACGATTTTGAGGCGATAGACCAACAAGTTAAGGTGTTGCCATCTCAGATGGATGTCGTGCATATCATCTGGGTCGCACCGGATCAGCCAATGACCTCCGTGAGACAAGAGTCTTTGATTCGTGAGCAAGTCCAAGGTGTGCTTTATCTCTTTCGTCTCATGAAAGTCTTGTTGGCACACGGTTACGGTGAGAAAGAGCTGCATTGGACCGTTATTACCACACAGGCACAAGCGGTACGCAAAAAGGATATCGTCAACCCCACCCATGCCAGTGTACATGGCTTCATCGGTTCGCTTGCTAAGGAATATCCGCATTGGAAAATTCGGCTGTTGGATATGGACGCGGATGAGAGTTGGCCGGTTCACGATATGCTGGCCTTACCTGGGGATCAAAATGGCGATGCCGTCGCCTATCGAGCCAAAGAGTGGTTTCAACAAGCGTTAGTGCCCGTGTTGGAGACGGATCAGGGATTACCCCCCTGTTATCGTTCTCAGGGGGTCTATGTGGTGATTGGCGGCGCAGGCGGGATTGGCGAGGCCTGGAGTCGGTGGATGATCGAGCGCTACCAAGCGCAGATCATCTGGATCGGCAGACGAAAAAAAGATGCTTTGATTCAGGAAAAATTGGACGCTTTAGACAAACTTGGCACCCCGCCCATCTATATCGAGGCGGATGCTGGCGACCTGATGGCTTTACAAAATGCGTATCAGCAAATTAAACGTCGCTATGGTCGGATTCACGGTGTGATTCATTCAGCGATTGTCCTGGCCGACAAAAGTTTGGCCAATATGGACGAACGGCAATTCCTGGCCGGTCTGAGAGCCAAAGTGGATGTGAGTGTACGGCTGGCACAAGTGTTTGCGAAAGAAACGCTGGATTTTGTCTTATTTTTTTCTTCTACTCAGTCCGTTGCTAAAATGCCAGGGCAAAGTAATTATGCGGCCGGTTGTACCTTTAAAGATGCCTTTGCCAGCCAACTGGCTCAGGAGTGGCCGTGCCAGGTCAAAGTCATCAACTGGGGCTATTGGGGAAGTGTCGGGGTGGTGGCGATCAGCTCATATCGTGAGCGTATGGCGCGGGCGGGGGTGAGGTCCATCGAGCCGGCAGAGGGGATGGCCGCCCTCCAAAGCCTACTGCAATCATCACTGGATCAGTTGGCCGTGGTCAACACTCTCCCCACTGCGAGCATTGCTCAACCTTCACGGAATCAGGCGTTGGAGGAATGGATCACGACGTATCCGGACGGGCTTCCTGTCTGTGTGGACAGTTTACCACAATATCTTCCGAATCAACCCCTTCCGGTTGTCGATAGCGGCACCGGGGTGCCCGACCAAACTGTGACCATAGAGGATTTATTGCCCCAACTCCTATTGGCTACGTTGCAGTCCTTAGGCTTAATCGAAGGGCGGGCCGAACAGCGTGCCGCCGCTTTACCGGCTGCTACCTTTTATAGACAATGGCTGGAAGAAAGCCTGACCTTCTTGTGGGCAAAAGAATATCTTGAGTATGATGGGCAGGGTTATACAAACAAGCTGCCCTCAGTTGACCTCGCACGTGTATGGCAGGAGTGGGAGCGGGAGAAAGTTCTCTGGCTGCAAGATCGCAATCAAAAGGCCATCGTGAGCCTGGTGGAAGCATGTATGCGTGCTTTGCCCGATATCCTTAGAGGAGCGCAACTGGCAACTGACGTCATATTCCCGGATTCATCCGTCGCACTGGTCGAACATATTTACAAAGGCAACGTGGTTGCAGATTATTATAATCAAATCCTTCAGAATAGTGTCGTGGCATATATTCAAGCACGACTGGCGCAAGCGCCTACGGCGCAAATCCGAATACTTGAAATTGGTGCCGGAACCGGTGGGACGACTTCTGGTTTACTGGCTGAACTCCGCCCATATCAGCGTCACATCGTAGAGTATTGTTATACAGATCTTTCAAAAGCCTTTCTAATACATGCCGAGAGGCAGTATGCCACAGAGCATCCGTATCTTGTGACACAGATTTTTGATGTGGAAAAACCGCTTGCTGAACAAGGTATACAGGCAAATCACTACGATGTCGTGATTGCAGCGAATGTCCTGCACGCGACAAAAAATATTCGCAATACGCTGCGCAATGCAAAAGCAGGCTTACGCCAACATGGTTTGCTCTTCCTAAATGAAATAAGTACGAAGTCCTTGTTTACTCATTTGACGTTTGGTTTGTTGGAAGGCTGGTGGCTGTATGAGGATGCGGCTTTGCGAATCACAGGCAGTCCGGTATTAAGTTCGGCAATTTGGGCCGATGTGTTGGCTGAGGAAGGCTTTAATTCCATTACGTTTCCTGCATTGTTGGCCGCTGAATCCGGGCATGATTTTGGGCAGCAAATTATTATTGCACAAAGTGATGGGATCGTGCGGCAGAAGGCTCGCCGCCAATCTTCACCTGTACTGCCATCTACACCCAAAAAGCAGAGCGTAAAACCGAAGGAAATAACCAAGCTGTCGCCCAATACTGAAACTTTGCGTGAGAAAGCGACAGTTTATATTAAAAAACTAGTTGCCTCAACACTGCAACTTCCAAGCGATCAGATCGACTCTGCCCAAGCCTTGGAAGCCTATGGGCTGGATTCGATTTTGGTGGTGCAGTTGACCAGTACATTACGCAAAGCATTTCACAACATTAGCAATACCTTGTTCTTTGAAGTACAAACGATTGATGGCGTTGTCGATTACTTACTTGAAAGGCAACCTGAGGTATTTAGTGATTTACTTGGAGTTGACAAACAGAAAATTGATGAACGTATTGTTGAAACAAGCACACCAATTGAGAGCCTCGAAAGTACAAGGCAAGCAAATGGGAGAAATCATTCTTTACAGAAACTAAATTTTAGAACGACCCAGAAGTTAAATGCTTTAGCTGCCTCAAAAAAACATGAGACTGTCCATGATCGGGATATCGCGATCATCGGTCTGAGTGGACGTTATCCGCAGGCTGAGAATGTCAATGCATTTTGGGAGTGTTTAAAGGCTGGGCAAAACTGTATTCGCGAAATCCCGCAGGAGCGGTGGGACTGGAGACGCTATTATGATGCGGAAAAAGGCAAAGAAGGAACACTCTACACGAAATGGGGCGGCTTTATTGACGATGTAGACAAATTTGACCCGTTATTTTTTAAATTGTCGGCGAGAGACGCCGAGCGCATGGACCCTCAGGGAAGGCTCTTTTTAGAGTGCGCCTACAGTTGTATGGAAGATGCGGGTTATACGCCGAGCACACTTTGTGACAGCCGTAAAGTAGGCGTTTTTGTTGGGGTGGTGAATAGCACGTATCGGCGTCAGCCAAGCTTCTGGTCGATGGCCAATCGGGTGTCCTACCTATTTAACTTTCAAGGCCCGAGCATGTCCGTGGACACAGCTTGTTCGTCCTCGCTGACCGCTCTGCATCTCGCGATTGAGAGTCTGCATAGCGGCACAAGCGAATGCGCGATTGCCGGCGGGGTGAACTTGATTCTGGATCCGATTCAATACCTGACGCTAAGCGCCATGACGATGCTTTCATCAAGCGACGCGTGCAAGTCTTTTGGGAATCAGGCCGATGGCTTTGTCGATGGCGAAGGCGTAGGGGCGGTGATCTTAAAGCCCCTGGCAAAAGCGGAGCAAGACGGAGACGCGATCTACGGCATTATCAAAGCCAGTATGATCAATGCGGGCGGCAAGACCAATGGTTATACCGTGCCAAATCCAATCGCACAATCGCACTTGATTCGGGAAGCCCTGGCGCGAGCCGAGGTTGACCCGAGAACCATTAGTTATGTGGAGGCTCATGGCACGGCCACGGCTTTAGGCGATTCCATTGAAATTACCGGCTTGAGCAAAGCCTTTGGCCTCAGTGAGGACAAGCAATTTTGCCCGATCGGTTCGGTGAAATCGAATATTGGTCACGCCGAAAGTGCGTCGGGTATTGCTAGTTTAACGAAAGTCTTGCTGCAATTGAAGCATCGCCAATTGGTGCCTTCCTTACATTCGCAGCAGCTCAACCCCAGTATTGATTTTGCTGAGACACCCTTTGTCGTGCAGCAGACCCTTGAGCCCTGGCATAGGCCCGTGTTGACGATTGATGGAGAAACCAAGACCTATCCGCGCATTGCCGGCATCTCATCCTTTGGAGCTGGTGGGGCGAACGCCCATGTGATTATCCAAGAATATATGAATGAGAAGGGCGATGCAGCGGCTGACGCCGAGGGACAGGGGTGGCCTGAGACCAGCTTGATTGTGGTTTCCGCCAGAGATGAAGATCGGCTTAGAGAACTTGTCAATCATCTGTGCCTTTATGCGAGAGCGTGTAGCCTGGCAGATCAGGGCAAGGCACAAACCGCCAAGCTGCAAGCCATGGCGTATACCCTCCAGGTGGGACGCGAAGCCATGGAAGTACGCCTAGGGGTCGTGGTGGCCTCTTTTGCTGAACTTAGTGAAAAGCTCCAGGGATTTTTGGACGGCCAACGCGATGTGGACAACTTGTATCGGGGACAGGTTAGACCCCATCGAGAAGCAATGGCGGTTCTTGCCGGTGATGACGTGTTCGCAGAAACGATTGATGCCTGGATTCACAGACACAAGTACGACAAAATCTTGGAGCTTTGGGTTAAAGGCTTTGTCTTCGACTGGAACAAGCTGTATGGCGAACAGAAGCCGCCTCGCATGCATTTGCCAACCTATCCTTTTGCACGGGAACGCTATTGGGCAAAAATAATTGATTTATCCCTCGATGGATTTCAAGTTGGTGCTCCACAGCAAGTTGTAGAGTGGATCCATCCTCTCGTTCATAAAAATACTTCTAATCTTGAGGAGCAACGTTTTAGCTCGACATTTAGTGGCCAGGAATTTTTTCTAGCAAATAATCGTGTCGATGGAGAGAAGGTGTTACCCGGCGTCGTCTATCTTGAAATGGCACGAGTGGCGGCAGAACAAGCACGGCCTCACCCCTCTACAAGCTTGGCGAAGAGCCATATTCAACTTAGAAATATCGGCTGGGCGACTCCCTTTGTCTGTGACCATTCGTCGCAAAGCGTGCATATCAGGATTGTGCCAGGTACTTATAAAGGCAGTGACGTCAGTTTCGAAGAGATGAGCTATGAAATCTATTCACACATAGATACAGAACGTGAGGTTGTCGTACACAGTCAGGGTGTCATCGCCTTGTGGCAGGCTCGTGAAGTCGCCGGGTTGGATTTGCCAGCTTTGCAGGCGAGCATCAATCAGAAATGTCTCAGTGCACAGCAATGTTATGACGCGTTTGCAGCGATGGGCATTGAGTATGGTCAAGGGCACCAAGGCATAGAGGATGTCTATATGACGCCTAGCCAAGCCGGTCGCTGTCAAGTGTTGGCAAAACTCAGGTTGCCTGCCGTTGTTGCTGAGACGAGCCATGATTTTGTTCTTCACCCTAGCATGATGGATGCAGCCTTACAGGCATGTATTGGACTGACGGTTGAACACGCCGTTCCCGAGTCTGGACAGATGTCGCTCCCCTTTGCCATAGACGCTATTGAAGTTATTGAAAAATGCACAGATACGATGTGGGCTTGGATACGCTATGCCGATCCTCATGCCGACCCAATACAACCGTTGAGTTCACGCGTGACCAAGGTTGACATCGATCTGTGTGATGAAAGCGGGAATCTATGTGTTCGGATAAAAGGATTTTCCACTCGCGTGGTTGCCATACCGGAGAGCAAAGCCATTGGAACTTGGATGAGCTTTCCAGTATGGAAAGAAAAATCCTGGTCTGAACATGAGCCTTCAGAATATGCTCAGCGGACGGTGATGTTGATAGAGATGGAGTGGGTGTCTGATCGTTTGATTGAGTCTCAAATCGAAGGCACGACTTGTGTTCATTTGACAACCCAAGCAAATTCACTGGCAGAGCGCTTTCAAGATATTTCAGTTCAGGTGTTTGAGCGGGTCAAAGCGCTCATGGAAGCAAAACTTAGAGGGTCAATCTTAATCCAGCTTCTGGTGCCTCACTCGGGAGAGACGCTGCTGTTTAGCGCACTTGCAGGCATACTCAGAACGGCTCACTTGGAAAACCCTGCGCTGTTGGGGCAGGTGATTATCCTGGAGCCGAGTGAAACCCAAGAGGGGGTAATCGACAAACTTCAGCGCGACAGCTCTTGCCCCGAAGATGCGTTAATCCGTTATCAGCAAGAAAGACGCCAGACGATGGCGTGGCAAGAATTGCCGATGTCAGAGCGAGAGCAGGCCGTGCAAGTTCCCTGGAAAGAAGGAGGTGTCTACCTGATTACAGGCGGCCTAGGTGGCGTTGGATTCATGTTTGCCAAACATCTTGCGCAGCACAGCAGGTCGGTTTCTCTGGTGCTGACCGGACGGTCGGAACTAGATGAGCAACGGCGCGAGCAGCTCAAAGAACTAGAAGCGTTGGGGGCCAGGGTTGACTATCTCTCGGTCGATGTCAGCCTTAAGGAGGCGGTTGAGCGCTTAATTGACTACATCGAAAGCGAGAGGGGATCGCTCACCGGCATTCTGCATAGTGCCGGTGTGATTCAGGATAACTTTATCATTCGAAAAGCAGTGCGTGAGTTTCAATCCGTGCTTGTGCCTAAAGTCGATGGCGTGATTCATTTGGATCAGGCAACGCAAGCGTTAAATCTCGATTTTTTTGTCCTGTTTTCTTCTCTCTCGGGCATTAACGGCAACGCCGGTCAGGTAGATTATGCCTGCGCCAACGCGTTTCTAGATGCTTACGCGCATTACCGCAATAGATTGGTTGCCATTAACAAGCGCTCCGGCCAAACGCTCTCTGTGAATTGGCCGCTGTGGAAAGAGGGGGGGATGCAAATCGATCCCCAGCGTGCAGAGGCGATGTTCCAACATTTGGGGCTGGTGGCGATGGAGACATCGCGTGGTATTCAGGCATTGATTCACGGTCTTTCCTCCGGACAGAGCCAGCTCATGGTGGTGGCAGGTGATCTCGAACGCCTGAAAGTTGCACATCCATCACGGCCATCATCGCCACCCTCTCAGATGGATCGTGAACACAATGTCATTGGTGAAAACGAGTTGGATGCCAATGCGTTGGCGTCAAGGTCTATTCACTATTTCAAAAACCTAATTGCGTCTATACTCAAGATACCTGCCCATCGTATTCAAAACGATGAGTTACTGGAATTGTACGGTATTGACTCTATTATTATTATGCAGTTGATCAATCAGTTGGAAAGAGACTTTGGTCCATTGTCGAAAACGCTCTTTTTTGAGTACCCAACCATTGAAGAAGTTAACCAATATTTTGTCGACTCATACAGACAAAAGCTCCACGTGGTCCTTGGCTTAGACAAGTCAAAGGCACCTGAAACTGACCACTCGGCTGTTGTCGATCCGGCTCGCCCAAAGGTACATCGGCGTTCTCGCTTGTTGGCACCGACATTAGATGAATCACCACTCCCCGTTGCGCAAACGCAGGATGTCGCCATTATCGGTGTTGCCGGACGTTATCCCCAATCCCCGGATCTTGAATCGTTCTGGGAAAATTTGTCGCAAGGTAAAAATTGTATTACTGAAGTTCCCGAAAGTCGTTGGGACCCCAGCTTGTATGTTGATTTTGACCCTTCCAACTCTGGTCAGGTGTATAGCAAGTGGGGTGGTTTCTTAGATGACGTGGACAAATTTGACGCTTTATTTTTCAATATTTCTCCTCGTGAAGCAGAGTTGATGAACCCGAATGAGCGTCTTTTCCTGGAAACCGTCTGGGAGCTGGTGGAACGTTCGGGGTATACACCGGAAAGAATACAGGAACAGCACGAAAATAACGTGGGGGTTTATATCGGGGCCATGTATCAGCAGTATCAGGCCTTAGCTTCCGAGCCCCTCATAGAGTCGGTCCTGTCCTTGTCTTCCCATAGTGCGATTGCGAATCGCGTGTCCTATTTTTTTGATTTCCAGGGCCCTAGTCTGGCCATCGACACGATGTGTTCCTCTTCATTAATTGCGATACAGTTAGCTTGTGACAGCCTGCTGAAAGGCGAGTGCCAGATGGCCATTGCCGGAGGTGTCAACCTCACGATTCATCCGAACAAATATATTGGCTTGAGCCTGAGTCAAATGATCAGTCGGCAAAACACCAGCAAAAGCTTTGGTGAGGGTGATGGTTATCTTCCGGCAGAAGGTGTCGGTGCCGTGTTGTTAAAGCCCTTGGCCAAGGCGATCGAAGATCAGGATTCCATTTTAGCCGTCATTAAATCCATTAGCACCAATCATAGCGGACATACGTATGAGTTTCGTGTACCCAACCCGAATGCGCAAGCCCAATTATTTGAAGCAAATTTCCGTAAATCCGGCATCGATCCACGCACGATTACGTATGTTGAATCGGCGGCCAATGGTTCTCCCTTGGGAGATCCGATCGAGGTCAGTGCACTTCGTAAAGCGTTTCAAAAATTCACTGCGGATCAGGGCTTTTGTGCGATTGGTTCCGTCAAATCCAATATCGGTCATGCAGAGGCAGCATCCGGCATCTCCCAACTGACAAAAGTGATATTACAGCTTCAGCATCAGCAACTTGTTCCGTCGATTAATGCAGACCCACTGAATCCAAATTTAAGCTTCGATGGTTCGCCATTTTATCTGCAACAACAACTGCAACCATGGGCACGTCCAGTCTTCAATATCGATGGTCAAGAGCGTGAGTTCCCCCGGCGCGCAACCGTTAGCTCCTTTGGGGCGGGAGGCTCGAATGCGCATTTGATTATCGAGGAATATATTGCTTCTGCGGGTAAGAACGCCGTGTCACCTGATATAGAGTTGGCAGCCGATCGCGAGTTGATGGTTTTTTCCGCAAAAAGCTGTGATCGTCTTCAGGCGATGCTGCAACAGATGCGTCATTATGTCGAATCCAACCAAGCACTTTCGCTAAAGAAGATGGCCTATACGCTCCAGGTAGGACGTATGGCGATGACACATCGAATCGCGATGCTGGTGCATAATCGAGAAGAGCTGATCCAGGGCATCCAAGATGCTTTGCATAGCCTAGAACAACCAGCCGGGATAATCAACACAACCATTCCAATATACATGGGTGATCTGGAGGCGGATCACTCGGAAGTAAAGCATTTGCTCTCCGGTCAATCCGGAGAGGCCATGCTGAAAGTGCTTTTCGCCGAAGAAAATCTGGAAAAAATTGCTCTTTACTGGGTTAAAGGAGGCCATATTCCCTGGCTGGCACTGCATCAAAAAGGTCAAATGTCTATGTTGTCTCTACCCACGTACCCTTTCTCCAAGCGGTACTGCTGGGTTGAGAGTAAAGCCCTGTCTCAAGTTGTAACCACGGCTGAGGCCGAATTACTTTCGAAAAGTACGGATGATCATATTTCCGTTGACAGAAATGAAGAATCAGTTCTTTCAGAGATTCTGTGCCGAACCTTAGGCCTAACAGCAGAAGAGTTTAATCAAAAGACCCCATTGGTTCAATATGGGGTGGATTCCGTTATGTTTGTGCAAATTTTTCAACAAATTAAAGACAAGATTGATAACCGCGTTAACTTGAGTCAGCTGCTGGAATGCCAAACCATGCAAGATATGATTTTCTATTTGACTGCGAAAAAGGAGGACGCGCAAACCGAGCCGGAGCTGGTGAACCTTTCCGGAGCCGGTCTTTCTTCATCACATGACACACGTTTTCCAGAGCTGGTCCATATGAACTCAAGTACCAGGGGAAGACCTGTATTCTGGTTCCATGGCATCGCGGGCGTTACGGTTTACGAGCCTGTTGCTGAAAAAAGCCAGCGCCCCTTCTATGGCGTTCAGCCCTGTAGCTGGATCAACCAAACCGCGGGACCTTCTCATATTCAGGCCATGGTGCAAGGTTATCTGGATGCCATACGATCCGTGCAGCCGGAAGGTCCTTACGATTTTGGTGGCTATTCGCTGGGTGGCATGTTGGCTTATGAAGCCACCCGTCAATTACAGGACATGGGAGAGAGCGTATCGACCATTGTGATGGTCGATACGCTACAGAGTAATCCTGATCGTAAGGATAAGTACTCGCGCAAAACAGATTATCTGGTTGTTTTGAATCGGTCCTTTGCCTCATCTGCATGGCAGAGCTCGGAAAATACCGTGCAGGACATGCTGATTCGTGCAGATGAGCTGGATGCAAGTCTAAGTGACGACGAGTATTTAACAGAGCTGATTGTCTTAGCCAAACAACGAGGACTGGTCAAGACAGAGACAGAGATCCGTGCCAGCCTTGAATATGCAACAACCCTTGATGAGTTTTATCAAACTGATCCCTTTACGGTTAGGCCCCTATCTGATCCCGATGCCGTTAACTGCTACTATTTCCGCAATAAGAATGGCGCGATGTTGGGTGATCAGGCGCCCTACTATTTTGCGACACCACAAGACAGGGAAATATTTGTCACCACCGATCAGTCAGCCGATTCGCGGCAGTGGGAAAAGAACTTGACGAACCTTCACATCATTGATATCGATTCGTCCAATCACATGACGATGTTCTCGGAAGAAAAACCACGCCAGACCATTCTTGAGTTCTGTGAAATCTTGTATTCTGAAGCCGGACTTCCGAATGCATTTCTTGACTTCTTTATGGCCAAGGCTCGAGAAATACATGGCAATATAGAGCTGGACAGATAA", "orf_prot_sequence": "MKKEFHIHASHPIVKHHQAYGQALLPGLAYIDLLYQFFREQGYEFAALELRNLSIYRPLLVGEDDGIQLLLQADDMAEGLWSVQLLDGEQRGAPESKAQQLYIKAEMYHHREAPVFDDVLDFQALQAVSHTQIPLNDIYAQCRSQGLVHSGMMKAEGTAYTLDDAQIIEVALPDEAASSAAGFMFHPALIDGSGVGSSNLFAALVEGEQRLFLPLFYERFRASARFERTCLVRVKTASVWRKNDMMYMDIEFFNESGEKIAELKNFVNKLVREAALINPNLKPASQAQSSKLKPYEEASSESQANPPRLDKSEALEGMEDLLKEIIAPYVDGSPEQLDPEAGYYELGLDSAILLQVVTALEKRFDAKLMPTLLFEYTTIEELAAYFVNENFATKHVAKEPATPLAPVLPGPIQTGHEDDIAIIGISGRYPGANNINEFWQNLVVGKDCISDVPEERWDWRSVAKHKSPSGKSVSKWGGFIQDPDCFDHQFFRISPREAEVLDPQERLFLQTCWECIEDAGYTPETLVTRQQAPHRRQSVGVFVGVMHKDYVFLGMEAIARGEQFHLSINNAPIANRVSYFCDFHGPSMVIDTVCSSSLTAIHLALESIRHGESDIALAGGVNLSLHPNKYLTYGLLDMYSSDGRCRAFGRGGDGYVSGEGVGAVVLKPLAQAIQDRDHIYAVVKGSMINHVGKVTGISVPNPVAQSDMILQCLEKTGIHPRTLSYVEAHGTGTSLGDPIEIQGLCKAFQTHTNDTQFCAIGSVKSNIGHTESAAGISGLSKVALQLHYQTLVPSLHSEAINPHLDLEASPFFVQRQTQHWERTSDHPRRAGLSSFGATGSNAHVILEEYIPEQSETDLAQPAEGVEQRLPVLIPLSAKNEERLKEAARNFYHYLISKPEDVAGHQVARLSDIAYTLQVGRRAMETRAIFLVDHQQQLVESLQAFLDDDHTKGNSWLGKQVKQQRHARRGEYSEAMLQQWMVQGRLDQLAQAWSEGVPLNWDALYSPESGVAKPSRVSLPTYPFAKARHWVPMEVKAVTPFAALHPLLHRNTSTLGEQRFSSTFSGEEFFLADHRVHGQKMLPGVAYLEMARAAVALATSAGEAQAIRFKNIIWQQPLVIDGTEKTIHIGLYAKANSQVDFTIYTGDEHGSDAPFPDEQNRRVHCRGIAMLTLSDRERETYLDLDHLQSQTGQNDFTPEQCYQAFAAMGIDYRDGHQGIAAVHAGADQILAELSLPASVLAHREPFVLHPSMMDSALQAAIGFALSAQVAGAQQPASLPYALESLDVRAACTPSMWVWIRYADNNSAGSPVQKFDLDLCDDRGKICVLMRGFSSRIFHAQASPCFAETLLPSQLHPLLHQHVPSENPVHDQFIAQFTGEEFFLRDHQQVMLGMAYLEMAHRAGQHRASQKILGLKNVVWSQLLFIAGQAREVSVHVQNEVLQHRFRITTQNEDSLQNIHCQGMLVVDQALYPERPDQLNIQDIQSRCSASIETTECDQLLQYTHGPSLLTIKQLWHNEHEALALLQLPDGMRSGREDYTLHPSMMNGAILTSVLFSLLNGPQEHLPMPFALDELWMYQEMPERAYAYVSMSSANNHDIELVDITGKCIVLFKGFTAAIQGAWQSQAPQNNVIYASTQWRESVLSGDEHANTAASAPIVMLAQDNPELAGLLRQRWPEASIEMLAPIGEDIAKTVQANFLQVFDRVKTCILEQPQRIQPIVVLLPENENDYLHDGLAALFKTARFEYRKIVGKLIRYTIDIDIEELAKSILMEVSHDDQHVDVYYSQTGTRKVKTLNEIYDFEKSHAHLLVEADLLHEGDVVWITGGLGGLGQIFTRHLSHTKGLKLILSGRSPLNAASEKVLRELQQSDVEMSYLSCDISDQQAVATLVQSILNKYGKLNGVIHSAGLTRDAYIHNKTREEMIAVLRPKMAGILAIEAACQDIQLNFMVLFSSIAGVFGSIGQADYAMANAFLDSFAEARNRRVQQGKCFGRTLSINWPLWRNGGMGVDAQNETLMQRNTGMIALETRAGLNAFELALSSEYSHILVAQGETEKIRSRLLSPRFVEENLSSVEADTTEPLEHQNQSEPSKAEQDQRAWLIRLLLKDLAAFVCRLQKVQPEEIDLEAEFSVYGFDSIGFMSFVNHLNDMYDLELMPTLFFEHSSLRALADALIEKHQEALLKKYESPKTAAQPSQDRMPIQARAVEMDKRQHPVSATMTPVESETTQGNPTPESLSTTDPIAIIGMSGKFPGSENLTAFWQHLEANRDLVSEIPEDRWDWRDYYGDHLSESGKTKIKWGGFIEGIDHFDPLFFGISPVEAEIMDPQFRLFLQTVWATIEDAGYRASALSGSKTGVYVGVTTTDYKDLMQQARARENSQEYHGMFPFMLANRVSYLFNFRGPSEAIDTACSSSLVAIHRATESIRQGSCEMAVAGGVNIIANPQLVLSATQGGMLSEDGRCKTFDQSANGYVRGEGVGAILLKPLARAIEDHDPICGVIRGSAENHGGKATSPTAPNPVAQQELLVSAYAQAGITPETVGYIEAHGTGTPLGDPIEINGLKSAFAQLYEQIGRPPANEPHCALGSVKTNIGHAEAAAGISGVLKVLLMMKHQKIPGNPHLKEPNPYLQLTGSPFHLAQDTQDWRALHDEVHNPIPRRAGVSSFGIGGSNAHLVLEEYTAEPAAEPVVCGEASLIILSAKNRACLVEAAGNLYRFLIDNRESSRGELLRLADIAYTLQVGREEMAHRLGFVASSLTELEERLQTFINVQGENQDLYEGHTKGNRSTLEAFESDDDLQEMLTKWVEGRRFEQILKLWVKGLAVNWESLYRGIQPRRISLPSYPFARERYWIPASAESLPVPAASPVSPIQVDNAAGVLMCHPVWEEKAAPVQVGSFDPASLHDCQHLILFCHMDVPLGLQDRFGTSSVCRVFQAQSDDVALGYSYLCEQVLTCLKEILENKPRDRVFVQIVIPGPETSEAEGASGLLHGLSALLKTAHLENPKVLGQLIEVGPRHTGDALIRCVQENCQSPDDVQVRYRHGRREVMAWEELPVSEPNAAPMPWKERGVYLITGGAGGLGFIVAREIARRVKAPILILAGRSHLSQAKRDELQQEAQRLGVQIEYRQADVSQPQEVNDLIRSILRDFTKLNGILHAAGLIRDSFMIRKTVDQLHQVLAPKVFGTVYLDEASKDVDLDFFLLFSSGAAALGNAGQADYAAANAFMDAYAEYRHALFASKQRFGRSLSINWPLWQEGGMQVDEPTLTALEQYAGIRALQTGSGLDALYRALSVTPNQIMVLEGDLAKIRQGLFSASTEPYRNESSRVEVDEERLLARTLHQCKTLFGGIIKLAADRVEAEEALEHYGIDSVIIAQMNLRLEEVFGEVSKTLLYEYQTLGELASYLATEYRDACMTWTGLTAIPTSDMTTVPDDAIPAKPQITSEPRRSSGVDVHALTPKAPAPSQDEPIAIIGLAGRYAQADTPRAYWENLQSGTDCVTEIPPDRWSLSGFYHEDLEEAIAQGKSYSKWGSFLNGFADFDPLFFSMSPREAIGIDPQERLFLQSSWEAMEDAGYTRETLRDQFQQRVGVFVGITKTGFSLYGPELWQRGDIVYPTTSFSSVANRISYLFNLRGPSLPIDTMCSSSLTAIHEACEHIRRGECELAIAGGVNLYLHPSTYVQMCAAHLLSQDGKCKSFGEGGNGFVPGEGVGTIVLKPLTQAIDDHDHIYAVIRASSVNHGGKTNGYTVPNPNAQAALIEDALDKAGVDARTLTYIEAHGTGTELGDPIEIRGLTQAFQKHTIDTAFCAVGSAKSNLGHLEAAAGIAGLTKIILQLQHAKIAPSLHASTLNPNINFAKTPFVVPQALSEWKRPIVDMHGEVKEYPRRTGISSFGAGGSNAHLIVEEYVKGTSVGETRASHHHDVIRNEAQVILLSAKNEDRLHCVAKDLHDYLNAEQGANLSLRDIAYTLQLGREAMDERLGLVVYSLDELRQKLNGFIAGESGIEDVYRGQVQGHKKALALFTEDDELQEAIEKWMQRGKFARLVELWSQGLAVDWNKLYCDREVIPYRVSLPTYPFEQHRYWIEDTLHASPKPVAESVGQSAVKLHPLIHENTSNFLAQRFRSCFRGDEFFLADHLVQGRRVLPGVAYLEMVRMAVSLAMDTQIEGYDLRFENVVWARPIIVDGQPLNMHTVLQVEDSTTISFEIYSQVDTEENDADVLHCQGSVEICVLEKEQELEVSHLLGECQKHHLSAAQCYEVFESAGIQYGPGHRGLDTVYVGDQQVLAKLLLPPSVASTAEQFILHPSLMDAALQASLGLAVGGVGSEPTPSLPYALETLDLCDAGARPSWAWIRESNQSSGEIQKLDIDLCDDQGRICVRMRGFSSRVLERAWGSQEDRLTLLSPVWNVISDPPTEGERDDVASEQVIIAGGSDLQRDILGQVHPGAVWLPADDFEAIDQQVKVLPSQMDVVHIIWVAPDQPMTSVRQESLIREQVQGVLYLFRLMKVLLAHGYGEKELHWTVITTQAQAVRKKDIVNPTHASVHGFIGSLAKEYPHWKIRLLDMDADESWPVHDMLALPGDQNGDAVAYRAKEWFQQALVPVLETDQGLPPCYRSQGVYVVIGGAGGIGEAWSRWMIERYQAQIIWIGRRKKDALIQEKLDALDKLGTPPIYIEADAGDLMALQNAYQQIKRRYGRIHGVIHSAIVLADKSLANMDERQFLAGLRAKVDVSVRLAQVFAKETLDFVLFFSSTQSVAKMPGQSNYAAGCTFKDAFASQLAQEWPCQVKVINWGYWGSVGVVAISSYRERMARAGVRSIEPAEGMAALQSLLQSSLDQLAVVNTLPTASIAQPSRNQALEEWITTYPDGLPVCVDSLPQYLPNQPLPVVDSGTGVPDQTVTIEDLLPQLLLATLQSLGLIEGRAEQRAAALPAATFYRQWLEESLTFLWAKEYLEYDGQGYTNKLPSVDLARVWQEWEREKVLWLQDRNQKAIVSLVEACMRALPDILRGAQLATDVIFPDSSVALVEHIYKGNVVADYYNQILQNSVVAYIQARLAQAPTAQIRILEIGAGTGGTTSGLLAELRPYQRHIVEYCYTDLSKAFLIHAERQYATEHPYLVTQIFDVEKPLAEQGIQANHYDVVIAANVLHATKNIRNTLRNAKAGLRQHGLLFLNEISTKSLFTHLTFGLLEGWWLYEDAALRITGSPVLSSAIWADVLAEEGFNSITFPALLAAESGHDFGQQIIIAQSDGIVRQKARRQSSPVLPSTPKKQSVKPKEITKLSPNTETLREKATVYIKKLVASTLQLPSDQIDSAQALEAYGLDSILVVQLTSTLRKAFHNISNTLFFEVQTIDGVVDYLLERQPEVFSDLLGVDKQKIDERIVETSTPIESLESTRQANGRNHSLQKLNFRTTQKLNALAASKKHETVHDRDIAIIGLSGRYPQAENVNAFWECLKAGQNCIREIPQERWDWRRYYDAEKGKEGTLYTKWGGFIDDVDKFDPLFFKLSARDAERMDPQGRLFLECAYSCMEDAGYTPSTLCDSRKVGVFVGVVNSTYRRQPSFWSMANRVSYLFNFQGPSMSVDTACSSSLTALHLAIESLHSGTSECAIAGGVNLILDPIQYLTLSAMTMLSSSDACKSFGNQADGFVDGEGVGAVILKPLAKAEQDGDAIYGIIKASMINAGGKTNGYTVPNPIAQSHLIREALARAEVDPRTISYVEAHGTATALGDSIEITGLSKAFGLSEDKQFCPIGSVKSNIGHAESASGIASLTKVLLQLKHRQLVPSLHSQQLNPSIDFAETPFVVQQTLEPWHRPVLTIDGETKTYPRIAGISSFGAGGANAHVIIQEYMNEKGDAAADAEGQGWPETSLIVVSARDEDRLRELVNHLCLYARACSLADQGKAQTAKLQAMAYTLQVGREAMEVRLGVVVASFAELSEKLQGFLDGQRDVDNLYRGQVRPHREAMAVLAGDDVFAETIDAWIHRHKYDKILELWVKGFVFDWNKLYGEQKPPRMHLPTYPFARERYWAKIIDLSLDGFQVGAPQQVVEWIHPLVHKNTSNLEEQRFSSTFSGQEFFLANNRVDGEKVLPGVVYLEMARVAAEQARPHPSTSLAKSHIQLRNIGWATPFVCDHSSQSVHIRIVPGTYKGSDVSFEEMSYEIYSHIDTEREVVVHSQGVIALWQAREVAGLDLPALQASINQKCLSAQQCYDAFAAMGIEYGQGHQGIEDVYMTPSQAGRCQVLAKLRLPAVVAETSHDFVLHPSMMDAALQACIGLTVEHAVPESGQMSLPFAIDAIEVIEKCTDTMWAWIRYADPHADPIQPLSSRVTKVDIDLCDESGNLCVRIKGFSTRVVAIPESKAIGTWMSFPVWKEKSWSEHEPSEYAQRTVMLIEMEWVSDRLIESQIEGTTCVHLTTQANSLAERFQDISVQVFERVKALMEAKLRGSILIQLLVPHSGETLLFSALAGILRTAHLENPALLGQVIILEPSETQEGVIDKLQRDSSCPEDALIRYQQERRQTMAWQELPMSEREQAVQVPWKEGGVYLITGGLGGVGFMFAKHLAQHSRSVSLVLTGRSELDEQRREQLKELEALGARVDYLSVDVSLKEAVERLIDYIESERGSLTGILHSAGVIQDNFIIRKAVREFQSVLVPKVDGVIHLDQATQALNLDFFVLFSSLSGINGNAGQVDYACANAFLDAYAHYRNRLVAINKRSGQTLSVNWPLWKEGGMQIDPQRAEAMFQHLGLVAMETSRGIQALIHGLSSGQSQLMVVAGDLERLKVAHPSRPSSPPSQMDREHNVIGENELDANALASRSIHYFKNLIASILKIPAHRIQNDELLELYGIDSIIIMQLINQLERDFGPLSKTLFFEYPTIEEVNQYFVDSYRQKLHVVLGLDKSKAPETDHSAVVDPARPKVHRRSRLLAPTLDESPLPVAQTQDVAIIGVAGRYPQSPDLESFWENLSQGKNCITEVPESRWDPSLYVDFDPSNSGQVYSKWGGFLDDVDKFDALFFNISPREAELMNPNERLFLETVWELVERSGYTPERIQEQHENNVGVYIGAMYQQYQALASEPLIESVLSLSSHSAIANRVSYFFDFQGPSLAIDTMCSSSLIAIQLACDSLLKGECQMAIAGGVNLTIHPNKYIGLSLSQMISRQNTSKSFGEGDGYLPAEGVGAVLLKPLAKAIEDQDSILAVIKSISTNHSGHTYEFRVPNPNAQAQLFEANFRKSGIDPRTITYVESAANGSPLGDPIEVSALRKAFQKFTADQGFCAIGSVKSNIGHAEAASGISQLTKVILQLQHQQLVPSINADPLNPNLSFDGSPFYLQQQLQPWARPVFNIDGQEREFPRRATVSSFGAGGSNAHLIIEEYIASAGKNAVSPDIELAADRELMVFSAKSCDRLQAMLQQMRHYVESNQALSLKKMAYTLQVGRMAMTHRIAMLVHNREELIQGIQDALHSLEQPAGIINTTIPIYMGDLEADHSEVKHLLSGQSGEAMLKVLFAEENLEKIALYWVKGGHIPWLALHQKGQMSMLSLPTYPFSKRYCWVESKALSQVVTTAEAELLSKSTDDHISVDRNEESVLSEILCRTLGLTAEEFNQKTPLVQYGVDSVMFVQIFQQIKDKIDNRVNLSQLLECQTMQDMIFYLTAKKEDAQTEPELVNLSGAGLSSSHDTRFPELVHMNSSTRGRPVFWFHGIAGVTVYEPVAEKSQRPFYGVQPCSWINQTAGPSHIQAMVQGYLDAIRSVQPEGPYDFGGYSLGGMLAYEATRQLQDMGESVSTIVMVDTLQSNPDRKDKYSRKTDYLVVLNRSFASSAWQSSENTVQDMLIRADELDASLSDDEYLTELIVLAKQRGLVKTETEIRASLEYATTLDEFYQTDPFTVRPLSDPDAVNCYYFRNKNGAMLGDQAPYYFATPQDREIFVTTDQSADSRQWEKNLTNLHIIDIDSSNHMTMFSEEKPRQTILEFCEILYSEAGLPNAFLDFFMAKAREIHGNIELDR", "perc_identity": 45.95}, "gnl|BL_ORD_ID|1663|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 73695, "orf_end": 97673, "orf_from": "BGC0001186.1|Misakinolide_18 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.8057, "max_identities": 16, "bit_score": 29.6462, "cvterm_id": "36920", "query": "DHQQQLVESLQAFLDDDHTKGNSWLGKQVK----QQRHARRGEYSEAMLQQWMVQG", "match": "+ +QQL+E    F        N W+G  ++     + +  RG++SE   +Q+ VQG", "sequence_from_db": "NFEQQLIEKCDLF-------ENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQG", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 76488, "query_end": 76643, "hit_start": 381, "hit_end": 528, "orf_dna_sequence": "GTGAAAAAAGAATTTCATATACATGCAAGCCACCCCATTGTGAAACATCACCAGGCCTATGGCCAGGCGTTGTTGCCGGGGCTGGCTTATATTGATTTGCTGTACCAGTTTTTTCGCGAGCAAGGGTATGAGTTTGCAGCTTTAGAACTTCGCAACCTGTCAATTTATCGCCCTTTGTTGGTTGGGGAAGATGATGGTATTCAGCTTTTGCTGCAAGCAGATGACATGGCCGAGGGGCTGTGGTCGGTTCAACTGTTAGACGGGGAGCAACGCGGTGCCCCGGAGTCTAAAGCGCAACAACTCTATATCAAGGCGGAAATGTATCACCACCGTGAAGCGCCTGTATTTGATGACGTGCTAGATTTTCAGGCCCTGCAAGCCGTCAGTCATACGCAAATCCCTTTGAATGATATCTATGCCCAGTGCCGTTCTCAGGGACTGGTTCACTCGGGGATGATGAAAGCGGAAGGGACGGCTTACACGCTGGATGACGCCCAAATCATCGAGGTGGCTTTGCCAGACGAAGCCGCTTCTTCTGCGGCCGGCTTTATGTTTCATCCTGCCCTTATCGACGGTAGTGGCGTGGGTTCATCCAATTTGTTTGCCGCGCTGGTAGAAGGTGAACAGCGTTTGTTTCTACCGTTATTCTATGAGCGTTTTCGCGCATCTGCACGGTTTGAGCGAACGTGCCTTGTCAGAGTTAAGACGGCTTCCGTGTGGCGAAAAAACGATATGATGTATATGGATATAGAGTTCTTTAATGAGTCTGGAGAAAAAATTGCGGAACTGAAAAACTTTGTCAATAAGCTGGTGCGAGAGGCCGCATTAATTAATCCGAATCTTAAGCCAGCAAGCCAGGCTCAATCGTCCAAACTCAAGCCGTATGAGGAAGCGTCTAGCGAGTCGCAAGCCAATCCGCCTCGGCTCGATAAGTCTGAGGCTTTAGAGGGCATGGAAGACCTGCTTAAGGAGATCATTGCGCCGTATGTGGATGGCTCGCCAGAGCAACTTGATCCGGAGGCTGGTTATTACGAACTCGGTCTGGACTCGGCAATCCTGCTGCAGGTGGTCACGGCACTGGAGAAACGATTCGACGCCAAACTCATGCCCACGTTGTTATTTGAATACACCACCATCGAAGAGCTCGCCGCTTATTTTGTCAATGAGAATTTTGCCACGAAACATGTGGCCAAAGAGCCGGCCACGCCTCTAGCGCCTGTCTTGCCTGGGCCCATACAGACCGGCCACGAGGATGACATCGCCATTATCGGTATTTCCGGTCGTTACCCAGGAGCCAATAATATCAATGAGTTTTGGCAAAATTTAGTTGTAGGCAAAGACTGTATTAGCGACGTGCCAGAAGAGCGATGGGACTGGCGCAGCGTGGCCAAGCACAAATCACCGTCGGGTAAAAGCGTCTCAAAATGGGGAGGATTTATCCAGGACCCCGATTGTTTTGACCATCAATTTTTTCGAATTTCTCCACGGGAAGCCGAGGTGCTCGATCCGCAGGAACGCCTGTTTTTGCAGACCTGCTGGGAATGTATTGAGGACGCTGGCTATACCCCAGAAACGTTGGTCACCCGGCAGCAAGCCCCGCATCGCCGGCAGAGTGTGGGCGTGTTTGTCGGGGTGATGCATAAAGATTACGTCTTTCTCGGCATGGAAGCCATTGCGCGCGGTGAGCAGTTTCATTTGTCAATTAACAATGCGCCGATTGCCAACCGGGTTTCCTATTTTTGTGATTTCCATGGCCCCTCCATGGTCATCGATACGGTGTGTTCGTCCTCACTCACCGCCATACACTTGGCTTTGGAAAGCATTCGGCACGGAGAAAGCGATATTGCGCTGGCTGGAGGCGTCAACCTATCGTTGCACCCGAACAAATATCTGACCTATGGCCTACTCGATATGTATTCTAGCGATGGGCGTTGCCGGGCGTTTGGCCGCGGCGGGGATGGTTATGTGTCAGGGGAAGGGGTCGGGGCTGTCGTGTTGAAACCGTTGGCGCAGGCCATTCAAGATCGGGATCATATTTATGCGGTGGTCAAAGGCAGCATGATCAATCATGTGGGAAAAGTGACCGGAATCAGCGTGCCGAATCCGGTGGCGCAGAGCGACATGATTTTACAGTGTCTGGAAAAAACCGGCATTCACCCACGGACGCTTAGCTATGTCGAAGCTCATGGCACGGGCACGTCGCTTGGCGACCCCATCGAGATACAGGGTTTGTGCAAAGCATTTCAAACGCACACCAACGATACCCAATTTTGTGCCATCGGATCGGTTAAATCCAATATTGGCCATACGGAGTCGGCTGCTGGCATTAGTGGTTTGAGCAAAGTGGCCTTGCAACTGCACTATCAAACCCTGGTGCCATCGCTACATTCCGAAGCCATCAATCCTCATCTTGATTTAGAGGCGTCGCCCTTTTTTGTGCAGCGTCAAACCCAGCATTGGGAGCGGACCTCAGACCATCCACGACGAGCGGGTTTAAGCTCGTTTGGTGCAACCGGCTCAAATGCGCATGTGATTCTGGAGGAGTATATACCCGAGCAGAGCGAAACCGACCTGGCACAGCCCGCAGAGGGTGTAGAGCAACGTCTACCTGTGTTGATTCCGCTATCCGCCAAAAATGAAGAGCGTCTTAAAGAGGCTGCGCGAAACTTCTATCACTATCTCATCTCAAAGCCCGAAGATGTCGCAGGGCATCAGGTGGCGAGACTCAGCGATATCGCCTACACCTTACAAGTCGGCCGAAGGGCGATGGAAACACGGGCTATTTTTCTCGTTGATCATCAACAGCAGTTGGTTGAAAGTCTCCAAGCTTTTTTGGATGACGATCATACAAAGGGAAATAGTTGGCTAGGCAAGCAGGTCAAGCAGCAAAGACACGCTAGACGTGGCGAATATAGCGAGGCAATGCTACAGCAATGGATGGTTCAGGGCAGACTCGATCAGCTTGCTCAGGCGTGGAGCGAAGGTGTTCCCTTGAATTGGGACGCCCTTTATTCGCCGGAGAGCGGTGTCGCAAAACCAAGCCGCGTCAGTTTACCGACTTACCCCTTTGCCAAAGCACGTCATTGGGTACCAATGGAAGTGAAGGCGGTGACACCATTTGCTGCACTTCACCCCTTGCTGCACCGCAACACCTCTACGCTGGGTGAACAGCGTTTTAGTTCGACGTTTAGTGGGGAAGAATTCTTCCTCGCTGATCATCGGGTGCATGGCCAAAAAATGTTGCCGGGGGTTGCTTATCTCGAAATGGCGCGAGCCGCCGTTGCTCTGGCCACCTCAGCCGGGGAGGCCCAGGCGATACGATTTAAGAACATCATCTGGCAACAACCGCTCGTTATAGATGGGACGGAAAAAACGATTCATATTGGCTTGTATGCGAAAGCAAATTCGCAAGTCGATTTTACCATTTATACCGGAGACGAGCATGGCTCGGACGCTCCCTTTCCCGATGAACAAAACCGCCGTGTTCACTGCCGCGGCATTGCCATGTTAACGTTGTCGGATCGTGAGCGTGAAACTTACCTGGATCTTGATCATTTGCAGTCCCAAACAGGACAAAACGATTTTACCCCGGAGCAGTGTTATCAGGCCTTTGCGGCGATGGGTATTGATTACCGCGATGGACATCAAGGCATTGCCGCAGTTCATGCCGGGGCTGATCAGATATTGGCAGAACTCAGCCTGCCTGCCTCCGTTTTGGCCCATCGTGAACCGTTTGTGCTCCATCCCAGTATGATGGATTCAGCGTTACAAGCGGCAATTGGTTTTGCACTTAGCGCGCAAGTTGCCGGCGCACAACAACCGGCTTCTTTACCTTATGCTTTGGAATCGCTTGACGTAAGAGCTGCTTGCACCCCTTCCATGTGGGTTTGGATACGCTATGCCGACAACAATAGCGCAGGTAGTCCGGTGCAAAAATTTGATTTGGACCTGTGCGATGATCGTGGCAAAATCTGTGTGCTGATGAGAGGCTTTTCTTCTCGTATCTTTCATGCCCAGGCCTCGCCTTGTTTTGCTGAAACGTTATTGCCTTCTCAGCTGCATCCCTTATTGCATCAACATGTTCCCTCAGAAAACCCAGTGCATGATCAGTTTATCGCTCAATTTACGGGAGAAGAGTTTTTTCTACGTGACCACCAGCAAGTGATGCTGGGTATGGCCTATCTCGAAATGGCCCACCGTGCCGGACAGCATCGCGCGAGTCAGAAGATTTTGGGGCTCAAAAATGTCGTCTGGAGCCAGCTTCTCTTTATTGCCGGACAAGCTCGTGAGGTATCTGTTCATGTACAGAATGAAGTCCTTCAGCATCGTTTTCGTATAACGACACAGAATGAGGATTCGCTGCAAAACATACATTGCCAGGGTATGCTGGTTGTTGACCAGGCTTTGTACCCGGAGAGACCTGACCAACTTAATATTCAAGATATTCAATCCCGCTGTTCAGCGAGCATCGAAACTACTGAGTGCGATCAACTGCTACAATACACCCATGGCCCCAGCCTGCTGACGATCAAACAATTGTGGCACAACGAACATGAAGCCTTGGCTTTGCTTCAATTGCCCGATGGTATGCGCTCGGGACGTGAAGATTATACACTTCACCCGAGCATGATGAACGGCGCGATCCTCACCAGTGTACTCTTTTCTTTGCTCAATGGGCCGCAAGAACACCTGCCCATGCCTTTTGCCTTGGACGAGCTTTGGATGTACCAGGAGATGCCTGAGCGTGCCTACGCTTATGTGAGTATGAGTTCGGCGAACAATCATGATATCGAACTGGTGGACATAACGGGCAAATGTATTGTTTTGTTTAAAGGTTTTACTGCTGCCATTCAAGGGGCATGGCAAAGCCAGGCGCCGCAAAACAATGTGATTTATGCGAGCACACAATGGCGAGAAAGCGTGTTGTCCGGTGACGAGCATGCGAACACGGCCGCATCTGCACCGATTGTGATGCTTGCACAAGACAATCCGGAGCTTGCCGGTTTATTACGCCAGAGATGGCCAGAAGCCAGCATTGAAATGCTGGCGCCCATCGGTGAGGATATCGCCAAAACAGTTCAGGCAAACTTCCTGCAGGTGTTTGATCGAGTCAAAACCTGTATCTTAGAACAGCCTCAACGCATTCAGCCAATTGTCGTCCTTCTACCTGAAAATGAAAACGATTATCTGCACGACGGTCTTGCTGCCTTGTTCAAAACGGCAAGGTTTGAGTATAGAAAAATAGTAGGGAAATTAATTCGCTATACGATTGATATAGATATAGAAGAACTTGCTAAATCTATTTTGATGGAAGTGTCTCATGATGATCAACATGTGGATGTCTATTACAGTCAAACAGGTACCAGAAAGGTTAAAACGCTAAACGAAATATACGACTTTGAAAAGAGCCATGCGCACCTTCTTGTTGAGGCCGATTTATTGCATGAAGGTGATGTGGTTTGGATCACTGGCGGCTTGGGCGGTTTAGGGCAGATTTTTACTAGGCACCTTAGTCATACCAAAGGCTTGAAGTTGATTTTGAGCGGGCGTTCGCCCTTGAATGCGGCTAGCGAAAAAGTGTTGCGCGAACTTCAGCAGTCTGACGTTGAGATGAGTTACTTGAGTTGCGATATCAGCGATCAACAAGCTGTGGCGACGCTTGTCCAAAGTATTCTGAACAAATATGGCAAATTAAATGGCGTCATTCATAGTGCTGGGTTGACCCGGGATGCCTATATTCACAATAAAACGCGTGAAGAAATGATCGCTGTGCTGCGCCCTAAAATGGCGGGCATTTTGGCAATTGAGGCGGCTTGTCAAGATATTCAACTGAATTTTATGGTGTTATTTTCTTCCATTGCAGGTGTTTTTGGCAGTATTGGCCAAGCGGATTACGCCATGGCAAATGCTTTTCTTGACAGCTTTGCCGAGGCGAGGAATCGTCGCGTTCAGCAAGGGAAATGCTTTGGTAGAACGCTTTCCATCAATTGGCCCCTGTGGCGCAACGGTGGTATGGGGGTGGATGCGCAGAATGAAACCCTGATGCAGCGCAATACCGGCATGATTGCGTTAGAAACCCGTGCGGGCCTAAATGCGTTTGAGCTGGCTTTGTCTTCTGAATATAGCCACATCTTGGTGGCTCAGGGGGAAACCGAAAAAATTCGTTCTCGTTTGTTGTCGCCTCGGTTCGTAGAGGAAAACCTGAGCTCGGTTGAAGCAGATACAACGGAGCCATTGGAACATCAAAATCAGAGCGAGCCAAGCAAAGCCGAGCAGGACCAGCGGGCATGGCTCATTCGGTTGCTGCTCAAGGATCTCGCGGCTTTTGTCTGTCGCCTTCAGAAAGTGCAACCTGAAGAGATTGACCTAGAAGCCGAGTTTTCCGTCTATGGATTTGACTCTATAGGTTTTATGAGTTTTGTCAATCATTTGAACGACATGTACGACTTGGAATTAATGCCGACGCTATTTTTTGAGCATTCCAGTTTGCGTGCGCTTGCCGACGCGCTGATCGAGAAGCATCAGGAAGCTTTACTGAAAAAATATGAGTCCCCGAAAACAGCTGCTCAGCCAAGCCAGGATCGCATGCCAATTCAAGCTCGTGCAGTCGAGATGGACAAACGCCAACACCCTGTATCTGCAACGATGACACCTGTTGAATCGGAAACGACTCAAGGGAATCCGACGCCAGAGAGTTTATCTACAACTGACCCGATTGCCATTATTGGTATGAGCGGCAAATTTCCCGGATCGGAAAACCTGACGGCGTTTTGGCAGCACCTAGAGGCTAATCGTGATCTTGTCAGTGAAATCCCTGAAGACCGTTGGGACTGGCGGGATTACTACGGTGATCACCTGAGCGAAAGCGGCAAGACGAAGATTAAGTGGGGTGGCTTTATAGAGGGCATCGATCATTTCGATCCCCTGTTTTTCGGCATTTCCCCAGTGGAAGCCGAAATCATGGACCCTCAATTTCGTCTCTTTTTGCAAACGGTTTGGGCCACGATTGAAGATGCAGGCTATCGTGCCAGTGCGCTGTCGGGTAGCAAAACCGGGGTTTATGTGGGCGTGACCACCACGGATTATAAAGATTTAATGCAGCAGGCGCGGGCGAGGGAAAACTCCCAGGAATACCATGGTATGTTTCCATTTATGCTGGCCAATCGCGTCTCCTATTTGTTCAATTTTCGTGGCCCTAGTGAGGCGATCGATACAGCTTGCTCCAGCTCCTTAGTGGCGATTCATCGTGCGACCGAAAGCATACGCCAAGGAAGCTGTGAGATGGCGGTAGCAGGTGGGGTGAACATTATTGCGAACCCGCAATTGGTTCTTTCAGCGACTCAAGGTGGTATGTTGAGTGAAGATGGGCGCTGCAAGACCTTTGATCAAAGTGCCAATGGCTATGTCAGAGGTGAGGGGGTTGGCGCGATTTTGTTAAAACCCTTGGCAAGAGCGATCGAGGACCATGATCCGATCTGCGGTGTGATTCGGGGTTCGGCGGAAAATCACGGCGGCAAAGCCACATCGCCCACCGCCCCAAATCCGGTGGCGCAGCAGGAATTGCTGGTTTCGGCTTACGCCCAAGCCGGTATCACCCCGGAAACCGTGGGTTATATTGAAGCTCACGGAACGGGTACGCCGCTCGGTGATCCGATTGAAATCAATGGACTCAAAAGCGCATTTGCCCAGCTTTATGAGCAAATCGGCCGGCCTCCCGCCAACGAGCCCCATTGTGCCTTGGGCTCTGTAAAAACCAATATCGGACATGCGGAAGCGGCTGCGGGCATTTCAGGTGTTCTCAAAGTCCTCTTGATGATGAAGCATCAAAAAATTCCCGGAAATCCACATCTCAAGGAGCCAAATCCCTATTTACAATTGACCGGTAGCCCTTTTCATTTGGCGCAGGATACGCAGGACTGGAGGGCGTTACACGACGAGGTTCACAACCCGATACCCCGGCGCGCTGGGGTGAGCAGTTTTGGCATTGGCGGTAGCAATGCCCATCTGGTGCTGGAAGAATATACTGCCGAGCCTGCCGCTGAGCCCGTGGTCTGCGGCGAAGCCTCGTTAATAATTTTATCAGCGAAAAATAGAGCGTGTCTGGTTGAGGCTGCCGGGAATCTCTATCGATTTCTCATCGATAACCGTGAATCCTCCCGAGGAGAGCTGTTGCGTCTTGCTGATATTGCCTACACGCTTCAGGTGGGACGCGAGGAGATGGCGCATCGTTTAGGATTTGTGGCTTCATCTCTTACAGAACTCGAAGAAAGACTTCAGACTTTCATCAATGTCCAAGGTGAAAATCAAGACTTATATGAGGGGCACACGAAGGGTAATCGGAGTACCTTAGAAGCTTTTGAGTCTGATGATGATTTACAGGAGATGCTTACAAAGTGGGTTGAAGGCAGGAGATTTGAGCAAATTTTAAAGCTTTGGGTCAAAGGGCTTGCTGTGAACTGGGAGAGCCTCTACCGCGGAATACAGCCTCGGCGTATCAGCCTACCAAGCTATCCCTTTGCACGTGAACGTTACTGGATTCCTGCATCGGCTGAATCTTTGCCCGTACCGGCTGCATCGCCGGTATCTCCCATACAGGTCGATAACGCTGCCGGGGTATTGATGTGCCACCCGGTCTGGGAAGAAAAAGCCGCTCCGGTTCAGGTCGGCTCCTTTGATCCTGCTTCGCTGCATGATTGTCAGCACCTGATTCTGTTTTGTCATATGGATGTCCCTTTGGGTTTACAGGACCGTTTCGGCACAAGTAGCGTTTGTCGTGTGTTTCAGGCCCAGAGTGACGATGTGGCGCTAGGTTATTCGTATCTTTGCGAGCAGGTTTTGACGTGTCTCAAAGAGATTCTGGAAAACAAACCGAGAGACCGGGTATTCGTGCAGATTGTGATTCCTGGTCCCGAGACGAGCGAGGCCGAAGGTGCGAGCGGCCTGTTGCATGGTCTCTCTGCGTTGCTTAAAACCGCGCATTTGGAAAATCCAAAAGTTCTCGGGCAACTTATCGAAGTGGGTCCGCGCCACACGGGTGATGCGTTGATCCGGTGCGTGCAGGAAAATTGTCAATCGCCAGACGATGTCCAGGTCAGATACCGCCATGGGCGGCGTGAAGTGATGGCCTGGGAAGAGCTTCCAGTGTCAGAACCGAACGCCGCTCCTATGCCCTGGAAAGAAAGGGGGGTGTATTTAATAACTGGCGGTGCGGGGGGCTTGGGGTTCATTGTTGCAAGAGAAATTGCTCGCCGTGTCAAAGCCCCAATTCTTATTCTGGCCGGACGTTCCCATTTAAGCCAGGCAAAACGGGATGAATTGCAGCAAGAAGCCCAACGCTTGGGGGTGCAGATCGAATATCGACAGGCTGATGTTAGTCAACCACAAGAGGTCAATGACCTCATTCGGAGTATTCTGCGCGACTTCACGAAGCTCAATGGCATTTTGCACGCCGCTGGCCTGATTCGCGACAGCTTTATGATTCGGAAGACAGTCGATCAGTTGCATCAGGTACTGGCGCCAAAAGTATTTGGCACGGTGTACCTGGATGAGGCAAGCAAGGATGTCGACCTGGATTTCTTTCTTTTATTTTCCTCGGGCGCTGCAGCACTGGGTAATGCGGGGCAAGCAGACTACGCTGCCGCCAATGCCTTTATGGATGCTTACGCCGAGTATCGTCATGCACTGTTCGCGTCAAAGCAACGTTTTGGCCGGAGTCTTTCGATCAACTGGCCGCTCTGGCAAGAGGGCGGTATGCAAGTGGATGAGCCGACCCTGACCGCGTTAGAGCAATACGCGGGCATCAGGGCACTGCAAACCGGTAGCGGATTAGATGCGCTGTACCGTGCGCTTAGCGTAACGCCGAACCAAATCATGGTACTAGAAGGCGATCTGGCCAAAATCCGTCAGGGGTTGTTTTCTGCCTCCACAGAACCGTATCGCAACGAATCTTCAAGGGTTGAGGTTGATGAGGAACGCTTGCTCGCCAGGACCTTGCACCAGTGTAAAACACTTTTTGGCGGCATTATCAAATTAGCCGCAGATCGAGTCGAGGCAGAAGAAGCGCTGGAGCACTATGGTATTGACTCCGTAATCATTGCCCAAATGAATCTGCGTTTGGAAGAGGTTTTTGGCGAGGTCTCTAAAACTTTGCTCTATGAATACCAGACGCTGGGGGAACTGGCTAGTTATTTAGCAACCGAGTACCGAGACGCATGCATGACGTGGACAGGCTTAACAGCTATCCCCACAAGTGACATGACAACAGTTCCGGACGACGCGATTCCGGCCAAGCCTCAAATCACTTCGGAGCCTCGGCGATCATCGGGGGTTGATGTTCATGCCCTGACGCCAAAAGCACCCGCGCCGTCGCAAGATGAGCCCATTGCGATCATCGGCCTGGCTGGCCGATATGCACAAGCCGATACGCCGCGCGCTTACTGGGAAAATTTGCAGTCAGGAACAGACTGTGTGACGGAAATTCCTCCGGATCGCTGGTCCCTGTCGGGCTTTTATCACGAGGATCTCGAAGAGGCCATTGCCCAGGGTAAGAGTTATAGCAAATGGGGAAGCTTCCTAAACGGTTTTGCCGATTTTGACCCGCTGTTCTTTTCGATGTCGCCTCGTGAAGCCATTGGCATTGACCCACAAGAGCGCCTGTTTCTGCAAAGTTCCTGGGAGGCGATGGAAGATGCCGGCTACACCAGAGAGACCCTTCGAGATCAGTTTCAGCAGCGAGTCGGGGTGTTTGTCGGTATTACCAAAACAGGTTTTAGCCTATACGGTCCAGAGCTGTGGCAGCGTGGTGACATTGTCTATCCGACCACCTCCTTCAGCTCGGTGGCCAATCGCATTTCTTATCTATTCAATCTGCGCGGCCCGAGTTTACCGATCGATACCATGTGCTCCTCTTCGCTAACGGCCATTCACGAAGCCTGCGAACATATACGCCGCGGTGAATGTGAGTTGGCCATTGCGGGTGGCGTCAACTTATATTTGCATCCCTCTACCTATGTGCAAATGTGCGCAGCCCATTTGCTGTCGCAAGATGGAAAATGTAAAAGCTTTGGCGAAGGCGGCAACGGTTTTGTCCCCGGTGAGGGCGTAGGTACGATCGTGCTGAAGCCGCTCACCCAAGCGATTGACGATCACGATCATATCTATGCCGTCATTCGTGCGTCGAGTGTGAACCACGGCGGCAAAACCAATGGCTATACGGTGCCCAACCCAAATGCGCAAGCCGCTCTGATTGAGGACGCGCTGGACAAAGCCGGGGTGGATGCGCGTACGCTTACATATATTGAAGCACACGGGACGGGAACCGAATTAGGTGATCCGATCGAAATTCGTGGTTTGACTCAGGCTTTTCAGAAACATACTATCGATACGGCGTTTTGCGCCGTGGGATCGGCTAAATCCAATTTGGGGCACCTGGAAGCGGCCGCCGGTATTGCCGGGCTGACGAAAATTATTCTGCAGTTGCAACATGCAAAAATTGCCCCGAGTCTGCATGCCTCGACATTAAACCCAAATATTAATTTTGCCAAAACCCCCTTTGTGGTGCCGCAAGCACTTTCAGAGTGGAAAAGACCCATTGTCGACATGCACGGCGAGGTCAAAGAATACCCCAGAAGAACGGGTATTTCCTCCTTTGGTGCCGGTGGGTCGAATGCCCACTTGATTGTTGAAGAGTATGTGAAGGGGACCTCGGTTGGAGAAACGAGGGCAAGTCATCATCACGATGTGATTCGCAACGAGGCCCAAGTCATTTTACTGTCAGCGAAAAATGAAGATCGTCTCCACTGTGTGGCAAAAGATTTACATGATTATCTCAACGCGGAGCAAGGCGCAAACTTAAGCCTGCGTGACATCGCCTATACGCTCCAGTTGGGCCGTGAGGCCATGGATGAACGTTTGGGGCTGGTTGTCTATTCGTTGGATGAGTTGCGACAAAAGCTTAACGGCTTTATTGCAGGAGAGAGTGGTATTGAAGATGTGTATCGCGGACAGGTTCAAGGTCATAAAAAAGCACTAGCGTTATTTACTGAAGATGATGAACTTCAAGAAGCGATTGAAAAATGGATGCAACGCGGAAAATTCGCCAGGTTGGTCGAGCTTTGGAGTCAGGGCCTGGCGGTTGATTGGAACAAACTATATTGCGATCGCGAAGTCATACCTTATCGCGTCAGCCTGCCAACATATCCCTTTGAGCAACATCGATACTGGATCGAAGACACGTTGCATGCCTCACCCAAGCCGGTGGCTGAGTCAGTGGGGCAAAGTGCGGTCAAACTACATCCGTTGATCCACGAAAACACTTCCAACTTTCTCGCGCAACGCTTCCGCTCATGTTTTCGTGGCGACGAGTTTTTCTTGGCCGATCATCTGGTGCAAGGTCGGCGCGTTTTGCCGGGCGTTGCTTATCTGGAAATGGTTCGCATGGCAGTCTCACTGGCGATGGATACGCAAATCGAGGGGTATGATTTACGTTTTGAGAATGTGGTTTGGGCAAGACCTATTATCGTGGACGGTCAGCCGCTCAATATGCATACCGTATTACAGGTAGAGGACAGCACTACCATTAGCTTTGAAATATACTCCCAGGTAGATACCGAGGAAAACGATGCCGATGTCTTACATTGCCAGGGCTCAGTTGAGATTTGCGTTTTAGAAAAAGAGCAAGAGTTAGAGGTGTCCCATTTACTAGGCGAGTGTCAGAAACACCATCTTTCTGCTGCCCAATGTTATGAAGTCTTTGAATCTGCTGGTATTCAATATGGCCCGGGGCACCGAGGCCTTGATACCGTCTATGTGGGAGATCAGCAGGTTCTGGCAAAATTGCTTTTGCCGCCATCGGTTGCAAGCACAGCGGAACAATTTATTTTACATCCGAGCTTGATGGATGCTGCCTTGCAGGCGTCGCTTGGCCTGGCCGTAGGCGGTGTTGGGTCCGAGCCCACCCCCTCCTTGCCCTATGCGTTGGAAACGCTTGATCTCTGCGACGCGGGGGCCAGACCAAGTTGGGCCTGGATTCGTGAATCCAACCAAAGCAGCGGGGAGATTCAAAAACTTGATATTGACCTGTGCGACGATCAAGGCCGCATCTGTGTTCGGATGCGAGGGTTTTCGTCACGTGTGCTCGAGCGGGCATGGGGCTCGCAAGAAGACCGTTTGACCCTGCTGAGTCCGGTATGGAATGTCATATCAGACCCGCCAACAGAAGGCGAGCGCGATGATGTTGCCAGTGAGCAGGTGATCATCGCCGGGGGTAGCGACCTGCAAAGAGATATCCTTGGGCAGGTTCACCCCGGTGCGGTGTGGTTACCAGCAGACGATTTTGAGGCGATAGACCAACAAGTTAAGGTGTTGCCATCTCAGATGGATGTCGTGCATATCATCTGGGTCGCACCGGATCAGCCAATGACCTCCGTGAGACAAGAGTCTTTGATTCGTGAGCAAGTCCAAGGTGTGCTTTATCTCTTTCGTCTCATGAAAGTCTTGTTGGCACACGGTTACGGTGAGAAAGAGCTGCATTGGACCGTTATTACCACACAGGCACAAGCGGTACGCAAAAAGGATATCGTCAACCCCACCCATGCCAGTGTACATGGCTTCATCGGTTCGCTTGCTAAGGAATATCCGCATTGGAAAATTCGGCTGTTGGATATGGACGCGGATGAGAGTTGGCCGGTTCACGATATGCTGGCCTTACCTGGGGATCAAAATGGCGATGCCGTCGCCTATCGAGCCAAAGAGTGGTTTCAACAAGCGTTAGTGCCCGTGTTGGAGACGGATCAGGGATTACCCCCCTGTTATCGTTCTCAGGGGGTCTATGTGGTGATTGGCGGCGCAGGCGGGATTGGCGAGGCCTGGAGTCGGTGGATGATCGAGCGCTACCAAGCGCAGATCATCTGGATCGGCAGACGAAAAAAAGATGCTTTGATTCAGGAAAAATTGGACGCTTTAGACAAACTTGGCACCCCGCCCATCTATATCGAGGCGGATGCTGGCGACCTGATGGCTTTACAAAATGCGTATCAGCAAATTAAACGTCGCTATGGTCGGATTCACGGTGTGATTCATTCAGCGATTGTCCTGGCCGACAAAAGTTTGGCCAATATGGACGAACGGCAATTCCTGGCCGGTCTGAGAGCCAAAGTGGATGTGAGTGTACGGCTGGCACAAGTGTTTGCGAAAGAAACGCTGGATTTTGTCTTATTTTTTTCTTCTACTCAGTCCGTTGCTAAAATGCCAGGGCAAAGTAATTATGCGGCCGGTTGTACCTTTAAAGATGCCTTTGCCAGCCAACTGGCTCAGGAGTGGCCGTGCCAGGTCAAAGTCATCAACTGGGGCTATTGGGGAAGTGTCGGGGTGGTGGCGATCAGCTCATATCGTGAGCGTATGGCGCGGGCGGGGGTGAGGTCCATCGAGCCGGCAGAGGGGATGGCCGCCCTCCAAAGCCTACTGCAATCATCACTGGATCAGTTGGCCGTGGTCAACACTCTCCCCACTGCGAGCATTGCTCAACCTTCACGGAATCAGGCGTTGGAGGAATGGATCACGACGTATCCGGACGGGCTTCCTGTCTGTGTGGACAGTTTACCACAATATCTTCCGAATCAACCCCTTCCGGTTGTCGATAGCGGCACCGGGGTGCCCGACCAAACTGTGACCATAGAGGATTTATTGCCCCAACTCCTATTGGCTACGTTGCAGTCCTTAGGCTTAATCGAAGGGCGGGCCGAACAGCGTGCCGCCGCTTTACCGGCTGCTACCTTTTATAGACAATGGCTGGAAGAAAGCCTGACCTTCTTGTGGGCAAAAGAATATCTTGAGTATGATGGGCAGGGTTATACAAACAAGCTGCCCTCAGTTGACCTCGCACGTGTATGGCAGGAGTGGGAGCGGGAGAAAGTTCTCTGGCTGCAAGATCGCAATCAAAAGGCCATCGTGAGCCTGGTGGAAGCATGTATGCGTGCTTTGCCCGATATCCTTAGAGGAGCGCAACTGGCAACTGACGTCATATTCCCGGATTCATCCGTCGCACTGGTCGAACATATTTACAAAGGCAACGTGGTTGCAGATTATTATAATCAAATCCTTCAGAATAGTGTCGTGGCATATATTCAAGCACGACTGGCGCAAGCGCCTACGGCGCAAATCCGAATACTTGAAATTGGTGCCGGAACCGGTGGGACGACTTCTGGTTTACTGGCTGAACTCCGCCCATATCAGCGTCACATCGTAGAGTATTGTTATACAGATCTTTCAAAAGCCTTTCTAATACATGCCGAGAGGCAGTATGCCACAGAGCATCCGTATCTTGTGACACAGATTTTTGATGTGGAAAAACCGCTTGCTGAACAAGGTATACAGGCAAATCACTACGATGTCGTGATTGCAGCGAATGTCCTGCACGCGACAAAAAATATTCGCAATACGCTGCGCAATGCAAAAGCAGGCTTACGCCAACATGGTTTGCTCTTCCTAAATGAAATAAGTACGAAGTCCTTGTTTACTCATTTGACGTTTGGTTTGTTGGAAGGCTGGTGGCTGTATGAGGATGCGGCTTTGCGAATCACAGGCAGTCCGGTATTAAGTTCGGCAATTTGGGCCGATGTGTTGGCTGAGGAAGGCTTTAATTCCATTACGTTTCCTGCATTGTTGGCCGCTGAATCCGGGCATGATTTTGGGCAGCAAATTATTATTGCACAAAGTGATGGGATCGTGCGGCAGAAGGCTCGCCGCCAATCTTCACCTGTACTGCCATCTACACCCAAAAAGCAGAGCGTAAAACCGAAGGAAATAACCAAGCTGTCGCCCAATACTGAAACTTTGCGTGAGAAAGCGACAGTTTATATTAAAAAACTAGTTGCCTCAACACTGCAACTTCCAAGCGATCAGATCGACTCTGCCCAAGCCTTGGAAGCCTATGGGCTGGATTCGATTTTGGTGGTGCAGTTGACCAGTACATTACGCAAAGCATTTCACAACATTAGCAATACCTTGTTCTTTGAAGTACAAACGATTGATGGCGTTGTCGATTACTTACTTGAAAGGCAACCTGAGGTATTTAGTGATTTACTTGGAGTTGACAAACAGAAAATTGATGAACGTATTGTTGAAACAAGCACACCAATTGAGAGCCTCGAAAGTACAAGGCAAGCAAATGGGAGAAATCATTCTTTACAGAAACTAAATTTTAGAACGACCCAGAAGTTAAATGCTTTAGCTGCCTCAAAAAAACATGAGACTGTCCATGATCGGGATATCGCGATCATCGGTCTGAGTGGACGTTATCCGCAGGCTGAGAATGTCAATGCATTTTGGGAGTGTTTAAAGGCTGGGCAAAACTGTATTCGCGAAATCCCGCAGGAGCGGTGGGACTGGAGACGCTATTATGATGCGGAAAAAGGCAAAGAAGGAACACTCTACACGAAATGGGGCGGCTTTATTGACGATGTAGACAAATTTGACCCGTTATTTTTTAAATTGTCGGCGAGAGACGCCGAGCGCATGGACCCTCAGGGAAGGCTCTTTTTAGAGTGCGCCTACAGTTGTATGGAAGATGCGGGTTATACGCCGAGCACACTTTGTGACAGCCGTAAAGTAGGCGTTTTTGTTGGGGTGGTGAATAGCACGTATCGGCGTCAGCCAAGCTTCTGGTCGATGGCCAATCGGGTGTCCTACCTATTTAACTTTCAAGGCCCGAGCATGTCCGTGGACACAGCTTGTTCGTCCTCGCTGACCGCTCTGCATCTCGCGATTGAGAGTCTGCATAGCGGCACAAGCGAATGCGCGATTGCCGGCGGGGTGAACTTGATTCTGGATCCGATTCAATACCTGACGCTAAGCGCCATGACGATGCTTTCATCAAGCGACGCGTGCAAGTCTTTTGGGAATCAGGCCGATGGCTTTGTCGATGGCGAAGGCGTAGGGGCGGTGATCTTAAAGCCCCTGGCAAAAGCGGAGCAAGACGGAGACGCGATCTACGGCATTATCAAAGCCAGTATGATCAATGCGGGCGGCAAGACCAATGGTTATACCGTGCCAAATCCAATCGCACAATCGCACTTGATTCGGGAAGCCCTGGCGCGAGCCGAGGTTGACCCGAGAACCATTAGTTATGTGGAGGCTCATGGCACGGCCACGGCTTTAGGCGATTCCATTGAAATTACCGGCTTGAGCAAAGCCTTTGGCCTCAGTGAGGACAAGCAATTTTGCCCGATCGGTTCGGTGAAATCGAATATTGGTCACGCCGAAAGTGCGTCGGGTATTGCTAGTTTAACGAAAGTCTTGCTGCAATTGAAGCATCGCCAATTGGTGCCTTCCTTACATTCGCAGCAGCTCAACCCCAGTATTGATTTTGCTGAGACACCCTTTGTCGTGCAGCAGACCCTTGAGCCCTGGCATAGGCCCGTGTTGACGATTGATGGAGAAACCAAGACCTATCCGCGCATTGCCGGCATCTCATCCTTTGGAGCTGGTGGGGCGAACGCCCATGTGATTATCCAAGAATATATGAATGAGAAGGGCGATGCAGCGGCTGACGCCGAGGGACAGGGGTGGCCTGAGACCAGCTTGATTGTGGTTTCCGCCAGAGATGAAGATCGGCTTAGAGAACTTGTCAATCATCTGTGCCTTTATGCGAGAGCGTGTAGCCTGGCAGATCAGGGCAAGGCACAAACCGCCAAGCTGCAAGCCATGGCGTATACCCTCCAGGTGGGACGCGAAGCCATGGAAGTACGCCTAGGGGTCGTGGTGGCCTCTTTTGCTGAACTTAGTGAAAAGCTCCAGGGATTTTTGGACGGCCAACGCGATGTGGACAACTTGTATCGGGGACAGGTTAGACCCCATCGAGAAGCAATGGCGGTTCTTGCCGGTGATGACGTGTTCGCAGAAACGATTGATGCCTGGATTCACAGACACAAGTACGACAAAATCTTGGAGCTTTGGGTTAAAGGCTTTGTCTTCGACTGGAACAAGCTGTATGGCGAACAGAAGCCGCCTCGCATGCATTTGCCAACCTATCCTTTTGCACGGGAACGCTATTGGGCAAAAATAATTGATTTATCCCTCGATGGATTTCAAGTTGGTGCTCCACAGCAAGTTGTAGAGTGGATCCATCCTCTCGTTCATAAAAATACTTCTAATCTTGAGGAGCAACGTTTTAGCTCGACATTTAGTGGCCAGGAATTTTTTCTAGCAAATAATCGTGTCGATGGAGAGAAGGTGTTACCCGGCGTCGTCTATCTTGAAATGGCACGAGTGGCGGCAGAACAAGCACGGCCTCACCCCTCTACAAGCTTGGCGAAGAGCCATATTCAACTTAGAAATATCGGCTGGGCGACTCCCTTTGTCTGTGACCATTCGTCGCAAAGCGTGCATATCAGGATTGTGCCAGGTACTTATAAAGGCAGTGACGTCAGTTTCGAAGAGATGAGCTATGAAATCTATTCACACATAGATACAGAACGTGAGGTTGTCGTACACAGTCAGGGTGTCATCGCCTTGTGGCAGGCTCGTGAAGTCGCCGGGTTGGATTTGCCAGCTTTGCAGGCGAGCATCAATCAGAAATGTCTCAGTGCACAGCAATGTTATGACGCGTTTGCAGCGATGGGCATTGAGTATGGTCAAGGGCACCAAGGCATAGAGGATGTCTATATGACGCCTAGCCAAGCCGGTCGCTGTCAAGTGTTGGCAAAACTCAGGTTGCCTGCCGTTGTTGCTGAGACGAGCCATGATTTTGTTCTTCACCCTAGCATGATGGATGCAGCCTTACAGGCATGTATTGGACTGACGGTTGAACACGCCGTTCCCGAGTCTGGACAGATGTCGCTCCCCTTTGCCATAGACGCTATTGAAGTTATTGAAAAATGCACAGATACGATGTGGGCTTGGATACGCTATGCCGATCCTCATGCCGACCCAATACAACCGTTGAGTTCACGCGTGACCAAGGTTGACATCGATCTGTGTGATGAAAGCGGGAATCTATGTGTTCGGATAAAAGGATTTTCCACTCGCGTGGTTGCCATACCGGAGAGCAAAGCCATTGGAACTTGGATGAGCTTTCCAGTATGGAAAGAAAAATCCTGGTCTGAACATGAGCCTTCAGAATATGCTCAGCGGACGGTGATGTTGATAGAGATGGAGTGGGTGTCTGATCGTTTGATTGAGTCTCAAATCGAAGGCACGACTTGTGTTCATTTGACAACCCAAGCAAATTCACTGGCAGAGCGCTTTCAAGATATTTCAGTTCAGGTGTTTGAGCGGGTCAAAGCGCTCATGGAAGCAAAACTTAGAGGGTCAATCTTAATCCAGCTTCTGGTGCCTCACTCGGGAGAGACGCTGCTGTTTAGCGCACTTGCAGGCATACTCAGAACGGCTCACTTGGAAAACCCTGCGCTGTTGGGGCAGGTGATTATCCTGGAGCCGAGTGAAACCCAAGAGGGGGTAATCGACAAACTTCAGCGCGACAGCTCTTGCCCCGAAGATGCGTTAATCCGTTATCAGCAAGAAAGACGCCAGACGATGGCGTGGCAAGAATTGCCGATGTCAGAGCGAGAGCAGGCCGTGCAAGTTCCCTGGAAAGAAGGAGGTGTCTACCTGATTACAGGCGGCCTAGGTGGCGTTGGATTCATGTTTGCCAAACATCTTGCGCAGCACAGCAGGTCGGTTTCTCTGGTGCTGACCGGACGGTCGGAACTAGATGAGCAACGGCGCGAGCAGCTCAAAGAACTAGAAGCGTTGGGGGCCAGGGTTGACTATCTCTCGGTCGATGTCAGCCTTAAGGAGGCGGTTGAGCGCTTAATTGACTACATCGAAAGCGAGAGGGGATCGCTCACCGGCATTCTGCATAGTGCCGGTGTGATTCAGGATAACTTTATCATTCGAAAAGCAGTGCGTGAGTTTCAATCCGTGCTTGTGCCTAAAGTCGATGGCGTGATTCATTTGGATCAGGCAACGCAAGCGTTAAATCTCGATTTTTTTGTCCTGTTTTCTTCTCTCTCGGGCATTAACGGCAACGCCGGTCAGGTAGATTATGCCTGCGCCAACGCGTTTCTAGATGCTTACGCGCATTACCGCAATAGATTGGTTGCCATTAACAAGCGCTCCGGCCAAACGCTCTCTGTGAATTGGCCGCTGTGGAAAGAGGGGGGGATGCAAATCGATCCCCAGCGTGCAGAGGCGATGTTCCAACATTTGGGGCTGGTGGCGATGGAGACATCGCGTGGTATTCAGGCATTGATTCACGGTCTTTCCTCCGGACAGAGCCAGCTCATGGTGGTGGCAGGTGATCTCGAACGCCTGAAAGTTGCACATCCATCACGGCCATCATCGCCACCCTCTCAGATGGATCGTGAACACAATGTCATTGGTGAAAACGAGTTGGATGCCAATGCGTTGGCGTCAAGGTCTATTCACTATTTCAAAAACCTAATTGCGTCTATACTCAAGATACCTGCCCATCGTATTCAAAACGATGAGTTACTGGAATTGTACGGTATTGACTCTATTATTATTATGCAGTTGATCAATCAGTTGGAAAGAGACTTTGGTCCATTGTCGAAAACGCTCTTTTTTGAGTACCCAACCATTGAAGAAGTTAACCAATATTTTGTCGACTCATACAGACAAAAGCTCCACGTGGTCCTTGGCTTAGACAAGTCAAAGGCACCTGAAACTGACCACTCGGCTGTTGTCGATCCGGCTCGCCCAAAGGTACATCGGCGTTCTCGCTTGTTGGCACCGACATTAGATGAATCACCACTCCCCGTTGCGCAAACGCAGGATGTCGCCATTATCGGTGTTGCCGGACGTTATCCCCAATCCCCGGATCTTGAATCGTTCTGGGAAAATTTGTCGCAAGGTAAAAATTGTATTACTGAAGTTCCCGAAAGTCGTTGGGACCCCAGCTTGTATGTTGATTTTGACCCTTCCAACTCTGGTCAGGTGTATAGCAAGTGGGGTGGTTTCTTAGATGACGTGGACAAATTTGACGCTTTATTTTTCAATATTTCTCCTCGTGAAGCAGAGTTGATGAACCCGAATGAGCGTCTTTTCCTGGAAACCGTCTGGGAGCTGGTGGAACGTTCGGGGTATACACCGGAAAGAATACAGGAACAGCACGAAAATAACGTGGGGGTTTATATCGGGGCCATGTATCAGCAGTATCAGGCCTTAGCTTCCGAGCCCCTCATAGAGTCGGTCCTGTCCTTGTCTTCCCATAGTGCGATTGCGAATCGCGTGTCCTATTTTTTTGATTTCCAGGGCCCTAGTCTGGCCATCGACACGATGTGTTCCTCTTCATTAATTGCGATACAGTTAGCTTGTGACAGCCTGCTGAAAGGCGAGTGCCAGATGGCCATTGCCGGAGGTGTCAACCTCACGATTCATCCGAACAAATATATTGGCTTGAGCCTGAGTCAAATGATCAGTCGGCAAAACACCAGCAAAAGCTTTGGTGAGGGTGATGGTTATCTTCCGGCAGAAGGTGTCGGTGCCGTGTTGTTAAAGCCCTTGGCCAAGGCGATCGAAGATCAGGATTCCATTTTAGCCGTCATTAAATCCATTAGCACCAATCATAGCGGACATACGTATGAGTTTCGTGTACCCAACCCGAATGCGCAAGCCCAATTATTTGAAGCAAATTTCCGTAAATCCGGCATCGATCCACGCACGATTACGTATGTTGAATCGGCGGCCAATGGTTCTCCCTTGGGAGATCCGATCGAGGTCAGTGCACTTCGTAAAGCGTTTCAAAAATTCACTGCGGATCAGGGCTTTTGTGCGATTGGTTCCGTCAAATCCAATATCGGTCATGCAGAGGCAGCATCCGGCATCTCCCAACTGACAAAAGTGATATTACAGCTTCAGCATCAGCAACTTGTTCCGTCGATTAATGCAGACCCACTGAATCCAAATTTAAGCTTCGATGGTTCGCCATTTTATCTGCAACAACAACTGCAACCATGGGCACGTCCAGTCTTCAATATCGATGGTCAAGAGCGTGAGTTCCCCCGGCGCGCAACCGTTAGCTCCTTTGGGGCGGGAGGCTCGAATGCGCATTTGATTATCGAGGAATATATTGCTTCTGCGGGTAAGAACGCCGTGTCACCTGATATAGAGTTGGCAGCCGATCGCGAGTTGATGGTTTTTTCCGCAAAAAGCTGTGATCGTCTTCAGGCGATGCTGCAACAGATGCGTCATTATGTCGAATCCAACCAAGCACTTTCGCTAAAGAAGATGGCCTATACGCTCCAGGTAGGACGTATGGCGATGACACATCGAATCGCGATGCTGGTGCATAATCGAGAAGAGCTGATCCAGGGCATCCAAGATGCTTTGCATAGCCTAGAACAACCAGCCGGGATAATCAACACAACCATTCCAATATACATGGGTGATCTGGAGGCGGATCACTCGGAAGTAAAGCATTTGCTCTCCGGTCAATCCGGAGAGGCCATGCTGAAAGTGCTTTTCGCCGAAGAAAATCTGGAAAAAATTGCTCTTTACTGGGTTAAAGGAGGCCATATTCCCTGGCTGGCACTGCATCAAAAAGGTCAAATGTCTATGTTGTCTCTACCCACGTACCCTTTCTCCAAGCGGTACTGCTGGGTTGAGAGTAAAGCCCTGTCTCAAGTTGTAACCACGGCTGAGGCCGAATTACTTTCGAAAAGTACGGATGATCATATTTCCGTTGACAGAAATGAAGAATCAGTTCTTTCAGAGATTCTGTGCCGAACCTTAGGCCTAACAGCAGAAGAGTTTAATCAAAAGACCCCATTGGTTCAATATGGGGTGGATTCCGTTATGTTTGTGCAAATTTTTCAACAAATTAAAGACAAGATTGATAACCGCGTTAACTTGAGTCAGCTGCTGGAATGCCAAACCATGCAAGATATGATTTTCTATTTGACTGCGAAAAAGGAGGACGCGCAAACCGAGCCGGAGCTGGTGAACCTTTCCGGAGCCGGTCTTTCTTCATCACATGACACACGTTTTCCAGAGCTGGTCCATATGAACTCAAGTACCAGGGGAAGACCTGTATTCTGGTTCCATGGCATCGCGGGCGTTACGGTTTACGAGCCTGTTGCTGAAAAAAGCCAGCGCCCCTTCTATGGCGTTCAGCCCTGTAGCTGGATCAACCAAACCGCGGGACCTTCTCATATTCAGGCCATGGTGCAAGGTTATCTGGATGCCATACGATCCGTGCAGCCGGAAGGTCCTTACGATTTTGGTGGCTATTCGCTGGGTGGCATGTTGGCTTATGAAGCCACCCGTCAATTACAGGACATGGGAGAGAGCGTATCGACCATTGTGATGGTCGATACGCTACAGAGTAATCCTGATCGTAAGGATAAGTACTCGCGCAAAACAGATTATCTGGTTGTTTTGAATCGGTCCTTTGCCTCATCTGCATGGCAGAGCTCGGAAAATACCGTGCAGGACATGCTGATTCGTGCAGATGAGCTGGATGCAAGTCTAAGTGACGACGAGTATTTAACAGAGCTGATTGTCTTAGCCAAACAACGAGGACTGGTCAAGACAGAGACAGAGATCCGTGCCAGCCTTGAATATGCAACAACCCTTGATGAGTTTTATCAAACTGATCCCTTTACGGTTAGGCCCCTATCTGATCCCGATGCCGTTAACTGCTACTATTTCCGCAATAAGAATGGCGCGATGTTGGGTGATCAGGCGCCCTACTATTTTGCGACACCACAAGACAGGGAAATATTTGTCACCACCGATCAGTCAGCCGATTCGCGGCAGTGGGAAAAGAACTTGACGAACCTTCACATCATTGATATCGATTCGTCCAATCACATGACGATGTTCTCGGAAGAAAAACCACGCCAGACCATTCTTGAGTTCTGTGAAATCTTGTATTCTGAAGCCGGACTTCCGAATGCATTTCTTGACTTCTTTATGGCCAAGGCTCGAGAAATACATGGCAATATAGAGCTGGACAGATAA", "orf_prot_sequence": "MKKEFHIHASHPIVKHHQAYGQALLPGLAYIDLLYQFFREQGYEFAALELRNLSIYRPLLVGEDDGIQLLLQADDMAEGLWSVQLLDGEQRGAPESKAQQLYIKAEMYHHREAPVFDDVLDFQALQAVSHTQIPLNDIYAQCRSQGLVHSGMMKAEGTAYTLDDAQIIEVALPDEAASSAAGFMFHPALIDGSGVGSSNLFAALVEGEQRLFLPLFYERFRASARFERTCLVRVKTASVWRKNDMMYMDIEFFNESGEKIAELKNFVNKLVREAALINPNLKPASQAQSSKLKPYEEASSESQANPPRLDKSEALEGMEDLLKEIIAPYVDGSPEQLDPEAGYYELGLDSAILLQVVTALEKRFDAKLMPTLLFEYTTIEELAAYFVNENFATKHVAKEPATPLAPVLPGPIQTGHEDDIAIIGISGRYPGANNINEFWQNLVVGKDCISDVPEERWDWRSVAKHKSPSGKSVSKWGGFIQDPDCFDHQFFRISPREAEVLDPQERLFLQTCWECIEDAGYTPETLVTRQQAPHRRQSVGVFVGVMHKDYVFLGMEAIARGEQFHLSINNAPIANRVSYFCDFHGPSMVIDTVCSSSLTAIHLALESIRHGESDIALAGGVNLSLHPNKYLTYGLLDMYSSDGRCRAFGRGGDGYVSGEGVGAVVLKPLAQAIQDRDHIYAVVKGSMINHVGKVTGISVPNPVAQSDMILQCLEKTGIHPRTLSYVEAHGTGTSLGDPIEIQGLCKAFQTHTNDTQFCAIGSVKSNIGHTESAAGISGLSKVALQLHYQTLVPSLHSEAINPHLDLEASPFFVQRQTQHWERTSDHPRRAGLSSFGATGSNAHVILEEYIPEQSETDLAQPAEGVEQRLPVLIPLSAKNEERLKEAARNFYHYLISKPEDVAGHQVARLSDIAYTLQVGRRAMETRAIFLVDHQQQLVESLQAFLDDDHTKGNSWLGKQVKQQRHARRGEYSEAMLQQWMVQGRLDQLAQAWSEGVPLNWDALYSPESGVAKPSRVSLPTYPFAKARHWVPMEVKAVTPFAALHPLLHRNTSTLGEQRFSSTFSGEEFFLADHRVHGQKMLPGVAYLEMARAAVALATSAGEAQAIRFKNIIWQQPLVIDGTEKTIHIGLYAKANSQVDFTIYTGDEHGSDAPFPDEQNRRVHCRGIAMLTLSDRERETYLDLDHLQSQTGQNDFTPEQCYQAFAAMGIDYRDGHQGIAAVHAGADQILAELSLPASVLAHREPFVLHPSMMDSALQAAIGFALSAQVAGAQQPASLPYALESLDVRAACTPSMWVWIRYADNNSAGSPVQKFDLDLCDDRGKICVLMRGFSSRIFHAQASPCFAETLLPSQLHPLLHQHVPSENPVHDQFIAQFTGEEFFLRDHQQVMLGMAYLEMAHRAGQHRASQKILGLKNVVWSQLLFIAGQAREVSVHVQNEVLQHRFRITTQNEDSLQNIHCQGMLVVDQALYPERPDQLNIQDIQSRCSASIETTECDQLLQYTHGPSLLTIKQLWHNEHEALALLQLPDGMRSGREDYTLHPSMMNGAILTSVLFSLLNGPQEHLPMPFALDELWMYQEMPERAYAYVSMSSANNHDIELVDITGKCIVLFKGFTAAIQGAWQSQAPQNNVIYASTQWRESVLSGDEHANTAASAPIVMLAQDNPELAGLLRQRWPEASIEMLAPIGEDIAKTVQANFLQVFDRVKTCILEQPQRIQPIVVLLPENENDYLHDGLAALFKTARFEYRKIVGKLIRYTIDIDIEELAKSILMEVSHDDQHVDVYYSQTGTRKVKTLNEIYDFEKSHAHLLVEADLLHEGDVVWITGGLGGLGQIFTRHLSHTKGLKLILSGRSPLNAASEKVLRELQQSDVEMSYLSCDISDQQAVATLVQSILNKYGKLNGVIHSAGLTRDAYIHNKTREEMIAVLRPKMAGILAIEAACQDIQLNFMVLFSSIAGVFGSIGQADYAMANAFLDSFAEARNRRVQQGKCFGRTLSINWPLWRNGGMGVDAQNETLMQRNTGMIALETRAGLNAFELALSSEYSHILVAQGETEKIRSRLLSPRFVEENLSSVEADTTEPLEHQNQSEPSKAEQDQRAWLIRLLLKDLAAFVCRLQKVQPEEIDLEAEFSVYGFDSIGFMSFVNHLNDMYDLELMPTLFFEHSSLRALADALIEKHQEALLKKYESPKTAAQPSQDRMPIQARAVEMDKRQHPVSATMTPVESETTQGNPTPESLSTTDPIAIIGMSGKFPGSENLTAFWQHLEANRDLVSEIPEDRWDWRDYYGDHLSESGKTKIKWGGFIEGIDHFDPLFFGISPVEAEIMDPQFRLFLQTVWATIEDAGYRASALSGSKTGVYVGVTTTDYKDLMQQARARENSQEYHGMFPFMLANRVSYLFNFRGPSEAIDTACSSSLVAIHRATESIRQGSCEMAVAGGVNIIANPQLVLSATQGGMLSEDGRCKTFDQSANGYVRGEGVGAILLKPLARAIEDHDPICGVIRGSAENHGGKATSPTAPNPVAQQELLVSAYAQAGITPETVGYIEAHGTGTPLGDPIEINGLKSAFAQLYEQIGRPPANEPHCALGSVKTNIGHAEAAAGISGVLKVLLMMKHQKIPGNPHLKEPNPYLQLTGSPFHLAQDTQDWRALHDEVHNPIPRRAGVSSFGIGGSNAHLVLEEYTAEPAAEPVVCGEASLIILSAKNRACLVEAAGNLYRFLIDNRESSRGELLRLADIAYTLQVGREEMAHRLGFVASSLTELEERLQTFINVQGENQDLYEGHTKGNRSTLEAFESDDDLQEMLTKWVEGRRFEQILKLWVKGLAVNWESLYRGIQPRRISLPSYPFARERYWIPASAESLPVPAASPVSPIQVDNAAGVLMCHPVWEEKAAPVQVGSFDPASLHDCQHLILFCHMDVPLGLQDRFGTSSVCRVFQAQSDDVALGYSYLCEQVLTCLKEILENKPRDRVFVQIVIPGPETSEAEGASGLLHGLSALLKTAHLENPKVLGQLIEVGPRHTGDALIRCVQENCQSPDDVQVRYRHGRREVMAWEELPVSEPNAAPMPWKERGVYLITGGAGGLGFIVAREIARRVKAPILILAGRSHLSQAKRDELQQEAQRLGVQIEYRQADVSQPQEVNDLIRSILRDFTKLNGILHAAGLIRDSFMIRKTVDQLHQVLAPKVFGTVYLDEASKDVDLDFFLLFSSGAAALGNAGQADYAAANAFMDAYAEYRHALFASKQRFGRSLSINWPLWQEGGMQVDEPTLTALEQYAGIRALQTGSGLDALYRALSVTPNQIMVLEGDLAKIRQGLFSASTEPYRNESSRVEVDEERLLARTLHQCKTLFGGIIKLAADRVEAEEALEHYGIDSVIIAQMNLRLEEVFGEVSKTLLYEYQTLGELASYLATEYRDACMTWTGLTAIPTSDMTTVPDDAIPAKPQITSEPRRSSGVDVHALTPKAPAPSQDEPIAIIGLAGRYAQADTPRAYWENLQSGTDCVTEIPPDRWSLSGFYHEDLEEAIAQGKSYSKWGSFLNGFADFDPLFFSMSPREAIGIDPQERLFLQSSWEAMEDAGYTRETLRDQFQQRVGVFVGITKTGFSLYGPELWQRGDIVYPTTSFSSVANRISYLFNLRGPSLPIDTMCSSSLTAIHEACEHIRRGECELAIAGGVNLYLHPSTYVQMCAAHLLSQDGKCKSFGEGGNGFVPGEGVGTIVLKPLTQAIDDHDHIYAVIRASSVNHGGKTNGYTVPNPNAQAALIEDALDKAGVDARTLTYIEAHGTGTELGDPIEIRGLTQAFQKHTIDTAFCAVGSAKSNLGHLEAAAGIAGLTKIILQLQHAKIAPSLHASTLNPNINFAKTPFVVPQALSEWKRPIVDMHGEVKEYPRRTGISSFGAGGSNAHLIVEEYVKGTSVGETRASHHHDVIRNEAQVILLSAKNEDRLHCVAKDLHDYLNAEQGANLSLRDIAYTLQLGREAMDERLGLVVYSLDELRQKLNGFIAGESGIEDVYRGQVQGHKKALALFTEDDELQEAIEKWMQRGKFARLVELWSQGLAVDWNKLYCDREVIPYRVSLPTYPFEQHRYWIEDTLHASPKPVAESVGQSAVKLHPLIHENTSNFLAQRFRSCFRGDEFFLADHLVQGRRVLPGVAYLEMVRMAVSLAMDTQIEGYDLRFENVVWARPIIVDGQPLNMHTVLQVEDSTTISFEIYSQVDTEENDADVLHCQGSVEICVLEKEQELEVSHLLGECQKHHLSAAQCYEVFESAGIQYGPGHRGLDTVYVGDQQVLAKLLLPPSVASTAEQFILHPSLMDAALQASLGLAVGGVGSEPTPSLPYALETLDLCDAGARPSWAWIRESNQSSGEIQKLDIDLCDDQGRICVRMRGFSSRVLERAWGSQEDRLTLLSPVWNVISDPPTEGERDDVASEQVIIAGGSDLQRDILGQVHPGAVWLPADDFEAIDQQVKVLPSQMDVVHIIWVAPDQPMTSVRQESLIREQVQGVLYLFRLMKVLLAHGYGEKELHWTVITTQAQAVRKKDIVNPTHASVHGFIGSLAKEYPHWKIRLLDMDADESWPVHDMLALPGDQNGDAVAYRAKEWFQQALVPVLETDQGLPPCYRSQGVYVVIGGAGGIGEAWSRWMIERYQAQIIWIGRRKKDALIQEKLDALDKLGTPPIYIEADAGDLMALQNAYQQIKRRYGRIHGVIHSAIVLADKSLANMDERQFLAGLRAKVDVSVRLAQVFAKETLDFVLFFSSTQSVAKMPGQSNYAAGCTFKDAFASQLAQEWPCQVKVINWGYWGSVGVVAISSYRERMARAGVRSIEPAEGMAALQSLLQSSLDQLAVVNTLPTASIAQPSRNQALEEWITTYPDGLPVCVDSLPQYLPNQPLPVVDSGTGVPDQTVTIEDLLPQLLLATLQSLGLIEGRAEQRAAALPAATFYRQWLEESLTFLWAKEYLEYDGQGYTNKLPSVDLARVWQEWEREKVLWLQDRNQKAIVSLVEACMRALPDILRGAQLATDVIFPDSSVALVEHIYKGNVVADYYNQILQNSVVAYIQARLAQAPTAQIRILEIGAGTGGTTSGLLAELRPYQRHIVEYCYTDLSKAFLIHAERQYATEHPYLVTQIFDVEKPLAEQGIQANHYDVVIAANVLHATKNIRNTLRNAKAGLRQHGLLFLNEISTKSLFTHLTFGLLEGWWLYEDAALRITGSPVLSSAIWADVLAEEGFNSITFPALLAAESGHDFGQQIIIAQSDGIVRQKARRQSSPVLPSTPKKQSVKPKEITKLSPNTETLREKATVYIKKLVASTLQLPSDQIDSAQALEAYGLDSILVVQLTSTLRKAFHNISNTLFFEVQTIDGVVDYLLERQPEVFSDLLGVDKQKIDERIVETSTPIESLESTRQANGRNHSLQKLNFRTTQKLNALAASKKHETVHDRDIAIIGLSGRYPQAENVNAFWECLKAGQNCIREIPQERWDWRRYYDAEKGKEGTLYTKWGGFIDDVDKFDPLFFKLSARDAERMDPQGRLFLECAYSCMEDAGYTPSTLCDSRKVGVFVGVVNSTYRRQPSFWSMANRVSYLFNFQGPSMSVDTACSSSLTALHLAIESLHSGTSECAIAGGVNLILDPIQYLTLSAMTMLSSSDACKSFGNQADGFVDGEGVGAVILKPLAKAEQDGDAIYGIIKASMINAGGKTNGYTVPNPIAQSHLIREALARAEVDPRTISYVEAHGTATALGDSIEITGLSKAFGLSEDKQFCPIGSVKSNIGHAESASGIASLTKVLLQLKHRQLVPSLHSQQLNPSIDFAETPFVVQQTLEPWHRPVLTIDGETKTYPRIAGISSFGAGGANAHVIIQEYMNEKGDAAADAEGQGWPETSLIVVSARDEDRLRELVNHLCLYARACSLADQGKAQTAKLQAMAYTLQVGREAMEVRLGVVVASFAELSEKLQGFLDGQRDVDNLYRGQVRPHREAMAVLAGDDVFAETIDAWIHRHKYDKILELWVKGFVFDWNKLYGEQKPPRMHLPTYPFARERYWAKIIDLSLDGFQVGAPQQVVEWIHPLVHKNTSNLEEQRFSSTFSGQEFFLANNRVDGEKVLPGVVYLEMARVAAEQARPHPSTSLAKSHIQLRNIGWATPFVCDHSSQSVHIRIVPGTYKGSDVSFEEMSYEIYSHIDTEREVVVHSQGVIALWQAREVAGLDLPALQASINQKCLSAQQCYDAFAAMGIEYGQGHQGIEDVYMTPSQAGRCQVLAKLRLPAVVAETSHDFVLHPSMMDAALQACIGLTVEHAVPESGQMSLPFAIDAIEVIEKCTDTMWAWIRYADPHADPIQPLSSRVTKVDIDLCDESGNLCVRIKGFSTRVVAIPESKAIGTWMSFPVWKEKSWSEHEPSEYAQRTVMLIEMEWVSDRLIESQIEGTTCVHLTTQANSLAERFQDISVQVFERVKALMEAKLRGSILIQLLVPHSGETLLFSALAGILRTAHLENPALLGQVIILEPSETQEGVIDKLQRDSSCPEDALIRYQQERRQTMAWQELPMSEREQAVQVPWKEGGVYLITGGLGGVGFMFAKHLAQHSRSVSLVLTGRSELDEQRREQLKELEALGARVDYLSVDVSLKEAVERLIDYIESERGSLTGILHSAGVIQDNFIIRKAVREFQSVLVPKVDGVIHLDQATQALNLDFFVLFSSLSGINGNAGQVDYACANAFLDAYAHYRNRLVAINKRSGQTLSVNWPLWKEGGMQIDPQRAEAMFQHLGLVAMETSRGIQALIHGLSSGQSQLMVVAGDLERLKVAHPSRPSSPPSQMDREHNVIGENELDANALASRSIHYFKNLIASILKIPAHRIQNDELLELYGIDSIIIMQLINQLERDFGPLSKTLFFEYPTIEEVNQYFVDSYRQKLHVVLGLDKSKAPETDHSAVVDPARPKVHRRSRLLAPTLDESPLPVAQTQDVAIIGVAGRYPQSPDLESFWENLSQGKNCITEVPESRWDPSLYVDFDPSNSGQVYSKWGGFLDDVDKFDALFFNISPREAELMNPNERLFLETVWELVERSGYTPERIQEQHENNVGVYIGAMYQQYQALASEPLIESVLSLSSHSAIANRVSYFFDFQGPSLAIDTMCSSSLIAIQLACDSLLKGECQMAIAGGVNLTIHPNKYIGLSLSQMISRQNTSKSFGEGDGYLPAEGVGAVLLKPLAKAIEDQDSILAVIKSISTNHSGHTYEFRVPNPNAQAQLFEANFRKSGIDPRTITYVESAANGSPLGDPIEVSALRKAFQKFTADQGFCAIGSVKSNIGHAEAASGISQLTKVILQLQHQQLVPSINADPLNPNLSFDGSPFYLQQQLQPWARPVFNIDGQEREFPRRATVSSFGAGGSNAHLIIEEYIASAGKNAVSPDIELAADRELMVFSAKSCDRLQAMLQQMRHYVESNQALSLKKMAYTLQVGRMAMTHRIAMLVHNREELIQGIQDALHSLEQPAGIINTTIPIYMGDLEADHSEVKHLLSGQSGEAMLKVLFAEENLEKIALYWVKGGHIPWLALHQKGQMSMLSLPTYPFSKRYCWVESKALSQVVTTAEAELLSKSTDDHISVDRNEESVLSEILCRTLGLTAEEFNQKTPLVQYGVDSVMFVQIFQQIKDKIDNRVNLSQLLECQTMQDMIFYLTAKKEDAQTEPELVNLSGAGLSSSHDTRFPELVHMNSSTRGRPVFWFHGIAGVTVYEPVAEKSQRPFYGVQPCSWINQTAGPSHIQAMVQGYLDAIRSVQPEGPYDFGGYSLGGMLAYEATRQLQDMGESVSTIVMVDTLQSNPDRKDKYSRKTDYLVVLNRSFASSAWQSSENTVQDMLIRADELDASLSDDEYLTELIVLAKQRGLVKTETEIRASLEYATTLDEFYQTDPFTVRPLSDPDAVNCYYFRNKNGAMLGDQAPYYFATPQDREIFVTTDQSADSRQWEKNLTNLHIIDIDSSNHMTMFSEEKPRQTILEFCEILYSEAGLPNAFLDFFMAKAREIHGNIELDR", "perc_identity": 28.57}, "gnl|BL_ORD_ID|1968|hsp_num:0": {"type_match": "Loose", "snp": {"original": "F", "change": "L", "position": 413}, "query_snp": {"original": "F", "change": "L", "position": 225}, "orf_strand": "+", "orf_start": 73695, "orf_end": 97673, "orf_from": "BGC0001186.1|Misakinolide_18 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.46903e-10, "bit_score": 63.1586, "max_identities": 79, "cvterm_id": "39507", "query": "TACSSSLVAIHRATESIRQGSCEMAVAGGVN--IIANPQLVLSATQGGMLSED---GRCKTFDQSANGYVRGEGVGAILL------------KPLARAIEDHDPICGVIRGSAENHGGKATSPTAPNPVAQQELLVSAYAQAGITPETVGYIEAHGTGTPLGDPIEINGLKSAFAQLYEQIGRPPANEPHCALGSVKTNIGHAEAAAGISGVLKVLLMMKHQKIPGNPHLKEPNPYLQL---TGSPFHLAQDTQDWRALHDEVHNPIPRRAGVSSFGIGGSNAHLVLEEY", "match": "+ACSS   AI  A   I  G  ++AV GGV   I A P    S  +      D      + FD+  +G+V GE  GA++L            KPLAR       + G    S   H     +P A + V     +  +   AG++P  + ++ AHGT TP+GD  E N ++ A                  A+ + K+ +GH+  A G    +  +L ++   IP   + + P+P + L    G P +      D+R     V+N         SFG GG N  L    Y", "sequence_from_db": "SACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGE-AGALMLIETEEHAKARGAKPLAR-------LLGAGITSDAFH---MVAPAA-DGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCD-------------QAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRY-----GDYRY---AVNN---------SFGFGGHNVALAFGRY", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 80907, "query_end": 81716, "hit_start": 504, "hit_end": 1248, "orf_dna_sequence": "GTGAAAAAAGAATTTCATATACATGCAAGCCACCCCATTGTGAAACATCACCAGGCCTATGGCCAGGCGTTGTTGCCGGGGCTGGCTTATATTGATTTGCTGTACCAGTTTTTTCGCGAGCAAGGGTATGAGTTTGCAGCTTTAGAACTTCGCAACCTGTCAATTTATCGCCCTTTGTTGGTTGGGGAAGATGATGGTATTCAGCTTTTGCTGCAAGCAGATGACATGGCCGAGGGGCTGTGGTCGGTTCAACTGTTAGACGGGGAGCAACGCGGTGCCCCGGAGTCTAAAGCGCAACAACTCTATATCAAGGCGGAAATGTATCACCACCGTGAAGCGCCTGTATTTGATGACGTGCTAGATTTTCAGGCCCTGCAAGCCGTCAGTCATACGCAAATCCCTTTGAATGATATCTATGCCCAGTGCCGTTCTCAGGGACTGGTTCACTCGGGGATGATGAAAGCGGAAGGGACGGCTTACACGCTGGATGACGCCCAAATCATCGAGGTGGCTTTGCCAGACGAAGCCGCTTCTTCTGCGGCCGGCTTTATGTTTCATCCTGCCCTTATCGACGGTAGTGGCGTGGGTTCATCCAATTTGTTTGCCGCGCTGGTAGAAGGTGAACAGCGTTTGTTTCTACCGTTATTCTATGAGCGTTTTCGCGCATCTGCACGGTTTGAGCGAACGTGCCTTGTCAGAGTTAAGACGGCTTCCGTGTGGCGAAAAAACGATATGATGTATATGGATATAGAGTTCTTTAATGAGTCTGGAGAAAAAATTGCGGAACTGAAAAACTTTGTCAATAAGCTGGTGCGAGAGGCCGCATTAATTAATCCGAATCTTAAGCCAGCAAGCCAGGCTCAATCGTCCAAACTCAAGCCGTATGAGGAAGCGTCTAGCGAGTCGCAAGCCAATCCGCCTCGGCTCGATAAGTCTGAGGCTTTAGAGGGCATGGAAGACCTGCTTAAGGAGATCATTGCGCCGTATGTGGATGGCTCGCCAGAGCAACTTGATCCGGAGGCTGGTTATTACGAACTCGGTCTGGACTCGGCAATCCTGCTGCAGGTGGTCACGGCACTGGAGAAACGATTCGACGCCAAACTCATGCCCACGTTGTTATTTGAATACACCACCATCGAAGAGCTCGCCGCTTATTTTGTCAATGAGAATTTTGCCACGAAACATGTGGCCAAAGAGCCGGCCACGCCTCTAGCGCCTGTCTTGCCTGGGCCCATACAGACCGGCCACGAGGATGACATCGCCATTATCGGTATTTCCGGTCGTTACCCAGGAGCCAATAATATCAATGAGTTTTGGCAAAATTTAGTTGTAGGCAAAGACTGTATTAGCGACGTGCCAGAAGAGCGATGGGACTGGCGCAGCGTGGCCAAGCACAAATCACCGTCGGGTAAAAGCGTCTCAAAATGGGGAGGATTTATCCAGGACCCCGATTGTTTTGACCATCAATTTTTTCGAATTTCTCCACGGGAAGCCGAGGTGCTCGATCCGCAGGAACGCCTGTTTTTGCAGACCTGCTGGGAATGTATTGAGGACGCTGGCTATACCCCAGAAACGTTGGTCACCCGGCAGCAAGCCCCGCATCGCCGGCAGAGTGTGGGCGTGTTTGTCGGGGTGATGCATAAAGATTACGTCTTTCTCGGCATGGAAGCCATTGCGCGCGGTGAGCAGTTTCATTTGTCAATTAACAATGCGCCGATTGCCAACCGGGTTTCCTATTTTTGTGATTTCCATGGCCCCTCCATGGTCATCGATACGGTGTGTTCGTCCTCACTCACCGCCATACACTTGGCTTTGGAAAGCATTCGGCACGGAGAAAGCGATATTGCGCTGGCTGGAGGCGTCAACCTATCGTTGCACCCGAACAAATATCTGACCTATGGCCTACTCGATATGTATTCTAGCGATGGGCGTTGCCGGGCGTTTGGCCGCGGCGGGGATGGTTATGTGTCAGGGGAAGGGGTCGGGGCTGTCGTGTTGAAACCGTTGGCGCAGGCCATTCAAGATCGGGATCATATTTATGCGGTGGTCAAAGGCAGCATGATCAATCATGTGGGAAAAGTGACCGGAATCAGCGTGCCGAATCCGGTGGCGCAGAGCGACATGATTTTACAGTGTCTGGAAAAAACCGGCATTCACCCACGGACGCTTAGCTATGTCGAAGCTCATGGCACGGGCACGTCGCTTGGCGACCCCATCGAGATACAGGGTTTGTGCAAAGCATTTCAAACGCACACCAACGATACCCAATTTTGTGCCATCGGATCGGTTAAATCCAATATTGGCCATACGGAGTCGGCTGCTGGCATTAGTGGTTTGAGCAAAGTGGCCTTGCAACTGCACTATCAAACCCTGGTGCCATCGCTACATTCCGAAGCCATCAATCCTCATCTTGATTTAGAGGCGTCGCCCTTTTTTGTGCAGCGTCAAACCCAGCATTGGGAGCGGACCTCAGACCATCCACGACGAGCGGGTTTAAGCTCGTTTGGTGCAACCGGCTCAAATGCGCATGTGATTCTGGAGGAGTATATACCCGAGCAGAGCGAAACCGACCTGGCACAGCCCGCAGAGGGTGTAGAGCAACGTCTACCTGTGTTGATTCCGCTATCCGCCAAAAATGAAGAGCGTCTTAAAGAGGCTGCGCGAAACTTCTATCACTATCTCATCTCAAAGCCCGAAGATGTCGCAGGGCATCAGGTGGCGAGACTCAGCGATATCGCCTACACCTTACAAGTCGGCCGAAGGGCGATGGAAACACGGGCTATTTTTCTCGTTGATCATCAACAGCAGTTGGTTGAAAGTCTCCAAGCTTTTTTGGATGACGATCATACAAAGGGAAATAGTTGGCTAGGCAAGCAGGTCAAGCAGCAAAGACACGCTAGACGTGGCGAATATAGCGAGGCAATGCTACAGCAATGGATGGTTCAGGGCAGACTCGATCAGCTTGCTCAGGCGTGGAGCGAAGGTGTTCCCTTGAATTGGGACGCCCTTTATTCGCCGGAGAGCGGTGTCGCAAAACCAAGCCGCGTCAGTTTACCGACTTACCCCTTTGCCAAAGCACGTCATTGGGTACCAATGGAAGTGAAGGCGGTGACACCATTTGCTGCACTTCACCCCTTGCTGCACCGCAACACCTCTACGCTGGGTGAACAGCGTTTTAGTTCGACGTTTAGTGGGGAAGAATTCTTCCTCGCTGATCATCGGGTGCATGGCCAAAAAATGTTGCCGGGGGTTGCTTATCTCGAAATGGCGCGAGCCGCCGTTGCTCTGGCCACCTCAGCCGGGGAGGCCCAGGCGATACGATTTAAGAACATCATCTGGCAACAACCGCTCGTTATAGATGGGACGGAAAAAACGATTCATATTGGCTTGTATGCGAAAGCAAATTCGCAAGTCGATTTTACCATTTATACCGGAGACGAGCATGGCTCGGACGCTCCCTTTCCCGATGAACAAAACCGCCGTGTTCACTGCCGCGGCATTGCCATGTTAACGTTGTCGGATCGTGAGCGTGAAACTTACCTGGATCTTGATCATTTGCAGTCCCAAACAGGACAAAACGATTTTACCCCGGAGCAGTGTTATCAGGCCTTTGCGGCGATGGGTATTGATTACCGCGATGGACATCAAGGCATTGCCGCAGTTCATGCCGGGGCTGATCAGATATTGGCAGAACTCAGCCTGCCTGCCTCCGTTTTGGCCCATCGTGAACCGTTTGTGCTCCATCCCAGTATGATGGATTCAGCGTTACAAGCGGCAATTGGTTTTGCACTTAGCGCGCAAGTTGCCGGCGCACAACAACCGGCTTCTTTACCTTATGCTTTGGAATCGCTTGACGTAAGAGCTGCTTGCACCCCTTCCATGTGGGTTTGGATACGCTATGCCGACAACAATAGCGCAGGTAGTCCGGTGCAAAAATTTGATTTGGACCTGTGCGATGATCGTGGCAAAATCTGTGTGCTGATGAGAGGCTTTTCTTCTCGTATCTTTCATGCCCAGGCCTCGCCTTGTTTTGCTGAAACGTTATTGCCTTCTCAGCTGCATCCCTTATTGCATCAACATGTTCCCTCAGAAAACCCAGTGCATGATCAGTTTATCGCTCAATTTACGGGAGAAGAGTTTTTTCTACGTGACCACCAGCAAGTGATGCTGGGTATGGCCTATCTCGAAATGGCCCACCGTGCCGGACAGCATCGCGCGAGTCAGAAGATTTTGGGGCTCAAAAATGTCGTCTGGAGCCAGCTTCTCTTTATTGCCGGACAAGCTCGTGAGGTATCTGTTCATGTACAGAATGAAGTCCTTCAGCATCGTTTTCGTATAACGACACAGAATGAGGATTCGCTGCAAAACATACATTGCCAGGGTATGCTGGTTGTTGACCAGGCTTTGTACCCGGAGAGACCTGACCAACTTAATATTCAAGATATTCAATCCCGCTGTTCAGCGAGCATCGAAACTACTGAGTGCGATCAACTGCTACAATACACCCATGGCCCCAGCCTGCTGACGATCAAACAATTGTGGCACAACGAACATGAAGCCTTGGCTTTGCTTCAATTGCCCGATGGTATGCGCTCGGGACGTGAAGATTATACACTTCACCCGAGCATGATGAACGGCGCGATCCTCACCAGTGTACTCTTTTCTTTGCTCAATGGGCCGCAAGAACACCTGCCCATGCCTTTTGCCTTGGACGAGCTTTGGATGTACCAGGAGATGCCTGAGCGTGCCTACGCTTATGTGAGTATGAGTTCGGCGAACAATCATGATATCGAACTGGTGGACATAACGGGCAAATGTATTGTTTTGTTTAAAGGTTTTACTGCTGCCATTCAAGGGGCATGGCAAAGCCAGGCGCCGCAAAACAATGTGATTTATGCGAGCACACAATGGCGAGAAAGCGTGTTGTCCGGTGACGAGCATGCGAACACGGCCGCATCTGCACCGATTGTGATGCTTGCACAAGACAATCCGGAGCTTGCCGGTTTATTACGCCAGAGATGGCCAGAAGCCAGCATTGAAATGCTGGCGCCCATCGGTGAGGATATCGCCAAAACAGTTCAGGCAAACTTCCTGCAGGTGTTTGATCGAGTCAAAACCTGTATCTTAGAACAGCCTCAACGCATTCAGCCAATTGTCGTCCTTCTACCTGAAAATGAAAACGATTATCTGCACGACGGTCTTGCTGCCTTGTTCAAAACGGCAAGGTTTGAGTATAGAAAAATAGTAGGGAAATTAATTCGCTATACGATTGATATAGATATAGAAGAACTTGCTAAATCTATTTTGATGGAAGTGTCTCATGATGATCAACATGTGGATGTCTATTACAGTCAAACAGGTACCAGAAAGGTTAAAACGCTAAACGAAATATACGACTTTGAAAAGAGCCATGCGCACCTTCTTGTTGAGGCCGATTTATTGCATGAAGGTGATGTGGTTTGGATCACTGGCGGCTTGGGCGGTTTAGGGCAGATTTTTACTAGGCACCTTAGTCATACCAAAGGCTTGAAGTTGATTTTGAGCGGGCGTTCGCCCTTGAATGCGGCTAGCGAAAAAGTGTTGCGCGAACTTCAGCAGTCTGACGTTGAGATGAGTTACTTGAGTTGCGATATCAGCGATCAACAAGCTGTGGCGACGCTTGTCCAAAGTATTCTGAACAAATATGGCAAATTAAATGGCGTCATTCATAGTGCTGGGTTGACCCGGGATGCCTATATTCACAATAAAACGCGTGAAGAAATGATCGCTGTGCTGCGCCCTAAAATGGCGGGCATTTTGGCAATTGAGGCGGCTTGTCAAGATATTCAACTGAATTTTATGGTGTTATTTTCTTCCATTGCAGGTGTTTTTGGCAGTATTGGCCAAGCGGATTACGCCATGGCAAATGCTTTTCTTGACAGCTTTGCCGAGGCGAGGAATCGTCGCGTTCAGCAAGGGAAATGCTTTGGTAGAACGCTTTCCATCAATTGGCCCCTGTGGCGCAACGGTGGTATGGGGGTGGATGCGCAGAATGAAACCCTGATGCAGCGCAATACCGGCATGATTGCGTTAGAAACCCGTGCGGGCCTAAATGCGTTTGAGCTGGCTTTGTCTTCTGAATATAGCCACATCTTGGTGGCTCAGGGGGAAACCGAAAAAATTCGTTCTCGTTTGTTGTCGCCTCGGTTCGTAGAGGAAAACCTGAGCTCGGTTGAAGCAGATACAACGGAGCCATTGGAACATCAAAATCAGAGCGAGCCAAGCAAAGCCGAGCAGGACCAGCGGGCATGGCTCATTCGGTTGCTGCTCAAGGATCTCGCGGCTTTTGTCTGTCGCCTTCAGAAAGTGCAACCTGAAGAGATTGACCTAGAAGCCGAGTTTTCCGTCTATGGATTTGACTCTATAGGTTTTATGAGTTTTGTCAATCATTTGAACGACATGTACGACTTGGAATTAATGCCGACGCTATTTTTTGAGCATTCCAGTTTGCGTGCGCTTGCCGACGCGCTGATCGAGAAGCATCAGGAAGCTTTACTGAAAAAATATGAGTCCCCGAAAACAGCTGCTCAGCCAAGCCAGGATCGCATGCCAATTCAAGCTCGTGCAGTCGAGATGGACAAACGCCAACACCCTGTATCTGCAACGATGACACCTGTTGAATCGGAAACGACTCAAGGGAATCCGACGCCAGAGAGTTTATCTACAACTGACCCGATTGCCATTATTGGTATGAGCGGCAAATTTCCCGGATCGGAAAACCTGACGGCGTTTTGGCAGCACCTAGAGGCTAATCGTGATCTTGTCAGTGAAATCCCTGAAGACCGTTGGGACTGGCGGGATTACTACGGTGATCACCTGAGCGAAAGCGGCAAGACGAAGATTAAGTGGGGTGGCTTTATAGAGGGCATCGATCATTTCGATCCCCTGTTTTTCGGCATTTCCCCAGTGGAAGCCGAAATCATGGACCCTCAATTTCGTCTCTTTTTGCAAACGGTTTGGGCCACGATTGAAGATGCAGGCTATCGTGCCAGTGCGCTGTCGGGTAGCAAAACCGGGGTTTATGTGGGCGTGACCACCACGGATTATAAAGATTTAATGCAGCAGGCGCGGGCGAGGGAAAACTCCCAGGAATACCATGGTATGTTTCCATTTATGCTGGCCAATCGCGTCTCCTATTTGTTCAATTTTCGTGGCCCTAGTGAGGCGATCGATACAGCTTGCTCCAGCTCCTTAGTGGCGATTCATCGTGCGACCGAAAGCATACGCCAAGGAAGCTGTGAGATGGCGGTAGCAGGTGGGGTGAACATTATTGCGAACCCGCAATTGGTTCTTTCAGCGACTCAAGGTGGTATGTTGAGTGAAGATGGGCGCTGCAAGACCTTTGATCAAAGTGCCAATGGCTATGTCAGAGGTGAGGGGGTTGGCGCGATTTTGTTAAAACCCTTGGCAAGAGCGATCGAGGACCATGATCCGATCTGCGGTGTGATTCGGGGTTCGGCGGAAAATCACGGCGGCAAAGCCACATCGCCCACCGCCCCAAATCCGGTGGCGCAGCAGGAATTGCTGGTTTCGGCTTACGCCCAAGCCGGTATCACCCCGGAAACCGTGGGTTATATTGAAGCTCACGGAACGGGTACGCCGCTCGGTGATCCGATTGAAATCAATGGACTCAAAAGCGCATTTGCCCAGCTTTATGAGCAAATCGGCCGGCCTCCCGCCAACGAGCCCCATTGTGCCTTGGGCTCTGTAAAAACCAATATCGGACATGCGGAAGCGGCTGCGGGCATTTCAGGTGTTCTCAAAGTCCTCTTGATGATGAAGCATCAAAAAATTCCCGGAAATCCACATCTCAAGGAGCCAAATCCCTATTTACAATTGACCGGTAGCCCTTTTCATTTGGCGCAGGATACGCAGGACTGGAGGGCGTTACACGACGAGGTTCACAACCCGATACCCCGGCGCGCTGGGGTGAGCAGTTTTGGCATTGGCGGTAGCAATGCCCATCTGGTGCTGGAAGAATATACTGCCGAGCCTGCCGCTGAGCCCGTGGTCTGCGGCGAAGCCTCGTTAATAATTTTATCAGCGAAAAATAGAGCGTGTCTGGTTGAGGCTGCCGGGAATCTCTATCGATTTCTCATCGATAACCGTGAATCCTCCCGAGGAGAGCTGTTGCGTCTTGCTGATATTGCCTACACGCTTCAGGTGGGACGCGAGGAGATGGCGCATCGTTTAGGATTTGTGGCTTCATCTCTTACAGAACTCGAAGAAAGACTTCAGACTTTCATCAATGTCCAAGGTGAAAATCAAGACTTATATGAGGGGCACACGAAGGGTAATCGGAGTACCTTAGAAGCTTTTGAGTCTGATGATGATTTACAGGAGATGCTTACAAAGTGGGTTGAAGGCAGGAGATTTGAGCAAATTTTAAAGCTTTGGGTCAAAGGGCTTGCTGTGAACTGGGAGAGCCTCTACCGCGGAATACAGCCTCGGCGTATCAGCCTACCAAGCTATCCCTTTGCACGTGAACGTTACTGGATTCCTGCATCGGCTGAATCTTTGCCCGTACCGGCTGCATCGCCGGTATCTCCCATACAGGTCGATAACGCTGCCGGGGTATTGATGTGCCACCCGGTCTGGGAAGAAAAAGCCGCTCCGGTTCAGGTCGGCTCCTTTGATCCTGCTTCGCTGCATGATTGTCAGCACCTGATTCTGTTTTGTCATATGGATGTCCCTTTGGGTTTACAGGACCGTTTCGGCACAAGTAGCGTTTGTCGTGTGTTTCAGGCCCAGAGTGACGATGTGGCGCTAGGTTATTCGTATCTTTGCGAGCAGGTTTTGACGTGTCTCAAAGAGATTCTGGAAAACAAACCGAGAGACCGGGTATTCGTGCAGATTGTGATTCCTGGTCCCGAGACGAGCGAGGCCGAAGGTGCGAGCGGCCTGTTGCATGGTCTCTCTGCGTTGCTTAAAACCGCGCATTTGGAAAATCCAAAAGTTCTCGGGCAACTTATCGAAGTGGGTCCGCGCCACACGGGTGATGCGTTGATCCGGTGCGTGCAGGAAAATTGTCAATCGCCAGACGATGTCCAGGTCAGATACCGCCATGGGCGGCGTGAAGTGATGGCCTGGGAAGAGCTTCCAGTGTCAGAACCGAACGCCGCTCCTATGCCCTGGAAAGAAAGGGGGGTGTATTTAATAACTGGCGGTGCGGGGGGCTTGGGGTTCATTGTTGCAAGAGAAATTGCTCGCCGTGTCAAAGCCCCAATTCTTATTCTGGCCGGACGTTCCCATTTAAGCCAGGCAAAACGGGATGAATTGCAGCAAGAAGCCCAACGCTTGGGGGTGCAGATCGAATATCGACAGGCTGATGTTAGTCAACCACAAGAGGTCAATGACCTCATTCGGAGTATTCTGCGCGACTTCACGAAGCTCAATGGCATTTTGCACGCCGCTGGCCTGATTCGCGACAGCTTTATGATTCGGAAGACAGTCGATCAGTTGCATCAGGTACTGGCGCCAAAAGTATTTGGCACGGTGTACCTGGATGAGGCAAGCAAGGATGTCGACCTGGATTTCTTTCTTTTATTTTCCTCGGGCGCTGCAGCACTGGGTAATGCGGGGCAAGCAGACTACGCTGCCGCCAATGCCTTTATGGATGCTTACGCCGAGTATCGTCATGCACTGTTCGCGTCAAAGCAACGTTTTGGCCGGAGTCTTTCGATCAACTGGCCGCTCTGGCAAGAGGGCGGTATGCAAGTGGATGAGCCGACCCTGACCGCGTTAGAGCAATACGCGGGCATCAGGGCACTGCAAACCGGTAGCGGATTAGATGCGCTGTACCGTGCGCTTAGCGTAACGCCGAACCAAATCATGGTACTAGAAGGCGATCTGGCCAAAATCCGTCAGGGGTTGTTTTCTGCCTCCACAGAACCGTATCGCAACGAATCTTCAAGGGTTGAGGTTGATGAGGAACGCTTGCTCGCCAGGACCTTGCACCAGTGTAAAACACTTTTTGGCGGCATTATCAAATTAGCCGCAGATCGAGTCGAGGCAGAAGAAGCGCTGGAGCACTATGGTATTGACTCCGTAATCATTGCCCAAATGAATCTGCGTTTGGAAGAGGTTTTTGGCGAGGTCTCTAAAACTTTGCTCTATGAATACCAGACGCTGGGGGAACTGGCTAGTTATTTAGCAACCGAGTACCGAGACGCATGCATGACGTGGACAGGCTTAACAGCTATCCCCACAAGTGACATGACAACAGTTCCGGACGACGCGATTCCGGCCAAGCCTCAAATCACTTCGGAGCCTCGGCGATCATCGGGGGTTGATGTTCATGCCCTGACGCCAAAAGCACCCGCGCCGTCGCAAGATGAGCCCATTGCGATCATCGGCCTGGCTGGCCGATATGCACAAGCCGATACGCCGCGCGCTTACTGGGAAAATTTGCAGTCAGGAACAGACTGTGTGACGGAAATTCCTCCGGATCGCTGGTCCCTGTCGGGCTTTTATCACGAGGATCTCGAAGAGGCCATTGCCCAGGGTAAGAGTTATAGCAAATGGGGAAGCTTCCTAAACGGTTTTGCCGATTTTGACCCGCTGTTCTTTTCGATGTCGCCTCGTGAAGCCATTGGCATTGACCCACAAGAGCGCCTGTTTCTGCAAAGTTCCTGGGAGGCGATGGAAGATGCCGGCTACACCAGAGAGACCCTTCGAGATCAGTTTCAGCAGCGAGTCGGGGTGTTTGTCGGTATTACCAAAACAGGTTTTAGCCTATACGGTCCAGAGCTGTGGCAGCGTGGTGACATTGTCTATCCGACCACCTCCTTCAGCTCGGTGGCCAATCGCATTTCTTATCTATTCAATCTGCGCGGCCCGAGTTTACCGATCGATACCATGTGCTCCTCTTCGCTAACGGCCATTCACGAAGCCTGCGAACATATACGCCGCGGTGAATGTGAGTTGGCCATTGCGGGTGGCGTCAACTTATATTTGCATCCCTCTACCTATGTGCAAATGTGCGCAGCCCATTTGCTGTCGCAAGATGGAAAATGTAAAAGCTTTGGCGAAGGCGGCAACGGTTTTGTCCCCGGTGAGGGCGTAGGTACGATCGTGCTGAAGCCGCTCACCCAAGCGATTGACGATCACGATCATATCTATGCCGTCATTCGTGCGTCGAGTGTGAACCACGGCGGCAAAACCAATGGCTATACGGTGCCCAACCCAAATGCGCAAGCCGCTCTGATTGAGGACGCGCTGGACAAAGCCGGGGTGGATGCGCGTACGCTTACATATATTGAAGCACACGGGACGGGAACCGAATTAGGTGATCCGATCGAAATTCGTGGTTTGACTCAGGCTTTTCAGAAACATACTATCGATACGGCGTTTTGCGCCGTGGGATCGGCTAAATCCAATTTGGGGCACCTGGAAGCGGCCGCCGGTATTGCCGGGCTGACGAAAATTATTCTGCAGTTGCAACATGCAAAAATTGCCCCGAGTCTGCATGCCTCGACATTAAACCCAAATATTAATTTTGCCAAAACCCCCTTTGTGGTGCCGCAAGCACTTTCAGAGTGGAAAAGACCCATTGTCGACATGCACGGCGAGGTCAAAGAATACCCCAGAAGAACGGGTATTTCCTCCTTTGGTGCCGGTGGGTCGAATGCCCACTTGATTGTTGAAGAGTATGTGAAGGGGACCTCGGTTGGAGAAACGAGGGCAAGTCATCATCACGATGTGATTCGCAACGAGGCCCAAGTCATTTTACTGTCAGCGAAAAATGAAGATCGTCTCCACTGTGTGGCAAAAGATTTACATGATTATCTCAACGCGGAGCAAGGCGCAAACTTAAGCCTGCGTGACATCGCCTATACGCTCCAGTTGGGCCGTGAGGCCATGGATGAACGTTTGGGGCTGGTTGTCTATTCGTTGGATGAGTTGCGACAAAAGCTTAACGGCTTTATTGCAGGAGAGAGTGGTATTGAAGATGTGTATCGCGGACAGGTTCAAGGTCATAAAAAAGCACTAGCGTTATTTACTGAAGATGATGAACTTCAAGAAGCGATTGAAAAATGGATGCAACGCGGAAAATTCGCCAGGTTGGTCGAGCTTTGGAGTCAGGGCCTGGCGGTTGATTGGAACAAACTATATTGCGATCGCGAAGTCATACCTTATCGCGTCAGCCTGCCAACATATCCCTTTGAGCAACATCGATACTGGATCGAAGACACGTTGCATGCCTCACCCAAGCCGGTGGCTGAGTCAGTGGGGCAAAGTGCGGTCAAACTACATCCGTTGATCCACGAAAACACTTCCAACTTTCTCGCGCAACGCTTCCGCTCATGTTTTCGTGGCGACGAGTTTTTCTTGGCCGATCATCTGGTGCAAGGTCGGCGCGTTTTGCCGGGCGTTGCTTATCTGGAAATGGTTCGCATGGCAGTCTCACTGGCGATGGATACGCAAATCGAGGGGTATGATTTACGTTTTGAGAATGTGGTTTGGGCAAGACCTATTATCGTGGACGGTCAGCCGCTCAATATGCATACCGTATTACAGGTAGAGGACAGCACTACCATTAGCTTTGAAATATACTCCCAGGTAGATACCGAGGAAAACGATGCCGATGTCTTACATTGCCAGGGCTCAGTTGAGATTTGCGTTTTAGAAAAAGAGCAAGAGTTAGAGGTGTCCCATTTACTAGGCGAGTGTCAGAAACACCATCTTTCTGCTGCCCAATGTTATGAAGTCTTTGAATCTGCTGGTATTCAATATGGCCCGGGGCACCGAGGCCTTGATACCGTCTATGTGGGAGATCAGCAGGTTCTGGCAAAATTGCTTTTGCCGCCATCGGTTGCAAGCACAGCGGAACAATTTATTTTACATCCGAGCTTGATGGATGCTGCCTTGCAGGCGTCGCTTGGCCTGGCCGTAGGCGGTGTTGGGTCCGAGCCCACCCCCTCCTTGCCCTATGCGTTGGAAACGCTTGATCTCTGCGACGCGGGGGCCAGACCAAGTTGGGCCTGGATTCGTGAATCCAACCAAAGCAGCGGGGAGATTCAAAAACTTGATATTGACCTGTGCGACGATCAAGGCCGCATCTGTGTTCGGATGCGAGGGTTTTCGTCACGTGTGCTCGAGCGGGCATGGGGCTCGCAAGAAGACCGTTTGACCCTGCTGAGTCCGGTATGGAATGTCATATCAGACCCGCCAACAGAAGGCGAGCGCGATGATGTTGCCAGTGAGCAGGTGATCATCGCCGGGGGTAGCGACCTGCAAAGAGATATCCTTGGGCAGGTTCACCCCGGTGCGGTGTGGTTACCAGCAGACGATTTTGAGGCGATAGACCAACAAGTTAAGGTGTTGCCATCTCAGATGGATGTCGTGCATATCATCTGGGTCGCACCGGATCAGCCAATGACCTCCGTGAGACAAGAGTCTTTGATTCGTGAGCAAGTCCAAGGTGTGCTTTATCTCTTTCGTCTCATGAAAGTCTTGTTGGCACACGGTTACGGTGAGAAAGAGCTGCATTGGACCGTTATTACCACACAGGCACAAGCGGTACGCAAAAAGGATATCGTCAACCCCACCCATGCCAGTGTACATGGCTTCATCGGTTCGCTTGCTAAGGAATATCCGCATTGGAAAATTCGGCTGTTGGATATGGACGCGGATGAGAGTTGGCCGGTTCACGATATGCTGGCCTTACCTGGGGATCAAAATGGCGATGCCGTCGCCTATCGAGCCAAAGAGTGGTTTCAACAAGCGTTAGTGCCCGTGTTGGAGACGGATCAGGGATTACCCCCCTGTTATCGTTCTCAGGGGGTCTATGTGGTGATTGGCGGCGCAGGCGGGATTGGCGAGGCCTGGAGTCGGTGGATGATCGAGCGCTACCAAGCGCAGATCATCTGGATCGGCAGACGAAAAAAAGATGCTTTGATTCAGGAAAAATTGGACGCTTTAGACAAACTTGGCACCCCGCCCATCTATATCGAGGCGGATGCTGGCGACCTGATGGCTTTACAAAATGCGTATCAGCAAATTAAACGTCGCTATGGTCGGATTCACGGTGTGATTCATTCAGCGATTGTCCTGGCCGACAAAAGTTTGGCCAATATGGACGAACGGCAATTCCTGGCCGGTCTGAGAGCCAAAGTGGATGTGAGTGTACGGCTGGCACAAGTGTTTGCGAAAGAAACGCTGGATTTTGTCTTATTTTTTTCTTCTACTCAGTCCGTTGCTAAAATGCCAGGGCAAAGTAATTATGCGGCCGGTTGTACCTTTAAAGATGCCTTTGCCAGCCAACTGGCTCAGGAGTGGCCGTGCCAGGTCAAAGTCATCAACTGGGGCTATTGGGGAAGTGTCGGGGTGGTGGCGATCAGCTCATATCGTGAGCGTATGGCGCGGGCGGGGGTGAGGTCCATCGAGCCGGCAGAGGGGATGGCCGCCCTCCAAAGCCTACTGCAATCATCACTGGATCAGTTGGCCGTGGTCAACACTCTCCCCACTGCGAGCATTGCTCAACCTTCACGGAATCAGGCGTTGGAGGAATGGATCACGACGTATCCGGACGGGCTTCCTGTCTGTGTGGACAGTTTACCACAATATCTTCCGAATCAACCCCTTCCGGTTGTCGATAGCGGCACCGGGGTGCCCGACCAAACTGTGACCATAGAGGATTTATTGCCCCAACTCCTATTGGCTACGTTGCAGTCCTTAGGCTTAATCGAAGGGCGGGCCGAACAGCGTGCCGCCGCTTTACCGGCTGCTACCTTTTATAGACAATGGCTGGAAGAAAGCCTGACCTTCTTGTGGGCAAAAGAATATCTTGAGTATGATGGGCAGGGTTATACAAACAAGCTGCCCTCAGTTGACCTCGCACGTGTATGGCAGGAGTGGGAGCGGGAGAAAGTTCTCTGGCTGCAAGATCGCAATCAAAAGGCCATCGTGAGCCTGGTGGAAGCATGTATGCGTGCTTTGCCCGATATCCTTAGAGGAGCGCAACTGGCAACTGACGTCATATTCCCGGATTCATCCGTCGCACTGGTCGAACATATTTACAAAGGCAACGTGGTTGCAGATTATTATAATCAAATCCTTCAGAATAGTGTCGTGGCATATATTCAAGCACGACTGGCGCAAGCGCCTACGGCGCAAATCCGAATACTTGAAATTGGTGCCGGAACCGGTGGGACGACTTCTGGTTTACTGGCTGAACTCCGCCCATATCAGCGTCACATCGTAGAGTATTGTTATACAGATCTTTCAAAAGCCTTTCTAATACATGCCGAGAGGCAGTATGCCACAGAGCATCCGTATCTTGTGACACAGATTTTTGATGTGGAAAAACCGCTTGCTGAACAAGGTATACAGGCAAATCACTACGATGTCGTGATTGCAGCGAATGTCCTGCACGCGACAAAAAATATTCGCAATACGCTGCGCAATGCAAAAGCAGGCTTACGCCAACATGGTTTGCTCTTCCTAAATGAAATAAGTACGAAGTCCTTGTTTACTCATTTGACGTTTGGTTTGTTGGAAGGCTGGTGGCTGTATGAGGATGCGGCTTTGCGAATCACAGGCAGTCCGGTATTAAGTTCGGCAATTTGGGCCGATGTGTTGGCTGAGGAAGGCTTTAATTCCATTACGTTTCCTGCATTGTTGGCCGCTGAATCCGGGCATGATTTTGGGCAGCAAATTATTATTGCACAAAGTGATGGGATCGTGCGGCAGAAGGCTCGCCGCCAATCTTCACCTGTACTGCCATCTACACCCAAAAAGCAGAGCGTAAAACCGAAGGAAATAACCAAGCTGTCGCCCAATACTGAAACTTTGCGTGAGAAAGCGACAGTTTATATTAAAAAACTAGTTGCCTCAACACTGCAACTTCCAAGCGATCAGATCGACTCTGCCCAAGCCTTGGAAGCCTATGGGCTGGATTCGATTTTGGTGGTGCAGTTGACCAGTACATTACGCAAAGCATTTCACAACATTAGCAATACCTTGTTCTTTGAAGTACAAACGATTGATGGCGTTGTCGATTACTTACTTGAAAGGCAACCTGAGGTATTTAGTGATTTACTTGGAGTTGACAAACAGAAAATTGATGAACGTATTGTTGAAACAAGCACACCAATTGAGAGCCTCGAAAGTACAAGGCAAGCAAATGGGAGAAATCATTCTTTACAGAAACTAAATTTTAGAACGACCCAGAAGTTAAATGCTTTAGCTGCCTCAAAAAAACATGAGACTGTCCATGATCGGGATATCGCGATCATCGGTCTGAGTGGACGTTATCCGCAGGCTGAGAATGTCAATGCATTTTGGGAGTGTTTAAAGGCTGGGCAAAACTGTATTCGCGAAATCCCGCAGGAGCGGTGGGACTGGAGACGCTATTATGATGCGGAAAAAGGCAAAGAAGGAACACTCTACACGAAATGGGGCGGCTTTATTGACGATGTAGACAAATTTGACCCGTTATTTTTTAAATTGTCGGCGAGAGACGCCGAGCGCATGGACCCTCAGGGAAGGCTCTTTTTAGAGTGCGCCTACAGTTGTATGGAAGATGCGGGTTATACGCCGAGCACACTTTGTGACAGCCGTAAAGTAGGCGTTTTTGTTGGGGTGGTGAATAGCACGTATCGGCGTCAGCCAAGCTTCTGGTCGATGGCCAATCGGGTGTCCTACCTATTTAACTTTCAAGGCCCGAGCATGTCCGTGGACACAGCTTGTTCGTCCTCGCTGACCGCTCTGCATCTCGCGATTGAGAGTCTGCATAGCGGCACAAGCGAATGCGCGATTGCCGGCGGGGTGAACTTGATTCTGGATCCGATTCAATACCTGACGCTAAGCGCCATGACGATGCTTTCATCAAGCGACGCGTGCAAGTCTTTTGGGAATCAGGCCGATGGCTTTGTCGATGGCGAAGGCGTAGGGGCGGTGATCTTAAAGCCCCTGGCAAAAGCGGAGCAAGACGGAGACGCGATCTACGGCATTATCAAAGCCAGTATGATCAATGCGGGCGGCAAGACCAATGGTTATACCGTGCCAAATCCAATCGCACAATCGCACTTGATTCGGGAAGCCCTGGCGCGAGCCGAGGTTGACCCGAGAACCATTAGTTATGTGGAGGCTCATGGCACGGCCACGGCTTTAGGCGATTCCATTGAAATTACCGGCTTGAGCAAAGCCTTTGGCCTCAGTGAGGACAAGCAATTTTGCCCGATCGGTTCGGTGAAATCGAATATTGGTCACGCCGAAAGTGCGTCGGGTATTGCTAGTTTAACGAAAGTCTTGCTGCAATTGAAGCATCGCCAATTGGTGCCTTCCTTACATTCGCAGCAGCTCAACCCCAGTATTGATTTTGCTGAGACACCCTTTGTCGTGCAGCAGACCCTTGAGCCCTGGCATAGGCCCGTGTTGACGATTGATGGAGAAACCAAGACCTATCCGCGCATTGCCGGCATCTCATCCTTTGGAGCTGGTGGGGCGAACGCCCATGTGATTATCCAAGAATATATGAATGAGAAGGGCGATGCAGCGGCTGACGCCGAGGGACAGGGGTGGCCTGAGACCAGCTTGATTGTGGTTTCCGCCAGAGATGAAGATCGGCTTAGAGAACTTGTCAATCATCTGTGCCTTTATGCGAGAGCGTGTAGCCTGGCAGATCAGGGCAAGGCACAAACCGCCAAGCTGCAAGCCATGGCGTATACCCTCCAGGTGGGACGCGAAGCCATGGAAGTACGCCTAGGGGTCGTGGTGGCCTCTTTTGCTGAACTTAGTGAAAAGCTCCAGGGATTTTTGGACGGCCAACGCGATGTGGACAACTTGTATCGGGGACAGGTTAGACCCCATCGAGAAGCAATGGCGGTTCTTGCCGGTGATGACGTGTTCGCAGAAACGATTGATGCCTGGATTCACAGACACAAGTACGACAAAATCTTGGAGCTTTGGGTTAAAGGCTTTGTCTTCGACTGGAACAAGCTGTATGGCGAACAGAAGCCGCCTCGCATGCATTTGCCAACCTATCCTTTTGCACGGGAACGCTATTGGGCAAAAATAATTGATTTATCCCTCGATGGATTTCAAGTTGGTGCTCCACAGCAAGTTGTAGAGTGGATCCATCCTCTCGTTCATAAAAATACTTCTAATCTTGAGGAGCAACGTTTTAGCTCGACATTTAGTGGCCAGGAATTTTTTCTAGCAAATAATCGTGTCGATGGAGAGAAGGTGTTACCCGGCGTCGTCTATCTTGAAATGGCACGAGTGGCGGCAGAACAAGCACGGCCTCACCCCTCTACAAGCTTGGCGAAGAGCCATATTCAACTTAGAAATATCGGCTGGGCGACTCCCTTTGTCTGTGACCATTCGTCGCAAAGCGTGCATATCAGGATTGTGCCAGGTACTTATAAAGGCAGTGACGTCAGTTTCGAAGAGATGAGCTATGAAATCTATTCACACATAGATACAGAACGTGAGGTTGTCGTACACAGTCAGGGTGTCATCGCCTTGTGGCAGGCTCGTGAAGTCGCCGGGTTGGATTTGCCAGCTTTGCAGGCGAGCATCAATCAGAAATGTCTCAGTGCACAGCAATGTTATGACGCGTTTGCAGCGATGGGCATTGAGTATGGTCAAGGGCACCAAGGCATAGAGGATGTCTATATGACGCCTAGCCAAGCCGGTCGCTGTCAAGTGTTGGCAAAACTCAGGTTGCCTGCCGTTGTTGCTGAGACGAGCCATGATTTTGTTCTTCACCCTAGCATGATGGATGCAGCCTTACAGGCATGTATTGGACTGACGGTTGAACACGCCGTTCCCGAGTCTGGACAGATGTCGCTCCCCTTTGCCATAGACGCTATTGAAGTTATTGAAAAATGCACAGATACGATGTGGGCTTGGATACGCTATGCCGATCCTCATGCCGACCCAATACAACCGTTGAGTTCACGCGTGACCAAGGTTGACATCGATCTGTGTGATGAAAGCGGGAATCTATGTGTTCGGATAAAAGGATTTTCCACTCGCGTGGTTGCCATACCGGAGAGCAAAGCCATTGGAACTTGGATGAGCTTTCCAGTATGGAAAGAAAAATCCTGGTCTGAACATGAGCCTTCAGAATATGCTCAGCGGACGGTGATGTTGATAGAGATGGAGTGGGTGTCTGATCGTTTGATTGAGTCTCAAATCGAAGGCACGACTTGTGTTCATTTGACAACCCAAGCAAATTCACTGGCAGAGCGCTTTCAAGATATTTCAGTTCAGGTGTTTGAGCGGGTCAAAGCGCTCATGGAAGCAAAACTTAGAGGGTCAATCTTAATCCAGCTTCTGGTGCCTCACTCGGGAGAGACGCTGCTGTTTAGCGCACTTGCAGGCATACTCAGAACGGCTCACTTGGAAAACCCTGCGCTGTTGGGGCAGGTGATTATCCTGGAGCCGAGTGAAACCCAAGAGGGGGTAATCGACAAACTTCAGCGCGACAGCTCTTGCCCCGAAGATGCGTTAATCCGTTATCAGCAAGAAAGACGCCAGACGATGGCGTGGCAAGAATTGCCGATGTCAGAGCGAGAGCAGGCCGTGCAAGTTCCCTGGAAAGAAGGAGGTGTCTACCTGATTACAGGCGGCCTAGGTGGCGTTGGATTCATGTTTGCCAAACATCTTGCGCAGCACAGCAGGTCGGTTTCTCTGGTGCTGACCGGACGGTCGGAACTAGATGAGCAACGGCGCGAGCAGCTCAAAGAACTAGAAGCGTTGGGGGCCAGGGTTGACTATCTCTCGGTCGATGTCAGCCTTAAGGAGGCGGTTGAGCGCTTAATTGACTACATCGAAAGCGAGAGGGGATCGCTCACCGGCATTCTGCATAGTGCCGGTGTGATTCAGGATAACTTTATCATTCGAAAAGCAGTGCGTGAGTTTCAATCCGTGCTTGTGCCTAAAGTCGATGGCGTGATTCATTTGGATCAGGCAACGCAAGCGTTAAATCTCGATTTTTTTGTCCTGTTTTCTTCTCTCTCGGGCATTAACGGCAACGCCGGTCAGGTAGATTATGCCTGCGCCAACGCGTTTCTAGATGCTTACGCGCATTACCGCAATAGATTGGTTGCCATTAACAAGCGCTCCGGCCAAACGCTCTCTGTGAATTGGCCGCTGTGGAAAGAGGGGGGGATGCAAATCGATCCCCAGCGTGCAGAGGCGATGTTCCAACATTTGGGGCTGGTGGCGATGGAGACATCGCGTGGTATTCAGGCATTGATTCACGGTCTTTCCTCCGGACAGAGCCAGCTCATGGTGGTGGCAGGTGATCTCGAACGCCTGAAAGTTGCACATCCATCACGGCCATCATCGCCACCCTCTCAGATGGATCGTGAACACAATGTCATTGGTGAAAACGAGTTGGATGCCAATGCGTTGGCGTCAAGGTCTATTCACTATTTCAAAAACCTAATTGCGTCTATACTCAAGATACCTGCCCATCGTATTCAAAACGATGAGTTACTGGAATTGTACGGTATTGACTCTATTATTATTATGCAGTTGATCAATCAGTTGGAAAGAGACTTTGGTCCATTGTCGAAAACGCTCTTTTTTGAGTACCCAACCATTGAAGAAGTTAACCAATATTTTGTCGACTCATACAGACAAAAGCTCCACGTGGTCCTTGGCTTAGACAAGTCAAAGGCACCTGAAACTGACCACTCGGCTGTTGTCGATCCGGCTCGCCCAAAGGTACATCGGCGTTCTCGCTTGTTGGCACCGACATTAGATGAATCACCACTCCCCGTTGCGCAAACGCAGGATGTCGCCATTATCGGTGTTGCCGGACGTTATCCCCAATCCCCGGATCTTGAATCGTTCTGGGAAAATTTGTCGCAAGGTAAAAATTGTATTACTGAAGTTCCCGAAAGTCGTTGGGACCCCAGCTTGTATGTTGATTTTGACCCTTCCAACTCTGGTCAGGTGTATAGCAAGTGGGGTGGTTTCTTAGATGACGTGGACAAATTTGACGCTTTATTTTTCAATATTTCTCCTCGTGAAGCAGAGTTGATGAACCCGAATGAGCGTCTTTTCCTGGAAACCGTCTGGGAGCTGGTGGAACGTTCGGGGTATACACCGGAAAGAATACAGGAACAGCACGAAAATAACGTGGGGGTTTATATCGGGGCCATGTATCAGCAGTATCAGGCCTTAGCTTCCGAGCCCCTCATAGAGTCGGTCCTGTCCTTGTCTTCCCATAGTGCGATTGCGAATCGCGTGTCCTATTTTTTTGATTTCCAGGGCCCTAGTCTGGCCATCGACACGATGTGTTCCTCTTCATTAATTGCGATACAGTTAGCTTGTGACAGCCTGCTGAAAGGCGAGTGCCAGATGGCCATTGCCGGAGGTGTCAACCTCACGATTCATCCGAACAAATATATTGGCTTGAGCCTGAGTCAAATGATCAGTCGGCAAAACACCAGCAAAAGCTTTGGTGAGGGTGATGGTTATCTTCCGGCAGAAGGTGTCGGTGCCGTGTTGTTAAAGCCCTTGGCCAAGGCGATCGAAGATCAGGATTCCATTTTAGCCGTCATTAAATCCATTAGCACCAATCATAGCGGACATACGTATGAGTTTCGTGTACCCAACCCGAATGCGCAAGCCCAATTATTTGAAGCAAATTTCCGTAAATCCGGCATCGATCCACGCACGATTACGTATGTTGAATCGGCGGCCAATGGTTCTCCCTTGGGAGATCCGATCGAGGTCAGTGCACTTCGTAAAGCGTTTCAAAAATTCACTGCGGATCAGGGCTTTTGTGCGATTGGTTCCGTCAAATCCAATATCGGTCATGCAGAGGCAGCATCCGGCATCTCCCAACTGACAAAAGTGATATTACAGCTTCAGCATCAGCAACTTGTTCCGTCGATTAATGCAGACCCACTGAATCCAAATTTAAGCTTCGATGGTTCGCCATTTTATCTGCAACAACAACTGCAACCATGGGCACGTCCAGTCTTCAATATCGATGGTCAAGAGCGTGAGTTCCCCCGGCGCGCAACCGTTAGCTCCTTTGGGGCGGGAGGCTCGAATGCGCATTTGATTATCGAGGAATATATTGCTTCTGCGGGTAAGAACGCCGTGTCACCTGATATAGAGTTGGCAGCCGATCGCGAGTTGATGGTTTTTTCCGCAAAAAGCTGTGATCGTCTTCAGGCGATGCTGCAACAGATGCGTCATTATGTCGAATCCAACCAAGCACTTTCGCTAAAGAAGATGGCCTATACGCTCCAGGTAGGACGTATGGCGATGACACATCGAATCGCGATGCTGGTGCATAATCGAGAAGAGCTGATCCAGGGCATCCAAGATGCTTTGCATAGCCTAGAACAACCAGCCGGGATAATCAACACAACCATTCCAATATACATGGGTGATCTGGAGGCGGATCACTCGGAAGTAAAGCATTTGCTCTCCGGTCAATCCGGAGAGGCCATGCTGAAAGTGCTTTTCGCCGAAGAAAATCTGGAAAAAATTGCTCTTTACTGGGTTAAAGGAGGCCATATTCCCTGGCTGGCACTGCATCAAAAAGGTCAAATGTCTATGTTGTCTCTACCCACGTACCCTTTCTCCAAGCGGTACTGCTGGGTTGAGAGTAAAGCCCTGTCTCAAGTTGTAACCACGGCTGAGGCCGAATTACTTTCGAAAAGTACGGATGATCATATTTCCGTTGACAGAAATGAAGAATCAGTTCTTTCAGAGATTCTGTGCCGAACCTTAGGCCTAACAGCAGAAGAGTTTAATCAAAAGACCCCATTGGTTCAATATGGGGTGGATTCCGTTATGTTTGTGCAAATTTTTCAACAAATTAAAGACAAGATTGATAACCGCGTTAACTTGAGTCAGCTGCTGGAATGCCAAACCATGCAAGATATGATTTTCTATTTGACTGCGAAAAAGGAGGACGCGCAAACCGAGCCGGAGCTGGTGAACCTTTCCGGAGCCGGTCTTTCTTCATCACATGACACACGTTTTCCAGAGCTGGTCCATATGAACTCAAGTACCAGGGGAAGACCTGTATTCTGGTTCCATGGCATCGCGGGCGTTACGGTTTACGAGCCTGTTGCTGAAAAAAGCCAGCGCCCCTTCTATGGCGTTCAGCCCTGTAGCTGGATCAACCAAACCGCGGGACCTTCTCATATTCAGGCCATGGTGCAAGGTTATCTGGATGCCATACGATCCGTGCAGCCGGAAGGTCCTTACGATTTTGGTGGCTATTCGCTGGGTGGCATGTTGGCTTATGAAGCCACCCGTCAATTACAGGACATGGGAGAGAGCGTATCGACCATTGTGATGGTCGATACGCTACAGAGTAATCCTGATCGTAAGGATAAGTACTCGCGCAAAACAGATTATCTGGTTGTTTTGAATCGGTCCTTTGCCTCATCTGCATGGCAGAGCTCGGAAAATACCGTGCAGGACATGCTGATTCGTGCAGATGAGCTGGATGCAAGTCTAAGTGACGACGAGTATTTAACAGAGCTGATTGTCTTAGCCAAACAACGAGGACTGGTCAAGACAGAGACAGAGATCCGTGCCAGCCTTGAATATGCAACAACCCTTGATGAGTTTTATCAAACTGATCCCTTTACGGTTAGGCCCCTATCTGATCCCGATGCCGTTAACTGCTACTATTTCCGCAATAAGAATGGCGCGATGTTGGGTGATCAGGCGCCCTACTATTTTGCGACACCACAAGACAGGGAAATATTTGTCACCACCGATCAGTCAGCCGATTCGCGGCAGTGGGAAAAGAACTTGACGAACCTTCACATCATTGATATCGATTCGTCCAATCACATGACGATGTTCTCGGAAGAAAAACCACGCCAGACCATTCTTGAGTTCTGTGAAATCTTGTATTCTGAAGCCGGACTTCCGAATGCATTTCTTGACTTCTTTATGGCCAAGGCTCGAGAAATACATGGCAATATAGAGCTGGACAGATAA", "orf_prot_sequence": "MKKEFHIHASHPIVKHHQAYGQALLPGLAYIDLLYQFFREQGYEFAALELRNLSIYRPLLVGEDDGIQLLLQADDMAEGLWSVQLLDGEQRGAPESKAQQLYIKAEMYHHREAPVFDDVLDFQALQAVSHTQIPLNDIYAQCRSQGLVHSGMMKAEGTAYTLDDAQIIEVALPDEAASSAAGFMFHPALIDGSGVGSSNLFAALVEGEQRLFLPLFYERFRASARFERTCLVRVKTASVWRKNDMMYMDIEFFNESGEKIAELKNFVNKLVREAALINPNLKPASQAQSSKLKPYEEASSESQANPPRLDKSEALEGMEDLLKEIIAPYVDGSPEQLDPEAGYYELGLDSAILLQVVTALEKRFDAKLMPTLLFEYTTIEELAAYFVNENFATKHVAKEPATPLAPVLPGPIQTGHEDDIAIIGISGRYPGANNINEFWQNLVVGKDCISDVPEERWDWRSVAKHKSPSGKSVSKWGGFIQDPDCFDHQFFRISPREAEVLDPQERLFLQTCWECIEDAGYTPETLVTRQQAPHRRQSVGVFVGVMHKDYVFLGMEAIARGEQFHLSINNAPIANRVSYFCDFHGPSMVIDTVCSSSLTAIHLALESIRHGESDIALAGGVNLSLHPNKYLTYGLLDMYSSDGRCRAFGRGGDGYVSGEGVGAVVLKPLAQAIQDRDHIYAVVKGSMINHVGKVTGISVPNPVAQSDMILQCLEKTGIHPRTLSYVEAHGTGTSLGDPIEIQGLCKAFQTHTNDTQFCAIGSVKSNIGHTESAAGISGLSKVALQLHYQTLVPSLHSEAINPHLDLEASPFFVQRQTQHWERTSDHPRRAGLSSFGATGSNAHVILEEYIPEQSETDLAQPAEGVEQRLPVLIPLSAKNEERLKEAARNFYHYLISKPEDVAGHQVARLSDIAYTLQVGRRAMETRAIFLVDHQQQLVESLQAFLDDDHTKGNSWLGKQVKQQRHARRGEYSEAMLQQWMVQGRLDQLAQAWSEGVPLNWDALYSPESGVAKPSRVSLPTYPFAKARHWVPMEVKAVTPFAALHPLLHRNTSTLGEQRFSSTFSGEEFFLADHRVHGQKMLPGVAYLEMARAAVALATSAGEAQAIRFKNIIWQQPLVIDGTEKTIHIGLYAKANSQVDFTIYTGDEHGSDAPFPDEQNRRVHCRGIAMLTLSDRERETYLDLDHLQSQTGQNDFTPEQCYQAFAAMGIDYRDGHQGIAAVHAGADQILAELSLPASVLAHREPFVLHPSMMDSALQAAIGFALSAQVAGAQQPASLPYALESLDVRAACTPSMWVWIRYADNNSAGSPVQKFDLDLCDDRGKICVLMRGFSSRIFHAQASPCFAETLLPSQLHPLLHQHVPSENPVHDQFIAQFTGEEFFLRDHQQVMLGMAYLEMAHRAGQHRASQKILGLKNVVWSQLLFIAGQAREVSVHVQNEVLQHRFRITTQNEDSLQNIHCQGMLVVDQALYPERPDQLNIQDIQSRCSASIETTECDQLLQYTHGPSLLTIKQLWHNEHEALALLQLPDGMRSGREDYTLHPSMMNGAILTSVLFSLLNGPQEHLPMPFALDELWMYQEMPERAYAYVSMSSANNHDIELVDITGKCIVLFKGFTAAIQGAWQSQAPQNNVIYASTQWRESVLSGDEHANTAASAPIVMLAQDNPELAGLLRQRWPEASIEMLAPIGEDIAKTVQANFLQVFDRVKTCILEQPQRIQPIVVLLPENENDYLHDGLAALFKTARFEYRKIVGKLIRYTIDIDIEELAKSILMEVSHDDQHVDVYYSQTGTRKVKTLNEIYDFEKSHAHLLVEADLLHEGDVVWITGGLGGLGQIFTRHLSHTKGLKLILSGRSPLNAASEKVLRELQQSDVEMSYLSCDISDQQAVATLVQSILNKYGKLNGVIHSAGLTRDAYIHNKTREEMIAVLRPKMAGILAIEAACQDIQLNFMVLFSSIAGVFGSIGQADYAMANAFLDSFAEARNRRVQQGKCFGRTLSINWPLWRNGGMGVDAQNETLMQRNTGMIALETRAGLNAFELALSSEYSHILVAQGETEKIRSRLLSPRFVEENLSSVEADTTEPLEHQNQSEPSKAEQDQRAWLIRLLLKDLAAFVCRLQKVQPEEIDLEAEFSVYGFDSIGFMSFVNHLNDMYDLELMPTLFFEHSSLRALADALIEKHQEALLKKYESPKTAAQPSQDRMPIQARAVEMDKRQHPVSATMTPVESETTQGNPTPESLSTTDPIAIIGMSGKFPGSENLTAFWQHLEANRDLVSEIPEDRWDWRDYYGDHLSESGKTKIKWGGFIEGIDHFDPLFFGISPVEAEIMDPQFRLFLQTVWATIEDAGYRASALSGSKTGVYVGVTTTDYKDLMQQARARENSQEYHGMFPFMLANRVSYLFNFRGPSEAIDTACSSSLVAIHRATESIRQGSCEMAVAGGVNIIANPQLVLSATQGGMLSEDGRCKTFDQSANGYVRGEGVGAILLKPLARAIEDHDPICGVIRGSAENHGGKATSPTAPNPVAQQELLVSAYAQAGITPETVGYIEAHGTGTPLGDPIEINGLKSAFAQLYEQIGRPPANEPHCALGSVKTNIGHAEAAAGISGVLKVLLMMKHQKIPGNPHLKEPNPYLQLTGSPFHLAQDTQDWRALHDEVHNPIPRRAGVSSFGIGGSNAHLVLEEYTAEPAAEPVVCGEASLIILSAKNRACLVEAAGNLYRFLIDNRESSRGELLRLADIAYTLQVGREEMAHRLGFVASSLTELEERLQTFINVQGENQDLYEGHTKGNRSTLEAFESDDDLQEMLTKWVEGRRFEQILKLWVKGLAVNWESLYRGIQPRRISLPSYPFARERYWIPASAESLPVPAASPVSPIQVDNAAGVLMCHPVWEEKAAPVQVGSFDPASLHDCQHLILFCHMDVPLGLQDRFGTSSVCRVFQAQSDDVALGYSYLCEQVLTCLKEILENKPRDRVFVQIVIPGPETSEAEGASGLLHGLSALLKTAHLENPKVLGQLIEVGPRHTGDALIRCVQENCQSPDDVQVRYRHGRREVMAWEELPVSEPNAAPMPWKERGVYLITGGAGGLGFIVAREIARRVKAPILILAGRSHLSQAKRDELQQEAQRLGVQIEYRQADVSQPQEVNDLIRSILRDFTKLNGILHAAGLIRDSFMIRKTVDQLHQVLAPKVFGTVYLDEASKDVDLDFFLLFSSGAAALGNAGQADYAAANAFMDAYAEYRHALFASKQRFGRSLSINWPLWQEGGMQVDEPTLTALEQYAGIRALQTGSGLDALYRALSVTPNQIMVLEGDLAKIRQGLFSASTEPYRNESSRVEVDEERLLARTLHQCKTLFGGIIKLAADRVEAEEALEHYGIDSVIIAQMNLRLEEVFGEVSKTLLYEYQTLGELASYLATEYRDACMTWTGLTAIPTSDMTTVPDDAIPAKPQITSEPRRSSGVDVHALTPKAPAPSQDEPIAIIGLAGRYAQADTPRAYWENLQSGTDCVTEIPPDRWSLSGFYHEDLEEAIAQGKSYSKWGSFLNGFADFDPLFFSMSPREAIGIDPQERLFLQSSWEAMEDAGYTRETLRDQFQQRVGVFVGITKTGFSLYGPELWQRGDIVYPTTSFSSVANRISYLFNLRGPSLPIDTMCSSSLTAIHEACEHIRRGECELAIAGGVNLYLHPSTYVQMCAAHLLSQDGKCKSFGEGGNGFVPGEGVGTIVLKPLTQAIDDHDHIYAVIRASSVNHGGKTNGYTVPNPNAQAALIEDALDKAGVDARTLTYIEAHGTGTELGDPIEIRGLTQAFQKHTIDTAFCAVGSAKSNLGHLEAAAGIAGLTKIILQLQHAKIAPSLHASTLNPNINFAKTPFVVPQALSEWKRPIVDMHGEVKEYPRRTGISSFGAGGSNAHLIVEEYVKGTSVGETRASHHHDVIRNEAQVILLSAKNEDRLHCVAKDLHDYLNAEQGANLSLRDIAYTLQLGREAMDERLGLVVYSLDELRQKLNGFIAGESGIEDVYRGQVQGHKKALALFTEDDELQEAIEKWMQRGKFARLVELWSQGLAVDWNKLYCDREVIPYRVSLPTYPFEQHRYWIEDTLHASPKPVAESVGQSAVKLHPLIHENTSNFLAQRFRSCFRGDEFFLADHLVQGRRVLPGVAYLEMVRMAVSLAMDTQIEGYDLRFENVVWARPIIVDGQPLNMHTVLQVEDSTTISFEIYSQVDTEENDADVLHCQGSVEICVLEKEQELEVSHLLGECQKHHLSAAQCYEVFESAGIQYGPGHRGLDTVYVGDQQVLAKLLLPPSVASTAEQFILHPSLMDAALQASLGLAVGGVGSEPTPSLPYALETLDLCDAGARPSWAWIRESNQSSGEIQKLDIDLCDDQGRICVRMRGFSSRVLERAWGSQEDRLTLLSPVWNVISDPPTEGERDDVASEQVIIAGGSDLQRDILGQVHPGAVWLPADDFEAIDQQVKVLPSQMDVVHIIWVAPDQPMTSVRQESLIREQVQGVLYLFRLMKVLLAHGYGEKELHWTVITTQAQAVRKKDIVNPTHASVHGFIGSLAKEYPHWKIRLLDMDADESWPVHDMLALPGDQNGDAVAYRAKEWFQQALVPVLETDQGLPPCYRSQGVYVVIGGAGGIGEAWSRWMIERYQAQIIWIGRRKKDALIQEKLDALDKLGTPPIYIEADAGDLMALQNAYQQIKRRYGRIHGVIHSAIVLADKSLANMDERQFLAGLRAKVDVSVRLAQVFAKETLDFVLFFSSTQSVAKMPGQSNYAAGCTFKDAFASQLAQEWPCQVKVINWGYWGSVGVVAISSYRERMARAGVRSIEPAEGMAALQSLLQSSLDQLAVVNTLPTASIAQPSRNQALEEWITTYPDGLPVCVDSLPQYLPNQPLPVVDSGTGVPDQTVTIEDLLPQLLLATLQSLGLIEGRAEQRAAALPAATFYRQWLEESLTFLWAKEYLEYDGQGYTNKLPSVDLARVWQEWEREKVLWLQDRNQKAIVSLVEACMRALPDILRGAQLATDVIFPDSSVALVEHIYKGNVVADYYNQILQNSVVAYIQARLAQAPTAQIRILEIGAGTGGTTSGLLAELRPYQRHIVEYCYTDLSKAFLIHAERQYATEHPYLVTQIFDVEKPLAEQGIQANHYDVVIAANVLHATKNIRNTLRNAKAGLRQHGLLFLNEISTKSLFTHLTFGLLEGWWLYEDAALRITGSPVLSSAIWADVLAEEGFNSITFPALLAAESGHDFGQQIIIAQSDGIVRQKARRQSSPVLPSTPKKQSVKPKEITKLSPNTETLREKATVYIKKLVASTLQLPSDQIDSAQALEAYGLDSILVVQLTSTLRKAFHNISNTLFFEVQTIDGVVDYLLERQPEVFSDLLGVDKQKIDERIVETSTPIESLESTRQANGRNHSLQKLNFRTTQKLNALAASKKHETVHDRDIAIIGLSGRYPQAENVNAFWECLKAGQNCIREIPQERWDWRRYYDAEKGKEGTLYTKWGGFIDDVDKFDPLFFKLSARDAERMDPQGRLFLECAYSCMEDAGYTPSTLCDSRKVGVFVGVVNSTYRRQPSFWSMANRVSYLFNFQGPSMSVDTACSSSLTALHLAIESLHSGTSECAIAGGVNLILDPIQYLTLSAMTMLSSSDACKSFGNQADGFVDGEGVGAVILKPLAKAEQDGDAIYGIIKASMINAGGKTNGYTVPNPIAQSHLIREALARAEVDPRTISYVEAHGTATALGDSIEITGLSKAFGLSEDKQFCPIGSVKSNIGHAESASGIASLTKVLLQLKHRQLVPSLHSQQLNPSIDFAETPFVVQQTLEPWHRPVLTIDGETKTYPRIAGISSFGAGGANAHVIIQEYMNEKGDAAADAEGQGWPETSLIVVSARDEDRLRELVNHLCLYARACSLADQGKAQTAKLQAMAYTLQVGREAMEVRLGVVVASFAELSEKLQGFLDGQRDVDNLYRGQVRPHREAMAVLAGDDVFAETIDAWIHRHKYDKILELWVKGFVFDWNKLYGEQKPPRMHLPTYPFARERYWAKIIDLSLDGFQVGAPQQVVEWIHPLVHKNTSNLEEQRFSSTFSGQEFFLANNRVDGEKVLPGVVYLEMARVAAEQARPHPSTSLAKSHIQLRNIGWATPFVCDHSSQSVHIRIVPGTYKGSDVSFEEMSYEIYSHIDTEREVVVHSQGVIALWQAREVAGLDLPALQASINQKCLSAQQCYDAFAAMGIEYGQGHQGIEDVYMTPSQAGRCQVLAKLRLPAVVAETSHDFVLHPSMMDAALQACIGLTVEHAVPESGQMSLPFAIDAIEVIEKCTDTMWAWIRYADPHADPIQPLSSRVTKVDIDLCDESGNLCVRIKGFSTRVVAIPESKAIGTWMSFPVWKEKSWSEHEPSEYAQRTVMLIEMEWVSDRLIESQIEGTTCVHLTTQANSLAERFQDISVQVFERVKALMEAKLRGSILIQLLVPHSGETLLFSALAGILRTAHLENPALLGQVIILEPSETQEGVIDKLQRDSSCPEDALIRYQQERRQTMAWQELPMSEREQAVQVPWKEGGVYLITGGLGGVGFMFAKHLAQHSRSVSLVLTGRSELDEQRREQLKELEALGARVDYLSVDVSLKEAVERLIDYIESERGSLTGILHSAGVIQDNFIIRKAVREFQSVLVPKVDGVIHLDQATQALNLDFFVLFSSLSGINGNAGQVDYACANAFLDAYAHYRNRLVAINKRSGQTLSVNWPLWKEGGMQIDPQRAEAMFQHLGLVAMETSRGIQALIHGLSSGQSQLMVVAGDLERLKVAHPSRPSSPPSQMDREHNVIGENELDANALASRSIHYFKNLIASILKIPAHRIQNDELLELYGIDSIIIMQLINQLERDFGPLSKTLFFEYPTIEEVNQYFVDSYRQKLHVVLGLDKSKAPETDHSAVVDPARPKVHRRSRLLAPTLDESPLPVAQTQDVAIIGVAGRYPQSPDLESFWENLSQGKNCITEVPESRWDPSLYVDFDPSNSGQVYSKWGGFLDDVDKFDALFFNISPREAELMNPNERLFLETVWELVERSGYTPERIQEQHENNVGVYIGAMYQQYQALASEPLIESVLSLSSHSAIANRVSYFFDFQGPSLAIDTMCSSSLIAIQLACDSLLKGECQMAIAGGVNLTIHPNKYIGLSLSQMISRQNTSKSFGEGDGYLPAEGVGAVLLKPLAKAIEDQDSILAVIKSISTNHSGHTYEFRVPNPNAQAQLFEANFRKSGIDPRTITYVESAANGSPLGDPIEVSALRKAFQKFTADQGFCAIGSVKSNIGHAEAASGISQLTKVILQLQHQQLVPSINADPLNPNLSFDGSPFYLQQQLQPWARPVFNIDGQEREFPRRATVSSFGAGGSNAHLIIEEYIASAGKNAVSPDIELAADRELMVFSAKSCDRLQAMLQQMRHYVESNQALSLKKMAYTLQVGRMAMTHRIAMLVHNREELIQGIQDALHSLEQPAGIINTTIPIYMGDLEADHSEVKHLLSGQSGEAMLKVLFAEENLEKIALYWVKGGHIPWLALHQKGQMSMLSLPTYPFSKRYCWVESKALSQVVTTAEAELLSKSTDDHISVDRNEESVLSEILCRTLGLTAEEFNQKTPLVQYGVDSVMFVQIFQQIKDKIDNRVNLSQLLECQTMQDMIFYLTAKKEDAQTEPELVNLSGAGLSSSHDTRFPELVHMNSSTRGRPVFWFHGIAGVTVYEPVAEKSQRPFYGVQPCSWINQTAGPSHIQAMVQGYLDAIRSVQPEGPYDFGGYSLGGMLAYEATRQLQDMGESVSTIVMVDTLQSNPDRKDKYSRKTDYLVVLNRSFASSAWQSSENTVQDMLIRADELDASLSDDEYLTELIVLAKQRGLVKTETEIRASLEYATTLDEFYQTDPFTVRPLSDPDAVNCYYFRNKNGAMLGDQAPYYFATPQDREIFVTTDQSADSRQWEKNLTNLHIIDIDSSNHMTMFSEEKPRQTILEFCEILYSEAGLPNAFLDFFMAKAREIHGNIELDR", "perc_identity": 27.24}, "gnl|BL_ORD_ID|1968|hsp_num:1": {"type_match": "Loose", "snp": {"original": "F", "change": "L", "position": 413}, "query_snp": {"original": "F", "change": "L", "position": 363}, "orf_strand": "+", "orf_start": 73695, "orf_end": 97673, "orf_from": "BGC0001186.1|Misakinolide_18 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.21954e-10, "bit_score": 62.3882, "max_identities": 100, "cvterm_id": "39507", "query": "NINEFWQNLVVGKDCISDVPEE---RWDWRSVAKHKSPSGKSVSKWGGFIQDPDCFDHQFFRISPREAEVLDPQERLFLQTCWECIEDAGYTPETLVTRQQAPHRRQSVGVFVGVMHKDYVFLGMEAIARGEQFHLS------INNAPIANRVSYFCDFHGPSMVIDTVCSSSLTAIHLALESIRHGESDIALAGGVNLSLHPNKYLTYGLLDMYSS-----DGRCRAFGRGGDGYVSGEGVGAVVLKPLAQAIQDRDHIYAVVKGSMINHVGKVTGIS---------VPNPVAQSDMILQCLEKTGIHPRTLSYVEAHGTGTSLGDPIEIQGLCKAFQTHTNDTQFCAIGSVKSNIGHTESAAGISGLSKVALQLHYQTLVPSLHSEAINPHLDLEASPFFVQRQTQHWERTSDHPRRAGLSSFGATGSNAHVILEEY", "match": "+I   W+ L+ G+  I  + +E   +WD                K GG ++DP   D    R+  R    +    +L     WE        P+           R +V V  G+   + +    + +  G    +S      I     A  +          M   + CSS   AI  A   I  G++D+A+ GGV   +       + ++   S+     +   R F +  DG+V GE  GA++L      I+  +H  A     +   +G   GI+           + V     + + LE  G+ P  + +V AHGT T +GD  E      A +    D    A+ + KS +GH+  A G        L L    + P+L+ E  +P +DL+              R  D+ R A  +SFG  G N  +    Y", "sequence_from_db": "DIESTWKGLLAGESGIHALEDEFVTKWDL-------------AVKIGGHLKDP--VDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPD-----------RFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGE-AGALML------IETEEHAKARGAKPLARLLG--AGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAE----ANAIRVAGCDQ--AAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDV--------VAGEPRYGDY-RYAVNNSFGFGGHNVALAFGRY", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 74994, "query_end": 76241, "hit_start": 81, "hit_end": 1248, "orf_dna_sequence": "GTGAAAAAAGAATTTCATATACATGCAAGCCACCCCATTGTGAAACATCACCAGGCCTATGGCCAGGCGTTGTTGCCGGGGCTGGCTTATATTGATTTGCTGTACCAGTTTTTTCGCGAGCAAGGGTATGAGTTTGCAGCTTTAGAACTTCGCAACCTGTCAATTTATCGCCCTTTGTTGGTTGGGGAAGATGATGGTATTCAGCTTTTGCTGCAAGCAGATGACATGGCCGAGGGGCTGTGGTCGGTTCAACTGTTAGACGGGGAGCAACGCGGTGCCCCGGAGTCTAAAGCGCAACAACTCTATATCAAGGCGGAAATGTATCACCACCGTGAAGCGCCTGTATTTGATGACGTGCTAGATTTTCAGGCCCTGCAAGCCGTCAGTCATACGCAAATCCCTTTGAATGATATCTATGCCCAGTGCCGTTCTCAGGGACTGGTTCACTCGGGGATGATGAAAGCGGAAGGGACGGCTTACACGCTGGATGACGCCCAAATCATCGAGGTGGCTTTGCCAGACGAAGCCGCTTCTTCTGCGGCCGGCTTTATGTTTCATCCTGCCCTTATCGACGGTAGTGGCGTGGGTTCATCCAATTTGTTTGCCGCGCTGGTAGAAGGTGAACAGCGTTTGTTTCTACCGTTATTCTATGAGCGTTTTCGCGCATCTGCACGGTTTGAGCGAACGTGCCTTGTCAGAGTTAAGACGGCTTCCGTGTGGCGAAAAAACGATATGATGTATATGGATATAGAGTTCTTTAATGAGTCTGGAGAAAAAATTGCGGAACTGAAAAACTTTGTCAATAAGCTGGTGCGAGAGGCCGCATTAATTAATCCGAATCTTAAGCCAGCAAGCCAGGCTCAATCGTCCAAACTCAAGCCGTATGAGGAAGCGTCTAGCGAGTCGCAAGCCAATCCGCCTCGGCTCGATAAGTCTGAGGCTTTAGAGGGCATGGAAGACCTGCTTAAGGAGATCATTGCGCCGTATGTGGATGGCTCGCCAGAGCAACTTGATCCGGAGGCTGGTTATTACGAACTCGGTCTGGACTCGGCAATCCTGCTGCAGGTGGTCACGGCACTGGAGAAACGATTCGACGCCAAACTCATGCCCACGTTGTTATTTGAATACACCACCATCGAAGAGCTCGCCGCTTATTTTGTCAATGAGAATTTTGCCACGAAACATGTGGCCAAAGAGCCGGCCACGCCTCTAGCGCCTGTCTTGCCTGGGCCCATACAGACCGGCCACGAGGATGACATCGCCATTATCGGTATTTCCGGTCGTTACCCAGGAGCCAATAATATCAATGAGTTTTGGCAAAATTTAGTTGTAGGCAAAGACTGTATTAGCGACGTGCCAGAAGAGCGATGGGACTGGCGCAGCGTGGCCAAGCACAAATCACCGTCGGGTAAAAGCGTCTCAAAATGGGGAGGATTTATCCAGGACCCCGATTGTTTTGACCATCAATTTTTTCGAATTTCTCCACGGGAAGCCGAGGTGCTCGATCCGCAGGAACGCCTGTTTTTGCAGACCTGCTGGGAATGTATTGAGGACGCTGGCTATACCCCAGAAACGTTGGTCACCCGGCAGCAAGCCCCGCATCGCCGGCAGAGTGTGGGCGTGTTTGTCGGGGTGATGCATAAAGATTACGTCTTTCTCGGCATGGAAGCCATTGCGCGCGGTGAGCAGTTTCATTTGTCAATTAACAATGCGCCGATTGCCAACCGGGTTTCCTATTTTTGTGATTTCCATGGCCCCTCCATGGTCATCGATACGGTGTGTTCGTCCTCACTCACCGCCATACACTTGGCTTTGGAAAGCATTCGGCACGGAGAAAGCGATATTGCGCTGGCTGGAGGCGTCAACCTATCGTTGCACCCGAACAAATATCTGACCTATGGCCTACTCGATATGTATTCTAGCGATGGGCGTTGCCGGGCGTTTGGCCGCGGCGGGGATGGTTATGTGTCAGGGGAAGGGGTCGGGGCTGTCGTGTTGAAACCGTTGGCGCAGGCCATTCAAGATCGGGATCATATTTATGCGGTGGTCAAAGGCAGCATGATCAATCATGTGGGAAAAGTGACCGGAATCAGCGTGCCGAATCCGGTGGCGCAGAGCGACATGATTTTACAGTGTCTGGAAAAAACCGGCATTCACCCACGGACGCTTAGCTATGTCGAAGCTCATGGCACGGGCACGTCGCTTGGCGACCCCATCGAGATACAGGGTTTGTGCAAAGCATTTCAAACGCACACCAACGATACCCAATTTTGTGCCATCGGATCGGTTAAATCCAATATTGGCCATACGGAGTCGGCTGCTGGCATTAGTGGTTTGAGCAAAGTGGCCTTGCAACTGCACTATCAAACCCTGGTGCCATCGCTACATTCCGAAGCCATCAATCCTCATCTTGATTTAGAGGCGTCGCCCTTTTTTGTGCAGCGTCAAACCCAGCATTGGGAGCGGACCTCAGACCATCCACGACGAGCGGGTTTAAGCTCGTTTGGTGCAACCGGCTCAAATGCGCATGTGATTCTGGAGGAGTATATACCCGAGCAGAGCGAAACCGACCTGGCACAGCCCGCAGAGGGTGTAGAGCAACGTCTACCTGTGTTGATTCCGCTATCCGCCAAAAATGAAGAGCGTCTTAAAGAGGCTGCGCGAAACTTCTATCACTATCTCATCTCAAAGCCCGAAGATGTCGCAGGGCATCAGGTGGCGAGACTCAGCGATATCGCCTACACCTTACAAGTCGGCCGAAGGGCGATGGAAACACGGGCTATTTTTCTCGTTGATCATCAACAGCAGTTGGTTGAAAGTCTCCAAGCTTTTTTGGATGACGATCATACAAAGGGAAATAGTTGGCTAGGCAAGCAGGTCAAGCAGCAAAGACACGCTAGACGTGGCGAATATAGCGAGGCAATGCTACAGCAATGGATGGTTCAGGGCAGACTCGATCAGCTTGCTCAGGCGTGGAGCGAAGGTGTTCCCTTGAATTGGGACGCCCTTTATTCGCCGGAGAGCGGTGTCGCAAAACCAAGCCGCGTCAGTTTACCGACTTACCCCTTTGCCAAAGCACGTCATTGGGTACCAATGGAAGTGAAGGCGGTGACACCATTTGCTGCACTTCACCCCTTGCTGCACCGCAACACCTCTACGCTGGGTGAACAGCGTTTTAGTTCGACGTTTAGTGGGGAAGAATTCTTCCTCGCTGATCATCGGGTGCATGGCCAAAAAATGTTGCCGGGGGTTGCTTATCTCGAAATGGCGCGAGCCGCCGTTGCTCTGGCCACCTCAGCCGGGGAGGCCCAGGCGATACGATTTAAGAACATCATCTGGCAACAACCGCTCGTTATAGATGGGACGGAAAAAACGATTCATATTGGCTTGTATGCGAAAGCAAATTCGCAAGTCGATTTTACCATTTATACCGGAGACGAGCATGGCTCGGACGCTCCCTTTCCCGATGAACAAAACCGCCGTGTTCACTGCCGCGGCATTGCCATGTTAACGTTGTCGGATCGTGAGCGTGAAACTTACCTGGATCTTGATCATTTGCAGTCCCAAACAGGACAAAACGATTTTACCCCGGAGCAGTGTTATCAGGCCTTTGCGGCGATGGGTATTGATTACCGCGATGGACATCAAGGCATTGCCGCAGTTCATGCCGGGGCTGATCAGATATTGGCAGAACTCAGCCTGCCTGCCTCCGTTTTGGCCCATCGTGAACCGTTTGTGCTCCATCCCAGTATGATGGATTCAGCGTTACAAGCGGCAATTGGTTTTGCACTTAGCGCGCAAGTTGCCGGCGCACAACAACCGGCTTCTTTACCTTATGCTTTGGAATCGCTTGACGTAAGAGCTGCTTGCACCCCTTCCATGTGGGTTTGGATACGCTATGCCGACAACAATAGCGCAGGTAGTCCGGTGCAAAAATTTGATTTGGACCTGTGCGATGATCGTGGCAAAATCTGTGTGCTGATGAGAGGCTTTTCTTCTCGTATCTTTCATGCCCAGGCCTCGCCTTGTTTTGCTGAAACGTTATTGCCTTCTCAGCTGCATCCCTTATTGCATCAACATGTTCCCTCAGAAAACCCAGTGCATGATCAGTTTATCGCTCAATTTACGGGAGAAGAGTTTTTTCTACGTGACCACCAGCAAGTGATGCTGGGTATGGCCTATCTCGAAATGGCCCACCGTGCCGGACAGCATCGCGCGAGTCAGAAGATTTTGGGGCTCAAAAATGTCGTCTGGAGCCAGCTTCTCTTTATTGCCGGACAAGCTCGTGAGGTATCTGTTCATGTACAGAATGAAGTCCTTCAGCATCGTTTTCGTATAACGACACAGAATGAGGATTCGCTGCAAAACATACATTGCCAGGGTATGCTGGTTGTTGACCAGGCTTTGTACCCGGAGAGACCTGACCAACTTAATATTCAAGATATTCAATCCCGCTGTTCAGCGAGCATCGAAACTACTGAGTGCGATCAACTGCTACAATACACCCATGGCCCCAGCCTGCTGACGATCAAACAATTGTGGCACAACGAACATGAAGCCTTGGCTTTGCTTCAATTGCCCGATGGTATGCGCTCGGGACGTGAAGATTATACACTTCACCCGAGCATGATGAACGGCGCGATCCTCACCAGTGTACTCTTTTCTTTGCTCAATGGGCCGCAAGAACACCTGCCCATGCCTTTTGCCTTGGACGAGCTTTGGATGTACCAGGAGATGCCTGAGCGTGCCTACGCTTATGTGAGTATGAGTTCGGCGAACAATCATGATATCGAACTGGTGGACATAACGGGCAAATGTATTGTTTTGTTTAAAGGTTTTACTGCTGCCATTCAAGGGGCATGGCAAAGCCAGGCGCCGCAAAACAATGTGATTTATGCGAGCACACAATGGCGAGAAAGCGTGTTGTCCGGTGACGAGCATGCGAACACGGCCGCATCTGCACCGATTGTGATGCTTGCACAAGACAATCCGGAGCTTGCCGGTTTATTACGCCAGAGATGGCCAGAAGCCAGCATTGAAATGCTGGCGCCCATCGGTGAGGATATCGCCAAAACAGTTCAGGCAAACTTCCTGCAGGTGTTTGATCGAGTCAAAACCTGTATCTTAGAACAGCCTCAACGCATTCAGCCAATTGTCGTCCTTCTACCTGAAAATGAAAACGATTATCTGCACGACGGTCTTGCTGCCTTGTTCAAAACGGCAAGGTTTGAGTATAGAAAAATAGTAGGGAAATTAATTCGCTATACGATTGATATAGATATAGAAGAACTTGCTAAATCTATTTTGATGGAAGTGTCTCATGATGATCAACATGTGGATGTCTATTACAGTCAAACAGGTACCAGAAAGGTTAAAACGCTAAACGAAATATACGACTTTGAAAAGAGCCATGCGCACCTTCTTGTTGAGGCCGATTTATTGCATGAAGGTGATGTGGTTTGGATCACTGGCGGCTTGGGCGGTTTAGGGCAGATTTTTACTAGGCACCTTAGTCATACCAAAGGCTTGAAGTTGATTTTGAGCGGGCGTTCGCCCTTGAATGCGGCTAGCGAAAAAGTGTTGCGCGAACTTCAGCAGTCTGACGTTGAGATGAGTTACTTGAGTTGCGATATCAGCGATCAACAAGCTGTGGCGACGCTTGTCCAAAGTATTCTGAACAAATATGGCAAATTAAATGGCGTCATTCATAGTGCTGGGTTGACCCGGGATGCCTATATTCACAATAAAACGCGTGAAGAAATGATCGCTGTGCTGCGCCCTAAAATGGCGGGCATTTTGGCAATTGAGGCGGCTTGTCAAGATATTCAACTGAATTTTATGGTGTTATTTTCTTCCATTGCAGGTGTTTTTGGCAGTATTGGCCAAGCGGATTACGCCATGGCAAATGCTTTTCTTGACAGCTTTGCCGAGGCGAGGAATCGTCGCGTTCAGCAAGGGAAATGCTTTGGTAGAACGCTTTCCATCAATTGGCCCCTGTGGCGCAACGGTGGTATGGGGGTGGATGCGCAGAATGAAACCCTGATGCAGCGCAATACCGGCATGATTGCGTTAGAAACCCGTGCGGGCCTAAATGCGTTTGAGCTGGCTTTGTCTTCTGAATATAGCCACATCTTGGTGGCTCAGGGGGAAACCGAAAAAATTCGTTCTCGTTTGTTGTCGCCTCGGTTCGTAGAGGAAAACCTGAGCTCGGTTGAAGCAGATACAACGGAGCCATTGGAACATCAAAATCAGAGCGAGCCAAGCAAAGCCGAGCAGGACCAGCGGGCATGGCTCATTCGGTTGCTGCTCAAGGATCTCGCGGCTTTTGTCTGTCGCCTTCAGAAAGTGCAACCTGAAGAGATTGACCTAGAAGCCGAGTTTTCCGTCTATGGATTTGACTCTATAGGTTTTATGAGTTTTGTCAATCATTTGAACGACATGTACGACTTGGAATTAATGCCGACGCTATTTTTTGAGCATTCCAGTTTGCGTGCGCTTGCCGACGCGCTGATCGAGAAGCATCAGGAAGCTTTACTGAAAAAATATGAGTCCCCGAAAACAGCTGCTCAGCCAAGCCAGGATCGCATGCCAATTCAAGCTCGTGCAGTCGAGATGGACAAACGCCAACACCCTGTATCTGCAACGATGACACCTGTTGAATCGGAAACGACTCAAGGGAATCCGACGCCAGAGAGTTTATCTACAACTGACCCGATTGCCATTATTGGTATGAGCGGCAAATTTCCCGGATCGGAAAACCTGACGGCGTTTTGGCAGCACCTAGAGGCTAATCGTGATCTTGTCAGTGAAATCCCTGAAGACCGTTGGGACTGGCGGGATTACTACGGTGATCACCTGAGCGAAAGCGGCAAGACGAAGATTAAGTGGGGTGGCTTTATAGAGGGCATCGATCATTTCGATCCCCTGTTTTTCGGCATTTCCCCAGTGGAAGCCGAAATCATGGACCCTCAATTTCGTCTCTTTTTGCAAACGGTTTGGGCCACGATTGAAGATGCAGGCTATCGTGCCAGTGCGCTGTCGGGTAGCAAAACCGGGGTTTATGTGGGCGTGACCACCACGGATTATAAAGATTTAATGCAGCAGGCGCGGGCGAGGGAAAACTCCCAGGAATACCATGGTATGTTTCCATTTATGCTGGCCAATCGCGTCTCCTATTTGTTCAATTTTCGTGGCCCTAGTGAGGCGATCGATACAGCTTGCTCCAGCTCCTTAGTGGCGATTCATCGTGCGACCGAAAGCATACGCCAAGGAAGCTGTGAGATGGCGGTAGCAGGTGGGGTGAACATTATTGCGAACCCGCAATTGGTTCTTTCAGCGACTCAAGGTGGTATGTTGAGTGAAGATGGGCGCTGCAAGACCTTTGATCAAAGTGCCAATGGCTATGTCAGAGGTGAGGGGGTTGGCGCGATTTTGTTAAAACCCTTGGCAAGAGCGATCGAGGACCATGATCCGATCTGCGGTGTGATTCGGGGTTCGGCGGAAAATCACGGCGGCAAAGCCACATCGCCCACCGCCCCAAATCCGGTGGCGCAGCAGGAATTGCTGGTTTCGGCTTACGCCCAAGCCGGTATCACCCCGGAAACCGTGGGTTATATTGAAGCTCACGGAACGGGTACGCCGCTCGGTGATCCGATTGAAATCAATGGACTCAAAAGCGCATTTGCCCAGCTTTATGAGCAAATCGGCCGGCCTCCCGCCAACGAGCCCCATTGTGCCTTGGGCTCTGTAAAAACCAATATCGGACATGCGGAAGCGGCTGCGGGCATTTCAGGTGTTCTCAAAGTCCTCTTGATGATGAAGCATCAAAAAATTCCCGGAAATCCACATCTCAAGGAGCCAAATCCCTATTTACAATTGACCGGTAGCCCTTTTCATTTGGCGCAGGATACGCAGGACTGGAGGGCGTTACACGACGAGGTTCACAACCCGATACCCCGGCGCGCTGGGGTGAGCAGTTTTGGCATTGGCGGTAGCAATGCCCATCTGGTGCTGGAAGAATATACTGCCGAGCCTGCCGCTGAGCCCGTGGTCTGCGGCGAAGCCTCGTTAATAATTTTATCAGCGAAAAATAGAGCGTGTCTGGTTGAGGCTGCCGGGAATCTCTATCGATTTCTCATCGATAACCGTGAATCCTCCCGAGGAGAGCTGTTGCGTCTTGCTGATATTGCCTACACGCTTCAGGTGGGACGCGAGGAGATGGCGCATCGTTTAGGATTTGTGGCTTCATCTCTTACAGAACTCGAAGAAAGACTTCAGACTTTCATCAATGTCCAAGGTGAAAATCAAGACTTATATGAGGGGCACACGAAGGGTAATCGGAGTACCTTAGAAGCTTTTGAGTCTGATGATGATTTACAGGAGATGCTTACAAAGTGGGTTGAAGGCAGGAGATTTGAGCAAATTTTAAAGCTTTGGGTCAAAGGGCTTGCTGTGAACTGGGAGAGCCTCTACCGCGGAATACAGCCTCGGCGTATCAGCCTACCAAGCTATCCCTTTGCACGTGAACGTTACTGGATTCCTGCATCGGCTGAATCTTTGCCCGTACCGGCTGCATCGCCGGTATCTCCCATACAGGTCGATAACGCTGCCGGGGTATTGATGTGCCACCCGGTCTGGGAAGAAAAAGCCGCTCCGGTTCAGGTCGGCTCCTTTGATCCTGCTTCGCTGCATGATTGTCAGCACCTGATTCTGTTTTGTCATATGGATGTCCCTTTGGGTTTACAGGACCGTTTCGGCACAAGTAGCGTTTGTCGTGTGTTTCAGGCCCAGAGTGACGATGTGGCGCTAGGTTATTCGTATCTTTGCGAGCAGGTTTTGACGTGTCTCAAAGAGATTCTGGAAAACAAACCGAGAGACCGGGTATTCGTGCAGATTGTGATTCCTGGTCCCGAGACGAGCGAGGCCGAAGGTGCGAGCGGCCTGTTGCATGGTCTCTCTGCGTTGCTTAAAACCGCGCATTTGGAAAATCCAAAAGTTCTCGGGCAACTTATCGAAGTGGGTCCGCGCCACACGGGTGATGCGTTGATCCGGTGCGTGCAGGAAAATTGTCAATCGCCAGACGATGTCCAGGTCAGATACCGCCATGGGCGGCGTGAAGTGATGGCCTGGGAAGAGCTTCCAGTGTCAGAACCGAACGCCGCTCCTATGCCCTGGAAAGAAAGGGGGGTGTATTTAATAACTGGCGGTGCGGGGGGCTTGGGGTTCATTGTTGCAAGAGAAATTGCTCGCCGTGTCAAAGCCCCAATTCTTATTCTGGCCGGACGTTCCCATTTAAGCCAGGCAAAACGGGATGAATTGCAGCAAGAAGCCCAACGCTTGGGGGTGCAGATCGAATATCGACAGGCTGATGTTAGTCAACCACAAGAGGTCAATGACCTCATTCGGAGTATTCTGCGCGACTTCACGAAGCTCAATGGCATTTTGCACGCCGCTGGCCTGATTCGCGACAGCTTTATGATTCGGAAGACAGTCGATCAGTTGCATCAGGTACTGGCGCCAAAAGTATTTGGCACGGTGTACCTGGATGAGGCAAGCAAGGATGTCGACCTGGATTTCTTTCTTTTATTTTCCTCGGGCGCTGCAGCACTGGGTAATGCGGGGCAAGCAGACTACGCTGCCGCCAATGCCTTTATGGATGCTTACGCCGAGTATCGTCATGCACTGTTCGCGTCAAAGCAACGTTTTGGCCGGAGTCTTTCGATCAACTGGCCGCTCTGGCAAGAGGGCGGTATGCAAGTGGATGAGCCGACCCTGACCGCGTTAGAGCAATACGCGGGCATCAGGGCACTGCAAACCGGTAGCGGATTAGATGCGCTGTACCGTGCGCTTAGCGTAACGCCGAACCAAATCATGGTACTAGAAGGCGATCTGGCCAAAATCCGTCAGGGGTTGTTTTCTGCCTCCACAGAACCGTATCGCAACGAATCTTCAAGGGTTGAGGTTGATGAGGAACGCTTGCTCGCCAGGACCTTGCACCAGTGTAAAACACTTTTTGGCGGCATTATCAAATTAGCCGCAGATCGAGTCGAGGCAGAAGAAGCGCTGGAGCACTATGGTATTGACTCCGTAATCATTGCCCAAATGAATCTGCGTTTGGAAGAGGTTTTTGGCGAGGTCTCTAAAACTTTGCTCTATGAATACCAGACGCTGGGGGAACTGGCTAGTTATTTAGCAACCGAGTACCGAGACGCATGCATGACGTGGACAGGCTTAACAGCTATCCCCACAAGTGACATGACAACAGTTCCGGACGACGCGATTCCGGCCAAGCCTCAAATCACTTCGGAGCCTCGGCGATCATCGGGGGTTGATGTTCATGCCCTGACGCCAAAAGCACCCGCGCCGTCGCAAGATGAGCCCATTGCGATCATCGGCCTGGCTGGCCGATATGCACAAGCCGATACGCCGCGCGCTTACTGGGAAAATTTGCAGTCAGGAACAGACTGTGTGACGGAAATTCCTCCGGATCGCTGGTCCCTGTCGGGCTTTTATCACGAGGATCTCGAAGAGGCCATTGCCCAGGGTAAGAGTTATAGCAAATGGGGAAGCTTCCTAAACGGTTTTGCCGATTTTGACCCGCTGTTCTTTTCGATGTCGCCTCGTGAAGCCATTGGCATTGACCCACAAGAGCGCCTGTTTCTGCAAAGTTCCTGGGAGGCGATGGAAGATGCCGGCTACACCAGAGAGACCCTTCGAGATCAGTTTCAGCAGCGAGTCGGGGTGTTTGTCGGTATTACCAAAACAGGTTTTAGCCTATACGGTCCAGAGCTGTGGCAGCGTGGTGACATTGTCTATCCGACCACCTCCTTCAGCTCGGTGGCCAATCGCATTTCTTATCTATTCAATCTGCGCGGCCCGAGTTTACCGATCGATACCATGTGCTCCTCTTCGCTAACGGCCATTCACGAAGCCTGCGAACATATACGCCGCGGTGAATGTGAGTTGGCCATTGCGGGTGGCGTCAACTTATATTTGCATCCCTCTACCTATGTGCAAATGTGCGCAGCCCATTTGCTGTCGCAAGATGGAAAATGTAAAAGCTTTGGCGAAGGCGGCAACGGTTTTGTCCCCGGTGAGGGCGTAGGTACGATCGTGCTGAAGCCGCTCACCCAAGCGATTGACGATCACGATCATATCTATGCCGTCATTCGTGCGTCGAGTGTGAACCACGGCGGCAAAACCAATGGCTATACGGTGCCCAACCCAAATGCGCAAGCCGCTCTGATTGAGGACGCGCTGGACAAAGCCGGGGTGGATGCGCGTACGCTTACATATATTGAAGCACACGGGACGGGAACCGAATTAGGTGATCCGATCGAAATTCGTGGTTTGACTCAGGCTTTTCAGAAACATACTATCGATACGGCGTTTTGCGCCGTGGGATCGGCTAAATCCAATTTGGGGCACCTGGAAGCGGCCGCCGGTATTGCCGGGCTGACGAAAATTATTCTGCAGTTGCAACATGCAAAAATTGCCCCGAGTCTGCATGCCTCGACATTAAACCCAAATATTAATTTTGCCAAAACCCCCTTTGTGGTGCCGCAAGCACTTTCAGAGTGGAAAAGACCCATTGTCGACATGCACGGCGAGGTCAAAGAATACCCCAGAAGAACGGGTATTTCCTCCTTTGGTGCCGGTGGGTCGAATGCCCACTTGATTGTTGAAGAGTATGTGAAGGGGACCTCGGTTGGAGAAACGAGGGCAAGTCATCATCACGATGTGATTCGCAACGAGGCCCAAGTCATTTTACTGTCAGCGAAAAATGAAGATCGTCTCCACTGTGTGGCAAAAGATTTACATGATTATCTCAACGCGGAGCAAGGCGCAAACTTAAGCCTGCGTGACATCGCCTATACGCTCCAGTTGGGCCGTGAGGCCATGGATGAACGTTTGGGGCTGGTTGTCTATTCGTTGGATGAGTTGCGACAAAAGCTTAACGGCTTTATTGCAGGAGAGAGTGGTATTGAAGATGTGTATCGCGGACAGGTTCAAGGTCATAAAAAAGCACTAGCGTTATTTACTGAAGATGATGAACTTCAAGAAGCGATTGAAAAATGGATGCAACGCGGAAAATTCGCCAGGTTGGTCGAGCTTTGGAGTCAGGGCCTGGCGGTTGATTGGAACAAACTATATTGCGATCGCGAAGTCATACCTTATCGCGTCAGCCTGCCAACATATCCCTTTGAGCAACATCGATACTGGATCGAAGACACGTTGCATGCCTCACCCAAGCCGGTGGCTGAGTCAGTGGGGCAAAGTGCGGTCAAACTACATCCGTTGATCCACGAAAACACTTCCAACTTTCTCGCGCAACGCTTCCGCTCATGTTTTCGTGGCGACGAGTTTTTCTTGGCCGATCATCTGGTGCAAGGTCGGCGCGTTTTGCCGGGCGTTGCTTATCTGGAAATGGTTCGCATGGCAGTCTCACTGGCGATGGATACGCAAATCGAGGGGTATGATTTACGTTTTGAGAATGTGGTTTGGGCAAGACCTATTATCGTGGACGGTCAGCCGCTCAATATGCATACCGTATTACAGGTAGAGGACAGCACTACCATTAGCTTTGAAATATACTCCCAGGTAGATACCGAGGAAAACGATGCCGATGTCTTACATTGCCAGGGCTCAGTTGAGATTTGCGTTTTAGAAAAAGAGCAAGAGTTAGAGGTGTCCCATTTACTAGGCGAGTGTCAGAAACACCATCTTTCTGCTGCCCAATGTTATGAAGTCTTTGAATCTGCTGGTATTCAATATGGCCCGGGGCACCGAGGCCTTGATACCGTCTATGTGGGAGATCAGCAGGTTCTGGCAAAATTGCTTTTGCCGCCATCGGTTGCAAGCACAGCGGAACAATTTATTTTACATCCGAGCTTGATGGATGCTGCCTTGCAGGCGTCGCTTGGCCTGGCCGTAGGCGGTGTTGGGTCCGAGCCCACCCCCTCCTTGCCCTATGCGTTGGAAACGCTTGATCTCTGCGACGCGGGGGCCAGACCAAGTTGGGCCTGGATTCGTGAATCCAACCAAAGCAGCGGGGAGATTCAAAAACTTGATATTGACCTGTGCGACGATCAAGGCCGCATCTGTGTTCGGATGCGAGGGTTTTCGTCACGTGTGCTCGAGCGGGCATGGGGCTCGCAAGAAGACCGTTTGACCCTGCTGAGTCCGGTATGGAATGTCATATCAGACCCGCCAACAGAAGGCGAGCGCGATGATGTTGCCAGTGAGCAGGTGATCATCGCCGGGGGTAGCGACCTGCAAAGAGATATCCTTGGGCAGGTTCACCCCGGTGCGGTGTGGTTACCAGCAGACGATTTTGAGGCGATAGACCAACAAGTTAAGGTGTTGCCATCTCAGATGGATGTCGTGCATATCATCTGGGTCGCACCGGATCAGCCAATGACCTCCGTGAGACAAGAGTCTTTGATTCGTGAGCAAGTCCAAGGTGTGCTTTATCTCTTTCGTCTCATGAAAGTCTTGTTGGCACACGGTTACGGTGAGAAAGAGCTGCATTGGACCGTTATTACCACACAGGCACAAGCGGTACGCAAAAAGGATATCGTCAACCCCACCCATGCCAGTGTACATGGCTTCATCGGTTCGCTTGCTAAGGAATATCCGCATTGGAAAATTCGGCTGTTGGATATGGACGCGGATGAGAGTTGGCCGGTTCACGATATGCTGGCCTTACCTGGGGATCAAAATGGCGATGCCGTCGCCTATCGAGCCAAAGAGTGGTTTCAACAAGCGTTAGTGCCCGTGTTGGAGACGGATCAGGGATTACCCCCCTGTTATCGTTCTCAGGGGGTCTATGTGGTGATTGGCGGCGCAGGCGGGATTGGCGAGGCCTGGAGTCGGTGGATGATCGAGCGCTACCAAGCGCAGATCATCTGGATCGGCAGACGAAAAAAAGATGCTTTGATTCAGGAAAAATTGGACGCTTTAGACAAACTTGGCACCCCGCCCATCTATATCGAGGCGGATGCTGGCGACCTGATGGCTTTACAAAATGCGTATCAGCAAATTAAACGTCGCTATGGTCGGATTCACGGTGTGATTCATTCAGCGATTGTCCTGGCCGACAAAAGTTTGGCCAATATGGACGAACGGCAATTCCTGGCCGGTCTGAGAGCCAAAGTGGATGTGAGTGTACGGCTGGCACAAGTGTTTGCGAAAGAAACGCTGGATTTTGTCTTATTTTTTTCTTCTACTCAGTCCGTTGCTAAAATGCCAGGGCAAAGTAATTATGCGGCCGGTTGTACCTTTAAAGATGCCTTTGCCAGCCAACTGGCTCAGGAGTGGCCGTGCCAGGTCAAAGTCATCAACTGGGGCTATTGGGGAAGTGTCGGGGTGGTGGCGATCAGCTCATATCGTGAGCGTATGGCGCGGGCGGGGGTGAGGTCCATCGAGCCGGCAGAGGGGATGGCCGCCCTCCAAAGCCTACTGCAATCATCACTGGATCAGTTGGCCGTGGTCAACACTCTCCCCACTGCGAGCATTGCTCAACCTTCACGGAATCAGGCGTTGGAGGAATGGATCACGACGTATCCGGACGGGCTTCCTGTCTGTGTGGACAGTTTACCACAATATCTTCCGAATCAACCCCTTCCGGTTGTCGATAGCGGCACCGGGGTGCCCGACCAAACTGTGACCATAGAGGATTTATTGCCCCAACTCCTATTGGCTACGTTGCAGTCCTTAGGCTTAATCGAAGGGCGGGCCGAACAGCGTGCCGCCGCTTTACCGGCTGCTACCTTTTATAGACAATGGCTGGAAGAAAGCCTGACCTTCTTGTGGGCAAAAGAATATCTTGAGTATGATGGGCAGGGTTATACAAACAAGCTGCCCTCAGTTGACCTCGCACGTGTATGGCAGGAGTGGGAGCGGGAGAAAGTTCTCTGGCTGCAAGATCGCAATCAAAAGGCCATCGTGAGCCTGGTGGAAGCATGTATGCGTGCTTTGCCCGATATCCTTAGAGGAGCGCAACTGGCAACTGACGTCATATTCCCGGATTCATCCGTCGCACTGGTCGAACATATTTACAAAGGCAACGTGGTTGCAGATTATTATAATCAAATCCTTCAGAATAGTGTCGTGGCATATATTCAAGCACGACTGGCGCAAGCGCCTACGGCGCAAATCCGAATACTTGAAATTGGTGCCGGAACCGGTGGGACGACTTCTGGTTTACTGGCTGAACTCCGCCCATATCAGCGTCACATCGTAGAGTATTGTTATACAGATCTTTCAAAAGCCTTTCTAATACATGCCGAGAGGCAGTATGCCACAGAGCATCCGTATCTTGTGACACAGATTTTTGATGTGGAAAAACCGCTTGCTGAACAAGGTATACAGGCAAATCACTACGATGTCGTGATTGCAGCGAATGTCCTGCACGCGACAAAAAATATTCGCAATACGCTGCGCAATGCAAAAGCAGGCTTACGCCAACATGGTTTGCTCTTCCTAAATGAAATAAGTACGAAGTCCTTGTTTACTCATTTGACGTTTGGTTTGTTGGAAGGCTGGTGGCTGTATGAGGATGCGGCTTTGCGAATCACAGGCAGTCCGGTATTAAGTTCGGCAATTTGGGCCGATGTGTTGGCTGAGGAAGGCTTTAATTCCATTACGTTTCCTGCATTGTTGGCCGCTGAATCCGGGCATGATTTTGGGCAGCAAATTATTATTGCACAAAGTGATGGGATCGTGCGGCAGAAGGCTCGCCGCCAATCTTCACCTGTACTGCCATCTACACCCAAAAAGCAGAGCGTAAAACCGAAGGAAATAACCAAGCTGTCGCCCAATACTGAAACTTTGCGTGAGAAAGCGACAGTTTATATTAAAAAACTAGTTGCCTCAACACTGCAACTTCCAAGCGATCAGATCGACTCTGCCCAAGCCTTGGAAGCCTATGGGCTGGATTCGATTTTGGTGGTGCAGTTGACCAGTACATTACGCAAAGCATTTCACAACATTAGCAATACCTTGTTCTTTGAAGTACAAACGATTGATGGCGTTGTCGATTACTTACTTGAAAGGCAACCTGAGGTATTTAGTGATTTACTTGGAGTTGACAAACAGAAAATTGATGAACGTATTGTTGAAACAAGCACACCAATTGAGAGCCTCGAAAGTACAAGGCAAGCAAATGGGAGAAATCATTCTTTACAGAAACTAAATTTTAGAACGACCCAGAAGTTAAATGCTTTAGCTGCCTCAAAAAAACATGAGACTGTCCATGATCGGGATATCGCGATCATCGGTCTGAGTGGACGTTATCCGCAGGCTGAGAATGTCAATGCATTTTGGGAGTGTTTAAAGGCTGGGCAAAACTGTATTCGCGAAATCCCGCAGGAGCGGTGGGACTGGAGACGCTATTATGATGCGGAAAAAGGCAAAGAAGGAACACTCTACACGAAATGGGGCGGCTTTATTGACGATGTAGACAAATTTGACCCGTTATTTTTTAAATTGTCGGCGAGAGACGCCGAGCGCATGGACCCTCAGGGAAGGCTCTTTTTAGAGTGCGCCTACAGTTGTATGGAAGATGCGGGTTATACGCCGAGCACACTTTGTGACAGCCGTAAAGTAGGCGTTTTTGTTGGGGTGGTGAATAGCACGTATCGGCGTCAGCCAAGCTTCTGGTCGATGGCCAATCGGGTGTCCTACCTATTTAACTTTCAAGGCCCGAGCATGTCCGTGGACACAGCTTGTTCGTCCTCGCTGACCGCTCTGCATCTCGCGATTGAGAGTCTGCATAGCGGCACAAGCGAATGCGCGATTGCCGGCGGGGTGAACTTGATTCTGGATCCGATTCAATACCTGACGCTAAGCGCCATGACGATGCTTTCATCAAGCGACGCGTGCAAGTCTTTTGGGAATCAGGCCGATGGCTTTGTCGATGGCGAAGGCGTAGGGGCGGTGATCTTAAAGCCCCTGGCAAAAGCGGAGCAAGACGGAGACGCGATCTACGGCATTATCAAAGCCAGTATGATCAATGCGGGCGGCAAGACCAATGGTTATACCGTGCCAAATCCAATCGCACAATCGCACTTGATTCGGGAAGCCCTGGCGCGAGCCGAGGTTGACCCGAGAACCATTAGTTATGTGGAGGCTCATGGCACGGCCACGGCTTTAGGCGATTCCATTGAAATTACCGGCTTGAGCAAAGCCTTTGGCCTCAGTGAGGACAAGCAATTTTGCCCGATCGGTTCGGTGAAATCGAATATTGGTCACGCCGAAAGTGCGTCGGGTATTGCTAGTTTAACGAAAGTCTTGCTGCAATTGAAGCATCGCCAATTGGTGCCTTCCTTACATTCGCAGCAGCTCAACCCCAGTATTGATTTTGCTGAGACACCCTTTGTCGTGCAGCAGACCCTTGAGCCCTGGCATAGGCCCGTGTTGACGATTGATGGAGAAACCAAGACCTATCCGCGCATTGCCGGCATCTCATCCTTTGGAGCTGGTGGGGCGAACGCCCATGTGATTATCCAAGAATATATGAATGAGAAGGGCGATGCAGCGGCTGACGCCGAGGGACAGGGGTGGCCTGAGACCAGCTTGATTGTGGTTTCCGCCAGAGATGAAGATCGGCTTAGAGAACTTGTCAATCATCTGTGCCTTTATGCGAGAGCGTGTAGCCTGGCAGATCAGGGCAAGGCACAAACCGCCAAGCTGCAAGCCATGGCGTATACCCTCCAGGTGGGACGCGAAGCCATGGAAGTACGCCTAGGGGTCGTGGTGGCCTCTTTTGCTGAACTTAGTGAAAAGCTCCAGGGATTTTTGGACGGCCAACGCGATGTGGACAACTTGTATCGGGGACAGGTTAGACCCCATCGAGAAGCAATGGCGGTTCTTGCCGGTGATGACGTGTTCGCAGAAACGATTGATGCCTGGATTCACAGACACAAGTACGACAAAATCTTGGAGCTTTGGGTTAAAGGCTTTGTCTTCGACTGGAACAAGCTGTATGGCGAACAGAAGCCGCCTCGCATGCATTTGCCAACCTATCCTTTTGCACGGGAACGCTATTGGGCAAAAATAATTGATTTATCCCTCGATGGATTTCAAGTTGGTGCTCCACAGCAAGTTGTAGAGTGGATCCATCCTCTCGTTCATAAAAATACTTCTAATCTTGAGGAGCAACGTTTTAGCTCGACATTTAGTGGCCAGGAATTTTTTCTAGCAAATAATCGTGTCGATGGAGAGAAGGTGTTACCCGGCGTCGTCTATCTTGAAATGGCACGAGTGGCGGCAGAACAAGCACGGCCTCACCCCTCTACAAGCTTGGCGAAGAGCCATATTCAACTTAGAAATATCGGCTGGGCGACTCCCTTTGTCTGTGACCATTCGTCGCAAAGCGTGCATATCAGGATTGTGCCAGGTACTTATAAAGGCAGTGACGTCAGTTTCGAAGAGATGAGCTATGAAATCTATTCACACATAGATACAGAACGTGAGGTTGTCGTACACAGTCAGGGTGTCATCGCCTTGTGGCAGGCTCGTGAAGTCGCCGGGTTGGATTTGCCAGCTTTGCAGGCGAGCATCAATCAGAAATGTCTCAGTGCACAGCAATGTTATGACGCGTTTGCAGCGATGGGCATTGAGTATGGTCAAGGGCACCAAGGCATAGAGGATGTCTATATGACGCCTAGCCAAGCCGGTCGCTGTCAAGTGTTGGCAAAACTCAGGTTGCCTGCCGTTGTTGCTGAGACGAGCCATGATTTTGTTCTTCACCCTAGCATGATGGATGCAGCCTTACAGGCATGTATTGGACTGACGGTTGAACACGCCGTTCCCGAGTCTGGACAGATGTCGCTCCCCTTTGCCATAGACGCTATTGAAGTTATTGAAAAATGCACAGATACGATGTGGGCTTGGATACGCTATGCCGATCCTCATGCCGACCCAATACAACCGTTGAGTTCACGCGTGACCAAGGTTGACATCGATCTGTGTGATGAAAGCGGGAATCTATGTGTTCGGATAAAAGGATTTTCCACTCGCGTGGTTGCCATACCGGAGAGCAAAGCCATTGGAACTTGGATGAGCTTTCCAGTATGGAAAGAAAAATCCTGGTCTGAACATGAGCCTTCAGAATATGCTCAGCGGACGGTGATGTTGATAGAGATGGAGTGGGTGTCTGATCGTTTGATTGAGTCTCAAATCGAAGGCACGACTTGTGTTCATTTGACAACCCAAGCAAATTCACTGGCAGAGCGCTTTCAAGATATTTCAGTTCAGGTGTTTGAGCGGGTCAAAGCGCTCATGGAAGCAAAACTTAGAGGGTCAATCTTAATCCAGCTTCTGGTGCCTCACTCGGGAGAGACGCTGCTGTTTAGCGCACTTGCAGGCATACTCAGAACGGCTCACTTGGAAAACCCTGCGCTGTTGGGGCAGGTGATTATCCTGGAGCCGAGTGAAACCCAAGAGGGGGTAATCGACAAACTTCAGCGCGACAGCTCTTGCCCCGAAGATGCGTTAATCCGTTATCAGCAAGAAAGACGCCAGACGATGGCGTGGCAAGAATTGCCGATGTCAGAGCGAGAGCAGGCCGTGCAAGTTCCCTGGAAAGAAGGAGGTGTCTACCTGATTACAGGCGGCCTAGGTGGCGTTGGATTCATGTTTGCCAAACATCTTGCGCAGCACAGCAGGTCGGTTTCTCTGGTGCTGACCGGACGGTCGGAACTAGATGAGCAACGGCGCGAGCAGCTCAAAGAACTAGAAGCGTTGGGGGCCAGGGTTGACTATCTCTCGGTCGATGTCAGCCTTAAGGAGGCGGTTGAGCGCTTAATTGACTACATCGAAAGCGAGAGGGGATCGCTCACCGGCATTCTGCATAGTGCCGGTGTGATTCAGGATAACTTTATCATTCGAAAAGCAGTGCGTGAGTTTCAATCCGTGCTTGTGCCTAAAGTCGATGGCGTGATTCATTTGGATCAGGCAACGCAAGCGTTAAATCTCGATTTTTTTGTCCTGTTTTCTTCTCTCTCGGGCATTAACGGCAACGCCGGTCAGGTAGATTATGCCTGCGCCAACGCGTTTCTAGATGCTTACGCGCATTACCGCAATAGATTGGTTGCCATTAACAAGCGCTCCGGCCAAACGCTCTCTGTGAATTGGCCGCTGTGGAAAGAGGGGGGGATGCAAATCGATCCCCAGCGTGCAGAGGCGATGTTCCAACATTTGGGGCTGGTGGCGATGGAGACATCGCGTGGTATTCAGGCATTGATTCACGGTCTTTCCTCCGGACAGAGCCAGCTCATGGTGGTGGCAGGTGATCTCGAACGCCTGAAAGTTGCACATCCATCACGGCCATCATCGCCACCCTCTCAGATGGATCGTGAACACAATGTCATTGGTGAAAACGAGTTGGATGCCAATGCGTTGGCGTCAAGGTCTATTCACTATTTCAAAAACCTAATTGCGTCTATACTCAAGATACCTGCCCATCGTATTCAAAACGATGAGTTACTGGAATTGTACGGTATTGACTCTATTATTATTATGCAGTTGATCAATCAGTTGGAAAGAGACTTTGGTCCATTGTCGAAAACGCTCTTTTTTGAGTACCCAACCATTGAAGAAGTTAACCAATATTTTGTCGACTCATACAGACAAAAGCTCCACGTGGTCCTTGGCTTAGACAAGTCAAAGGCACCTGAAACTGACCACTCGGCTGTTGTCGATCCGGCTCGCCCAAAGGTACATCGGCGTTCTCGCTTGTTGGCACCGACATTAGATGAATCACCACTCCCCGTTGCGCAAACGCAGGATGTCGCCATTATCGGTGTTGCCGGACGTTATCCCCAATCCCCGGATCTTGAATCGTTCTGGGAAAATTTGTCGCAAGGTAAAAATTGTATTACTGAAGTTCCCGAAAGTCGTTGGGACCCCAGCTTGTATGTTGATTTTGACCCTTCCAACTCTGGTCAGGTGTATAGCAAGTGGGGTGGTTTCTTAGATGACGTGGACAAATTTGACGCTTTATTTTTCAATATTTCTCCTCGTGAAGCAGAGTTGATGAACCCGAATGAGCGTCTTTTCCTGGAAACCGTCTGGGAGCTGGTGGAACGTTCGGGGTATACACCGGAAAGAATACAGGAACAGCACGAAAATAACGTGGGGGTTTATATCGGGGCCATGTATCAGCAGTATCAGGCCTTAGCTTCCGAGCCCCTCATAGAGTCGGTCCTGTCCTTGTCTTCCCATAGTGCGATTGCGAATCGCGTGTCCTATTTTTTTGATTTCCAGGGCCCTAGTCTGGCCATCGACACGATGTGTTCCTCTTCATTAATTGCGATACAGTTAGCTTGTGACAGCCTGCTGAAAGGCGAGTGCCAGATGGCCATTGCCGGAGGTGTCAACCTCACGATTCATCCGAACAAATATATTGGCTTGAGCCTGAGTCAAATGATCAGTCGGCAAAACACCAGCAAAAGCTTTGGTGAGGGTGATGGTTATCTTCCGGCAGAAGGTGTCGGTGCCGTGTTGTTAAAGCCCTTGGCCAAGGCGATCGAAGATCAGGATTCCATTTTAGCCGTCATTAAATCCATTAGCACCAATCATAGCGGACATACGTATGAGTTTCGTGTACCCAACCCGAATGCGCAAGCCCAATTATTTGAAGCAAATTTCCGTAAATCCGGCATCGATCCACGCACGATTACGTATGTTGAATCGGCGGCCAATGGTTCTCCCTTGGGAGATCCGATCGAGGTCAGTGCACTTCGTAAAGCGTTTCAAAAATTCACTGCGGATCAGGGCTTTTGTGCGATTGGTTCCGTCAAATCCAATATCGGTCATGCAGAGGCAGCATCCGGCATCTCCCAACTGACAAAAGTGATATTACAGCTTCAGCATCAGCAACTTGTTCCGTCGATTAATGCAGACCCACTGAATCCAAATTTAAGCTTCGATGGTTCGCCATTTTATCTGCAACAACAACTGCAACCATGGGCACGTCCAGTCTTCAATATCGATGGTCAAGAGCGTGAGTTCCCCCGGCGCGCAACCGTTAGCTCCTTTGGGGCGGGAGGCTCGAATGCGCATTTGATTATCGAGGAATATATTGCTTCTGCGGGTAAGAACGCCGTGTCACCTGATATAGAGTTGGCAGCCGATCGCGAGTTGATGGTTTTTTCCGCAAAAAGCTGTGATCGTCTTCAGGCGATGCTGCAACAGATGCGTCATTATGTCGAATCCAACCAAGCACTTTCGCTAAAGAAGATGGCCTATACGCTCCAGGTAGGACGTATGGCGATGACACATCGAATCGCGATGCTGGTGCATAATCGAGAAGAGCTGATCCAGGGCATCCAAGATGCTTTGCATAGCCTAGAACAACCAGCCGGGATAATCAACACAACCATTCCAATATACATGGGTGATCTGGAGGCGGATCACTCGGAAGTAAAGCATTTGCTCTCCGGTCAATCCGGAGAGGCCATGCTGAAAGTGCTTTTCGCCGAAGAAAATCTGGAAAAAATTGCTCTTTACTGGGTTAAAGGAGGCCATATTCCCTGGCTGGCACTGCATCAAAAAGGTCAAATGTCTATGTTGTCTCTACCCACGTACCCTTTCTCCAAGCGGTACTGCTGGGTTGAGAGTAAAGCCCTGTCTCAAGTTGTAACCACGGCTGAGGCCGAATTACTTTCGAAAAGTACGGATGATCATATTTCCGTTGACAGAAATGAAGAATCAGTTCTTTCAGAGATTCTGTGCCGAACCTTAGGCCTAACAGCAGAAGAGTTTAATCAAAAGACCCCATTGGTTCAATATGGGGTGGATTCCGTTATGTTTGTGCAAATTTTTCAACAAATTAAAGACAAGATTGATAACCGCGTTAACTTGAGTCAGCTGCTGGAATGCCAAACCATGCAAGATATGATTTTCTATTTGACTGCGAAAAAGGAGGACGCGCAAACCGAGCCGGAGCTGGTGAACCTTTCCGGAGCCGGTCTTTCTTCATCACATGACACACGTTTTCCAGAGCTGGTCCATATGAACTCAAGTACCAGGGGAAGACCTGTATTCTGGTTCCATGGCATCGCGGGCGTTACGGTTTACGAGCCTGTTGCTGAAAAAAGCCAGCGCCCCTTCTATGGCGTTCAGCCCTGTAGCTGGATCAACCAAACCGCGGGACCTTCTCATATTCAGGCCATGGTGCAAGGTTATCTGGATGCCATACGATCCGTGCAGCCGGAAGGTCCTTACGATTTTGGTGGCTATTCGCTGGGTGGCATGTTGGCTTATGAAGCCACCCGTCAATTACAGGACATGGGAGAGAGCGTATCGACCATTGTGATGGTCGATACGCTACAGAGTAATCCTGATCGTAAGGATAAGTACTCGCGCAAAACAGATTATCTGGTTGTTTTGAATCGGTCCTTTGCCTCATCTGCATGGCAGAGCTCGGAAAATACCGTGCAGGACATGCTGATTCGTGCAGATGAGCTGGATGCAAGTCTAAGTGACGACGAGTATTTAACAGAGCTGATTGTCTTAGCCAAACAACGAGGACTGGTCAAGACAGAGACAGAGATCCGTGCCAGCCTTGAATATGCAACAACCCTTGATGAGTTTTATCAAACTGATCCCTTTACGGTTAGGCCCCTATCTGATCCCGATGCCGTTAACTGCTACTATTTCCGCAATAAGAATGGCGCGATGTTGGGTGATCAGGCGCCCTACTATTTTGCGACACCACAAGACAGGGAAATATTTGTCACCACCGATCAGTCAGCCGATTCGCGGCAGTGGGAAAAGAACTTGACGAACCTTCACATCATTGATATCGATTCGTCCAATCACATGACGATGTTCTCGGAAGAAAAACCACGCCAGACCATTCTTGAGTTCTGTGAAATCTTGTATTCTGAAGCCGGACTTCCGAATGCATTTCTTGACTTCTTTATGGCCAAGGCTCGAGAAATACATGGCAATATAGAGCTGGACAGATAA", "orf_prot_sequence": "MKKEFHIHASHPIVKHHQAYGQALLPGLAYIDLLYQFFREQGYEFAALELRNLSIYRPLLVGEDDGIQLLLQADDMAEGLWSVQLLDGEQRGAPESKAQQLYIKAEMYHHREAPVFDDVLDFQALQAVSHTQIPLNDIYAQCRSQGLVHSGMMKAEGTAYTLDDAQIIEVALPDEAASSAAGFMFHPALIDGSGVGSSNLFAALVEGEQRLFLPLFYERFRASARFERTCLVRVKTASVWRKNDMMYMDIEFFNESGEKIAELKNFVNKLVREAALINPNLKPASQAQSSKLKPYEEASSESQANPPRLDKSEALEGMEDLLKEIIAPYVDGSPEQLDPEAGYYELGLDSAILLQVVTALEKRFDAKLMPTLLFEYTTIEELAAYFVNENFATKHVAKEPATPLAPVLPGPIQTGHEDDIAIIGISGRYPGANNINEFWQNLVVGKDCISDVPEERWDWRSVAKHKSPSGKSVSKWGGFIQDPDCFDHQFFRISPREAEVLDPQERLFLQTCWECIEDAGYTPETLVTRQQAPHRRQSVGVFVGVMHKDYVFLGMEAIARGEQFHLSINNAPIANRVSYFCDFHGPSMVIDTVCSSSLTAIHLALESIRHGESDIALAGGVNLSLHPNKYLTYGLLDMYSSDGRCRAFGRGGDGYVSGEGVGAVVLKPLAQAIQDRDHIYAVVKGSMINHVGKVTGISVPNPVAQSDMILQCLEKTGIHPRTLSYVEAHGTGTSLGDPIEIQGLCKAFQTHTNDTQFCAIGSVKSNIGHTESAAGISGLSKVALQLHYQTLVPSLHSEAINPHLDLEASPFFVQRQTQHWERTSDHPRRAGLSSFGATGSNAHVILEEYIPEQSETDLAQPAEGVEQRLPVLIPLSAKNEERLKEAARNFYHYLISKPEDVAGHQVARLSDIAYTLQVGRRAMETRAIFLVDHQQQLVESLQAFLDDDHTKGNSWLGKQVKQQRHARRGEYSEAMLQQWMVQGRLDQLAQAWSEGVPLNWDALYSPESGVAKPSRVSLPTYPFAKARHWVPMEVKAVTPFAALHPLLHRNTSTLGEQRFSSTFSGEEFFLADHRVHGQKMLPGVAYLEMARAAVALATSAGEAQAIRFKNIIWQQPLVIDGTEKTIHIGLYAKANSQVDFTIYTGDEHGSDAPFPDEQNRRVHCRGIAMLTLSDRERETYLDLDHLQSQTGQNDFTPEQCYQAFAAMGIDYRDGHQGIAAVHAGADQILAELSLPASVLAHREPFVLHPSMMDSALQAAIGFALSAQVAGAQQPASLPYALESLDVRAACTPSMWVWIRYADNNSAGSPVQKFDLDLCDDRGKICVLMRGFSSRIFHAQASPCFAETLLPSQLHPLLHQHVPSENPVHDQFIAQFTGEEFFLRDHQQVMLGMAYLEMAHRAGQHRASQKILGLKNVVWSQLLFIAGQAREVSVHVQNEVLQHRFRITTQNEDSLQNIHCQGMLVVDQALYPERPDQLNIQDIQSRCSASIETTECDQLLQYTHGPSLLTIKQLWHNEHEALALLQLPDGMRSGREDYTLHPSMMNGAILTSVLFSLLNGPQEHLPMPFALDELWMYQEMPERAYAYVSMSSANNHDIELVDITGKCIVLFKGFTAAIQGAWQSQAPQNNVIYASTQWRESVLSGDEHANTAASAPIVMLAQDNPELAGLLRQRWPEASIEMLAPIGEDIAKTVQANFLQVFDRVKTCILEQPQRIQPIVVLLPENENDYLHDGLAALFKTARFEYRKIVGKLIRYTIDIDIEELAKSILMEVSHDDQHVDVYYSQTGTRKVKTLNEIYDFEKSHAHLLVEADLLHEGDVVWITGGLGGLGQIFTRHLSHTKGLKLILSGRSPLNAASEKVLRELQQSDVEMSYLSCDISDQQAVATLVQSILNKYGKLNGVIHSAGLTRDAYIHNKTREEMIAVLRPKMAGILAIEAACQDIQLNFMVLFSSIAGVFGSIGQADYAMANAFLDSFAEARNRRVQQGKCFGRTLSINWPLWRNGGMGVDAQNETLMQRNTGMIALETRAGLNAFELALSSEYSHILVAQGETEKIRSRLLSPRFVEENLSSVEADTTEPLEHQNQSEPSKAEQDQRAWLIRLLLKDLAAFVCRLQKVQPEEIDLEAEFSVYGFDSIGFMSFVNHLNDMYDLELMPTLFFEHSSLRALADALIEKHQEALLKKYESPKTAAQPSQDRMPIQARAVEMDKRQHPVSATMTPVESETTQGNPTPESLSTTDPIAIIGMSGKFPGSENLTAFWQHLEANRDLVSEIPEDRWDWRDYYGDHLSESGKTKIKWGGFIEGIDHFDPLFFGISPVEAEIMDPQFRLFLQTVWATIEDAGYRASALSGSKTGVYVGVTTTDYKDLMQQARARENSQEYHGMFPFMLANRVSYLFNFRGPSEAIDTACSSSLVAIHRATESIRQGSCEMAVAGGVNIIANPQLVLSATQGGMLSEDGRCKTFDQSANGYVRGEGVGAILLKPLARAIEDHDPICGVIRGSAENHGGKATSPTAPNPVAQQELLVSAYAQAGITPETVGYIEAHGTGTPLGDPIEINGLKSAFAQLYEQIGRPPANEPHCALGSVKTNIGHAEAAAGISGVLKVLLMMKHQKIPGNPHLKEPNPYLQLTGSPFHLAQDTQDWRALHDEVHNPIPRRAGVSSFGIGGSNAHLVLEEYTAEPAAEPVVCGEASLIILSAKNRACLVEAAGNLYRFLIDNRESSRGELLRLADIAYTLQVGREEMAHRLGFVASSLTELEERLQTFINVQGENQDLYEGHTKGNRSTLEAFESDDDLQEMLTKWVEGRRFEQILKLWVKGLAVNWESLYRGIQPRRISLPSYPFARERYWIPASAESLPVPAASPVSPIQVDNAAGVLMCHPVWEEKAAPVQVGSFDPASLHDCQHLILFCHMDVPLGLQDRFGTSSVCRVFQAQSDDVALGYSYLCEQVLTCLKEILENKPRDRVFVQIVIPGPETSEAEGASGLLHGLSALLKTAHLENPKVLGQLIEVGPRHTGDALIRCVQENCQSPDDVQVRYRHGRREVMAWEELPVSEPNAAPMPWKERGVYLITGGAGGLGFIVAREIARRVKAPILILAGRSHLSQAKRDELQQEAQRLGVQIEYRQADVSQPQEVNDLIRSILRDFTKLNGILHAAGLIRDSFMIRKTVDQLHQVLAPKVFGTVYLDEASKDVDLDFFLLFSSGAAALGNAGQADYAAANAFMDAYAEYRHALFASKQRFGRSLSINWPLWQEGGMQVDEPTLTALEQYAGIRALQTGSGLDALYRALSVTPNQIMVLEGDLAKIRQGLFSASTEPYRNESSRVEVDEERLLARTLHQCKTLFGGIIKLAADRVEAEEALEHYGIDSVIIAQMNLRLEEVFGEVSKTLLYEYQTLGELASYLATEYRDACMTWTGLTAIPTSDMTTVPDDAIPAKPQITSEPRRSSGVDVHALTPKAPAPSQDEPIAIIGLAGRYAQADTPRAYWENLQSGTDCVTEIPPDRWSLSGFYHEDLEEAIAQGKSYSKWGSFLNGFADFDPLFFSMSPREAIGIDPQERLFLQSSWEAMEDAGYTRETLRDQFQQRVGVFVGITKTGFSLYGPELWQRGDIVYPTTSFSSVANRISYLFNLRGPSLPIDTMCSSSLTAIHEACEHIRRGECELAIAGGVNLYLHPSTYVQMCAAHLLSQDGKCKSFGEGGNGFVPGEGVGTIVLKPLTQAIDDHDHIYAVIRASSVNHGGKTNGYTVPNPNAQAALIEDALDKAGVDARTLTYIEAHGTGTELGDPIEIRGLTQAFQKHTIDTAFCAVGSAKSNLGHLEAAAGIAGLTKIILQLQHAKIAPSLHASTLNPNINFAKTPFVVPQALSEWKRPIVDMHGEVKEYPRRTGISSFGAGGSNAHLIVEEYVKGTSVGETRASHHHDVIRNEAQVILLSAKNEDRLHCVAKDLHDYLNAEQGANLSLRDIAYTLQLGREAMDERLGLVVYSLDELRQKLNGFIAGESGIEDVYRGQVQGHKKALALFTEDDELQEAIEKWMQRGKFARLVELWSQGLAVDWNKLYCDREVIPYRVSLPTYPFEQHRYWIEDTLHASPKPVAESVGQSAVKLHPLIHENTSNFLAQRFRSCFRGDEFFLADHLVQGRRVLPGVAYLEMVRMAVSLAMDTQIEGYDLRFENVVWARPIIVDGQPLNMHTVLQVEDSTTISFEIYSQVDTEENDADVLHCQGSVEICVLEKEQELEVSHLLGECQKHHLSAAQCYEVFESAGIQYGPGHRGLDTVYVGDQQVLAKLLLPPSVASTAEQFILHPSLMDAALQASLGLAVGGVGSEPTPSLPYALETLDLCDAGARPSWAWIRESNQSSGEIQKLDIDLCDDQGRICVRMRGFSSRVLERAWGSQEDRLTLLSPVWNVISDPPTEGERDDVASEQVIIAGGSDLQRDILGQVHPGAVWLPADDFEAIDQQVKVLPSQMDVVHIIWVAPDQPMTSVRQESLIREQVQGVLYLFRLMKVLLAHGYGEKELHWTVITTQAQAVRKKDIVNPTHASVHGFIGSLAKEYPHWKIRLLDMDADESWPVHDMLALPGDQNGDAVAYRAKEWFQQALVPVLETDQGLPPCYRSQGVYVVIGGAGGIGEAWSRWMIERYQAQIIWIGRRKKDALIQEKLDALDKLGTPPIYIEADAGDLMALQNAYQQIKRRYGRIHGVIHSAIVLADKSLANMDERQFLAGLRAKVDVSVRLAQVFAKETLDFVLFFSSTQSVAKMPGQSNYAAGCTFKDAFASQLAQEWPCQVKVINWGYWGSVGVVAISSYRERMARAGVRSIEPAEGMAALQSLLQSSLDQLAVVNTLPTASIAQPSRNQALEEWITTYPDGLPVCVDSLPQYLPNQPLPVVDSGTGVPDQTVTIEDLLPQLLLATLQSLGLIEGRAEQRAAALPAATFYRQWLEESLTFLWAKEYLEYDGQGYTNKLPSVDLARVWQEWEREKVLWLQDRNQKAIVSLVEACMRALPDILRGAQLATDVIFPDSSVALVEHIYKGNVVADYYNQILQNSVVAYIQARLAQAPTAQIRILEIGAGTGGTTSGLLAELRPYQRHIVEYCYTDLSKAFLIHAERQYATEHPYLVTQIFDVEKPLAEQGIQANHYDVVIAANVLHATKNIRNTLRNAKAGLRQHGLLFLNEISTKSLFTHLTFGLLEGWWLYEDAALRITGSPVLSSAIWADVLAEEGFNSITFPALLAAESGHDFGQQIIIAQSDGIVRQKARRQSSPVLPSTPKKQSVKPKEITKLSPNTETLREKATVYIKKLVASTLQLPSDQIDSAQALEAYGLDSILVVQLTSTLRKAFHNISNTLFFEVQTIDGVVDYLLERQPEVFSDLLGVDKQKIDERIVETSTPIESLESTRQANGRNHSLQKLNFRTTQKLNALAASKKHETVHDRDIAIIGLSGRYPQAENVNAFWECLKAGQNCIREIPQERWDWRRYYDAEKGKEGTLYTKWGGFIDDVDKFDPLFFKLSARDAERMDPQGRLFLECAYSCMEDAGYTPSTLCDSRKVGVFVGVVNSTYRRQPSFWSMANRVSYLFNFQGPSMSVDTACSSSLTALHLAIESLHSGTSECAIAGGVNLILDPIQYLTLSAMTMLSSSDACKSFGNQADGFVDGEGVGAVILKPLAKAEQDGDAIYGIIKASMINAGGKTNGYTVPNPIAQSHLIREALARAEVDPRTISYVEAHGTATALGDSIEITGLSKAFGLSEDKQFCPIGSVKSNIGHAESASGIASLTKVLLQLKHRQLVPSLHSQQLNPSIDFAETPFVVQQTLEPWHRPVLTIDGETKTYPRIAGISSFGAGGANAHVIIQEYMNEKGDAAADAEGQGWPETSLIVVSARDEDRLRELVNHLCLYARACSLADQGKAQTAKLQAMAYTLQVGREAMEVRLGVVVASFAELSEKLQGFLDGQRDVDNLYRGQVRPHREAMAVLAGDDVFAETIDAWIHRHKYDKILELWVKGFVFDWNKLYGEQKPPRMHLPTYPFARERYWAKIIDLSLDGFQVGAPQQVVEWIHPLVHKNTSNLEEQRFSSTFSGQEFFLANNRVDGEKVLPGVVYLEMARVAAEQARPHPSTSLAKSHIQLRNIGWATPFVCDHSSQSVHIRIVPGTYKGSDVSFEEMSYEIYSHIDTEREVVVHSQGVIALWQAREVAGLDLPALQASINQKCLSAQQCYDAFAAMGIEYGQGHQGIEDVYMTPSQAGRCQVLAKLRLPAVVAETSHDFVLHPSMMDAALQACIGLTVEHAVPESGQMSLPFAIDAIEVIEKCTDTMWAWIRYADPHADPIQPLSSRVTKVDIDLCDESGNLCVRIKGFSTRVVAIPESKAIGTWMSFPVWKEKSWSEHEPSEYAQRTVMLIEMEWVSDRLIESQIEGTTCVHLTTQANSLAERFQDISVQVFERVKALMEAKLRGSILIQLLVPHSGETLLFSALAGILRTAHLENPALLGQVIILEPSETQEGVIDKLQRDSSCPEDALIRYQQERRQTMAWQELPMSEREQAVQVPWKEGGVYLITGGLGGVGFMFAKHLAQHSRSVSLVLTGRSELDEQRREQLKELEALGARVDYLSVDVSLKEAVERLIDYIESERGSLTGILHSAGVIQDNFIIRKAVREFQSVLVPKVDGVIHLDQATQALNLDFFVLFSSLSGINGNAGQVDYACANAFLDAYAHYRNRLVAINKRSGQTLSVNWPLWKEGGMQIDPQRAEAMFQHLGLVAMETSRGIQALIHGLSSGQSQLMVVAGDLERLKVAHPSRPSSPPSQMDREHNVIGENELDANALASRSIHYFKNLIASILKIPAHRIQNDELLELYGIDSIIIMQLINQLERDFGPLSKTLFFEYPTIEEVNQYFVDSYRQKLHVVLGLDKSKAPETDHSAVVDPARPKVHRRSRLLAPTLDESPLPVAQTQDVAIIGVAGRYPQSPDLESFWENLSQGKNCITEVPESRWDPSLYVDFDPSNSGQVYSKWGGFLDDVDKFDALFFNISPREAELMNPNERLFLETVWELVERSGYTPERIQEQHENNVGVYIGAMYQQYQALASEPLIESVLSLSSHSAIANRVSYFFDFQGPSLAIDTMCSSSLIAIQLACDSLLKGECQMAIAGGVNLTIHPNKYIGLSLSQMISRQNTSKSFGEGDGYLPAEGVGAVLLKPLAKAIEDQDSILAVIKSISTNHSGHTYEFRVPNPNAQAQLFEANFRKSGIDPRTITYVESAANGSPLGDPIEVSALRKAFQKFTADQGFCAIGSVKSNIGHAEAASGISQLTKVILQLQHQQLVPSINADPLNPNLSFDGSPFYLQQQLQPWARPVFNIDGQEREFPRRATVSSFGAGGSNAHLIIEEYIASAGKNAVSPDIELAADRELMVFSAKSCDRLQAMLQQMRHYVESNQALSLKKMAYTLQVGRMAMTHRIAMLVHNREELIQGIQDALHSLEQPAGIINTTIPIYMGDLEADHSEVKHLLSGQSGEAMLKVLFAEENLEKIALYWVKGGHIPWLALHQKGQMSMLSLPTYPFSKRYCWVESKALSQVVTTAEAELLSKSTDDHISVDRNEESVLSEILCRTLGLTAEEFNQKTPLVQYGVDSVMFVQIFQQIKDKIDNRVNLSQLLECQTMQDMIFYLTAKKEDAQTEPELVNLSGAGLSSSHDTRFPELVHMNSSTRGRPVFWFHGIAGVTVYEPVAEKSQRPFYGVQPCSWINQTAGPSHIQAMVQGYLDAIRSVQPEGPYDFGGYSLGGMLAYEATRQLQDMGESVSTIVMVDTLQSNPDRKDKYSRKTDYLVVLNRSFASSAWQSSENTVQDMLIRADELDASLSDDEYLTELIVLAKQRGLVKTETEIRASLEYATTLDEFYQTDPFTVRPLSDPDAVNCYYFRNKNGAMLGDQAPYYFATPQDREIFVTTDQSADSRQWEKNLTNLHIIDIDSSNHMTMFSEEKPRQTILEFCEILYSEAGLPNAFLDFFMAKAREIHGNIELDR", "perc_identity": 22.78}}, "BGC0001186.1|Misakinolide_21 # 100141 # 100563 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.511": {"gnl|BL_ORD_ID|1828|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 100141, "orf_end": 100563, "orf_from": "BGC0001186.1|Misakinolide_21 ", "model_name": "FosA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "1979", "ARO_accession": "3003210", "ARO_name": "FosA4", "ARO_category": {"36272": {"category_aro_accession": "3000133", "category_aro_cvterm_id": "36272", "category_aro_name": "fosfomycin thiol transferase", "category_aro_description": "Catalyzes the addition of a thiol group from a nucleophilic molecule to fosfomycin.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.99914, "max_identities": 17, "bit_score": 24.2534, "cvterm_id": "35914", "query": "FMDHRPLNPGHVLVIPKGHEPDLHCLDEPTYLAVMKVGKHLAEVLAELFEPPKVGL", "match": "+ D+R     +  + P GH+ +LH            VG HLA+ LA   E P  G+", "sequence_from_db": "WKDNRSEGASYYFLDPDGHKLELH------------VG-HLAQRLAACRERPYKGM", "sequence_from_broadstreet": "MLQGLNHLTLAVSDLASSLAFYQRLPGMRLHARWDSGAYLSCGALWLCLSLDAQRRKTPAQESDYTHYAFSVAEEHFAEVVAQLAHAGAEVWKDNRSEGASYYFLDPDGHKLELHVGHLAQRLAACRERPYKGMVFFD", "dna_sequence_from_broadstreet": "ATGCTGCAGGGATTGAATCATCTGACGCTGGCGGTCAGCGATCTGGCGTCAAGCCTGGCGTTTTATCAGCGGTTACCTGGAATGCGTCTGCACGCCCGTTGGGATAGCGGAGCATATCTTTCCTGCGGGGCGTTGTGGCTATGCTTGTCGCTGGATGCGCAGCGGCGTAAAACGCCCGCTCAGGAAAGCGACTATACCCATTATGCTTTCAGCGTGGCGGAAGAGCACTTTGCCGAGGTGGTCGCCCAGCTGGCGCACGCGGGGGCCGAAGTATGGAAAGACAACCGCAGCGAAGGGGCGTCGTACTATTTTCTCGACCCTGACGGCCATAAGCTGGAACTGCATGTGGGTCATTTGGCACAGCGGCTGGCCGCCTGTCGGGAACGCCCGTACAAGGGGATGGTCTTTTTTGACTGA", "partial": "0", "query_start": 100225, "query_end": 100392, "hit_start": 273, "hit_end": 402, "orf_dna_sequence": "ATGGACGAGTCCTGTGTTTTTTGTCGTATTGTTGCTGGGATGACACCTTCTCATCAGGTGTTTGAAGATGATGATGTGATCGCGTTCATGGATCATCGGCCTTTGAATCCAGGGCATGTACTTGTGATTCCGAAAGGGCATGAACCCGATCTACACTGTTTGGATGAGCCCACGTATCTCGCGGTCATGAAGGTAGGTAAACATTTGGCAGAAGTCTTGGCCGAGCTGTTTGAGCCGCCTAAAGTCGGTCTTTTTGTCATTGGCTTTCACGTGCCACATGTGCACGTGCACGTCGTGCCACTCTATACCATCGACGATTTCACGGCTGATGCCATCAAGTTGGCCATGCGTAGGAAGCCGGATACGGAGGCGCTGGCGGAGATCTGTCAGCGTATCCGTGAGCATTTGTCAACGGCTTGCTAG", "orf_prot_sequence": "MDESCVFCRIVAGMTPSHQVFEDDDVIAFMDHRPLNPGHVLVIPKGHEPDLHCLDEPTYLAVMKVGKHLAEVLAELFEPPKVGLFVIGFHVPHVHVHVVPLYTIDDFTADAIKLAMRRKPDTEALAEICQRIREHLSTAC", "perc_identity": 30.36}, "gnl|BL_ORD_ID|4699|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 100141, "orf_end": 100563, "orf_from": "BGC0001186.1|Misakinolide_21 ", "model_name": "Staphylococcus aureus mupA conferring resistance to mupirocin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "2270", "ARO_accession": "3000521", "ARO_name": "Staphylococcus aureus mupA conferring resistance to mupirocin", "ARO_category": {"36585": {"category_aro_accession": "3000446", "category_aro_cvterm_id": "36585", "category_aro_name": "antibiotic-resistant isoleucyl-tRNA synthetase (ileS)", "category_aro_description": "Mupirocin inhibits protein synthesis by interfering with isoleucyl-tRNA synthetase (ileS).  Mutations in ileS can confer low-level mupirocin resistance.", "category_aro_class_name": "AMR Gene Family"}, "36693": {"category_aro_accession": "3000554", "category_aro_cvterm_id": "36693", "category_aro_name": "mupirocin", "category_aro_description": "Mupirocin, also known as pseudomonic acid, is a bacteriostatic polyketide antibiotic from Pseudomonas fluorescens used to treat S. aureus and MRSA. It inhibits Ile tRNA synthetase.", "category_aro_class_name": "Antibiotic"}, "45733": {"category_aro_accession": "3007151", "category_aro_cvterm_id": "45733", "category_aro_name": "mupirocin-like antibiotic", "category_aro_description": "A group of antibiotics including mupirocin and similar mixtures (such as those including pseudomonic acid A).", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.52179, "max_identities": 29, "bit_score": 24.2534, "cvterm_id": "35508", "query": "SHQVFEDDDVIAFMDHRPLNPGHVLVIPKGHEPDL----HCLDEPTYLAVMKVGKHLAEVLAELFEPPKV--GLFVIGFHVPHVHVHVVPLY--TIDDFTADAIKLAM", "match": "S+Q+ ED+D +  +D + L+P    +I +GH  +L      L +   L + +       V  EL E  K    +F   F + ++H++V+  Y  TI  F    IK+++", "sequence_from_db": "SYQLSEDNDCVILLD-KNLSPE---LIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTI-HFNNKEIKISL", "sequence_from_broadstreet": "MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY", "dna_sequence_from_broadstreet": "TTGACAAAGAAATATTTAAACACCCAGAATGAAATATCAGCATTTTGGAATACTCAAAAGATATTTAAAAAATCAATTGACAATAGAAAAGGACAGGAAAGTTTTGTTTTTTATGACGGCCCCCCAACTGCAAATGGCCTTCCTCATGCTGGCCATGTTCTTGGAAGAGTAATCAAGGATTTAGTTGCAAGATTAAAAACTATGCAAGGTTTTTATGTAGAAAGAAAAGCAGGATGGGATACCCATGGCTTACCAGTTGAATTAGAGGTTGAAAAAAAAATTGGAATTAAAGGAAAACAAGACATTGAAAAGTATGGAATAGAAAATTTTATAAATGAATGTAAAAAAAGTGTATTTAATTATGAAAAAGAATGGCGGGATTTTTCTAAAGATTTAGGATACTGGGTTGACATGGACTCCCCCTATATAACTCTTGAGAATAATTATATTGAAAGTGTATGGAATATATTATCTACATTCCATAAAAAAGGACTATTATATAAGGGACATAAGGTGACTCCTTATTGTACACATGATCAAACCGCTTTAAGTTCTCATGAAGTAGCGCAAGGCTATAAAAACGTTAAAGATTTATCAGCTGTTGTTAAATTTCAACTTACAAATAGTAAAGATACTTATTTCTTAAGTTGGACTACCACTCCCTGGACTTTGCCTGCAAATGTAGCATTAGCTATAAATAAAGATCTTAATTATTCAAAAATTCGGGTAGAAAATGAGTATTATATCTTAGCTACAGATCTAATTAATTCTATAATAACTGAAAAATACGAAATTATTGATACCTTTTCAGGAAGTAATTTAATTAATTTAAAATACATTCCTCCTTTTGAAAGCGACGGTTTAGTTAATGCATATTACGTTGTTGATGGAGAATTTGTTACTAACTCAGAAGGAACTGGTATTGTTCATATAGCACCAGCTCATGGGGAAGATGACTACCAATTGGTTTTAGAGCGTGATTTGGATTTCTTAAATGTTATAACAAGAGAAGGAGTATATAATGATAGGTTCCCTGAATTAGTTGGTAATAAAGCTAAAAATAGTGATATAGAAATCATAAAATTATTATCCAAAAAACAACTTTTATATAAAAAACAAAAATATGAGCATAATTATCCTCATTGTTGGAGATGTGGTAATCCTTTGATATATTATGCGATGGAAGGTTGGTTTATTAAAACAACTAATTTTAAGAATGAAATTATTAACAATAATAATAATATAGAGTGGTTTCCTTCTCATATTAAGGAAGGGAGAATGGGAAATTTCTTAGAAAATATGGTTGATTGGAACATTGGTAGAAATAGATATTGGGGAACACCATTAAATGTATGGATTTGCAATGATTGTAATCACGAATACGCACCAAGTAGTATTAAGGATTTACAAAATAATTCCATCAATAAAATTGATGAAGATATTGAGTTGCATAGACCTTATGTTGATAATATCACTCTTAGTTGCCCTAAGTGTAATGGGAAAATGTCTCGAGTAGAAGAAGTAATCGATGTTTGGTTTGATAGCGGCTCTATGCCGTTTGCTCAGCATCATTATCCTTTTGATAACCAGAAAATTTTTAATCAACACTTTCCAGCTGATTTTATTGCAGAAGGAGTTGATCAAACGAGAGGCTGGTTTTACAGTTTACTAGTAATTTCTACTATTCTAAAAGGAAAATCTTCTTATAAACGTGCTTTATCTTTAGGACATATTCTAGACAGTAATGGTAAAAAAATGTCTAAAAGTAAAGGAAACGTTATTAATCCAACTGAATTAATTAATAAGTACGGAGCCGATTCTTTAAGATGGGCCTTAATTTCGGATAGTGCTCCATGGAATAACAAAAGATTCTCAGAAAATATAGTAGCTCAGACCAAATCGAAATTTATAGATACGCTTGATAATATTTATAAATTTTATAATATGTATAATAAAATAGATCACTATAATCCTAATAATGAAATTACAAAAAGTAGAAATACATTAGATAATTGGGCTCTTTCTCGCTTAAACACCTTAATAAAAGAAAGTAATATTTATGTAAATAATTACGATTTCACTTCCGCAGCCAGATTAATTAACGAATATACCAATACAATAAGTAATTGGTATATCGGAGATTCGAGAGGACGATTTTGGGAACAAGGAATTTCTAACGATAAAAAAGATGCGTACAATACGCTTTATGAAATTTTAACAACTTTATCAAGACTAGTGGCTCCATTTGTTCCATTTATATCTGAAAAAATCCATTATAATTTGACTGGAAAAAGTGTGCATTTACAAGATTATCCACAATATAAAGAAAGTTTTATTAATCAAGCATTGGAAGATGAAATGCATACCGTTATAAAAATTGTAGAATTATCTAGACAGGCTCGCAAAAATGCAGATTTAAAAATTAAGCAACCTTTATCGAAAATGGTGATTAAACCTAATAGTCAATTAAACTTAAGTTTTTTACCTAATTACTATTCAATAATAAAAGACGAATTAAATATAAAAAACATTGAATTAACTGATAATATTAATGACTATATTACCTATGAGCTTAAATTGAATTTTTCTTCTGTGGGACCAAAACTAGGGAACAAAACGAAAAATATTCAAACATTGATAGACTCCCTATCAGAGTATGATAAAAAAAGTTTAATTGAGTCTAATAACTTCAAAAGTTTATCTTCTGATGCTGAGTTAACTAAGGATGATTTTATAATTAAAACCTTACCTAAGGATAGTTATCAACTCAGTGAAGATAATGACTGCGTTATATTATTAGATAAAAATTTATCTCCTGAATTAATTCGCGAAGGACATGCTAGAGAGCTCATTAGATTAATTCAACAATTAAGAAAAAAGAAAAATTTACCAATAAATCAACGTATTGATATTTATATCGGTGTAACTGGGGAATTATTAGAATCAATAAAAACCAATAAAAATATGTTTAAAGAAAATTTCGTGATTAAAAATATACACTTAAATGTTATAGATGAATATGAAAATACTATTCATTTTAATAATAAAGAAATAAAAATTTCCTTATTATATTAA", "partial": "0", "query_start": 100189, "query_end": 100488, "hit_start": 2757, "hit_end": 3066, "orf_dna_sequence": "ATGGACGAGTCCTGTGTTTTTTGTCGTATTGTTGCTGGGATGACACCTTCTCATCAGGTGTTTGAAGATGATGATGTGATCGCGTTCATGGATCATCGGCCTTTGAATCCAGGGCATGTACTTGTGATTCCGAAAGGGCATGAACCCGATCTACACTGTTTGGATGAGCCCACGTATCTCGCGGTCATGAAGGTAGGTAAACATTTGGCAGAAGTCTTGGCCGAGCTGTTTGAGCCGCCTAAAGTCGGTCTTTTTGTCATTGGCTTTCACGTGCCACATGTGCACGTGCACGTCGTGCCACTCTATACCATCGACGATTTCACGGCTGATGCCATCAAGTTGGCCATGCGTAGGAAGCCGGATACGGAGGCGCTGGCGGAGATCTGTCAGCGTATCCGTGAGCATTTGTCAACGGCTTGCTAG", "orf_prot_sequence": "MDESCVFCRIVAGMTPSHQVFEDDDVIAFMDHRPLNPGHVLVIPKGHEPDLHCLDEPTYLAVMKVGKHLAEVLAELFEPPKVGLFVIGFHVPHVHVHVVPLYTIDDFTADAIKLAMRRKPDTEALAEICQRIREHLSTAC", "perc_identity": 26.85}, "gnl|BL_ORD_ID|900|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 100141, "orf_end": 100563, "orf_from": "BGC0001186.1|Misakinolide_21 ", "model_name": "lmrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "974", "ARO_accession": "3002881", "ARO_name": "lmrC", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37630": {"category_aro_accession": "3001231", "category_aro_cvterm_id": "37630", "category_aro_name": "celesticetin", "category_aro_description": "Produced by Streptomyces caelestis, which also produces the macrolide niddamycin.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.97291, "max_identities": 16, "bit_score": 23.483, "cvterm_id": "36862", "query": "RPLNPGHVLVIPKGHE----PDLHCLDEPTYLAVMKVGKHLAEVLAE", "match": "R L+ G VL I    +    PD+  LDEPT    +   + L +V+ E", "sequence_from_db": "RSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEE", "sequence_from_broadstreet": "MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK", "dna_sequence_from_broadstreet": "ATGGCTGACGCGAGTATTGTCTGCACCAATCTCTCCTTCTCCTGGCCCGACGAGACGCCGGTCTTCGACGGGTTGTCCTTTGCCCTCGGCGCCGGCCGTTGCGGCCTCGTGGGCCCCAATGGCGCGGGAAAGTCCACACTGTTGCGGCTCGCCGTAGGGGAACTCACCCCTACCGCAGGCTCGATCACCGCGCAGGGACATGTCGGGTACCTGCCGCAGTCCCTGCCGCTGATCGACGGCACCGTCGACGAGGCCCTGGAGATCGCCTCCATCCGGGCGGCTCTGCATGCCATCGAGTCAGGTGACGTGGACGAGGCGCACTTCACCACTGTGGGCGATCACTGGGACATCGAGGAACGCACCACGATCGTCCTGGACCGTCTGGGTCTCGGCGACGTGTCCCTTGACCGCCCGCTTCGCTCCCTCAGCGGCGGCCAGGTCCTCGCCATCGGCCTGGCCGCGCAGCTCCTGAAGCGACCCGACGTGCTGATCCTCGACGAACCCACCAACAACCTTGACCTGGCCGCCCGGCAGCGGCTCTACCAGGTCGTCGAAGAGTGGAAGGGGGCCCTCCTCGTCGTCAGCCACGACCGGGAGCTCCTGGACCGCGTAGACACCATCGCCGAGCTGCAGGCATCCGAACTCCGCCTCTACGGTGGCAACTTCACCGCCTACACGGAAGCCGTCGAGCTGGAACAGGAGAACGTGCAGCGCGCGGTGCGCGGGGCGGAGCAGGAGTTGCGCCGCCACAAGCGCGAGGCGCAGGCGGCCCAGGAGCGGGCCCAGCGCCGGGCCAGCAACGCCAAGCGCAACAAGGCTTCGTCGGGGGTGCCCCGTATCCACGCGGGCGCCCTTCAGCGACAGGCTCAGGAATCGGCGGGCCGCGCCGCCTCGGTGCACCAGGACCGGGTGTCCCAGGCCAAGGCCAAGCTGGACGAGGCCAGTCAGGGGATGCGTGAGGAAGCGCGCCTGGCGATCACCCTTCCGCAGACCTCGGTCCCGGCCGGACGCACCGTGTTGACGTGCCATGAGGCCAATGTCCGGTACGGGGAACGGACGTTGTTCACCGGCTCGGGCGTCGACCTCGGGATCCGCGGGCCGGAGCGGATCGCGCTGCTCGGGCCCAACGGCTCGGGCAAGTCAACGCTGTTGAAGCTGATCGCCGGCGAGCTCGAACCCTCCTCGGGGACGGTCACGGCGCCGACGGACCGGGTGTCCTATCTCTCGCAGCGCCTCGATCTGCTCGACTTGGACGCCAGCGTCCTGGACAACCTGCGCCGTTTCGCCCCGCATCTGCAGGACGGCGAAGTCCGCTACCGCCTGGCGCAGTTCCTCTTCCGCGGCGACCGAGTTCATCGCACCGCCGGATGGCTCTCCGGCGGTGAGCGGCTGCGCGCGACCCTGGCGTGTGTCCTGTCCACGGACCCTGCCCCTCAGCTGCTCCTGCTGGACGAGCCGACGAACAACCTCGACCTCAACAGTGCCGCCCAGCTGGAGAACGCGCTCAACGCCTTCCAGGGCGCCTTCGTAGTCGTCAGCCACGACCAGGCGTTCCTGCGCGCCATCGGTGTCTCGCGCTGGCTGCGCCTGGCGGACGGAACCCTGGAGGAGATCGCGGAGGCGGACGACGCGTGGCCTCATCGGGATAAGTGA", "partial": "0", "query_start": 100237, "query_end": 100365, "hit_start": 417, "hit_end": 558, "orf_dna_sequence": "ATGGACGAGTCCTGTGTTTTTTGTCGTATTGTTGCTGGGATGACACCTTCTCATCAGGTGTTTGAAGATGATGATGTGATCGCGTTCATGGATCATCGGCCTTTGAATCCAGGGCATGTACTTGTGATTCCGAAAGGGCATGAACCCGATCTACACTGTTTGGATGAGCCCACGTATCTCGCGGTCATGAAGGTAGGTAAACATTTGGCAGAAGTCTTGGCCGAGCTGTTTGAGCCGCCTAAAGTCGGTCTTTTTGTCATTGGCTTTCACGTGCCACATGTGCACGTGCACGTCGTGCCACTCTATACCATCGACGATTTCACGGCTGATGCCATCAAGTTGGCCATGCGTAGGAAGCCGGATACGGAGGCGCTGGCGGAGATCTGTCAGCGTATCCGTGAGCATTTGTCAACGGCTTGCTAG", "orf_prot_sequence": "MDESCVFCRIVAGMTPSHQVFEDDDVIAFMDHRPLNPGHVLVIPKGHEPDLHCLDEPTYLAVMKVGKHLAEVLAELFEPPKVGLFVIGFHVPHVHVHVVPLYTIDDFTADAIKLAMRRKPDTEALAEICQRIREHLSTAC", "perc_identity": 34.04}}, "BGC0001186.1|Misakinolide_22 # 100560 # 101270 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.547": {"gnl|BL_ORD_ID|915|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 100560, "orf_end": 101270, "orf_from": "BGC0001186.1|Misakinolide_22 ", "model_name": "ErmG", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "989", "ARO_accession": "3000522", "ARO_name": "ErmG", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35946": {"category_aro_accession": "0000027", "category_aro_cvterm_id": "35946", "category_aro_name": "roxithromycin", "category_aro_description": "Roxithromycin is a semi-synthetic, 14-carbon ring macrolide antibiotic derived from erythromycin. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35974": {"category_aro_accession": "0000057", "category_aro_cvterm_id": "35974", "category_aro_name": "telithromycin", "category_aro_description": "Telithromycin is a semi-synthetic derivative of erythromycin. It is a 14-membered macrolide and is the first ketolide antibiotic to be used in clinics. Telithromycin binds the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35982": {"category_aro_accession": "0000065", "category_aro_cvterm_id": "35982", "category_aro_name": "clarithromycin", "category_aro_description": "Clarithromycin is a methyl derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome and is used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), and skin structure infections.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "36315": {"category_aro_accession": "3000176", "category_aro_cvterm_id": "36315", "category_aro_name": "dirithromycin", "category_aro_description": "Dirithromycin is an oxazine derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome to inhibit bacterial protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36722": {"category_aro_accession": "3000583", "category_aro_cvterm_id": "36722", "category_aro_name": "pristinamycin IA", "category_aro_description": "Pristinamycin IA is a type B streptogramin antibiotic produced by Streptomyces pristinaespiralis. It binds to the P site of the 50S subunit of the bacterial ribosome, preventing the extension of protein chains.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37016": {"category_aro_accession": "3000672", "category_aro_cvterm_id": "37016", "category_aro_name": "madumycin II", "category_aro_description": "Madumycin II is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37017": {"category_aro_accession": "3000673", "category_aro_cvterm_id": "37017", "category_aro_name": "griseoviridin", "category_aro_description": "Griseoviridin is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "37019": {"category_aro_accession": "3000675", "category_aro_cvterm_id": "37019", "category_aro_name": "pristinamycin IB", "category_aro_description": "Pristinamycin IB is a class B streptogramin similar to pristinamycin IA, the former containing a N-methyl-4-(methylamino)phenylalanine instead of a N-methyl-4-(dimethylamino)phenylalanine in its class A streptogramin counterpart (one less methyl group).", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37022": {"category_aro_accession": "3000678", "category_aro_cvterm_id": "37022", "category_aro_name": "pristinamycin IC", "category_aro_description": "Pristinamycin IC is a class B streptogramin derived from virginiamycin S1.", "category_aro_class_name": "Antibiotic"}, "37023": {"category_aro_accession": "3000679", "category_aro_cvterm_id": "37023", "category_aro_name": "vernamycin C", "category_aro_description": "Vernamycin C is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37024": {"category_aro_accession": "3000680", "category_aro_cvterm_id": "37024", "category_aro_name": "patricin A", "category_aro_description": "Patricin A is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37025": {"category_aro_accession": "3000681", "category_aro_cvterm_id": "37025", "category_aro_name": "patricin B", "category_aro_description": "Patricin B is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37026": {"category_aro_accession": "3000682", "category_aro_cvterm_id": "37026", "category_aro_name": "ostreogrycin B3", "category_aro_description": "Ostreogrycin B3 is a derivative of pristinamycin IA, with an additional 3-hydroxy group on its 4-oxopipecolic acid.", "category_aro_class_name": "Antibiotic"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00686795, "max_identities": 15, "bit_score": 33.8834, "cvterm_id": "39568", "query": "SVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDVFALT", "match": "++ +IG G       LV           +TA++ +  +CEV R +   YP   +   D+   T", "sequence_from_db": "NIFEIGAGKGHFTAELVKRCNF------VTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFT", "sequence_from_broadstreet": "MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSATISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSTLIVLKRKPAKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYKIFNG", "dna_sequence_from_broadstreet": "ATGAACAAAGTAAATATAAAAGATAGTCAAAATTTTATTACTTCAAAATATCACATAGAAAAAATAATGAATTGCATAAGTTTAGATGAAAAAGATAACATCTTTGAAATAGGTGCAGGGAAAGGTCATTTTACTGCTGAATTGGTAAAGAGATGTAATTTTGTTACGGCGATAGAAATTGATTCTAAATTATGTGAGGTAACTCGTAATAAGCTCTTAAATTATCCTAACTATCAAATAGTAAATGATGATATACTGAAATTTACATTTCCTAGCCACAATCCATATAAAATATTTGGCAGCATACCTTACAACATAAGCACAAATATAATTCGAAAAATTGTTTTTGAAAGTTCAGCCACAATAAGTTATTTAATAGTGGAATATGGTTTTGCTAAAATGTTATTAGATACAAACAGATCACTAGCATTGCTGTTAATGGCAGAGGTAGATATTTCTATATTAGCAAAAATTCCTAGGTATTATTTCCATCCAAAACCTAAAGTGGATAGCACATTAATTGTATTAAAAAGAAAGCCAGCAAAAATGGCATTTAAAGAGAGAAAAAAATATGAAACTTTTGTAATGAAATGGGTTAACAAAGAGTACGAAAAACTGTTTACAAAAAATCAATTTAATAAAGCTTTAAAACATGCGAGAATATATGATATAAACAATATTAGTTTCGAACAATTTGTATCGCTATTTAATAGTTATAAAATATTTAACGGCTAA", "partial": "0", "query_start": 100740, "query_end": 100928, "hit_start": 96, "hit_end": 267, "orf_dna_sequence": "ATGGTCGACTTCCGGCAGCGCAGTACAGCACCTGAGCATATGGATCACGCTACAATCGACGGCCATGAAGTGGTGGCGGCACTCAACGAGATCGAGTATGTTAACCGTTTTCTCGGTGGCATTAACGCTTCGCGAGAAGCGCTTTCCCGCTTGCTATCGAGCGGAAACTGGCCGTCTCTAAGCGTTCTCGATATCGGTACGGGCTCAGCCGATATTCCCATGGCTCTGGTGCACTGGGCTCGCCGCCAACAGATCGCCATCAACATCACGGCGGTGGATTTTAATCCCGCCATCTGTGAGGTCGCGCGACAGCGCACGACGACATATCCGGAAATAACGGTCCAGAAATCGGATGTGTTTGCCCTCACGGACTCGACAACGTTTGACGTGGTACATTGCGCCATGTTCCTCCACCACTTCCCACAATCGCAAGCCGCTGACATTTTACGGATCATGTACCGCCTCTGCCGACACGGCATCATCGTCAATGACTTGCACCGCCACCCCTTCGCCTATTACAGCATAACCTATCTGAGTCGCCTGTTATCACTCAGCCCCATGTTTCAACACGATGGCCCGATCAGTGTGTTGCGCGGTTTTCAGCGGCCCGATCTGGAAGCCTTGATCAAGATGGGTGGACTCGCGAATGCAGAGATCACTTGGCGATGGCCATTTCGCTATGTGATGACAGCTTGGAAATTGCTCGCCTAG", "orf_prot_sequence": "MVDFRQRSTAPEHMDHATIDGHEVVAALNEIEYVNRFLGGINASREALSRLLSSGNWPSLSVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDVFALTDSTTFDVVHCAMFLHHFPQSQAADILRIMYRLCRHGIIVNDLHRHPFAYYSITYLSRLLSLSPMFQHDGPISVLRGFQRPDLEALIKMGGLANAEITWRWPFRYVMTAWKLLA", "perc_identity": 23.81}, "gnl|BL_ORD_ID|912|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 100560, "orf_end": 101270, "orf_from": "BGC0001186.1|Misakinolide_22 ", "model_name": "ErmA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "985", "ARO_accession": "3000347", "ARO_name": "ErmA", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35946": {"category_aro_accession": "0000027", "category_aro_cvterm_id": "35946", "category_aro_name": "roxithromycin", "category_aro_description": "Roxithromycin is a semi-synthetic, 14-carbon ring macrolide antibiotic derived from erythromycin. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35974": {"category_aro_accession": "0000057", "category_aro_cvterm_id": "35974", "category_aro_name": "telithromycin", "category_aro_description": "Telithromycin is a semi-synthetic derivative of erythromycin. It is a 14-membered macrolide and is the first ketolide antibiotic to be used in clinics. Telithromycin binds the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35982": {"category_aro_accession": "0000065", "category_aro_cvterm_id": "35982", "category_aro_name": "clarithromycin", "category_aro_description": "Clarithromycin is a methyl derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome and is used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), and skin structure infections.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "36315": {"category_aro_accession": "3000176", "category_aro_cvterm_id": "36315", "category_aro_name": "dirithromycin", "category_aro_description": "Dirithromycin is an oxazine derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome to inhibit bacterial protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36722": {"category_aro_accession": "3000583", "category_aro_cvterm_id": "36722", "category_aro_name": "pristinamycin IA", "category_aro_description": "Pristinamycin IA is a type B streptogramin antibiotic produced by Streptomyces pristinaespiralis. It binds to the P site of the 50S subunit of the bacterial ribosome, preventing the extension of protein chains.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37016": {"category_aro_accession": "3000672", "category_aro_cvterm_id": "37016", "category_aro_name": "madumycin II", "category_aro_description": "Madumycin II is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37017": {"category_aro_accession": "3000673", "category_aro_cvterm_id": "37017", "category_aro_name": "griseoviridin", "category_aro_description": "Griseoviridin is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "37019": {"category_aro_accession": "3000675", "category_aro_cvterm_id": "37019", "category_aro_name": "pristinamycin IB", "category_aro_description": "Pristinamycin IB is a class B streptogramin similar to pristinamycin IA, the former containing a N-methyl-4-(methylamino)phenylalanine instead of a N-methyl-4-(dimethylamino)phenylalanine in its class A streptogramin counterpart (one less methyl group).", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37022": {"category_aro_accession": "3000678", "category_aro_cvterm_id": "37022", "category_aro_name": "pristinamycin IC", "category_aro_description": "Pristinamycin IC is a class B streptogramin derived from virginiamycin S1.", "category_aro_class_name": "Antibiotic"}, "37023": {"category_aro_accession": "3000679", "category_aro_cvterm_id": "37023", "category_aro_name": "vernamycin C", "category_aro_description": "Vernamycin C is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37024": {"category_aro_accession": "3000680", "category_aro_cvterm_id": "37024", "category_aro_name": "patricin A", "category_aro_description": "Patricin A is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37025": {"category_aro_accession": "3000681", "category_aro_cvterm_id": "37025", "category_aro_name": "patricin B", "category_aro_description": "Patricin B is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37026": {"category_aro_accession": "3000682", "category_aro_cvterm_id": "37026", "category_aro_name": "ostreogrycin B3", "category_aro_description": "Ostreogrycin B3 is a derivative of pristinamycin IA, with an additional 3-hydroxy group on its 4-oxopipecolic acid.", "category_aro_class_name": "Antibiotic"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0139276, "max_identities": 17, "bit_score": 33.113, "cvterm_id": "35508", "query": "ASREALSRLLSSGNWPSL-SVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDVFALT", "match": " S++ +  +L+  N     +V++IG+G       LV  +R      ++TA++ +  +C+V ++       I V ++D+   +", "sequence_from_db": "TSKKHVKEILNHTNISKQDNVIEIGSGKGHFTKELVKMSR------SVTAIEIDGGLCQVTKEAVNPSENIKVIQTDILKFS", "sequence_from_broadstreet": "MNQKNPKDTQNFITSKKHVKEILNHTNISKQDNVIEIGSGKGHFTKELVKMSRSVTAIEIDGGLCQVTKEAVNPSENIKVIQTDILKFSFPKHINYKIYGNIPYNISTDIVKRITFESQAKYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQPLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYKLFH", "dna_sequence_from_broadstreet": "ATGAACCAGAAAAACCCTAAAGACACGCAAAATTTTATTACTTCTAAAAAGCATGTAAAAGAAATATTGAATCACACGAATATCAGTAAACAAGACAACGTAATAGAAATCGGATCAGGAAAAGGACATTTTACCAAAGAGCTAGTCAAAATGAGTCGATCAGTTACTGCTATAGAAATTGATGGAGGCTTATGTCAAGTGACTAAAGAAGCGGTAAACCCCTCTGAGAATATAAAAGTGATTCAAACGGATATTCTAAAATTTTCCTTCCCAAAACATATAAACTATAAGATATATGGTAATATTCCTTATAACATCAGTACGGATATTGTCAAAAGAATTACCTTTGAAAGTCAGGCTAAATATAGCTATCTTATCGTTGAGAAGGGATTTGCGAAAAGATTGCAAAATCTGCAACGAGCTTTGGGTTTACTATTAATGGTGGAGATGGATATAAAAATGCTCAAAAAAGTACCACCACTATATTTTCATCCTAAGCCAAGTGTAGACTCTGTATTGATTGTTCTTGAACGACATCAACCATTGATTTCAAAGAAGGACTACAAAAAGTATCGATCTTTTGTTTATAAGTGGGTAAACCGTGAATATCGTGTTCTTTTCACTAAAAACCAATTCCGACAGGCTTTGAAGCATGCAAATGTCACTAATATTAATAAACTATCGAAGGAACAATTTCTTTCTATTTTCAATAGTTACAAATTGTTTCACTAA", "partial": "0", "query_start": 100686, "query_end": 100928, "hit_start": 39, "hit_end": 267, "orf_dna_sequence": "ATGGTCGACTTCCGGCAGCGCAGTACAGCACCTGAGCATATGGATCACGCTACAATCGACGGCCATGAAGTGGTGGCGGCACTCAACGAGATCGAGTATGTTAACCGTTTTCTCGGTGGCATTAACGCTTCGCGAGAAGCGCTTTCCCGCTTGCTATCGAGCGGAAACTGGCCGTCTCTAAGCGTTCTCGATATCGGTACGGGCTCAGCCGATATTCCCATGGCTCTGGTGCACTGGGCTCGCCGCCAACAGATCGCCATCAACATCACGGCGGTGGATTTTAATCCCGCCATCTGTGAGGTCGCGCGACAGCGCACGACGACATATCCGGAAATAACGGTCCAGAAATCGGATGTGTTTGCCCTCACGGACTCGACAACGTTTGACGTGGTACATTGCGCCATGTTCCTCCACCACTTCCCACAATCGCAAGCCGCTGACATTTTACGGATCATGTACCGCCTCTGCCGACACGGCATCATCGTCAATGACTTGCACCGCCACCCCTTCGCCTATTACAGCATAACCTATCTGAGTCGCCTGTTATCACTCAGCCCCATGTTTCAACACGATGGCCCGATCAGTGTGTTGCGCGGTTTTCAGCGGCCCGATCTGGAAGCCTTGATCAAGATGGGTGGACTCGCGAATGCAGAGATCACTTGGCGATGGCCATTTCGCTATGTGATGACAGCTTGGAAATTGCTCGCCTAG", "orf_prot_sequence": "MVDFRQRSTAPEHMDHATIDGHEVVAALNEIEYVNRFLGGINASREALSRLLSSGNWPSLSVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDVFALTDSTTFDVVHCAMFLHHFPQSQAADILRIMYRLCRHGIIVNDLHRHPFAYYSITYLSRLLSLSPMFQHDGPISVLRGFQRPDLEALIKMGGLANAEITWRWPFRYVMTAWKLLA", "perc_identity": 20.73}, "gnl|BL_ORD_ID|1170|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 100560, "orf_end": 101270, "orf_from": "BGC0001186.1|Misakinolide_22 ", "model_name": "ErmT", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1275", "ARO_accession": "3000595", "ARO_name": "ErmT", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35946": {"category_aro_accession": "0000027", "category_aro_cvterm_id": "35946", "category_aro_name": "roxithromycin", "category_aro_description": "Roxithromycin is a semi-synthetic, 14-carbon ring macrolide antibiotic derived from erythromycin. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35974": {"category_aro_accession": "0000057", "category_aro_cvterm_id": "35974", "category_aro_name": "telithromycin", "category_aro_description": "Telithromycin is a semi-synthetic derivative of erythromycin. It is a 14-membered macrolide and is the first ketolide antibiotic to be used in clinics. Telithromycin binds the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35982": {"category_aro_accession": "0000065", "category_aro_cvterm_id": "35982", "category_aro_name": "clarithromycin", "category_aro_description": "Clarithromycin is a methyl derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome and is used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), and skin structure infections.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "36315": {"category_aro_accession": "3000176", "category_aro_cvterm_id": "36315", "category_aro_name": "dirithromycin", "category_aro_description": "Dirithromycin is an oxazine derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome to inhibit bacterial protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36722": {"category_aro_accession": "3000583", "category_aro_cvterm_id": "36722", "category_aro_name": "pristinamycin IA", "category_aro_description": "Pristinamycin IA is a type B streptogramin antibiotic produced by Streptomyces pristinaespiralis. It binds to the P site of the 50S subunit of the bacterial ribosome, preventing the extension of protein chains.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37016": {"category_aro_accession": "3000672", "category_aro_cvterm_id": "37016", "category_aro_name": "madumycin II", "category_aro_description": "Madumycin II is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37017": {"category_aro_accession": "3000673", "category_aro_cvterm_id": "37017", "category_aro_name": "griseoviridin", "category_aro_description": "Griseoviridin is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "37019": {"category_aro_accession": "3000675", "category_aro_cvterm_id": "37019", "category_aro_name": "pristinamycin IB", "category_aro_description": "Pristinamycin IB is a class B streptogramin similar to pristinamycin IA, the former containing a N-methyl-4-(methylamino)phenylalanine instead of a N-methyl-4-(dimethylamino)phenylalanine in its class A streptogramin counterpart (one less methyl group).", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37022": {"category_aro_accession": "3000678", "category_aro_cvterm_id": "37022", "category_aro_name": "pristinamycin IC", "category_aro_description": "Pristinamycin IC is a class B streptogramin derived from virginiamycin S1.", "category_aro_class_name": "Antibiotic"}, "37023": {"category_aro_accession": "3000679", "category_aro_cvterm_id": "37023", "category_aro_name": "vernamycin C", "category_aro_description": "Vernamycin C is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37024": {"category_aro_accession": "3000680", "category_aro_cvterm_id": "37024", "category_aro_name": "patricin A", "category_aro_description": "Patricin A is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37025": {"category_aro_accession": "3000681", "category_aro_cvterm_id": "37025", "category_aro_name": "patricin B", "category_aro_description": "Patricin B is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "37026": {"category_aro_accession": "3000682", "category_aro_cvterm_id": "37026", "category_aro_name": "ostreogrycin B3", "category_aro_description": "Ostreogrycin B3 is a derivative of pristinamycin IA, with an additional 3-hydroxy group on its 4-oxopipecolic acid.", "category_aro_class_name": "Antibiotic"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0238685, "max_identities": 18, "bit_score": 32.3426, "cvterm_id": "36841", "query": "SVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDV--FALTDSTTFDVVHCAMFLHHFPQSQAADILR", "match": "++++IG+G       L   A+R      +TA++ +P +C + + +   Y    V   D+  F    + ++ +        + P + + DI+R", "sequence_from_db": "NIIEIGSGKGHFSFEL---AKRCNY---VTAIEIDPKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKI------FGNIPYNISTDIIR", "sequence_from_broadstreet": "MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFSFELAKRCNYVTAIEIDPKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIFGNIPYNISTDIIRKIVFESTATESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHPSKISLKDRKQYENFVMKWVNKEYIKLFSKNQFYQALKYARIDDLNNISFEQFLSLFNSYKLFNR", "dna_sequence_from_broadstreet": "ATGAACAAAAAAAATATAAAAGATAGTCAAAACTTTATTACTTCAAAGCATCATATAAATGAAATTTTGAGAAATGTACATTTAAATACAAATGATAATATTATTGAGATTGGTTCAGGGAAAGGTCATTTCTCGTTTGAATTAGCTAAAAGGTGTAATTATGTAACCGCCATTGAAATAGATCCTAAATTATGTAGGATAACTAAAAACAAACTTATTGAATATGAGAACTTCCAGGTTATCAATAAAGATATTTTACAATTTAAGTTTCCTAAAAATAAGTCATATAAGATATTTGGAAATATACCCTACAATATAAGTACAGATATAATTCGAAAAATTGTTTTTGAAAGCACAGCTACAGAAAGTTATTTAATAGTGGAATATGGATTTGCTAAAAGGTTGCTAAATACAAATCGTTCACTAGCACTATTTTTAATGACAGAAGTTGATATATCCATATTAAGTAAAATCCCTAGAGAATACTTTCATCCAAAACCTAGAGTTAATAGCTCGTTAATTGTATTAAAAAGACACCCTTCAAAAATATCACTCAAAGATAGAAAACAATATGAAAATTTTGTTATGAAATGGGTTAACAAAGAATACATAAAACTATTTTCCAAAAACCAATTTTATCAAGCCTTAAAATATGCAAGAATTGACGATTTAAACAATATTAGCTTTGAACAATTCTTGTCTCTTTTCAATAGCTATAAATTATTTAATAGATAA", "partial": "0", "query_start": 100740, "query_end": 101009, "hit_start": 96, "hit_end": 336, "orf_dna_sequence": "ATGGTCGACTTCCGGCAGCGCAGTACAGCACCTGAGCATATGGATCACGCTACAATCGACGGCCATGAAGTGGTGGCGGCACTCAACGAGATCGAGTATGTTAACCGTTTTCTCGGTGGCATTAACGCTTCGCGAGAAGCGCTTTCCCGCTTGCTATCGAGCGGAAACTGGCCGTCTCTAAGCGTTCTCGATATCGGTACGGGCTCAGCCGATATTCCCATGGCTCTGGTGCACTGGGCTCGCCGCCAACAGATCGCCATCAACATCACGGCGGTGGATTTTAATCCCGCCATCTGTGAGGTCGCGCGACAGCGCACGACGACATATCCGGAAATAACGGTCCAGAAATCGGATGTGTTTGCCCTCACGGACTCGACAACGTTTGACGTGGTACATTGCGCCATGTTCCTCCACCACTTCCCACAATCGCAAGCCGCTGACATTTTACGGATCATGTACCGCCTCTGCCGACACGGCATCATCGTCAATGACTTGCACCGCCACCCCTTCGCCTATTACAGCATAACCTATCTGAGTCGCCTGTTATCACTCAGCCCCATGTTTCAACACGATGGCCCGATCAGTGTGTTGCGCGGTTTTCAGCGGCCCGATCTGGAAGCCTTGATCAAGATGGGTGGACTCGCGAATGCAGAGATCACTTGGCGATGGCCATTTCGCTATGTGATGACAGCTTGGAAATTGCTCGCCTAG", "orf_prot_sequence": "MVDFRQRSTAPEHMDHATIDGHEVVAALNEIEYVNRFLGGINASREALSRLLSSGNWPSLSVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDVFALTDSTTFDVVHCAMFLHHFPQSQAADILRIMYRLCRHGIIVNDLHRHPFAYYSITYLSRLLSLSPMFQHDGPISVLRGFQRPDLEALIKMGGLANAEITWRWPFRYVMTAWKLLA", "perc_identity": 19.57}, "gnl|BL_ORD_ID|2108|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 100560, "orf_end": 101270, "orf_from": "BGC0001186.1|Misakinolide_22 ", "model_name": "Erm(49)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3324", "ARO_accession": "3004626", "ARO_name": "Erm(49)", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.933748, "max_identities": 14, "bit_score": 27.7202, "cvterm_id": "42610", "query": "VLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDVFALT", "match": "V++IG G   I   L H AR+      + A++F+  + E  + +  +  ++ +   D+   T", "sequence_from_db": "VIEIGPGKGIITNELAHKARK------VVAIEFDEELYEKLKNKFQSNNKVDIIYGDILNYT", "sequence_from_broadstreet": "MRNIKDTQNFLHSKELVRHLIGICNIKLDDVVIEIGPGKGIITNELAHKARKVVAIEFDEELYEKLKNKFQSNNKVDIIYGDILNYTPRIPSYCVFSNIPFNITSEILNKFLSDKKNEKMFLIMQYEPFIKYAGNPYGAETLRSMLYKPFFDMDLKYRFDPSDFKPAPQARIVLASFERKQFPDVKKEEEKLYKDFLAYIYTNKGETFFAKIKTLFSSNQIKRVWGQIKIDKTTKISEVPYESILKVFKLFFLYGTDANKQLVVNSFNNMNKQNNKLQKNHRNNSKAKSWNSNRKRKPYHRNNV", "dna_sequence_from_broadstreet": "ATGAGAAATATTAAGGACACTCAAAATTTTTTACATAGCAAGGAGCTAGTTAGGCACTTAATAGGAATCTGTAATATAAAGTTGGACGATGTGGTTATAGAAATTGGTCCTGGAAAAGGAATAATTACTAACGAATTAGCTCATAAAGCAAGAAAGGTTGTTGCCATTGAATTTGATGAAGAACTATACGAAAAGCTAAAAAACAAATTTCAAAGCAACAATAAAGTTGACATAATTTATGGGGATATTTTAAACTATACTCCTAGAATTCCTAGTTATTGCGTTTTTTCAAACATTCCATTTAACATTACCTCTGAAATACTAAATAAGTTTTTGAGCGACAAAAAGAATGAGAAAATGTTTTTAATAATGCAATATGAGCCATTTATAAAATACGCAGGTAATCCATACGGAGCTGAAACATTAAGATCAATGCTTTATAAACCATTTTTTGATATGGATTTAAAATATAGATTCGATCCGTCTGATTTTAAGCCAGCACCACAAGCAAGAATCGTTTTGGCTTCCTTTGAAAGAAAGCAATTTCCTGATGTTAAAAAGGAAGAGGAAAAACTATATAAAGATTTTCTTGCATATATTTATACTAACAAGGGTGAAACATTCTTTGCAAAGATTAAAACATTGTTTTCAAGCAATCAAATTAAACGAGTTTGGGGTCAGATTAAGATAGACAAGACAACAAAAATAAGCGAAGTACCATATGAATCAATTTTAAAGGTTTTTAAGCTTTTTTTCTTGTACGGAACAGATGCTAATAAACAGTTAGTTGTAAATTCATTTAACAATATGAACAAGCAAAATAACAAGCTTCAAAAAAATCACAGAAACAATAGCAAGGCAAAAAGTTGGAATTCAAATCGTAAAAGAAAGCCTTATCATAGAAATAATGTATAA", "partial": "0", "query_start": 100743, "query_end": 100928, "hit_start": 93, "hit_end": 261, "orf_dna_sequence": "ATGGTCGACTTCCGGCAGCGCAGTACAGCACCTGAGCATATGGATCACGCTACAATCGACGGCCATGAAGTGGTGGCGGCACTCAACGAGATCGAGTATGTTAACCGTTTTCTCGGTGGCATTAACGCTTCGCGAGAAGCGCTTTCCCGCTTGCTATCGAGCGGAAACTGGCCGTCTCTAAGCGTTCTCGATATCGGTACGGGCTCAGCCGATATTCCCATGGCTCTGGTGCACTGGGCTCGCCGCCAACAGATCGCCATCAACATCACGGCGGTGGATTTTAATCCCGCCATCTGTGAGGTCGCGCGACAGCGCACGACGACATATCCGGAAATAACGGTCCAGAAATCGGATGTGTTTGCCCTCACGGACTCGACAACGTTTGACGTGGTACATTGCGCCATGTTCCTCCACCACTTCCCACAATCGCAAGCCGCTGACATTTTACGGATCATGTACCGCCTCTGCCGACACGGCATCATCGTCAATGACTTGCACCGCCACCCCTTCGCCTATTACAGCATAACCTATCTGAGTCGCCTGTTATCACTCAGCCCCATGTTTCAACACGATGGCCCGATCAGTGTGTTGCGCGGTTTTCAGCGGCCCGATCTGGAAGCCTTGATCAAGATGGGTGGACTCGCGAATGCAGAGATCACTTGGCGATGGCCATTTCGCTATGTGATGACAGCTTGGAAATTGCTCGCCTAG", "orf_prot_sequence": "MVDFRQRSTAPEHMDHATIDGHEVVAALNEIEYVNRFLGGINASREALSRLLSSGNWPSLSVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDVFALTDSTTFDVVHCAMFLHHFPQSQAADILRIMYRLCRHGIIVNDLHRHPFAYYSITYLSRLLSLSPMFQHDGPISVLRGFQRPDLEALIKMGGLANAEITWRWPFRYVMTAWKLLA", "perc_identity": 22.58}, "gnl|BL_ORD_ID|2588|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 100560, "orf_end": 101270, "orf_from": "BGC0001186.1|Misakinolide_22 ", "model_name": "OXA-664", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "2909", "ARO_accession": "3004479", "ARO_name": "OXA-664", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.55617, "max_identities": 22, "bit_score": 25.409, "cvterm_id": "41739", "query": "LHHFPQSQAADILRIMY---RLCRHGIIVNDLHRHPFAYYSITYLSRLLSLSPMFQH----------DGPISVLRGFQR", "match": "L+H  Q+  + ++ + Y   +L R G   NDLHR   AY   +    L +L  + QH          DG    L+ ++R", "sequence_from_db": "LNHMFQAVDSAVVFVTYDGEKLQRFG---NDLHRAETAYIPASTFKILNALIGLQQHKTTTTEVFVWDGKARALKSWER", "sequence_from_broadstreet": "MWMLKTISCSVLSWMLLSACSQQTLKDQMQQPLMMQQPRLAELNHMFQAVDSAVVFVTYDGEKLQRFGNDLHRAETAYIPASTFKILNALIGLQQHKTTTTEVFVWDGKARALKSWERDMTLAEAMQVSAVPVYQTLARRIGLPLMQKELHRVDYGNAQIGTQVDRFWLDGPLKITPQQEAEFAYRLATQTLPFDIHVQQEVKEMLYVERRGVAKLYAKSGWGADVKPQVG", "dna_sequence_from_broadstreet": "ATGTGGATGTTAAAAACGATATCTTGTTCAGTTTTAAGCTGGATGTTGTTAAGTGCATGCAGTCAGCAAACTCTGAAAGATCAAATGCAACAGCCATTGATGATGCAACAACCACGGTTAGCAGAGTTGAATCATATGTTTCAAGCAGTGGATAGCGCCGTGGTCTTTGTGACTTATGATGGGGAAAAATTACAGCGTTTTGGCAATGATTTGCATCGTGCCGAAACTGCCTATATACCAGCTTCAACTTTTAAAATACTAAATGCTTTAATTGGTTTGCAGCAGCATAAAACCACGACCACTGAAGTATTTGTATGGGATGGAAAAGCACGTGCATTGAAAAGTTGGGAACGGGATATGACTTTGGCAGAGGCGATGCAAGTCTCGGCAGTTCCCGTCTATCAAACCTTAGCGCGACGAATTGGTCTACCACTGATGCAAAAAGAGCTTCATCGTGTCGATTATGGAAATGCTCAGATTGGGACACAGGTTGATCGGTTTTGGTTAGATGGACCCTTAAAAATCACACCACAACAAGAAGCTGAATTTGCTTACAGACTTGCGACTCAGACTTTACCTTTTGATATACATGTGCAACAAGAGGTAAAGGAAATGCTTTATGTGGAGCGACGCGGTGTTGCTAAATTGTATGCTAAGTCAGGATGGGGAGCCGATGTAAAACCTCAGGTGGGTTAG", "partial": "0", "query_start": 100968, "query_end": 101165, "hit_start": 126, "hit_end": 354, "orf_dna_sequence": "ATGGTCGACTTCCGGCAGCGCAGTACAGCACCTGAGCATATGGATCACGCTACAATCGACGGCCATGAAGTGGTGGCGGCACTCAACGAGATCGAGTATGTTAACCGTTTTCTCGGTGGCATTAACGCTTCGCGAGAAGCGCTTTCCCGCTTGCTATCGAGCGGAAACTGGCCGTCTCTAAGCGTTCTCGATATCGGTACGGGCTCAGCCGATATTCCCATGGCTCTGGTGCACTGGGCTCGCCGCCAACAGATCGCCATCAACATCACGGCGGTGGATTTTAATCCCGCCATCTGTGAGGTCGCGCGACAGCGCACGACGACATATCCGGAAATAACGGTCCAGAAATCGGATGTGTTTGCCCTCACGGACTCGACAACGTTTGACGTGGTACATTGCGCCATGTTCCTCCACCACTTCCCACAATCGCAAGCCGCTGACATTTTACGGATCATGTACCGCCTCTGCCGACACGGCATCATCGTCAATGACTTGCACCGCCACCCCTTCGCCTATTACAGCATAACCTATCTGAGTCGCCTGTTATCACTCAGCCCCATGTTTCAACACGATGGCCCGATCAGTGTGTTGCGCGGTTTTCAGCGGCCCGATCTGGAAGCCTTGATCAAGATGGGTGGACTCGCGAATGCAGAGATCACTTGGCGATGGCCATTTCGCTATGTGATGACAGCTTGGAAATTGCTCGCCTAG", "orf_prot_sequence": "MVDFRQRSTAPEHMDHATIDGHEVVAALNEIEYVNRFLGGINASREALSRLLSSGNWPSLSVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPAICEVARQRTTTYPEITVQKSDVFALTDSTTFDVVHCAMFLHHFPQSQAADILRIMYRLCRHGIIVNDLHRHPFAYYSITYLSRLLSLSPMFQHDGPISVLRGFQRPDLEALIKMGGLANAEITWRWPFRYVMTAWKLLA", "perc_identity": 27.85}}, "BGC0001186.1|Misakinolide_23 # 101272 # 102378 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.607": {"gnl|BL_ORD_ID|412|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 101272, "orf_end": 102378, "orf_from": "BGC0001186.1|Misakinolide_23 ", "model_name": "adeR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "480", "model_id": "456", "ARO_accession": "3000553", "ARO_name": "adeR", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.828734, "max_identities": 12, "bit_score": 28.4906, "cvterm_id": "35507", "query": "PPAIARHVKFLYRRSQIDSRHTCSQALYNAIELDT", "match": "P  +   V+ + RR+Q  ++ T    LY  IE+DT", "sequence_from_db": "PNEVVARVQAVLRRTQFANKATNKNKLYKNIEIDT", "sequence_from_broadstreet": "MFDHSFSFDCQDKVILVVEDDYDIGDIIENYLKREGMSVIRAMNGKQAIELHASQPIDLILLDIKLPELNGWEVLNKIRQKAQTPVIMLTALDQDIDKVMALRIGADDFVVKPFNPNEVVARVQAVLRRTQFANKATNKNKLYKNIEIDTDTHSVYIHSENKKILLNLTLTEYKIISFMIDQPHKVFTRGELMNHCMNDSDALERTVDSHVSKLRKKLEEQGIFQMLINVRGVGYRLDNPLAVKDDA", "dna_sequence_from_broadstreet": "ATGTTTGATCATTCTTTTTCTTTTGATTGCCAAGATAAAGTTATTCTTGTGGTAGAAGATGACTACGATATTGGCGACATTATTGAAAATTATTTAAAACGTGAAGGCATGAGTGTTATTCGGGCCATGAATGGAAAGCAAGCGATTGAATTGCACGCTAGCCAACCCATCGATTTAATCTTACTTGATATTAAATTACCCGAATTAAACGGTTGGGAAGTATTAAATAAAATACGCCAAAAAGCTCAGACTCCCGTGATCATGTTGACGGCGCTAGATCAAGATATTGATAAAGTTATGGCATTACGCATAGGTGCAGATGACTTTGTGGTGAAGCCTTTTAACCCAAATGAAGTCGTCGCTAGAGTTCAGGCAGTCCTAAGACGTACTCAGTTTGCAAACAAAGCAACTAATAAAAATAAACTCTATAAAAATATTGAAATTGATACCGACACTCATAGCGTTTATATACACTCTGAGAATAAGAAGATCTTGCTTAATCTGACGCTGACTGAATATAAAATTATTTCATTCATGATTGATCAGCCTCATAAAGTTTTTACGCGCGGAGAGCTTATGAATCACTGCATGAATGATAGCGATGCACTAGAGCGAACCGTAGATAGCCATGTGAGTAAGCTGAGAAAAAAACTAGAAGAACAAGGCATATTTCAAATGTTAATTAATGTGCGTGGCGTGGGATATAGACTAGATAATCCCCTAGCTGTAAAAGATGATGCCTAA", "partial": "0", "query_start": 101377, "query_end": 101481, "hit_start": 345, "hit_end": 450, "orf_dna_sequence": "GTGCACCACGAAATCGAATCGACGGCGCTGTGGTCAATTGGCACTGCCGTGCCGACCTTCCAATTCAGCCAGCAAAAAGCCCTGACGTATGCCCTCTCCCGCATTCCACCAGCGATCGCACGGCACGTTAAATTCCTCTACCGACGCTCGCAAATCGACTCGCGCCACACCTGCAGTCAGGCGCTCTACAATGCCATTGAGTTGGATACCGGCGAGGCGGCTGGGGATGAGGCGAGTACCGCCGAACGGATGCAAGCGTACGAATCCCAAGCAGCCGACCTCGCAGCGAGGGCGGCGAAGCGAGCGCTCGCTCAAGCACCCCACTTCTCTGCTGCTGATATCACCCACCTGGTCATGGTCACCTGCACGGGCTTTGTGTCGCCCGGACCGGATGTGTTGCTCTTTGAGCAACTCGGCTTGCGGTCGGATGTGAGACGTGTACAAGTGGGCTTCATGGGGTGCCATGGGGCGATGAACGGCCTACACACCGCTGCGGCGATCTGCCGCAGTGAGCCCCAAGCCGTGGTGGTGGTAGCCAGCCTCGAGCTCTGTACCCTCCACTTTCAGAGCACACTGACGGAAGAAAACTTGGTGATTACCAGCTTGTTCAGCGATGGGGCTGCCGCTGCGTTGCTCAGCGGCAAGGCCTTTACAGATGGTCAGCCGCGATGCTATCTCGATGCCTTCGGCTCGCGGGTCTACCCCGAGGCCCGCGACGCCATTGCCTGGCGGGTGGGCAACCAAGGGTTTGATATGGGATTAGCCCTGTCGAATGCCCACGATCTACGCCCGTTGATCCCGGATTTTGTCGGCGACTGGCTCTCGTCGTACGAGCTGCATCAAGACGACATCGATCTCTGGGCCATTCATCCCGGTGGCCGAGCCGTACTCGACACGTGCGAGTGGGCCCTGGGGTTTGCCCCTGATGCACTGGCCAGCTCCCGGTGGGTGCTGCGTCACTATGGCAATATGTCATCGCCAACGATCTTGTTTGTCATGGATCACCTGCTAGCAAAGACCAAGGCGAATCGAGTCCGTCGCGGTCTGTCGCTCGGCTTTGGGCCCGGCGTGACCTTAGAGGGTATCCTGTGGCACGAAGGCGATTGA", "orf_prot_sequence": "MHHEIESTALWSIGTAVPTFQFSQQKALTYALSRIPPAIARHVKFLYRRSQIDSRHTCSQALYNAIELDTGEAAGDEASTAERMQAYESQAADLAARAAKRALAQAPHFSAADITHLVMVTCTGFVSPGPDVLLFEQLGLRSDVRRVQVGFMGCHGAMNGLHTAAAICRSEPQAVVVVASLELCTLHFQSTLTEENLVITSLFSDGAAAALLSGKAFTDGQPRCYLDAFGSRVYPEARDAIAWRVGNQGFDMGLALSNAHDLRPLIPDFVGDWLSSYELHQDDIDLWAIHPGGRAVLDTCEWALGFAPDALASSRWVLRHYGNMSSPTILFVMDHLLAKTKANRVRRGLSLGFGPGVTLEGILWHEGD", "perc_identity": 34.29}}}